Unnamed: 0,Entry,Entry Name,EC number,Protein names,Sequence,Protein families,Function [CC],Function Class
1,A0A0B4U9L8,VMF1_VIPAA,3.4.24.-,Zinc metalloproteinase-disintegrin-like protein F1 (EC 3.4.24.-) (Fibrinogenase 1) (Metalloproteinase F1) (P-IIIa metalloproteinase F1) (Snake venom metalloproteinase) (SVMP) (VaF1),MLQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKLTALLKGAIQQPEQKYEDAMQYEFKVNGKPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGHIQNDAHLTASISACNGLKGHFQLRGETYLIEPLKIPDSEAHAVYKYENVEKEDEGPKKCGVTQTNWKSDEPIKASQFILTPEQRAYMNANKYIKLAIVVDNVMFRKYTGNFTAIRTRIYEIVNTLNLIYTILNIHIALVFLEIWSKGDSINVQSVVDVTLNSFGEWRERDLLNRKRHDNAQLLTGINFNGDTIGFGFVGSMCIPKKSVGIVQDHSKTHLLVATTMAHELGHNLGINHDGDSCTCQANSCIMAAKLSHQPSYQFSDCSINELWMYLISHTPRCILNEPLTTDVVSPAVCGNYVVEEGEECDCGSLWYCRNPCCDAATCKLKPGAECGDGVCCYQCRFVTAGTVCRPARSECDIPEYCSGQSVECPMDHIQKNGKPCLMNHGYCYNGRCPIMIHQCIALWGPGTTVSSDVCFQRNESGQGYSYCRRENNQNIPCAPQDVKCGRLYCKFHNVNTLPCNFKYSDFAPDYGLVDHGTKCGDGKVCNSNRQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Zinc metalloprotease that has fibrinogenolytic activity. Does not have hemorrhagic activity in rats. Cleaves insulin B chain at '38-Ala-|-Leu-39' and '40-Tyr-|-Leu-41' bonds. Hydrolyzes only partially and weakly isolated extracellular matrix (ECM) bovine fibronectin and basal membrane (BM) protein human collagen IV in vitro. Murine laminin is not hydrolyzed, neither isolated nor in a solubilized BM preparation. Nidogen is hydrolyzed at '350-Ser-|-Phe-351' bond in a solubilized BM preparation. Hydrolyzes plasma proteins involved in blood coagulation in vitro. Has alpha-fibrinogenase activity cleaving human fibrinogen alpha chain at '432-Lys-|-Leu-433' bond, but does not cleave beta or gamma chains. Does not cleave fibrin. Hydrolyzes only partially bovine prothrombin at '200-Ser-|-Gly-201' bond, factor X (FX) heavy chain, and very slowly, FX light chain and plasminogen in vitro, without activating any of them. Has no effect in plasma thrombin generation. Does not inhibit platelet aggregation induced by collagen in vitro. May have a delayed pathological action as an anticoagulant in envenomed patients after they received serotherapy as it is not recognized by the venom antiserum. {ECO:0000269|PubMed:25549999}.",Metalloprotease
2,A0A0S4FKT4,VSP1_CRODO,3.4.21.-,Thrombin-like enzyme collinein-1 (SVTLE collinein-1) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNINEHNFLVALYEYWSQSFLCGGTLINGEWVLTAAHCDRKHILIYVGVHDRSVQFDKEQRRFPKEKYFFNCRNNFTKWDKDIMLIRLNKPVSYSEHIAPLSLPSSPPIVGSVCRVMGWGTIKSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATIRILCAGVLEGGIDTCHRDSGGPLICNGEFQGIVSWGDGSCAQPDKPALYSKVFDHLDWIQNIIAGSETVNCPS,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease (PubMed:26227411, PubMed:31131001, PubMed:34506860). Releases fibrinopeptide A and B in the conversion of fibrinogen to fibrin, with preferential activity on the alpha chain of fibrinogen (PubMed:26227411, PubMed:34506860). Also hydrolyzes N-p-toluensulfonyl arginine ester (TAME) and chromogenic artificial substrates of the blood coagulation cascade: S-2222 for factor Xa, S-2302 for kallikrein and S-2238 for thrombin (PubMed:26227411). When tested in vitro, the recombinant protein does not degrade blood clots, suggesting that this toxin lacks fibrinolytic activity (PubMed:31131001). In addition, it moderately inhibits human Kv10.1/KCNH1/EAG1 currents, with a mechanism independent of its enzymatic activity. It selectively blocks Kv10.1/KCNH1/EAG1 in a time and dose-dependent manner (IC(50)=4.2 uM for native protein and IC(50)=2.5 uM for recombinant protein). It may have a preference in interacting with Kv10.1/KCNH1/EAG1 in its closed state, since the inhibitory effect of the toxin is decreased at more depolarized potentials. Corroboratively, it may have possible antitumor applications, since it reduces the viability of human breast cancer cell line MCF-7, which strongly expresses Kv10.1/KCNH1/EAG1, but does not affect the liver carcinoma and the non-tumorigenic epithelial breast cell lines, which weakly express Kv10.1/KCNH1/EAG1 (PubMed:32161292). When tested on peripheral blood mononuclear cells (PBMC), the native protein shows mild cytotoxicity, whereas the recombinant protein does not show any cytotoxicity (PubMed:34506860). Native form is not immununogenic, since it does not induce statistically significant antibody production in mice, whereas recombinant form shows an antibody titer slightly higher than the native form (PubMed:34506860). In vivo, subplantar injection in mice paw induces a discreet paw edema (PubMed:31131001). In addition, intraperitoneal injection of the recombinant protein into mice led to fibrinogen depletion, resulting in the blood incoagulability (PubMed:31131001). {ECO:0000269|PubMed:26227411, ECO:0000269|PubMed:31131001, ECO:0000269|PubMed:32161292, ECO:0000269|PubMed:34506860}.",Serine Protease
3,A0A193CHJ5,PA2BC_CROTA,3.1.1.4,Phospholipase A2 crotoxin basic subunit CBc (CB1) (CTX subunit CBc) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRALWIVAVLLVGVEGHLLQFNKMIKFETRKNAIPFYAFYGCYCGWGGRGRPKDATDRCCFVHDCCYGKLAKCNTKWDIYPYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer CA-CB: Crotoxin is a potent presynaptic neurotoxin that possesses phospholipase A2 (PLA2) activity and exerts a lethal action by blocking neuromuscular transmission (By similarity). It consists of a non-covalent association of a basic and weakly toxic PLA2 subunit (CBa2, CBb, CBc, or CBd), with a small acidic, non-enzymatic and non-toxic subunit (CA1, CA2, CA3 or CA4) (By similarity). The complex acts by binding to a specific 48-kDa protein (R48) receptor located on presynaptic membranes, forming a transient ternary complex CA-CB-R48, followed by dissociation of the CA-CB complex and release of the CA subunit (By similarity). At equilibrium, only the CB subunits remain associated with the specific crotoxin receptor (By similarity). {ECO:0000250|UniProtKB:C0HM14}.; FUNCTION: Monomer CBc: The basic subunit of crotoxin is a snake venom phospholipase A2 (PLA2) that exhibits weak neurotoxicity (10-fold less than the heterodimer) and very strong anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (By similarity). In addition, it shows the same effects described for the heterodimer and binds the nucleotide-binding domain (NBD1) of CFTR chloride channels and increases the channel current (By similarity). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:35737043). {ECO:0000250|UniProtKB:P62022, ECO:0000269|PubMed:35737043}.",Phospholipase
4,A0A1Z0YU59,MAMB1_DENAN,,Mambaquaretin-1 (MQ-1) (MQ1) (Upsilon-Da2a),RPSFCNLPVKPGPCNGFFSAFYYSQKTNKCHSFTYGGCKGNANRFSTIEKCRRTCVG,Venom Kunitz-type family,"FUNCTION: Selectively interacts with vasopressin V2 receptor (V2R/AVPR2) and fully inhibits three major signaling pathways of this receptor that are GalphaS protein, the interaction with beta-arrestin and activation of MAP kinase (PubMed:28630289, PubMed:35122240). Inhibits vasopressin binding human V2R in the nanomolar range (Ki=5.02 nM), and also potently inhibits vasopressin-induced cAMP production (IC(50)=94 nM) (PubMed:35122240). In vivo, this protein shows an aquaretic effect (PubMed:28630289, PubMed:35122240). Urine output increases and urine osmolality decreases dramatically under treatment with this protein, without differences observed between healthy mice and the pcy mice model of the autosomal-dominant polycystic kidney disease (ADPKD) (PubMed:28630289). This protein does not modify electrolyte, protein and urea excretions in the urine samples, but produces a 3-fold decrease of creatinine levels (PubMed:28630289). Intraperitoneal injection of this protein into the pcy mice significantly reduces the number of renal cysts and the total area of cysts (PubMed:28630289). This protein also shows high efficacy in preventing hyponatremia in rat models (induced by DAVP) (PubMed:33052234). Is highly visible in mice liver and kidney after intravenous injection (PubMed:33052234). Is rapidly eliminated in the liver, whereas it exhibits slow elimination in the kidney due to the high expression of V2R which acts as a reservoir (PubMed:33052234). In addition, its elimination from blood is rapid (PubMed:33052234). Fluorescent MQ1 probes could also be used for imaging V2R-overexpressing cancer cells; note that these probes label the three renal cancer cell lines CAKI-2, ACHN and A498 that highly express V2R (PubMed:33052234). In vivo, does not show any toxicity on animals, even at highest doses tested, such as prostration, spidy coat, appetite or weight loss (PubMed:33052234). {ECO:0000269|PubMed:28630289, ECO:0000269|PubMed:33052234, ECO:0000269|PubMed:35122240}.",Vascular Interaction
5,A0A2D0TC04,PDE_NAJAT,3.6.1.-,Venom phosphodiesterase (PDE) (EC 3.6.1.-),LKQSKQPLESCRNRCNETFSEELSYCSCDNKCTERKACCWDYQDICVLPTQSWSCNKLRCGEKRMANVLCSCSEDCLTKKDCCTDYKSICKRETSWLKDQCASSSASQCPEGFDQSPLILFSMDGFRAEYLETWDTLMPNINKLKTCGTHAKYMRAVYPTKTFVNHYTIVTGLYAETHGIIDNNMYDVKLNQNFSLSGSNMRNAAWWGGQPIWHTASYQGLKAATYFWPGSEVKINGSYPTIYKVYNKSTPFEARVMEVLKWLDLPKAKRPDFSTLYIEEPDTTGHKFGPVSGQVIKSLQMADRTLGMLMEGLKQRNLHNCVNLILLADHGMEAISCNRLEYMTDYFNTVDFFMYEGAAPRIRSKNVPKDFYTFDSEAIVKKLTCRKPKQHFKAYLAKDLPKRLHFANNIRIDKVNLMVDRQWLAVRNKKYKYCSGGTHGYDNEFKSMEAIFLAHGPGFKEKTEVTSFENIEVYNLMCDLLKLKPAPNNGTHGSLNHLLKNPFYNPSPAKEQSPPLYCLFGPVPSPDVSGCKCSSITDLEAVNQRLNLIDQAKMQSEADNLPYGRPHVLQHSKYCLLHQTKYISAYSQDILMPLWNSYTISKSLVKPTSAPPSASDCLRLDVRIPTVQSQTCSNYQPDLAITPGFLYPPDFSSSGPEQYDALITSNIVPMYKEFARLWNYFHSTLLPKYATERNGLNVISGPIFDYNYDGHFDPYDTIDQYVNNTKIPIPTHYFVVLTSCENSTKTPLNCPPGSLKVLSFILPHRPDNSESCADKSPDNLWVEERMQTHTARVRDVELLTGLDFYSALKQPLSETLRLKTFLPIFINSVN,Nucleotide pyrophosphatase/phosphodiesterase family,"FUNCTION: Hydrolyzes ADP with high activity. Shows weak or no activity on 5'-AMP, 5'-GMP, 3'-AMP, ATP, cAMP, and cGMP. Is devoid of monophosphatase and proteinase activities. Dose-dependently inhibits platelet aggregation induced by ADP and collagen. {ECO:0000250|UniProtKB:W8E7D1}.",Hydrolase
7,A0A411EZW9,PA21_AGKPL,3.1.1.4,Acidic phospholipase A2 AplTX-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLLGVEGDLMQFETLIMKIAKRSGMFWYSAYGCYCGWGGQGRPQDATDRCCFVHDCCYGKVTGCDPKLDSYTYSVENGDVVCGGNDPCKKEICECDRAAAICFRDNKVTYDNKYWRFPPQNCKEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that triggers a high neuromuscular toxicity in chick biventer cervicis preparations, but not in mouse phrenic nerve-diaphragm (PND) preparations, suggesting a selective neurotoxin activity towards birds (PubMed:28063838). Does not induce myotoxic, coagulant, anticoagulant, edema, and antibacterial activities (PubMed:28063838). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:28063838). {ECO:0000269|PubMed:28063838}.",Phospholipase
8,A0A6B7FMR5,VMMP3_VIPAA,,Disintegrin-like/cysteine-rich protein MPIII-3 (D'C protein MPIII-3) (Metalloproteinase-like protein of class P-III MPIII-3) (Snake venom metalloproteinase precursor-derived protein MPIII-3) (SVMP precursor-derived protein MPIII-3) (Snake venom metalloproteinase-like) (SVMP-like) (Vaa-MPIII-3) (VaaMPIII-3),MIQVLLVIICLAVFPYQVSSIILESGNINNYEVVYPQKVTALPKGAIQQLEQKYEDAMQYQFKVKGEPVVLHLEKNKDFFPEDYSETHYSPDDREITTNPPVEDHCYYYGHIQNDADSTASISACNGLKGYFTLRGVTYLIEPLKIPESEAHAIYKYENVEKEDEDPKKCEFRRAGTECRPARSECDVAEYCTGQSAECPTDVFHSNGKPCLNNFGYCYNGNCPIMYHQCYALFGPNATVGQDGCFEWNKKGESYFYCRKENDVPIPCAPEDIKCGRLFCELIKNTCKYDYSEDPDYGMVDHGTKCGDGKVCINRHCVDVTTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIe sub-subfamily","FUNCTION: Abolishes platelet aggregation induced by collagen, ADP (IC(50)=292 nM) and arachidonic-acid. The inhibition of collagen-induced platelet aggregation may be due to its ability to bind collagen and block the binding site on collagen for platelets and/or to its ability to bind to the platelet alpha-2/beta-1 collagen receptor (ITGA2/ITGB1) to block its interaction with collagen and hence prevent platelet stimulation. The inhibition of ADP- or arachidonic-acid-induced platelet aggregation may be due to it acting as an antagonist of the ADP receptors or thromboxane-prostanoid receptors of the platelets, respectively. Does not interact with integrins alpha-IIb (ITGA2B) or beta-3 (ITGB3) nor platelet glycoproteins VI (GP6) or IX (GP9) in vitro, however, the detection is dependent on experimental conditions and may happen in vivo. Able to bind to platelet glycoprotein Ib alpha chain (GP1BA) receptor in vitro, although this interaction may have pathologically only limited effect in vivo as it is not able to abolish the von Willebrand factor (vWF)-dependent platelet agglutination induced by ristocetin. Does not affect blood coagulation. {ECO:0000269|PubMed:35448841}.",Vascular Interaction
9,A0S864,3NBA_BOIIR,,Irditoxin subunit A (IrTxA),MKTLLLAVAVVAFVCLGSADQLGLGRQQIDWGQGQAVGPPYTLCFECNRMTSSDCSTALRCYRGSCYTLYRPDENCELKWAVKGCAETCPTAGPNERVKCCRSPRCNDD,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily","FUNCTION: This bird and reptile-specific postsynaptic neurotoxin inhibits the chick muscle alpha-1-beta-1-gamma-delta (CHRNA1-CHRNB1-CHRNG-CHNRD) nicotinic acetylcholine receptor (nAChR) 100-fold more compared with the mouse receptor. In vivo, produces rapid flaccid paralysis, dyspnea and increased respiratory rate in geckos. At sublethal doses geckos were immobilized for up to three days and then recovered. Chicks injected with lethal doses showed rapid onset of inactivity, dyspnea and neck droop, and no extended paralysis with survival was seen. {ECO:0000269|PubMed:18952712}.",Neurotoxin
10,A0S865,3NBB_BOIIR,,Irditoxin subunit B (IrTxB),MKTLLLAVAVVAFVCLGSADQLGLGRQQIDWGKGQAKGPPYTLCFECNRETCSNCFKDNRCPPYHRTCYTLYRPDGNGEMKWAVKGCAKTCPTAQPGESVQCCNTPKCNDY,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily","FUNCTION: This bird and reptile-specific postsynaptic neurotoxin inhibits the chick muscle alpha-1-beta-1-gamma-delta (CHRNA1-CHRNB1-CHRNG-CHRND) nicotinic acetylcholine receptor (nAChR) 100-fold more compared with the mouse receptor. In vivo, produces rapid flaccid paralysis, dyspnea and increased respiratory rate in geckos. At sublethal doses geckos were immobilized for up to three days and then recovered. Chicks injected with lethal doses showed rapid onset of inactivity, dyspnea and neck droop, and no extended paralysis with survival was seen. {ECO:0000269|PubMed:18952712}.",Neurotoxin
11,A2TK72,VM3A2_DEIAC,3.4.24.-,Zinc metalloproteinase recombinant fibrinogenase II (FIIa) (rF II) (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),KREAEANRTPEQQIYDPYKYVETVFVVDKAMVTKYNGDLDKIKTRMYEAANNMNEMYRYMFFRVVMVGLIIWTEEDKITVKPDVDYTLNAFAEWRKTYLLAEKKHDNAQLITGIDFRGSIIGYAYIGSMCHPKRSVGIIQDYSPINLVLAVIMAHEMGHNLGIHHDDGYCYCGGYPCIMGPSISPEPSKFFSNCSYIQCWDFIMNHNPECIDNEPLGTDIISPPLCGNELLEA,"Venom metalloproteinase (M12B) family, P-III subfamily","FUNCTION: Snake venom zinc metalloprotease that acts at several levels. It has direct fibrino(geno)lytic activity (Aalpha chain of fibrinogen is cleaved quickly, Bbeta chain slowly, and gamma chain even more slowly) and degradation of TNF-alpha. These activities permit to protect against sepsis and disseminated intravascular coagulation (PubMed:17964518, PubMed:18634754, PubMed:19013210, PubMed:19070354). It inhibits ADP-induced platelet aggregation in human platelet-rich plasma (IC(50)=65.4 ug/ml) (PubMed:19013210). It decreases the activity of complement by degrading human C5, C6 and C9 in vitro, decreasing serum levels of C1q, C3 and C4 in rat, and inhibiting the MAC deposition on HUVECs membrane. This inhibition of complement protects against hyperacute rejection that is the main barrier in xenotransplantation (PubMed:23178656). Has preference for Lys at the P1 position. Cleaves insulin B chain at '36-Val-|-Glu-37', '39-Leu-|-Tyr-40', and '48-Phe-|-Phe-49' bonds. Also cleaves fibronectin and type IV collagen (PubMed:19013210). {ECO:0000269|PubMed:17964518, ECO:0000269|PubMed:18634754, ECO:0000269|PubMed:19013210, ECO:0000269|PubMed:19070354, ECO:0000269|PubMed:23178656}.",Metalloprotease
12,A3R0T9,VM3_OPHHA,3.4.24.-,Zinc metalloproteinase-disintegrin-like ohanin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLVVFPYQGSSIILESGKVNDYEVVYPQKIPVLPKSKIQRREQKMYEDTMKYEFKVNGEPVVLHLERNKELFSKDYTETHYSPDGREITTSPPVEDHCYYHGYIQSDIDSTAILNACNGLKGYFRHHGEAYHIEPLKFSDSEAHAVYKYENIEKEDETPKICGVKHSTWESDEPIEKISQKKDFLEEKKYLELYIVADYVMFRKYGRNVTTIRMRVFDMVNYITVVYKALNIHVALIGFEIWSLKDKFVINASTKNNLLHFSIWRSTVLRKRNDNAQLLTGVDLNGYTLGSAYLKAMCDVLQSVGIVQDYSKSPYLVGAAMAHEIGHNLGMEHDTKTCSCMRGNCIMSPEEEGSDFPMEFSSCSLYDFQNYMLTDTPQCLINKPSNTSIIKNAVCGNYVEEEGEECDCGSPEQCENNCCEAATCKLKPGAKCAKGACCKKCQFKKAGAECRAARNECDLPEFCIGQSAECPMDRFHKNGHSCQNDQGYCFRGYCPTLAKQCITLWGSDAKVAPDECFQNNTNGNEYDYCKKTNNVIIPCKPTDVKCGRLYCTGGTENPSEGEKISSDPCKASYSEIEDIGMVDHRTKCGEKMVCSDGKCIPL,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase that has hemorrhagic activity. Inhibits ADP-, TMVA- and stejnulxin-induced platelet aggregation in a dose-dependent manner (on washed platelet, but not on platelet rich plasm). Also specifically degrades alpha-chain of fibrinogen (FGA). {ECO:0000269|PubMed:17337026}.",Metalloprotease
13,A4PBQ9,VM3VA_CROAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like VAP2A (EC 3.4.24.-) (Crotalus atrox metalloprotease) (CAMP) (Snake venom metalloproteinase) (SVMP) (Vascular apoptosis-inducing protein 2) (VAP2) (Vascular apoptosis-inducing protein 2A) (VAP2A),MIQVLLVTICLAAFPYQGSSIILESGNVNDYEIVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKQLFSKDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTQNWKSYEPIKKASQLVVTAEHQKYNPFRFVELVLVVDKAMVTKNNGDLDKIKTRMYELANTVNDIYRYMYIHVALVGLEIWSNEDKITVKPEADYTLNAFGEWRKTDLLTRKKHDNAQLLTAIDLDRVIGLAYVGSMCHPKRSTGIIQDYSPINLVVAVIMAHEMGHNLGINHDRGYCSCGDYACIMRPEISPEPSTFFSNCSYFDCWDFITNHNPECIVNEPLGTDIISPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYNGNCPIMYHQCYDLFGADVYEAEDSCFERNQKGNYYGYCRKENGNKIPCAPEDVKCGRLYCKDNSPGQNNSCKMFYSNEDEHKGMVLPGTKCADGKVCSNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Is implied in permanent muscle damage by attacking the collagen scaffold and other important basement membrane proteins of muscle, and by preventing muscle regeneration through disrupting the functions of satellite cells (PubMed:30695027). Displays collagenolytic activity, fibrinogenolytic activity (on both Aalpha and Bbeta, but not gamma chains) and inhibits CRP-XL-induced platelet aggregation (PubMed:30695027). In vivo, induces hemorrhage and fluctuations in muscle size by intramuscular injection into mice (PubMed:30695027). Also induces apoptosis in endothelial cells, without triggering cell detachment (PubMed:9578458). {ECO:0000269|PubMed:30695027, ECO:0000269|PubMed:9578458}.",Fibrinogenolytic Enzyme
14,A4VBF0,PA2H_VIPNI,,Acidic phospholipase A2 inhibitor chain HPD-1I (svPLA2 homolog) (Heterodimeric neurotoxic phospholipases A2 acidic subunit),MRTLWIVAVCLIGVEGNLFQFGDMILQKTGKEAVHSYAIYGCYCGWGGQGRAQDATDRCCFAQDCCYGRVNDCNPKTATYTYSFENGDIVCGDNDLCLRAVCECDRAAAICLGENVNTYDKNYEYYSISHCTEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer: slightly affects neuromuscular transmission acting presynaptically. It has a low catalytic activity, a low anticoagulant activity and weakly inhibits ADP-induced platelet aggregation. {ECO:0000269|PubMed:18083205}.; FUNCTION: Monomer: has no activity (neurotoxic, catalytic, anticoagulant and a ADP-induced platelet aggregation), but inhibits phospholipase A2. {ECO:0000269|PubMed:18083205}.",Phospholipase
15,A6MEY4,PA2B_BUNFA,3.1.1.4,Basic phospholipase A2 BFPA (svPLA2) (EC 3.1.1.4) (Antimicrobial phospholipase A2) (Phosphatidylcholine 2-acylhydrolase),MNPAHLLVLLAVCVSLLGAANIPPQSLNLYQFKNMIQCAGTQLCVAYVKYGCYCGPGGTGTPLDQLDRCCQTHDHCYDNAKKFGNCIPYFKTYEYTCNKPDLTCTDAKGSCARNVCDCDRAAAICFAAAPYNLANFGINKETHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits blood coagulation and shows bactericidal activities against both Gram-negative and -positive bacteria (E.coli, MIC=0.4 uM and S.aureus, MIC=0.1 uM). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:17383773}.",Phospholipase
20,A8CG86,PA2A1_DABRR,3.1.1.4,Acidic phospholipase A2 Drk-a1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 Drk-a1') (Phospholipase A2-I),MRTLWIVAVCLIGVEGNLFQFAEMIVKMTGKEAVHSYAIYGCYCGWGGQGKPQDATDRCCFVHDCCYGTVNDCNPKMATYSYSFENGDIVCGDNNLCLKTVCECDRAAAICLGQNVNTYDKNYENYAISHCTEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits high hydrolytic activities and shows strong preference for the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:17611171}.,Phospholipase
21,A8E2V8,PA2A_TRIGS,3.1.1.4,Acidic phospholipase A2 Tgc-E6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLLGVEGSLMQFEMLIMKLAKSSGMFWYSAYGCYCGWGGQGRPQDATDRCCFVHDCCYGKATGCDPKKDVYTYSEENGDIVCGGDDPCRKEVCECDKAAAICFRDNMDTYNSKTYWMFPAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits the ADP-(IC(50)=272 nM) and collagen-induced (IC(50)=518 nM) human platelet aggregation in platelet rich plasma. Exhibits very high hydrolytic activities toward the synthetic lecithin, and prefers the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:22115990}.",Phospholipase
23,A8QL56,VSP1_OPHHA,3.4.21.-,Alpha- and beta-fibrinogenase OhS1 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MALIRVLASLLILQLSYAVTPFDRIIGGFECNEYEHRSLVHLYNSSGFFCSGTLLNHEWVLTAAHCNRDDIQIKLGVHNVSVNYEDEQIRVPKEKLCCHSTNNCTQLGQDIMLIRLNSSVNYSEHIAPLSLPSNRPSMGSVCRVMGWGLLTSPEVTFPKVPHCVDINILHIQVCQAAYPSMSENYLLCAGVLEGGKDSCKGDSGGPLICNREIQGIVSWGGFPCAQLLEPGVYTKVFDYIDWIEGIIAGNTSVTCPSDNF,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that possesses potent fibrinogenolytic (on both alpha- (FGA) and beta-chains (FGB)) and amidolytic activities. Selectively cleaves Arg-|-Xaa or Lys-|-Xaa bonds. {ECO:0000269|PubMed:8079373}.,Serine Protease
24,A8YPR6,SVMI_ECHOC,,Snake venom metalloprotease inhibitor 02D01 (02E11) (10F07) (Svmpi-Eoc7) [Cleaved into: Tripeptide pEKW 1; Tripeptide pEKW 2; Tripeptide pEKW 3; Tripeptide pEKW 4; Tripeptide pEKW 5; Tripeptide pEKW 6; Tripeptide pEKW 7; Tripeptide pEKW 8; Tripeptide pEKW 9; Tripeptide pEKW 10; Tripeptide pEKW 11; Poly-His-poly-Gly peptide 4 (pHpG-4); Poly-His-poly-Gly peptide 3 (pHpG-3); Poly-His-poly-Gly peptide 2 (pHpG-2); Poly-His-poly-Gly peptide 1 (pHpG-1); C-type natriuretic peptide (CNP)],MFVSRLAASGLLLLSLLALSLDGKPLPQRQPHHIQPMEQKWLAPDAPPLEQKWLAPDAPPLEQKWLAPAAPPLEQKWLAPDAPPMEQKWLAPDAPPMEQKWLAPDAPPMEQKWLAPDAPPMEQKWLAPDAAPLEQKWLAPDAPPMEQKWLAPDAPPMEQKWQPQIPSLMEQRQLSSGGTTALRQELSPRAEAASGPAVVGGGGGGGGGSKAALALPKPPKAKGAAAATSRLMRDLRPDGKQASQKWGRLVDHDHDHHHHHHPGSSVGGGGGGGGGGARRLKGLAKKGVAKGCFGLKLDRIGSMSGLGC,Natriuretic peptide family; PHpG family,"FUNCTION: pEKW and poly-His-poly-Gly peptides may serve as metalloproteinase inhibitors during glandular storage. Their inhibition may be instantly disengaged, by dilution or physiochemical change, when venom is injected into tissue of the prey. {ECO:0000303|PubMed:18029259}.; FUNCTION: [C-type natriuretic peptide]: has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.",Kunitz Family
25,A8YPR9,SVMI1_CERCE,,Snake venom metalloprotease inhibitor 02A10 (01F09) [Cleaved into: Tripeptide pEKW 1; Tripeptide pEKW 2; Tripeptide pEKW 3; Tripeptide pEKW 4; Tripeptide pEKW 5; Tripeptide pEKW 6; Tripeptide pEKW 7; Tripeptide pEKW 8; Tripeptide pEKW 9; Tripeptide pEKW 10; Tripeptide pEKW 11; Tripeptide pEKW 12; Tripeptide pEKW 13; Tripeptide pEKW 14; Tripeptide pEKW 15; Tripeptide pEKW 16; Tripeptide pEKW 17; C-type natriuretic peptide (CNP)],MSVSRLAASGLLLVSLLALALDGKPVEKWSPWLWPPRPRPPIPPLQQQKWLDPPIPQQQKWLDPPIPQQQKWLDPPIPQQQKWLNPPIPQQQKWLDPPIPQQQKWLNPPIPQQQKWLNPPIPQQQKWLNPPIPQQQKWLNPPIPQQQKWLDPPIPQQQKWLDPPIPQQQKWLDPPIPQQQKWLNPPIPQQQKWLDPPIPQQQKWLDPPIPQQQKWLNPPIPQQQKWQRPLQPEVPSLMELHQERQKQGRMMHHDEDPGDAAEGPRRQKKEPGKPEGNGCFGKKIDRINAGFGCPKLPPSGGH,Natriuretic peptide family,"FUNCTION: pEKW peptides may serve as metalloproteinase inhibitors during glandular storage. Their inhibition may be instantly disengaged, by dilution or physiochemical change, when venom is injected into tissue of the victim. {ECO:0000269|PubMed:18029259}.; FUNCTION: [C-type natriuretic peptide]: Exhibits hypotensive and vasodepressor activity. Acts by activating natriuretic receptors (NPR1 and/or NPR2 and/or NPR3) (By similarity). {ECO:0000250}.",Kunitz Family
26,B0VXV8,BNP_SISCA,,Bradykinin potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide-1) (BPP-1); Bradykinin-potentiating peptide-2 (BPP-2); Bradykinin inhibitor peptide homolog; C-type natriuretic peptide (CNP)],MFVSRLAASGLLLLALLAVSLDGKPVQQWSQNWPGPKVPPLVVQQWSQNWPHPQIPPLVVQNWKSPTQLQPRESPAGGTTALREELSLGPDAALDTPPAGPDVGPRGSKAAAAPQRLSKSKGASATSTASRPMRDLRTDGKQARQNWGRMLNPDHHSAPGGGGGGGGGGARRLKGLAKKRAGSGCFGLKLDRIGSMSGLGC,Bradykinin-potentiating peptide family; Bradykinin inhibitor peptide family; Natriuretic peptide family,FUNCTION: [Bradykinin-potentiating peptide 10c]: Inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain. May also potentiate the hypotensive effects of bradykinin. {ECO:0000269|PubMed:11994001}.; FUNCTION: [Bradykinin inhibitor peptide homolog]: Antagonizes the vasodilatory actions of bradykinin at the B2 bradykinin receptor. {ECO:0000250}.; FUNCTION: [C-type natriuretic peptide]: has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.,Kunitz Family
27,B3A0N3,PA2B3_BOTMA,3.1.1.4,Basic phospholipase A2 Bmaj-9 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLWQWGQMILKETGKLPFSYYTAYGCYCGWGGRGGKPKADTDRCCFVHDC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that causes irreversible neuromuscular blockade in chick biventer cervicis muscle preparations. The neuromuscular blockade is mediated by inhibitory action at the presynaptic motor nerve endings. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|Ref.1}.,Phospholipase
28,B3EWF8,3SX1_MICMP,,Mipartoxin-1 (Mipartoxin-I) (Three-finger toxin) (3FTx),MKTLLLTLVVVTIVCLDLGNSLKCYVSREGKTQTCPEGEKLCEKYAVSYFHDGRWRYRYECTSACHRGPYNVCCSTDLCNK,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: Snake venom neurotoxin that blocks neuromuscular transmission on both avian and mouse nerve-muscle preparations, presenting a postsynaptic action through the nicotinic acetylcholine receptor (nAChR). Reversibly inhibits twitches in mouse phrenic nerve diaphragm and irreversibly in chick biventer cervicis muscle. Has no cytotoxic activity towards C2C12 cells up to 180 ug/ml. {ECO:0000269|PubMed:22677806}.",Neurotoxin
29,B3EWH2,AON_AZEFE,,Azemiopsin,DNWWPKPPHQGPRPPRPRPKP,,"FUNCTION: In vitro, reversibly blocks human muscle-type nicotinic acetylcholine receptors (nAChR) alpha-1-beta-1-epsilon-delta/CHRNA1-CHRNB1-CHRNE-CHRND (EC(50)=0.44 uM) and alpha-1-beta-1-gamma-delta/CHRNA1-CHRNB1-CHRNG-CHRND (EC(50)=1.56 uM). Binds to nAChR from T.californica (IC(50)=0.03-0.18 uM), human neuronal nAChR alpha-7/CHRNA7 (IC(50)=22 uM) and acetylcholine-binding proteins (AChBP) from L.stagnalis (IC(50)=63 uM) and A.californica (IC(50)=230 uM). {ECO:0000269|PubMed:22613724}.",Neurotoxin
30,B3EWP6,PA2_LACMR,3.1.1.4,Phospholipase A2 (Lmr-PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFGDLINKIARRNGILYYSFYGCYCGLGGRGRPQDATDRCCFVHDCCYGKVTGCDPK,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays mild but significant inhibition of mouse platelet aggregation induced by ADP and collagen (PubMed:26145564). In vivo, induces edema in the foot pads and gastrocnemius muscles of mice but shows no myonecrotic or myotoxic activity (PubMed:26145564). PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:26145564). {ECO:0000269|PubMed:26145564}.",Phospholipase
32,B6CQR5,PA2A2_MACLB,3.1.1.4,Acidic phospholipase A2 2 (Vl-PLA2-2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVWLTGVEGDLSQFGDMINKKTGTFGLFSYIYYGCYCGWGGKGKPQDATDRCCFVHDCCYGSVNGCDPKLSTYSYSFQNGDIVCGDDDPCLRAVCECDRVAAICSGENMNTYDKKYMLYSLFDCKEESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase that inhibits ADP- and collagen-induced human platelet aggregation. This inhibition is completely inhibited by abolition of catalytic activity in case of collagen as inducer and partially inhibited in case of ADP as inducer. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:19467252}.,Phospholipase
34,B7S4N9,VKT_OXYSC,,"Kunitz-type serine protease inhibitor taicotoxin (Taicatoxin, serine protease inhibitor component) (TCX) (TSPI) (Venom protease inhibitor 1) (Venom protease inhibitor 2)",MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCHLPPKPGPCRAAIPRFYYNPHSKQCEKFIYGGCHGNANSFKTPDECNYTCLGVSLPK,Venom Kunitz-type family,"FUNCTION: Heterotrimer: blocks the voltage-dependent L-type calcium channels (Cav) from the heart, and the small conductance calcium-activated potassium channels (KCa) in the chromaffin cells and in the brain. Is very toxic to mice.; FUNCTION: Monomer: serine protease inhibitor that inhibits plasma kallikrein (Ki=0.057 nM), tissue kallikrein (Ki=0.23 nM), trypsin (Ki=0.31 nM), plasmin (Ki=6.1 nM), elastase (Ki=201 nM), factor Xa (Ki=871 nM), alpha-factor XIIa (Ki=2380 nM). Does not inhibit APC, urokinase-type plasminogen activator (uPA/PLAU), tissue plasminogen activator (tPA/PLAT), thrombin and factor VIIa. In addition, the monomer inhibits fibrinolysis in whole blood and prolonged the intrinsec clotting time.",Serine Protease
35,B8K1W0,VM3DK_DABRR,3.4.24.-,Zinc metalloproteinase-disintegrin-like daborhagin-K (EC 3.4.24.-) (Haemorrhagic metalloproteinase russelysin) (Snake venom metalloproteinase) (SVMP),MMQVLLVTICLAVFPYHGSSIILESGNVNDYEVVYPQKVTAMPKEAVKQPEQKYEDAMQYKFEVNGEPVLLHLEKNKDLFSEDYSETHYSPDGREITTKPLVQDHCYYHGHIQNDAHSSASISACNGLKGHFKLRGEMYLIEPLKLSDSEAHAVYKYENVEKEDEALKMCGVTQTNWESDEPIKKASLLVATSERNRYFNPYSYVELIITVDHSMVTKYKNDLTAIRTWVFELVNTINEIFKYLYIRVPLVGLEIWKNRDLINVTSAANVTLDLFGEWRKSYLLPRKIHDNSQLLTAIDLNGLTIGMAYVSTMCQSKYSVGVVQDHSKINLRVAVTMAHEIGHNLGLTHDGVYCTCGGYSCIMSAVLGDQPSKYFSNCSYNQYRRFLTEHNPECIINPPLRTDIVSPPACGNELLERGEECDCGSPENCRDPCCDAASCKLHSWVECESGKCCNQCRFKRAGTECRPARDECDKAEQCTGRSANCPVDEFHENGRPCLHNFGYCYNGKCPIMYHQCHALFGQNVTGVQDSCFQYNRLGVYYAYCRKENGRKIPCAPKDEKCGRLYCSYKSPGNQIPCLPYYIPSDENKGMVDHGTKCGDGKVCSNGQCVDLNIAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloprotease that possesses high hemorrhagic activity (minimum hemorrhagic dose (MHD)=0.82 ug) when subcutaneously injected into mice. May also potently degrade alpha chain of fibrinogen (FGA).,Metalloprotease
36,B8QCG6,NGFV_AGKCO,,Venom nerve growth factor (v-NGF) (vNGF),FLIGIWAAPKSEDNVPLGSPATSDLSDTSCAKTHEALKTSRNIDQHYPAPKKAEDQEFGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQNVDNANSLNRNIRAKREDHPVHNRGEYSVCDSVNVWVANKTTATDIRGNVVTVMVDVNINNNVYKQYFFETKCRNPNPVPTGCRGIDARHWNSYC,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
37,C0HJD3,3NB_OXYFU,,Fulgimotoxin (FTx),QAIGPPFGLCFQCNQKTSSDCFNAKRCPPFHRTCYTLYKPDGGEEWAVKGCAKGCPTAGPDERVKCCHTPRCNN,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily","FUNCTION: Reptile-specific three-finger toxin that is lethal at low doses for lizards, but not for mice. Probably acts as a neurotoxin. {ECO:0000269|PubMed:23851011}.",Neurotoxin
38,C0HJE7,OXLA_CRODU,1.4.3.2,L-amino acid oxidase bordonein-L (LAAO) (LAO) (EC 1.4.3.2),MNVFFMFSLLFLAALGSCAHDRNPLEECFRETDYEEFLEIARNGLTVTSNPKHVVIVGAGMAGLSAAYVLAGAGHQVTVLEASERVGGRVRTYRKKDWYANLGPMRLPTKHRIVREYIRKFGLQLNEFFQENENAWYFIKNIRKRVREVKNNPGILEYPVKPSEEGKSAAQLYVESLRKVVKELKRTNCKYILDKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFGYEKRFDEIVGGMDQLPTSMYEAIKEKVQVHFNARVIEIQQNDRETKVTYQTSANEMSSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCKRKFWEDDGIRGGKSTTDLPSRFIYYPNHNFTSGVGVIIAYGIGDDANFFQALDFKDCADIVINDLSLIHQLPKEDIQTFCRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPFKRIYFAGEYTAQFHGWIDSTIKSGLTAARDVNRASENPSGIHLSNDNEF,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:26273287, PubMed:31078582). Is highly active on L-Met, L-Leu, L-Trp, and L-Phe, moderately active on L-Ile, L-His, and L-Arg, and weakly or not active on L-Gln, L-Val, L-Asn, L-Ala, L-Lys, L-Ser, L-Thr, L-Pro, L-Asp, L-Gly, L-Tyr, L-Cys and L-Glu (PubMed:31078582). This enzyme exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation (PubMed:26273287). Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation (PubMed:26273287). These different effects are probably due to different experimental conditions (PubMed:26273287). In vitro, the enzyme exhibits cytotoxicity against fibroblast cell line and kills Leishmania amazonensis promastigotes, intensified by substrate addition (PubMed:31078582). {ECO:0000269|PubMed:26273287, ECO:0000269|PubMed:31078582}.",Vascular Interaction
39,C0HJL8,PA2B_BOTNI,3.1.1.4,Phospholipase A2 nigroviriditoxin basic subunit B (Ngvtx-B) (svPLA2) (EC 3.1.1.4) (Phospholipase A(2)),NLLQFNRMIKLETKKNAVPFYAFYGCYCGWGGQGQPKDATDRCCFEHDCCYGKLTKCNTKSDLYSYSSKYGFLLCGKGTWCEEQICECDRIAATCLRRSLDTYKLKYMFYLDSYCKGPSEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Heterodimer A-B: Nigroviriditoxin possesses phospholipase A2 (PLA2) activity. It consists of a non-covalent association of a basic PLA2 subunit B with a non-enzymatic subunit A. {ECO:0000269|PubMed:25434534}.; FUNCTION: Subunit B: Snake venom phospholipase A2 (PLA2) that induces myonecrosis in mice. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:25434534}.,Phospholipase
40,C0HJU3,PA2A1_BOTPA,3.1.1.4,Acidic phospholipase A2 (Bp-PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLVQFKTLIMKIAGRSVVYKYFYYGCYCGWGGIGQPRDATDRCCFVHD,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows myotoxicity and induces paw edema in mice (PubMed:17451767). Exhibits indirect hemolytic activity (PubMed:17451767). Inhibits platelet aggregation induced by ADP and collagen (PubMed:17451767). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:17451767). {ECO:0000269|PubMed:17451767}.,Phospholipase
41,C0HK05,PA2BC_CROLT,3.1.1.4,Basic phospholipase A2 ColTx-1 (svPLA2) (EC 3.1.1.4) (Basic phospholipase A2 ColTx-I) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRKNAIPFYAFYGCYCGWGGRGRPKDATDRCCFVH,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows edema-inducing activity and local and systemic myotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:26996495}.,Phospholipase
42,C0HKB8,PA2A1_MICDM,3.1.1.4,Acidic phospholipase A2 (MdumPLA2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLIDFKNMIKCTTKRSVLDFADYGCYCGSGGSGTPVDDLDRCCKVHDDCYGEAEKVHGCWPKWTLYSYDCSNGQLTCKDNNTKCKDFVCNCDRTAAICFAKAPYDDNNFMINNPRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows strong myotoxicity and induces edema in mice. Shows no cytotoxicity in vitro. Has a strong anticoagulant effect in vitro. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:28315380}.,Phospholipase
43,C0HKB9,PA2B1_MICMP,3.1.1.4,Basic phospholipase A2 (Mm-20) (MmipPLA2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLIHFSSMIKCTIPGSKPVPDYSDYGCYCGKGGSGTPVDALDRCCQVHDKCYGDAESIYGCTPFLTYYSYECSERQDLCRGNGTKCKAFVCNCDRLAALCFAKAPYNKKNYNINLNRCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows weak myotoxicity and induces edema in mice (PubMed:28315380). Shows no cytotoxicity in vitro (PubMed:28315380). Has an anticoagulant effect in vitro (PubMed:21963438, PubMed:28315380). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:21963438, PubMed:28315380). {ECO:0000269|PubMed:21963438, ECO:0000269|PubMed:28315380}.",Phospholipase
44,C0HKC3,PA2B9_AGKPL,3.1.1.4,Basic phospholipase A2 APL-D49 (svPLA2) (EC 3.1.1.4) (Apl-D49) (AplP3) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLLGVEGNLFQFEKLIKKMTGKSGMLWYSAYGCYCGWGGQGRPKDATDRCCFVHDCCYGKVTGCNPKMDIYTYSVENGNIVCGGTNPCKKQICECDRAAAICFRDNLKTYDSKTYWKYPKKNCKEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that does not show antibacterial activity (PubMed:29928892). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:28633930). {ECO:0000269|PubMed:28633930, ECO:0000269|PubMed:29928892}.",Phospholipase
46,C0HLF0,PA2_POROP,3.1.1.4,Basic phospholipase A2 (PoPLA2) (PophPLA2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLFQFRKMIKKMTKKEPVVYYAFYGCYCGKGGRGKPKDATDRCCFVHDCCYEKVTGCNPKWGYYTYSMNKQIVCGGDDPCKKQVCECDKAAAICFRDNLKTYKKKYMSFPNFFCTDPSEKC,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays moderate myotoxic activity in vivo, and cytotoxic activity in vitro. In vitro, shows anticoagulant activity on human plasma and in mice causes inflammatory cell infiltration and myonecrosis in the gastrocnemius muscles of CD-1 mice 3 hours after injection (100 ug). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:29886171}.",Phospholipase
47,C0HLF7,PA2B_OPHSH,3.1.1.4,Basic phospholipase A2 sphenotoxin subunit B (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKEETGKNAIPFYAFYGCYCGWGGSGKPKDATDRCCFEHDCCYGKLTNCNTKWDIYSYSLKDGYITCGKGTWCEKEVCECDKCLRRNLRTYKYGYMFYL,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer A-B: Sphenotoxin is a potent neurotoxin that possesses phospholipase A2 (PLA2) activity. It consists of a non-covalent association of a basic PLA2 subunit B with a non-enzymatic subunit A. {ECO:0000269|PubMed:30205237}.; FUNCTION: Monomer B: Not found in vivo. In vitro, potent neurotoxin that possesses phospholipase A2 (PLA2) activity and exerts a lethal action by blocking neuromuscular transmission. Induces paralysis of the hind legs and neuromuscular blockade in mouse phrenic nerve-diaphragm preparations. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:30205237}.",Phospholipase
48,C0HM14,PA2BD_CRODU,3.1.1.4,Phospholipase A2 crotoxin basic subunit CBd (CTX subunit CBd) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRKNAIPFYAFYGCYCGWGGRGRPKDATDRCCFVHDCCYGKLAKCNTKWDIYRYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer CA-CB: Crotoxin is a potent presynaptic neurotoxin that possesses phospholipase A2 (PLA2) activity and exerts a lethal action by blocking neuromuscular transmission (PubMed:8513799). It consists of a non-covalent association of a basic and weakly toxic PLA2 subunit (CBa2, CBb, CBc, or CBd), with a small acidic, non-enzymatic and non-toxic subunit (CA1, CA2, CA3 or CA4) (PubMed:8513799). The complex acts by binding to a specific 48-kDa protein (R48) receptor located on presynaptic membranes, forming a transient ternary complex CA-CB-R48, followed by dissociation of the CA-CB complex and release of the CA subunit (PubMed:12657321). At equilibrium, only the CB subunits remain associated with the specific crotoxin receptor (PubMed:12657321). In addition to neurotoxicity, crotoxin has been found to exert myotoxicity, nephrotoxicity, and cardiovascular toxicity (By similarity). Moreover, anti-inflammatory, immunomodulatory, anti-tumor and analgesic effects of crotoxin have also been reported (By similarity). {ECO:0000250|UniProtKB:P62022, ECO:0000269|PubMed:12657321, ECO:0000269|PubMed:8513799}.; FUNCTION: Monomer CBd: The basic subunit of crotoxin is a snake venom phospholipase A2 (PLA2) that exhibits weak neurotoxicity (10-fold less than the heterodimer) and very strong anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (By similarity). In addition, it shows the same effects described for the heterodimer and binds the nucleotide-binding domain (NBD1) of CFTR chloride channels and increases the channel current (By similarity). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:8513799). {ECO:0000250|UniProtKB:P62022, ECO:0000269|PubMed:8513799}.",Phospholipase
49,C0HM96,TXVE_CRODU,,Snake venom vascular endothelial growth factor (svVEGF) (VEGF-F),QVMPFMEVYERSVCQTREMLVSILDEYPSEVAHLFRPSCVTVLRCGGCCTEESLTCTATGKRSVGREIMRVDPRQGTSKIEVMQFTEHTECECRPGSTVNNGKRKKNPKEGEPR,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom vascular endothelial growth factor (svVEGF) that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. Induces an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase (By similarity). Induces angiogenesis and migration of human vascular endothelial cells in vitro (PubMed:37624240). Exhibits angiogenic activity by inducing human umbilical vein endothelial cells (HUVEC) to develop vessels in vitro (PubMed:37624240). Induces cellular migration of HUVEC cells towards a wound in scratch assays, enhancing wound closure after 12 h by 49.5% (PubMed:37624240). Induces dose-dependent leukocyte recruitment to the peritoneal cavity leading to increased vascular permeability in mice (PubMed:37624240). {ECO:0000250|UniProtKB:P83942, ECO:0000269|PubMed:37624240}.",Vascular Interaction
50,C0K3N1,TXVE_BITAR,,Snake venom vascular endothelial growth factor toxin barietin (svVEGF) (VEGF-F),MAAYLLAVAILFCIQGWPSGTVQGEVRPFMEVYQRSVCQPRETLVSILEEYPDKISKIFRPSCVAVLRCGGCCSDESLTCTSVGERTVELQVMQVTPKTLSSKIKVMKFREHTACECRPRSGSRVNIGKHKRSPEEGEREPSSPLTPGSL,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection. The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces angiogenesis in vitro, probably through VEGF receptor (KDR/VEGFR-2) signaling. {ECO:0000250|UniProtKB:P83942}.",Vascular Interaction
51,C0L2T8,VM2C1_CRODO,3.4.24.-,Zinc metalloproteinase/disintegrin (Metalloproteinase PII) (MPII) [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin Cdc],MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVIYPRKVTALPKGAVQPKYEDTMQYELKVNGQPVVLHLEKNKGLFSKDYSETHYSPDGRKITTNPSVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYIIEPLELSDSEDHAVFKLENVEKEDEAPKMCGVTQNWESNEPIKKASHLNLNPEHQRYVEIVIVVDHGMFTKYNGDSDKIRQRVHQMVNIMKESYRYMYIDISLAGIEIWSNKDLINVQPAAPNTLKSFGEWRETDLPKRKSHDNAQLLTSIDFNGQTIGIANIGAICDPKPSTRVVQDHSKINLRVALTMTHELSHNLGIHHDTGSCSCSGYSCIMSPVISDEPSKYFSDCSYIQCWNFIMNQKPQCILKKPLRTDTVSTPVSGNELLEARIECDCGSIENPCCYATTCKLRPGSQCAEGMCCDQCRFMKKGTVCRVSLVNKNDDTCTGQSADCPRNVLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Snake venom zinc metalloproteinase that causes hemorrhage by provoking the degradation of the sub-endothelial matrix proteins (fibronectin, laminin, type IV collagen, nidogen, and gelatins). {ECO:0000250|UniProtKB:P34182}.; FUNCTION: [Disintegrin Cdc]: Displays low cytotoxicity. In vitro, inhibits cancer cell migration (human breast cancer cell line MDA-MB-231) with a significant rate after 24 hours of incubation. {ECO:0000269|PubMed:30377432}.",Metalloprotease
52,C3W4R6,PA2A1_MACLB,3.1.1.4,Acidic phospholipase A2 1 (Vl-PLA2-1) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVWLMGVEGDLSQFGDMINKKTGTFGLFSYIYYGCYCGWGGKGKPQDATDRCCFVHDCCYGSVNGCDPKLSTYSYSFQNGDIVCGDDDPCLRAVCECDRVAAICFGENMNTYDKKYMLYSLFDCKEESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase that inhibits ADP- and collagen-induced human platelet aggregation. This inhibition is completely inhibited by abolition of catalytic activity in case of collagen as inducer and partially inhibited in case of ADP as inducer. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:19467252}.,Phospholipase
53,D3TTC1,VM3KL_NAJAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like kaouthiagin-like (K-like) (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQALLVIICLAVFPHQGSSIILESGNVNDYEVVYPQKVPALLKGGVQNPQPETKYEDTMRYEFQVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAVISACDGLKGHFEHQGETYFIEPLKISNSEAHAIYKDENVENEDETPEICGVTETTWESDESIEKTSQFTNTPEQDRYLQDKKYIEFYVIVDNRMYRYYNNDKPAIKIRVYEMINAVNTKFRPLKIHIALIGLEIWSNKDKFEVKPAASVTLKSFGEWRETVLLPRKRNDNAQLLTGIDFNGNTVGRAYIGSLCKTNESVAIVQDYNRRISLVASTITHELGHNLGIHHDKASCICIPGPCIMLKKRTAPAFQFSSCSIREYREYLLRDRPQCILNKPLSTDIVSPPICGNYFVEVGEECDCGSPQACQSACCNAATCQFKGAETECRVAKDDCDLPELCTGQSAECPTDSLQRNGHPCQNNQSYCYNGTCPTLTNQCITLLGPHFTVSPKGCFDLNMRGDDGSFCRMEDGTKIPCAAKDVKCGRLYCTEKNTMSCLIPPNPDGIMAEPGTKCGDGMVCSKGQCVDVQTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that cleaves the membrane-bound precursor of TNF-alpha (TNF) into its mature soluble form showing the same digestion pattern than ADAM17. {ECO:0000269|PubMed:19932752}.,Metalloprotease
54,D3TTC2,VM3H_NAJAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like atragin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQALLVIICLAVFPHQGSSIILESGNVNDYEVVYPQKVPALLKGGVQNPQPETKYEDTMRYEFQVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAVISACDGLKGHFEHQGETYFIEPLKISNSEAHAIYKDENVENEDETPEICGVTETTWESDESIEKTSQLTNTPEQDRYLQAKKYIEFYVVVDNIMYRHYKRDQPVIKRKVYEMINTMNMIYRRLNFHIALIGLEIWSNINEINVQSDVRATLNLFGEWREKKLLPRKRNDNAQLLTGIDFNGTPVGLAYIGSICNPKTSAAVVQDYSSRTRMVAITMAHEMGHNLGMNHDRGFCTCGFNKCVMSTRRTKPAYQFSSCSVREHQRYLLRDRPQCILNKPLSTDIVSPPICGNYFVEVGEECDCGSPADCQSACCNATTCKLQHEAQCDSEECCEKCKFKGARAECRAAKDDCDLPELCTGQSAECPTDVFQRNGLPCQNNQGYCYNGKCPIMTNQCIALRGPGVKVSRDSCFTLNQRTRGCGLCRMEYGRKIPCAAKDVKCGRLFCKRRNSMICNCSISPRDPNYGMVEPGTKCGDGMVCSNRQCVDVKTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that seems to inhibit cell migration. This activity is dominated by the local structure of the hyper-variable region. {ECO:0000269|PubMed:19932752}.,Metalloprotease
55,D6PXE8,VM3B_NAJAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like atrase-B (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQALLVIICLAVFPHQGSSIILESGNVNDYEVVYPQKVPALLKGGVQNPQPETKYEDTMRYEFQVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAVISACDGLKGHFEHQGETYFIEPLKISNSEAHAIYKDENVENEDETPEICGVTETTWESDESIEKTSQLTNTPEQDRYLQDKKYIEFYVIVDNRMYRYYNNDKPAIKIRVYEMINAVNTKFRPLKIHIALIGLEIWSNKDKFEVKPAASVTLKSFGEWRETVLLPRKRNDNAQLLTGIDFNGNTVGRAYIGSLCKTNESVAIVQDYNRRISLVASTMTHELGHNLGIHHDKASCICIPGPCIMLKKRTAPAFQFSSCSIREYREYLLRDRPQCILNKPLSTDIVSPPICGNYFVEVGEECDCGSPQACQSACCNAATCQFKGAETECRVAKDDCDLPELCTGQSAECPTDSLQRNGHPCQNNQGYCYNRTCPTLTNQCITLLGPHFTVSPKGCFDLNMRGDDGSFCGMEDGTKIPCAAKDVKCGRLYCTEKNTMSCLIPPNPDGIMAEPGTKCGDGMVCSKGQCVDVQTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc protease that inhibits the classical and alternative pathways of complement by cleaving factor B, C6, C7, and C8. Also slowly and selectively degrades alpha-chain of fibrinogen (FGA), and shows edema-inducing activity. {ECO:0000269|PubMed:20837040}.",Metalloprotease
56,E0Y419,VSPBF_MACLB,3.4.21.-,Beta-fibrinogenase (VLBF) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLLLQLSHAQKSSELVVGGDECNINEHRSLVFLYNSSFGCGGTLINQEWVLSAAHCDMENMRIYLGWHNFSLPNMNQKRRVAKEKFFCLSSKNYTEWDKDIMLIKMNRPVTYSTHVAPLSLPSSPPSVGSVCRIMGWGAITSPNETYPDVPHCANINILNYTVCRAAHPWLPAQSRTLCAGILQGGIDTCKGDSGGPLICNGQIQGIVSWGDNPCAQPLKPGHYTNVFDYTDWIQSIIAGNTTATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that has fibrinogenolytic activities by hydrolyzing the beta chain of fibrinogen (FGB). Typical arginine esterase which hydrolyzes esters and amides of arginine. {ECO:0000269|PubMed:11910177, ECO:0000269|PubMed:2028469}.",Serine Protease
57,E0Y421,VSPY_MACLB,3.4.21.-,Chymotrypsin-like protease VLCTLP (EC 3.4.21.-) (Snake venom serine protease) (SVSP) (Vipera Lebetina with chymotrypsin-like proteolytic activity),MVLIRVLANLLLLQLSYAQKSSELVVGGDECNINEHRSLVFLYNSSFGCGGTLINQQWVLSAAHCDMENVQIYLGLHNLRLRNQDEQIRVAEEKFFCLSNKSYTKWDKDIMLIRLNSSVTYNTHIAPLSLPSSPPRVGSVCRIMGWGAITSPNETFPNVPHCANINILRYSVCRAAYRGLPAQSRTLCAGILQGGIGSCMGDSGGPLICNGEIQGIVSWGDDICAQPHKPVHYTKVFDYSDWIQSIIAGNTTATCPL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease with tyrosine-specific chymotrypsin-like activity. Hydrolyzes the N-acetyl-L-tyrosine ethyl ester (ATEE). Has weak fibrinogenolytic activity. Weakly hydrolyzes azocasein, Aalpha-chain (FGA) and more slowly Bbeta-chain (FGB) of fibrinogen. Optimal substrates are angiotensins I and II (AGT). {ECO:0000269|PubMed:20950666}.",Serine Protease
58,F8QN53,PA2A2_VIPRE,3.1.1.4,Acidic phospholipase A2 Vur-PL2B (Vur-PL2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRILWIVAVCLIGVEGNLYQFGKMIRYKTGKSALLSYSDYGCYCGWGGQGKPKDATDRCCFVHDCCYGRVNGCDPKLTIYSYSFENGDIVCGGDDSCKRAVCECDRVAAICFGENLNTYDKKYKNYPSSQCTETEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 that causes internal bleeding, shows very strong anticoagulant activities and inhibits ADP-induced platelet aggregation (PubMed:21185324). Shows very low cytotoxicity (PubMed:21185324). Is not able (or very weakly) to suppress the acetylcholine (ACh)-evoked current mediated by alpha-7-similar nAChRs in L.stagnalis neurons (IC(50)>30 uM) and to compete with alpha-bungarotoxin for binding to muscle- and alpha-7 neuronal nAChR types, as well as to AChBPs (PubMed:25522251). In inhibition of alpha-bungarotoxin binding, this toxin is similarly active against T.californica nAChR (IC(50)>100 uM), human alpha-7 nAChR (IC(50)=29 uM), and L.stagnalis AChBP (IC(50)>30 uM) (PubMed:25522251). {ECO:0000269|PubMed:21185324, ECO:0000269|PubMed:25522251}.",Phospholipase
59,F8QN54,PA2B_VIPRE,3.1.1.4,Basic phospholipase A2 vurtoxin (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLIGVEGSLLEFGMMILEETGKNPLTSYSFYGCYCGVGGKGTPKDATDRCCFVHDCCYGNLPDCNPKIDRYKYHRKNGAIVCGKGTSCENRICECDRAAAICFRKNLKTYNHIYKYYPDFLCKKESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 that may have a strong anticoagulant activity (PubMed:21185324). Is able to suppress the acetylcholine (ACh)-evoked current mediated by alpha-7 (CHRNA7)-similar nAChRs in L.stagnalis neurons (IC(50)=10.5 uM) and to compete with alpha-bungarotoxin for binding to muscle- and alpha-7 neuronal nAChR types, as well as to AChBPs (PubMed:25522251). In inhibition of alpha-bungarotoxin binding, this toxin is mostly active against T.californica nAChR (IC(50)=0.26 uM), it is moderately active against human alpha-7 nAChR (IC(50)=14 uM), and is not active against L.stagnalis and A.californica AChBP (IC(50)>30 uM) (PubMed:25522251). {ECO:0000269|PubMed:21185324, ECO:0000269|PubMed:25522251}.",Phospholipase
60,F8RKW5,NGFV_DRYCN,,Venom nerve growth factor (v-NGF) (vNGF),MSMMCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRENHPVHNQGEHSVCDSVSDWVIKTTATDIHGNMVTVMGDINFTNEVYKQYFFETKCRNPNPVPSGCRGIDSKVWNSYCTTTQTFVKALTMEGSRASWRFIRIDTACVCVISRKTENF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
61,G8XQX1,OXLA_DABRR,1.4.3.2,L-amino-acid oxidase (DrLAO) (LAAO) (EC 1.4.3.2),MNVFFMFSLLFLATLGSCADDKNPLEECFREDDYEEFLEIAKNGLKKTSNPKHIVIVGAGMSGLSAAYVLAGAGHKVTVLEASERPGGRVRTHRNVKEGWYANLGPMRVPEKHRIIREYIRKFGLKLNEFVQETENGWYFIKNIRKRVGEVKKDPGLLKYPVKPSEAGKSAGQLYQESLGKAVEELKRTNCSYILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDQLPTSMYRAIEESVHFKARVIKIQQNAEKVTVTYQTTQKNLLLETADYVIVCTTSRAARRITFKPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIQGGKSTTDLPSRFIYYPNHNFTTGVGVIIAYGIGDDANFFQALNLNECADIVFNDLSSIHQLPKKDLQTFCYPSIIQKWSLDKYAMGAITTFTPYQFQHFSEALTAPVGRIFFAGEYTANAHGWIDSTIKSGLTAARDVNRASEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:21802487). Is highly active on L-Tyr followed by L-Phe, L-Met, L-Leu, L-Trp, and weakly active on L-Ile, L-Arg, L-Val, L-Lys, and L-Ala (PubMed:21802487). Inhibits ADP- and collagen-induced platelet aggregation (PubMed:21802487). This inhibition is inhibited by catalase, indicating the importance of generated H(2)O(2) for the inhibitory effect (PubMed:21802487). This effect on platelets among snake L-amino-acid oxidases is however controversial, since some of them induce aggregation, whereas the other inhibit agonist-induced aggregation (By similarity). In vivo, this enzyme induces a rapid, substantial and reversible increase in the paw volume of mice (edema) (PubMed:21802487). In addition, myofibrosis, and inflammatory cell infiltration on the paw tissue are also observed (PubMed:21802487). {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:21802487}.",Kunitz Family
62,G9I929,VKTA_MICTN,,Kunitz-type neurotoxin MitTx-alpha,MSSGGLLLLLGLLTLCAELTPVSSQIRPAFCYEDPPFFQKCGAFVDSYYFNRSRITCVHFFYGQCDVNQNHFTTMSECNRVCHG,Venom Kunitz-type family,"FUNCTION: MitTx, a heteromeric complex between Kunitz- and phospholipase-A2-like proteins, potently, persistently and selectively activates rat and chicken acid-sensing ion channel ASIC1 (PubMed:22094702, PubMed:24507937). Both alternatively spliced rat isoforms ASIC1a and ASIC1b are activated, with a higher potency for ASIC1a (EC(50)=9.4 nM) vs ASIC1b (EC(50)=23 nM) (PubMed:22094702). The rat ASIC3 subtype is also sensitive to the heterodimer, but with a lower potency (EC(50)=830 nM) (PubMed:22094702). On rat ASIC2a, the toxin shows a very weak activation, but produces a remarkable potentiation (>100-fold) of protons when the extracellular pH drops below neutrality (PubMed:22094702). Moderate and weak activations are also observed on the heterotrimers Asic1a-Asic2a and Asic1a-Asic3 (expressed in CHO cells), respectively (PubMed:22094702). The binding sites of the beta subunit of MitTx and the spider psalmotoxin-1 overlap, explaining why these toxins are mutually exclusive (PubMed:22094702, PubMed:24507937). In vivo, the heterodimer elicits robust pain-related behavior in mice by activation of ASIC1 channels on capsaicin-sensitive nerve fibers (PubMed:22094702). {ECO:0000269|PubMed:22094702, ECO:0000269|PubMed:24507937}.",Phospholipase
63,G9I930,PA2HB_MICTN,,Basic phospholipase A2 homolog MitTx-beta (svPLA2 homolog),MDKMNPAHLLVLAAVCVSLLGASSIPPQALNLNQFRLMIKCTNDRVWADFVDYGCYCVARDSNTPVDDLDRCCQAQKQCYDEAVKVHGCKPLVMFYSFECRYLASDLDCSGNNTKCRNFVCNCDRTATLCILTATYNRNNHKIDPSRCQ,"Phospholipase A2 family, Group I subfamily, K49 sub-subfamily","FUNCTION: Heterodimer: MitTx, a heteromeric complex between Kunitz- and phospholipase-A2-like proteins, potently, persistently and selectively activates rat and chicken acid-sensing ion channel ASIC1 (PubMed:22094702, PubMed:24507937). Both alternatively spliced rat isoforms ASIC1a and ASIC1b are activated, with a higher potency for ASIC1a (EC(50)=9.4 nM) vs ASIC1b (EC(50)=23 nM) (PubMed:22094702). The rat ASIC3 subtype is also sensitive to the heterodimer, but with a lower potency (EC(50)=830 nM) (PubMed:22094702). On rat ASIC2a, the toxin shows a very weak activation, but produces a remarkable potentiation (>100-fold) of protons when the extracellular pH drops below neutrality (PubMed:22094702). Moderate and weak activations are also observed on the heterotrimers Asic1a-Asic2a and Asic1a-Asic3 (expressed in CHO cells), respectively (PubMed:22094702). The binding sites of the beta subunit of MitTx and the spider psalmotoxin-1 toxin overlap, explaining why these toxins are mutually exclusive (PubMed:22094702, PubMed:24507937). In vivo, the heterodimer elicits robust pain-related behavior in mice by activation of ASIC1 channels on capsaicin-sensitive nerve fibers (PubMed:22094702). {ECO:0000269|PubMed:22094702, ECO:0000269|PubMed:24507937}.; FUNCTION: Monomer: does not have phospholipase A2 activity but may maintain some lipid-binding character from its PLA2 lineage, which could aid in effecting neuronal depolarization. {ECO:0000305|PubMed:22094702}.",Phospholipase
64,I2C090,VCO3_OPHHA,,Ophiophagus venom factor (OVF) (CVF-like) (Complement C3 homolog) [Cleaved into: OVF alpha chain; OVF gamma chain; OVF beta chain],MEGMALYLVAALLIGFPGSSHGALYTLITPGVLRTDTEEQILVEAHGDNTPKQLDIFVHDFPRKQKILFQKRVDMNPAGDMLVTPTIKIPAEEVSKDSRQNQYVVVQVTGPQVRLEKVVLLSYQSGFVFIQTDKGIYTPGSPVLYRVFSMDHNMRQMDKTVVVEFQTPEGIVVSSNRIDLNFTRPYNLPELGSLGTWKIVAKYEHSPENYTAYFDVRKYVLPSFEVHLQPSEKSFYIDGNENFHVSITARYLYGEEVEGVAFVLFGVKIDGAKKSIPDSLTRIPILDGDGEATLKRDTLRSRFPNLNELVGHTLYASVTVITESGSDMVATEQSGIHIVTSPYQIYFTKTPKYFKPGMPYELTVYVTNPDGSPAAKVPVVSEAIHSEGTTLSDGTAKLILNTPLDTQSLLITVRTNHGDLPRERQATKSMTATAYQTQGGSGNYLHVAITSTEIKPGDNLPVNFNVRGNANSLNQVKYFTYLVGRQPKGAGQNLVAMNLRITPDLIPSFRFVAYYQVGNNEIVADSVWVDVKDTCMGTLVVKGASLTDNQIHMPGAAMKIKLEGDPGAQVGLVAVDKAVYVLNDKYKISQAKIWDTIEKSDFGCTAGGGQNNLGVFEDAGLALTTSTNLNTKQRSDTKCPQPANRRRRSSVLLLDSKASKAAQFQDQDLRKCCEDSMHENPMGYTCEKRAKYIQEGDACKAAFLECCRYIKGILDENQWESGLFLPRNDNEDGFIQDSDIIPRTDFPKSWLWHTVQLTEQPNSNGISSKTMSIYLKESITTWEVLAVSFTPTKGICVAEPYEIKVMKDFFIDLRVPYSVVRKEQVEIRAVLYNYAGRDIYVRVELLYNPAFCSASTEEQRYRQQFTIKALSSRAVPFVIVPLQQGLHDIEVRASVQGWESVSDGVKKKLKVVPEGVQKCIVTIIKLDPRAKGVDGTQREVVKARKLDDKVPDTEIETKITIQADPVAQIIENSIDGSKLNHLIITPSGCGEQNMIRMTAPVIATYYLDTTEQWETLGRNHRNEAVKQIMTGYAQQMVYKKANHSYAAFTNRASSTWLTAYVVKVFAMATKMVAGISHEIICGGVRWLILNRQQPDGAFKENAPVLSGTMQGGIQGDESEVTVTAFTLVALLESKTICNDSVNSLDSSIKKATDYLLKKYEKLQRPYTTALTAYALAAADRLNDDRVLMAASTGKNRWEEYNAHTHNVEGTSYALLALLKMKKFDQTGPIVRWLTDQNFYGGTYGQTQATVMLFQALAEYKIQMPTHKDLNLDIIIKLPERELPLHYRLDATNAILARTAETKLNQDFTVSASGDGTATMTILTVYNAQLQEKANVCNKFHLDVSVENIHLNFKHAKGAKGALMLKICMRYLGEVDSTMTIIDISMLTGFLPDAEDLTRLSEGVDRYISRYEVDNNMAQKVAVIIYLDKVSHSEDECLQFKILKHFEVGFIQPGSVKVYSYYNLDEQCTKFYHPDKGTGLLNKICVGNICRCAAETCSLLSQQEKIDLPLRIQKACASNVDYVYKTKLLRIEEKDGYDIYVMDVLEVIKPGTDENPQANARQYISQRKCQEALNLNVNDDYLIWGLRSDLWPMKDKFSYLITKNTWIERWPHEDECQDEEFQNLCLDFAHLSNILTIFGCPT,Venom complement C3 homolog family,"FUNCTION: Complement-activating protein in cobra venom. It is a structural and functional analog of complement component C3b, the activated form of C3. It binds factor B (CFB), which is subsequently cleaved by factor D (CFD) to form the bimolecular complex OVF/Bb. OVF/Bb is a C3/C5 convertase that cleaves both complement components C3 and C5. Structurally, it resembles the C3b degradation product C3c, which is not able to form a C3/C5 convertase. Unlike C3b/Bb, OVF/Bb is a stable complex and completely resistant to the actions of complement regulatory factors H (CFH) and I (CFI). Therefore, OVF continuously activates complement (By similarity). As a result, OVF exhibits complement-depleting activity. {ECO:0000250, ECO:0000269|PubMed:22561424}.",General Toxin
65,I2G9B4,VKT_MACLN,,Kunitz-type serine protease inhibitor PIVL,MSSGGLLLLLGLLTLWAELTPVSSQDRPKFCYLPADPAECNAYMPRFYYDSASNKCKEFIYGGCRGNANNFKNRAECRHTCVASRKGIQPRIASN,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that inhibits trypsin. Exhibits an anti-tumor effect and displays integrin inhibitory activity without being cytotoxic. Is able to dose-dependently inhibit the adhesion, migration and invasion of human glioblastoma U87 cells. Also impairs the function of alpha-v/beta-3 (ITGAV/ITGB3) and to a lesser extent, the activity of alpha-v/beta-6 (ITGAV/ITGB6), alpha-v/beta-5 (ITGAV/ITGB5), alpha-1/beta-1 (ITGA1/ITGB1) and alpha-5/beta-1 (ITGA5/ITGB1) integrins. {ECO:0000269|PubMed:23262217}.",Serine Protease
66,I4CHP3,VSPI_GLOHA,3.4.21.-,Thrombin-like enzyme AhV_TL-I (SVTLE AhV_TL-I) (EC 3.4.21.-),IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHCDRKNFRIKLGMHSKKVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSKHIAPFSLPSSPPSVGSVCRIMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCKGDSGGPLICNGQFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIENIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like enzyme that shows fibrinogenolytic activity against both the Aalpha (FGA) and Bbeta (FGB) chains of bovine fibrinogen. This enzyme has poor esterolytic activity upon BAEE substrate. It induces mouse thoracic aortic ring contraction with EC(50)=147 nmol/L. It shows vasoconstrictor effects that are independent of the enzymatic activity, but related to the release of calcium ions form the calcium store, potentially through the activation of ryanodine receptors. {ECO:0000269|PubMed:23052203}.",Serine Protease
67,I6L8L6,PA2H1_BOTBZ,,Basic phospholipase A2 homolog 2 (svPLA2 homolog) (Myotoxin II) (MTX-II),SLFQLGKMILQETGKNPAASYGAYGCNCGVLGRGKPKDATDRCCYVHKCCKKKLTGCDPKKDRYSYSWKDKTIVCGENNPCLKELCECDKAVAICLRENLNTYNKKYRYHLKPFCKKADPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Is myotoxic and displays edema-inducing activities in mouse paw (PubMed:18602430). Also displays cytotoxic activity against some cell lines, and antimicrobial activities against E.coli, C.albicans and Leishmania (PubMed:18602430). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (PubMed:24145104). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (PubMed:24145104). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (PubMed:24145104). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (PubMed:24145104). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (PubMed:24145104). {ECO:0000269|PubMed:18602430, ECO:0000305|PubMed:24145104}.",Phospholipase
69,K4LLQ2,VSP_BOTBA,3.4.21.-,Thrombin-like enzyme barnettobin (Bb-TLE) (SVTLE) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),APKELQVSYAHKSSELVIGGDECDINEHPFLAFLYSRGNFCGLTLINQEWVLTAAHCDRRFMPIYLGIHTLSVPNDDEVIRYPKDNFICPNNNIIDEKDKDIMLIRLNRPVKNSEHIAPISLPSNLPSVGSVCRVMGWGSITAPNDTFPDVPHCANINLFNDTVCHGAYKRFPVKSRTLCAGVLQGGKDKCMGDSGGPLICNGPFHGILFWGDDPCALPRKPALYTKGFEYPPWIQSIIAKNTTETCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease that releases only fibrinopeptide A from human Aalpha chain of fibrinogen (specific coagulant activity was 251.7 NIH thrombin units/mg). Also shows fibrino(geno)lytic activities in vitro and defibrinogenating effects in vivo. {ECO:0000269|PubMed:23578498}.,Serine Protease
70,N0A5N4,VAE2_GLOHA,3.4.21.-,Thrombin-like enzyme agkihpin-2 (TLE agkihpin-2) (EC 3.4.21.-) (Agkihpin) (Snake venom arginine esterase) (SVAE) (Snake venom thrombin-like enzyme) (SVTLE),MILGDDECNINEHRFLVALYTSRTLFCGGTLINQEWVLTAAHCNMEDIQIKLGMHSKKVPNEDEQKRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSAHIAPLSLPSSPPSVGSVCRTMGWGRISSTKETYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCVGDSGGPLICNGQFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIENIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like enzyme that shows fibrinogenolytic activity against bovine fibrinogen alpha and beta chains, but not gamma chain. Hydrolyzes fibrin. Enhances ADP-induced human platelet aggregation. Has arginine esterase activity for TAMe (tosyl-arginine methyl ester) substrate. Reduces thrombin-induced thrombosis. Does not have hemorrhagic activity (PubMed:27666486, PubMed:28579355). Reduces the motility of human liver cancer HepG2 cells in a wound-healing assay (PubMed:28579355). {ECO:0000269|PubMed:27666486, ECO:0000269|PubMed:28579355}.",Serine Protease
71,O57385,PA2H_DEIAC,,Basic phospholipase A2 homolog acutohaemolysin (svPLA2 homolog) (Dac-K49),MRALWIVAVLLVGVEGSLFELGKMIWQETGKNPVKNYGLYGCNCGVGGRGEPLDATDRCCFVHKCCYKKLTDCDSKKDRYSYKWKNKAIVCGKNQPCMQEMCECDKAFAICLRENLDTYNKSFRYHLKPSCKKTSEQC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:10930841). Is myotoxic (By similarity). Has a strong indirect hemolytic activity and anticoagulant activity (PubMed:10930841). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:10930841}.",Phospholipase
72,O57413,VM2T3_PROMU,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase TM-3 (SVMP) (EC 3.4.24.-) (Atrolysin e) (Fibrinlysin) (Trimutase); Disintegrin trimucrin],MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVSALPKGAVQPKYEDAMQYEFKVNGEAVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYPIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYIKLAIVVDHGMYTKYSSNFKKIRKRVHQMVSNINEMCRPLNIAITLALLDVWSEKDFITVQADAPTTAGLFGDWRERVLLKKKNHDHAQLLTDTNFARNTIGWAYVGRMCDEKYSVAVVKDHSSKVFMVAVTMTHELGHNLGMEHDDKDKCKCDTCIMSAVISDKQSKLFSDCSKDYYQTFLTNDNPQCILNAPLRTDTVSTPVSGNEFLEAGEECDCGSPENPCCDAATCKLRPGAQCAEGLCCDQCRFKKKRTICRRARGDNPDDRCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase TM-3]: Potent fibrinogenolytic protease which cleaves mainly the Aalpha chain of fibrinogen (FGA) and slightly the Bbeta (FGB) and the gamma (FGG) chains (PubMed:7488093, PubMed:8193588). May possess hemorrhagic activity (PubMed:7488093). Compared to other SVMP, the substrate-binding pocket is relatively shallow (PubMed:12077431). Is less susceptible to tripeptide inhibitors than TM-1 (AC U3KRG1) and TM-2 (PubMed:9703966). {ECO:0000269|PubMed:12077431, ECO:0000269|PubMed:7488093, ECO:0000269|PubMed:8193588, ECO:0000269|PubMed:9703966}.; FUNCTION: [Disintegrin trimucrin]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3). {ECO:0000250|UniProtKB:P17349}.",Kunitz Family
73,O93364,OXLA_CROAD,1.4.3.2,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2),MNVFFMFSLLFLAALGSCAHDRNPLEECFRETDYEEFLEIAKNGLTATSNPKRVVIVGAGMAGLSAAYVLAGAGHQVTVLEASERVGGRVRTYRKKDWYANLGPMRLPTKHRIVREYIKKFDLKLNEFSQENENAWYFIKNIRKRVREVKNNPGLLEYPVKPSEEGKSAAQLYVESLRKVVEELRSTNCKYILDKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFGYEKRFDEIVGGMDQLPTSMYEAIKEKVQVHFNARVIEIQQNDREATVTYQTSANEMSSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFTSGVGVIIAYGIGDDANFFQALDFKDCADIVINDLSLIHELPKEDIQTFCHPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPFKRIYFAGEYTAQFHGWIDSTIKSGLTAARDVNRASENPSGIHLSNDNEF,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:6067195). Is active on L-Arg, L-Phe, L-Met, and L-Leu and is weakly active on L-Val (PubMed:6067195). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:6067195}.",Vascular Interaction
74,O93523,VM3BP_BOTJA,3.4.24.49,Zinc metalloproteinase-disintegrin-like bothropasin (EC 3.4.24.49) (Snake venom metalloproteinase) (SVMP) [Cleaved into: Disintegrin-like bothropasin],MIEVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGREITTYPAVEDHCYYHGRIENDADSTASISACNGLKGHFKLQRETYFIEPLKLSNSEAHAVFKYENVEKEDEAPKMCGVTQNWKSYEPIKKASQLVVTAEQQKYNPFRYVELFIVVDQGMVTKNNGDLDKIKARMYELANIVNEILRYLYMHAALVGLEIWSNGDKITVKPDVDYTLNSFAEWRKTDLLTRKKHDNAQLLTAIDFNGPTIGYAYIGSMCHPKRSVAIVEDYSPINLVVAVIMAHEMGHNLGIHHDTDFCSCGDYPCIMGPTISNEPSKFFSNCSYIQCWDFIMKENPQCILNEPLGTDIVSPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYALFGADVYEAEDSCFKDNQKGNYYGYCRKENGKKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNDDEHKGMVLPGTKCADGKVCSNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily",FUNCTION: [Zinc metalloproteinase-disintegrin-like bothropasin]: Has caseinolytic activity. Causes hemorrhage on rabbit skin and causes myonecrosis in mouse tibialis anterior muscle.; FUNCTION: [Disintegrin-like bothropasin]: Inhibits platelet aggregation.,Metalloprotease
75,P00596,PA2A1_NAJKA,3.1.1.4,Acidic phospholipase A2 CM-II (CM 2) (svPLA2) (EC 3.1.1.4) (Acidic phospholipase A2 1) (NnkPLA-I) (Phosphatidylcholine 2-acylhydrolase),MNPAHLLILAAVCVSPLGAFSNRPMPLNLYQFKNMIQCTVPNRSWWDFADYGCYCGRGGSGTPVDDLDRCCQVHDNCYNEAEKISRCWPYFKTYSYECSQGTLTCKGDNDACAAAVCDCDRLAAICFAGAPYNNNNYNIDLKARCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (Probable). Is able to suppress the acetylcholine (ACh)-evoked current mediated by alpha-7 (CHRNA7)-similar nAChRs in L.stagnalis neurons (IC(50)=37 nM) and to compete with alpha-bungarotoxin for binding to muscle- and alpha-7 neuronal nAChR types, as well as to AChBPs (PubMed:25522251). In inhibition of alpha-bungarotoxin binding, this toxin is similarly active against T.californica nAChR (IC(50)=1.2 uM), human alpha-7 nAChR (IC(50)=3.2 uM), and L.stagnalis AChBP (IC(50)=1.0 uM), whereas it is not active against A.californica AChBP (IC(50)>100 uM) (PubMed:25522251). {ECO:0000269|PubMed:25522251, ECO:0000305}.",Neurotoxin
77,P00598,PA2A1_NAJAT,3.1.1.4,Acidic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (Muscarinic protein) (MP) (Phosphatidylcholine 2-acylhydrolase),MTPAHLLILAAVCVSPLGASSNRPMPLNLYQFKNMIQCTVPSRSWWDFADYGCYCGRGGSGTPVDDLDRCCQVHDNCYNEAEKISGCWPYFKTYSYECSQGTLTCKGGNNACAAAVCDCDRLAAICFAGAPYNNNNYNIDLKARCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has high affinity for muscarinic acetylcholine receptors mAChRs (CHRM) and has the ability to activate them. In guinea-pig ileum, produces an onset and dose-dependent contraction. Has also weak anticoagulant activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18281071, ECO:0000269|PubMed:3117784}.",Phospholipase
78,P00608,PA2B_NOTSC,3.1.1.4,Basic phospholipase A2 notexin (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLVQFSYLIQCANHGKRPTWHYMDYGCYCGAGGSGTPVDELDRCCKIHDDCYDEAGKKGCFPKMSAYDYYCGENGPYCRNIKKKCLRFVCDCDVEAAFCFAKAPYNNANWNIDTKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. Is directly toxic to skeletal muscle upon local application in vivo (dystrophic effect). Also has direct nephrotoxicity in experimental mice; a single subcutaneous dose (1.38 ug/kg) produces renal tubular and glomerular damage within 24 hours (PubMed:7580101). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
80,P00614,PA2TA_OXYSC,3.1.1.4,Basic phospholipase A2 taipoxin alpha chain (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFGFMIRCANRRSRPVWHYMDYGCYCGKGGSGTPVDDLDRCCQVHDECYGEAVRRFGCAPYWTLYSWKCYGKAPTCNTKTRCQRFVCRCDAKAAECFARSPYQNSNWNINTKARCR,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling. May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum.; FUNCTION: Monomer (alpha chain): Snake venom phospholipase A2 (PLA2) alpha chain that possesses the same high enzymatic activity as the heterotrimer. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
81,P00615,PA2HB_OXYSC,,Neutral phospholipase A2 homolog taipoxin beta chain 1 (svPLA2 homolog),MHPAHLLVLLAVCVSLLGASDIPPLPLNLVQFGKMIECAIRNRRPALDFMNYGCYCGKGGSGTPVDDLDRCCQVHDECYAEAEKHGCYPSLTTYTWECRQVGPYCNSKTQCEVFVCACDFAAAKCFAQEDYNPAHSNINTGERCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling. May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum.; FUNCTION: Monomer (beta chain): Snake venom phospholipase A2 homolog that is neither toxic nor enzymatically active. Does not bind calcium.",Phospholipase
82,P00616,PA2HG_OXYSC,,Acidic phospholipase A2 homolog taipoxin gamma chain (svPLA2 homolog),MHPAHLLVLLAVCVSLLGSSEIPQPSLDFEQFSNMIQCTIPCGESCLAYMDYGCYCGPGGSGTPIDDLDRCCKTHDECYAEAGKLSACKSVLSEPNNDTYSYECNEGQLTCNDDNDECKAFICNCDRTAVTCFAGAPYNDLNYNIGMIEHCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling. May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum.; FUNCTION: Monomer (gamma chain): Snake venom phospholipase A2 homolog that is neither toxic nor enzymatically active. Does not bind calcium (PubMed:22776098). {ECO:0000269|PubMed:10748068, ECO:0000269|PubMed:22776098, ECO:0000269|PubMed:7722520, ECO:0000269|PubMed:976268}.",Phospholipase
83,P00617,PA2B1_BUNMU,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A1 chain (Beta-BuTX A1 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MNPAHLLVLSAVCVSLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAEKKHKCNPKTQSYSYKLTKRTIICYGAAGTCGRIVCDCDRTAALCFGNSEYIEGHKNIDTARFCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
84,P00618,PA2B2_BUNMU,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A2 chain (Beta-BuTX A2 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MLIFLWCGAVCVSLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAEKKHKCNPKTQSYSYKLTKRTIICYGAAGTCARIVCDCDRTAALCFGNSEYIERHKNIDTKRHCR,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
85,P00619,PA2A3_BUNMU,3.1.1.4,Acidic phospholipase A2 beta-bungarotoxin A3 chain (Beta-BuTX A3 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLSAVCVSLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYTNYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAANIRDCNPKTQSYSYKLTKRTIICYGAAGTCARVVCDCDRTAALCFGDSEYIEGHKNIDTARFCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
88,P00625,PA2A1_OVOOK,3.1.1.4,Acidic phospholipase A2 DE-I (svPA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 Ook-E6) (Phospholipase A2 PLA2-01),MRTLWIMAVLLLGVEGHLMQFETLIMKIAGRSGVWWYGSYGCYCGAGGQGRPQDPSDRCCFVHDCCYGKVTGCNTKDEFYTYSEENGAITCGGENPCLKEVCECDLAAAICFRDNLDTYNSKKYWMFPAKNCLEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits the ADP- and collagen-induced human platelet aggregation (By similarity). Exhibits high hydrolytic activities and preferred the anionic micelles to the zwitterionic micelles. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000250, ECO:0000269|PubMed:22115990}.",Phospholipase
89,P00626,PA2BA_VIPAA,3.1.1.4,Basic phospholipase A2 ammodytoxin A (AtxA) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLIGVEGSLLEFGMMILGETGKNPLTSYSFYGCYCGVGGKGTPKDATDRCCFVHDCCYGNLPDCSPKTDRYKYHRENGAIVCGKGTSCENRICECDRAAAICFRKNLKTYNYIYRNYPDFLCKKESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that acts as a presynaptic neurotoxin, an inhibitor of blood coagulation, and has been found to bind with high affinity to intracellular proteins. The response of indirectly stimulated neuromuscular preparations to ammodytoxin (Atx) is triphasic. The first phase, the transient inhibition of the acetylcholine (ACh) release, starts soon after the addition of Atx and lasts for several minutes. This phase is probably independent of Atx enzymatic activity. The effect may be due to the specific binding of the toxin to presynaptic receptors. These receptors, called N-type receptors, are still unidentified. It is noteworthy that a neuronal isoform of the M-type PLA2 receptor (R180) has been identified as a high-affinity receptor for Atx in neuronal plasma membranes. It was demonstrated however that this receptor is not essential for expression of neurotoxicity by Atx. The second phase corresponds to an augmentation of neurotransmitter release. A peak is reached 10-20 minutes after exposure of the preparation to Atx and is followed by a gradual reduction. In this phase, the enzymatic activity of Atx of the mammalian is not significant. It is speculated that the increased release of neurotransmitter in this phase is induced by the interference of Atx with voltage-gated potassium channels. Measurements of ionic currents showed however that voltage-gated potassium channels are not affected by Atx. The third phase of the response of neuromuscular preparations to Atx, which corresponds to a complete and irreversible paralysis, is clearly dependent on the hydrolytic activity of the toxin. In addition to its presynaptic neurotoxicity, Atx shows an anticoagulant activity by binding with high affinity to activated coagulation factor X (F10) thus inhibiting the formation of the prothrombinase complex (FX/FV) and its activity (IC(50) is 20 nM). Surprisingly, Atx was discovered to bind intracellular proteins such as calmodulin (CaM) (IC(50) is 6 nM), 14-3-3 proteins gamma (YWHAG) and epsilon (YWHAE) (by similarity with AtxC), as well as R25 (by similarity with AtxC), a mitochondrial integral membrane protein found in cerebral cortex. These findings raised a doubt about the dogma of the exclusively extracellular action of PLA2s, defended by the potential instability of these molecules in the reducing environment of the eukaryotic cytosol coupled with their possible inability to act as enzymes in this cellular compartment, due to too low concentration of calcium ions. This hypothesis was challenged efficiently by demonstrating the internalization of AtxA into a culture cells, but still remains to be directly demonstrated in vivo. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:11600150, ECO:0000269|PubMed:15485650, ECO:0000269|PubMed:16039772, ECO:0000269|PubMed:16815622, ECO:0000269|PubMed:3986212}.",Phospholipase
90,P00627,PA2B6_BUNFA,3.1.1.4,Basic phospholipase A2 6 (svPLA2) (EC 3.1.1.4) (KBf VI) (KBf-6) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme VI) (Toxin VI),AVCVSLLGAANIPPQSLNLYQFKNMIECAGTRTWLAYVKYGCYCGPGGTGTPLDELDRCCQTHDHCYDNAKKFGNCIPYLKTYVYTCNKPDITCTGAKGSCGRNVCDCDRAAAICFAAAPYNLANFGIDKEKHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Very weakly suppress the acetylcholine (ACh)-evoked current mediated by alpha-7-similar nAChRs in L.stagnalis neurons. {ECO:0000269|PubMed:25522251}.,Phospholipase
91,P00628,PA2BV_BUNFA,3.1.1.4,Basic phospholipase A2 KBf-VA (KBf Va) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Toxin V-2),AVCVSLLGAANIPPQPLNLLQFKNMIQCAGSRLWVAYVKYGCYCGPGGTGTPLDQLDRCCQTHDHCYDNAKKFGNCIPYFKSYEYTCNKPDLTCTDAKGSCARNVCDCDRAAAICFAAAPYNLANFGINKETHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
92,P00629,PA2B3_BUNFA,3.1.1.4,Basic phospholipase A2 Vb-2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Toxin V-3),AVCVSLLGAANIPPQPLNLLQFKNMIQCAGSRLWVAYVKYGCYCGPGGTGTPLDQLDRCCQTHDHCYDNAKKFGNCIPYFKTYEYTCNKPDITCTDAKGSCGRTVCDCDRAAAICFAAAPYNLANFGIDKEKHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has only a weak enzymatic activity. Inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
93,P00980,VKTHA_DENAN,,Kunitz-type serine protease inhibitor homolog alpha-dendrotoxin (Alpha-DTX) (Protease inhibitor 1 homolog) (Toxin C13S2C3) (Venom basic protease inhibitor 1 homolog),QPRRKLCILHRNPGRCYDKIPAFYYNQKKKQCERFDWSGCGGNSNRFKTIEECRRTCIG,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor homolog that blocks voltage-gated potassium channels (Kv1.1/KCNA1, Kv1.2/KCNA2, and Kv1.6/KCNA6) (IC(50)=0.4-150 nM) and facilitates neurotransmitter release. {ECO:0000269|PubMed:10936620, ECO:0000269|PubMed:23771044}.",Serine Protease
94,P00981,VKTHK_DENPO,,Kunitz-type serine protease inhibitor homolog dendrotoxin K (DTX-K) (Venom basic protease inhibitor K),SGHLLLLLGLLTLWAELTPVSGAAKYCKLPLRIGPCKRKIPSFYYKWKAKQCLPFDYSGCGGNANRFKTIEECRRTCVG,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor homolog that selectively blocks voltage-gated potassium channels homooligomer Kv1.1/KCNA1 (EC(50)=0.6 nM) and Kv1.1-containing heterooligomer. {ECO:0000269|PubMed:10429207, ECO:0000269|PubMed:8612784, ECO:0000269|PubMed:9134213}.",Serine Protease
95,P00982,VKTHD_DENAN,,Kunitz-type serine protease inhibitor homolog delta-dendrotoxin (Delta-DTX) (Dendrotoxin delta-DaTX) (Protease inhibitor K) (Toxin C13S1C3) (Venom basic protease inhibitor K),AAKYCKLPVRYGPCKKKIPSFYYKWKAKQCLPFDYSGCGGNANRFKTIEECRRTCVG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor homolog that blocks voltage-gated potassium channels (Kv). {ECO:0000269|PubMed:10698633}.,Serine Protease
96,P01021,BNP_GLOBL,,Bradykinin-potentiating and C-type natriuretic peptides (Angiotensin-converting enzyme inhibitor) (BPP-CNP homolog) [Cleaved into: Blomhotin; Bradykinin-potentiating peptide A (BPP-a) (Potentiator A); Leu3-blomhotin (Potentiator D); Bradykinin-potentiating peptide B (BPP-b) (Potentiator B); Bradykinin-potentiating peptide C (BPP-c) (Potentiator C); Bradykinin-potentiating peptide E (BPP-e) (Potentiator E); Bradykinin-potentiating peptide Ahb1 (BPP-Ahb1); Bradykinin-potentiating peptide Ahb2 (BPP-Ahb2); C-type natriuretic peptide],MFVSRLAASGLLLLALMALSLDGKPVQQWSQGRPPGPPIPRLVVQQWSQGLPPGPPIPRLVVQQWSQGLPPGPPIPPLVVQQWSQGLPPRPKIPPLVVQQWSQGLPPRPKIPPLVVQKWDPPPVSPPLLLQPHESPAGGTTALREELSLGPEAASGPAAAGADGGRSGSKAPAALHRLSKSKGASATSASASRPMRDLRTDGKQARQNWARMVNPDHHAVGGCCCGGGGGGARRLKGLVKKGVAKGCFGLKLDRIGTMSGLGC,Bradykinin-potentiating peptide family; Natriuretic peptide family,"FUNCTION: [Blomhotin]: Inhibits the rabbit lung angiotensin-converting enzyme (ACE) (IC(50)=15 uM) (PubMed:10866809). Contracts the rat gastric fundus smooth muscle in a rapid and transient manner (PubMed:10519653, PubMed:10866809). {ECO:0000269|PubMed:10519653, ECO:0000269|PubMed:10866809}.; FUNCTION: [Bradykinin-potentiating peptide A]: Causes no contraction of the rat gastric fundus smooth muscle even at high concentrations. Causes very weak contraction of the isolated guinea pig ileum (PubMed:4323853). Causes weak contraction on rat uterus (PubMed:4323853). {ECO:0000269|PubMed:4323853}.; FUNCTION: [Bradykinin-potentiating peptide B]: Inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain (Ki=30 nM, IC(50)=1.1 uM) (PubMed:10866809, PubMed:11994001, PubMed:23082758). It binds ACE in a zinc-independent manner (PubMed:23056909). Also potentiates the hypotensive effects of bradykinin. Causes high contraction of the isolated guinea pig ileum and weak contraction on rat uterus (PubMed:4323853). {ECO:0000269|PubMed:10866809, ECO:0000269|PubMed:11994001, ECO:0000269|PubMed:23082758, ECO:0000269|PubMed:4323853}.; FUNCTION: [Bradykinin-potentiating peptide C]: Inhibits the activity of the angiotensin-converting enzyme (ACE) by interacting with the same potency to its C- and N-domains (PubMed:11994001). Inhibits the rabbit lung angiotensin-converting enzyme (ACE) (IC(50)=7.1 uM) (PubMed:10866809). Causes weak contraction of the isolated guinea pig ileum (PubMed:4323853). Causes weak contraction on rat uterus (PubMed:4323853). {ECO:0000269|PubMed:10866809, ECO:0000269|PubMed:11994001, ECO:0000269|PubMed:4323853}.; FUNCTION: [Leu3-blomhotin]: Inhibits the rabbit lung angiotensin-converting enzyme (ACE) (IC(50)=46 uM) (PubMed:10866809). Synthetic Leu3-blomhotin contracts the rat gastric fundus smooth muscle in a rapid and transient manner (PubMed:10866809). Causes moderate contraction of the isolated guinea pig ileum (PubMed:4323853). Causes weak contraction on rat uterus (PubMed:4323853). {ECO:0000269|PubMed:10866809, ECO:0000269|PubMed:4323853}.; FUNCTION: [Bradykinin-potentiating peptide E]: Causes weak contraction of the isolated guinea pig ileum (PubMed:4323853). Causes about 50-fold more potentiating activity on rat uterus than on guinea pig ileum (PubMed:4323853). {ECO:0000269|PubMed:4323853}.; FUNCTION: [Bradykinin-potentiating peptide Ahb1]: Synthetic peptide potentiates the bradykinin in vivo. {ECO:0000269|PubMed:11994001}.; FUNCTION: [Bradykinin-potentiating peptide Ahb2]: Synthetic peptide does not show any bradykinin-potentiating effects. {ECO:0000269|PubMed:11994001}.; FUNCTION: [C-type natriuretic peptide]: has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.",Metalloprotease
97,P01391,3L21_NAJKA,,Alpha-cobratoxin (Alpha-CT) (Alpha-CbT) (Alpha-Cbtx) (Alpha-Ctx) (Alpha-elapitoxin-Nk2a) (Alpha-EPTX-Nk2a) (Long neurotoxin 1) (Siamensis 3),IRCFITPDITSKDCPNGHVCYTKTWCDAFCSIRGKRVDLGCAATCPTVKTGVDIQCCSTDNCNPFPTRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Monomer: binds with high affinity to muscular (alpha-1-beta-1-gamma-delta/CHRNA1-CHRNB1-CHRNG-CHRND) nAChR (tested on Torpedo californica, Kd=0.2-4.5 nM) and neuronal alpha-7/CHRNA7 nicotinic acetylcholine receptors (Kd=13-105 nM) (PubMed:18381281, PubMed:22223648, PubMed:9305882). Also inhibits GABA(A) channels (PubMed:26221036). Heteropentamer targets studied are composed of alpha-1-beta-3-gamma-2 (GABRA1-GABRB3-GABRG2) subunits (IC(50)=236 nM), alpha-1-beta-2-gamma-2 (GABRA1-GABRB2-GABRG2) subunits (IC(50)=469 nM), alpha-2-beta-2-gamma-2 (GABRA2-GABRB2-GABRG2) subunits (IC(50)=485 nM), alpha-5-beta-3-gamma-2 (GABRA5-GABRB3-GABRG2) subunits (IC(50)=635 nM), and alpha-2-beta-3-gamma-2 (GABRA2-GABRB3-GABRG2) subunits (IC(50)=1099 nM) (activated by 10 uM GABA) (PubMed:26221036). {ECO:0000269|PubMed:18381281, ECO:0000269|PubMed:22223648, ECO:0000269|PubMed:26221036, ECO:0000269|PubMed:30025921}.; FUNCTION: Homodimer: binds with high affinity (but lower than the monomeric form) to muscular (IC(50)=9.7 nM) and with low affinity to neuronal alpha-7/CHRNA7 nAChRs (IC(50)=1370 nM) (PubMed:22223648). However, it acquires (compared to the monomeric form) the capacity to block alpha-3/beta-2 (CHRNA3/CHRNB2) nAChRs (PubMed:18381281). {ECO:0000269|PubMed:18381281, ECO:0000269|PubMed:22223648}.; FUNCTION: Heterodimer with cytotoxin 3 (AC P01446): is slightly more active than the homodimer in inhibiting alpha-7/CHRNA7 nAChR and is considerably more active in blocking the alpha-3-beta-2/CHRNA3-CHRNB2 nAChR. {ECO:0000269|PubMed:22223648}.",Neurotoxin
98,P01398,3LKB_BUNMU,,Kappa-bungarotoxin (Kappa-bgt) (Kappa-1-bungarotoxin) (Long neurotoxin 2) (Neuronal bungarotoxin) (nBgt) (Toxin F),MKTLLLTLVVVTIVCLDLGYTRTCLISPSSTPQTCPNGQDICFLKAQCDKFCSIRGPVIEQGCVATCPQFRSNYRSLLCCTTDNCNH,"Snake three-finger toxin family, Long-chain subfamily, Kappa-neurotoxin sub-subfamily","FUNCTION: Postsynaptic neurotoxin that binds and inhibits neuronal nicotinic acetylcholine receptors (nAChR) with high affinity (IC(50)<100 nM). Is a selective, and slowly reversible antagonist of alpha-3/CHRNA3-containing and some alpha-4/CHRNA4-containing AChRs. {ECO:0000269|PubMed:3986193, ECO:0000303|PubMed:9027980}.",Neurotoxin
99,P01445,3SA7A_NAJKA,,Cytotoxin 2 (CX2) (Toxin CM-7A),LKCNKLIPLAYKTCPAGKNLCYKMFMVSNKTVPVKRGCIDVCPKNSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Monomer: shows cytolytic activity. {ECO:0000269|PubMed:18381281}.; FUNCTION: Heterodimer: has no cytolytic activity, but retains most of the alpha-cobratoxin capacity to compete with alpha-bungarotoxin for binding to Torpedo and alpha-7/CHRNA7 nicotinic acetylcholine receptors (nAChRs) as well as to Lymnea stagnalis acetylcholine-binding protein. {ECO:0000269|PubMed:18381281}.",General Toxin
100,P01446,3SA3_NAJKA,,Cytotoxin 3 (CX3) (Toxin CM-7),LKCNKLIPLAYKTCPAGKNLCYKMFMVSNKTVPVKRGCIDACPKNSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Heterodimer: has no cytolytic activity, but retains most of the alpha-cobratoxin capacity to compete with alpha-bungarotoxin for binding to Torpedo and alpha-7/CHRNA7 nicotinic acetylcholine receptors (nAChRs) as well as to Lymnea stagnalis acetylcholine-binding protein. {ECO:0000269|PubMed:18381281}.; FUNCTION: Monomer: shows cytolytic activity (PubMed:18381281). Exhibits concentration-dependent growth inhibitory effects in the lung cell lines A549 (IC(50)=1.22 ug/ml) and NL20 (IC(50)=2.76 ug/ml), in the prostate cell lines PC-3 (IC(50)=4.46 ug/ml) and RWPE-1 (IC(50)=0.65 ug/ml), and in the breast cell lines MCF-7 (IC(50)=12.23 ug/ml) and 184B5 (IC(50)=2.83 ug/ml), with high selectivity for the lung cancer cell line A549 (selectivity index=2.26) (PubMed:33263003). Induces primarily necrosis in the A549 cell line, and mainly late apoptosis in the MCF-7 and PC-3 cell lines (PubMed:33263003). {ECO:0000269|PubMed:18381281, ECO:0000269|PubMed:33263003}.",Kunitz Family
101,P04084,PA2HA_VIPAE,,Acidic phospholipase A2 homolog vipoxin A chain (svPLA2 homolog) (Acidic phospholipase A2 inhibitor vipoxin A chain) (Vipoxin acidic component) (VAC) (Vipoxin non-toxic component),NLFQFGDMILQKTGKEAVHSYAIYGCYCGWGGQGRAQDATDRCCFAQDCCYGRVNDCNPKTATYTYSFENGDIVCGDNDLCLRAVCECDRAAAICLGENVNTYDKNYEYYSISHCTEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Heterodimer: postsynaptic neurotoxin. {ECO:0000269|PubMed:23554559}.; FUNCTION: Monomer: Acidic phospholipase A2 homolog that is non-toxic. {ECO:0000269|PubMed:23554559}.,Phospholipase
102,P04361,PA2HB_AGKPI,,Basic phospholipase A2 homolog AppP2 (svPLA2 homolog) (APP-K49),SVLELGKMILQETGKNAITSYGSYGCNCGWGHRGQPKDATDRCCFVHKCCYKKLTDCNHKTDRYSYSWKNKAIICEEKNPCLKEMCECDKAVAICLRENLDTYNKKYKAYFKLKCKKPDTC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that lacks enzymatic activity (PubMed:1429612, PubMed:28633930). Displays edema-inducing activities (PubMed:1429612). Is myotoxic (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:Q6JK69, ECO:0000269|PubMed:1429612, ECO:0000269|PubMed:28633930}.",Phospholipase
103,P04971,VSPF_BOTAT,3.4.21.74,Thrombin-like enzyme batroxobin (BX) (SVTLE) (EC 3.4.21.74) (Bothrops atrox serine proteinase) (Defibrase) (Fibrinogen-clotting enzyme) (Reptilase) (Snake venom serine protease) (SVSP) (Venombin A),MVLIRVIANLLILQVSYAQKSSELVIGGDECDINEHPFLAFMYYSPRYFCGMTLINQEWVLTAAHCNRRFMRIHLGKHAGSVANYDEVVRYPKEKFICPNKKKNVITDKDIMLIRLDRPVKNSEHIAPLSLPSNPPSVGSVCRIMGWGAITTSEDTYPDVPHCANINLFNNTVCREAYNGLPAKTLCAGVLQGGIDTCGGDSGGPLICNGQFQGILSWGSDPCAEPRKPAFYTKVFDYLPWIQSIIAGNKTATCP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease. Cleaves Arg-Gly bonds in fibrinogen alpha chains (FGA). {ECO:0000269|PubMed:1011993}.,Serine Protease
104,P05620,VSP1_PROFL,3.4.21.74,Thrombin-like enzyme flavoxobin (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Habutobin) (Snake venom serine protease 1) (SVSP),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVALYDAWSGRFLCGGTLINPEWVLTAAHCDSKNFKMKLGAHSKKVLNEDEQIRNPKEKFICPNKKNDEVLDKDIMLIKLDSPVSYSEHIAPLSLPSSPPSVGSVCRIMGWGSITPVEETFPDVPHCANINLLDDVECKPGYPELLPEYRTLCAGVLQGGIDTCGFDSGTPLICNGQFQGIVSYGGHPCGQSRKPGIYTKVFDYNAWIQSIIAGNTAATCLP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that clots fibrinogen (FGA) by releasing fibrinopeptide A. According to PubMed:8585090, only cleaves rabbit fibrinogen, whereas no specificity is described in PubMed:3910643 (tests done on bovine fibrinogen). Also acts as a C3 convertase that independently cleaves human C3 and kick-starts the complement cascade. Also increases urokinase-type plasminogen activator (PLAU) and plasminogen activator inhibitor (SERPINE1) in cultured bovine pulmonary artery endothelial cells. Dose-dependently inhibits collagen-induced platelet aggregation. {ECO:0000269|PubMed:10708795, ECO:0000269|PubMed:12225369, ECO:0000269|PubMed:3910643, ECO:0000269|PubMed:8585090, ECO:0000269|PubMed:8817813, ECO:0000269|PubMed:9241744}.",Serine Protease
105,P06859,PA2A1_PROFL,3.1.1.4,Acidic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme I) (pgPLA 1a/pgPLA 2a),MRTLWIMAVLLVGVDGGLWQFENMIIKVVKKSGILSYSAYGCYCGWGGRGKPKDATDRCCFVHDCCYGKVTGCNPKLGKYTYSWNNGDIVCEGDGPCKEVCECDRAAAICFRDNLDTYDRNKYWRYPASNCQEDSEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that is highly lipolytic and myolytic. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:1288500}.,Phospholipase
106,P08878,PA2H_CRODU,,"Phospholipase A2 homolog crotoxin acid subunit CA (CTX subunit CA) (Crotapotin) [Cleaved into: Crotoxin chain alpha CA1, CA2 and CA4; Crotoxin chain alpha CA3; Crotoxin chain beta CA2, CA3 and CA4; Crotoxin chain beta CA1; Crotoxin chain gamma (Analgesic peptide) (Crotalphine)]",MRALWIVAVLLVGVEGSLVEFETLMMKIAGRSGISYYSSYGCYCGAGGQGWPQDASDRCCFEHDCCYAKLTGCDPTTDVYTYRQEDGEIVCGEDDPCGTQICECDKAAAICFRNSMDTYDYKYLQFSPENCQGESQPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: CAalpha-CAbeta-CAgamma: The acidic subunit of crotoxin (CA) is a heterotrimer of three disulfide-linked chains generated by post-translational maturation of a PLA2-like precursor. CA has no PLA2 activity and is not neurotoxic by itself, but plays several important functions in the crotoxin complex by increasing the lethal potency of the uncomplexed CB subunit. It acts by physically occluding the hydrophobic interfacial binding surface (IBS) of CB (PubMed:21787789). This effect decreases the adsorption of CB to phospholipid membranes, targeting the crotoxin complex to reach the specific presynaptic receptor (R48) at the neuromuscular junction. It also prevents the formation of the reactive CB dimer. Moreover, the CA subunit inhibits the catalytic activity by partially masking the catalytic site of CB (PubMed:21787789) and inhibits its anticoagulant activity. {ECO:0000269|PubMed:21787789}.; FUNCTION: Heterodimer CA-CB: Crotoxin is a potent presynaptic neurotoxin that possesses phospholipase A2 (PLA2) activity and exerts a lethal action by blocking neuromuscular transmission. It consists of a non-covalent association of a basic and weakly toxic PLA2 subunit (CBa2, CBb, CBc, or CBd), with a small acidic, non-enzymatic and non-toxic subunit (CA1, CA2, CA3 or CA4). The complex acts by binding to a specific 48-kDa protein (R48/CAPT) receptor located on presynaptic membranes, forming a transient ternary complex CA-CB-R48, followed by dissociation of the CA-CB complex and release of the CA subunit (PubMed:12657321). At equilibrium, only the CB subunits remain associated with the specific crotoxin receptor. In addition to neurotoxicity, crotoxin has been found to exert myotoxicity, nephrotoxicity, and cardiovascular toxicity (PubMed:20109480). Moreover, anti-inflammatory, immunomodulatory, anti-tumor and analgesic effects of crotoxin have also been reported (PubMed:20109480). {ECO:0000269|PubMed:12657321, ECO:0000269|PubMed:20109480}.; FUNCTION: [Crotoxin chain gamma]: Found in the venom as a monomer and stabilized by one disulfide bond (Cys-131 and Cys-138) (PubMed:18495297). This peptide induces potent antinociceptive effects in acute and chronic pain models (PubMed:18495297, PubMed:18703042). This effect is mediated by the release of peripheral dynorphin A, an endogenous agonist of kappa-opioid receptors, and this release is dependent on cannabinoid receptor CB2 activation (PubMed:24460677). {ECO:0000269|PubMed:18495297, ECO:0000269|PubMed:18703042, ECO:0000269|PubMed:24460677}.",Phospholipase
107,P09872,VSPCA_AGKCO,3.4.21.-,Protein C activator (EC 3.4.21.-) (ACC-C) (Snake venom serine protease) (SVSP),VIGGDECNINEHRFLALVYANGSLCGGTLINQEWVLTARHCDRGNMRIYLGMHNLKVLNKDALRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLPSNPPSVGSVCRIMGWGTITSPNATLPDVPHCANINILDYAVCQAAYKGLAATTLCAGILEGGKDTCKGDSGGPLICNGQFQGILSVGGNPCAQPRKPGIYTKVFDYTDWIQSIISGNTDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that selectively cleaves the heavy chain of protein C (PROC). This activation is thrombomodulin-independent. {ECO:0000269|PubMed:3624272}.,Serine Protease
108,P0C1Z0,3SE2_DENAN,,Fasciculin-2 (Fas-2) (Fas2) (Acetylcholinesterase toxin F-VII) (Fasciculin-II) (FAS-II) (Toxin TA1),TMCYSHTTTSRAILTNCGENSCYRKSRRHPPKMVLGRGCGCPPGDDNLEVKCCTSPDKCNY,"Snake three-finger toxin family, Short-chain subfamily, Acn-esterase inhibitor sub-subfamily","FUNCTION: Interferes with neuromuscular transmission by inhibiting the enzyme acetylcholinesterase (AChE) present at the neuromuscular junction. It selectively binds and inhibits with a 1:1 stoichiometry the mammalian and electric fish AChE at picomolar concentrations. It is highly specific for the peripheral site of AChE and blocks the entry of acetylcholine into the active site of the enzyme (through the Met-33 residue), thereby preventing its breakdown. It has been called fasciculin since after injection into mice it causes severe, generalized and long-lasting (5-7 hours) fasciculations. {ECO:0000269|PubMed:6530667}.",Phosphodiesterase
110,P0C2D4,OXLA_NAJKA,1.4.3.2,L-amino-acid oxidase (K-LAO) (LAAO) (EC 1.4.3.2),DDRRSPLEECFQQNDYEEFLEIAKNGLKKTXNPKHVXV,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:1612186). Is very active against L-Phe and L-Tyr, moderately active against L-Trp, L-Met, L-Leu, L-norleucine (L-2-aminohexanoate), L-Arg and L-norvaline (L-2-aminopentanoate), and slightly active against L-His, L-cystine, and L-Ile (PubMed:1612186). L-Gln, L-Lys, L-Asn, L-ornithine, L-Ala and L-Val are oxidized very slowly (PubMed:1612186). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities (By similarity). This protein inhibits both agonist- and shear stress-induced platelet aggregation (SIPA) (PubMed:11600144). Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:11600144, ECO:0000269|PubMed:1612186}.",Vascular Interaction
111,P0C2D7,OXLA_VIPBB,1.4.3.2,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2),ADDKNPLEECFREDDYEEFLEIAKNGLKKTSNPKHIVYPVKPSEQLYEESLRDQLPTSMHRYPSMIQKIFFAGEYTANAHGWIDSTIK,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:16574513). Is highly active on L-Met, L-Leu, L-Phe, L-Ile, and L-Arg, moderately active on L-His, L-Trp, L-Asn, L-Glu, and L-Val, and weakly or not active on L-Gln, L-Lys, L-Asp, L-Ala, L-Tyr, L-Ser, L-Pro, L-Gly, L-Thr, and L-Cys (PubMed:16574513). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities (By similarity). In addition, this protein has an ability to induce apoptosis in cultured HeLa and K562 cells, and inhibits ADP-induced platelet aggregation dose-dependently. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:16574513}.",Vascular Interaction
112,P0C577,VSPG_BITGA,3.4.21.55,Thrombin-like enzyme gabonase (SVTLE) (EC 3.4.21.55) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Venombin-AB),VVGGAECKIDGHRCLALLY,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease. Releases both fibrinopeptides A and B from fibrinogen (FGA and FGB) to form fibrin clots. Also activates factor XIII (F13A). The activity of the enzyme is stabilized by calcium ion.,Serine Protease
113,P0C5B4,VSPGL_GLOSH,3.4.21.-,Thrombin-like enzyme gloshedobin (SVTLE) (EC 3.4.21.-) (Defibrase) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MVLIRVQANLLILQLSYAQKSSELIIGGDECNINEHRFLVALYTSRSRRFYCGGTLINQEWVLTAAHCDRKNIRIKLGMHSEKVPNEDAETRVPKEKFFCLSSKTYTKWDKDIMLMRLKRPVNNSTHIAPVSLPSNPPSVDSVCRVMGWGTITSPQETYPDVPHCANINILDYEVCQAAHGGLPATSRTLCAGILKGGKDSCKGDSGGPLICNGQFQGIASWGAHPCGQSLKPGVYTKVFDYTEWIQSIIAGNTDATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. The recombinant form clots fibrinogen by cleaving fibrinogen Aalpha chain (FGA), and slowly Bbeta chain (FGB). Has amidolytic activities. {ECO:0000269|PubMed:19286459, ECO:0000269|PubMed:19639313}.",Serine Protease
114,P0C6E3,VM2B1_AGKBI,3.4.24.-,Zinc metalloproteinase-disintegrin bilitoxin-1 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) [Cleaved into: Disintegrin],QRYNPYKYIELFLVVDNRMVTKYNGDLDKIKTRIYELVNILNEIYRPLYIRVALVGIEFWCNKDLINVKSASSVTLASFANWRESVLPNRTSHDNAQLLTAIVFNRGVIGSAYPAGMCDPNRSVGTVQDHSEINLQVAITMAHEIGHNLGMGHDNNSCTCGGYSCIMLPALSDQPSKYFSNCSYIQYRDFIMNQDPQCILNEPSGTDIVSPPVCGNDILEVGEECDCGCPRNCQDPCCNAATCKKYSWVQCESGECCDQCRFKGAGTECRRAMGDDPGGRCTGQSADCPRN,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIc sub-subfamily","FUNCTION: This hemorrhagic toxin hydrolyzes the Aalpha-chain (FGA) and more slowly the Bbeta-chain (FGB) of fibrin and fibrinogen. Also hydrolyzes casein. It lacks platelet aggregation inhibitory activity. After intramuscular injection, it acts rapidly to disrupt the capillary endothelium without damaging the intercellular junctions, and also appears to damage skeletal muscle cells. Cleaves insulin B chain at '27-Asn-|-Gln-28', '34-His-|-Leu-35', '38-Ala-|-Leu-39', '40-Tyr-|-Leu-41', '46-Arg-|-Gly-47' and '48-Phe-|-Phe-49' bonds (PubMed:2676645). {ECO:0000269|PubMed:2219144, ECO:0000269|PubMed:2676645}.",Kunitz Family
115,P0C6E4,VM2JN_PROJR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin jerdonatin],MIQVLLVTVCLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKRAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYLIEPLKLPDSEAHAVYKYENIEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYVKLAIVVDYGMYTKYNRDSDKITVRVHEMVNHITEMYRPLNIDITLSLLDVWSEKDLITVQSDSDVTLEVFGDWRESVLLKRRSHDCAHLLTDTKLNDNTIGVAYKKGMCDPKLSVGLVQDYSKNVFMVAVTMTHEIGHNLGMEHDEDKNGKKCKCDTCIMSPVISDKQSKLFSDCSKNDYQTFLTNYKPQCILNAPLRTDTVSTPVSGNELLEEGEDCYCHIPPNPCCDPATCKLTPGSQCAEGLCCDQCRFKKKGTICRFARGDYPDDRCTGLSDDCPRWNDL,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin jerdonatin]: Inhibits ADP- and collagen-induced human platelet aggregation with IC(50) of 123 and 135 nM, respectively. Inhibits sperm-egg binding in a concentration-dependent manner, but has no effect on the fusion of sperm-egg. {ECO:0000269|PubMed:15364294}.",General Toxin
116,P0C6E8,VM3G1_CRAGM,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase graminelysin (SVMP) (EC 3.4.24.-) (Graminelysin I); Disintegrin-like],KMCGVTQNWESYESTKKASQLNLTPEQQRFPQRYIKLGIFVDHGMYTKYSGNSERITKRVHQMINNINMMCRALNIVTTLSLLEIWSEKDLITVQASAPTTLTLFGAWRETVLLNRTSHDHAQLLTATIFNGNVIGRAPVGGMCDPKRSVAIVRDHNAIVFVVAVTMTHEMGHNLGNHHDEDKCNCNTCIMSKVLSRQPSKYFSECSKDYYQTFLTNHNFQCILNAPLRTDTVSTPVSGNELLEAGEDCDCGSPANPCCDAATCKLRPGAQCGEGLCCDQCRFTSAGTECRAARSECDIAESCAGQSADCPTDDFHRNGQPCLNNHGYCYNGNCPIMFYQCIALFGSNATVGQDGCFDANDIGHKYFHCRKDNEKYIPCAPQDVKCGRLFCTYIYDIDLCRYDDSANGMVAQGTKCADGKVCNSNRQCADVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: [Snake venom metalloproteinase graminelysin]: Cleaves the alpha chain of fibrinogen (FGA) preferentially and cleaves the beta chain (FGB) either on longer incubation or at high concentrations. Induces apoptosis of endothelial cells (prior to cell detachment). {ECO:0000269|PubMed:11463342, ECO:0000269|PubMed:11776320, ECO:0000269|PubMed:12878166}.; FUNCTION: Disintegrin: inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
117,P0C6R9,VM3A_BOTAL,3.4.24.-,Zinc metalloproteinase-disintegrin-like alternagin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) [Cleaved into: Disintegrin-like alternagin-C (Alt-C)],IISPPVCGNELLEVGEECDCGTPENCQNXCCDAATCKLKSGSQCGHXDCCEQCKFTKSGTECRASMSECDPAEHCTGQSXXCXXDVFHKNGQPCLDNYGYCYNGNCPIMYHAQCYALFGADVYEAEDSCFKDNQKGNYYGYCRKENXXXXXCXXXDVKCGRLYCKDNSPKQNNPCKMFYSNDDEHKGNVLPGTKCE,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: [Zinc metalloproteinase-disintegrin-like alternagin]: hemorrhagic protease that acts as a potent inhibitor of collagen-induced adhesion by blockage of alpha-2/beta-1 (ITGA2/ITGB1) integrin. Cleaves at Leu-|-Met bonds (PubMed:11368322). {ECO:0000269|PubMed:11368322}.; FUNCTION: Disintegrin alternagin-C: potent inhibitor of the collagen binding to alpha-2/beta-1 (ITGA2/ITGB1) integrin. Has a chemotactic activity on neutrophils and this effect involves actin cytoskeleton rearrangement, FAK, PI3-kinase and Erk-2 activities. Induces endothelial cell proliferation, and these effects are mediated at least in part by an increased expression of vascular endothelial growth factor (VEGF). In injured muscles, reduces both MMP-2 mRNA and gelatinolytic activity, suggesting that it changes the overall balance of extracellular matrix protein turnover during muscle regeneration. In low concentrations, induces formation of new vessels and up-regulates the expression of VEGF receptor 2 (KDR) without affecting VEGF receptor 1 (FLT1) expression. In high concentrations, strongly inhibits angiogenesis, and the expression of both receptors is down-regulated. Has very low plasma clotting activity.",Metalloprotease
118,P0C6S4,VM2TO_ERIMA,,Disintegrin eristostatin,QEEPCATGPCCRRCKFKRAGKVCRVARGDWNDDYCTGKSCDCPKNPWNG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Is a potent inhibitor of ADP-induced platelet aggregation. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) receptor on the platelet surface. Binds with the same high affinity to resting and activated platelets. Also binds the alpha-4/beta-1 (ITGA4/ITGB1) integrin. Is a potent inhibitor of human and murine melanoma metastases in mouse model systems, also due to the inhibition of binding between the alpha-4/beta-1 integrin and the vascular cell adhesion protein VCAM1. Reacts neither with the integrin alpha-V/beta-3 (ITGAV/ITGB3) vitronectin receptor nor with the integrin alpha-5/beta-1 (ITGA5/ITGB1) fibronectin receptor. Has no effect on cell proliferation or angiogenesis. Specifically inhibits cell migration on fibronectin, but not that on collagen IV or laminin. May involve fibronectin-binding integrins that mediate cell migration. {ECO:0000269|PubMed:17316731, ECO:0000269|PubMed:7538018, ECO:0000269|PubMed:7549046, ECO:0000269|PubMed:7641809, ECO:0000269|PubMed:8042985, ECO:0000269|PubMed:9457071}.",Kunitz Family
119,P0C7B0,VM3H6_GLOBR,3.4.24.-,Zinc metalloproteinase-disintegrin-like brevilysin H6 (Mt-a) (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) [Cleaved into: p45K; Disintegrin-like p29K],MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLGKNKQLFSKDYSETHYSPDGREITTNPPVEDHCYYHGRIENDADSTRSISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENILKEDEAPKMCGVTQNWESYEPIKKASQLNLTPEQQRYNPFRFVELVLVADKGMVTKNNGDLNKIKTRMYELANNLNDIYRYMYIHVALVGVEIWSDGDKITVTPNVDDTLSSFAEWRKTHLLTRKKHDNAQLLTAIDFNGPTIGYAYIASMCHPKRSVGIVQDYSPINLVLSVVMAHEMGHNLGIHHDHSYCSCGDYACIMGATISHEPSTFFSNCSYIQCWDFIMDHNPECIVNEPLGTDIVSPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRESMSECDPAEHCTGQSSECPADVFHKNGQPCLHNYGYCYNGNCPIMYHQCYALWGADVYEAEDSCFESNKKGNYYGYCRKENGKKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNEDEHKGMVLPGTKCGDGKVCSNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily",FUNCTION: Shows weak hemorrhagic activity. Rapidly degrades the alpha-chain of fibrinogen (FGA). {ECO:0000269|PubMed:10920250}.,Fibrinogenolytic Enzyme
120,P0C7B1,VM3BG_BOTAL,3.4.24.-,Zinc metalloproteinase-disintegrin-like BaG (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),SISACNGLKGHFLIEPLKLSDSEKTDLLNRSHDNAQLSPINLVVAVIMAHEMGHGMVLPGTK,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Snake venom Zinc metalloproteinase that inhibits ADP-induced platelet aggregation and inhibits the alpha-5/beta-1 (ITGA5/ITGB1) integrin, a fibronectin receptor. Has caseinolytic activity. Induces the detachment of cells that are bound to fibronectin. {ECO:0000269|PubMed:12893294}.",Metalloprotease
122,P0C8M1,PA2B1_BOTMO,3.1.1.4,Basic phospholipase A2 BmTX-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLWQFNKMIKKEVGKLPFPFYGAYGCYCGWGGRGEKPKDGTDRCCFVHDCCYKKLTGCPKWDDRYSYSWKDITIVCGEDLPCEEICECDRAAAVCFYENLGTYNKKYMKHLKPCKKADYPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows enzymatic activity in the presence of a synthetic substrate. In vitro, blocks the neuromuscular transmission in young chick biventer cervicis preparations. In mice, induces myonecrosis and a systemic interleukin-6 response upon intramuscular injection. Also induces edema and exerts a strong pro-inflammatory effect. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18501940}.",Phospholipase
123,P0C942,PA2B1_LACMU,3.1.1.4,Basic phospholipase A2 LmTX-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLKFNKMIKFETRKNAIPFYAFYGCYCGWGGRXXXXXXXXXCCFVHDCCYGKXXXXXXXWDLYRYSLKSGYLTCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays neurotoxic and myotoxic activities. Induces inflammatory edema by mechanisms involving mast cell activation and arachidonic acid metabolites. Increases plasma creatine kinase activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:16626776, ECO:0000269|PubMed:17208264, ECO:0000269|PubMed:18766430, ECO:0000269|PubMed:18996140}.",Phospholipase
124,P0CAR9,PA2A1_CERCE,3.1.1.4,Acidic phospholipase A2 CC-PLA2-1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVWLMGVEGNLYQFGKMIKHKTGKSALLSYSAYGCYCGWGGQGKPQDATDHCCFVHDCCYGEVSGCYPKTAFTLKFENQDIICGDEDPCNRAVCECDRVAAICFGENVNTSDKKYLFYSSSYCEEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits blood coagulation and platelet aggregation induced by ADP and arachidonic acid. Inhibits tumor cell adhesion and migration in a dose-dependent manner. Abolishes the attachment of human brain microvascular endothelial cells (HBMEC) to fibrinogen (IC(50)=0.12 uM) and dramatically reduces its adhesion to fibronectin (IC(50)=0.12 uM), whereas no effect is observed on type I collagen, vitronectin or laminin 1. Also blocks the cell migration toward fibronectin and fibrinogen. These effects are not dependent of the catalytic activity, but are mediated by alpha-5/beta-1 (ITGA5/ITGB1) and alpha-v-containing (ITGAV) integrins. Also shows anti-angiogenic activity in chicken chorioallantoix membrane assay. Has a relatively high enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:20142800, ECO:0000269|Ref.2}.",Phospholipase
125,P0CAS0,PA2A2_CERCE,3.1.1.4,Acidic phospholipase A2 CC-PLA2-2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVWLMGVEGNLFQFGKMIKHKTGKSALLSYSGNPCYCGWGGQGPPQDATDHCCFVHDCCYGEENACYPKTAFTLKFENQIIICDEDPCNYAVCMCDRVAAICGGENVATSDAKYLFYRSMGCEEESVQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 that inhibits blood coagulation and platelet aggregation induced by ADP and arachidonic acid. Inhibits tumor cell adhesion and migration in a dose-dependent manner. Abolishes the attachment of human brain microvascular endothelial cells (HBMEC) to fibrinogen (IC(50)=0.2 uM) and dramatically reduces its adhesion to fibronectin (IC(50)=0.3 uM), whereas no effect is observed on type I collagen, vitronectin or laminin 1. Also blocks the cell migration toward fibronectin and fibrinogen. These effects are not dependent of the catalytic activity, but are mediated by alpha-5/beta-1 (ITGA5/ITGB1) and alpha-v-containing (ITGAV) integrins. Also shows anti-angiogenic activity in chicken chorioallantoix membrane assay. Has a relatively high enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:20142800, ECO:0000269|Ref.2}.",Phospholipase
126,P0CAS2,PA2B6_CRODO,3.1.1.4,Phospholipase A2 crotoxin basic chain (CB) (Crotoxin-B) (svPLA2) (EC 3.1.1.4) (CdcolF6a) (F6a) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRRNAIPPYAFYGCYCGWGGRGRPKDATDRCCFVHDCCYGKLAKCNTKWDFYRYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYRYGYMIYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer CA-CB: Crotoxin is a potent presynaptic neurotoxin that possesses phospholipase A2 (PLA2) activity and exerts a lethal action by blocking neuromuscular transmission (PubMed:16003952, PubMed:17203389). It consists of a non-covalent association of a basic and weakly toxic PLA2 subunit (CB), with a small acidic, non-enzymatic and non-toxic subunit (CA also named crotapotin). The complex acts by binding to a specific 48-kDa protein (R48) receptor located on presynaptic membranes, forming a transient ternary complex CA-CB-R48, followed by dissociation of the CA-CB complex and release of the CA subunit. At equilibrium, only the CB subunits remain associated with the specific crotoxin receptor. In addition to neurotoxicity, crotoxin has been found to exert nephrotoxicity, and cardiovascular toxicity. Moreover, anti-inflammatory, immunomodulatory, anti-tumor and analgesic effects of crotoxin have also been reported (By similarity). {ECO:0000250, ECO:0000269|PubMed:16003952, ECO:0000269|PubMed:17203389}.; FUNCTION: Monomer CB: The basic subunit of crotoxin is a snake venom phospholipase A2 (PLA2) that exhibits weak neurotoxicity (PubMed:17203389, PubMed:16003952) and strong anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (By similarity). In addition, it exerts myotoxicity (PubMed:17203389, PubMed:16003952, PubMed:17915277), nephrotoxicity, and cardiovascular toxicity as well as anti-inflammatory, immunomodulatory, anti-tumor and analgesic effects (By similarity). Also shows a strong antimicrobial activity against X.axonopodis passiforae (Gram-negative) which is completely dependent on the enzymatic activity (PubMed:16003952). PLA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides. {ECO:0000250, ECO:0000269|PubMed:16003952, ECO:0000269|PubMed:17203389, ECO:0000269|PubMed:17915277}.",Phospholipase
127,P0CAS5,PA2BE_CRODU,3.1.1.4,Basic phospholipase A2 F15 (svPLA2) (EC 3.1.1.4) (CdtF15) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRKNAVPFYAFYGCYCGWGGQRRPKDATDRCCFVHDCCYGKLTKCNTKWDIYRYSLKSGYITCGKGTWCKEQICECDRVAAECLRRSLSTYKNEYMFYPKSRCRRPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows moderate neurotoxic activity in isolated mouse phrenic nerve diaphragm but shows high neurotoxic activity in a chick biventer cervis preparation. Also shows a high bactericidal effect against both Gram-negative and Gram-positive bacteria. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12875878}.,Phospholipase
128,P0CAS7,PA2BG_CRODU,3.1.1.4,Basic phospholipase A2 F17 (svPLA2) (EC 3.1.1.4) (CdtF17) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMLKFETRKNAVPFYAFGCYCGWGGQRRPKDATDRCCFVHDCCYEKVTKCNTKWDFYRYSLKSGYITCGKGTWCKEQICECDRVAAECLRRSLSTYKNEYMFYPDSRCREPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has anticoagulant activity and inhibits bactericial growth of the Gram-negative bacteria Xanthomonas axonopodis pv. passiflorae (in monomeric form). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12018617}.,Phospholipase
129,P0CB14,VM1K_CALRH,3.4.24.-,Snake venom metalloproteinase kistomin (SVMP) (EC 3.4.24.-),MIEVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKITALSEGAAQQKYEDTMQYEFKVNGEPVVLHLEKNKELFAKDYSETHYSPDGTRITTYPSVEDHCYYQGRIHNDADSTASISTCNGLKGHFKFHGERYFIEPLKLPGSEAHAVYKYENIEKEDETPKMCGVIQKWKSDELIKKPFRLNLTPQQQESPQAKVYLVIVADKSMVDKHNGNIKKIEEQGHQMVNTMNECYRPMGIIIIMAGIECWTTNDFFEVKSSAKETLYSFAKWRVEDLSKRKPHNDAQFLTNKDFDGNTVGLAFVGGICNEKYCAGVVQDHTKVPLLMAITMGHEIGHNLGMEHDEANCKCKACVMAPEVNNNPTKKFSDCSRNYYQKFLKDRKPECLFKKPLRTDTVSTPVSGNEPLEVITMDDFYA,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloprotease that inhibits platelet aggregation by binding specifically to platelet glycoprotein VI (GP6) and platelet glycoprotein Ib alpha (GP1BA). It inhibits the interaction between collagen and platelet GP6 by cleaving GP6 (at '225-Glu-|-Ala-226' and '238-Val-|-Phe-239' bonds), and inhibits vWF-induced platelet aggregation by cleaving GP1BA and vWF. Cleavage of GP1BA occurs at two distinct sites to generate two soluble fragments. It also cleaves alpha- (FGA) and subsequently the gamma-chain (FGG) of fibrinogen, leaving the beta-chain unaffected. It also inhibits collagen-, convulxin- and ristocetin-induced platelet aggregation. It blocks the adhesion of platelet to immobilized collagen, but only exerts a slight inhibition to fibrinogen. In vivo, it exerts potent antithrombotic effect. {ECO:0000269|PubMed:1477097, ECO:0000269|PubMed:17609416, ECO:0000269|PubMed:18624975, ECO:0000269|PubMed:8251530}.",Metalloprotease
131,P0CC17,OXLA_BOTAT,1.4.3.2,L-amino-acid oxidase (BatroxLAAO) (LAO) (EC 1.4.3.2),MNVFFTFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIAKNGLSTTSNPKRVVIVGAGMSGLSAAYVLANAGHQVTVLEASERAGGRVKTYRNEKEGWYANLGPMRLPEKHRIVREYIRKFDLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVHLNARVIKIQQDVKEVTVTYQTSEKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPNGVGVIIAYGIGDDANYFQALDFEDCGDIVINDLSLIHQLPKEEIQAICRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNRASEIKK,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:18804547). Shows high catalytic activity against L-Met, L-Leu, L-Phe, L-Trp, L-Tyr, L-Ile (PubMed:18804547). Shows no or weak activity on L-Cys, L-Val, L-Gln, L-Thr, L-Ser, L-Lys, L-Arg, L-Asn, L-Glu, L-Gly, L-Pro, L-Asp and L-His (PubMed:18804547). Induces platelet aggregation in platelet-rich plasma, probably due to hydrogen peroxide production, since catalase inhibits aggregation effect (PubMed:18804547). Induces moderate mouse paw edema (PubMed:18804547). Induces apoptosis and shows cytotoxicity against several cancer cell lines, which is inhibited by catalase (PubMed:18804547, PubMed:21300133). Shows hemolytic activity and antibacterial activities against both Gram-positive and Gram-negative bacteria (PubMed:21300133). Has parasiticidal activities against both trypanosomes and leishmania, as a result of enzyme-catalyzed hydrogen peroxide production (PubMed:21300133). Unlike other snake venom L-amino acid oxidases, does not induce hemorrhage (with 50 ug of enzyme) (PubMed:18804547). {ECO:0000269|PubMed:18804547, ECO:0000269|PubMed:21300133}.",General Toxin
132,P0CG03,VSPBH_BOTAL,3.4.21.-,Thrombin-like enzyme bhalternin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKASELVIGGDECNINEHRSLVVLFNSSGFLCAGTLINQEWVLTAANCDRKNIRIKLGMHSKNVTNEDEQTRVPKRSTFVSVAKTSHQTLGTRTSMLIRLKRPVNDSPHIAPLSLPSSPPSVGSVCRVMGWGTISPTKVSYPDVPHCANINLLDYEVCREAHGGLPATSRTLCAGILEGGKDSCQGDSGGPLICNGQFQGILSWGVHPCGQPHKPGVYTKVSDYSEWIQSIIAGNTDVTCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that induces blood clotting in vitro, defibrinogenation in vivo (by intraperitoneal injection into mice), albuminolytic and fibrinogenolytic activities. Preferentially cleaves the alpha chain of fibrinogen (FGA). Causes hemolysis in the heart, causes apparent hyperemia and lymphocytic interstitial pneumonitis in the lung, causes necrosis and inflammatory infiltrate in the liver, and causes glomerular congestion in the kidney. Also provokes a drastic myonecrosis. {ECO:0000269|PubMed:20184912}.",Serine Protease
133,P0CG56,PA2BB_CRODU,3.1.1.4,Phospholipase A2 crotoxin basic subunit CBb (CTX subunit CBb) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRKNAVPFYAFYGCYCGWGGQGRPKDATDRCCFVHDCCYGKLAKCNTKWDIYRYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYKNGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer CA-CB: Crotoxin is a potent presynaptic neurotoxin that possesses phospholipase A2 (PLA2) activity and exerts a lethal action by blocking neuromuscular transmission. It consists of a non-covalent association of a basic and weakly toxic PLA2 subunit (CBa2, CBb, CBc, or CBd), with a small acidic, non-enzymatic and non-toxic subunit (CA1, CA2, CA3 or CA4). The complex acts by binding to a specific 48-kDa protein (R48) receptor located on presynaptic membranes, forming a transient ternary complex CA-CB-R48, followed by dissociation of the CA-CB complex and release of the CA subunit. At equilibrium, only the CB subunits remain associated with the specific crotoxin receptor. In addition to neurotoxicity, crotoxin has been found to exert myotoxicity, nephrotoxicity, and cardiovascular toxicity (PubMed:20109480). Moreover, anti-inflammatory, immunomodulatory, anti-tumor and analgesic effects of crotoxin have also been reported (PubMed:20109480). {ECO:0000269|PubMed:20109480, ECO:0000269|PubMed:8630095}.; FUNCTION: Monomer CBb: The basic subunit of crotoxin is a snake venom phospholipase A2 (PLA2) that exhibits weak neurotoxicity (10-fold less than the heterodimer) and strong anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity. In addition, it shows the same effects described for the heterodimer and binds the nucleotide-binding domain (NBD1) of CFTR chloride channels and increases the channel current (PubMed:27241308). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:27241308}.",Phospholipase
134,P0CG57,PA2HC_OXYSC,,Neutral phospholipase A2 homolog taipoxin beta chain 2 (svPLA2 homolog),NLVQFGFMIECAIRNRRPALDFMNYGCYCGTVGRGTPVDDLDRCCQVHDECYATAEKHGCYPSLTTYQWECRQVGNECNSKTQCEVFVCACDLAAAKCLAQEDYNPAHFNINTGERCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling. May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum.; FUNCTION: Monomer (beta chain): Snake venom phospholipase A2 homolog that is neither toxic nor enzymatically active. Does not bind calcium.",Phospholipase
135,P0DI84,OXLA_VIPAA,1.4.3.2,L-amino-acid oxidase (LAO) (VAA-LAAO I) (EC 1.4.3.2),DRNPLEECFRETDYEEFLEIARNGLKKTSNPKHVVVVGAGMSGLSAAYVLAGAGHKVTVLEASERAGGRVRTHRNSKEGWYANLGPMRIPEKHRIVREYIRKFGLNLNEFSQENDNAWYFIKNIRKRVGEVNKDPGLLKYPVKPSEEGKSAGQLYEESLGSAVKDLKRTNCSYILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDQLPTSMYRAIEEKVKFNARVIKIQQNANQVTVTYQTPEKDTSSNTADYVIVCTTSRAARRIQFEPPLPPKKQHALRSVHYRSGTKIFLTCSSKFWEDDGIHGGKSTTDLPSRFIYYPNHNFSTGVGVIIAYGIGDDANFFQALKFKDCADIVFNDLSLIHQLPKEEIQSFCYPSMIQKWSLDKYAMGAITTFTPYQFQRFSEALTAPQGRIFFAGEYTAEAHGWIDSTIKSGLTAARDVNRASEQ,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
136,P0DI88,OXLA_BOTJA,1.4.3.2,L-amino-acid oxidase (BjarLAAO-I) (LAO) (EC 1.4.3.2),ADDKNPLEECFRETDYEEFLEIARNGLKATSNPKRVV,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:18346051). Is highly active on L-Leu, L-Met, moderately active on L-Arg, L-Trp, L-Phe, L-Val, L-His, and L-Ile, and is weakly or not active on L-Cys, L-Lys, L-Ala, L-Thr, L-Asp, L-Ser, and L-Pro (PubMed:18346051, PubMed:19101583). Exhibits diverse biological activities, such as hemorrhage, edema, apoptosis of vascular endothelial cells or tumor cell lines, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). This protein induce hemolysis and has antibacterial and antiparasitic activities (against the Gram-positive S.aureus). Tested in vivo, this protein significantly inhibits Ehrlich ascite tumors growth and induces an influx of polymorphonuclear cells, as well as spontaneous liberation of hydrogen peroxide from peritoneal macrophages. {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:18346051, ECO:0000269|PubMed:19101583, ECO:0000269|PubMed:20615423}.",Vascular Interaction
138,P0DI90,OXLA2_DABRR,1.4.3.2,L-amino-acid oxidase L2 (LAAO-L2) (LAO) (EC 1.4.3.2),ADDKNPLEECFCEDDDYCEG,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:18384385). Is active on L-Ile, L-Leu, L-Met, L-Phe, L-Trp, and L-Tyr (PubMed:18384385). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250, ECO:0000269|PubMed:18384385}.",Vascular Interaction
140,P0DJ42,VM1CR_CROAT,3.4.24.-,Snake venom metalloproteinase crotalin (SVMP) (EC 3.4.24.-),LLRRKSHDHAQNHDGDKCLRGASLGYYQSFLNQYKPQCILNKP,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloproteinase that inhibits ristocin-induced platelet aggregation by abolishing the binding of von Willebrand factor (vWF) to platelet glycoprotein Ib alpha (GPIBA) through the cleavage of both GP1BA and vWF. Also has fibrinogenolytic activities by degrading the alpha- (FGA) and beta-chain (FGB) of fibrinogen. In vivo, induces a slight hemorrhage when applied to chick chorioallantoic membrane and has potent antithrombic effect. {ECO:0000269|PubMed:11776320, ECO:0000269|PubMed:9473223}.",Metalloprotease
141,P0DJ43,VM3_MICIK,3.4.24.-,Zinc metalloproteinase-disintegrin-like mikarin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),TNTPEQDRYLQVKKYLEYVVVDNNMYRNYGNAGPCVMSAEISFEPLQEFSSCDIQEPLSQDIVQPAVCGNYYVEVGGECDCGSPKPCRSACCNAATCKLQREHQCDSGECCEKKDDCDLPEICTGRSAKCSCVISQGDLGYGMVEPGTKCTDGMVCSNEQCVDVQTAAK,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that calcium-independently catalyzes the conversion of prothrombin (F2) to alpha-thrombin through the formation of a thrombin intermediate. {ECO:0000269|PubMed:12485606}.,Metalloprotease
142,P0DJ44,VM3_VIPAA,3.4.24.-,Zinc metalloproteinase-disintegrin-like VaH1 (EC 3.4.24.-) (Snake venom metalloprotease) (SVMP),MVTKYSSIFMSPILSNPPILYFSDCSREXYQKXLTN,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that exhibits strong hemorrhagic activity. It also degrades alpha-chain of fibrinogen (FGA), but not the beta- and the gamma-chains. Possesses potent azocaseinolytic activity and cleaves insulin B-chain, hydrolyzing it at positions Ala(14)-Leu(15), followed by Tyr(16)-Leu(17) and His(10)-Leu(11). In vivo, subcutaneous injection into mice induces strong hemorrhage. {ECO:0000269|PubMed:11602279}.",Metalloprotease
143,P0DJ86,VSPL_BOTLC,3.4.21.74,Thrombin-like enzyme leucurobin (Leuc) (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECDINEHPFLAFMYYSPRYFCGMTLINQEWVLTAAHCNRRFMRIXXXXHAGSVANYDEVVRXXXXXFICPNKKKNVITDKDIMLIRLDRPVKNSEHIAPLSLPSNPPSVGSVCRIMGWGAITTSEDTYPDVPHCANINLFNNTVCREAYNGLPAKTLCAGVLQGGIDTCGGDSGGPLICNGQFQGILSWGSDPCAEPRKPAFYTKVFDYLPWIQSIIAGNKTATCP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that cleaves Arg-Gly bonds in alpha-chain of fibrinogen (FGA). Induces temporary episodes of opisthotonos and rapid rolling around the long axis of the animal (gyroxin-like effect), when injected into the tail veins of mice (0.143 ug/g mouse). {ECO:0000269|PubMed:16481207}.",Serine Protease
144,P0DJE1,VM1B1_BOTAT,3.4.24.-,Snake venom metalloproteinase Batx-1 (SVMP) (EC 3.4.24.-) (Batx-I),YIELAVVADHGIFTKYNSNLNTIR,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Zinc metalloproteinase that exhits a weak hemorrhagic activity. Degrades preferentially the Aalpha- (FGA) and Bbeta-chains (FGB) of fibrinogen, and partially degrades gamma-chain (FGG) at higher concentration. Induces a mild myotoxicity, but lacks coagulant activity on human plasma or bovin fibrinogen and defibrinating activity. {ECO:0000269|PubMed:20600221}.",Metalloprotease
145,P0DJE2,VM3A_VIPAA,3.4.24.-,Zinc metalloproteinase-disintegrin-like ammodytagin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),KSAAXVTLDLFGDWRAKRHDNAQLLTGINLNGQTLGIAFMSKXSVGLIQDYXKSYLLVASVMAHELGHNLGMEHDDGNCICPAKCIDNKPLRTDIVSPAVCGNYFVELTPGSQCADGVCCDQCRKAGVTVAPDLCFDYNQLGTEDKFTHSPDDPDYGMVDLGTKCADGKVCNSNRQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that has fibrinogenolytic and hemorrhagic activities in mouse and rats. Hydrolyzes the Aalpha-chain (FGA) and more slowly the Bbeta-chain of fibrinogen (FGB), without affecting the gamma-chain. Its hemorrhagic activity results of its involvement in cleavage of basal membrane components (nidogen and fibronectin but not laminin) and depletion of fibrinogen, prothrombin (F2) and factor X (F10) in blood circulation. Also possess potent azocaseinolytic activity and cleaves insulin B-chain, hydrolyzing it at positions Gln(4)-His(5), His(10)-Leu(11) and Tyr(16)-Leu(17). {ECO:0000269|PubMed:21933678}.",Metalloprotease
146,P0DJE9,VSP1_BOTMA,3.4.21.-,Thrombin-like enzyme TLBm (SVTLE TLBm) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNINESPFLAFLYSQLLSSRRYFCGMTLINQEWVLTAAHCNLYPDRKDMNWWLLIKLGKHSGSTRRWVANYDEQVRYWPKEKFIWWYCPNKKKDVINNYVWVWWDKDILLWELWMLIRLNRPVKYSEHIAPLSLPSSPPSAKWWHVGSVCRIMGWGQITETWWNSEDTLPDVPRCANINLFNYEVCRAYNQRWWRGLPAKTLCAGDLEGIIRGGWDTCVGDSGGPLICDGQYQGIAYWGSKPCAEPDEPAAYSKVFDHLDWSQSVIAGGTWWRGDDTCP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like enzyme that induces the formation of fibrin clot. Cleaves the Aalpha-chain of fibrinogen (FGA) with higher activity than the Bbeta-chain (FGB). Induces platelet aggregation in both platelet-rich plasma and in washed platelet preparations. This aggregation is strongly inhibited by preincubation of the enzyme with PMSF. {ECO:0000269|PubMed:19931298}.,Serine Protease
147,P0DJF0,VSP48_BOTJR,3.4.21.-,Thrombin-like enzyme BJ-48 (SVTLE BJ-48) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VVGGDCIPQVPFLAFLYSEYFC,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like serine protease which cleaves specifically the Aalpha chain of human fibrinogen (FGA) to release fibrinopeptide A. Also cleaves rapidly the Bbeta chain of human fibrinogen (FGB). Is selective for Arg over Lys at position 1 of the tripeptide substrates. {ECO:0000269|PubMed:17433397}.,Serine Protease
148,P0DJG3,VSP1_BOTAN,3.4.21.-,Thrombin-like enzyme TLBan (SVTLE TLBan) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNINEHPFLVALYYSTFFCGMTLINQEWVLTAAHESEKFPKEKYFIFCPNNKDIMLIRLDKPVSNSEHIAPLSLPSSPPSVGSVCRKPALYTKVFDYLLWIQSIIAGNTATCP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease, with high clotting activity in vitro. Has also fibrinogenolytic ability, showing a fast degradation of fibrinogen Aalpha chain (FGA), a slow degradation of Bbeta chain (FGB) and no degradation of gamma chain. Also causes platelet aggregation in platelet rich plasma (PRP) and washed platelet suspension. {ECO:0000269|PubMed:22155303}.",Serine Protease
149,P0DJG7,VSP2_DEIAC,3.4.21.-,Thrombin-like enzyme acutobin-2 (SVTLE) (EC 3.4.21.-) (Acutobin II) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGVECDINEHRFL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease that has high fibrinogen-clotting activity (2025 NIH units/mg) on human fibrinogen. Shows esterase and amidase activities. {ECO:0000269|PubMed:17904430}.,Serine Protease
150,P0DJH3,VMP3A_DEIAC,3.4.24.-,Zinc metalloproteinase-disintegrin-like AAV1 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) [Cleaved into: Disintegrin-like AAV1-C],DVVSPPVCGN,"Venom metalloproteinase (M12B) family, P-III subfamily","FUNCTION: Zinc metalloprotease-disintegrin AAV1: snake venom zinc metalloprotease that binds to the platelet collagen receptor glycoprotein VI (GP6) thus inhibiting collagen- and convulxin- (a GP6 agonist) induced platelet aggregation and the tyrosine phosphorylation of intracellular signaling proteins (LAT, SYK, p76SLP76, PIK3C, and PLCG2) that follows GP6 activation. Interestingly, blocks platelet aggregation but does not affect shape change. Also degrades the Aalpha chain of fibrinogen (FGA), followed by the Bbeta chain (FGB). {ECO:0000269|PubMed:17029743}.; FUNCTION: Disintegrin AAV1-C: 30 kDa fragment of AAV1 autoproteolysed in absence of Ca(2+) that shows more potent inhibition of convulxin-induced platelet aggregation than AAV1. {ECO:0000269|PubMed:17029743}.",Metalloprotease
151,P0DJH5,VM3DM_DABSI,3.4.24.-,Zinc metalloproteinase-disintegrin-like daborhagin-M (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),VATSEPNRYFNPYSYVELIITVDHS,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that possesses high hemorrhagic activity (minimum hemorrhagic dose, MHD=0.86 ug) when subcutaneously injected into mice. Has potent fibrinogenolytic activity on alpha-chain of fibrinogen (FGA). Hydrolyzes model substrate (beta-chain of insulin) at Ala(14)-Leu(15) and Tyr(16)-Leu(17) followed by His(10)-Leu(11) and Phe(24)-Phe(25). {ECO:0000269|PubMed:18554518}.",Metalloprotease
152,P0DJJ6,VM1B_BOTLC,3.4.24.-,Snake venom metalloproteinase BleucMP (SVMP) (EC 3.4.24.-),TLTSFGEWR,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloprotease that has fibrino(geno)lytic activities. Hydrolyzes the alpha-chain (FGA) and more slowly the beta-chain of fibrinogen (FGB), without affecting the gamma-chain. Preferentially hydrolyzes the beta-chain (FGB) of fibrin. In vivo, shows a low edema-inducing effect. This action may be attributed to degradation of proteins in the cell membrane and consequent release of inflammatory mediators and leukocyte infiltrate. {ECO:0000269|PubMed:21130897}.",Metalloprotease
153,P0DJJ9,PA2B2_PROFL,3.1.1.4,Basic phospholipase A2 BP-II (svPLA2) (EC 3.1.1.4) (Basic protein II) (BP2) (BPII) (PflLys49-PLA2 BPII) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVDGSLVQLWKMIFQETGKEAAKNYGLYGCNCGVGRRGKPKDATDSCCYVHKCCYKKVTGCNPKMDSYSYSWKNKAIVCGEKNPPCLKQVCECDKAVAICLRENLGTYNKKYTIYPKPFCKKADTC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows anticoagulant activities, strong myolytic activity, infiltration of polymorphonuclear cells, and edema in stromal tissues. Induces cell death of Jurkat cells in a concentration-dependent manner. Shows a low phospholipase A2 activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:19463843, ECO:0000269|PubMed:2341374}.",Phospholipase
154,P0DKR6,3SX1_DENPO,,Mambalgin-1 (Mamb-1) (Pi-Dp1),MKTLLLTLLVVTIVCLDLGYSLKCYQHGKVVTCHRDMKFCYHNTGMPFRNLKLILQGCSSSCSETENNKCCSTDRCNK,"Snake three-finger toxin family, Short-chain subfamily, Mambalgin sub-subfamily","FUNCTION: This three-finger toxin inhibits ASIC channels. It acts as a gating modifier toxin by decreasing the apparent proton sensitivity of activation and by slightly increasing the apparent proton sensitivity for inactivation (PubMed:23034652). It binds more tightly to the closed state and to a much lesser extent the inactivated/desensitized state of ASIC1a isoform of ASIC1 (PubMed:23034652). It interacts directly with the outside surface of the thumb domain of chicken ASIC1a (ASIC1a), but does not insert into the acidic pocket as suggested for mambalgin-2 (PubMed:29872539). This binding leads to relocation of the thumb domain that could disrupt the acidic pocket of cASIC1a (PubMed:29872539). It reversibly inhibits rat ASIC1a (IC(50)=3.4-55 nM), rat ASIC1a-ASIC2b (IC(50)=61 nM), rat ASIC1a-ASIC1b (IC(50)=72 nM), human ASIC1a (IC(50)=127-580 nM), chicken ASIC1a (IC(50)=123.6 nM), rat ASIC1b (IC(50)=22.2-203 nM), rat ASIC1a-ASIC2a (IC(50)=152-252 nM) (PubMed:23034652, PubMed:23624383, PubMed:24619065, PubMed:25873388, PubMed:26680001, PubMed:29872539). In vivo, it shows a potent naloxone-resistant analgesic effect against acute and inflammatory pain upon central and peripheral injection (PubMed:23034652). In addition, it also has an opioid-independent effect on both thermal and mechanical inflammatory pain after systemic administration and is effective against neuropathic pain (PubMed:26680001). {ECO:0000269|PubMed:23034652, ECO:0000269|PubMed:23624383, ECO:0000269|PubMed:24619065, ECO:0000269|PubMed:26680001, ECO:0000269|PubMed:29872539}.",Neurotoxin
155,P0DL26,VSP27_BOTPI,3.4.21.-,Thrombin-like enzyme BpirSP27 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VVGGDECNINEHRSLVAIFNSTGFFCSGILLNQEWVLTASHCDSTNFQMK,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that interferes with the hemostatic system of the prey. It preferentially degrades the Bbeta chain (FGB) of fibrinogen, with minor effects on the Aalpha chain (FGA). It presents a lower ability to degrade fibrin clots than BpirSP41. It hydrolyzes chromogenic substrates S-2238 (used for testing thrombin activity), S-2222 (factor Xa), S-2266 (glandular kallikrein and factor XIa), S-2302 (plasma kallikrein, factor XIa and XIIa), and S-2251 (plasmin). It shows a decrease in the clotting time of human plasma in the presence of increasing doses of the enzyme. Its minimum coagulant dose (MCD) is 3.5 ug. It also promotes platelet aggregation in a concentration-dependent manner in the presence or absence of calcium. It also shows 20% inhibition of the hemolytic activity promoted by the complement pathways and possess only a minor role in the induction of edema and pain in rat. {ECO:0000269|PubMed:22819993, ECO:0000269|PubMed:23499645}.",Serine Protease
156,P0DL27,VSP41_BOTPI,3.4.21.-,Thrombin-like enzyme BpirSP41 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VVGGDECDINEHPFLAFLYSHGYFCGLTLINQEWVLTAAHCDRRFMRIYL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that interferes with the hemostatic system of the prey. It almost completely degrades both Aalpha (FGA) and Bbeta (FGB) chains of fibrinogen. It presents a higher ability to degrade fibrin clots than BpirSP27. It hydrolyzes chromogenic substrates S-2238 (used for testing thrombin activity), S-2222 (factor Xa), S-2266 (glandular kallikrein and factor XIa), and S-2302 (plasma kallikrein, factor XIa and XIIa). It shows a decrease in the clotting time of human plasma in the presence of increasing doses of the enzyme. Its minimum coagulant dose (MCD) is 20 ug. It promotes platelet aggregation with a maximum of aggregation of 20%, regardless of the concentration increase or the presence of calcium. It also shows 40% inhibition of the hemolytic activity promoted by the complement pathways and possess only a minor role in the induction of edema and pain in rat. {ECO:0000269|PubMed:22819993, ECO:0000269|PubMed:23499645}.",Serine Protease
157,P0DL29,VM1_BOTPI,3.4.24.-,Snake venom metalloproteinase BpirMP (SVMP) (EC 3.4.24.-) (Alpha-fibrinogenase) (Fibrinolytic metalloproteinase) (Zinc metalloproteinase),TYIEVAVVADHRMFKKYNSNLNTIRKWVHEMVNSMNGVYRSMDVHLSLANLEVWSKKDLINVQKDSRETLKSFGEWRERDLLPRISHDNAQLLTAIVFDQQTIGRAYIGGMCDPRHSVGVVMDHSKINLQVAVTMAHELGHNLGMEHDENQCHCDAPSCVMXXXXXXXXXXXXXXCXXXXXXXXXTKHNPQCILNEPL,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Zinc metalloprotease that preferentially degrades Aalpha chain of fibrinogen (FGA) (at a dose of 5 ug, whereas at a dose of 10 ug, both FGA and FGB are completely degraded). Degrades fibrin gel in a dose-dependent manner, as well blood clots formed in vitro (thrombolytic activity). Induces hemorrhage (in the dorsal skin of mice), with an MHD of 50 ug. The basal membrane components collagen (all chains of type IV) (COL4A4), fibronectin (FN1), laminin and nidogen are all degraded by this toxin. {ECO:0000269|PubMed:23385358}.",Metalloprotease
158,P0DM51,PA2B1_BOTPA,3.1.1.4,Basic phospholipase A2 BnpTX-1 (BnPTx-I) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLWQFGKMILKVAGKLPFPYYGAYGCYCGWGGRGKPKDPTDRCCFVHDCC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2). In vitro, shows anticoagulant activity and induces cytotoxicity when tested on C2C12 myoblasts/myotubes. In vivo, when tested on mice, induces myotoxicity (intramuscular injection), edema (injection in the subplantar region) and lethality. Also induces neurotoxic effect on mouse neuromuscular preparations and has bactericidal activity on the Gram-negative bacteria E.coli (ATCC29648) and the Gram-positive S.aureus (ATCC 25923). The catalytic and anticoagulant activities of BnpTX-I are higher than those of BnpTX-II. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15302537}.",Phospholipase
159,P0DM89,VM32A_GLOBR,3.4.24.-,Zinc metalloproteinase-disintegrin-like brevilysin H2a (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),QQRYLNAKRYVKLAIVADRSMVTKHNGKLKKLRKWIYRIVNTINEVYRSLNILVALVYLEIWSKEDLINVTSAAKDTLASFGNWRATDLLKRRSHDAAHLLTNIKFDGTTVGKAYVASMCQQDSSVGINQDHSKINLLVALTMAHELGHNLGMSHDVVNTEKQCNCGTCVMAPTISDQISKLFSNCSKNDYENFLTLYKPQCILNEPSKTDIVSPPVCGNELLEVGEECDCGSPETCQNPCCDAATCKLTSGSQCAKGLCCDQCKFSKSGTECRAAKDDCDIAESCTGQSADCPTDDLQRNGKPCQNNAGYCYNGKCPIMLNQCISFYGSNATVAPDICFNYNLKGEGNFYCRKEQATIFPCAQKDKKCGRLFCVLGPTGKRISCKNTYSEDDPNYGMVDLGTKCEDGKVCNSNRECVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Non-hemorrhagic metalloproteinase that degrades fibrinogen. The alpha chain (FGA) is rapidly degraded, the beta chain (FGB) is degraded very slowly, while the gamma chain is left intact. Shows a prefential cleavage at X-Leu bonds. Cleaves insulin B chain at '29-His-|-Leu-30', '33-Ser-|-His-34', '38-Ala-|-Leu-39' and '40-Tyr-|-Leu-41' bonds. {ECO:0000269|Ref.1}.",Fibrinogenolytic Enzyme
160,P0DM90,VM32B_GLOBR,3.4.24.-,Zinc metalloproteinase-disintegrin-like brevilysin H2b (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),QQRYLNAKRYVKLAIVADRSMVTKHNGKLKKLRKWIYRIVNTINEVYRSLNILVALVYLEIWSKEDLINVTSAAKDTLASFGNWRATDLLKRRSHDAAHLLTNIKFDGTTVGKAYVASMCQQDSSVGINQDHSKINLLVALTMAHELGHNLGMSHDVVNTEKQCNCGTCVMAPTISDQISKLFSNCSKNDYENFLTLYKPQCILNEPSKTDIVSPPVCGNELLEVGEECDCGSPETCQNPCCDAATCKLTSGSQCAKGLCCDQCKFSKSGTECRAAKDDCDIAESCTGQSADCPTDDLQRNGQPCGNNAQYCRKGKCPIMTNQCISFYGPNAAVAPDACFDYNLKGEGNFYCRKEQATIFPCAQKDKKCGRLFCVLGPTGKRISCEHTYSQDDPDIGMVLPGTKCADGKVCNSNRECVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Non-hemorrhagic metalloproteinase that degrades fibrinogen. The alpha chain (FGA) is rapidly degraded, the beta chain (FGB) is degraded very slowly, while the gamma chain is left intact. Shows a prefential cleavage at X-Leu bonds. Cleaves insulin B chain at '29-His-|-Leu-30', '33-Ser-|-His-34', '38-Ala-|-Leu-39' and '40-Tyr-|-Leu-41' bonds. {ECO:0000269|Ref.1}.",Fibrinogenolytic Enzyme
161,P0DPS3,VASP1_VIPAA,,Snake venom serine protease VaSP1,VIGGDECNINEHPFLVALHTARXXRFYCAGTLINQEWVLTAARCDRXXXXXILGVHSKXXXXXXXXXXXXXXXXXXXXXXTYTRWDKDIMLIRLKRXXXXXXXXXXXXXXXXXXXXXXXXXIMGWGTITTTKVTYPDVPHCADINMFDYSVCQKXXXKLPEKSRTLCAGILQGGIDSCKGISGGPLICNGEIQGIVSYGK,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease active on several blood coagulation enzymes. It completely cleaves fibrinogen Aalpha chain (FGA) after 120 minutes, partially cleaves Bbeta chain (FGB) (overnight) and has no activity on gamma chain. It does not release fibrinopeptides A and/or B exclusively, since the enzyme does not provoke fibrin polymerisation. It also degrades fibrin as efficiently as plasmin, and exhibits potent ability to cleave plasminogen and prothrombin, as well as heavy chain of factor X (F10). In vitro, it cleaves insulin B-chain (at positions His38-Leu39, Ala40-Leu41 and Tyr16-Leu17). {ECO:0000269|PubMed:24269689}.",Serine Protease
162,P0DPS4,PA2B_CERCE,3.1.1.4,Basic phospholipase A2 Cc2-PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFGKMINHMVGKSPIFSYGDYGCYCGWGGKGTPVDATDRCCFVHDCCYGRANGCDPKLSTYSYNFQNGNIVCGNKYGCLRHICECDRVAAICFGENVNTYDKKFLSSSRCRQTSEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Basic phospholipase A2 that inhibits ADP-, thrombin- and arachidonic acid-induced platelet aggregation (PubMed:24384926, PubMed:30239061). It also exhibits anticoagulant effects upon human plasma in vitro (PubMed:30239061). It induces a high hemolytic activity reaching its maximum after 24 hours (PubMed:24384926). It induces a marked elevation of plasmatic levels of interleukin-6 and -10, eosinophil peroxidase and complement lytic activities and it also provokes a drastic increase of lymphocytes, monocytes and neutrophils in peripheral blood accompanied by a rapid intense migration of neutrophils to the peritoneal cavity (PubMed:24384926). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:24384926, ECO:0000269|PubMed:30239061}.",Phospholipase
163,P0DQD1,PLA2_WALAE,3.1.1.4,Non-toxic phospholipase A2 (WaPLA2) (svPLA2) (Phosphatidylcholine 2-acylhydrolase) (EC 3.1.1.4),NLYQFKNMVQCVGTQLCVAYVKYGCYCGPG,"Phospholipase A2 family, Group I subfamily","FUNCTION: Relatively highly potent phospholipase A2 that displays potent antimicrobial and hemolytic activities. It does not show cytotoxic effects on the three human cell lines tested. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. It shows similar potencies on both Gram-negative and Gram-positive bacteria: B.cereus (MIC>9 ug/ml), B.subtilis (MIC>12 ug/ml), E.faecalis (MIC>7 ug/ml), S.epidermidis (MIC>12 ug/ml), S.aureux (MIC>5 ug/ml), E.coli (MIC>7 ug/ml), K.pneumonia (MIC>8 ug/ml), P.aeruginosa (MIC>10 ug/ml), and S.enteric (MIC>9 ug/ml). It also shows antifungal activities: A.niger (MIC>15 ug/ml), B.cinerea (MIC>12 ug/ml), F.solani (MIC>15 ug/ml), and P.digitatum (MIC>10 ug/ml). {ECO:0000269|PubMed:29885399}.",Phospholipase
165,P0DQQ0,PA2B3_BOTBZ,3.1.1.4,Basic phospholipase A2 BbTX-III (svPLA2) (EC 3.1.1.4) (Brazilitoxin III) (BbTX-III) (Phosphatidylcholine 2-acylhydrolase),SLWEWGQMILKETGKNPFPYYGAYGCYCGWGGRRKPKDATDRCCFVHDCCRYKKLTGCPKTNDRYSYSRLDYTIVCGEDDPCKEICECDKAAAVCFRENLRTYNKKYMAHLRVLCKKDKPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits myotoxin and anticoagulant activity (PubMed:19539640). Displays edema-inducing activities in mouse paw (PubMed:19539640). Also displays cytotoxic activity against some cell lines and myotubes, and antimicrobial activities against E.coli, C.albicans and Leishmania (PubMed:19539640). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:19539640}.",Phospholipase
166,P0DQQ4,PDE_CRODO,3.6.1.-,Venom phosphodiesterase CdcPDE (PDE) (EC 3.6.1.-),GLKEPVQPQVSCRYRCNETFSRMASGCSCDDKCTERQACCSDYEDTCVLPTQSWSCSKLRCGEKRIANVLCSCSEDCLEKKDCCTDYKTICKGETSWLKDKCASSGATQCPAGFEQSPLILFSMDGFRAGYLENWDSLMPNINKLKTCGTHAKYMRAVYPTKTFVNHYTIATGLYPESHGIIDNNIYDVNLNLNFSLSSSTARNPAWWGGQPIWHTATYQGLKAATYFWPGSEVKINGSYPTIFKNYDKSIPFEARVTEVLKWLDLPKAKRPDFFTLYIEEPDTTGHKYGPVSGEIIKALQMADRTLGMLMEGLKQRNLHNCVNLILLADHGMEEISCDRLEYMANYFDNVDFFMYEGPAPRIRSKNVPKDFYTFDSEGIVKNLTCRKPKQYFKAYLSKDLPKRLHYANNIRIDKVNLMVDQQWMAVRDKKFTRCKGGTHGYDNEFKSMQAIFLAHGPGFNEKNEVTSFENIEVYNLMCDLLKLKPAPNDGTHGSLNHLLKNPFYTPSPAKEQSSPLSCPFGPVPSPDVSGCKCSSITELEKVNQRLNLNNQAKTESEAHNLPYGRPQVLQNHSKYCLLHQAKYISAYSQDILMPLWSSYTIYRSTSTSVPPSASDCLRLDVRIPAAQSQTCSNYQPDLTITPGFLYPPNFNSSNFEQYDALITSNIVPMFKGFTRLWNYFHTTLIPKYARERDGLNVISGPIFDYNYDGHFDSYDTIKQHVSNTKIPIPTHYFVVLTSCENQINTPLNCLGPLKVLSFILPHRPDNSESCADTSPENLWVEERIQIHTARVRDVELLTGLNFYSGLKQPLPETLQLKTFLPIFVNPVN,Nucleotide pyrophosphatase/phosphodiesterase family,"FUNCTION: Hydrolyzes ADP with high activity. Shows weak or no activity on 5'-AMP, 5'-GMP, 3'-AMP, ATP, cAMP, and cGMP (By similarity). Is devoid of monophosphatase and proteinase activities (By similarity). Inhibits ADP-induced platelet aggregation and is cytotoxic to human keratinocytes (PubMed:33636276). Kinetic parameters indicated a higher affinity for the substrate bis(p-nitrophenyl) phosphate compared to others snake venom PDEs (PubMed:33636276). Is recognized by the crotalid antivenom produced by the Instituto Butantan (PubMed:33636276). {ECO:0000250|UniProtKB:W8E7D1, ECO:0000269|PubMed:33636276}.",General Toxin
167,P0DRC8,VM1_MACLN,3.4.24.-,Snake venom metalloproteinase Mlp4.2 (SVMP) (EC 3.4.24.-),QFSDCSKDEYQRYLT,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom metalloproteinase that disrupts the muscle fibers interaction with extracellular matrix proteins. In vitro, is able to proteolyse extracellular matrix proteins surrounding muscle fibers such as laminin and fibronectin, but does not show any direct cytolytic activity towards the myogenic cell line C2C12 in culture. In vivo, induces a massive degeneration of myofibers, but has no hemorrhagic activity. {ECO:0000269|PubMed:20398688}.",Vascular Interaction
168,P0DUG4,PA2TI_NAJHH,3.1.1.4,Phospholipase A2 TI-Nh (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Thrombin inhibitor from Naja haje),NVYQYRKMLQCAMPNGGPFECCQTHDNCYGEAEKLKACTSTHSSPYFK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Phospholipase A2 with weak enzymatic activity, which partially inhibits thrombin enzymatic activity (Ki=73 nM), completely inhibits thrombin-induced platelet aggregation and retards fibrin clot formation (IC(50)=0.2 nM) (PubMed:19622365). May exert this anticoagulant effect through a non-enzymatic mechanism (PubMed:19622365). {ECO:0000269|PubMed:19622365}.",Phospholipase
169,P0DUN0,PA23_BOTHY,3.1.1.4,Acidic phospholipase A2 PhTX-III (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLMQFETLIMKSGVWYYGSYGCYCGSGGQFRPQDASDRCCFVHDCCYGKNGDIVCGGDDPCKKQICECDRVAATCFRDNKVTYDNKYWFFPAKFPPQNCKEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces inflammatory response, with local edema and release of cytokines IL-1 alpha, IL-6 and TNF-alpha (PubMed:29124136). Does not exhibit myotoxic, anticoagulant and antibacterial effects (PubMed:29124136). Release of pro-inflammatory cytokines may be due to mast cell degranulation, and edema may be induced by arachidonic acid that results from the PLA2 catalytic activity (PubMed:29124136). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:29124136). {ECO:0000269|PubMed:29124136}.",Phospholipase
170,P0DUN1,PA22_BOTHY,3.1.1.4,Basic myotoxic phospholipase A2 PhTX-II (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMILKETGKNAIPFYAFYGCYCGWGGRGKPKDKTDDRCCFVHDCCYGKLTGCPKWDIYPYSLKSGYITCGKGTWCEEQICECDRAAAICFRENLDTYNKYGYMFYPDSRCKGPSEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces myotoxicity and local edema in mice (PubMed:25365526). In addition, it causes neuromuscular blockade in avian neuromuscular preparations with a significant direct action on skeletal muscle function (PubMed:25365526). Myotoxic action is exerted by both enzymatic and non-enzymatic mechanisms (PubMed:25365526). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:25365526). {ECO:0000269|PubMed:25365526}.",Phospholipase
171,P0DUN2,PA21_BOTHY,3.1.1.4,Basic phospholipase A2 Ph-TX1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLWEFGKMILKETGKNPFPYYGAYGCYCGWGGRGKPKDKTDDRCCFVHDCCRYKKLTGCPKTNDRYSYSWKDLTIVCGEDDPCKELCECDKAAAVCFRENLGTYNKKYRYHLRSLCKKADKPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces in vivo myotoxicity, moderates footpad edema, and causes in vitro neuromuscular blockade. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:21496495}.",Phospholipase
172,P0DUN3,PA2A1_BOTBZ,3.1.1.4,Acidic phospholipase A2 braziliase-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLWQFEMLIMKIALTSGFMFYSSYGCYCGWGGHGRPKDASDRCCFVHDCCYGKVTTCNPKFGVVVCGGDDPCKKQICECDRVAATCFRDNKYWFYGAKXCQEESDPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that induces significant edematogenic activity. Shows mild cytotoxicity on Trypanosoma cruzi and Leishmania infantum. Also inhibits ADP- and collagen-induced platelet aggregation. Does not show myotoxic activity. {ECO:0000269|PubMed:28951306}.,Phospholipase
173,P0DUN4,PA2A2_BOTBZ,3.1.1.4,Acidic phospholipase A2 braziliase-II (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLWQFEMLIMKIAKTSGFMFYSSYGCYCGWGGHGRPQDASDRCCFVHDCCYGKVTGVVVCGGDDPCKXQICECDRVAATCFRDNKYWFFPAK,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that induces significant edematogenic activity. Shows mild cytotoxicity on Trypanosoma cruzi and Leishmania infantum. Also inhibits ADP- and collagen-induced platelet aggregation. Does not show myotoxic activity. {ECO:0000269|PubMed:28951306}.,Phospholipase
174,P0DUN5,PA2_BOTBS,3.1.1.4,Basic phospholipase A2 Bbil-TX (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKNAIPFYAFYGCYCGWGGRCCFVHDCCYGKWDIYPYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces myonecrosis, when intramuscularly injected into mice (PubMed:23509754). Does not show systemic myotoxic effect (after intravenous injection) (PubMed:23509754). Does not show cytotoxic activities in myotubes and myoblasts (PubMed:23509754). Induces marked paw edema after subplantar injections (PubMed:23509754). Also induces an increase in vascular permeability and in the levels of TNF-alpha, IL-6, and IL-1 cytokines (PubMed:23509754). causes enzymatic-dependent neuromuscular blockade in avian and mammalian neuromuscular preparations in vitro essentially by a presynaptic mechanism with no significant direct action on skeletal muscle function (PubMed:23541434, PubMed:25572337). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:23509754). {ECO:0000269|PubMed:23509754, ECO:0000269|PubMed:23541434, ECO:0000269|PubMed:25572337}.",Phospholipase
175,P0DV78,OXLA2_BOTJR,1.4.3.2,L-amino-acid oxidase BjussuLAAO-II (LAO) (EC 1.4.3.2),ADDRNPLEECFRETDYEEFLEIARNGLSDTDNPKEGWYANLGPMRLNEFSQENENAWYFIKDPGVLDYPVKPSEVGKHDDIFAYEKRFDEIVGGMDKEVTVTYQTSEKFEPPLPPK,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (By similarity) (PubMed:28495622). Shows very high enzymatic activity on L-Met and L-Leu, high activity on L-Ile, L-Phe and L-Tyr and moderate activity on L-His (PubMed:28495622, PubMed:30534149). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, and antibacterial, as well as regulation of platelet aggregation (By similarity). Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation (By similarity). These different effects are probably due to different experimental conditions (By similarity). In vitro, has a strong antiprotozoal effect against Leishmania amazonensis (IC(50)=4.56 ug/mL) and Trypanosoma cruzi (IC(50)=4.85 ug/mL) (PubMed:28495622). It also causes cell death and DNA damage in hepatocarcinoma cells (HepG2) in vitro by inducing oxidative stress (PubMed:30654040). It exerts cytotoxicity towards colorectal adenocarcinomahuman cells (Caco-2) by acting on multiple intracellular targets (PubMed:29222016). It diminishes cell viability by decreasing mitochondrial activity, the activity of acid phosphatases, and lysosomal function (PubMed:29222016). In addition, it increases intracellular levels of reactive oxygen species and DNA damage, it elevates the expression of the pro-inflammatory cytokine genes TNF and IL6, and lowers the expression of the apoptotic-related genes (PubMed:29222016). Also induces cytotoxicity (IC(50)=1.80 ug/mL) and apoptosis in MCF-7 cells (a human breast adeno-carcinoma cell line) by activating the intrinsic and extrinsic apoptosis pathways, but are not cytotoxic towards MCF-10A cells (a non-tumorigenic human breast epithelial cell line) (PubMed:28495622). {ECO:0000250|UniProtKB:Q6TGQ9, ECO:0000269|PubMed:28495622, ECO:0000269|PubMed:29222016, ECO:0000269|PubMed:30534149, ECO:0000269|PubMed:30654040}.",Vascular Interaction
176,P0DW98,TXVE_PROJR,,Snake venom vascular endothelial growth factor toxin (TjsvVEGF) (svVEGF) (VEGF-F) (Vascular permeability factor) (VPF),MAAYLLAVAILFCIQGWPSATVQGQVMPFMEVYERSACQTRETLVSILKEYPDEVAHLFKPSCVPVLRCSGCCSDESLKCTATGKHSVGREVMRVDPHKGTSKIEVMQFKEHTDCECRPRSPGDVNNGRNPEEGEPRARFPFV,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability when intradermally injected into mice (PubMed:26107411). Also provokes a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces angiogenesis in vitro (By similarity). Unlike other crotalid VEGFs, this protein interacts with VEGF receptor-2 (KDR) with a high affinity (Kd=413 pM), whereas no interaction is detected with VEGF receptor-1 (FLT1) (PubMed:26107411). {ECO:0000250|UniProtKB:P83942, ECO:0000269|PubMed:26107411}.",Vascular Interaction
177,P11407,PA2BC_VIPAA,3.1.1.4,Basic phospholipase A2 ammodytoxin C (AtxC) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLIGVEGSLLEFGMMILGETGKNPLTSYSFYGCYCGVGGKGTPKDATDRCCFVHDCCYGNLPDCSPKTDRYKYHRENGAIVCGKGTSCENRICECDRAAAICFRKNLKTYNYIYRNYPDILCKEESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that acts as a presynaptic neurotoxin, an inhibitor of blood coagulation, and has been found to bind with high affinity to intracellular proteins. The response of indirectly stimulated neuromuscular preparations to ammodytoxin (Atx) is triphasic. The first phase, the transient inhibition of the acetylcholine (ACh) release, starts soon after the addition of Atx and lasts for several minutes. This phase is probably independent of Atx enzymatic activity. The effect may be due to the specific binding of the toxin to presynaptic receptors. These receptors, called N-type receptors, are still unidentified. It is noteworthy that a neuronal isoform of the M-type PLA2 receptor (R180) has been identified as a high-affinity receptor for Atx in neuronal plasma membranes. It was demonstrated however that this receptor is not essential for expression of neurotoxicity by Atx. The second phase corresponds to an augmentation of neurotransmitter release. A peak is reached 10-20 minutes after exposure of the preparation to Atx and is followed by a gradual reduction. In this phase, the enzymatic activity of Atx of the mammalian is not significant. It is speculated that the increased release of neurotransmitter in this phase is induced by the interference of Atx with voltage-gated potassium channels. Measurements of ionic showed however that voltage-gated potassium channels are not affected by Atx. The third phase of the response of neuromuscular preparations to Atx, which corresponds to a complete and irreversible paralysis, is clearly dependent on the hydrolytic activity of the toxin. In addition to its presynaptic neurotoxicity, Atx shows an anticoagulant activity by binding with high affinity to activated coagulation factor X (F10) thus inhibiting the formation of the prothrombinase complex (FX/FV) and its activity (IC(50) is 240 nM). Surprisingly, Atx was discovered to bind intracellular proteins such as calmodulin (CaM), 14-3-3 proteins gamma (YWHAG) and epsilon (YWHAE), as well as R25, a mitochondrial integral membrane protein found in cerebral cortex. These findings raised a doubt about the dogma of the exclusively extracellular action of PLA2s, defended by the potential instability of these molecules in the reducing environment of the eukaryotic cytosol coupled with their possible inability to act as enzymes in this cellular compartment, due to too low concentration of calcium ions. This hypothesis was challenged efficiently by demonstrating the internalization of AtxA into a culture cells, but still remains to be directly demonstrated in vivo (By similarity). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000250, ECO:0000269|PubMed:11600150, ECO:0000269|PubMed:16039772, ECO:0000269|PubMed:16156665}.",Phospholipase
178,P13208,SRTX_ATREN,,"Sarafotoxin [Cleaved into: Sarafotoxin-A, Ser-isoform (SRTX-A) (Sarafotoxin-A) (S6A); Sarafotoxin-C (SRTX-C) (S6C); Sarafotoxin-B (SRTX-B) (S6B); Sarafotoxin-E (SRTX-E) (S6E); Sarafotoxin-A, Thr-isoform]",MALLPRLAAGGLLLLLALAALEGKPAPSALSQLLEKRSEDQAAAGRIIDGGDTKQAARDPSPQRNVEPLCSCKDMSDKECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCSCKDMTDKECLYFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCKDMTDKECLYFCHQGIIWRDTKQAARDPSPQRNVEPLCSCKDMSDKECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCSCKDMTDKECLYFCHQDVIWRDTKQAARDPSPQRNVEPLCSCKDMSDKECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCSCKDMTDKECLNFCHQDVIWKNADTSANPEFLG,Endothelin/sarafotoxin family,"FUNCTION: Vasoconstrictor activity. These toxins cause cardiac arrest probably as a result of coronary vasospasm. {ECO:0000269|PubMed:21889567}.; FUNCTION: [Sarafotoxin-B]: Vasoconstrictor activity. Causes cardiac arrest probably as a result of coronary vasospasm (By similarity). Displays high agonistic activities towards endothelin-2 receptor (EDNRB) (displays affinity in the picomolar range) and endothelin-1 receptor (EDNRA) (lower affinities) (PubMed:21889567). {ECO:0000250, ECO:0000269|PubMed:21889567}.",General Toxin
179,P14418,PA2A_GLOHA,3.1.1.4,Acidic phospholipase A2 (svPLA2) (EC 3.1.1.4) (APLA2) (Phosphatidylcholine 2-acylhydrolase),SLIQFETLIMKVAKKSGMFWYSNYGCYCGWGGQGRPQDATDRCCFVHDCCYGKVTGCDPKMDVYSFSEENGDIVCGGDDPCKKEICECDRAAAICFRDNLTLYNDKKYWAFGAKNCPQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that acts in vivo as an anti-thrombotic agent. Inhibits platelet aggregation induced by ADP, arachidonic acid, and thrombin. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18456297}.",Phospholipase
180,P14420,PA2B_VIPAE,3.1.1.4,Basic phospholipase A2 vipoxin B chain (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Vipoxin toxic component),NLFQFAKMINGKLGAFSVWNYISYGCYCGWGGQGTPKDATDRCCFVHDCCYGRVRGCNPKLAIYSYSFKKGNIVCGKNNGCLRDICECDRVAANCFHQNKNTYNKNYKFLSSSRCRQTSEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer: postsynaptic neurotoxin.; FUNCTION: Monomer: snake venom phospholipase A2 (PLA2) that shows hemolytic activity and inhibition of platelet aggregation. The hemolytic activity occurs only in presence of fatty acids (unsaturated fatty acids facilitate induce a strong hemolytic activity, whereas saturated fatty acids induce a slight activity). The inhibition of platelet aggregation is almost maximal when aggregation is induced by collagen, and arachidonic acid, whereas it is only of 30% when the aggregation is induced by ADP. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
181,P14421,PA2N_GLOHA,3.1.1.4,Neutral phospholipase A2 agkistrodotoxin (AGTX) (ATX) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMIKEETGKNAIPFYAFYGCYCGGGGQGKPKDGTDRCCFVHDCCYGRLVNCNTKSDIYSYSLKEGYITCGKGTNCEEQICECDRVAAECFRRNLDTYNNGYMFYRDSKCTETSEEC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
182,P14424,PA2BB_VIPAA,3.1.1.4,Basic phospholipase A2 ammodytoxin B (AtxB) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLIGVEGSLLEFGMMILGETGKNPLTSYSFYGCYCGVGGKGTPKDATDRCCFVHDCCYGNLPDCSPKTDRYKYHRENGAIVCGKGTSCENRICECDRAAAICFRKNLKTYNHIYMYYPDFLCKKESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that acts as a presynaptic neurotoxin, an inhibitor of blood coagulation, and has been found to bind with high affinity to intracellular proteins. The response of indirectly stimulated neuromuscular preparations to ammodytoxin (Atx) is triphasic. The first phase, the transient inhibition of the acetylcholine (ACh) release, starts soon after the addition of Atx and lasts for several minutes. This phase is probably independent of Atx enzymatic activity. The effect may be due to the specific binding of the toxin to presynaptic receptors. These receptors, called N-type receptors, are still unidentified. It is noteworthy that a neuronal isoform of the M-type PLA2 receptor (R180) has been identified as a high-affinity receptor for Atx in neuronal plasma membranes. It was demonstrated however that this receptor is not essential for expression of neurotoxicity by Atx. The second phase corresponds to an augmentation of neurotransmitter release. A peak is reached 10-20 minutes after exposure of the preparation to Atx and is followed by a gradual reduction. In this phase, the enzymatic activity of Atx of the mammalian is not significant. It is speculated that the increased release of neurotransmitter in this phase is induced by the interference of Atx with voltage-gated potassium channels. Measurements of ionic currents showed however that voltage-gated potassium channels are not affected by Atx. The third phase of the response of neuromuscular preparations to Atx, which corresponds to a complete and irreversible paralysis, is clearly dependent on the hydrolytic activity of the toxin. In addition to its presynaptic neurotoxicity, Atx shows an anticoagulant activity by binding with high affinity to activated coagulation factor X (F10) thus inhibiting the formation of the prothrombinase complex (FX/FV) and its activity (IC(50) is 82 nM). Surprisingly, Atx was discovered to bind intracellular proteins such as calmodulin (CaM), 14-3-3 proteins gamma (YWHAG) and epsilon (YWHAE) (by similarity with AtxC), as well as R25 (by similarity with AtxC), a mitochondrial integral membrane protein found in cerebral cortex. These findings raised a doubt about the dogma of the exclusively extracellular action of PLA2s, defended by the potential instability of these molecules in the reducing environment of the eukaryotic cytosol coupled with their possible inability to act as enzymes in this cellular compartment, due to too low concentration of calcium ions. This hypothesis was challenged efficiently by demonstrating the internalization of AtxA into a culture cells, but still remains to be directly demonstrated in vivo (By similarity). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000250, ECO:0000269|PubMed:16039772}.",Phospholipase
183,P14530,VM2HA_PROFL,3.4.24.53,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase HR2a (SVMP) (EC 3.4.24.53) (Snake venom metalloproteinase HR2b) (Trimerelysin II); Disintegrin flavostatin (Platelet aggregation activation inhibitor)],MIEVLLVTICLAVFPYPGSSIILESGNVDDYEVVYPQKLTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIQNDADSTASISACDGLKGYFKLQGETYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYIELAIVVDHGMYTKYSSNFKKIRKRVHQMVNNINEMYRPLNIAITLSLLDVWSEKDLITMQAVAPTTARLFGDWRETVLLKQKDHDHAQLLTDINFTGNTIGWAYMGGMCNAKNSVGIVKDHSSNVFMVAVTMTHEIGHNLGMEHDDKDKCKCEACIMSAVISDKPSKLFSDCSKDYYQTFLTNSKPQCIINAPLRTDTVSTPVSGNEFLEAGEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRRARGDNPDDRCTGQSADCPRNS,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase HR2a]: Zinc protease that induces hemorrhage. {ECO:0000269|PubMed:9114455}.; FUNCTION: [Disintegrin flavostatin]: Inhibits platelet aggregation induced by ADP, thrombin, and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3). {ECO:0000269|PubMed:9114455}.",Metalloprotease
185,P15167,VM1AD_CROAT,3.4.24.42,Snake venom metalloproteinase atrolysin-D (SVMP) (EC 3.4.24.42) (Hemorrhagic metalloproteinase atrolysin D) (Hemorrhagic toxin D) (HT-D),MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKELFSKDYSETHYSPDGRKITTNPSVEDHCYYRGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKLENVEKEDEAPKMCGVTQNWESYEPIKKASDLNLNPDQQNLPQRYIELVVVADHRVFMKYNSDLNTIRTRVHEIVNFINGFYRSLNIHVSLTDLEIWSNEDQINIQSASSDTLNAFAEWRETDLLNRKSHDNAQLLTAIELDEETLGLAPLGTMCDPKLSIGIVQDHSPINLLMGVTMAHELGHNLGMEHDGKDCLRGASLCIMRPGLTKGRSYEFSDDSMHYYERFLKQYKPQCILNKPLRIDPVSTPVSGNELLEAGEE,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloproteinase that causes hemorrhage by provoking the degradation of the sub-endothelial matrix proteins (fibronectin, laminin, type IV collagen, nidogen, and gelatins). {ECO:0000269|PubMed:2817904}.",Metalloprotease
187,P17347,VM2EA_ECHCS,3.4.24.-,Disintegrin metalloproteinase/disintegrin echistatin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin echistatin (Ech) (Carinatin) (Disintegrin echistatin-alpha-1) (Platelet aggregation activation inhibitor); Disintegrin echistatin-alpha-2],IGIAYNRGMCDPKKSVGTVMDHSTEHLSVAVAMAHEMGHNLGMDHDGNQCNCGGAGCVMSEELIESRSYKFSDCSKNQYQNYLTIYKPQCILNQPLRTDTVSTPVSGNELLQNSANPCYDPLTCHPREGEQCESGPCCRNCKFLKEGTICKRARGDDMDDYCNGKTCDCPRNPHKGPATAKGSVLM,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250|UniProtKB:Q5XUW8, ECO:0000305}.; FUNCTION: [Disintegrin echistatin]: Potent inhibitor of ligand binding to the integrins alpha-V/beta-3 (ITGAV/ITGB3) (IC(50)=20.7 nM), alpha-IIb/beta-3 (ITGA2B/ITGB3) (IC(50)=51.5 nM), alpha-5/beta-1 (ITGA5/ITGB1) (IC(50)=132.6 nM), and moderate inhibitor of ligand binding to the integrin alpha-V/beta-5 (ITGAV/ITGB5) (IC(50)=286.4 nM) (PubMed:33182321, PubMed:9269775). Competition with fibrinogen for the RGD recognition sites on the alpha-IIb/beta-3 integrin (glyco-protein IIb/IIIa complex) results in the inhibition of platelet aggregation and other antithrombotic properties such as an ability to prevent coronary thrombosis in animal models (Probable) (PubMed:2320569, PubMed:3198653). Is also a potent inhibitor of bone resorption. This results from the blocking of the interaction of alpha-V/beta-3 integrin on the surface of osteoclasts with bone extracellular matrix (Probable). In addition, interaction with alpha-V/beta-3 also inhibits human umbilical vein endothelial cells (HUVEC) proliferation (IC(50)=103.2 nM) and inhibits the migration of some tumor cells (IC(50)=1.5-154.5 nM), suggesting that this disintegrin could be a good scaffold to design potent antiangiogenic agents by modifying its unique C-terminal tail structure (Probable) (PubMed:33182321). {ECO:0000269|PubMed:2320569, ECO:0000269|PubMed:3198653, ECO:0000269|PubMed:33182321, ECO:0000269|PubMed:9269775, ECO:0000305|PubMed:9269775}.",Kunitz Family
188,P17349,VM2E1_PROEL,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin elegantin-1a; Disintegrin elegantin-1b; Disintegrin elegantin-1c],MIQVLLVTICLAVFPYQGSSIILESGNVDDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEAVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYIKLAIVVDHGMYTKYSSNFKKIRKRVHQMVSNINEMCRPLNIAITLALLDVWSEKDFITVQADAPTTAGLFGDWRERVLLKKKNHDHAQLLTDTNFARNTIGWAYLGRMCDEKYSVGVVQDHSSKVFMVAVTMTHELGHNLGMEHDDKDKCKCEACIMSAVISDKQSKLFSDCSKDYYQTFLTNDNPQCILNAPLRTDTVSTPVSGNEFLEAGEECDCGSPENPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRRARGDNPDDRCTGQSADCPRNGLYS,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin elegantin-1a]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3). {ECO:0000269|PubMed:2191722}.",Fibrinogenolytic Enzyme
189,P17935,PA2HL_VIPAA,,Basic phospholipase A2 homolog ammodytin L (AMDL) (AtnL) (svPLA2 homolog),MRILWIVAVCLIGVEGSVIEFGKMIQEETDKNPLTSYSFYGCHCGLGNKGKPKDATDRCCFVHSCCYAKLPDCSPKTNRYEYHRENGAIVCGSSTPCKKQICECDRAAAICFRENLKTYNKKYKVYLRFKCKGVSEKC,"Phospholipase A2 family, Group II subfamily, S49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity.Snake venom phospholipase A2 homolog that Is very active in inducing myonecrosis in vivo and shows a potent calcium-independent membrane-damaging activity in vitro, most probably by binding and incorporating in the membrane. Also acts as a presynaptic neurotoxin. A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:10653156, ECO:0000269|PubMed:11005629, ECO:0000269|PubMed:1765075, ECO:0000269|PubMed:17927217, ECO:0000269|PubMed:7662700, ECO:0000269|PubMed:8835336, ECO:0000269|PubMed:8973554, ECO:0000269|PubMed:9514950}.",Phospholipase
190,P18964,VSPA_DABSI,3.4.21.95,Factor V activator RVV-V alpha (EC 3.4.21.95) (Russel's viper venom FV activator alpha) (RVV-V alpha) (Snake venom serine protease) (SVSP),VVGGDECNINEHPFLVALYTSTSSTIHCGGALINREWVLTAAHCDRRNIRIKLGMHSKNIRNEDEQIRVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPVSLPSRSRGVGSRCRIMGWGKISTTEDTYPDVPHCTNIFIVKHKWCEPLYPWVPADSRTLCAGILKGGRDTCHGDSGGPLICNGQIQGIVAGGSEPCGQHLKPAVYTKVFDYNNWIQNIIAGNRTVTCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Venom serine protease that activates factor V (F5) in a calcium-independent manner. It cleaves the Arg(1545)-Ser(1546) linkage in the human factor V molecule. Induces the coagulation of mammalian plasma. {ECO:0000269|PubMed:16807918, ECO:0000269|PubMed:3053712}.",Serine Protease
191,P18965,VSPG_DABSI,3.4.21.95,Factor V activator RVV-V gamma (EC 3.4.21.95) (Russel's viper venom FV activator gamma) (RVV-V gamma) (Snake venom serine protease) (SVSP),MVLIKVLANLLVLQLSYAQKSSELVVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRRNIRIKLGMHSKNIRNEDEQIRVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPVSLPSRSRGVGSRCRIMGWGKISTTEDTYPDVPHCTNIFIVKHKWCEPLYPWVPADSRTLCAGILKGGRDTCHGDSGGPLICNGEMHGIVAGGSEPCGQHLKPAVYTKVFDYNNWIQSIIAGNRTVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Venom serine protease that selectively activates factor V (F5) in a calcium-independent manner. It cleaves the Arg(1545)-Ser(1546) linkage in the human factor V molecule. Induces the coagulation of mammalian plasma. {ECO:0000269|PubMed:3053712}.,Serine Protease
192,P20164,VM3HB_PROFL,3.4.24.-,Zinc metalloproteinase-disintegrin-like HR1b (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) (Trimerelysin I) (Trimerelysin-1) [Cleaved into: Disintegrin-like 1b],MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVMYPQKVAALPKGAVQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLKFSDSEAHAVYKYENVEKEEEAPKMCGVTQTNWESDEPIKKASKLVVTAEQQRFPRRYIKLAIVVDHGIVTKHHGNLKKIRKWIYQLVNTINNIYRSLNILVALVYLEIWSKQNKITVQSASNVTLDLFGDWRESVLLKQRSHDCAQLLTTIDFDGPTIGKAYTASMCDPKRSVGIVQDYSPINLVVAVIMTHEMGHNLGIPHDGNSCTCGGFPCIMSPMISDPPSELFSNCSKAYYQTFLTDHKPQCILNAPSKTDIVSPPVCGNELLEAGEECDCGSPENCQYQCCDAASCKLHSWVKCESGECCDQCRFRTAGTECRAAESECDIPESCTGQSADCPTDRFHRNGQPCLYNHGYCYNGKCPIMFYQCYFLFGSNATVAEDDCFNNNKKGDKYFYCRKENEKYIPCAQEDVKCGRLFCDNKKYPCHYNYSEDLDFGMVDHGTKCADGKVCSNRQCVDVNEAYKSTTVFSLI,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: [Zinc metalloproteinase-disintegrin-like HR1b]: Zinc protease that induces hemorrhage. Has preference for Tyr, Leu, Arg, Met, and Phe at the P1 position, in descending order (in vitro). Shows equal preference for the sequences of Ala-Asp and Arg-Ile at the P3-P2 position with different enzyme cleavage sites across the P1 position: the N-terminus side for Ala-Asp and the C-terminus side for Arg-Ile. {ECO:0000269|PubMed:18256489}.; FUNCTION: [Disintegrin-like 1b]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors alpha-IIb/beta-3 (ITGA2B/ITGB3). {ECO:0000250}.",Metalloprotease
193,P20165,VM1T2_PROFL,3.4.24.53,Snake venom metalloproteinase trimerelysin-2 (SVMP) (EC 3.4.24.53) (H2 metalloproteinase) (H2-proteinase) (Trimerelysin II),QRFPQRYIELAIVVDHGMYKKYNQNSDKIKVRVHQMVNHINEMYRPLNIAISLNRLQIWSKKDLITVKSASNVTLESFGNWRETVLLKQQNNDCAHLLTATNLNDNTIGLAYKKGMCNPKLSVGLVQDYSPNVFMVAVTMTHELGHNLGMEHDDKDKCKCEACIMSDVISDKPSKLFSDCSKNDYQTFLTKYNPQCILNAP,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Major venom non-hemorrhagic metalloproteinase.,General Toxin
194,P20474,PA2B3_BOTAS,3.1.1.4,Basic phospholipase A2 myotoxin I (MT-I) (svPLA2) (EC 3.1.1.4) (Myotoxic phospholipase) (Myotoxin III) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVEGSLIEFAKMILEETKRLPFPYYTTYGCYCGWGGQGQPKDATDRCCFVHDCCYGKLSNCKPKTDRYSYSRKSGVIICGEGTPCEKQICECDKAAAVCFRENLRTYKKRYMAYPDLLCKKPAEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays local myotoxic activity. It also displays anticoagulant action in plasma and edema-inducing activities (PubMed:2327788, PubMed:9839670). In addition, it shows cytotoxic activity to a variety of cell types and bactericidal activity to a variety of Gram-negative and Gram-positive bacteria (PubMed:9654096, PubMed:9920486). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000250|UniProtKB:P24605, ECO:0000269|PubMed:2327788, ECO:0000269|PubMed:6426093, ECO:0000269|PubMed:8218369, ECO:0000269|PubMed:8456450, ECO:0000269|PubMed:9654096, ECO:0000269|PubMed:9839670, ECO:0000269|PubMed:9920486}.",Phospholipase
195,P20897,VM1H2_CRORU,3.4.24.48,Snake venom metalloproteinase HT-2 (SVMP) (EC 3.4.24.48) (Hemorrhagic metalloproteinase HT-2) (Hemorrhagic toxin II) (Ruberlysin),QNLPQSYIELVVVADHRMFMKYNSDLNTIRTRVHEIVNFINEFYRSLNIRVSLTDLEIWSDQDFITVQSSAKNTLHSFGEWRKSVLLNRKRHDNAQLLTAIVLDDYTLGLAYLNSMCHPRNSVGLIQDHSPINLLMGVTMAHELGHNLGMEHDGKDCLRGASLCIMRPGLTPGRSYEFSDASMRYYQKFLDQYKPQCILNKP,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: This protein is a zinc protease from snake venom that induces hemorrhage.,Metalloprotease
196,P21963,LECG_CROAT,,C-type lectin Cal (CTL) (Galactose-specific lectin) (Rattlesnake lectin) (RSL),NNCPLDWLPMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQENVWIGLRDKKKDFSWEWTDRSCTDYLTWDKNQPDHYQNKEFCVELVSLTGYRLWNDQVCESKDAFLCQCKF,True venom lectin family,FUNCTION: Galactose-binding protein which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. Calcium-dependent lectin. Shows high hemagglutinating activity (MHC=10 ng/ml) (PubMed:1989986). {ECO:0000269|PubMed:1989986}.,Binding Protein
197,P22796,VM1H2_LACMU,3.4.24.-,Snake venom metalloproteinase hemorrhagic factor 2 (SVMP) (EC 3.4.24.-) (Hemorrhagic factor II) (LHF-II) (LHFII),FSQKYIELVVVADHGMFTKYNGNLNTIRTRVHEIVNTLNGFYRSLNILISLTDLEIWSNQDLINVQSAANDTLKTFGEWRERVLLNRISHDNAQLLTAIDLADNTIGIAYTGGMCYPKNSVGIVQDHSPKTLLIAVTMAHELGHNLGMKHDENHCHCSASFCIMPPSISEGPSYEFSDCSKDYYQMFLTKRKPQCILNKP,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloproteinase that induces weak hemorrhage and mild myonecrosis. Shows mild myotoxicity by killing myocytes. Also induces edema in the mouse footpad at doses where hemorrhage is absent. In vitro, degrades laminin, fibronectin, and type IV collagen, suggesting this toxin play a role in local tissue damage by degrading extracellular matrix, and possibly by degrading muscle extracellular matrix. Hemorrhage is not due to cytotoxicity towards endothelial cells in culture, and may only play a minor role in local bleeding characteristic of L.muta envenomations. Also induces the synthesis of several endogenous matrix metalloproteinases, which in turn, may participate in extracellular matrix degradation. {ECO:0000269|PubMed:10400290}.",Metalloprotease
198,P23026,PA2BA_PSETE,3.1.1.4,Basic phospholipase A2 textilotoxin A chain (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MHPAHLLVLLGVCVSLLGASDIPPLPLNLVQFSYLIRCANKYKRPGWHYANYGCYCGSGGRGTPVDDVDRCCQAHDKCYEDAEKLGCYPKWTTYYYYCGANGPYCKTRTKCQRFVCNCDVVAADCFASYPYNRRYWFYSNKKRCR,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom oligomeric phospholipase A2 that has potent presynaptic neurotoxicity. Chain A possesses a very low toxicity, but is essential for neurotoxicity. Possesses a low enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8431471}.",Phospholipase
199,P23028,PA2HD_PSETE,,Acidic phospholipase A2 homolog textilotoxin D chain (svPLA2 homolog),MHPAHLLVLLGVCVSLLGAASIPRPSLNIMLFGNMIQCTIPCEQSWLGYLDYGCYCGSGSSGIPVDDVDKCCKTHDECYYKAGQIPGCSVQPNEVFNVDYSYECNEGQLTCNESNNECEMAVCNCDRAAAICFARFPYNKNYWSINTEIHCR,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom oligomeric phospholipase A2 that has potent presynaptic neurotoxicity. Chain D is not itself neurotoxic, but it is essential for the neurotoxicity of textilotoxin. Chain D possesses a very low phospholipase activity. {ECO:0000269|PubMed:2015288}.",Phospholipase
201,P24027,PA2BA_CRODU,3.1.1.4,Phospholipase A2 crotoxin basic chain CBa2 (CB2) (CTX subunit CBa2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRALWIVAVLLVGVEGSLLQFNKMIKFETRKNAVPFYAFYGCYCGWGGQGRPKDATDRCCFVHDCCYGKLAKCNTKWDIYRYSLKSGYITCGKGTWCKEQICECDRVAAECLRRSLSTYKNEYMFYPDSRCREPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer CA-CB: Crotoxin is a potent presynaptic neurotoxin that possesses phospholipase A2 (PLA2) activity and exerts a lethal action by blocking neuromuscular transmission. It consists of a non-covalent association of a basic and weakly toxic PLA2 subunit (CBa2, CBb, CBc, or CBd), with a small acidic, non-enzymatic and non-toxic subunit (CA1, CA2, CA3 or CA4). The complex acts by binding to a specific 48-kDa protein (R48) receptor located on presynaptic membranes, forming a transient ternary complex CA-CB-R48, followed by dissociation of the CA-CB complex and release of the CA subunit. At equilibrium, only the CB subunits remain associated with the specific crotoxin receptor. In addition to neurotoxicity, crotoxin has been found to exert myotoxicity, nephrotoxicity, and cardiovascular toxicity (PubMed:20109480). Moreover, anti-inflammatory, immunomodulatory, anti-tumor and analgesic effects of crotoxin have also been reported (PubMed:20109480). {ECO:0000269|PubMed:20109480}.; FUNCTION: Monomer CBa2: The basic subunit of crotoxin is a snake venom phospholipase A2 (PLA2) that exhibits weak neurotoxicity (10-fold less than the heterodimer) and strong anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (IC(50) is 41 nM) (PubMed:18062812). In addition, it shows the same effects described for the heterodimer and binds the nucleotide-binding domain (NBD1) of CFTR chloride channels and increases the channel current (PubMed:27241308). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18062812, ECO:0000269|PubMed:27241308}.",Phospholipase
202,P24335,WAG13_TROWA,,Waglerin-3 (SL-Waglerin-1) (SL-I) [Cleaved into: Waglerin-1 (Lethal peptide I) (Waglerin I) (Wtx-1)],SLGGKPDLRPCHPPCHYIPRPKPR,Waglerin family,"FUNCTION: Waglerin-1 selectively blocks the epsilon subunit of muscle nicotinic acetylcholine receptor (nAChR). Has also effects on rodent ionotropic GABA(A) receptors (GABR), since it potentiates I(GABA) in some neurons and depresses I(GABA) in others. In mice, it elicits tachypnea, ocular proptosis, rapid collapse and spasms, whereas no toxic effects on respiration and blood pressure are observed in rats.; FUNCTION: Waglerin-3 selectively blocks the epsilon subunit of muscle nicotinic acetylcholine receptor (nAChR). It elicits tachypnea, ocular proptosis, rapid collapse and spasms in mice. It causes death by respiratory failure.",Neurotoxin
203,P24605,PA2H2_BOTAS,,Basic phospholipase A2 homolog 2 (svPLA2 homolog) (Myotoxin II) (Basp-II) (Lys49 Mt-II) (MtxII),MRTLWIMAVLLVGVEGSLFELGKMILQETGKNPAKSYGAYGCNCGVLGRGKPKDATDRCCYVHKCCYKKLTGCNPKKDRYSYSWKDKTIVCGENNSCLKELCECDKAVAICLRENLNTYNKKYRYYLKPLCKKADAC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Is myotoxic and induces a dose-dependent edema in the mouse foot pad (PubMed:2781572, PubMed:9839670). Also exhibits strong anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (IC(50) is 3 nM) (PubMed:18062812). In addition, it shows cytotoxic activity to a variety of cell types and bactericidal activity to a variety of Gram-negative and Gram-positive bacteria (PubMed:7886694, PubMed:9654096, PubMed:9920486). Also induces a very rapid release of large amounts of potassium ions and ATP from muscle cells, which accounts for the pain reaction characteristic of viperid envenomations (PubMed:20660736). The released ATP amplifies the effect of the myotoxins, acting as a 'danger signal', which spreads and causes further damage by acting on purinergic receptors (PubMed:20660736). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:18062812, ECO:0000269|PubMed:1899180, ECO:0000269|PubMed:20660736, ECO:0000269|PubMed:2781572, ECO:0000269|PubMed:7886694, ECO:0000269|PubMed:9654096, ECO:0000269|PubMed:9839670, ECO:0000269|PubMed:9920486}.",Phospholipase
204,P25428,NGFV_MACLB,,Venom nerve growth factor (v-NGF) (vNGF) [Cleaved into: Truncated venom nerve growth factor],MSMLCYTLIIAFLIGIWAAPKSEDNVSLGSPATPDLSDTSCAKTHEALKTSRNTDQHYPAPKKAEDQEFGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNADSLNRNIRAKRATHPVHNRGEFSVCDSVSVWVANKTTATDIRGNVVTVMVDVKLNNNVYRQYFFETKCKNPSPVSSGCRGIDAKHWNSYCTTTDTFVRALTMEGNQASWRFIRIDTACVCVISRKNDNFG,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). It promotes neurite outgrowth in rat PC12 pheochromocytoma cells (PubMed:19463841). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899, ECO:0000269|PubMed:19463841}.",Metalloprotease
205,P28375,3SPM_DENJA,,Dendroaspin (Glycoprotein IIb-IIIa antagonist) (Mambin) (Platelet aggregation inhibitor),RICYNHLGTKPPTTETCQEDSCYKNIWTFDNIIRRGCGCFTPRGDMPGPYCCESDKCNL,"Snake three-finger toxin family, Short-chain subfamily, Antiplatelet toxin sub-subfamily","FUNCTION: Inhibits ADP-induced platelet aggregation and inhibits the binding of purified platelet fibrinogen receptor alpha-IIb/beta-3 (ITGA2B/ITGB3) to immobilized fibrinogen (PubMed:1591238). Has also been described to inhibit cell adhesion to fibrinogen, fibronectin, laminin and collagen (PubMed:11336631, PubMed:16798616). {ECO:0000269|PubMed:11336631, ECO:0000269|PubMed:1591238, ECO:0000269|PubMed:16798616}.",Fibrinogenolytic Enzyme
206,P28891,VM1F_AGKCO,3.4.24.72,Snake venom metalloproteinase fibrolase (SVMP) (EC 3.4.24.72) (Fibrinolytic metalloproteinase) (Fibrinolytic proteinase) (Alfimeprase),QQRFPQRYVQLVIVADHRMNTKYNGDSDKIRQWVHQIVNTINEIYRPLNIQFTLVGLEIWSNQDLITVTSVSHDTLASFGNWRETDLLRRQRHDNAQLLTAIDFDGDTVGLAYVGGMCQLKHSTGVIQDHSAINLLVALTMAHELGHNLGMNHDGNQCHCGANSCVMAAMLSDQPSKLFSDCSKKDYQTFLTVNNPQCILNKP,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom zinc metalloprotease that exhibits direct fibrinolytic activity.,Metalloprotease
207,P30403,VM2RH_CALRH,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase rhodostoxin (SVMP) (EC 3.4.24.-) (Hemorrhagic protein); Disintegrin rhodostomin (RHO) (RHOD) (Disintegrin kistrin) (Platelet aggregation activation inhibitor)],MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVIALSEGAAQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFAKDYSETHYSPDGTRITTYPSVEDHCYYQGRIHNDADSTASISACNGLKGHFKLQGETYFIEPMKLPDSEAHAVFKYENIEKEDESPKMCGVTETNWESDEPIKKVSQLNLNHEIKRHVDIVVVVDSRFCTKHSNDLEVIRKFVHEVVNAIIESYKYMHFGISLVNLETWCNGDLINVQEDSYETLKAFGKWRESDLIKHVNHSNAQFLMDMKFIKNIIGKAYLDSICDPERSVGIVQNYHGITLNVAAIMAHEMGHNLGVRHDGEYCTCYGSSECIMSSHISDPPSKYFSNCSYYQFWKYIENQNPQCILNKPLRTVSIPVSGNEHLEAGKECDCSSPENPCCDAATCKLRPGAQCGEGLCCEQCKFSRAGKICRIPRGDMPDDRCTGQSADCPRYHSHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase rhodostoxin]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin rhodostomin]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors alpha-IIb/beta-3 (ITGA2B/ITGB3).",Fibrinogenolytic Enzyme
208,P30431,VM3JA_BOTJA,3.4.24.73,Zinc metalloproteinase-disintegrin-like jararhagin (EC 3.4.24.73) (HF2-proteinase) (JG) (Jararafibrase I) (JF I) (Snake venom metalloproteinase) (SVMP) [Cleaved into: Disintegrin-like jararhagin-C (Jaracetin)],ATRPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGREITTYPPVEDHCYYHGRIENDADSTASISACNGLKGYFKLQRETYFIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQNWKSYEPIKKASQLAFTAEQQRYDPYKYIEFFVVVDQGTVTKNNGDLDKIKARMYELANIVNEIFRYLYMHVALVGLEIWSNGDKITVKPDVDYTLNSFAEWRKTDLLTRKKHDNAQLLTAIDFNGPTIGYAYIGSMCHPKRSVGIVQDYSPINLVVAVIMAHEMGHNLGIHHDTGSCSCGDYPCIMGPTISNEPSKFFSNCSYIQCWDFIMNHNPECIINEPLGTDIISPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYALFGADVYEAEDSCFKDNQKGNYYGYCRKENGKKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNDDEHKGMVLPGTKCADGKVCSNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase-disintegrin-like jararhagin: causes hemorrhage. This is the result of the degradation of sub-endothelial matrix proteins leading to the disruption of the blood vessel endothelium, with accompanying disturbances in platelet function. It is able to degrade von Willebrand factor (vWF) and it hydrolyzes the alpha-chain of fibrinogen (FGA) while leaving the beta and gamma chains unaffected. It inhibits collagen-induced platelet aggregation through the binding to alpha-2/beta-1 integrin (ITGA2/ITGB1) (collagen receptor), and it cleaves the beta-1 subunit of the same integrin, inhibiting platelet interaction and ultimately causing impairment of signal transduction. It has inability to be affected by the plasma inhibitor alpha(2)-macroglobulin. In fibroblasts, it functions as a collagen-mimetic substrate and, in endothelial cells, it causes apoptosis and indirectly inhibits cell proliferation by release of angiostatin-like compounds. It induces a strong pro-inflammatory response characterized by intense leukocyte accumulation and release of cytokines at the site of the injection. Although hemorrhage and edema are a response to the direct effect of this toxin, jararhagin-induced inflammation and necrosis are dependent on macrophages and key pro-inflammatory cytokines or their receptors. It also possesses anti-tumorgenic properties.; FUNCTION: [Disintegrin-like jararhagin-C]: The monomeric form inhibits collagen- and ADP-induced platelet aggregation, but has no effect on glycoprotein Ib-IX-dependent (GP1BA/GP5/GP9) platelet agglutination. Locally activates the early events of an acute inflammatory response as leukocyte rolling and pro-inflammatory cytokine release.; FUNCTION: [Disintegrin-like jararhagin-C]: The dimeric form jaracetin may be a dimeric form of jararhagin-C. It binds to von Willebrand factor (VWF) and induces its interaction with GPIbalpha (GP1BA) (via the vWF A1 domain), resulting in platelet aggregation. Also binds the alpha-2 subunit of the alpha-2/beta-1 (ITGA2/ITGB1) integrin. It potently induces platelet aggregation in citrated platelet-rich plasma.",Metalloprotease
209,P31100,PA2A7_DABSI,3.1.1.4,Acidic phospholipase A2 RV-7 (svPLA2) (EC 3.1.1.4) (F7) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 inhibitor) (S4) (Viperotoxin F) (Viperotoxin non-toxic acidic component),MRTLWIVAVCLIGVEGNLFQFGEMILEKTGKEVVHSYAIYGCYCGWGGQGRAQDATDRCCFVHDCCYGTVNDCNPKTATYSYSFENGDIVCGDNDLCLRTVCECDRAAAICLGQNVNTYDKNYEYYSISHCTEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer: RV-4/RV-7 targets the presynaptic sites of the neuromuscular junction. {ECO:0000269|PubMed:8835338}.; FUNCTION: Monomer: snake venom phospholipase A2 (PLA2) RV-7 that has low enzymatic activity and is not toxic. It inhibits the enzymatic activity of RV-4 in vitro but potentiates its lethal potency and neurotoxicity. It may facilitate the specific binding of RV-4 to its presynaptic binding sites, probably by acting as a chaperone, minimizing distraction and destruction of RV-4 en route to the site of action by reducing non-specific binding to muscle and other organs. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8835338}.",Phospholipase
210,P33589,VSPF_LACMU,3.4.21.74,Thrombin-like enzyme gyroxin analog (LM-TL) (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Venombin A),VIGGDECNINEHRFLVALYDGLSGTFLCGGTLINQEWVLTAQHCNRSLMNIYLGMHNKNVKFDDEQRRYPKKKYFFRCNKNFTKWDEDIRLNRPVRFSAHIEPLSLPSNPPSEDSVCRVMGWGQITSPPETLPDVPHCANINLFNYTVCRGAYPRMPTKVLCAGVLEGGIDTCNRDSGGPLICNGQFQGIVFWGPDPCAQPDKPGVYTKVFDYLDWIQSVIAGNTTCS,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease, that cleaves alpha-chain of fibrinogen (FGA) releases only fibrinopeptide A. Shows coagulant, esterase and amidase activities. Induces the barrel rotation syndrome in mice, which is manifested by gyroxin-like, rapid rolling motions. May also reversibly increase the permeability of the blood brain barrier (BBB) in mice. {ECO:0000269|PubMed:11137545, ECO:0000269|PubMed:2781576, ECO:0000269|PubMed:8354384}.",Serine Protease
211,P34128,NGFV_BUNMU,,Venom nerve growth factor (v-NGF) (vNGF),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPAKSDFSDTNCAQTHEGLKTSRNTDQHHPTPKKSEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVKFLDTEDTLNRNIWANNENHPVHNQGEHSVCDSISVWVTNKTKATDIKGNTVTVMVDVNLNNEVYKQYFFETKCRNPNPVPSGCRGIDSRHWNSYCTTTDTFVKALTMEGNRASWRFIRIDTACVCVISRKTENF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
213,P34182,VM2AE_CROAT,3.4.24.44,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase atrolysin-E (SVMP) (EC 3.4.24.44) (Hemorrhagic metalloproteinase HT-E) (Hemorrhagic toxin E); Disintegrin atrolysin-E (Atrolysin-E disintegrin) (Atrolysin E/D); Disintegrin atrolysin-E (4-73); Disintegrin atrolysin-E (3-73)],MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVIYPRKVTALPKGAVQPKYEDTMQYELKVNGEPVVLHLEKNKGLFSKDYSETHYSFDGRKITTNPSVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLKLSDSEAHAVFKLKNVEKEDEAPKMCGVTQNWESYEPIKKASDLNLNPEHQRYVELFIVVDHGMYTKYNGDSDKIRQRVHQMVNIMKESYTYMYIDILLAGIEIWSNGDLINVQPASPNTLNSFGEWRETDLLKRKSHDNAQLLTSIAFDEQIIGRAYIGGICDPKRSTGVVQDHSEINLRVAVTMTHELGHNLGIHHDTDSCSCGGYSCIMSPVISDEPSKYFSDCSYIQCWEFIMNQKPQCILKKPLRTDTVSTPVSGNELLEAGIECDCGSLENPCCYATTCKMRPGSQCAEGLCCDQCRFMKKGTVCRVSMVDRNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase atrolysin-E]: Snake venom zinc metalloproteinase that causes hemorrhage by provoking the degradation of the sub-endothelial matrix proteins (fibronectin, laminin, type IV collagen, nidogen, and gelatins). {ECO:0000269|PubMed:2817904}.; FUNCTION: [Disintegrin atrolysin-E]: Potent inhibitor of both collagen- (IC(50)=4 nM) and ADP-induced (IC(50)=8 nM) platelet aggregation. May act by binding to the platelet receptor GPIIb/GPIIIa (ITGA2B/ITGB3). {ECO:0000269|PubMed:9637732}.",Metalloprotease
214,P45881,PA2B2_BOTJR,,Basic phospholipase A2 homolog bothropstoxin-II (Bothropstoxin II) (BthTX-II) (BtxtxII) (svPLA2 homolog) (BJU-PLA2) (BJUPLA2) (BOJU-II) (Myotoxic phospholipase A2),MRTLWIMAVLLVGVEGDLWQFGQMILKETGKLPFPYYTTYGCYCGWGGQGQPKDATDRCCFVHDCCYGKLTNCKPKTDRYSYSRENGVIICGEGTPCEKQICECDKAAAVCFRENLRTYKKRYMAYPDVLCKKPAEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows low enzymatic activity even tough it conserves the catalytic residues (PubMed:9619591). Shows a strong myotoxic activity and induces indirect hemolysis, anticoagulant properties, and cytotoxic activities (PubMed:11018293). In vivo, it induces muscle necrosis, accompanied by polymorphonuclear cell infiltration, and edema in the mouse paw (PubMed:11018293, PubMed:1660822). It exerts its function even in the absence of extracellular calcium, indicating it is not a calcium-dependent enzyme (PubMed:20878713). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:11018293, ECO:0000269|PubMed:20878713, ECO:0000269|PubMed:9619591}.",Phospholipase
215,P49121,PA2H1_AGKCL,,Basic phospholipase A2 homolog MT1 (svPLA2 homolog) (ACL myotoxin),MRTLWIVALLLVGVEGSLLELGKMILQETGKNAITSYGSYGCNCGWGHRGQPKDATDRCCFVHKCCYKKLTDCNHKTDRYSYSWKNKAIICEEKNPCLKEMCECDKAVAICLRENLDTYNKKYKAYFKFKCKKPETC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Has myotoxic activities (PubMed:9920492). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:9920492}.",Phospholipase
218,P58399,PA2H1_BOTPI,,Basic phospholipase A2 homolog piratoxin-1 (svPLA2 homolog) (Myotoxin SIV-SP5) (Piratoxin-I) (PrTX-I),SLFELGKMILQETGKNPAKSYGAYGCNCGVLGRGKPKDATDRCCYVHKCCYKKLTGCNPKKDRYSYSWKDKTIVCGENNPCLKELCECDKAVAICLRENLGTYNKLYRYHLKPFCKKADDC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) homolog that lacks enzymatic activity (PubMed:7660366). Is myotoxic and displays edema-inducing activities (PubMed:7660366). Induces neuromuscular blockage (PubMed:26192963). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:22205953, ECO:0000269|PubMed:26192963, ECO:0000269|PubMed:7660366}.",Phospholipase
219,P59071,PA2B8_DABRR,3.1.1.4,Basic phospholipase A2 VRV-PL-VIIIa (svPLA2) (EC 3.1.1.4) (DPLA2) (P1) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 4) (PLA24),SLLEFGKMILEETGKLAIPSYSSYGCYCGWGGKGTPKDATDRCCFVHDCCYGNLPDCNPKSDRYKYKRVNGAIVCEKGTSCENRICECDKAAAICFRQNLNTYSKKYMLYPDFLCKGELKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows weak neurotoxicity and medium anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (IC(50) is 130 nM) (PubMed:18062812). It also damages vital organs such as lung, liver and kidney, displays edema-inducing activities when injected into the foot pads of mice and induces necrosis of muscle cells when injected into the thigh muscle. Has a low enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18062812, ECO:0000269|PubMed:2115497, ECO:0000269|PubMed:8835338}.",Phospholipase
222,P60244,VM1A3_DEIAC,3.4.24.-,Snake venom metalloproteinase acutolysin-C (SVMP) (EC 3.4.24.-) (Hemorrhagin III),PAPQTSIELFLIVDHSMYAKYNSNSSKITTTLKARVNIMNAIYSSLNLVITLSGIEMWSAADLITVQSSSRNTLKLFASWRETDLLKRTSNDNAQLLTATNFNGNTVGLAYLKTMCNSKYSVGLIQDHSAIPLLMAVTMAHELGHNLGMNHDGAGCSCATCIMAPVLSSGPAKSFSDCSKHDYQSFLTIHKPQCLLN,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: This protein is an alkaline zinc metalloprotease from snake venom that possesses weak hemorrhagic activity.,Metalloprotease
223,P60305,3SA8_NAJKA,,Cytotoxin 1 (CTX1) (CX1) (Cardiotoxin F8) (Cardiotoxin-I) (CTX-I) (Toxin CM-6),LKCNKLIPIASKTCPAGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Monomer: shows cytolytic activity (apoptosis is induced in C2C12 cells, but no cytotoxicity is observed on INS-1E) (PubMed:18381281, PubMed:22807058). In addition, this toxin shows insulinotropic activity that may be mediated by the modulation of potassium channels (Kv) (PubMed:22807058). It induces the increase of intracellular calcium release (PubMed:24552570). It induces insulin secretion from rat INS-1E cells in absence and in presence of glucose, without affecting cell viability and integrity (PubMed:22807058). In presence of glucose, the insulinotropic activity is increased, suggesting a possible synergistic effect with glucose (PubMed:22807058). Its insulinotropic activity does not involve GLP-1R signaling (PubMed:22807058, PubMed:24552570). {ECO:0000269|PubMed:18381281, ECO:0000269|PubMed:22807058, ECO:0000269|PubMed:24552570}.; FUNCTION: Heterodimer: has no cytolytic activity, but retains most of the alpha-cobratoxin capacity to compete with alpha-bungarotoxin for binding to Torpedo and alpha-7/CHRNA7 nicotinic acetylcholine receptors (nAChRs) as well as to Lymnea stagnalis acetylcholine-binding protein. {ECO:0000269|PubMed:18381281}.",General Toxin
224,P60615,3L21A_BUNMU,,"Alpha-bungarotoxin (Alpha-Bgtx) (Alpha-Btx) (Alpha-bungarotoxin, isoform A31) (Alpha-BTX A31) (Alpha-BgTx(A31)) (Alpha-bungarotoxin (A31)) (BGTX A31) (Alpha-elapitoxin-Bm2a) (Alpha-EPTX-Bm2a) (Long neurotoxin 1)",MKTLLLTLVVVTIVCLDLGYTIVCHTTATSPISAVTCPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (tested on Torpedo marmorata, Kd=0.4 nM) and neuronal (tested on chimeric alpha-7/CHRNA7, Kd=0.95 nM) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (PubMed:9305882). It also shows an activity on GABA(A) receptors (PubMed:16549768, PubMed:25634239). It antagonises GABA-activated currents with high potency when tested on primary hippocampal neurons (PubMed:25634239). It inhibits recombinantly expressed GABA(A) receptors composed of alpha-2-beta-2-gamma-2 (GABRA2-GABRB2-GABRG2) subunits with high potency (62.3% inhibition at 20 uM of toxin) (PubMed:25634239). It also shows a weaker inhibition on GABA(A) receptors composed of alpha-1-beta-2-gamma-2 (GABRA1-GABRB2-GABRG2) subunits, alpha-4-beta-2-gamma-2 (GABRA4-GABRB2-GABRG2) subunits, and alpha-5-beta-2-gamma-2 (GABRA5-GABRB2-GABRG2) subunits (PubMed:25634239). A very weak inhibition is also observed on GABA(A) receptor composed of alpha-1-beta-3-gamma-2 (GABRA1-GABRB3-GABRG2) (PubMed:26221036). It has also been shown to bind and inhibit recombinant GABA(A) receptor beta-3/GABRB3 subunit (Kd=about 50 nM) (PubMed:16549768). In addition, it blocks the extracellular increase of dopamine evoked by nicotine only at the higher dose (4.2 uM) (PubMed:9840221). In vivo, when intraperitoneally injected into mice, induces flaccid paralysis of the limbs and respiratory distress, and causes death in a dose-dependent manner. {ECO:0000269|PubMed:16549768, ECO:0000269|PubMed:25634239, ECO:0000269|PubMed:9305882, ECO:0000269|PubMed:9840221}.",Neurotoxin
225,P60770,3S1CB_NAJAT,,Cobrotoxin (CBT) (CBTX) (CTX) (Atratoxin) (Cobratide) (Short neurotoxin 1),MKTLLLTLLVVTIVCLDLGYTLECHNQQSSQTPTTTGCSGGETNCYKKRWRDHRGYRTERGCGCPSVKNGIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. Has a higher toxicity than cobrotoxin-b (PubMed:9498573). In vivo, when tested on rat arthritis models, shows anti-inflammation and immunosuppression effects (PubMed:27840083). {ECO:0000269|PubMed:27840083, ECO:0000269|PubMed:9498573}.",Neurotoxin
226,P60775,3S1EA_LATSE,,Erabutoxin a (ETXA) (Ea) (Short neurotoxin 1a),MKTLLLTLVVVTIVCLDLGYTRICFNHQSSQPQTTKTCSPGESSCYNKQWSDFRGTIIERGCGCPTVKPGIKLSCCESEVCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular nicotinic acetylcholine receptors (nAChRs) (tested on Torpedo marmorata, Kd=21 uM) and with low affinity to neuronal alpha-7/CHRNA7 nAChRs (tested on chimeric alpha-7/CHRNA7, Kd=0.07 nM) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission (PubMed:7721859). Blocks the extracellular increase of dopamine evoked by nicotine at 4.2 uM concentrations (PubMed:9840221). In vivo, produces peripheral paralysis. {ECO:0000269|PubMed:7721859, ECO:0000269|PubMed:9305882, ECO:0000269|PubMed:9840221}.",Neurotoxin
227,P61898,NGFV_NAJAT,,Venom nerve growth factor (v-NGF) (vNGF) (Cobra nerve growth factor) (cNGF),EDHPVHNLGEHSVCDSVSAWVTKTTATDIKGNTVTVMENVNLDNKVYKEYFFETKCKNPNPEPSGCRGIDSSHWNSYCTETDTFIKALTMEGNQASWRFIRIETACVCVITKKKGN,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (PubMed:22649032). {ECO:0000250|UniProtKB:P61899, ECO:0000269|PubMed:22649032}.",Metalloprotease
228,P61899,NGFV_NAJKA,,Venom nerve growth factor (v-NGF) (vNGF),EDHPVHNLGEHSVCDSVSAWVTKTTATDIKGNTVTVMENVNLDNKVYKEYFFETKCKNPNPEPSGCRGIDSSHWNSYCTETDTFIKALTMEGNQASWRFIRIETACVCVITKKKGN,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (PubMed:20164177). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000269|PubMed:20164177}.",Metalloprotease
229,P62022,PA2BC_CRODU,3.1.1.4,Phospholipase A2 crotoxin basic subunit CBc (CB1) (CTX subunit CBc) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRALWIVAVLLVGVEGHLLQFNKMIKFETRKNAIPFYAFYGCYCGWGGRGRPKDATDRCCFVHDCCYGKLAKCNTKWDIYPYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer CA-CB: Crotoxin is a potent presynaptic neurotoxin that possesses phospholipase A2 (PLA2) activity and exerts a lethal action by blocking neuromuscular transmission (By similarity). It consists of a non-covalent association of a basic and weakly toxic PLA2 subunit (CBa2, CBb, CBc, or CBd), with a small acidic, non-enzymatic and non-toxic subunit (CA1, CA2, CA3 or CA4) (By similarity). The complex acts by binding to a specific 48-kDa protein (R48) receptor located on presynaptic membranes, forming a transient ternary complex CA-CB-R48, followed by dissociation of the CA-CB complex and release of the CA subunit (By similarity). At equilibrium, only the CB subunits remain associated with the specific crotoxin receptor (By similarity). In addition to neurotoxicity, crotoxin has been found to exert myotoxicity, nephrotoxicity, and cardiovascular toxicity (PubMed:20109480). Moreover, anti-inflammatory, immunomodulatory, anti-tumor and analgesic effects of crotoxin have also been reported (PubMed:20109480). {ECO:0000250|UniProtKB:C0HM14, ECO:0000269|PubMed:20109480}.; FUNCTION: Monomer CBc: The basic subunit of crotoxin is a snake venom phospholipase A2 (PLA2) that exhibits weak neurotoxicity (10-fold less than the heterodimer) and very strong anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (IC(50) is 0.7 nM) (PubMed:18062812). In addition, it shows the same effects described for the heterodimer and binds the nucleotide-binding domain (NBD1) of CFTR chloride channels and increases the channel current (PubMed:27241308). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18062812, ECO:0000269|PubMed:27241308}.",Phospholipase
230,P62023,PA2B1_CROSS,3.1.1.4,Basic phospholipase A2 Mtx-b (svPLA2) (EC 3.1.1.4) (Mojave toxin basic chain) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 CB1),MRALWIVAVLLVGVEGHLLQFNKMIKFETRKNAIPFYAFYGCYCGWGGRGRPKDATDRCCFVHDCCYGKLAKCNTKWDIYPYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
232,P67861,TXVE_DABRR,,Snake venom vascular endothelial growth factor toxin VR-1 (svVEGF) (VEGF-F),MAAYLLAVAILFCIQGWPSGTVQGQVRPFLDVYERSACQTRETLVSILQEHPDEISDIFRPSCVAVLRCSGCCTDESMKCTPVGKHTADIQIMRMNPRTHSSKMEVMKFMEHTACECRPRWKQGEPEGPKEPRRGGVRAKFPFD,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces angiogenesis probably through VEGF receptor (KDR/VEGFR-2) signaling, as well as drastic hypotension. The hypotension is mediated by nitric oxide, which is produced by VEGF-activated endothelium NO synthase. May also induce vascular permeability. {ECO:0000269|PubMed:14600159}.",Vascular Interaction
233,P67862,TXVE_PROFL,,Snake venom vascular endothelial growth factor toxin TfsvVEGF (svVEGF) (VEGF-F),MAAYLLAVAILFCIQGWPSGTVQGQVMPFMEVYSRSACQTRETLVPILKEYPDEVSHLFKPSCVPVLRCGGCCSDESLTCTATGKHSVGREIMRVDPHKGTSKMEVMQFKEHTACECRPRSPGDVNNGKDKRNPEEGGPRARFPFV,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein strongly increases vascular permeability, and weakly stimulates angiogenesis. Interacts with VEGF receptor-1 (FLT1) with a high affinity, whereas it binds to VEGF receptor-2 (KDR) with a low affinity. Stimulates autophosphorylation of VEGF receptor-1 (VEGFR-1/FLT1), and VEGF receptor-2 (VEGFR-2/KDR). {ECO:0000269|PubMed:15328352}.",Vascular Interaction
234,P67863,TXVE_VIPAA,,Snake venom vascular endothelial growth factor toxin vammin (svVEGF) (VEGF-F),MAAYLLAVAILFCIQGWPSGTVQGQVRPFLEVHERSACQARETLVPILQEYPDEISDIFRPSCVAVLRCSGCCTDESLKCTPVGKHTVDLQIMRVNPRTQSSKMEVMKFTEHTACECRPRRKQGEPDGPKEKPRRGGVRARFPFV,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase (PubMed:14600159). Also induces angiogenesis in vitro, probably through VEGF receptor (KDR/VEGFR-2) signaling (PubMed:14600159). May also induce capillary permeability through VEGF receptor (KDR/VEGFR-2) signaling. {ECO:0000269|PubMed:14600159}.",Vascular Interaction
235,P68515,BNP_BOTIN,,"Bradykinin-potentiating and C-type natriuretic peptides (Angiotensin-converting enzyme inhibitor) (BPP-CNP homolog) [Cleaved into: Bradykinin-potentiating peptide 13a (BPP-13a) (Bradykinin-potentiating peptide S3,1); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide S4,3,1); Bradykinin-potentiating peptide 12b (BPP-12b) (Bradykinin-potentiating peptide S4,3,2); Bradykinin-potentiating peptide 11e (BPP-11e); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide S5,2) (Bradykinin-potentiating peptide Va) (BPPVa) (Proline-rich peptide 5a) (PRO-5a); C-type natriuretic peptide (CNP)]",MVLSRLAASGLLLLALLALSVDGKPVQQWAQGGWPRPGPEIPPLKVQQWAQGGWPRPGPEIPPLTVQQWAQNWPHPQIPPLTVQQWAQLGPPPRPQIPPLEVQQWAQGRAPHPPIPPAPLQKWAPVQKWAPLLQPHESPASGTTALREELSLGPEAASGVPSAGAEVGRSGSKAPAAPHRLSKSKGAAATSAASRPMRDLRPDGKQARQNWGRMVHHDHHAAVGGGGGGGGGGARRLKGLAKKGAAKGCFGLKLDRIGTMSGLGC,Bradykinin-potentiating peptide family; Natriuretic peptide family,"FUNCTION: [Bradykinin-potentiating peptide 5a]: Modestly inhibits ACE (with highest affinity for the N-site) and reveals strong bradykinin-potentiating activity. Induces nitric oxide (NO) production depended on muscarinic acetylcholine receptor M1 subtype (CHRM1) and bradykinin B2 receptor (BDKRB2) activation. Both these receptors contribute to the vasodilation induced by this peptide that may have an indirect action on BDKRB2 and a direct agonistic action on CHRM1.; FUNCTION: [Bradykinin-potentiating peptide 10c]: Peptide with several activities. It inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain (PubMed:11994001). It evokes transient hypotension (-14 mmHg) similar to that evoked by 0.5 ug of bradykinin, when injected alone into rats. It has a high bradykinin-potentiating effect (120%), when 60 nmol of BPP-10c are coinjected with 0.5 ug of bradykinin into rats (PubMed:22869554). Does not affect angiotensin-1 pressor effects. Shows potent and long-lasting antihypertensive activity as well as a reduction of the heart rate (PubMed:17475904). It also binds and dose-dependently promotes the activation of cytosolic argininosuccinate synthase (ASS1), an enzyme that catalyzes the conversion of citrulline, L-aspartate and ATP to argininosuccinate, AMP and pyrophosphate. It also enhances ASS1-dependent arginine production in HEK 293 cells, as well as in spontaneous hypertensive rat (SHR) and Wistar rat plasma. In addition, it induces the production of nitric-oxide (NO) by HUVEC cells via the endothelial nitric-oxide synthase (NOS3), which use arginine as a substrate and produce NO. It has been shown to be internalized by ASS1-expressing endothelial (HUVEC) and kidney (HEK 293) cells, and is detected homogenously distributed within the cell cytoplasm for up to 2 hours (PubMed:19491403). {ECO:0000269|PubMed:11994001, ECO:0000269|PubMed:17475904, ECO:0000269|PubMed:19491403, ECO:0000269|PubMed:22869554}.; FUNCTION: [C-type natriuretic peptide]: has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.",Vascular Interaction
236,P80958,3S1CC_NAJAT,,Cobrotoxin-b (CBT-b) (Atratoxin-b) (Cobrotoxin III) (CBT-III) (Cobrotoxin IV) (CBT IV) (NT3) (Short neurotoxin),MKTLLLTLLVVTIVCLDLGYTLECHNQQSSQTPTTKTCSGETNCYKKWWSDHRGTIIERGCGCPKVKPGVNLNCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Has a lower toxicity than cobrotoxin. {ECO:0000269|PubMed:9498573}.",Neurotoxin
237,P80963,PA2H_BOTSC,,Basic phospholipase A2 homolog Bsc-K49 (svPLA2 homolog) (Myotoxin I),MRTLWIVAVLLVGVEGSMYELGKMILLETGKNAATSYIAYGCNCGVGRRGQPLDATDRCCYVHKCCYKKLTGCNPLTDRYSHSLKNKTIVCGENKPCLKEMCECDKALAICLGKNVNTYNKNYKITMKMFCKKPDAC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 that lacks enzymatic activity. Is myotoxic, and displays edema-inducing activities (PubMed:9056257). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:9056257}.",Phospholipase
238,P80966,PA2A1_OPHHA,3.1.1.4,Acidic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (APLA2-1) (OHV A-PLA2) (OHV-APLA2) (Phosphatidylcholine 2-acylhydrolase),MNPAHLLVLSAVCVSLLGASSIPPQPLHLIQFGNMIQCTVPGFLSWIKYADYGCYCGAGGSGTPVDKLDRCCQVHDNCYTQAQKLPACSSIMDSPYVKIYSYDCSERTVTCKADNDECAAFICNCDRVAAHCFAASPYNNNNYNIDTTTRC,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that may exhibit cardiotoxicity, myotoxicity, antiplatelet activity, and edema-inducing activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:9028866}.",Phospholipase
239,P81165,PA2H2_CERGO,,Basic phospholipase A2 homolog GodMT-II (svPLA2 homolog) (Myotoxin II),SMYQLWKMILQETGKNAVPSYGLYGCNCGVGSRGKPKDATDRCCFVHKCCYKKLTDCSPKTDSYSYSWKDKTIVCGDNNPCLQEMCECDKAVAICLRENLDTYNKNYKIYPKPLCKKADAC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity but shows high myotoxic activities (PubMed:1524423). In vivo, induces a mild edema when subcutaneously injected into mice foot pad (PubMed:1524423). {ECO:0000269|PubMed:1524423}.",Phospholipase
241,P81382,OXLA_CALRH,1.4.3.2,L-amino-acid oxidase (LAO) (MPV-LAAO) (EC 1.4.3.2),MNVFFMFSLLFLAALGSCADDRNPLAECFQENDYEEFLEIARNGLKATSNPKHVVIVGAGMAGLSAAYVLAGAGHQVTVLEASERPGGRVRTYRNEEAGWYANLGPMRLPEKHRIVREYIRKFDLRLNEFSQENDNAWYFIKNIRKKVGEVKKDPGLLKYPVKPSEAGKSAGQLYEESLGKVVEELKRTNCSYILNKYDTYSTKEYLIKEGDLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVDGMDKLPTAMYRDIQDKVHFNAQVIKIQQNDQKVTVVYETLSKETPSVTADYVIVCTTSRAVRLIKFNPPLLPKKAHALRSVHYRSGTKIFLTCTTKFWEDDGIHGGKSTTDLPSRFIYYPNHNFTNGVGVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKKDIQSFCYPSVIQKWSLDKYAMGGITTFTPYQFQHFSDPLTASQGRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNLASENPSGIHLSNDNEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:11248687, PubMed:8080286). Shows high affinity for L-Phe, L-Trp, L-Met, L-Leu, and L-Ile, moderate affinity for L-Arg, L-Asp, and L-His, and very low affinity for L-Gln, L-Lys, and L-Ala (PubMed:8080286). Also shows high activity on L-norleucine (L-2-aminohexanoate), and L-norvaline (L-2-aminopentanoate) and a weak activity on L-ornithine and L-aminobutyric acid (PubMed:8080286). Also exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, and antiparasitic activities, as well as regulation of platelet aggregation (By similarity). Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). A possible explanation of high efficacy it that LAAO may bind to target cells through its sialylated glycan moiety that would bind to sialic acid-binding lectins (siglec) on target cells (PubMed:11453999). This interaction may result in production of locally high concentrations of hydrogen peroxide in or near the binding interface, leading, in turn to oxidative damage of the siglec or another adjacent cell structural elements (PubMed:11453999). {ECO:0000250, ECO:0000269|PubMed:11248687, ECO:0000269|PubMed:8080286, ECO:0000305|PubMed:11453999}.",Vascular Interaction
242,P81383,OXLA_OPHHA,1.4.3.2,L-amino-acid oxidase (LAO) (Oh-LAAO) (EC 1.4.3.2),MNDFLLLLLVLFLGVPRSENHVINLEECFQEPEYENWLATASHGLTKTLNPKKIVIVGAGISGLTAAKLFREAGHEVVILEASDRVGGRIKTHREDGWYVDVGPMRVPQTHRIVREYIKKFNISLNPFRQTDENAWYLIKHVRQKMSANNPENFGYQLNPNERGKSASQLFDETLDKVTDDCTLQKEKYDSFSTKEYLIKEGKLSTGAVEMIGDFLNEEAGFHNSFLISVMDHFLFLNNSFDEITGGFDQLPERFFKDMDSIVHLNSTVEKIVHINNKVTVFYEGLSTNMRLVADYVLITATARATRLIKFVPPLSIPKTRALRSLIYASATKIILVCTDKFWEKDGIHGGRSITDLPSRVIYYPNHDFTNGIGVLLASYTWYSDSEFYTTLSDEKCVDVVMDDLVEIHNVSKDYLKSVCGKHVVQKWALDQYSMGAFSTYTPYQITHYSQMLAQNEGRIYFAGEYTAHPHGWIETSMKSAIREAINIHNA,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:17543361, PubMed:2044840). Is very active against L-Lys, L-Phe, L-Leu, L-Tyr, L-Trp, L-Arg, and L-Met, moderately active against L-His, L-cystine, and L-Ile, and slightly active against L-Gln, L-Asn, L-Ala, and L-Val (PubMed:2044840). L-Glu, L-Ser, L-Pro and Gly are oxidized very slowly (PubMed:2044840). Its activity on platelet aggregation is controversial. It has potent inhibitory activity on platelet aggregation induced by ADP and the thromboxane analog U46619, but not by thrombin, mucetin, ristocetin and stejnulxin (PubMed:17543361), but it has also been shown to induce platelet aggregation through the formation of hydrogen peroxide (PubMed:7886693). It binds to bacteria and shows antibacterial activities by generating hydrogen peroxide. Binding and antibacterial activities are higher against Gram-positive than against Gram-negative bacteria. May also have an ability to induce hemorrhage, hemolysis, edema, apoptosis. {ECO:0000269|PubMed:17543361, ECO:0000269|PubMed:2044840, ECO:0000269|PubMed:21059402, ECO:0000269|PubMed:2619759, ECO:0000269|PubMed:7886693, ECO:0000269|PubMed:9304806}.",Kunitz Family
244,P82114,PA2H1_BOTMO,,Basic phospholipase A2 homolog MjTX-I (Basic phospholipase A2 homolog 1) (svPLA2 homolog) (Basic phospholipase A2 homolog BomoTx) (Myotoxin I),MRTLWIMAVLLVGVEGSLVELGKMILQETGKNPVTSYGAYGCNCGVLGRGKPKDATDRCCYVHKCCYKKLTDCNPKKDRYSYSWKDKTIVCGENNSCLKELCECDKAVAICLRENLDTYNKKYKNNYLKPFCKKADPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:28265084). In vivo, it displays local myotoxin and edema-inducing activities and is lethal by intraperitoneal injection (PubMed:10620318, PubMed:33865953). The myotoxicity effect is weaker in comparison to other myotoxins, probably due to the formation of high molecular weight complexes and to the oligomeric conformation (conventional dimer) (PubMed:10620318, PubMed:23573271). It shows specificity toward neurons and myotubes, but not on a variety of other cell types (PubMed:10620318, PubMed:28265084). This PLA2 excites a cohort of sensory neurons via ATP release and consequent activation of P2RX2 and/or P2RX3 purinergic receptors (PubMed:28265084). Pannexin hemichannels act as downstream mediators of toxin-evoked ATP release (PubMed:28265084). In vivo, it elicits nonneurogenic inflammatory pain, thermal hyperalgesia, and mechanical allodynia, of which the latter is completely dependent on purinergic signaling (PubMed:28265084). {ECO:0000269|PubMed:10620318, ECO:0000269|PubMed:23573271, ECO:0000269|PubMed:28265084, ECO:0000269|PubMed:33865953}.",Phospholipase
245,P82475,TXVE2_MACLB,,Snake venom vascular endothelial growth factor toxin ICPP (svVEGF) (Increasing capillary permeability protein) (Increasing capillary-2) (IC2) (VEGF-F),QVRPFPDVYQRSACQARETLVSILQEYPDEISDIFRPSCVAVLRCSGCCTDESLKCTPVGKHTVDMQIMRVNPRTQSSKMEVMKFTEHTACECRPRRKQGEPDGPKEKPR,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein increases vascular permeability and angiogenesis probably through VEGF receptor (KDR/VEGFR-2) signaling (PubMed:12021274). Induces DNA synthesis in human umbilical vein endothelial cells, and promotes mouse embryonic stem cell proliferation and differentiation (PubMed:12021274). It may also induce a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase (By similarity). {ECO:0000250|UniProtKB:P83942, ECO:0000269|PubMed:12021274}.",Vascular Interaction
247,P82896,PA2A5_TRIST,3.1.1.4,Acidic phospholipase A2 5 (svPLA2) (EC 3.1.1.4) (PA2-Vb) (PLA2-V) (Phosphatidylcholine 2-acylhydrolase),NLMQFELLIMKVAGRSGIVWYSDYGCFCGKGGHGRPQDATDRCCFVHDCCYGKVTECDPKMDFYRYSSNNGDIVCEANNPCTKEICECDKAAAICFRDNKDTYDNKYWNIPMEGCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits platelet aggregation induced by ADP, arachidonic acid and PAF (Ref.1). Acts in a enzymatic independent manner on a proteinase-activated receptor (PAR1, F2R) to evoke calcium release through the inositol 1,4,5-trisphosphate receptor (ITPR1, IP3R) and induces mouse aorta contraction (PubMed:25447533). PAR1, phospholipase C and IP3R inhibitors suppress PA2-induced aorta contraction (PubMed:25447533). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:25447533, ECO:0000269|Ref.1}.",Phospholipase
248,P82935,3NO2_NAJKA,,Tryptophan-containing weak neurotoxin (WTX),MKTLLLTLVVVTIVCLDLGYTLTCLNCPEMFCGKFQICRNGEKICFKKLHQRRPLSWRYIRGCADTCPVGKPYEMIECCSTDKCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily","FUNCTION: Neurotoxin that irreversibly inhibits nicotinic acetylcholine receptors (nAChR) and allosterically interacts with muscarinic acetylcholine receptors (mAChR) (PubMed:11279130, PubMed:19682302). The loop II is involved in the interaction of this toxin with nAChR and mAChR (PubMed:26242733, PubMed:27343701). On nAChR, it acts as a competitive antagonist (muscle-type and alpha-7/CHRNA7) with IC(50) values in the micromolar range (PubMed:11279130, PubMed:27343701). On mAChR, in presence of ACh, it partially inhibits the effect of acetylcholine (ACh) (allosteric antagonist), whereas in the absence of ACh, it activates the receptor (allosteric agonist) (PubMed:19682302). It also shows a very weak inhibition of GABA(A) receptor composed of alpha-1-beta-3-gamma-2 (GABRA1 and GABRB3 and GABRG2) subunits (10 uM inhibit 31% current) (PubMed:26221036). In vivo, is nonlethal to mice at concentrations up to 20 mg/kg, but exerts a myorelaxant effect, induces a dose-dependent decrease in blood pressure and an increase in heart rate in mice and rats (PubMed:15581687, PubMed:17371532). {ECO:0000269|PubMed:11279130, ECO:0000269|PubMed:15581687, ECO:0000269|PubMed:17371532, ECO:0000269|PubMed:19682302, ECO:0000269|PubMed:26221036, ECO:0000269|PubMed:27343701}.",Neurotoxin
250,P82981,VSP2_AGKCO,3.4.21.-,Thrombin-like enzyme contortrixobin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Venombin B),VVGGDECNINEHRFLVAIFNSNGFVCSGTLINQEWVLTAAHCDSTDFQIKLGAHSKKVLNEDEQIRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHIAPLSLPSSPPSVGSVCHIMGWGSITPIEVTFPDVPHCAYINLLDDAACQPGYPEVLPEYRTLCAGILEGGKDTCNYDSGGPLICNGQFQGIVSYGAHPCGQSLKPGIYTKVFDYNDWIQSIIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that cleaves beta chain of fibrinogen (FGB), releasing fibrinopeptide B. Has a coagulant activity activating blood coagulation factors V (F5) and XIII (F13A1). {ECO:0000269|PubMed:10956019}.",Serine Protease
251,P83253,DID1A_MACLB,,Disintegrin lebein-1-alpha (ML-3) (MS-II) (Platelet aggregation activation inhibitor),MIQVLLVTICLAVFPYQGSSIILESGNVNDYEIVYPKKVTVLPTGAMNSGNPCCDPVTCKPRRGEHCVSGPCCRNCKFLNAGTICNRARGDDMNDYCTGISSDCPRNPYKD,"Disintegrin family, Dimeric disintegrin subfamily","FUNCTION: Strongly inhibits ADP-induced platelet aggregation on human platelet-rich plasma. Also avidly binds to the laminin-binding beta-1 integrins (alpha-3/beta-1, alpha-6/beta-1, and alpha-7/beta-1) in an RGD-independent manner. {ECO:0000269|PubMed:11343790, ECO:0000269|PubMed:12719418}.",Binding Protein
252,P83255,VM1F_MACLB,3.4.24.72,Snake venom metalloproteinase fibrolase (SVMP) (EC 3.4.24.72) (Fibrinolytic proteinase) (Non-hemorrhagic fibrinolytic metalloproteinase) (VlF),ERFAPRYIELVIVADHSVATKYNDNVTAILSWVHQLVNNIILFYRDLNVHFTLSAVEVWSNGDLINVQPEATVTLNLFGEWRERDLLNRRMHDNAQLLNNVALDDNTIGLAYDEGMCDPKYSVGIVKDHSAINRMVAATMAHEIGHNLGMNHDGSQCNCGGNGCVMSAVLMQQHSYQFSDCSKDEYQRYLTNHNPQCILNQP,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Has fibrino(geno)lytic activity on the alpha and beta chains of fibrinogen (FGA and FGB). Inhibits human ADP- and collagen-induced platelet aggregation on platelet-rich plasma but does not affect the thrombin-induced aggregation of rabbit washed platelets. Slightly degrades plasminogen. {ECO:0000269|PubMed:1926182, ECO:0000269|PubMed:9175244}.",Fibrinogenolytic Enzyme
253,P83302,3SX1_OPHHA,,Neurotoxin Oh9-1 (OMEGA-neurotoxin Oh9-1) (Three-finger toxin) (3FTx),LICHRVHGLQTCEPDQKFCFRKTTMFFPNHPVLLMGCTSSCPTEKYSVCCSTDKCNK,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: This toxin binds and inhibits rat muscle adult alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE (IC(50)=3.1 uM) and fetal alpha-1-beta-1-gamma-delta/CHRNA1-CHRNB1-CHRNG-CHRND (IC(50)=5.6 uM) nicotinic acetylcholine receptors (nAChR) (PubMed:26448325). Shows a very low inhibition on rat neuronal alpha-3-beta-2/CHRNA3-CHRNB2 nAChR (IC(50)=50.2 uM) nAChR (PubMed:26448325). Binds to the acetylcholine-binding pocket and acts as a competitive antagonist (PubMed:26448325). Does not inhibit human glycine receptor (homopentamer composed of alpha-1 subunits, GLRA1), but seems to potentiate it (about 2-fold increased activity) (PubMed:26448325). {ECO:0000269|PubMed:12056805, ECO:0000269|PubMed:26448325}.",Neurotoxin
255,P83512,VM1B1_BOTAS,3.4.24.-,Snake venom metalloproteinase BaP1 (SVMP) (EC 3.4.24.-) (Hemorrhagic metalloproteinase BaP1) (Bap-1),MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTELPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGRKIITYPSFEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTETNWESYEPIKKASQSNLTPEQQRFSPRYIELAVVADHGIFTKYNSNLNTIRTRVHEMLNTVNGFYRSVDVHAPLANLEVWSKQDLIKVQKDSSKTLKSFGEWRERDLLPRISHDHAQLLTAVVFDGNTIGRAYTGGMCDPRHSVGVVRDHSKNNLWVAVTMAHELGHNLGIHHDTGSCSCGAKSCIMASVLSKVLSYEFSDCSQNQYETYLTNHNPQCILNKPLLTVSGNELLEAGE,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Zinc metalloprotease that exhibits a weak hemorrhagic activity (with a minimum hemorrhagic dose of 20 ug by intradermal and intramuscular injection into mice). The basal membrane components collagen (all chains of type IV) (COL4A4), laminin and nidogen are all degraded by this toxin (PubMed:23385358). Rapidly degrades the Aalpha-chain (FGA) of fibrinogen, and later on, degrades the Bbeta-chain (FGB) of fibrinogen (PubMed:7778126). Also activates the complement system, and induces rat neutrophil chemotaxis (PubMed:11200361). Induces edema in mouse food pad and shows a mild myotoxicity (PubMed:7778126). {ECO:0000269|PubMed:11200361, ECO:0000269|PubMed:20600221, ECO:0000269|PubMed:23385358, ECO:0000269|PubMed:7778126}.",Metalloprotease
256,P83519,LECG_BOTJR,,C-type lectin BJcuL (CTL) (Galactose-specific lectin) (Snake venom galactoside-binding lectin) (SVgalL),MGRFLFVASSACWFVFLSLSGAKGNNCPQDWLPMNGLCYKIFNELKAWKDAEMFCRKYKPGCHLASIHLYGESPEIAEYISDYHKGQSEVWIGLCDKKKDFSWEWTDRSCTDYLSWDKNQPDHYQNKEFCVELVSNTGYRLWNDQVCESKNAFLCQCKF,True venom lectin family,"FUNCTION: Galactose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. Calcium-dependent lectin. Also binds lactose and raffinose (PubMed:28003128). Shows high hemagglutinating activity on mammalian erythrocytes (PubMed:16309723, Ref.5). It also involved in immunological functions, since it is able of inducing potent neutrophil activation (PubMed:16309723, PubMed:21266049). In vivo, it causes edema and increases vascular permeability after injection into mouse hind paws (10-100 ug/paw). In anesthetized rats, it decreases the blood pressure by approximately 15%, with a rapid return to the resting level (PubMed:16309723). Is an effective inhibitor of cell growth in some cancer cell lines, especially against renal and pancreatic cancer cell lines, human breast and ovarian carcinoma, glioblastoma and a bovine brain microvascular endothelial cell line (PubMed:10628348, PubMed:11478954). {ECO:0000269|PubMed:10628348, ECO:0000269|PubMed:11478954, ECO:0000269|PubMed:16309723, ECO:0000269|Ref.5}.",Kunitz Family
257,P83912,VM2JT_PROJR,3.4.24.-,Zinc metalloproteinase-disintegrin jerdonitin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGSSIILESGNIDDYEVVYPRKVTALPKGAVQQKYEDTMQYEFKVNEEPVVLHLEKNKGLFSKDYSETHYSPDGREITTYPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYFIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTETNWESDEPIKKLSQIMIPPEQQRYIELVIVADHRMYTKYDGDKTEISSKIYETANNLNEIYRHLKIHVVLIGLEMWSSGELSKVTLSADETLDSFGEWRERDLLQRKRHDNAQLLTGMIFNEKIEGRAYKESMCDPKRSVGIVRDHRTRPHLVANRMAHELGHNLGFHHDGDSCTCGANSCIMSATVSNEPSSRFSDCSLFQYSSDIIHNPFTSRCLYNEPSKTDIVSPSVCGNYYMEVGEDCDCGPPANCQNPCCDAATCRLTPGSQCADGLCCDQCRFMKKGTICRIARGDDLDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIb sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase that inhibits ADP-induced human platelet aggregation (IC(50)=120 nM (native) and IC(50)=248 nM (recombinant)). May act by binding to the receptor GPIIb/GPIIIa (ITGA2B/ITGB3) on the platelet surface (PubMed:14511668). Degrades the alpha-chain of fibrinogen completely and the beta-chain partially, leaving the gamma chain intact (Ref.2). Also inhibits the growth of several cell lines, including human liver cancer cells (Bel7402), human leukemia cells (K562) and human gastric carcinoma cells (BGC823) (PubMed:19732785). {ECO:0000269|PubMed:14511668, ECO:0000269|PubMed:19732785, ECO:0000269|Ref.2}.",Metalloprotease
258,P83942,TXVE_VIPAP,,Snake venom vascular endothelial growth factor toxin HF (svVEGF) (Heparin-binding dimeric hypotensive factor) (Hypotensive factor) (HF) (VEGF-F),QVRPFLEVHERSACQARETLVSILQEYPDEISDIFRPSCVAVLRCSGCCTDESLKCTPVGKHTVDLQIMRVNPRTQSSKMEVMKFTEHTACECRPRRKQGEPDGPKEKPR,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection (PubMed:10512636). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase (PubMed:14600159). Also induces angiogenesis in vitro, probably through VEGF receptor (KDR/VEGFR-2) signaling (PubMed:14600159). {ECO:0000269|PubMed:10512636, ECO:0000269|PubMed:14600159}.",Vascular Interaction
259,P84035,VM3BA_BOTAS,3.4.24.-,Snake venom metalloproteinase basparin-A (SVMP) (EC 3.4.24.-),SHDNAQLLTAIKAYIATMCDPKMAVIMAHEIGHGGYYGYCRKIPCAPEDVKDDDIGMVLPGTK,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase that catalyzes the conversion of prothrombin (F2) to alpha-thrombin through formation of a thrombin intermediate, without requiring additional cofactors. Also inhibits collagen-dependent platelet aggregation in vitro, an effect that does not depend on proteolytic activity. In vivo, at low doses, induces defibrin(ogen)ation when injected intravenously or intramuscularly into mice. At higher doses, causes sudden death by intravenous administration due to numerous occluding thrombi in pulmonary vessels. {ECO:0000269|PubMed:13679078}.",Metalloprotease
260,P84674,PA2B5_DABRR,3.1.1.4,Basic phospholipase A2 VRV-PL-V (svPLA2) (EC 3.1.1.4) (P2-1) (P2-2) (P3) (Phosphatidylcholine 2-acylhydrolase),SLLEFGMMILEETGKLAVPFYSSYGCYCGWGGKGTPKDATDRCCFVHDCCYGNLPDCTPKPDRYKYKRVNGAIVCEQGTSCENRICECDKAAAICFTKNLNTYSKIYMLYPDFLCKGELKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has a low enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8835338, ECO:0000269|Ref.1}.",Phospholipase
262,P84776,PA2H_PROMB,,Basic phospholipase A2 homolog zhaoermiatoxin (svPLA2 homolog),SLIELTKMVFQETGKNPVTYYTLYGCNCGVGRRGKPKDATDRCCFVHRCCYKKLTGCDPKKDRYSYSWENKAIVCGEKNPCLKELCECDKAVAICLRKNLGTYDKNYRFTMKFLCDKPEKC,"Phospholipase A2 family, Group II subfamily, R49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that induces myonecrosis, and edema. Has low myotoxic activity. {ECO:0000269|PubMed:16635500}.",Phospholipase
263,P84787,VSP2_PROEL,3.4.21.-,Thrombin-like enzyme elegaxobin-2 (SVTLE) (EC 3.4.21.-) (Elegaxobin II) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNINEHPFLVLVYYDEYQCGGTLINEEWVLTAAHCDGENMEIHLGMHSKKVPNKDRRRRVPKEKFFCDSSKNYTKWNKDIMLIRLNRPVRKSAHIAPLSLPSSPPSVGSVCRIMGWGTISPTEETYPDVPHCANINLLDYEVCRAAYPELPATSRTLCAGILEGGKDSCGGDSGGPLICNGQFQGIVSWGGDPCAQPHEPGSYTNVFDHLDWIKGIIAGNTDATCPL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that clots rabbit fibrinogen. Only the beta chain of fibrinogen (FGB) is cleaved, releasing fibrinopeptide B. Human and bovine fibrinogen are unaffected. Also cleaves Met-Lys and Arg-Ser bonds in heat-denatured bovine plasma kininogen to release Lys-bradykinin. {ECO:0000269|PubMed:12676434}.",Serine Protease
264,P84907,VM1LA_BOTLC,3.4.24.-,Snake venom metalloproteinase leucurolysin-A (Leuc-A) (SVMP) (EC 3.4.24.-),QQFSPRYIELVVVADHGMFKKYNSNLNTIRKWVHEMLNTVNGFFRSMNVDASLVNLEVWSKKDLIKVEKDSSKTLTSFGEWRERDLLPRISHDHAQLLTVIFLDEETIGIAYTAGMCDLSQSVAVVMDHSKKNLRVAVTMAHELGHNLGMRHDGNQCHCNAPSCIMADTLSKGLSFEFSDCSQNQYQTYLTKHNPQCILNKP,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Non-hemorrhagic metalloproteinase that hydrolyzes the alpha chains of fibrinogen, as well as fibrin, fibronectin and casein. Beta and gamma chains are also hydrolyzed, but more slowly. Thrombolytic activity is also observed. Induces detachment of endothelial cells followed by death, and inhibits endothelial cell adhesion to fibronectin. Induces edema in mouse paw. Inhibits ADP-induced platelet aggregation on human platelet-rich plasma with an IC(50) of 2.8 uM. {ECO:0000269|PubMed:16139412, ECO:0000269|PubMed:17482228}.",Fibrinogenolytic Enzyme
265,P85092,3SI1A_DENAN,,Toxin AdTx1 (Rho-elapitoxin-Da1a) (Rho-Da1a) (Rho-EPTX-Da1a),LTCVTSKSIFGITTEDCPDGQNLCFKRRHYVVPKIYDSTRGCAATCPIPENYDSIHCCKTDKCNE,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Orthosteric antagonist of the alpha-1A adrenergic receptor (ADRA1A) with an affinity of 0.35 nM (PubMed:20015090). Has also affinity for ADRA1B > ADRA2C > ADRA1D (PubMed:23935897). Acts as a relaxant of smooth muscle. Reduces prostatic muscle tone as efficiently as tamsulosin (an antagonist presently used), but with fewer cardiovascular side effects (PubMed:23005263). {ECO:0000269|PubMed:20015090, ECO:0000269|PubMed:21419153, ECO:0000269|PubMed:23005263, ECO:0000269|PubMed:23935897}.",Vascular Interaction
266,P85109,VSP1_GLOBR,3.4.21.-,Thrombin-like enzyme kangshuanmei (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNINEHRFLVALYHSRSRTFLCGGTLINQEWVLTAAHCDRFFMYIRLGMHNKNVNFDDEQRRSPKEKYFFRCSNNFTKWDKDIMLIRLDSPVNNSAHIAPLSLPSNPPSVGSVCRVMGWGQTTSPQEDLSDVPRCANINLFNFTVCRAAYPWLPATSRVLCAGDMEGGIDTCNRDSGGPLICNGQFQGIVSKGQNLCAQPRKPALYTKVFDHLDWIQSIIAGNKTVTCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Cleaves bonds after Arg and Lys, converts fibrinogen (FGA and FGB) to fibrin and releases both fibrinopeptides A and B, and fibrinogen peptide Bbeta1-42. Has a blood clotting activity. {ECO:0000269|PubMed:11491462, ECO:0000269|PubMed:16908038}.",Serine Protease
267,P85314,VM1BI_BOTMO,3.4.24.-,Snake venom metalloproteinase BmooMPalpha-I (SVMP) (EC 3.4.24.-),EQQKFSPRYIELVVVADHGMFKKYNSNLNTIRKWVHEMVNSMNGFYRSVDVTASLANLEVWSKKDLINVQKDSRETLKSFGEWRERDLLPRISHDNAQLLTAIVFDGHTIGRAYTGGMCDPRHSVGVVMDHSPKNLQVAVTMAHELGHNLGMHHDGNQCHCDAASCIMADSLSVVLSYEFSDCSQNQYQTYLTKHNPQCILNEPL,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloproteinase that cleaves the alpha chain of fibrinogen (FGA) first followed by the beta chain (FGB) and shows no effect on the gamma chain. Cleaves only the beta chain of fibrin, leaving the gamma-dimer untouched. Shows proteolytic activity towards azocasein. Causes defibrinogenation when intraperitoneally administered on mice. {ECO:0000269|PubMed:18187176}.",Metalloprotease
268,P85420,VM11_BOTAT,3.4.24.-,Snake venom metalloproteinase atroxlysin-1 (SVMP) (EC 3.4.24.-) (Atroxlysin-I),TPEQQRYVDLFIVVDHGMFMKYNGNSDKIRRRIHQMVNIMKEAYSTMYIDILLTGVEIWSNKDLINVQPAAPQTLDSFGEWRKTDLLNRKSHDNAQLLTSTDFNGPTIGLAYVGSMCDPKRSTGVIQDHSEQDLMVAITMAHELGHNLGISHDTGSCSCGGYSCIMSPVLSHEPSKYFSDCSYIQCWDFIMKENPQCILNKR,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloproteinase that acts on fibrinogen, fibrin, fibronectin (FN1), type I collagen, type IV collagen, integrin alpha-7/beta-1 (ITGA7/ITGB1) and integrin alpha-1/beta-1 (ITGA1/ITGB1). Binds to fibronectin (FN1), fibrinogen and, weakly, to type I collagen and laminin. Cleaves Xaa-Leu bonds. Inhibits ADP- and collagen-induced platelet aggregation both in the presence (IC(50)=1.4 uM for collagen) and in the absence (IC(50)=2.2 uM for collagen) of cofactors. Has hemorrhagic activity. {ECO:0000269|PubMed:20102699}.",Metalloprotease
269,P86092,VM3LB_BOTLC,3.4.24.-,Zinc metalloproteinase leucurolysin-B (Leuc-B) (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),DTVLLNRISHDNAQLLAIVFNENVIGKAYTGGMCDPRYSVGVVMDHSPINRLVADTMAHEMGHNLGIHHDTGSCSCGGHSCIMSRVISHQPLQYFSNCSYIEYWDFITKLNPQCILNEPLRTDIVSPPVCGNELLEMGEECDCGSPRNCRDLCCDAATCKLHSWVECESGECCDQCRFIKAGNVCRPPRKECDVAEACTGQSAQCPTDDFKRNGQPCLNNYAYCYQGNCPIMYHQCYALFGSDATMAQDSCFQVNKKGNEYFYCRLENGINIPCAQEDVKCGRLFCHNMKYEQDCNYSDRGMVDNGTKCAEGKVCNSNRQAYQR,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase that acts as a potent hemorrhagic toxin. Hydrolyzes the insulin B chain at the 14-Ala-|-Leu-15 bond but not the 16-Tyr-|-Leu-17 bond. Degrades the alpha-chain of fibrin and hydrolyzes the Aalpha-chain of fibrinogen (FGA) while leaving the beta and gamma chains unaffected. Degrades type-I collagen and its gelatin. Degrades the alpha-1 chain of type-IV collagen and its gelatin but not the alpha-2 chain. Degrades plasma fibronectin, plasma vitronectin and basement membrane enactin. It inhibits collagen-induced platelet aggregation. {ECO:0000269|PubMed:17963685}.",Metalloprotease
270,P86169,PA2BA_CRODR,3.1.1.4,Basic phospholipase A2 A (svPLA2) (EC 3.1.1.4) (Crotoxin basic chain 1) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRKNAIPFYAFYGCYCGWGGRGRPKDATDRCCFVHDCCYGKLAKCNTKWDIYPYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A that has strong antimicrobial activity against the Gram-negative bacterium X.axonopodis. Antimicrobial activity is not abolished by EDTA or p-BPB and is therefore not strongly dependent on the enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:19013478}.,Phospholipase
271,P86453,PA2HB_BOTAL,,Basic phospholipase A2 homolog BaTX (svPLA2 homolog),SLFELGKMILQETGKNPAKSYGAYYCYCGWGGQGQPKDATDRCCYVHKCCYKKLTGCNPKKDRYSYSWKDKTIVCGENNSCLKELCECDKAVAICLRENLNTYNKKYRYYLKPLCKKADAC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:17270350). Is myotoxic and displays edema-inducing activities (PubMed:17270350, PubMed:17915277). In vitro, produced time-dependent, irreversible neuromuscular blockade in isolated mouse phrenic nerve-diaphragm and chick biventer cervicis preparations (PubMed:17270350, PubMed:19463969). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:17270350, ECO:0000269|PubMed:17915277, ECO:0000269|PubMed:19463969}.",Phospholipase
272,P86523,PA2AA_ACAAN,3.1.1.4,Phospholipase A2 P-elapitoxin-Aa1a alpha chain (P-EPTX-Aa1a alpha chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFGFMIRCANKRRRPVWPYEESGC,"Phospholipase A2 family, Group I subfamily","FUNCTION: Heterotrimer: presynaptic neurotoxin. Inhibits nerve-evoked twitch contractions but not responses to cholinergic agonists acetylcholine and carbachol and to depolarizing agonist KCl. Causes a fade in tetanic contractions. Displays a triphasic mode of action with depression, enhancement and blockade of neurotransmission. Does not display myotoxic activity such as changes in baseline muscle tension or inhibition of directly stimulated muscle twitches. All subunits are necessary for maximum toxicity. {ECO:0000269|PubMed:20361942}.; FUNCTION: Monomer: Snake venom phospholipase A2 (PLA2) alpha chain that has enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:20361942}.",Phospholipase
273,P86535,OXLA1_DABRR,1.4.3.2,L-amino-acid oxidase L1 (LAAO-L1) (LAO) (EC 1.4.3.2),ADDINPKEECFFEDDYYEFE,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:18384385). Is active on L-Met, L-Ile, L-Leu, L-Phe, L-Trp, and L-Tyr (PubMed:18384385). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250, ECO:0000269|PubMed:18384385}.",Vascular Interaction
274,P86802,VM1H1_BOTMA,3.4.24.-,Snake venom metalloproteinase HF-1 (BmHF-1) (SVMP) (EC 3.4.24.-),PCWKGWSEDEQNLWPQRYIQLVVVADHGMFMKYNGDLAAIRKRVHELVNNINGFYRSLNIDVSLTDLEIWSDQDFITVVQSSSAKNTLNSFGEWREADLLRRKSHDHAQLLTAIDLDDDTVGLAYTSSMCNPRKSVAWGQDHSEEPINLLDVGVTMAHELGHNLGMNHDEEKKCHCGASLCIMSPSITEGPSLEFSDDSMGYYQSFLVVVNYNPQCILNKPEDQYYYILSPKHRIYSW,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloprotease that is weakly hemorrhagic and has Aalpha, Bbeta fibrinogenolytic activities. Cleaves the Aalpha chain of fibrinogen first, followed by the Bbeta chain and shows no effect on the gamma chain. Has caseinolytic activity. Induces dose-dependent edema. {ECO:0000269|PubMed:20607373}.",Metalloprotease
275,P86803,PA2B1_BOTMA,3.1.1.4,Basic phospholipase A2 BmjeTX-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLWQFGQMILKETGKIPFPYYGAYGCYCGWGGRGGKPKAGTDRCCYVHDCCYGKLTSCPKTDDRYSYSWLDGTIVCGEDDPCKELCECDKKIAVCFRENLGTYNKKYRYHLKSCKKADKPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces a slight blockade of neuromuscular contraction in an indirectly stimulated chick biventer cervicis nerve-muscle preparation. Does not inhibit contraction of chick biventer cervicic nerve-muscle preparation in response to treatment with acetylcholine or KCl. The neuromuscular blockade is mediated by inhibitory action at the presynaptic motor nerve endings. Lyses skeletal myoblasts and myotubes in vitro, and intramuscular injection causes local muscle necrosis. Induces edema in the mouse foot pad. Induces a transient increase of IL-6 levels. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:20195718}.",Phospholipase
276,P86804,PA2B2_BOTMA,3.1.1.4,Basic phospholipase A2 BmjeTX-II (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLWQWGQMILKETGKIPFSYYGAYGCYCGWGGRGGKPKAGTDRCCYVHDCCYGKLTSCPKTDDRYSYSRLDLTIVCGEDDPCKELCECDKKIAVCFRENLGTYNKKYRYHLKSCKKADKPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces blockade of neuromuscular contraction in an indirectly stimulated chick biventer cervicis nerve-muscle preparation. Does not inhibit contraction of chick biventer cervicic nerve-muscle preparation in response to treatment with acetylcholine or KCl. The neuromuscular blockade is mediated by inhibitory action at the presynaptic motor nerve endings. Lyses skeletal myoblasts and myotubes in vitro, and intramuscular injection causes local muscle necrosis. Induces edema in the mouse foot pad. Induces a transient increase of IL-6 levels. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:20195718}.",Phospholipase
277,P86805,PA2B9_CRODM,3.1.1.4,Basic phospholipase A2 9 (svPLA2) (EC 3.1.1.4) (Cdc-9) (Phosphatidylcholine 2-acylhydrolase),SLVQFNKMIKFETRKSGLPFYAAYGCYCGWGGQRPKDATDRCCFVHDCCYGKVAKCNTKWDIYSYSLKSGYITCGKGTWCKEQICECDRVAAECLRRSLSTYKNEYMFYPDSRCREPPEYTC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has a strong dose-dependent anticoagulant effect. In vivo, intramuscular and intervenal injection causes muscle necrosis. Induces moderate edema in the mouse foot pad. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:19747981}.",Phospholipase
278,P86806,PA2BA_CRODM,3.1.1.4,Basic phospholipase A2 10 (svPLA2) (EC 3.1.1.4) (Cdc-10) (Phosphatidylcholine 2-acylhydrolase),SLLQFNKMIKFETRKSGVPFYAAYGCYCGWGGRRPKDPTDRCCFVHDCCYGKLTKCNTKWDIYSYSLKSGYITCGKGTWCKEQICECDRVAAECLRRSLNTYKNEYMFYPDSRCRGPPEYTC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has a strong dose-dependent anticoagulant effect. In vivo, intramuscular and intervenal injection causes muscle necrosis. Induces moderate edema in the mouse foot pad. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:19747981}.",Phospholipase
279,P86907,PA2A_BOTAM,3.1.1.4,Acidic phospholipase A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLMQFETLIKKIAGRSGVWFYGFYGCYCGSGGRGKPKDATDRCCFVHDCCYGKVTGCDPKMDFYTYSEENGVVVCGGDDPCKKQICECDRVAATCFRDNKTYDNNKYWFYPAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that displays low systemic toxicity and causes severe symptoms only at very high concentrations (15 mg/kg). Has neither coagulant nor anticoagulant activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:22975267}.,Phospholipase
280,P86976,VM1B1_BOTBA,3.4.24.-,Zinc metalloproteinase barnettlysin-1 (EC 3.4.24.-) (Barnettlysin-I) (Snake venom metalloproteinase) (SVMP),TPEQQRYVELFIVVDHGMFMKXXXXXXXXXXXIHQMVNIMKEAYRYLYIDILLTGVEIWSNKDLINVQPAAPQTLDSFGEWRXXXXXXXKSHDNAQLLTSTDFDGPTIGLAYVGSMCDPKRSTAVIQDHSEIDLLVAVTMDHELGHNLGIRHDTGSCSCGGYPCVMSPVISHDISKYFSDCSYIQCWDFIMKENPQCILNKR,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Non-hemorrhagic metalloproteinase that hydrolyzes the alpha chains of fibrinogen and fibrin but has no activity on beta- and gamma-chains. Cleaves X-Leu bonds. Inhibits platelet aggregation induced by the von Willebrand factor (VWF) (IC(50) is 1.4 uM) and type I collagen (IC(50) is 3.2 uM). Acts by cleaving the vWF and its receptor GPIb, and by cleaving the collagen-binding Alpha-2A domain of the collagen receptor alpha-2/beta-1 integrin (ITGA2/ITGB1). Also degrades the extracellular matrix protein fibronectin (FN1), but has no effect on laminin and type I collagen. {ECO:0000269|PubMed:26723171}.",Fibrinogenolytic Enzyme
281,Q02471,PA2B4_DABSI,3.1.1.4,Basic phospholipase A2 RV-4 (svPLA2) (EC 3.1.1.4) (F4) (Phosphatidylcholine 2-acylhydrolase) (S2) (Viperotoxin F) (Viperotoxin toxic basic component),MRTLWIVAVCLIGVEGNLFQFARMINGKLGAFSVWNYISYGCYCGWGGQGTPKDATDRCCFVHDCCYGGVKGCNPKLAIYSYSFQRGNIVCGRNNGCLRTICECDRVAANCFHQNKNTYNKEYKFLSSSKCRQRSEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Heterodimer RV-4/RV-7: acts as a presynaptic neurotoxin.; FUNCTION: Monomer: snake venom phospholipase A2 (PLA2) that acts as a presynaptic neurotoxin. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
282,Q06ZW0,3NB_BOIDE,,Denmotoxin,MKTLLLAVAVVAFVCLGSADQLGLGRQQIDWGQGQAVGLPHGFCIQCNRKTWSNCSIGHRCLPYHMTCYTLYKPDENGEMKWAVKGCARMCPTAKSGERVKCCTGASCNSD,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily",FUNCTION: This bird-specific postsynaptic neurotoxin irreversibly binds and inhibits the chick muscle alpha-1-beta-1-gamma-delta (CHRNA1-CHRNB1-CHRNG-CHNRD) nicotinic acetylcholine receptor (nAChR) 100-fold more compared with the mouse receptor. The weak binding to mouse receptor is reversible. {ECO:0000269|PubMed:16864572}.,Neurotoxin
283,Q072L5,VM2_BOTAS,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin bothrasperin],MIEVLLVTICLAVSPYQGSSIILESGNVNDYEVVYPRKVTELPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGRKIITYPSFEDHCYYHGRIENDADSTASISACNGLKGHFKIQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTETNWESYEPIKKASQSNLTPEQQRFSPRYIELAVVADHGIFTKYNSNLNTIRTRVHEMLNTVNGFYRSVNVTASLASLEVWSKKDLIKVEKDSSKTLTSFGEWRERDLLPRISHDHAQLLTTIVFDNYVIGITEFGKMCDPKLSVGVVRDHSEINLQVAVAMAHELGHNLGMYHDGNQCHCDAASCIMADTLREVLSYEFSDCSQNQYETYLTKHNPQCILNEPLLIVSGNELLEAGEECDCDAPENPCCDAATCKLRPGAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IId sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: Disintegrin: Inhibits ADP- (IC(50)=59 nM) and collagen-induced (IC(50)=49 nM) aggregation of human platelets. In vitro, inhibits adhesion of endothelial cells to vitronectin, type-I collagen and, to a lower degree, fibronectin and laminin. {ECO:0000269|PubMed:25457103}.",General Toxin
284,Q072L6,VSPL_BOTAS,3.4.21.-,Thrombin-like enzyme asperase (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVVLFNSSGFLCAGTLVQDEWVLTAANCDSKNFQMQLGVHSKKVLNEDEQTRDPKEEASLCPNRKKDDEVDKDIMLIKLDSRVSNSEHIAPLSLPSSPPSVGSVCRIMGWGTISPTKETYPDVPHCANINILDHAVCRAAYPWQPVSSTTLCAGILQGGKDTCWGDSGGPLICNGEFQGIVSWGAHPCGQPHNPGVYTKVSDYTEWIKSIIAGNTAAACPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that clots human plasma and bovine fibrinogen. Upon intravenous injection in mice, this protease renders blood unclottable (defibri(ogen)ation). Intravenous administration (10 and 5 ug) induces a gyroxin-like effect: loss of the righting reflex, opisthotonus, and intermittent rotations over the long axis of the body. These effects persisted during approximately 10 minutes, after which the animals apparently recovers. {ECO:0000269|PubMed:17994164}.",Serine Protease
285,Q10749,VM3M1_NAJMO,3.4.24.-,Snake venom metalloproteinase-disintegrin-like mocarhagin (MOC) (Mocarhagin-1) (SVMP) (EC 3.4.24.-) (Zinc metalloproteinase mocarhagin),MIQALLVAICLAVFPYQGSSIILESGNVNDYEVVYPQKVPALSKGGVQNPQPETKYEDTMQYEFHVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSSPVQDHCYYHGYIQNEADSSAVISACDGLKGHFKHQGETYFIEPLELSDSEAHAIYKDENVEEEEEIPKICGVTQTTWESDEPIEKSSQLTNTPEQDRYLQAKKYIEFYVVVDNVMYRKYTGKLHVITRRVYEMVNALNTMYRRLNFHIALIGLEIWSNGNEINVQSDVQATLDLFGEWRENKLLPRKRNDNAQLLTSTEFNGTTTGLGYIGSLCSPKKSVAVVQDHSKSTSMVAITMAHQMGHNLGMNDDRASCTCGSNKCIMSTKYYESLSEFSSCSVQEHREYLLRDRPQCILNKPSRKAIVTPPVCGNYFVERGEECDCGSPEDCQNTCCDAATCKLQHEAQCDSGECCEKCKFKGAGAECRAAKNDCDFPELCTGRSAKCPKDSFQRNGHPCQNNQGYCYNGTCPTLTNQCATLWGPGAKMSPGLCFMLNWNARSCGLCRKENGRKILCAAKDVKCGRLFCKKKNSMICHCPPPSKDPNYGMVAPGTKCGVKKVCRNRQCVKV,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase that inhibits platelet aggregation by cleaving platelet glycoprotein Ib alpha (GP1BA) at Glu-298/Asp-299, and abolishes binding of von Willebrand factor (VWF) to GPIBA. Cleaves P-selectin glycoprotein ligand-1 (PSGL-1/SELPLG) at Tyr-51/Asp-52, and completely abolishes the binding of PSGL-1 to P-selectin. Anionic amino acid sequences containing sulfated tyrosines are needed for cleavages. Inhibits the thrombin-induced platelet aggregation, and the thrombin-induced release of ATP and ADP. Has lectin activity (inhibited by heparin). {ECO:0000269|PubMed:12598411, ECO:0000269|PubMed:7592904, ECO:0000269|PubMed:8664285, ECO:0000269|PubMed:8931262}.",Metalloprotease
286,Q14FJ4,VM2OC_ECHOC,3.4.24.-,Zinc metalloproteinase/disintegrin (Long ocellatusin precursor Eo-00006) (EOC00006) [Cleaved into: Snake venom metalloproteinase Eoc6 (SVMP) (EC 3.4.24.-); Disintegrin ocellatusin],MIQVLLVTICLAVFPFQGSSKTLKSGNVNDYEVVNPQKITGLPVGAFKQPEKKYEDAVQYEFEVNGEPVVLHLEKNKGLFSEDYSETHYSPDGSEITTNPPVEDHCYYHGRVQNDADSTASISTCNGLKGFFTLRGETYLIEPLKVPDSESHAVYKYEDAKKKDEAPKMCGVTLTNWESDEPIKKASHLVATSEQQHFHPRYVQLVIVADHSMVTKNNNDLTALTTWIHQIVNDMIVMYRILNIHITLANVEIWSSGDLIAVTSSAPTTLRSFGEWRARNLVNRITHDNAQLITAVHLDNLIGYGYLGTMCDPQSSVAITEDHSTDHLWVAATMAHEMGHNLGMNHDGNQCNCGAAGCIMSAIISQYRSYQFSDCSMNEYRNYITTHNPPCILNQALRTDTVSTPVSENELLQNSVNPCYDPVTCQPKEKEDCESGPCCDNCKFLKEGTICKMARGDNMHDYCNGKTCDCPRNPYKGEHDPMEWPAPAKGSVLM,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily",FUNCTION: [Snake venom metalloproteinase Eoc6]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin ocellatusin]: Inhibits ADP-induced platelet aggregation (IC(50)=168 nM). Inhibits alpha-5/beta-1 (ITGA5/ITGB1) integrin and induces the expression of a ligand-induced binding site epitope on beta-1 integrin subunit. Has a direct chemotactic stimulus on human neutrophils in vitro. {ECO:0000269|PubMed:11852062}.,General Toxin
287,Q18DC8,RE123_ECHOC,3.4.23.15,Renin (EC 3.4.23.15) (Angiotensinogenase) (Renin-like aspartic protease EOC123) (SVAP EOC123) (Snake venom aspartic protease EOC123),MLQSWEFVLLISCFLCFSSDALQRISLKKMPSIRETLQEMGMKVADVLPSLKHRFSYLDEGLHNKTASTILTNFRDTQYYGEISIGTPAQIFKVVFDTGSSNLWVPSHQCSPLYSACVSHNRYDSSESSTYKPKGTKITLTYGQGYIEGFLSQDIVRVADIPITQFFTEAIALPSIPFMYAHFDGVLGMGYPKQAIGGVIPVFDNIMSEKVLSENVFSVYYSRHSESNTGGEIILGGSDPSHYTGDFHYVSTSREGYWHVDLKGVSIENKIALCHDGCTATIDTGTSFISGPASSISVLMETIGATLSRGDYVIDCNQINLLPDISFHLGDMTYSLSSSTYVLKYSDETECTVAFSAIDIPPPRGPLWLLGATFIKQYYIEFDRQNNRIGFATSF,Peptidase A1 family,"FUNCTION: Renin is a highly specific endopeptidase, whose only known function is to generate angiotensin I from angiotensinogen in the plasma, initiating a cascade of reactions that produce an elevation of blood pressure and increased sodium retention by the kidney (Probable). This protein is also found in snake venom and shown to specifically cleave human and porcine angiotensinogen into angiotensin I. It does not have general protease activity, no cleavage of alpha or beta casein. May be directly responsible for elevation of blood pressure in the victims of envenomation (PubMed:28734982). {ECO:0000269|PubMed:28734982, ECO:0000305}.",General Toxin
288,Q18DC9,RE51_ECHOC,3.4.23.15,Renin (EC 3.4.23.15) (Angiotensinogenase) (Renin-like aspartic protease) (Renin-like aspartic protease EOC51) (SVAP EOC51) (Snake venom aspartic protease EOC51),MLRSWEFVLLISCFLCFSSDALQRISLKKMPSIRETLQEMGMKVADVLPSLKHRISYLDEGLHNKTASTILTNFRDTQYYGEISIGTPAQIFKVVFDTGSSNLWVPSRQCSPLYSACVSHNRYDSSESSTYKPKGTKITLTYAQGYIKGFFSQDIVRVADIPIIQFFTEAIALPSIPFIFARFDGVLGMGYPKQAIGGVIPVFDNIMSEKVLSENVFSVYYSRHSESNTGGEIILGGSDPSHYTGDFHYVSTSREGYWHVDLKGVSIENKIVLCHDGCTATIDTGTSFISGPASSISVLMETIGATLSDGDYVIDCKKINLLPDITFHLGDMTYSLSSSTYVLKFSDETECTVAFMAVDIPPPLGPLWLLGATFIKQYYIEFDRQNNRIGFATSF,Peptidase A1 family,"FUNCTION: Renin is a highly specific endopeptidase, whose only known function is to generate angiotensin I from angiotensinogen in the plasma, initiating a cascade of reactions that produce an elevation of blood pressure and increased sodium retention by the kidney (Probable). This protein is also found in snake venom and shown to specifically cleave human and porcine angiotensinogen into angiotensin I. It does not have general protease activity, no cleavage of alpha or beta casein. May be directly responsible for elevation of blood pressure in the victims of envenomation (PubMed:28734982). {ECO:0000269|PubMed:28734982, ECO:0000305}.",General Toxin
289,Q1PHZ4,VM3B1_BOTJR,3.4.24.-,Zinc metalloproteinase-disintegrin-like BjussuMP-1 (EC 3.4.24.-) (BjussuMP-I) (Snake venom metalloproteinase) (SVMP),EFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGRQITTYPPVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTETNWEYEEPIKKASKLVVTAEQQKFPYRYVEIVVVVDRRMVTKYNGDLKKIRKWVYELVNIVNNIYRSLNVHVALVGLEIWSKGDKITVQPDSDYTLNSFGEWRERDLLPRKKHDNAQLLTAVVFDGPTIGRAYIAGMCDPRHSVGVVMDHSKENLQVAVTMAHELGHNLGMEHDENQCHCDAPSCVMASVLSVVLSYEFSDCSQNQYQTYLTKHNPQCILNEPLLTVSGNELLEAGEECDCGAPENPCCDAATCKLRPGAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFHRNGQPCLYNHGYCYNGKCPIMFYQCYFLFGSNATVAEDDCFNNNKKGDKYFYCRKENEKYIPCAQEDVKCGRLFCDNKKYPCHYNYSEDLDFGMVDHGTKCADGKVCSNRQCVDVNEAYKSTTVFSLI,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: This protein is a zinc metalloprotease from snake venom that causes hemorrhage in mice after intradermal injection. It inhibits platelet aggregation induced by collagen and ADP. Has moderate edema activity, but no myotoxic activity. It hydrolyzes the Aalpha-chain and more slowly the Bbeta-chain of fibrinogen, without affecting the gamma-chains. It also shows proteolytic activity on casein. It is unable to clot plasma. It also shows bactericidal activity against E.coli and S.aureus. {ECO:0000269|PubMed:15246772, ECO:0000269|PubMed:17081786}.",Metalloprotease
290,Q1RP78,PA2B2_VIPNI,3.1.1.4,Basic phospholipase A2 chain HDP-2P (svPLA2) (EC 3.1.1.4) (Heterodimeric neurotoxic phospholipases A2 basic subunit 2) (Phosphatidylcholine 2-acylhydrolase),MRILWIVAVCLIGVEGNLFQFAKMINGKLGAFSVWNYISYGCYCGWGGQGTPKDATDRCCFVHDCCYGRVRGCNPKLAIYAYSFKKGNIVCGKNNGCLRDICECDRVAANCFHQNKNTYNKNYRFLSSSRCRQTSEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Monomer: snake venom phospholipase A2 (PLA2) that affects neuromuscular transmission presynaptically. It has catalytic activity, anticoagulant activity and weakly inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18083205}.; FUNCTION: Heterodimer: shows the same activities as the monomer, but with a lower potency. {ECO:0000269|PubMed:18083205}.",Phospholipase
291,Q1RP79,PA2B1_VIPNI,3.1.1.4,Basic phospholipase A2 chain HDP-1P (svPLA2) (EC 3.1.1.4) (Heterodimeric neurotoxic phospholipases A2 basic subunit 1) (Phosphatidylcholine 2-acylhydrolase),MRILWIVAVCLIGVEGNLFQFAKMINGKLGAFSVWNYISYGCYCGWGGQGTPKDATDRCCFVHDCCYGRVRGCNPKLAIYAYSFKKGNIVCGKNNGCLRDICECDRVAANCFHQNQNTYNKNYKFLSSSRCRQTSEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer: shows the same activities as the monomer, but with a lower potency.; FUNCTION: Monomer: snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity, anticoagulant activity and that weakly inhibits ADP-induced platelet aggregation (PubMed:18083205). Inhibits exocytosis in pancreatic beta cells, confirming it can act presynaptically in inhibiting the exocytosis of neurotransmitters in neurons (PubMed:19500614). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18083205, ECO:0000269|PubMed:19500614}.",Phospholipase
292,Q27J47,VSPPA_LACMU,3.4.21.-,Venom plasminogen activator LV-PA (EC 3.4.21.-) (LMUT0402S) (Plasminogen activating proteinase) (Snake venom serine protease) (SVSP),MVLITVLANLLILQLSYAQKSSKLVFGGDECNINEHRSLVVLFNSSGFLCAGTLINKEWVLTAAHCDSENFQMQLGVHSKKVPNKDEETRDPKEKFICPNRKKNDEKDKDIMLIRLNRPVSNSEHIALLSLPSSPPSVGSVCRIMGWGTISPTKEIYPDVPHCADINILDHAVCRAAYSGWLATSTTLCAGILEGGKDSCHGDSGGPLICNGQFQGIVSLGRHPCGHPDEPGVYTKVFDYTDWIQSIIAGNTDAACPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that activates plasminogen. Weakly hydrolyzes the alpha chain of human fibrinogen without releasing fibrinopeptide A. Does not hydrolyze plasma kallikrein or factor Xa. Does not clot fibrinogen. Does not affect platelet function. Induces hypotensive effects on rats. Shows a preferential cleavage at Lys-|-Xaa over Arg-|-Xaa bonds. {ECO:0000269|PubMed:10871053, ECO:0000269|PubMed:17034951}.",Serine Protease
293,Q27J49,BNP_LACMU,,Bradykinin-potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide 1 (BPP 1); Bradykinin-potentiating peptide 2 (BPP 2); Bradykinin-potentiating peptide 3 (BPP 3); Bradykinin-potentiating peptide 4 (BPP 4); Bradykinin-potentiating peptide 5 (BPP 5); Bradykinin inhibitor peptide (BIP); C-type natriuretic peptide (CNP) (Lm-CNP)],MFVSRLAASGLLLLALLAVSLDGKPVQQWSHKGWPPRPQIPPLVVQQWSQKPWPPGHHIPPVVVQEWPPGHHIPPLVVQQWSQKKWPPGHHIPPLVVQKWDPPPISPPLLKPHESPAGGTTALREELSLGPEAALDTPPAGPDVGPRGSKAPAAPHRLPKSKGASATSAASRPMRDLRTDGKQARQNWGRMMNPDHHAVGGGGGGGGARRLKGLAKKRVGDGCFGLKLDRIGSMSGLGC,Bradykinin-potentiating peptide family; Bradykinin inhibitor peptide family; Natriuretic peptide family,FUNCTION: Bradykinin-potentiating peptide both inhibits the activity of the angiotensin-converting enzyme (ACE) and enhances the action of bradykinin by inhibiting the peptidases that inactivate it. It acts as an indirect hypotensive agent (By similarity). {ECO:0000250}.; FUNCTION: [Bradykinin inhibitor peptide]: antagonizes the vasodilatory actions of bradykinin at the B2 bradykinin receptor. {ECO:0000269|PubMed:16277978}.; FUNCTION: [C-type natriuretic peptide]: has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.,Kunitz Family
294,Q2LD49,VM3TM_TRIST,3.4.24.-,Zinc metalloproteinase-disintegrin-like TSV-DM (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTSLPKGAVQQKYEDAMQYELKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGRKITTKPPVKDHCYYHGHIQNDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTETNWESDEPIKEASQSNLTPEQQSYLNAPKYVKFFLVADHIMYLKYGRNLTTLRTRIFDTVNVVYLILLRINIHVLLVGMEIWSHKDKIIVQSVPAVTLKLFATWREADLLKHKSHGCAHLLTGINFNGPTAGLAYLGAICNPMYSAGIVQDHNKIHHLVAIAMAHELGHNLGINHDKDTCTCRAKACVMAGTISCDASYLFSDCSRQEHREFLIKNMPQCILKKPLKTDVVSPPVCGNYFVEVGEDCDCGSPATCRDSCCNPTNCKLRQGAQCAEGLCCDQCRFKGAGTECRPASSECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNGTCPSMTDQCIALFGPNAAVSQDACFQFNREGNHYGYCRKEQNTKIACEPENVKCGRLYCIDSSPANKNPCNIVYLPNDEEKGMVLAGTKCADGRACNSNGQCVGVNGAYKSTTGFSQI,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily",FUNCTION: Snake venom zinc metalloprotease that hydrolyzes the alpha-chain (FGA) and more slowly the beta-chain (FGB) of fibrinogen. Inhibits cell proliferation and induces cell morphologic changes transiently on human umbilical vein endothelial cells. {ECO:0000269|PubMed:16487560}.,Metalloprotease
295,Q2PE51,BNP_CRODO,,Bradykinin-potentiating and C-type natriuretic peptides (Angiotensin converting enzyme inhibitor-CNP) (ACEI-CNP) (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide-1 (BPP-1); Bradykinin-potentiating peptide-2 (BPP-2); Bradykinin inhibitor peptide homolog (Cdc peptide) (Novel peptide); C-type natriuretic peptide (CNP)],MFVSRLAASGLLLLALLAVSLDGKPLQQWSQRWPHLEIPPLVVQNWKSPTQLQARESPAGGTTALREELSLGPEAALDTPPAGPDGGPRGSKAAAAAPQRLSKSKGASATSAASRDLRTDGKQARQNWGRLVSPDHHSAAGGGGGGGGGARRLKGLAKKRAGNGCFGLKLDRIGSMSGLGC,Bradykinin-potentiating peptide family; Natriuretic peptide family,"FUNCTION: Bradykinin-potentiating peptide both inhibits the activity of the angiotensin-converting enzyme (ACE) and enhances the action of bradykinin by inhibiting the peptidases that inactivate it. It acts as an indirect hypotensive agent (By similarity). {ECO:0000250}.; FUNCTION: [Bradykinin inhibitor peptide homolog]: antagonizes the vasodilatory actions of bradykinin at the B2 bradykinin receptor (By similarity). Has no demonstrable hypotensive activity when injected intravenously in rats. {ECO:0000250, ECO:0000269|PubMed:16979945}.; FUNCTION: [C-type natriuretic peptide]: has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.",Kunitz Family
296,Q2PQJ3,VSP1_BOTJR,3.4.21.-,Thrombin-like enzyme BjussuSP-1 (SVTLE BjussuSP-1) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Jararacussin-I) (Snake venom serine protease 1) (SVSP) (Thrombin-like enzyme BjussuSP-I) (SVTLE BjussuSP-I),VLGGDECDINEHPFLAFLYSHGYFCGLTLINQEWVVTAAHCDSTNFQMQLGVHSKKVLNEDEQTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLPSNPPSVGSVCRIMGWGSITIPNETYPDVPYCANINLVDYEVCQGAYNGLPAKTTLCAGVLEGGKDTCVGDSGGPLICNGQFQGIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRNIAGNTDATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like enzyme that shows clotting activity upon human plasma. Shows specific fibrinogenolytic activity for Aalpha chain (FGA). Hydrolyzes fibrin, BAPNA and TAME, as well as chromogenic artificial substrates of the blood coagulation cascasde: S-27654 for factor X (F10), S-2302 for kallikrein (KLK), factor XIa (F11), and XIIa (F12), and S-2266 for kallikrein and factor XIa (F11). Subcutaneous injection into mice induces a mild edema. Intravenous and intramuscular injection reduce plasma fibrinogen concentration and increase the levels of fibrin(ogen) degradation products. Intramuscular injection also promotes an increase in the expression of proMMP-9, but is unable to activate it. {ECO:0000269|PubMed:17292935, ECO:0000269|PubMed:17466550, ECO:0000269|PubMed:17996740}.",Serine Protease
297,Q2PWA3,PA2HP_PROMU,,Basic phospholipase A2 homolog promutoxin (svPLA2 homolog),MRTLWIMAVLLLGVEGSVIELGKMVFQETGKNPVKNYGLYGCNCGVGKRGKPVDATDSCCFVHRCCYKKVTGCDPKKDRYSYSWENKAIVCGEKNPPCLKQVCECDKAVAICLRENLGTYDKKHRVTMKFLCKAPESC,"Phospholipase A2 family, Group II subfamily, R49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Exhibits potent myotoxicity causing myonecrosis and edema in the gastrocnemius muscle of mice (PubMed:16793192). Is also able to stimulate the release of IL12 (IL12A-IL12B), TNF-alpha (TNF), IL6 and IL1-beta (IL1B) from human monocytes, and induce IL2, TNFalpha and IL6 release from T-cells (PubMed:16793192). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:16793192}.",Phospholipase
298,Q2UXQ5,VM3E2_ECHOC,3.4.24.-,Zinc metalloproteinase-disintegrin-like EoVMP2 (EC 3.4.24.-) (Haemorrhagic 56 kDa metalloproteinase) (Snake venom metalloproteinase) (SVMP) (Zinc metalloproteinase-disintegrin-like Eoc22),MMQVLLVTICLAVFPYQGSSIILESGNVNDYEIVYPQKVTALPIEAILQPEQKYEDAMQYEFEVNGEPVVLHLEKNKNLFTKDYSETHYSPDGREITTKPLIEDHCYYHGRIQNDAHSTASISACNGLKGHFKLQGETYLIEPLKIPDSEAHAVYKYENIEKEDEALKMCGVKHTNWESDEPIKEASQLFATSEQHRFRERYIEFFIVVDQRMYNKHNNDSAAIRTWIFEMLNTVNEIYLPWNIHVPLVGLEFWTQGDLINVVSSADKTLDSFGEWRRRDLLNRKAHDNAHLITAMHFDAQTLGLAYTGSMCHPKYSTGVFQDSSEINIFVAITLAHELGHNLGISHDVPSCTCQTKACIMSPYLSDQPTKLFSNCSEIQYERFLTQRNPKCMINKPLRTDIISPPVCGNGLLEREEECDCGSPENCRDPCCDAASCKLHSWVECESGECCDQCRFKRAGTLCRPARDDCDMAESCSGHSADCPIDGFHANGQPCSHNLGYCYNGKCPLTLYQCRAFLGKDVVGVQESCFQYNRLGNTYAYCRKENGRKIPCAPKDEKCGRLYCSYKSFGDYISCLPCYRANEEDKGMVDEGTKCGEGKVCSNGYCVDLNVAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that possesses high hemorrhagic activity. It inhibits collagen-induced platelet aggregation and activates prothrombin (F2). {ECO:0000269|PubMed:12893057, ECO:0000269|PubMed:15863354}.",Metalloprotease
299,Q2YHJ2,PA2B_CRABR,3.1.1.4,Basic phospholipase A2 Tbo-G6D49 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVEGSLLEFGRMIKEETGKNPLFSYISYGCYCGWGGQGQPKDATDRCCFVHDCCYGKLWSCSPKTDIYFYYRKNGAIVCARGTWCEKQICECDKAAAICFRENLGTYKDEYQSYGKSRCTEKSLKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs hemostasis. It weakly inhibits ADP-induced platelet aggregation when tested on platelet rich plasma from human and rabbit blood (15-25% of inhibition at 5-10 ug of enzyme), and dose-dependently inhibits blood coagulation, possibly by inhibiting thrombin activation. Exhibits strong hydrolytic activities toward L-dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15955061}.",Phospholipase
300,Q2YHJ3,PA2A_CRABR,3.1.1.4,Acidic phospholipase A2 Tbo-E6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWILAVLLLGVKGNLLQFEMMINKMAGRSGIRWYSDYGCYCGKGGHGQPQDATDRCCFVHDCCYGKVSGCDPKMAFYKYSSDKNDIVCGGNNPCLKEICECDRAAAICFRDNLSTYDNKYWNVPSETCQVESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs hemostasis. It weakly inhibits ADP-induced platelet aggregation when tested on platelet rich plasma from human and rabbit blood (15-25% of inhibition at 5-10 ug of enzyme), and dose-dependently inhibits blood coagulation, possibly by inhibiting thrombin activation. Exhibits high hydrolytic activities toward L-dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15955061}.",Phospholipase
301,Q2YHJ4,PA2HB_CRABR,,Basic phospholipase A2 homolog Tbo-K49 (svPLA2 homolog),MRTLWIMAVLLVGVEGSVIELGKMILQETGKNPVTYYSAYGCNCGPLGRRKPLDATDRCCFMHKCCYKKLTDSNPIKDSYSYSWENKAIVCKEKNPRLKEMCECDKAVAICFRENMGTYNKKERINTKIFCKKTSEPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks catalytic activity (PubMed:15955061). It induces local edema (PubMed:15955061). Is myotoxic (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:15955061}.",Phospholipase
302,Q2YHJ6,PA2AA_CRAPU,3.1.1.4,Acidic phospholipase A2 Tpu-E6a (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLLGVKGNLLQFELMIKKMSGRSGIRWYSDYGCYCGKGGHGQPQDATDRCCFVHDCCYGKVSGCDPKMAFYKYSSDNNDIVCGGNNPCLKEICECDRAAAICFRDNLSTYDNKYWNVPSETCQVESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs hemostasis. It weakly inhibits ADP-induced platelet aggregation when tested on platelet rich plasma from human and rabbit blood (15-25% of inhibition at 5-10 ug of enzyme), and dose-dependently inhibits blood coagulation, possibly by inhibiting thrombin activation. Exhibits high hydrolytic activities toward L-dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15955061}.",Phospholipase
303,Q2YHJ7,PA2B_CRAPU,3.1.1.4,Basic phospholipase A2 Tpu-G6D49 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVEGSLLEFGRMIKEETGKNPLFSYISYGCYCGWGGQGQPKDATDRCCFVHDCCYGKLWSCSPKTDIYFYYRKNGAIVCARGTWCEKQICECDKAAAICFRENLGTYKAEYESYGKSRCTEKSLKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs hemostasis. It weakly inhibits ADP-induced platelet aggregation when tested on platelet rich plasma from human and rabbit blood (15-25% of inhibition at 5-10 ug of enzyme), and dose-dependently inhibits blood coagulation, possibly by inhibiting thrombin activation. Also induces local edema a few hours after injection in the hind foot. Exhibits high hydrolytic activities toward L-dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15955061}.",Phospholipase
304,Q2YHJ8,PA2HB_CRAPU,,Basic phospholipase A2 homolog Tpu-K49b (svPLA2 homolog),MRTLWIMAVLLVGVEGSVIQLGKMILQETGKNPVKYYGAYGCNCGPLGRRKPLDATDRCCYMHKCCYKKLTDSNPIKDSYSYSWENKAIVCKEKNPRLKEMCECDKAVAICFRENMDTYNKKERINTKIFCKKTPEPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks catalytic activity (PubMed:15955061). Induces mild local edema (PubMed:15955061). Is myotoxic (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:15955061}.",Phospholipase
305,Q2YHJ9,PA2HA_CRAPU,,Basic phospholipase A2 homolog Tpu-K49a (svPLA2 homolog),MRTLWIMAVLLVGVEGSVIQLGKMILQETGKNPVKYYGAYGCNCGPLGRRKPLDATDRCCYMHKCCYKKLTDSNPIKDRYSYSWENKAIVCKEKNPRLKEMCECDKAVAICFRENMRTYNKKERINTKIFCKKTPEPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks catalytic activity (PubMed:15955061). Induces local edema a few hours after injection in the hind foot (PubMed:15955061). Is myotoxic (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:15955061}.",Phospholipase
306,Q330K6,TXVE2_PROMU,,Snake venom vascular endothelial growth factor toxin (svVEGF) (PM-VEGF) (TM-VEGF) (VEGF-F),MAVYLLAVAILFCIQGWPSGTVQGEVMPFMEVYDRSACQTREMLVPILKEYPNEVSHLFKPSCVPVLRCGGCCSDESLTCTATGKRSVGREVMRVDPHKGTSKIEVMQFKEHTACECRPRSPGDVNDGRNPKEGEPRARFPFV,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein activates the vascular endothelial growth factor receptor-1 (VEGFR-1/FLT1), and consequently promotes the proliferation and tissue factor production of endothelial cells, the neovascularization in the chicken chorioallantoic membrane, and increases vascular permeability. Also stimulates tissue-factor production and human monocyte chemotaxis. {ECO:0000269|PubMed:15711751}.",Vascular Interaction
307,Q3I5F4,NGFV_OXYSC,,Venom nerve growth factor (v-NGF) (vNGF),MSMLCYTLIIVFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRETHPVHNLGEYSVCDSISVWVANKTEAMDIKGKPVTVMVDVNLNNHVFKQYFFETKCRNPNPVPSGCRGIDSGHWNSYCTTTQTFVRALTMEGNQASWRFIRIDTACVCVISRKTENF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
308,Q45Z47,PA22_OXYSC,3.1.1.4,Phospholipase A2 OS2 (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MHPAHLLVLLAVCVSLLGASDIPPLPLNLAQFGFMIRCANGGSRSPLDYTDYGCYCGKGGRGTPVDDLDRCCQVHDECYGEAEKRLGCSPFVTLYSWKCYGKAPSCNTKTDCQRFVCNCDAKAAECFARSPYQKKNWNINTKARCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows high presynaptic neurotoxicity in vertebrata that is independent of catalytic activity (PubMed:2544597, PubMed:10548416, PubMed:16669624), as well as local myotoxicity when intramuscularly injected into mice (PubMed:16669624). Blocks acetylcholine release in Aplysia neurons (PubMed:8583413), and potentiates pro-inflammatory cellular signaling (PubMed:12782627). Potentiates glutamate excitoxicity when coinjected into brain of rats (PubMed:10548416). May act by binding in a calcium-dependent fashion and with high affinity to a neuronal-type (N-type) PLA2 receptor, and with very high affinity to a muscle-type (M-type) PLA2 receptor. In vitro, shows a high-specific activity on E.coli membranes and is more efficient on the anionic phospholipid POPG than on the anionic phospholipid POPS or the zwitterionic phospholipid POPC. Exerts catalytically-independent anti-HIV (IC(50) is 35 nM) activity and catalytically-dependent antimalarial activity (IC(50) is 3.1 nM when tested on P.falciparum grown in serum that contains lipoproteins). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:10548416, ECO:0000269|PubMed:12782627, ECO:0000269|PubMed:16669624, ECO:0000269|PubMed:2160984, ECO:0000269|PubMed:2544597, ECO:0000269|PubMed:8583413}.",Phospholipase
309,Q4F867,OXLA_DABSI,1.4.3.2,L-amino-acid oxidase (DRS-LAAO) (LAO) (EC 1.4.3.2),ADDKNPLEECFREDDHRIVREYIRKFGLKLNEFVQETENGWYFIKNIRKRVGEVKKDPGLLKYPVKPSEAGKSAGQLYQESLGKAVEELKRTNCSYILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDQLPTSMYRAIEESVRFKARVIKIQQNAEKVTVTYQTTQKNLLLETVDYVIVCTTSRAARRITFKPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIQGGKSTTDLPSRFIYYPNHNFTTGVGVIIAYGIGDDANFFQALNLNECADIVFNDLSSIHQLPKKDLQTFCYPSIIQKWSLDKYAMGAITTFTPYQFQHFSEALTAPVGRIFFAGEYTANAHGWIDSTIKSGLTAARDVNRASEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:19523971). Is highly active on L-Leu followed by L-Phe and L-Ile, moderately active on L-Asp, L-Glu, and L-Lys, and not active on L-Pro, L-Asn, L-Gly, L-Ser and L-Cys (PubMed:19523971). Exhibits diverse biological activities such as antibacterial activity (Minimal inhibitory concentrations (MIC) are 9.0 ug/ml against S.aureus, 144.0 ug/ml against P.aeruginosa and 288.0 ug/ml against E.coli) and inhibition of ADP- and TMVA-induced platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. Unlike other snake venom L-amino acid oxidases, does not induce hemorrhage. This protein may also induce hemolysis, edema, apoptosis and have antiparasitic activities. {ECO:0000269|PubMed:19523971}.",Kunitz Family
312,Q4VM07,VM3VB_MACLB,3.4.24.-,Zinc metalloproteinase-disintegrin-like VLAIP-B (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MMQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKITALPKGAIQQPEQKYEDAIKYEFKVNGKPVVLHLEKNKGLFSEDYSETHYTPDGREITINPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLRIPDSEAHAIYKYENIEKEDEAPKMCGVTQTNWESDEPIKASQLNLTPEQRTYLKSKKYVELVIVADYIMFWKYDRSLSTIRTRIYEIVNTLNVIYRFLNIYIALVAVEIWSKGDLINVTSSAYDTLDSFGEWRERDLLNRKRHDNAQLLTGINFNGPSAGRGFVGRMCQPKYSVGIVQDHSKIYLLVASAMAHEMGHNLGMDHDRIDCTCGAKSCIMSGILRCETSYLFSDCSREEHRKYLINKMPQCILNKPLKTDIVSPAVCGNYFVEVGEECDCGSPANCQDRCCDAATCKLRPGAQCGDGVCCYQCKFRRAGTVCRPANGECDVSDLCTGQSAECPTDQFQRNGQPCQNNKGYCYNGTCPIMEKQCISLFGASATVAQDSCFQFNRRGNHYGYCRKENNTKIACAPEDVKCGRLYCLDNSSGHKNPCQIYYIPSDENKGMVDPGTKCGDGMVCSNGKCVDVTIAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: This metalloproteinase hydrolyzes azocasein, and insulin B-chain (at the '38-Ala-|-Leu-39' bond). Also hydrolyzes the Aalpha-chain (FGA) and more slowly the Bbeta-chain of fibrinogen (FGB), without affecting the gamma-chain. Cleaves alpha-chain of fibrinogen at '432-Lys-|-Leu-433' and '535-Pro-|-Met-536' bonds. Does not cleave fibrin. Inhibits endothelial cell adhesion to extracellular matrix proteins such as fibrinogen, fibronectin, vitronectin, collagen I, and collagen IV. Induces apoptosis in vascular endothelial cells. {ECO:0000269|PubMed:15922394}.",Fibrinogenolytic Enzyme
313,Q4VM08,VM3VA_MACLB,3.4.24.-,Zinc metalloproteinase-disintegrin-like VLAIP-A (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) (Vipera lebetina apoptosis-inducing protein),MMQVLLVTISLAVFPYQGSSIILESGNVNDYEVVYPQKVTAMPKGAVKQPEQKYEDAMQYEFKVKGEPVVLLLEKNKDLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADSSASISACNGLKGHFMLQGETYLIEPLKLPDSEAHAVYKYENVEKEDEAPKMCGVTQTNWESDEPIKKASQLNLTPEQRRYLNSPKYIKLVIVADYIMFLKYGRSLITIRTRIYEIVNILNVIYRVLNIYIALLGLEIWNNGDKINVLPETKVTLDLFGKWRERDLLNRRKHDNAQLLTDINFNGPTAGLGYVGSMCDPQYSAGIVQDHNKVNFLVALAMAHEMGHNLGMEHDEIHCTCGAKSCIMSGTLSCEASIRFSNCSREEHQKYLINKMPQCILNKPLKTDIVSPAVCGNYLVELGEDCDCGSPRDCQNPCCNAATCKLTPGSQCADGECCDQCKFRRAGTVCRPANGECDVSDLCTGQSAECPTDQFQRNGQPCQNNNGYCYSGTCPIMGKQCISLFGASATVAQDACFQFNSLGNEYGYCRKENGRKIPCAPQDVKCGRLYCFDNLPEHKNPCQIYYTPSDENKGMVDPGTKCGDGKACSSNRQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that hydrolyzes the alpha-chain (FGA) and more slowly the beta-chain (FGB) of fibrinogen, without affecting the gamma-chain. Cleaves alpha-chain of fibrinogen at '432-Lys-|-Leu-433' and '535-Pro-|-Met-536' bonds. Induces apoptosis in vascular endothelial cells and inhibits endothelial cell adhesion to extracellular matrix proteins such as fibrinogen, fibronectin, vitronectin, collagen I, and collagen IV. Also hydrolyzes azocasein, and insulin B-chain (at the '38-Ala-|-Leu-39' bond). {ECO:0000269|PubMed:15922394}.",Metalloprotease
314,Q4VRI5,PA21_OXYSC,3.1.1.4,Phospholipase A2 OS1 (PLA2) (EC 3.1.1.4) (OS5) (Phosphatidylcholine 2-acylhydrolase),MHPAHLLVLLAVCVSLLGAARIPPLPLSLLNFANLIECANHGTRSALAYADYGCYCGKGGRGTPLDDLDRCCHVHDDCYGEAEKLPACNYLMSSPYFNSYSYKCNEGKVTCTDDNDECKAFICNCDRTAAICFAGATYNDENFMISKKRNDICQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has a low specific activity on phospholipid substrates, and is neither neurotoxic, nor myotoxic. Induces endothelial cell migration which is mediated, at least in part, by its hydrolytic products (PubMed:11090064). Shows antimalarial activity, but is not able to potently inhibit HIV-1 replication (PubMed:16669624). Binds in a calcium-independent fashion with very high affinity to a muscle-type (M-type) PLA2 receptor, but is a very poor ligand for neuronal-type (N-type) receptors. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:10548416, ECO:0000269|PubMed:11090064, ECO:0000269|PubMed:16669624, ECO:0000269|PubMed:2160984}.",Phospholipase
315,Q53B58,3L255_OPHHA,,Alpha-elapitoxin-Oh3a (CM-11) (Long neurotoxin OH-55),MKTLLLTLVVVTIVCLDLGYTTKCYVTPDVKSETCPAGQDICYTETWCDAWCTSRGKRVNLGCAATCPIVKPGVEIKCCSTDNCNPFPTRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscular and neuronal nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (PubMed:35341214). Pseudo-irreversibly inhibits twitches in chick biventer cervicis nerve-muscle preparations in a concentration-dependent manner (PubMed:35341214). {ECO:0000269|PubMed:35341214}.",Neurotoxin
319,Q58L95,FAXC_OXYMI,3.4.21.6,Venom prothrombin activator omicarin-C catalytic subunit (vPA) (EC 3.4.21.6) (Venom coagulation factor Xa-like protease) [Cleaved into: Omicarin-C catalytic subunit light chain; Omicarin-C catalytic subunit heavy chain],MAPQLLLCLILTFLWSLPEAESNVFLKSKVANRFLQRTKRANSLFEEFRSGNIERECIEERCSKEEAREVFEDDEKTETFWNVYVDGDQCSSNPCHYRGTCKDGIGSYTCTCLFGYEGKNCERVLYKSCRVDNGNCWHFCKPVQNDIQCSCAEGYLLGEDGHSCVAGGNFSCGRNIKTRNKREASLPDFVQSQNATLLKKSDNPSPDIRIVNGMDCKLGECPWQAVLVDEKEGVFCGGTILSPIYVLTAAHCINQTEKISVVVGEIDKSRVETGHLLSVDKIYVHKKFVPPKKGYKFYEKFDLVSYDYDIAIIQMKTPIQFSENVVPACLPTADFANQVLMKQDFGIISGFGRIFEKGPKSNTLKVLKVPYVDRHTCMVSSESPITPTMFCAGYDTLPRDACQGDSGGPHITAYRDTHFITGIVSWGEGCAKKGKYGIYTKVSKFILWIKRIMRQKLPSTESSTGRL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake prothrombin activator that attacks the hemostatic system of prey. This catalytic subunit is functionally similar to blood coagulation factor Xa. It requires a non-catalytic subunit present in the venom, which is similar to coagulation factor Va, to be fully active (By similarity). {ECO:0000250}.",General Toxin
320,Q58L96,FAXC_OXYSU,3.4.21.6,Venom prothrombin activator oscutarin-C catalytic subunit (vPA) (EC 3.4.21.6) (Factor VII activator) (Snake venom serine protease) (SVSP) (Venom coagulation factor Xa-like protease) [Cleaved into: Oscutarin-C catalytic subunit light chain; Oscutarin-C catalytic subunit heavy chain],MAPQLLLCLILTFLWSLPEAESNVFLKSKVANRFLQRTKRANSLYEEFRSGNIERECIEERCSKEEAREVFEDDEKTETFWNVYVDGDQCSSNPCHYRGTCKDGIGSYTCTCLSGYEGKNCERVLYKSCRVDNGNCWHFCKPVQNDIQCSCAEGYLLGEDGHSCVAGGNFSCGRNIKTRNKREASLPDFVQSQNAILLKKSDNPSPDIRIVNGMDCKLGECPWQAVLVDEKEDAFCGGTILSPIYVLTAAHCINQTKMISVVVGEINISRKNPGRLLSVDKIYVHQKFVPPKKGYEFYEKFDLVSYDYDIAILQMKTPIQFSENVVPACLPTADFANQVLMKQDFGIVSGFGRIFEKGPQSKTLKVLKVPYVDRHTCMLSSESPITPTMFCAGYDTLPRDACQGDSGGPHITAYRDTHFITGIVSWGEGCAQTGKYGVYTKVSKFILWIKRIMRQKLPSTESSTGRL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake prothrombin (F2) activator that attacks the hemostatic system of prey. This catalytic subunit is functionally similar to blood coagulation factor Xa. For prothrombin activation, it requires a non-catalytic subunit present in the venom, which is similar to coagulation factor Va, to be fully active. In contrast to the 8 other snake venoms tested, this protein is the only one to also activate factor VII (F7). However, in contrast to prothrombin activation, the factor Va-like subunit is not essential for this activation. {ECO:0000269|PubMed:1604437, ECO:0000269|PubMed:3531198, ECO:0000269|PubMed:6986908}.",General Toxin
323,Q5MCS0,VSPHA_HYDHA,3.4.21.-,Serine protease harobin (EC 3.4.21.-) (Fibrin(ogen)olytic enzyme) (Snake venom serine protease) (SVSP),MPLIRVLASLLILQLSYGKSLDNGAKAITSLDRIIGGFECNPSEHRSLVYLYNSAGFFCSGTLLNHEWVLTAAHCNREDIQIRLGVHNVHVHYEDEQIRVPKEKLCCLSTNNCTQFSQDIMLIRLNSPVNYSEHIAPLSLPSNPPSMGSVCCVMGWGTITSPEVTYPEVPHCVDINILHIPVCQAAYPTMSGKNILCAGILEGGKDSCKGDSGGPLICNGQIQGIVSWGRFPCAQFLEPGIYTKVFDYKDWIEGIIAGNSNVICP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Serine protein with fibrinolytic and fibrinogenolytic activities. Degrades Bbeta-chain (FGB) of fibrinogen first and then the Aalpha-chain (FGA). Gamma-chain (FGG) are also digested on prolonged incubation. In vitro, it cleaves high molecular weight (HMW) kininogen (KNG) releasing bradykinin that promotes vasodilation. In vitro and in vivo, it cleaves angiotensin-2 (AGT). This explains the reduction of blood pressure in hypertensive rats. Has also antithrombotic effects on thrombosis animal models. {ECO:0000269|PubMed:17544404}.",Serine Protease
324,Q5W959,VSP14_BOTJA,3.4.21.-,Snake venom serine protease HS114 (SVSP) (EC 3.4.21.-) (BjSP) (Thrombin-like enzyme HS114) (SVTLE),MVLVRVVANLLILQLSYAQKVSELVVGGDECNINEHRSLVAIFNSTGFFCSGILLNQEWVLTASHCDSTNFQMKIGVHSKKTLNQDEQTRNPKEKIFCPNKKNDDALDKDLMLVRLDSPVSDSEHIAPLSLPSSPPSVGSVCRIMGWGSITPIQKTNPDVPHCANINLLDDAVCRAAYPELPAEYRTLCAGVPEGGIDTCNGDSGGPLICNGQFQGIVFYGAHPCGQAPKPGLYTKVIDYNTWIESVIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that shows non-specific action on fibrinogen (PubMed:30145175). It preferentially degrades fibrinogen Aalpha (FGA), releasing fibrinopeptide A, and shows a lower activity on fibrinogen Bbeta (FGB), releasing fibrinopeptide B and other uncommon fibrinopeptides (PubMed:30145175). Also shows low fibrinolytic activity compared to plasmin (PubMed:30145175). Has high enzymatic activity on the substrates for activated protein C and factor XIa, and for thrombin (PubMed:30145175). Shows a wide activity spectrum at different peptide sequences, with a preferential cleavage at Lys-|-Xaa over Arg-|-Xaa bonds (PubMed:30145175). {ECO:0000269|PubMed:30145175}.",Serine Protease
325,Q5XUW8,VM2IA_BOTIN,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase insularinase-A (SVMP) (EC 3.4.24.-); Disintegrin insularin],MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYARKVTELPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGRQIITYPPFEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLPDSEAHAVYKYENVEKEDEAPKMCGVTETNWESYEPIEKASQSNLTPEQQKFSPRYIELAVVADHGMFTKYNSNLNTIRTRVHEMVNTLNGFFRSVNVDASLANLEVWSKKDLIKVEKDSSKTLTSFGEWRERDLLPRISHDHAQLLTTIVFDQQTIGLAYTAGMCDPRQSVAVVMDHSKKNLRVAVTMAHELGHNLGMDHDDTCTCGAKSCIMASTISKGLSFEFSKCSQNQYQTYLTDHNPQCILNKPLTTVSGNELLEAGEECDCGAPENPCCDAATCKLRPRAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase insularinase-A]: Non-hemorrhagic proteinase that activates prothrombin (F2) calcium-independently. Activates factor X (F10) and hydrolyzes the Aalpha-chain and more slowly the Bbeta-chain of fibrin and fibrinogen without affecting the gamma chain. It induces neither detachment nor apoptosis of human endothelial cells and is also not able to trigger an endothelial pro-inflammatory cell response. Nitric oxide and prostacyclin levels released by endothelial cells are significantly increased after treatment with insularinase A. {ECO:0000269|PubMed:16006246}.; FUNCTION: [Disintegrin insularin]: Inhibits ADP-induced platelet aggregation (IC(50)=0.8 uM for native protein) (PubMed:21073888). Interestingly, inhibits the adhesion of HUVECs to immobilized fibrinogen at very low concentrations (IC(50)=36 nM) (PubMed:21073888). {ECO:0000269|PubMed:21073888}.",Fibrinogenolytic Enzyme
326,Q5YF90,NGFV1_NAJSP,,Venom nerve growth factor 1 (v-NGF-1) (vNGF-1) (Nerve growth factor I),MSMLCYTLIIAFLIGIWAVPKSEDNAPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPRSQRIKQFGSASNIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDALNRNIRAKRETHPVHNRGEYSVCDSISVWVANKTTATDIKGKPVTVMVDVNLNNHVYKQYFFETKCRNPNPVPSGCRGIDSRHWNSYCTTTHTFVKALTMEGNRASWRFIRIDTACVCVISRKTENF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
327,Q698K8,VM2L4_GLOBR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase brevilysin L4 (SVMP) (Snake venom metalloproteinase hxl-1) (EC 3.4.24.-); Disintegrin brevicaudin-1a; Disintegrin brevicaudin-1b (Disintegrin adinbitor) (Disintegrin halystatin)],EDEAPKMCGVTQNWESYEPIKKASQSNLTPAHQRYIELVIVADHGMFTKYNGDSDKIREWVRQMVNTVDEIYSYMYIDVALAGLEIWSNEDLINVQPAAPHTLDSFGKWRERDLLHRIHHDNAMLLTAIDFDGPTIGLAYVGTMCKPKGSTGVVQDHSTINLRVAVTMAHEIGHNLGIHHDTGSCSCGGYSCIMSPVISHEPSKYFSDCSYTQCWDFIMNQKPQCILNKPLRTDTVSTPVSGNELLEAGEECDCGSPGNPCCDAATCKLRQGAQCAEGLCCDQCRFMKKGTVCRIARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase brevilysin L4]: metalloproteinase that impairs hemostasis in the envenomed animal (By similarity). Shows autoproteolysis dependent on pH and temperature. Does not show hemorrhagic activity. {ECO:0000250, ECO:0000269|PubMed:15188058, ECO:0000269|Ref.3}.; FUNCTION: [Disintegrin brevicaudin-1a]: Inhibits platelet aggregation induced by ADP (IC(50) is 200 nM), collagen (IC(50) is 500 nM), thrombin and epinephrin (IC(50) is 300 nM). Does not inhibit aggregation induced by ristocetin.; FUNCTION: [Disintegrin brevicaudin-1b]: Inhibits platelet aggregation induced by ADP (IC(50) is 100 nM), collagen (IC(50) is 500 nM), thrombin and epinephrin (IC(50) is 300 nM). Does not inhibit aggregation induced by ristocetin. Significantly inhibits angiogenesis both in vivo and in vitro.",General Toxin
328,Q6EER2,PA2BB_SISTE,3.1.1.4,Basic phospholipase A2 sistruxin B (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRALWIVAVLLVGVEGNLLQFNKMIKFETNKNAIPFYAFYGCYCGWGGRGRPKDATDRCCFVHDCCYGKLPNCDTKWDIYSYSLKSGFITCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYLDSRCKGPSEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
329,Q6EER4,PA2B_BOTSC,3.1.1.4,Basic phospholipase A2 Bs-N6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVLLVGVEGNLLQFNKMIKIMTRKNGIPYYSSYGCYCGWGGQGQPLDATDRCCFVHDCCYEKLTDCSPKTDIYSYSWKSGVIICGEGTPCEKQICECDRVAAVCFGANLGTYKKSYMFYPDFLCTEPSEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows myotoxic activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
330,Q6H3C8,PA2AF_TRIST,3.1.1.4,Acidic phospholipase A2 Ts-A6 (svPLA2) (EC 3.1.1.4) (CTs-A6) (Phosphatidylcholine 2-acylhydrolase),MRALWIMAVLLLGVEGHLMQFENMIKKVTGRSGIWWYGSYGCYCGKGGQGLPQDASDRCCFVHDCCYGKVNGCDPKDDFYVYSSENRDIVCGEDNPCTKEICECDKAAAICFRDNMDTYQNKYWFYPSSNCNEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows a moderate inhibition of ADP-induced human platelet aggregation when tested on platelet rich plasma. Exhibits high hydrolytic activities and prefers the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12959640}.,Phospholipase
331,Q6H3D0,PA2AA_TRIST,3.1.1.4,Acidic phospholipase A2 Ts-A1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLQVGVEGHLMQFETLIMKVAGRSGVWYYGSYGCFCGAGGQGRPQDASDRCCFVHDCCYGKVNGCDPKKDFYTYSEENGAIVCGGDDPCKKEICECDKDAAICFRDNKDTYDNKYWFFPAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows a moderate inhibition of ADP-induced human platelet aggregation when tested on platelet rich plasma. Exhibits high hydrolytic activities and prefers the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12959640}.,Phospholipase
332,Q6JK69,PA2H1_BOTAT,,Phospholipase A2 homolog 1 (svPLA2 homolog) (Myotoxin I),MRTLWIMAVLLVGVEGSLVELGKMILQETGKNPLTSYGAYGCNCGVGGRGKPKDATDRCCYVHKCCYKKMTDCDPKKDRYSYSWKDKTIVCGEKNSCLKELCECDKAVAICLRENLDTYNKKYKNNYLKPFCKKADAC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic and anticoagulant activities (PubMed:15225567). In mice, it induces conspicuous local myonecrosis, edema, and a systemic interleukin-6 response (PubMed:15225567). In vitro, it is cytolytic upon myoblasts, and weakly bactericidal (PubMed:15225567). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:15225567}.",Phospholipase
333,Q6LEM5,BNP1_BOTJA,,Bradykinin-potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide 6a (BPP-6a); Bradykinin-potentiating peptide 10a (BPP-10a) (Bradykinin-potentiating peptide IV-1-A) (BPPIV-1-A) (Bradykinin-potentiating peptide V-8); Bradykinin-potentiating peptide 13a+QQWA (BPP-13a+QQWA); Bradykinin-potentiating peptide 13a+QWA (BPP-13a+QWA); Bradykinin-potentiating peptide 13a (BPP-13a) (Bradykinin-potentiating peptide III-1-A) (III-1-A) (Bradykinin-potentiating peptide V-9); Bradykinin-potentiating peptide 10c+QQWA (BPP-10c+QQWA); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide IV-1-Bbeta) (BPP IV-1-Bbeta) (Bradykinin-potentiating peptide V-7); Bradykinin-potentiating peptide 10c-F (BPP-10c-F); Bradykinin-potentiating peptide 11b (BPP-11b) (Bradykinin-potentiating peptide IIa) (BPP-IIa); Bradykinin-potentiating peptide IIb (BPP-IIb); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide Va) (BPPVa) (Proline-rich peptide 5a) (Bj-PRO-5a) (PRO-5a); Poly-His-poly-Gly peptide 1 (pHpG-1); C-type natriuretic peptide (Bj-CNP)],MVLSRLAASGLLLLALLALSVDGKPVQQWAQSWPGPNIPPLKVQQWAQGGWPRPGPEIPPLTVQQWAQNWPHPQIPPLTVQQWAQGRAPGPPIPPLTVQQWAQGRAPHPPIPPAPLQKWAPLQKWAPLLQPHESPASGTTALREELSLGPEAASGVPSAGAEVGRSGSKAPAAPHRLSKSKGAAATRPMRDLRPDGKQARQNWGRMAHHDHHAAAGGGGGGGGGARRLKGLAKKGAAKGCFGLKLDRIGTMSGLGC,Bradykinin-potentiating peptide family; PHpG family; Natriuretic peptide family,"FUNCTION: [Bradykinin-potentiating peptide 5a]: Modestly inhibits ACE (with highest affinity for the N-site) and reveals strong bradykinin-potentiating activity. Induces nitric oxide (NO) production depended on muscarinic acetylcholine receptor M1 subtype (CHRM1) and bradykinin B2 receptor (BDKRB2) activation. Both these receptors contribute to the vasodilation induced by this peptide that may have an indirect action on BDKRB2 and a direct agonistic action on CHRM1.; FUNCTION: [Bradykinin-potentiating peptide 10c]: Peptide with several activities. It inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain (PubMed:11994001). It evokes transient hypotension (-14 mmHg) similar to that evoked by 0.5 ug of bradykinin, when injected alone into rats. It has a high bradykinin-potentiating effect (120%), when 60 nmol of BPP-10c are coinjected with 0.5 ug of bradykinin into rats (PubMed:22869554). Does not affect angiotensin-1 pressor effects. Shows potent and long-lasting antihypertensive activity as well as a reduction of the heart rate (PubMed:17475904). It also binds and dose-dependently promotes the activation of cytosolic argininosuccinate synthase (ASS1), an enzyme that catalyzes the conversion of citrulline, L-aspartate and ATP to argininosuccinate, AMP and pyrophosphate. It also enhances ASS1-dependent arginine production in HEK 293 cells, as well as in spontaneous hypertensive rat (SHR) and Wistar rat plasma. In addition, it induces the production of nitric-oxide (NO) by HUVEC cells via the endothelial nitric-oxide synthase (NOS3), which use arginine as a substrate and produce NO. It has been shown to be internalized by ASS1-expressing endothelial (HUVEC) and kidney (HEK 293) cells, and is detected homogenously distributed within the cell cytoplasm for up to 2 hours (PubMed:19491403). {ECO:0000269|PubMed:11994001, ECO:0000269|PubMed:17475904, ECO:0000269|PubMed:19491403, ECO:0000269|PubMed:22869554}.; FUNCTION: [Bradykinin-potentiating peptide 10c-F]: Has much lower activity than the full-length bradykinin-potentiating peptides. {ECO:0000269|PubMed:17315274}.; FUNCTION: [Poly-His-poly-Gly peptide 1]: May serve as a metalloproteinase inhibitor during glandular storage. Their inhibition may be instantly disengaged, by dilution or physiochemical change, when venom is injected into tissue of the victim. {ECO:0000250|UniProtKB:A8YPR6}.; FUNCTION: [C-type natriuretic peptide]: has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.",Kunitz Family
334,Q6RY98,SRTXL_ATRMM,,Long-sarafotoxin (L-SRTX) [Cleaved into: Sarafotoxin-m (SRTX-m); Sarafotoxin-m1 (SRTX-m1); Sarafotoxin-m2 (SRTX-m2); Sarafotoxin-m3 (SRTX-m3); Sarafotoxin-m4 (SRTX-m4); Sarafotoxin-m5 (SRTX-m5)],IWDEPVVVSARDTEEAARVPSPQKRSQPLCSCNDINDKECMYFCHQDVIWDEPVVVSVRDTEEAARVPSPQKRPQPRCSCNDMNDKECMYFCHQDVIWDEPVVVSVRDTEEAARVPSPQKRSQPRCSCNDMNDKECVYFCHLDIIWDEPVVVSVRDTEEATRVPSPQKRSQPLCSCNDINDKECMYFCHQDIIWDEPVVVSVRDTEEAARVPSPQKRSQPLCSCNDINDKECMYFCHQDIIWDEPVVVSVRDTEEAARVPSPQKRSQPLCSCNDINDKECMYFCHQDVIWDEPVVVSVQDTEEAARVPSPQKRSQPLCSCNNMSDKECLNFCNLDIIWENVDTSADPEFLG,Endothelin/sarafotoxin family,"FUNCTION: Vasoconstrictor activity. These toxins cause cardiac arrest probably as a result of coronary vasospasm. The major effects of sarafotoxin-m are a progressive decrease in heart rate (bradycardia) that turns into an arrhythmic phase that is followed by an A-V block. {ECO:0000269|PubMed:15350691}.; FUNCTION: [Sarafotoxin-m]: Vasoconstrictor activity. Causes cardiac arrest probably as a result of coronary vasospasm (By similarity). Displays low agonistic activities towards endothelin-2 receptor (EDNRB) (displays affinity in the micromolar range) (PubMed:21889567). {ECO:0000250, ECO:0000269|PubMed:15350691, ECO:0000269|PubMed:21889567}.",General Toxin
335,Q6SLM1,PA2B5_BUNCE,3.1.1.4,Basic phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),LVAVCVSLLGAANIPPQPLNLKQFKNMIQCAGTRTWTSYIGYGCYCGYGGSGTPVDELDRCCYTHDHCYNKAANIPGCNPLIKTYSYTCTKPNITCNDTSDSCARFICDCDRTAAICFASAPYNINNIMISASTSCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows anticoagulant and neurotoxic activities. {ECO:0000250}.; FUNCTION: PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
336,Q6SLM2,PA2A1_BUNCE,3.1.1.4,Acidic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),LVAVCVSLLGAANIPPQPLNLYQLMNMIQCANTRTWPSYTNYGCYCGKGGSGTPVDDLDRCCYTHDHCYNDAKNIDGCNPVTKTYSYTCTEPTITCNDSKDKCARFVCDCDRTAAICFAKAPYNTSNVMIRSTNSCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows anticoagulant and neurotoxic activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
338,Q6T179,PA2A4_NAJSG,3.1.1.4,Acidic phospholipase A2 4 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SNRPMPLNIYQFKNMIQCTVPSRSWWDFADYGCYCGRGGSGTPVDDLDRCCQVHDNCYNQAQEITGCRPKWKTYTYECSQGTLTCKGRNNACAATVCDCDRLAAICFAGAPYNDNNYNIDLKARCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits strong anticoagulant activity, which is not due to the catalytic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
339,Q6T271,VM2BI_BITGA,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase-4 (SVMP) (EC 3.4.24.-); Disintegrin bitisgabonin (Bitisgabonin-1) (Bitisgabonin-2)],KYENVEKGDEAPKKCGVTHTNLESDEPIEKASQLFGTSEQQRFDPRHIELVIVADHGMVMKHNGDLTAVRTWLHQIGNNLNVMFADLNIRITMAGLEMWSEKDLIDIQSAASETLRLFGEWRERYLLNRRMHDNAQLLTTVNLDGDTVGLAYVGGMCDPKNSVGIVQDHSRIAREVAATMAHELGHNLGMAHDGNQCNCGANGCVMSEEIIERTSYQFSDCSKEEYRTFLDNHNPQRILNEPLRTDTVSTPVYGNVLQNSPHPCCDPVTCKPKAWEHCISGPCCRDCKFLRPGTVCRVARGDWNDDFCTGRSSECESNPWNFWNH,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily","FUNCTION: [Snake venom metalloproteinase-4]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin bitisgabonin]: In dimer with gabonin-1 (bitisgabonin-1), is a potent inhibitor of the adhesion of the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. {ECO:0000269|PubMed:17203976}.; FUNCTION: [Disintegrin bitisgabonin]: In dimer with gabonin-2 (bitisgabonin-2), preferentially inhibits the adhesion of the alpha-4/beta-1 (ITGA4/ITGB1) and alpha-9/beta-1 (ITGA9/ITGB1) integrins to VCAM-1 and acts also as a strong antagonist of alpha-5/beta-1 (ITGA5/ITGB1). {ECO:0000269|PubMed:17203976}.",Kunitz Family
340,Q6TGQ8,OXLA_BOTMO,1.4.3.2,L-amino-acid oxidase BmooLAAO-I (LAO) (EC 1.4.3.2),MNVFFTFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIAKNGLSTTSNPKRVVIVGAGMSGLSAAYVLANAGHQVTVLEASERAGGRVKTYRNEKEGWYANLGPMRLPEKHRIVREYIRKFDLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVHLNARVIKIQQDVKEVTVTYQTSEKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPNGVGVIIAYGIGDDANYFQALDFEDCGDIVINDLSLIHQLPKEEIQAICRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNSAS,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the toxicity of the venom (PubMed:17320169). Shows very high activity on L-Met, and L-Leu, high activity on L-Ile, L-Phe and L-Tyr and moderate activity on L-His, L-Val and L-Ala (PubMed:17320169, PubMed:30534149). Exhibits diverse biological activities, such as edema, apoptosis of tumor cell lines, antibacterial activities against both Gram-positive and Gram-negative bacteria, as well as induction of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. Unlike other snake venom L-amino acid oxidases, does not induce hemorrhage. It may also induce hemolysis. Has parasiticidal activities against and leishmania, as a result of enzyme-catalyzed hydrogen peroxide production (PubMed:11162565, PubMed:17292326). {ECO:0000269|PubMed:11162565, ECO:0000269|PubMed:17292326, ECO:0000269|PubMed:17320169, ECO:0000269|PubMed:30534149}.",General Toxin
341,Q6TGQ9,OXLA1_BOTJR,1.4.3.2,L-amino-acid oxidase BjussuLAAO-I (BjsuLAAO) (LAO) (EC 1.4.3.2),MNVFFMFSKPGKLADDRNPLEECFRETDYEEFLEIAKNGLSTTSNPKRVVIVGAGMSGLSAAYVLANAGHQVTVLEASERAGGQVKTYRNEKEGWYANLGPMRLPEKHRIVREYIRKFGLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLDYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVHLNARVIKIQQDVKEVTVTYQTSEKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPNGVGVIIAYGIGDDANYFEALDFEDCGDIVINDLSLIHQLPKEEIQAICRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIASTIKSGPEGLDVNRASE,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:22490662). Shows high specificity for L-Met, L-Leu, L-Phe, L-Tyr, L-Ile, L-Trp, a moderate activity on L-Cys and low activity on L-Val, L-Lys, L-Arg, L-His, L-Gln, L-Thr and L-Ser (PubMed:22490662). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, and antibacterial, as well as regulation of platelet aggregation (By similarity). Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation (By similarity). These different effects are probably due to different experimental conditions (By similarity). In vitro, shows parasiticidal activities against both trypanosomes and leishmania, as a result of enzyme-catalyzed hydrogen peroxide production (PubMed:17292326). {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:17292326, ECO:0000269|PubMed:22490662}.",Vascular Interaction
342,Q71QE8,PA2BN_CROVV,3.1.1.4,Basic phospholipase A2 Cvv-N6 (svPLA2) (EC 3.1.1.4) (Cvv myotoxin) (Phosphatidylcholine 2-acylhydrolase),MRTFWIVALLLVGVEGNLLQFNKMIKMMTKKNAFPFYTSYGCYCGWGGRGRPKDATDRCCFVHDCCYEKLTNCSPKTDIYSYSWKRGVIICGKGTPCEKQICECDRAAAVCFRENLPTYKKRYMFYLDFLCTDPSEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that is myotoxic and displays moderate edema-inducing activity in rat paws (PubMed:12623078, PubMed:9028014). Does not show neurotoxic activity (PubMed:15032748, PubMed:9028014). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12623078, ECO:0000269|PubMed:15032748, ECO:0000269|PubMed:9028014}.",Phospholipase
345,Q7SID6,PA2A_DEIAC,3.1.1.4,Acidic phospholipase A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLIQFETLIMKVVKKSGMFWYSAYGCYCGWGGHGRPQDATDRCCFVHDCCYGKVTGCDPKMDSYTYSEENGDIVCGGDDPCKREICECDRVAAVCFRDNLDTYNSDTYWRYPTKNCQEEPDPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8931260}.,Phospholipase
346,Q7SYF1,VSPP_CERCE,3.4.21.-,Thrombin-like enzyme cerastocytin (SVTLE) (EC 3.4.21.-) (C.cerastes platelet proaggregant protein) (CC-PPP) (Factor VIII activator) (Fibrinogen-clotting enzyme) (Proaggregant serine proteinase) (Snake venom serine protease) (SVSP),MVLISVLASLLVLQLSYAQKSSELVIGGAECNINEHRSLVLLYNSSRLFGGGTLINKEWVLSAAHCDGENMKIYLGLHHFRLPNKDRQIRVAKEKYFCRDRKSIVDKDIMLIKLNKPVNNSTHIAPLSLPSSPPSVGSDCRIMGWGTITSPNDTYPKVPHCANINILEHSLCERAYNDLSASSRTLCAGIEKGGIDTCKGDSGGPLICNGQIQGIVSWGDEVCGKPNKPGVYTKVFDYTDWIRNIIAGNTAATCPQ,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease which potently induces platelet aggregation and has fibrinogenolytic activities. Clots purified fibrinogen and hydrolyzes alpha-chains (FGA). High concentrations of this enzyme also cleave prothrombin (F2) and factor X (F10). Is also able to activate factor XIII (F8). {ECO:0000269|PubMed:12962484, ECO:0000269|PubMed:7766651, ECO:0000269|PubMed:9080583}.",Serine Protease
347,Q7SZE1,VSPSX_GLOIT,3.4.21.-,Thrombin-like enzyme saxthrombin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Thrombin-like enzyme defibrase),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHCDNTNFQMKLGVHSKKVLNEDEQTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHIVPLSLPSSPPSVGSVCHIMGWGSITPIKVTYPDVPYCAYINLLDDAVCQAGYPELLTEYRTLCAGILEGGKDTCGGDSGGPLICNGQFQGIVSFGAHPCGQGLKPGVYTKVFDYNHWIQSIIAGNTTVTCPQ,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease that shows strong blood coagulation activity in vitro. {ECO:0000269|PubMed:17671373}.,Serine Protease
350,Q7T1M3,BNP_BOTJR,,Bradykinin-potentiating and C-type natriuretic peptides isoform 2 (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide 10a (BPP-10a); Bradykinin-potentiating peptide 6a (BPP-6a); Bradykinin-potentiating peptide 13a (BPP-13a) (Bradykinin-potentiating peptide XIIIa) (BPP-XIIIa); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide Xc) (BPP-Xc); Bradykinin-potentiating peptide 10c-F (BPP-10c-F); Bradykinin-potentiating peptide 11b (BPP-11b); Bradykinin-potentiating peptide AP (BPP-AP); Bradykinin-potentiating peptide 11e (BPP-11e) (Bradykinin-potentiating peptide XIe) (BPP-XIe); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide Va) (BPPVa)],MVLSRLAASGLLLLALLALSVDGKPVQQWAQSWPGPNIPQLLVQQWAQGGWPRPGPEIPPLTVQQWAQNWPHPQIPPLTVQQWAQGRPPGPPIPPLTVQQWAQARPPHPPIPPAPLQKWAPVQKWAPVQKWAPVQKWAPLLQPT,Bradykinin-potentiating peptide family,"FUNCTION: [Bradykinin-potentiating peptide 10c]: Peptide with several activities. It inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain (PubMed:11994001). It evokes transient hypotension (-14 mmHg) similar to that evoked by 0.5 ug of bradykinin, when injected alone into rats. It has a high bradykinin-potentiating effect (120%), when 60 nmol of BPP-10c are coinjected with 0.5 ug of bradykinin into rats (PubMed:22869554). Does not affect angiotensin-1 pressor effects. Shows potent and long-lasting antihypertensive activity as well as a reduction of the heart rate (PubMed:17475904). It also binds and dose-dependently promotes the activation of cytosolic argininosuccinate synthase (ASS1), an enzyme that catalyzes the conversion of citrulline, L-aspartate and ATP to argininosuccinate, AMP and pyrophosphate. It also enhances ASS1-dependent arginine production in HEK 293 cells, as well as in spontaneous hypertensive rat (SHR) and Wistar rat plasma. In addition, it induces the production of nitric-oxide (NO) by HUVEC cells via the endothelial nitric-oxide synthase (NOS3), which use arginine as a substrate and produce NO. It has been shown to be internalized by ASS1-expressing endothelial (HUVEC) and kidney (HEK 293) cells, and is detected homogenously distributed within the cell cytoplasm for up to 2 hours (PubMed:19491403). {ECO:0000269|PubMed:11994001, ECO:0000269|PubMed:17475904, ECO:0000269|PubMed:19491403, ECO:0000269|PubMed:22869554}.; FUNCTION: [Bradykinin-potentiating peptide 11e]: Acts as indirect hypotensive agent. Increases leukocyte rolling flux and adhesion by five-fold in post-capillary venules, without any increments in vasodilation of arterioles.; FUNCTION: [Bradykinin-potentiating peptide AP]: Acts as indirect hypotensive agent. Potently induces vasodilation of arterioles, with only a small increase in leukocyte rolling flux.",Vascular Interaction
351,Q7T1R0,PA2B1_BUNFL,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A1 chain (Beta-BuTX A1 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MNPAHLLVLPAVCVSFLGASIIPPQSLNLIQFKDMIRCTIPCERTWGEYADYGCYCGKGGSGRPVDALDRCCYVHDNCYGEAQKRNCNPYMKSYSFKCAKRTLFCYDAPGSCARFVCDCDRTAALCFGDSEYIGRHKNIDTKRHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:11738240}.,Phospholipase
352,Q7T1T4,VM1B2_BOTJR,3.4.24.-,Snake venom metalloproteinase BjussuMP-2 (SVMP) (EC 3.4.24.-) (BOJUMET I) (BjussuMP-II) (Nonhemorrhagic metalloprotease MP-II),TELPKGAVQPKYEDAMQYEFKGNGEPVVLHLEKNKGLFSEDYSETHYSPDGRQIITYPPFEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTETNWESYEPIKKASPSNLTPEQQKFSPRYIEVAVVADHRMFKKYNSNLNTIRKWVHEMVNSMNGVYRSMDVHLSLANLEVWSKKDLINVQKDSRETLKSFGEWRERDLLPRISHDNAQLLTAVVFDQQTIGRAYIAGMCDPRHSVGVVMDHSKENLQVAVTMAHELGHNLGMEHDENQCHCDAPSCVMASVLSVVLSYEFSDCSQNQYQTYLTKHNPQCILNEPLLTVSGNELLEAGE,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: This metalloproteinase displays proteolytic activity on fibrin, fibrinogen, collagen, casein and gelatin. It inhibits ADP- and collagen-induced platelet aggregation and displays a very low edema inducing activity. {ECO:0000269|PubMed:18006118}.",Fibrinogenolytic Enzyme
353,Q7T2Q0,SLB_ECHML,,Snaclec EMS16 subunit beta (EMS16B),MGRLISVRFSLLVVFLSLSGIGAGLCCPLGWSSFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHGSEEEAFVSKLASKALKFTSMWIGLNNPWKDCKWEWSDNARFDYKAWKRRPYCTVMVVKPDRIFWFTRGCEKSVSFVCKFLTDPAV,Snaclec family,"FUNCTION: EMS16 is a potent and selective inhibitor of alpha-2/beta-1 (ITGA2/ITGB1) integrin and acts as a potent antagonist of platelet aggregation and cell migration. Binds specifically to the I domain of the alpha-2 subunit, in a metal ion-independent fashion. {ECO:0000269|PubMed:10933804}.",Kunitz Family
354,Q7T2R1,PA2AA_DABSI,3.1.1.4,Acidic phospholipase A2 daboiatoxin A chain (DbTx-A) (svPLA2) (EC 3.1.1.4) (Phospholipase A2 Dsm-a1) (Phospholipase A2 inhibitor) (Phospholipase A2-III),MRTLWIMAVCLIGVEGNFFQFAEMIVKMTGKEAVHSYAIYGCYCGWGGQGKPQDATDRCCFVHDCCYGTVNDCNPKMATYSYSFENGDIVCGDNNLCLKTVCECDRAAAICLGQNVNTYDKNYENYAISHCTEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer (A and B chains): phospholipase A2 that acts as a presynaptic neurotoxin and shows a PLA2 activity of 1377 umol/min/mg. In vivo, induces edema and produces neurotoxic symptoms in mice. Also exhibits indirect hemolysis, a strong myonecrotic activity and cytotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.; FUNCTION: Monomer: Snake venom phospholipase A2 (PLA2) that shows a PLA2 activity of 578 umol/min/mg.",Phospholipase
355,Q7T3S7,PA2A1_ECHCA,3.1.1.4,Acidic phospholipase A2 EC-I (EC-I-PLA2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MKTLWIVAVWLIAVEGNLYQFGRMIWNRTGKLPILSYGSYGCYCGWGGQGPPKDATDRCCLVHDCCYTRVGDCSPKMTLYSYRFENGDIICDNKDPCKRAVCECDREAAICLGENVNTYDKKYKSYEDCTEEVQEC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits human platelet aggregation induced by ADP, collagen and epinephrin (possibly by binding the platelet receptor alpha-IIb/beta-III) and induces mild edema in the foot pads of mice. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:10519645}.",Phospholipase
356,Q7T3T5,PA2AB_DABSI,3.1.1.4,Acidic phospholipase A2 daboiatoxin B chain (DbTx-B) (svPLA2) (EC 3.1.1.4) (Acidic phospholipase A2-II) (Phosphatidylcholine 2-acylhydrolase),MCLIGVEGNLFQFARLIDAKQEAFSFFKYISYGCYCGWGGQGTPKDATDRCCFVHDCCYARVKGCNPKLVEYSYSYRTGKIVCGGDDPCLRAVCECDRVAAICFRENMNTYDKKYMLYSIFDCKEESDQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Monomer: Snake venom phospholipase A2 (PLA2) that shows a high PLA2 activity (2110 umol/min/mg).; FUNCTION: Heterodimer (A and B chains): snake venom phospholipase A2 that shows a moderate PLA2 activity (1377 umol/min/mg). Acts as a presynaptic neurotoxin. In vivo, induces edema and produces neurotoxic symptoms in mice. It exhibits indirect hemolysis and a strong myonecrotic activity and is cytotoxic. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
357,Q7ZTA6,PA2AB_CROVV,3.1.1.4,Acidic phospholipase A2 Cvv-E6b (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWILAVLLLGVEGNLVQFELLIMKVAKRSGLLSYSAYGCYCGWGGYGRPQDATDRCCFVHDCCYGKVTDCNPKTASYTYSEENGEIVCGGDDPCKKQVCECDRVAAICFRDNIPSYDNKYIQFPAKNCQEKPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows very low inhibition of ADP-induced platelet aggregation in platelet-rich plasma of human, rabbit and guinea pig. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12623078}.",Phospholipase
358,Q7ZTA7,PA2AD_CROOA,3.1.1.4,Acidic phospholipase A2 CoaPLA2 (svPLA2) (EC 3.1.1.4) (Cvv-E6d) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 CoaTx-I),MRTLWIVAVLLLGVEGSLVQFEMLIMKVAKRSGLFSYSAYGCYCGWGGHGRPQDATDHCCFVHDCCYGKVTDCNPKTASYTYSEENGEIVCGGDDPCKKQVCECDRVAAICFRDNIPTYDNKYWRFPPENCQEEPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows very low inhibition of ADP-induced platelet aggregation in platelet-rich plasma of human, rabbit and guinea pig (PubMed:12623078). Shows edema-inducing activity and myotoxicity (PubMed:24707493). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12623078, ECO:0000269|PubMed:24707493}.",Phospholipase
359,Q7ZTA8,PA2AE_CROVV,3.1.1.4,Acidic phospholipase A2 Cvv-E6e (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWILAVLLLGVEGNLVQFELLIMKVAKRSGLLSYSAYGCYCGWGGHGRPQDATDRCCFVHDCCYGKVTDCNPKTASYTYSEENGEIVCGGDDPCKKQVCECDRVAAICFRDNIPSYDNKYIQFPAKNCQEKPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that significantly inhibits ADP-induced platelet aggregation in platelet-rich plasma of human, rabbit and guinea pig. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12623078}.",Phospholipase
360,Q7ZZS9,VM2J_PROJR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase TJM-1 (SVMP) (EC 3.4.24.-); Disintegrin jerdonin],MIQVLLVTICLAVFPYQGSSIILESGNVDDYEVVYPQKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYHHGRVHNDADSTASISACDGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRHIELAIVVDHGMYTKYSSNFKKIRKRVHQMVSNINEMCRPLNIAITLSLLDVWSEKDLITVQADAPTTAGLFGDWRERVLLKKKNHDHAQLLTDINFTGDTIGWAYVGGMCNAKYSVGTVKDHSSNVFVVAVTMTHEIGHNLGMEHDDKDKCKCEACIMAPVISDKQSKLFSDCSKDYYQTFLTNKKPQCILNAPLRTDTVSTPISGNEFLEAGEECDCGSPSNPCCDVGTCKLSPGAQCADGLCCDQCRFKKKGKICRRARGDNPDDRCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily",FUNCTION: [Snake venom metalloproteinase TJM-1]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin jerdonin]: Inhibits platelet aggregation induced by ADP and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3). Has antitumor-growth activity. {ECO:0000269|PubMed:15037031}.,Fibrinogenolytic Enzyme
361,Q800C4,PA2AA_CROVV,3.1.1.4,Acidic phospholipase A2 Cvv-E6a (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVLLLGVEGSLVQFETLIMKIAGRSGLLWYSAYGCYCGWGGHGLPQDATDRCCFVHDCCYGKATDCNPKTVSYTYSEENGEIVCGGDNPCGTQICECDKAAAICFRDNIPSYSNKYWLFLPKNCRGDPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that significantly inhibits ADP-induced platelet aggregation in platelet-rich plasma of human, rabbit and guinea pig. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12623078}.",Phospholipase
362,Q805A2,PA2BN_PROFL,3.1.1.4,Basic phospholipase A2 PLA-N (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 PLA-N(O)),MRTLWIMAVLLVGVEGNLLQFNKMIKIMTKKNGFPFYTSYGCYCGWGGRGKPKDATDRCCFVHDCCYEKLTDCSPKSDIYSYSWKTGVIICGEGTECEKQICECDRAAAVCFGQNLRTYKKKYMFYPDFLCTDPTEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities, as well as presynaptic neurotoxicity and myotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:14738313}.",Phospholipase
363,Q805F4,VM2PB_AGKPI,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin piscivostatin-beta (PVS-beta)],MIQVLLVTLCLAAFPYQGNSIILESGNVNDYEVLYPQKVTALPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSSDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTQTNWKSDKPIKKASQLNLTPEQQRFPQRYIELVVVADHRMFTKYNGNLNTIRIWVHELVNTMNVFYRPLNIHVSLTDLEVWSDQDLINVQPAAADTLEAFGDWRETVLLNRISHDNAQLLTAIELDGETIGLANRGTMCDPKLSTGIVQDHSAINLWVAVTMAHEMGHNLGISHDGNQCHCDANSCIMSEELRQQLSFEFSDCSQNQYQTFLTDHNPQCMLNEPLRTDIVSTPVSGNELWETGEESDFDAPANPCCDAATCKLTPGSQCAEGLCCDQCKFMKEGTVCHRAKGDDLDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily",FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin piscivostatin-beta]: Inhibits platelet aggregation induced by ADP. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3). Also inhibits platelet aggregate dissociation in human platelet-rich plasma. {ECO:0000269|PubMed:11530017}.,Fibrinogenolytic Enzyme
364,Q805F6,VM2AB_AGKCO,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin acostatin-beta],MIQVLLVTLCLAAFPYQGSSIILESGNVNDYEVLYPQKVIALPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSSDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYLIEPLKLPDSEAHAVYKYENVEKEDEAPKMCGVTQTNWKSDKPIKKASQLNLTPEQQGFPQRYIELVVVADHRMFTKYNSNLNTIRIWVHELVNTMNVFYRPLNIRVSLTDLEVWSNRDLINVQPAAADTLEAFGDWRETVLLNRISHDNAQLLTAIELDGETIGLANRGTMCDPKLSTGIVQDHSAINLWVAVTMAHEMGHNLGISHDGNQCHCDANSCIMSEELREQLSFEFSDCSQNQYQTYLTDHNPQCMLNEPLRTDIVSTPVSGNELLETGEESDFDAPANPCCDAATCKLTTGSQCADGLCCDQCKFMKEGTVCRRARGDDLDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily",FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal (By similarity). This product has not been identified in the venom. {ECO:0000250}.; FUNCTION: [Disintegrin acostatin-beta]: Inhibits platelet aggregation in human platelet-rich plasma induced by ADP. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3).,Fibrinogenolytic Enzyme
365,Q805F7,DIDA_AGKCO,,"Disintegrin acostatin-alpha [Cleaved into: Disintegrin acostatin-alpha, processed form]",MIQVLLVTLCLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAIQPKNPCCDAATCKLTPGSQCAEGLCCDQCKFIKAGKICRRARGDNPDYRCTGQSGDCPRKHFYA,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits ADP-induced platelet aggregation in human platelet-rich plasma. {ECO:0000269|PubMed:12450389}.,Fibrinogenolytic Enzyme
366,Q8AWI5,VM3HA_GLOHA,3.4.24.-,Zinc metalloproteinase-disintegrin-like halysase (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) (Vascular apoptosis-inducing protein) (VAP),MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVPALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFTLQGETYLIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPEQQRYLNAKKYVKLVMVADYIMYLKYDRNLTTVRTRMYDIVNVINVIYQRMNIHVALVGLEIWSNKDKFILRSAADVTLKLFATWRETDLLKRKSHDNAQLLTGINFNGPTAGLGYLGGICNPMYSAGIVQDHNKIHHLVAIAMAHEMGHNLGIDHDKDTCTCGAKSCVMAGTLSCEASYLFSDCSRKEHQAFLIKDMPQCILKKPLKTDVVSPPVCGNYFVEVGEDCDCGSPATCRDSCCDAATCKLRQGAQCAEGLCCDQCRFKGAGTECRAATDECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNGKCPIMTDQCIALFGPNAAVSEDACFQFNLEGNHYGYCRKEQNTKIACEPQNVKCGRLYCIDSSPANKNPCNIYYSPGDEDKGMVLPGTKCADGKACSNGQCVDVNRAS,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Strongly inhibits the collagen-induced human platelet aggregation (inhibition of alpha-2/beta-1 (ITGA2/ITGB1) integrin). Hydrolyzes the Aalpha-chain of fibrinogen, without cleavage of Bbeta- and gamma-chains. Degrades type IV collagen (but not types I, II and V), fibronectin and vitronectin and also integrins alpha-1/beta-1 (ITGA1/ITGB1) and alpha-5/beta/1 (ITGA5/ITGB1) (but not alpha-V/beta-3 (ITGAV/ITGB3) and alpha-V/beta-5 (ITGAV/ITGB5) integrins). Both metalloproteinase (peptidase M12B) and disintegrin-like domains (recombinantly expressed and named halydin) play characteristic roles to inhibit human platelet aggregation. Induces apoptosis and strongly inhibits proliferation of endothelial cells as well as adhesion of the cells to extracellular matrix proteins. The apoptosis is closely associated with activation of caspase-3 and decreased level of Bcl-X(L)/Bax. Apohalysase, which lacks metalloprotease activity, is also able to induce the apoptosis. Cleaves insulin B chain at '34-His-|-Leu-35', '37-Glu-|-Ala-38', '38-Ala-|-Leu-39', '39-Leu-|-Tyr-40', '40-Tyr-|-Leu-41', '47-Gly-|-Phe-48' and '48-Phe-|-Phe-49' bonds (PubMed:16329990). {ECO:0000269|PubMed:12963038, ECO:0000269|PubMed:14688240, ECO:0000269|PubMed:16329990}.",Metalloprotease
367,Q8AXY1,PA2A_BOTJR,3.1.1.4,Acidic phospholipase A2 BthA-1 (svPLA2) (EC 3.1.1.4) (BOJU-III) (BthA-I-PLA2) (Hypotensive phospholipase A2) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVEGSLWQFGKMINYVMGESGVLQYLSYGCYCGLGGQGQPTDATDRCCFVHDCCYGKVTGCDPKIDSYTYSKKNGDVVCGGDDPCKKQICECDRVATTCFRDNKDTYDIKYWFYGAKNCQEKSEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities (activity that is inhibited by EDTA and dexamethasone), inhibits phospholipid-dependent collagen/ADP-induced platelet aggregation, possess hypotensive as well as anticoagulant activities. In addition, this enzyme shows bactericidal activity against E.coli and S.aureus. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12167491, ECO:0000269|PubMed:15214498, ECO:0000269|PubMed:15294287}.",Phospholipase
368,Q8AY81,VSPST_TRIST,3.4.21.-,Thrombin-like enzyme stejnobin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MMLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDFWSGDFLCGGTLINQEYVLTAAHCKTRNMYIYLGMHNKSVQFDDEQRRYPKKKYFFRCRNNFTRWDKDIMLIRLNRPVRNSAHIAPLSLPSSPPTVGSVCRVMGWGTITSPNETLPDVPRCANINLFNYTVCHGVFPWLPARSRILCAGVLQGGIDTCKRDSGGPLICNGQFQGIVSWGPKPCAQPRKPALYTKVFDHLDWIQSIIAGNTTVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease that has fibrinogen-clotting activity (FGA or FGB). {ECO:0000269|PubMed:9604287}.,Serine Protease
369,Q8JH85,VSPA_MACLB,3.4.21.-,Alpha-fibrinogenase (VLAF) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLVMLHLSYGEKSSELVIGGRPCNINQHRSLALLYNSSGFLCGGTLINQQWVLSAAHCDMENMQIYLGLHNFSLPNMDQKRRVAEEKFFCLSNKSYTKWDKDIMLIKLNRRVKTSTHIAPLSLPSNPPRLRSVCRIMGWGSITSPRETLPYVPHCANIMILRYWVCRAIYGSLPAKSRTLCAGVPRRRIGSCLGDSGGPLICNGQIQGIASWGSDPCVNHGAPGVYTKVFDYNDWIQSIIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Degrades alpha chain of fibrinogen (FGA), and has strong caseinolytic activity. Cleaves oxidized insulin B-chain at '40-Tyr-|-Leu-41', '48-Phe-|-Phe-49' and '49-Phe-|-Tyr-50', and glucagon at the bonds '62-Tyr-|-Ser-63', 66-Leu-|-Asp-67' and '78-Leu-|-Met-79' bonds. {ECO:0000269|PubMed:11910177, ECO:0000269|PubMed:3304428}.",Fibrinogenolytic Enzyme
370,Q8JIR2,VM3HA_PROFL,3.4.24.-,Zinc metalloproteinase/disintegrin-like HR1a (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) [Cleaved into: Disintegrin-like 1a],MIQVLLVTICLAVFPYQGSSIILGSGNVNDYEVVYPRKVTAVPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGREITTYPSVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLRFSDSEAHAVFKYENVEKEDEAPKMCGVTQTNWESDEPIKKASKLVVTAEQQRYLNNFRFIELVIVADYRMFTKFNSNLNEVKTWVYEIVNTLNEIYRYLYVRVALVALEVWSNGDLSSVTLSAYDTLDSFGEWRKRDLLKRKSHDNAQLLTAIDFNGTIIGLAHVASMCDPKCSTGIVQDYSSRNLVVAVIMAHEMGHNLGIRHDRENCTCHANSCIMSAVISDQPSKYFSNCSHVQYWNYINDDEPQCILNEPLRTDIVSPPVCGNELLEVGEECDCGSPATCRYPCCDAATCKLHSWVECESGECCEQCRFRTAGTECRARRSECDIAESCTGHSADCPTDRFHRNGQPCLHNFGYCYNGNCPIMYHQCYALWGANATVAKDSCFEDNQKGNDYGYCRKENGRKIPCEPQDVKCGRLYCSLGNQLPCRFFYTPTDENIGMVDTGTKCGDKKVCSNRQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: [Zinc metalloproteinase/disintegrin-like HR1a]: Zinc protease that induces hemorrhage and has proteolytic activity (PubMed:18061641). Has preference for Ala, His, Pro, Met, and Tyr at the P1 position, in descending order (in vitro). Predominantly prefers Val and Asp at the P3 and P2 positions, respectively (PubMed:18256489). {ECO:0000269|PubMed:18061641, ECO:0000269|PubMed:18256489}.; FUNCTION: [Disintegrin-like 1a]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors alpha-IIb/beta-3 (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Metalloprotease
371,Q8QGR0,3SIM7_DENAN,,Muscarinic toxin 7 (MT-7) (MT7) (Muscarinic toxin 1) (m1-toxin),MKTLLLTLVVVTIVCLDLGYTLTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Binds specifically and irreversibly to an allosteric site of the muscarinic acetylcholine M1 receptor (CHRM1) at subnanomolar concentrations and shows a very slow dissociation rate (PubMed:10799315, PubMed:11562434, PubMed:12488533, PubMed:21557730). It also inhibits agonist-mediated guanosine 5'-O-(3'-thiotriphosphate) (GTP-g-S) binding and downstream signaling, and decreases the dissociation rate of orthosteric antagonists (N-methylscopolamine (NMS) or pirenzepine) (PubMed:10799315, PubMed:15033377). Is a potent negative allosteric modulator (NAM) for CHRM1 activation and a positive allosteric modulator (PAM) for antagonist binding (Probable). {ECO:0000269|PubMed:10799315, ECO:0000269|PubMed:11562434, ECO:0000269|PubMed:12488533, ECO:0000269|PubMed:15033377, ECO:0000269|PubMed:21557730, ECO:0000305}.",Binding Protein
372,Q8UVG0,VM3BE_BOTER,3.4.24.-,Zinc metalloproteinase-disintegrin-like berythractivase (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) (ery1),MIQVLLVIICLEAFPYQGSSIILESGNVNDYEVVYPRKVTALSKGAVHPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSEIHYSPDGREITTYPLVEDHCYYHGRIQNDADSSASISACNGLKGHFKLQGEMYLIEPFKLPDSEAHAVFKYENVEKEDEAPKMCGVTETNWESDEPIKKASLLNLTPEQQAYLDAKKYVEFVVVLDHGMYKKYKDDLDKIKRRIYEIVNTMNEMFIPLNICVALTGLEIWSKGDKINVTSESWFTLILFTNWRGADLLKRKSHDNAQLLTNTDFDGSTIGRAHIGSMCHPYLSVGIIQDYSPVNLLVASTMAHEMGHNLGMHHDNDTCTCGAPSCVMAAAISKDPSKLFSNCSQEYQRKYLIKNRPQCLLNKPLRTDIISPPVCGNELLEVGEECDCGTPENCRDPCCNATTCKLTPGSQCVEGLCCDQCRFRKTGTECRAAKHDCDLPESCTGQSADCPMDDFQRNGHPCQNNNGYCYNGKCPTMENQCIDLVGPKATVAEDSCFKDNQKGNDYGYCRKENGKKIPCEPQDVKCGRLYCNDNSPGQNNPCKCIYFPRNEDRGMVLPGTKCADGKVCSNRHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Potent activator of prothrombin (F2). Does not elicit any hemorrhagic response. Barely inhibits collagen-induced platelet aggregation. Binds neither collagen, nor the jararhagin monoclonal antibody MAJar3. Hydrolyzes the Aalpha-chain of fibrin and fibrinogen, without affecting the Bbeta- and gamma-chains. Is capable of triggering endothelial pro-inflammatory and procoagulant cell responses, but fails to trigger apoptosis. Induces von Willebrand factor release, and the expression of both ICAM1 and E-selectin (SELE) (without increase in VCAM1) in endothelial cells (HUVEC). Is also able to up-regulate the synthesis of the coagulation factor TF (F3). Enhances nitric oxide (NO) generation, prostacyclin production and interleukin-8 release. {ECO:0000269|PubMed:15899699, ECO:0000269|PubMed:16626772, ECO:0000269|PubMed:18096518}.",Fibrinogenolytic Enzyme
373,Q90249,PA2H1_BOTJR,,Basic phospholipase A2 homolog bothropstoxin-I (Bothropstoxin I) (BthTx-I) (BtxtxI) (svPLA2 homolog) (BOJU-I) (Myotoxic phospholipase A2-like) (Phospholipase A2 homolog 1),MRTLWIMAVLLVGVEGSLFELGKMILQETGKNPAKSYGAYGCNCGVLGRGKPKDATDRCCYVHKCCYKKLTGCDPKKDRYSYSWKDKTIVCGENNPCLKELCECDKAVAICLRENLGTYNKKYRYHLKPFCKKADPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Shows local myotoxic activity (PubMed:11018293, PubMed:12079495, PubMed:31906173). Induces inflammation, since it induces edema and leukocytes infiltration (PubMed:11018293, PubMed:31906173). In addition, it induces NLRP3 NLRP3, ASC (PYCARD), caspase-1 (CASP1), and IL-1beta (IL1B) gene expression in the gastrocnemius muscle, showing that it is able to activate NLRP3 inflammasome (PubMed:31906173). It also damages artificial and myoblast membranes by a calcium-independent mechanism, has bactericidal activity, and induces neuromuscular blockade (PubMed:27531710). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity) (PubMed:27531710). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity) (PubMed:27531710). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity) (PubMed:27531710). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity) (PubMed:27531710). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity) (PubMed:27531710). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:11018293, ECO:0000269|PubMed:11829743, ECO:0000269|PubMed:12079495, ECO:0000269|PubMed:17157889, ECO:0000269|PubMed:17346668, ECO:0000269|PubMed:18160090, ECO:0000269|PubMed:27531710, ECO:0000269|PubMed:3176051, ECO:0000269|PubMed:31906173}.",Phospholipase
374,Q90282,VM3VB_CROAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like VAP2B (EC 3.4.24.-) (Catrocollastatin) (Snake venom metalloproteinase) (SVMP) (Vascular apoptosis-inducing protein 2B) (VAP2B) [Cleaved into: Disintegrin-like catrocollastatin-C],MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVIYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLGKNKGLFSKDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVYKYENVEKEDEALKMCGVTQNWESYEPIKKASQLVVTAEHQKYNPFRFVELFLVVDKAMVTKNNGDLDKIKTRMYEIVNTVNEIYRYMYIHVALVGLEIWSNEDKITVKPEAGYTLNAFGEWRKTDLLTRKKHDNAQLLTAIDLDRVIGLAYVGSMCHPKRSTGIIQDYSEINLVVAVIMAHEMGHNLGINHDSGYCSCGDYACIMRPEISPEPSTFFSNCSYFECWDFIMNHNPECILNEPLGTDIISPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYDLFGADVYEAEDSCFERNQKGNYYGYCRKENGNKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNEDEHKGMVLPGTKCADGKVCSNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: [Zinc metalloproteinase-disintegrin-like VAP2B]: Zinc metalloprotease that abolishes platelet aggregation induced by collagen, but has no effect on platelet aggregation induced by ADP or thromboxane analog. This inhibition may be due to its ability to bind collagen and block the binding site on collagen for platelets and/or to its ability to bind to the platelet alpha-2/beta-1 collagen receptor (ITGA2/ITGB1) to block its interaction with collagen and hence prevent platelet stimulation.; FUNCTION: [Disintegrin-like catrocollastatin-C]: Abolishes platelet aggregation induced by collagen (IC(50)=66 nM) but not ADP-stimulated platelet aggregation. This inhibition may be due to its ability to bind collagen and block the binding site on collagen for platelets and/or to its ability to bind to the platelet alpha-2/beta-1 collagen receptor (ITGA2/ITGB1) to block its interaction with collagen and hence prevent platelet stimulation.",Metalloprotease
375,Q90392,VM1AC_CROAT,3.4.24.42,Snake venom metalloproteinase atrolysin-C (SVMP) (EC 3.4.24.42) (Hemorrhagic metalloproteinase atrolysin C) (Hemorrhagic toxin C) (HT-C),MIEVVLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKELFSKDYSETHYSPDGRKITTNPSVEDHCYYRGRIENDADSTASISACNGLKGHFKLQGELYLIEPLELSDSEAHAVFKLENVEKEDEAPKMCGVTQNWESYEPIKKASDLNLNPDQQNLPQRYIELVVVADHRVFMKYNSDLNTIRTRVHEIVNFINGFYRSLNIHVSLTDLEIWSNEDQINIQSASSDTLNAFAEWRETDLLNRKSHDNAQLLTAIELDEETLGLAPLGTMCDPKLSIGIVQDHSPINLLMGVTMAHELGHNLGMEHDGKDCLRGASLCIMRPGLTKGRSYEFSADSMHYYERFLKQYKPQCILNKPLRIDPVSTPVSGNELLEAGEE,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloproteinase that causes hemorrhage by provoking the degradation of the sub-endothelial matrix proteins (fibronectin, laminin, type IV collagen, nidogen, and gelatins). {ECO:0000269|PubMed:2817904, ECO:0000269|Ref.2}.",Metalloprotease
376,Q90495,VM3E_ECHCA,3.4.24.-,Zinc metalloproteinase-disintegrin-like ecarin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQILLVIICLAVFPYQGCSIILGSGNVNDYEVVYPQKVTALPKGAVQQPEQKYEDAMQYEFEVKGEPVVLHLEKNKELFSEDYSETHYSSDDREITTNPSVEDHCYYHGRIQNDAESTASISACNGLKGHFKLRGETYFIEPLKIPDSEAHAVYKYENIENEDEAPKMCGVTQDNWESDEPIKKTLGLIVPPHERKFEKKFIELVVVVDHSMVTKYNNDSTAIRTWIYEMLNTVNEIYLPFNIRVALVGLEFWCNGDLINVTSTADDTLHSFGEWRASDLLNRKRHDHAQLLTNVTLDHSTLGITFVYGMCKSDRSVELILDYSNITFNMAYIIAHEMGHSLGMLHDTKFCTCGAKPCIMFGKESIPPPKEFSSCSYDQYNKYLLKYNPKCILDPPLRKDIASPAVCGNEIWEEGEECDCGSPADCRNPCCDAATCKLKPGAECGNGECCDKCKIRKAGTECRPARDDCDVAEHCTGQSAECPRNEFQRNGQPCLNNSGYCYNGDCPIMLNQCIALFSPSATVAQDSCFQRNLQGSYYGYCTKEIGYYGKRFPCAPQDVKCGRLYCLDNSFKKNMRCKNDYSYADENKGIVEPGTKCEDGKVCINRKCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that catalyzes the conversion of prothrombin (F2) to alpha-thrombin through formation of a thrombin intermediate. Has a low Km for prothrombin and a high kcat. Cleaves the 320-Arg-Ile-321 bond in prothrombin and produces meizothrombin which is ultimately converted to alpha-thrombin by autolysis. {ECO:0000269|PubMed:956136}.,Metalloprotease
377,Q90W38,NGFV_BOTJR,,Venom nerve growth factor (v-NGF) (vNGF) (Bj-NGF),MSMLCYTLIITLLIGIWAAPKSEDNVPLGSPATSDLSVTSCTKTHEALKTSRNTDQHYPAPKKEEDQEFGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVDDANSLNRNIRAKREDHPVHNRGEYSVCDSVNVWVANKTTATDIRGNVVTVMVDVNINNNVYKQYFFETKCRNPNPVPTGCRGIDARHWNSYCTTTNTFVKALTMEGNQASWRFIRIDTACVCVISRKNENFG,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
378,Q90W39,PA2BT_PROMU,3.1.1.4,Basic phospholipase A2 trimucrotoxin (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (TMV-D49-PLA2),MRTLWIVAVLLLGVEGNLLQFNKMIKIMTKKNAIPFYSSYGCYCGWGGQGKPKDATDRCCFVHDCCYGKLTDCSPKSDIYSYSWKTGIIICGEGTECEKKICECDRAAAVCLGHNLRTYKKRYMFYPDFLCTDPSEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities, as well as presynaptic neurotoxicity and low myotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748, ECO:0000269|PubMed:7487947, ECO:0000269|Ref.2}.",Phospholipase
379,Q90WA8,PA2B2_BUNFA,3.1.1.4,Basic phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (KBf II) (KBf-2) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme II),MNPAHLLVLLAVCVSLLAAANIPPQSLNLLQFKNMIECAGTRTWMAYVKYGCYCGPGGTGTPLDELDRCCQTHDQCYDNAKKFGNCIPYFKTYVYTCNKPDITCTGAKGSCGRTVCDCDRAAALCFAAAPYNLANFGINKETHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
380,Q90WC0,VM2HS_GLOBR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase brevilysin L4 (SVMP) (Snake venom metalloproteinase hxl-1) (EC 3.4.24.-); Disintegrin salmosin-1 (Platelet aggregation inhibitor); Disintegrin salmosin-1 minor component (Disintegrin brevicaudin-2b)],EAPKMCGVTQNWESYEPIKKASQSNLTPAHQRYIELVIVADHGMFTKYNGDSDKIREWVRQMVNTVDEIYSYMYIDVALAGLEIWSNEDLINVQPAAPHTLDSFGKWRERDLLHRIHHDNAMLLTAIDFDGPTIGLAYVGTMCKPKGSTGVVQDHSTINLRVAVTMAHEIGHNLGIHHDTGSCSCGGYSCIMSPVISHEPSKYFSDCSYTQCWDFIMNQKPQCILNKPLRTDTVSTPVSGNELLEAGEECDCGSPGNPCCDAATCKLRQGAQCAEGLCCDQCRFMKEGTICRRARGDDLDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase brevilysin L4]: metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250, ECO:0000269|PubMed:10446992, ECO:0000269|PubMed:10944460, ECO:0000269|PubMed:12615062, ECO:0000269|PubMed:14977354, ECO:0000269|PubMed:9722022, ECO:0000269|PubMed:9856345, ECO:0000269|Ref.3}.; FUNCTION: [Disintegrin salmosin-1]: Inhibits GPIIb/GPIIIa (ITGA2B/ITGB3) binding to immobilized fibrinogen with an IC(50) of 2.2 nM and ADP-induced platelet aggregation with an IC(50) of 131 nM, respectively. Inhibits angiogenesis. By binding to vitronectin receptor (alpha-V/beta-3 (ITGAV/ITGB3)), also induces apoptosis of endothelial cells by blocking their attachment to extracellular matrix proteins.; FUNCTION: [Disintegrin salmosin-1 minor component]: Inhibits platelet aggregation induced by ADP (IC(50) is 30 nM), collagen (IC(50) is 500 nM), thrombin and epinephrin (IC(50) is 160 nM).",Fibrinogenolytic Enzyme
382,Q90YA6,VM2E2_PROEL,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin elegantin-2a; Disintegrin elegantin-2b; Disintegrin elegantin-2c; Disintegrin elegantin-2d; Disintegrin elegantin-2e; Disintegrin elegantin-2f],MIQVLLVTICLAVFPYQGSSIILESGNVDDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEAVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYIKLAIVVDHGMYTKYSSNFKKIRKRVHQMVSNINEMCRPLNIAITLALLDVWSEKDFITVQADAPTTAGLFGDWRERVLLKKKNHDHAQLLTDTNFARNTIGWAYLGRMCDEKYSVGVVQDHSSKVFMVAVTMTHELGHNLGMEHDDKDKCKCEACIMSAVISDKQSKLFSDCSKDYYQTFLTNDNPQCILNAPLRTDTVSTPVSGNEFLEAGEECDCGSPENPCCDAATCKLRPGAQCADGLCCDQCRFIEEGIICRRARGDDLDDYCNGISGDCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: Disintegrin elegantin-2a-f: inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
383,Q90ZI3,VM3H1_PROFL,3.4.24.-,Zinc metalloproteinase-disintegrin-like HV1 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) (Vascular apoptosis-inducing protein) (VAP),MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQQKYEDAMQYEFTVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADLTASISACDGLKGHFKLQGETYIIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQSNWESDESIKEDSQSNLTPAQQKYLNAKKYVKFFLVADHIMYLKYGRNLTTLRTRMFDTVNIVNQILQRINIHVALIGIEIWSKEDKIIVQSVPDVTLKLFATWRESVLLKRKNHDNAHLLTGINFNGPTAGLAYLGGICKPMYSAGIVQDHNKIHHLVAIAMAHEMGHNLGMDHDKDTCTCRAKACVMAGTLSCDASYLFSDCSRQEHRAFLIKNMPQCILKKPLKTDVVSPPVCGNYFVEVGEDCDCGSPATCRDPCCDAATCKLRQGAQCAEGLCCDQCRFKAAGTECRAATDECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNRTCPTMNNQCIALFGPNAAVSQDACFQFNRQGNYYGYCRKEQNTKIACEPQNVKCGRLYCIDSSPAKKNPCNIIYSPNDEDKGMVLPGTKCADGMACNSNGQCVDVNRTY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase-disintegrin-like that potently activates prothrombin (F2). Does not elicit any hemorrhagic response. Barely inhibits collagen-induced platelet aggregation. Hydrolyzes the alpha-chain of fibrin and fibrinogen (FGA), without affecting the Bbeta- and gamma-chains (By similarity). Induces apoptosis in cultured vascular endothelial cells. {ECO:0000250, ECO:0000269|PubMed:11389737}.",Metalloprotease
384,Q91053,VSP1_GLOUS,3.4.21.-,Thrombin-like enzyme calobin-1 (SVTLE) (EC 3.4.21.-) (Calobin I) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MVLISVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYNSRSRTLFCGGTLINQEWVLTAAHCERKNFRIKLGIHSKKVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVSNSEHIAPLSLPSSPPSVGSVCRIMGWGRISPTKETYPDVPHCANINLLEYEMCRAPYPEFGLPATSRTLCAGILEGGKDTCRGDSGGPLICNGQFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIQSIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease. Has a coagulant activity. Acts on alpha-chains of fibrinogen (FGA) generating fibrinopeptide A. {ECO:0000269|PubMed:8797081}.,Serine Protease
385,Q91132,VCO3_NAJKA,,Cobra venom factor (CVF) (CVFk) (Complement C3 homolog) [Cleaved into: Cobra venom factor alpha chain; Cobra venom factor gamma chain; Cobra venom factor beta chain],MERMALYLVAALLIGFPGSSHGALYTLITPAVLRTDTEEQILVEAHGDSTPKQLDIFVHDFPRKQKTLFQTRVDMNPAGGMLVTPTIEIPAKEVSTDSRQNQYVVVQVTGPQVRLEKVVLLSYQSSFLFIQTDKGIYTPGSPVLYRVFSMDHNTSKMNKTVIVEFQTPEGILVSSNSVDLNFFWPYNLPDLVSLGTWRIVAKYEHSPENYTAYFDVRKYVLPSFEVRLQPSEKFFYIDGNENFHVSITARYLYGEEVEGVAFVLFGVKIDDAKKSIPDSLTRIPIIDGDGKATLKRDTFRSRFPNLNELVGHTLYASVTVMTESGSDMVVTEQSGIHIVASPYQIHFTKTPKYFKPGMPYELTVYVTNPDGSPAAHVPVVSEAFHSMGTTLSDGTAKLILNIPLNAQSLPITVRTNHGDLPRERQATKSMTAIAYQTQGGSGNYLHVAITSTEIKPGDNLPVNFNVKGNANSLKQIKYFTYLILNKGKIFKVGRQPRRDGQNLVTMNLHITPDLIPSFRFVAYYQVGNNEIVADSVWVDVKDTCMGTLVVKGDNLIQMPGAAMKIKLEGDPGARVGLVAVDKAVYVLNDKYKISQAKIWDTIEKSDFGCTAGSGQNNLGVFEDAGLALTTSTNLNTKQRSAAKCPQPANRRRRSSVLLLDSNASKAAEFQDQDLRKCCEDVMHENPMGYTCEKRAKYIQEGDACKAAFLECCRYIKGVRDENQRESELFLARDDNEDGFIADSDIISRSDFPKSWLWLTKDLTEEPNSQGISSKTMSFYLRDSITTWVVLAVSFTPTKGICVAEPYEIRVMKVFFIDLQMPYSVVKNEQVEIRAILHNYVNEDIYVRVELLYNPAFCSASTKGQRYRQQFPIKALSSRAVPFVIVPLEQGLHDVEIKASVQEALWSDGVRKKLKVVPEGVQKSIVTIVKLDPRAKGVGGTQLEVIKARKLDDRVPDTEIETKIIIQGDPVAQIIENSIDGSKLNHLIITPSGCGEQNMIRMAAPVIATYYLDTTEQWETLGINRRTEAVNQIVTGYAQQMVYKKADHSYAAFTNRASSSWLTAYVVKVFAMAAKMVAGISHEIICGGVRWLILNRQQPDGAFKENAPVLSGTMQGGIQGAEEEVYLTAFILVALLESKTICNDYVNSLDSSIKKATNYLLKKYEKLQRPYTTALTAYALAAADQLNDDRVLMAASTGRDHWEEYNAHTHNIEGTSYALLALLKMKKFDQTGPIVRWLTDQNFYGETYGQTQATVMAFQALAEYEIQMPTHKDLNLDITIELPDREVPIRYRINYENALLARTVETKLNQDITVTASGDGKATMTILTFYNAQLQEKANVCNKFHLNVSVENIHLNAMGAKGALMLKICTRYLGEVDSTMTIIDISMLTGFLPDAEDLTRLSKGVDRYISRYEVDNNMAQKVAVIIYLNKVSHSEDECLHFKILKHFEVGFIQPGSVKVYSYYNLDEKCTKFYHPDKGTGLLNKICIGNVCRCAGETCSSLNHQERIDVPLQIEKACETNVDYVYKTKLLRIEEQDGNDIYVMDVLEVIKQGTDENPRAKTHQYISQRKCQEALNLKVNDDYLIWGSRSDLLPTKDKISYIITKNTWIERWPHEDECQEEEFQKLCDDFAQFSYTLTEFGCPT,Venom complement C3 homolog family,"FUNCTION: Complement-activating protein in cobra venom. It is a structural and functional analog of complement component C3b, the activated form of C3. It binds factor B (CFB), which is subsequently cleaved by factor D (CFD) to form the bimolecular complex CVF/Bb. CVF/Bb is a C3/C5 convertase that cleaves both complement components C3 and C5. Structurally, it resembles the C3b degradation product C3c, which is not able to form a C3/C5 convertase. Unlike C3b/Bb, CVF/Bb is a stable complex and completely resistant to the actions of complement regulatory factors H (CFH) and I (CFI). Therefore, CVF continuously activates complement resulting in the depletion of complement activity.",General Toxin
386,Q91401,VM1AT_CROAT,3.4.24.43,Snake venom metalloproteinase atroxase (SVMP) (EC 3.4.24.43) (Nonhemorrhagic metalloprotease atroxase),EDQQNLSQRYIELVVVADHRVFMKYNSDLNIIRKRVHELVNTINGFYRSLNIDVSLTDLEIWSDQDFITVDSSAKNTLNSFGEWREADLLRRKSHDHAQLLTAINFEGKIIGRAYTSSMCNPRKSVGIXKDHSPINLLVGVTMAHELGHNLGMNHDGEKCLRGASLCIMRPGLTPGRSYEFSDDSMGYYQSFLKQYNPQIXNK,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloprotease that has Aalpha, Bbeta fibrin(ogen)olytic activities. It cleaves the Aalpha chain of fibrinogen first followed by the Bbeta chain and shows no effect on the gamma chain. Does not induce or inhibit platelet aggregation, and is unable to activate plasminogen. Exhibits low lethality when tested on mice. Intravenous administration results in thrombolysis within one hour followed by recanalization. Fibrinogenolytic activity results in a 60% decrease in the rat's plasma fibrinogen level. Histological examination of kidney, liver, heart and lung tissue shows no necrosis nor hemorrhage. {ECO:0000269|PubMed:2646751, ECO:0000269|PubMed:3167016}.",Metalloprotease
387,Q91516,VSPPA_TRIST,3.4.21.-,Venom plasminogen activator TSV-PA (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MELIRVLANLLILQLSYAQKSSELVFGGDECNINEHRSLVVLFNSNGFLCGGTLINQDWVVTAAHCDSNNFQLLFGVHSKKILNEDEQTRDPKEKFFCPNRKKDDEVDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSVGSVCRIMGWGKTIPTKEIYPDVPHCANINILDHAVCRTAYSWRQVANTTLCAGILQGGRDTCHFDSGGPLICNGIFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWIKSIIAGNKDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that activates plasminogen. {ECO:0000269|PubMed:7730329}.,Serine Protease
388,Q92032,VM1AH_AGKCL,3.4.24.-,Snake venom metalloproteinase ACLH (SVMP) (EC 3.4.24.-) (ACL hemorrhagic toxin I) (ACLH-I) (ACLHT-I) (Hemorrhagic metalloproteinase ACLH),MIQVLLVTLCLAAFPYQGSSIILESGNVNDYEVVYPRKVTPVPKGAVQPKYEDAMQYELKVNGEPVVLHLERNKGLFSKDYSETHYSPDGRKITTYPPVEDHCYYHGRIQNDADSIASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEAPKICGVTQNWESYEPIKKASQLNLNYQYQRYVELVTVVDHGMYTKYNGDSDKIRQWVHQMVNTMKESYRYMYIDISLAGVEIWSNKDLIDVQPAARHTLDSFGEWRERDLLHRISHDNAQLLTSTDFDGPTIGLAYVGTMCDPKLSTGVVEDHSKINFLVAVTMAHEMGHNLGMRHDTGSCSCGGYSCIMSPVISDDSPKYFSNCSYIQCWDFIMKENPQCILNKPLRTDTVSTPVSGDELLEA,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: This zinc hemorrhagic metalloproteinase has fibrino(geno)lytic activities. It causes hemorrhage and has myonecrotic activity on both fiber types I and II. The recombinant enzyme, without post-translational modifications, also has proteolytic activity, but does not show any hemorrhagic activity. {ECO:0000269|PubMed:11072042, ECO:0000269|PubMed:15313443, ECO:0000269|PubMed:8444323}.",Metalloprotease
389,Q92035,ACES_BUNFA,3.1.1.7,Acetylcholinesterase (BfAChE) (EC 3.1.1.7),MPSCQPGKMPAPWPWWLQLLLCIPSCVAVLPGRAGELKVSTQTGSVRGLSLPVLDGHVSAFLGIPFAEPPLGRMRFLRPEPVKPWQHVLDATSYKPACYQMVDTSYPGFQGTEMWNPNRGMSEDCLYLNIWVPSPRPKDAPVLVWIYGGGFYSGAASLDVYDGRFLTYTQNVILVSLSYRVGAFGFLGLPGSPEAPGNMGLLDQRLALQWIQNNIHPFGGNPRAVTVFGESAGAASVGMHLLSTQSRTLFQRAILQSGGPNAPWATVTPAESRGRAALLGKQLGCHFNNDSELVSCLRSKNPQELIDEEWSVLPYKSIFRFPFVPVIDGDFFPDTPEAMLSSGNFKETQVLLGVVKDEGSYFLIYGLPGFSKDNESLISRADFLEGVRMSVPHANDIATDAVVLQYTDWQDQDNREKNREALDDIVGDHNVICPVVQFANDYAKRNSKVYAYLFDHRASNLLWPPWMGVPHGYEIEFVFGLPLNDSLNYTPQEKELSRRMMRYWANFARTGNPTDPADKSGAWPTYTASQPQYVQLNTQPLATQPSLRAQICAFWNHFLPKLLNATDNIEEAERQWKLEFHLWSAYMMHWKSQFDHYNKQDRCSEL,Type-B carboxylesterase/lipase family,"FUNCTION: In muscle, it terminates signal transduction at the neuromuscular junction by rapid hydrolysis of the acetylcholine released into the synaptic cleft. In liver, its function is unclear: it could serve as a safeguard against any diffusion of acetylcholine from synapses into the circulation. In venom, its toxic role is unclear: it could result in less musculatory control by rapidly hydrolyzing acetylcholine, or that it works synergistically with alkaline phosphatase (ALP) in paralyzing prey through hypotension.",Neurotoxin
390,Q92084,PA2NA_NAJSP,3.1.1.4,Neutral phospholipase A2 muscarinic inhibitor (NPLA) (svPLA2) (EC 3.1.1.4) (NAJPLA-2A) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 A),MNPAHLLILAAVCVSPLGASSNRPMPLNLYQFKNMIQCTVPNRSWWHFADYGCYCGRGGSGTPVDDLDRCCQIHDNCYNEAEKISRCWPYFKTYSYECSQGTLTCKGGNNACAAAVCDCDRLAAICFAGAPYNDNNYNIDLKARCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits the muscarinic acetylcholine receptors (mAChR/CHRM) with no subtype selectivity. Shows catalytic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8638927}.,Phospholipase
391,Q98995,VM2L2_MACLB,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase lebetase (SVMP) (EC 3.4.24.-) (Fibrinolytic protease) (Le-3) (Le3) (Lebetase II) (Lebetase-2); Disintegrin VLE5A],MIQVLLVTICLAVFPYQGSSKTLKSGNVNDYEVVNPQAVTGLPKGAVKQPEKKYEDTMQYEFEVNGEPVVLHLEKNRGLFSKDYSETHYSPDGREITTNPAVEDHCYYHGRIQNDADSTASISACNGLKGYFTLRGETYLIEPLKLPDSEAHAVYKYENIEKEDEAPKMCGVTQTNWASDEPIKKASQLNLTPEQQRFEPRYIELVIVADHAMVTKYNGDLAAITTWVHQLVNNINGFYRDLNVHITLSAVEVWTNGDLINVQPAASVTLNLFGEWRERDLLNRRMHDHAQLLTGIDLDDNIIGLAYDDSMCDPRYSVGIVQDHSAIIRLVAVTMAHELGHNLGMNHDGDQCNCGANGCVMSVVLIEQRSYQFSDCSKNKYQTYLTNRNPQCILNQPLRTDTVSTPVSGNELLQNSGNPCCDPVTCQPRRGEHCVSGKCCRNCKFLRAGTVCKRAVGDDMDDYCTGISSDCPRNPYKD,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily","FUNCTION: [Snake venom metalloproteinase lebetase]: Fibrinolytic and fibrinogenolytic metalloproteinase that hydrolyzes the Aalpha-chain and more slowly the Bbeta-chain of fibrin and fibrinogen. Its fibrinolytic activity is direct, without any plasminogen activation. Also hydrolyzes casein and B-chain of oxidized insulin. Inhibits ADP-induced and collagen-induced platelet aggregation. Shows low hemorrhagic activity. Cleaves the plasma proteinase inhibitors alpha(2)-macroglobulin (A2M) and pregnancy zone protein (PZP), and is inhibited by them. The metalloprotease has no strict P1-P1' specificity requirement. Hydrolysis at sites with a Pro residue at P1 is observed with bradykinin, substance P, PZP and alpha chain fibrinogen (FGA) (PubMed:11910177). {ECO:0000269|PubMed:10556563, ECO:0000269|PubMed:10669797, ECO:0000269|PubMed:11910177, ECO:0000269|PubMed:2065076, ECO:0000269|PubMed:8694817, ECO:0000269|PubMed:9678676}.; FUNCTION: [Disintegrin VLE5A]: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of the alpha-4/beta-1 (ITGA4/ITGB1) integrin to VCAM-1. Inhibition on alpha-2b/beta-3 (ITGA2B/ITGB3) is low (By similarity). {ECO:0000250}.",Metalloprotease
392,Q98SP2,VM2J2_BOTJA,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase jararafibrase-2 (SVMP) (EC 3.4.24.-) (Jararafibrase II); Disintegrin bothrostatin (D-BTT)],MIEVLLVTICLAAFPYQGSSIILESGNVNDYEVIYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGRKITTNPPVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVFKFENVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPEHQRYIELFLVVDHGMFMKYNGNSDKIRRRIHQMVNIMKEAYRYLYIDIALTGVEIWSNKDMINVQPAAPQTLDSFGEWRKTDLLNRKSHDNAQLLTSTDFKDQTIGLAYWGSMCDPKRSTAVIEDHSETDLLVAVTMAHELGHNLGIRHDTGSCSCGGYSCIMAPVISHDIAKYFSDCSYIQCWDFIMKDNPQCILNKQLRTDTVSTPVSGKNFGAGEECDCGTPGNPCCDAVTCKLRPGAQCAEGLCCDQCRFMKEGTVCRRARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase jararafibrase-2]: Impairs hemostasis in the envenomed animal (By similarity). Does not exhibit detectable plasminogen activating activity. Has hemagglutinating activity on red blood cells. Cleaves insulin B chain at '38-Ala-|-Leu-39' and '40-Tyr-|-Leu-41' bonds (PubMed:8087204). {ECO:0000250, ECO:0000269|PubMed:1523677, ECO:0000269|PubMed:15737609, ECO:0000269|PubMed:8087204}.; FUNCTION: [Disintegrin bothrostatin]: This recombinant protein shows high inhibitory activity on collagen-induced platelet aggregation.",Kunitz Family
393,Q9DF33,PA2A2_OPHHA,3.1.1.4,Acidic phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (APLA2-2) (Phosphatidylcholine 2-acylhydrolase),MNPAHLLVLSAVCVSLLGASSIPPQPLHLVQFNGMIRCTIPGSIPWWDYSDYGCYCGSGGSGTPVDELDRCCQVHDNCYTQAQQLTECSPYSKRYSYDCSEGTLTCKADNDECAAFVCDCDRVAAICFAGAPYNKENINIDTTTRC,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing and moderate anticoagulant activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
394,Q9DF52,PA2B_BUNCE,3.1.1.4,Basic phospholipase A2 KPA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLVAVCVSLLGAANIPPQPLNLIQFKNMIQCAGTRPWTAYVNYGCYCGKGGSGTPVDELDRCCYTHDNCYNEAEKIPGCNPNIKTYSYTCTEPNLTCTDTADTCARFLCDCDRTAAICFASAPYNSNNVMISSSTNCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows anticoagulant and neurotoxic activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
395,Q9DGB9,VM3V1_CROAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like VAP1 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) (Vascular apoptosis-inducing protein 1) (Vap-1),MIQVLLVTISLAVFPYQGSSVILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPPVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPEQQRYLNAKKYVKLFLVADYIMYLKYGRNLTAVRTRMYDIVNVITPIYHRMNIHVALVGLEIWSNTDKIIVQSSADVTLDLFAKWRATDLLSRKSHDNAQLLTGINFNGPTAGLGYLGGICNTMYSAGIVQDHSKIHHLVAIAMAHEMGHNLGMDHDKDTCTCGTRPCVMAGALSCEASFLFSDCSQKDHREFLIKNMPQCILKKPLKTDVVSPAVCGNYFVEVGEECDCGSPRTCRDPCCDATTCKLRQGAQCAEGLCCDQCRFKGAGTECRAAKDECDMADVCTGRSAECTDRFQRNGQPCKNNNGYCYNGKCPIMADQCIALFGPGATVSQDACFQFNREGNHYGYCRKEQNTKIACEPQDVKCGRLYCFPNSPENKNPCNIYYSPNDEDKGMVLPGTKCADRKACSNGQCVDVTTPY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Zinc metalloprotease that has fibrinogenolytic and hemorrhagic activities. It induces apoptosis in vascular endothelial cells (VEC), without degrading extracellular matrix (it cannot cleave collagen) or inhibiting adhesion of VEC. VAP1-induced apoptosis is inhibited by antibodies for integrin alpha-3, alpha-6, beta-1 and CD9. Apoptosis is accompanied by severe cell fragmentation, which is controlled by caspases. {ECO:0000269|PubMed:11071872, ECO:0000269|PubMed:11821125, ECO:0000269|PubMed:15922392, ECO:0000269|PubMed:18657564, ECO:0000269|PubMed:9196035}.",Metalloprotease
396,Q9I834,PA2H2_BOTMO,,Basic phospholipase A2 homolog myotoxin II (MjTX-II) (svPLA2 homolog) (Basic phospholipase A2 homolog 2) (M-VI),SLFELGKMILQETGKNPAKSYGVYGCNCGVGGRGKPKDATDRCCYVHKCCYKKLTGCDPKKDRYSYSWKDKTIVCGENNSCLKELCECDKAVAICLRENLDTYNKKYRYNYLKPFCKKADPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) homolog that lacks enzymatic activity. Shows high myotoxin activities (PubMed:16442348, PubMed:31748642, PubMed:9637370). Also shows neurotoxicity, since it induces muscle paralysis when tested on mouse phrenic-diaphragm preparations (PubMed:16442348, PubMed:23810946, PubMed:26457430, PubMed:30679550). Displays edema-inducing activities (PubMed:16442348, PubMed:26457430, PubMed:9637370). Also displays antimicrobial activity against E.coli and C.albicans, as well as antitumoral activity against some human and mice cell lines (PubMed:16442348). In addition, it is effective as parasiticidal agent against Leishmania sp. and S.mansoni (PubMed:16442348). It also disrupts negatively charged liposomes in a dose- and temperature-dependent manner and shows toxicity by intraperitoneal route (PubMed:16442348). In contrast to other phospholipase A2-like toxins, this myotoxin does not require fatty acid binding to be active (PubMed:29287778). {ECO:0000269|PubMed:16442348, ECO:0000269|PubMed:23810946, ECO:0000269|PubMed:26457430, ECO:0000269|PubMed:30679550, ECO:0000269|PubMed:9637370, ECO:0000305|PubMed:29287778}.",Phospholipase
397,Q9I8X1,VSPP_DEIAC,3.4.21.-,Snake venom serine protease Dav-PA (SVSP) (AaV-SP-I) (AaV-SP-II) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTDFQMQLGVHSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPLSLPSSPPSVGSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGIVQGGKDTCGGDSGGPLICNGQFQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNIAGNTDATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that has fibrinogenolytic activities. Also possess esterolysis and amidolytic activities. Selectively cleaves Arg-|-Xaa bonds. {ECO:0000269|PubMed:12595722, ECO:0000269|PubMed:15632114}.",Serine Protease
398,Q9IAB0,VM2CO_AGKCO,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin contortrostatin],MIQVLLVTLCLAAFPYQGSSIILESGNVNDYEVLYPQKVTALPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSSDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTQTNWESDEPIKKASQLNLTPEQQGFPQRYIELVVVADHRMFTKYNGNLNTIRIWVHELVNTMNVFYRPLNIRVSLTDLEVWSDQDLINVQPAAADTLEAFGDWRETVLLNRISHDNAQLLTAIELDGETIGLANRGTMCDPKLSTGIVQDHSAINLWVAVTMAHEMGHNLGISHDGNQCHCDANSCIMSEELREQLSFEFSDCSQNQYQTYLTDHNPQCMLNEPLRTDIVSTPVSGNELLETGEESDFDAPANPCCDAATCKLTTGSQCADGLCCDQCKFMKEGTVCRRARGDDLDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IId sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal (By similarity). This protein has not been identified in the venom. {ECO:0000250, ECO:0000269|PubMed:10700384}.; FUNCTION: [Disintegrin contortrostatin]: Inhibits ADP-induced platelet aggregation. Binds and inhibits integrins GPIIb/GPIIIa (ITGA2B/ITGB3), alpha-5/beta-1 (ITGA5/ITGB1), alpha-V/beta-3 (ITGAV/ITGB3), and alpha-V/beta-5 (ITGAV/ITGB5). It blocks cancer cell adhesion (tested on human breast cancer cell line MDA-MB-435) to fibronectin and vitronectin and thus prevents invasion of cancer cells. {ECO:0000269|PubMed:10700384}.",General Toxin
399,Q9IAT9,PA2H_BOTPA,,Basic phospholipase A2 homolog BnSP-7 (svPLA2 homolog) (Phospholipase A2 II),SLFELGKMILQETGKNPAKSYGAYGCNCGVLGRGQPKDATDRCCYVHKCCYKKLTGCDPKKDRYSYSWKDKTIVCGENNPCLKELCECDKAVAICLRENLGTYNKKYRYHLKPFCKKADPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that lacks enzymatic activity (PubMed:10860537). Is myotoxic and displays edema-inducing activity (PubMed:10860537, PubMed:9972319). Displays bactericidal activity and promotes the blockage of the neuromuscular contraction of the chick biventer cervicis muscle (PubMed:10860537, PubMed:9972319). Also disrupts artificial membranes, and provokes tissue damages characterized by edema, necrosis and inflammation (PubMed:10860537, PubMed:9972319). May act as pro-inflammatory mediators, inducing metalloproteinase and cytokine production from the inflammatory and satellite cells (PubMed:19673103). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:10860537, ECO:0000269|PubMed:19673103, ECO:0000269|PubMed:9972319}.",Phospholipase
400,Q9PRP4,VSPF_LACMR,3.4.21.74,Thrombin-like enzyme LMR-47 (SVTLE LM-47) (SVTLE LMR-47) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Gyroxin analog) (Snake venom serine protease) (SVSP) (Venombin A),VIGGDECNINEHRFLVALYDGLSGTFLCGG,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that specifically hydrolyzes the Aalpha chain of fibrinogen (FGA). Exhibits strong N-p-tosyl-L-arginine methyl esterase activity, and hydrolyzes tripeptide nitroanilide derivatives weakly or not at all.",Serine Protease
401,Q9PSM4,LECG_LACST,,C-type lectin LmsL (CTL) (Galactose-specific lectin) (Mutina),NNCPQDWLPMNGLCYKIFDEQKAWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQAEVWIGLWDKKKDFSWEWTDRSCTDYLTWDKNQPDHYEGKEFCVELVSLTGYRLWNDQVCESKNAFLCQCKF,True venom lectin family,"FUNCTION: Galactose-binding protein which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. Is a calcium-dependent lectin. Shows high hemagglutinating activity, that is inhibited by lactose, galactose and inositol. {ECO:0000269|PubMed:3671807, ECO:0000269|Ref.2}.",Binding Protein
402,Q9PSN0,LECG_BITAR,,C-type lectin PAL (CTL) (BaL) (Galactose-specific lectin),NNCPPDWLPMNGLCYKIFDELKAWEDAERFCRKYKPGCHLASFHQYGESLEIAEYISDYHKGQAEVWIGLWDKKKDFSWEWTDRSCTDYLTWDKNQPDHYQNKEFCVELVSLTGYRLWNDQVCGSKNAFLCQCKF,True venom lectin family,"FUNCTION: Galactose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. This is a calcium-dependent lectin (PubMed:8593494). Shows high hemagglutinating activity (MHC is 0.25 ug/ml on rabbit erythrocytes) (PubMed:10484740). {ECO:0000269|PubMed:10484740, ECO:0000269|PubMed:8593494}.",Binding Protein
403,Q9PT41,VSPF5_MACLB,3.4.21.95,Factor V activator (FVA) (VLFVA) (EC 3.4.21.95) (Lebetina viper venom FV activator) (LVV-V) (Snake venom serine protease) (SVSP),MVLIRVLANLLVLQLSYAQKSSELVVGGDECDINEHPFLVALYTSSSSTVHCAGTLINQEWVLTAVHCDRKNIRIKLGMHSKNIRNEDEQIRVPRRKFFCLNTKFPNGKDKDIMLIRLRRPVKNSAHIAPISLPSSPSSPRSRCRIMGWGKISTTEETYPDVPHCAKIFIVKHAWCEALYPWVPADSRTLCAGILQGGKDTCEGDSGGPLICNGQIQGIVSGGSDPCGQRLKPAVYTKVFDYTDWIQSIIAGNTTATCP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Venom serine protease that converts factor V (F5) to the active form Va in the presence of calcium ions and phospholipids. It cleaves the Arg(1545)-Ser(1546) linkage in the human factor V molecule. Has hydrolytic activities against BAEE (1.2 U/mg), TAME, and Pro-Phe-Arg-MCA (4.9 U/mg). Shows coagulant activity. {ECO:0000269|PubMed:11910177, ECO:0000269|PubMed:16807918, ECO:0000269|PubMed:9920400}.",Serine Protease
404,Q9PT51,VSPB_GLOBL,3.4.21.-,Beta-fibrinogenase brevinase (EC 3.4.21.-) (Snake venom serine protease) (SVSP) [Cleaved into: Beta-fibrinogenase brevinase chain A; Beta-fibrinogenase brevinase chain B],VIGGDECNINEHRFLALLYSERFQCGGTLINEEWVLTAAHCDMGNMYIYLGVHNVSVQYDDEQRRYPKKKYFCLSSRNYNQWDNDIMLIRLNRPVRNSAHIAPLSLPSGPPSVGSVCRVMGWGTITSPNETYPDVPHCANINILDYEVCRAAYAGLPATSRTLCAGILEGGKDSCRGDSGGPLICNGEIQGIVSWGGNICAQPREPGLYTKVFDYIDWIQSIIAGNTTVNCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that has fibrinogenolytic activities. Preferentially cleaves the Bbeta-chain (FGB) and more slowly the Aa-chain (FGA) of fibrinogen, but does not affect the gamma-chain. Has also fibrinolytic activity. May play a role in antithrombotic reaction as well as thrombolytic reaction. {ECO:0000269|PubMed:10403823}.",Serine Protease
405,Q9PTU8,VSP3_BOTJA,3.4.21.-,Snake venom serine protease BPA (SVSP) (EC 3.4.21.-) (Bothrops protease A) (BPA),MVLIRVIANLLILQLSNAQKSSELVIGGDECNITEHRFLVEIFNSSGLFCGGTLIDQEWVLSAAHCDMRNMRIYLGVHNEGVQHADQQRRFAREKFFCLSSRNYTKWDKDIMLIRLNRPVNNSEHIAPLSLPSNPPSVGSVCRIMGWGTITSPNATFPDVPHCANINLFNYTVCRGAHAGLPATSRTLCAGVLQGGIDTCGGDSGGPLICNGTFQGIVSWGGHPCAQPGEPALYTKVFDYLPWIQSIIAGNTTATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that has a potent and selective fibrinogenolytic activity. Preferentially cleaves the alpha-chain (FGA) of human and rat fibrinogen at Arg-|-Gly bonds, and slowly digests the beta-chain (FGB) (PubMed:18433459). In vivo, completely avoids thrombus formation induced in rat, decreases the fibrinogen plasma level and prolonges the recalcification time. Possesses esterolytic and amidolytic activities. {ECO:0000269|PubMed:14161003, ECO:0000269|PubMed:18433459}.",Serine Protease
406,Q9PVF0,PA2AB_CALRH,3.1.1.4,Acidic phospholipase A2 S1E6-b (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),VEGSLVQFETLIMKLAKRSGFFWYSFYGCYCGWGGHGLPQDPTDRCCFVHDCCYGKVTNCNPKTATYSYTEENDGIVCGGDDPCKKQVCECDRVAAMCFRDNKDTYDSDKYWKLPPQKCQEDPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase that inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:11054123}.,Phospholipase
407,Q9PVF1,PA2AA_CALRH,3.1.1.4,Acidic phospholipase A2 S1E6-a (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),VEGSLVQFETMIMKLAKRSGFFWYSFYGCYCGWGGHGLPQDPTDRCCFVHDCCYGKVTNCNPKTATYSYTEENDGIVCGGDDPCKKQVCECDRVAAMCFRDNKDTYDSDKYWKLPPQKCQEDPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:11054123}.,Phospholipase
408,Q9PVF2,PA2AE_CALRH,3.1.1.4,Acidic phospholipase A2 H1E6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWILAVLQVGVEGHLLQFETMIIKMTKQTGLFSYSFYGCYCGWGGHGRPQDPTDRCCFVHDCCYGKVTNCDPKAAAYSYTIENGGIVCGGDDPCKKQICECDRAAAMCFRDNLDTYNYAKYWKFSAKDCQEESDPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:11054123}.,Phospholipase
409,Q9PVF4,PA2HD_CALRH,,Basic phospholipase A2 homolog W6D49 (svPLA2 homolog) (Inactive basic phospholipase A2 W6D49) (CRV-W6D49) (svPLA2),MRTLWILAVLLVSVDGSMFNLWKMIMVMTGKEATKNYGMYGCNCGPMKRGKPKDATDQCCADHDCCYKKLTDCDPKKESYSYKFEKGEILCGETNPCLNQACECDKAVATCFRDNLDTYNKKQQFNTGIFCSKAKAC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Shows myotoxin activities and displays edema-inducing activities (PubMed:11054123). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:11054123}.",Phospholipase
410,Q9PW35,VM1AA_DEIAC,3.4.24.-,Snake venom metalloproteinase acutolysin-A (SVMP) (EC 3.4.24.-) (Hemorrhagin I) (HI),MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGRRITTHPLVEDHCYYRGHIRNDADSTASISACNGLKGHFKLQGEMYLIEPMKMSYSEAHAVYKYGNVEKEDEAPKMCGVTQNWESYEPIKKASQLIVSTEFQRYMEIVIVVDHSMVKKYNGDSDKIKAWVYEMINTITESYSYLYIDIILSGLEIWSEKDLINVETSAENTLKSFGEWRAKDLIHRISHDNAQLLTATDFDGPTIGLAYVASMCDPKRSVGVVQDHSSVNRLVAITLAHEMAHNLGVRHDEGSCSCGSGYTCIMSPVINSEVIKYFSDCSYIQCREYISKENPPCILNKPLRTDTVSTPVSGNELLEAGKDYD,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: This protein is a zinc metalloprotease from snake venom that possesses hemorrhagic activity.,Metalloprotease
411,Q9PW56,BNP2_BOTJA,,Bradykinin-potentiating and C-type natriuretic peptides (Brain BPP-CNP) (bBPP-CNP) (Evasin-CNP) [Cleaved into: Bradykinin-potentiating peptide 13a+QQWA (BPP-13a+QQWA); Bradykinin-potentiating peptide 13a+QWA (BPP-13a+QWA); Bradykinin-potentiating peptide 13a (BPP-13a); Bradykinin-potentiating peptide 10c+QQWA (BPP-10c+QQWA); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Evasin-10c); Bradykinin-potentiating peptide 12b (BPP-12b) (Evasin-12b); Bradykinin-potentiating peptide AP; Bradykinin-potentiating peptide APL (BPP-APL); Bradykinin-potentiating peptide 11e (BPP-11e) (Evasin-11e); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide Va) (BPPVa) (Evasin-5a) (Proline-rich peptide 5a) (Bj-PRO-5a) (PRO-5a); Poly-His-poly-Gly peptide 1 (pHpG-1); C-type natriuretic peptide (Bj-CNP)],MVLSRLAASGLLLLALLALSVDGKPVQQWAQGGWPRPGPEIPPLKVQQWAQGGWPRPGPEIPPLTVQQWAQNWPHPQIPPLTVQQWAQWGRPPGPPIPPLTVQQWAQARPPHPPIPPAPLQKWAPVQKWAPLLQPHESPASGTTALREELSLGPEAASGVPSAGAEVGRSGSKAPAAPHRLSKSKGAAATSAASRPMRDLRPDGKQARQNWGRMVHHDHHAAVGGGGGGGGGGARRLKGLAKKGAAKGCFGLKVDRIGTMSGLGC,Bradykinin-potentiating peptide family; PHpG family; Natriuretic peptide family,"FUNCTION: [Bradykinin-potentiating peptide 5a]: Modestly inhibits ACE (with highest affinity for the N-site) and reveals strong bradykinin-potentiating activity. Induces nitric oxide (NO) production depended on muscarinic acetylcholine receptor M1 subtype (CHRM1) and bradykinin B2 receptor (BDKRB2) activation. Both these receptors contribute to the vasodilation induced by this peptide that may have an indirect action on BDKRB2 and a direct agonistic action on CHRM1.; FUNCTION: [Bradykinin-potentiating peptide 10c]: Peptide with several activities. It inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain (PubMed:11994001). It evokes transient hypotension (-14 mmHg) similar to that evoked by 0.5 ug of bradykinin, when injected alone into rats. It has a high bradykinin-potentiating effect (120%), when 60 nmol of BPP-10c are coinjected with 0.5 ug of bradykinin into rats (PubMed:22869554). Does not affect angiotensin-1 pressor effects. Shows potent and long-lasting antihypertensive activity as well as a reduction of the heart rate (PubMed:17475904). It also binds and dose-dependently promotes the activation of cytosolic argininosuccinate synthase (ASS1), an enzyme that catalyzes the conversion of citrulline, L-aspartate and ATP to argininosuccinate, AMP and pyrophosphate. It also enhances ASS1-dependent arginine production in HEK 293 cells, as well as in spontaneous hypertensive rat (SHR) and Wistar rat plasma. In addition, it induces the production of nitric-oxide (NO) by HUVEC cells via the endothelial nitric-oxide synthase (NOS3), which use arginine as a substrate and produce NO. It has been shown to be internalized by ASS1-expressing endothelial (HUVEC) and kidney (HEK 293) cells, and is detected homogenously distributed within the cell cytoplasm for up to 2 hours (PubMed:19491403). {ECO:0000269|PubMed:11994001, ECO:0000269|PubMed:17475904, ECO:0000269|PubMed:19491403, ECO:0000269|PubMed:22869554}.; FUNCTION: [Poly-His-poly-Gly peptide 1]: May serve as a metalloproteinase inhibitor during glandular storage. Their inhibition may be instantly disengaged, by dilution or physiochemical change, when venom is injected into tissue of the victim. {ECO:0000250|UniProtKB:A8YPR6}.; FUNCTION: [C-type natriuretic peptide]: has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.",Kunitz Family
412,Q9PWF3,MYC2_CRODU,,Crotamine (Crt) (Myotoxin),MKILYLLFAFLFLAFLSEPGNAYKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSGK,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. As a cell-penetrating peptide, crotamine has high specificity for actively proliferating cells, and interacts inside the cell with subcellular and subnuclear structures, like vesicular compartments, chromosomes and centrioles. It penetrates into the cells as fast as five minutes after its addition to cell culture medium (PubMed:18662711). In vivo, after intraperitoneal administration, it is found in cells of peritoneal fluid and bone marrow, demonstrating preferential nuclear and perinuclear localization. To enter the cell, it interacts with the chains of heparan sulfate membrane proteoglycan (HSPG), and is endocytosed (in complex with HSPG) in vesicles which are transported into the cell with the help of clathrin. Inside the cell, crotamine accumulates in lysosomal vesicles. As soon as the peptide accumulates in endosomes/lysosomes vesicles, these compartments are disrupted and their contents released into the cytosol. This loss of lysosomal content induces cell death at high concentrations, or promotes the distribution of crotamine in cytoplasmic compartments, which is a step before crotamine nuclear uptake (PubMed:15231729, PubMed:17491023). As a potassium channel inhibitor, this toxin selectively inhibits Kv1.1/KCNA1, Kv1.2/KCNA2 and Kv1.3/KCNA3 channels with an IC(50) of 369, 386 and 287 nM, respectively (PubMed:22498659). The inhibition of Kv1.3/KCNA channels induced by this toxin occurs rapidly and is voltage-independent. The channel inhibition is reversible after washing, suggesting a pure and classical channel blockage effect, without effects in potassium channel kinetics (PubMed:22498659). As an antimicrobial peptide, crotamine shows antibacterial activity against E.coli and B.subtilis, and antifungal activity against Candida spp., Trichosporon spp. and C.neoformans. It kills bacteria through membrane permeabilization. {ECO:0000269|PubMed:1176086, ECO:0000269|PubMed:15231729, ECO:0000269|PubMed:17491023, ECO:0000269|PubMed:17588630, ECO:0000269|PubMed:18662711, ECO:0000269|PubMed:19706485, ECO:0000269|PubMed:21386851, ECO:0000269|PubMed:22142367, ECO:0000269|PubMed:22498659, ECO:0000269|PubMed:23022146, ECO:0000269|PubMed:667499, ECO:0000269|PubMed:9839677}.",Kunitz Family
413,Q9W6M5,VM3AH_DEIAC,3.4.24.-,Zinc metalloproteinase-disintegrin-like acurhagin (Acur) (EC 3.4.24.-) (Acutolysin e2) (Snake venom metalloproteinase) (SVMP) (Zinc metalloproteinase-disintegrin-like acutolysin-E),MIQVLLVTICLAAFPYQGSSIILESGDVNDYEVVYPRKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKHLFSKDYSETHYSPDGREITINPPVEDHCYYHGRIENDGDSTASISACNGLKGNFKLQGETYLIEPMKLSDSEAHAVFKYENVEKEDEAPKMCGVTQKWKSYEPIKKISQLNLIPEQQIYDPFKYVETVVVVDKAMVTKYNGDLDKIKTKMYEAANNMNEMYRYMFFRVVMVGLIIWTEEDKITVKPDVDYTLNAFAEWRKTYLLAEKKHDNAQLITGIDFRGSIIGYAYIGSMCHPKRSVGIIQDYSPINLVLAVIMAHEMGHNLGIHHDDGYCYCGGYPCIMGPSISPEPSKFFSNCSYIQCWDFIMNHNPECIDNEPLGTDIISPPLCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFRTSGTECRASMSECDPAEHCTGQSSECPADVFHKNGEPCLDNYGYCYNGNCPIMYHQCYALFGADIYEAEDSCFESNKKGNYYGYCRKENGKKIPCASEDVKCGRLYCKDDSPGQNNPCKMFYSNDDEHKGMVLPGTKCADGKVCSNGHCVDVTTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that causes hemorrhage and dose-dependently inhibits platelet aggregation triggered by collagen. This inhibition is due to its binding to glycoprotein VI (GP6) and collagen. The binding to GP6 results in inhibition of the signaling pathway (decrease of tyrosine phosphorylation of signaling proteins such as Syk, LAT, PI3-K and PLCgamma2). Preferentially cleaves alpha chain (FGA) of fibrinogen, followed by beta chain (FGB). Also degrades the extracellular matrix protein fibronectin (FN1), and cleaves collagen and von Willebrand factor (VWF). {ECO:0000269|PubMed:12008947, ECO:0000269|PubMed:16023283}.",Metalloprotease
414,Q9W7J3,PA2A2_PSETE,3.1.1.4,Acidic phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Pt-PLA2),MHPAHLLVPLGVCVSLLGAARIPPLPLSLVEFRILIKCANHNSRNVLDYADYGCYCGKGGSGTPVDELDRCCQAHDYCYDDAEKLPACNYRFSGPYWNPYSYKCNEGEVTCTDDNDECKAFICNCDRTAAICFAGAPYNDENFMITIKKKNICQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows moderate enzymatic activity and exhibits procoagulant activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:14678780}.,Phospholipase
415,Q9W7J4,PA2A1_PSETE,3.1.1.4,Acidic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Pt-PLA1),MHPAHLLVLLGVCVSLLGAARIPPLPLSLDDFSNLITCANRGSRSWLDYAHYGCFCGSGGSGTPVDDLDRCCQVHDNCFGDAEKLPACNYLFSGPYWNPYSYKCNEGEITCTDDNDECAAFICNCDRTAAICFAGATYNDENFMVTIKKKNICQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows moderate enzymatic activity and exhibits procoagulant activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:14678780}.,Phospholipase
416,Q9YGP1,LECG_TRIST,,C-type lectin TsL (Galactose-binding lectin) (CTL),MGRFIFVSFGLLVVFLSLSGAKGSCCTNDSLPMNGMCYKIFDEPKTWEDAEMFCRKYKPGCHLASFHRLAESLDIAEYISDYHKRQAEVWIGLLDRKKDFSWEWTDRSCTDYLNWDKNQPDHYKDKEFCVELVSLTGYHRWNDQVCESKNSFLCQCKF,True venom lectin family,FUNCTION: Galactose-binding protein which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin.,Binding Protein
417,Q9YI19,VM2MC_GLOBR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase brevilysin L6 (SVMP) (Snake venom metalloproteinase Mt-c) (EC 3.4.24.-); Disintegrin],MIQVLLVIICLADFPYQGTSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKGYSETHYSPDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKHQGEMYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTQTNWKSDEPIKASQQQRFPQRYIELVVVADHGMFTKYDSNLDTIRTWVHELVNSINEFYRSLNIDVSLTELEIWSNQDLINVQSAAGDTLEAFGDWRETDLLNRISHDNAQLLTATELDGNTIGLAHVASMCDPKRSTGVVQDHSAINLLVAVTMAHETGHNLGMNHDGNQCHCGANSCVMGDVLSEGVSYEFSDCSENEYQTYLTDRNPQCILNEPLRTDTVSTPVSGNELLEAGKECDCGAPANPCCDAETCKLRPGQQCAEGLCCDQCRFMKEGTICQEAKGDWNDDTCNGISAGCPRNGFYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IId sub-subfamily","FUNCTION: [Snake venom metalloproteinase brevilysin L6]: Shows weak degradation of alpha-fibrinogen, but has no activity on beta- and gamma-chains. Digests luteinizing hormone-releasing hormone (LH-RH) and oxidized insulin at X-Leu, X-Phe, and X-Val bonds as well as X-His bond. Does not show fibrinogen-clotting activity. Does not show hemorrhagic activity. {ECO:0000269|PubMed:9880798}.; FUNCTION: [Disintegrin]: Inhibits ADP-induced platelet aggregation. {ECO:0000250}.",Fibrinogenolytic Enzyme
418,R4NNL0,VMH3_VIPAA,3.4.24.-,Zinc metalloproteinase-disintegrin-like protein H3 (EC 3.4.24.-) (H3 metalloproteinase 1) (Hemorrhagin 3) (P-IIIc metalloproteinase H3) (Snake venom metalloproteinase) (SVMP) (VaH3),MIQVLLVIICLAVFPYQGSSIILESGNVNDYEVVYLQKVTAMNKGAVKQPEQKYEDTMQYEFKVNGEPVILHLEKNKDLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFQLRGETYFIEPLKIPDSEAHAVYKYENVEKEDEAPKTCGVTQTNWESDELIKKASQLNLTPEQQRYLNSPKYIKLVIVADYIMFLKYGRSLITIRTRIYEIVNLLNVIYRVLNIYIALVGLEIWNNGDKINVLPEAKVTLDLFGKWRETDLLNRRKHDNAQLLTGINFNGPTAGLGYLGSMCNPQYSAGIVQDHNKVNFLVALAMAHEMGHNLGMDHDGIQCTCGAKSCIMSGTLSCEASIRFSNCSQEEHRKYLINKMPQCILNKPLKTDIVSPAVCGNYLVELGEDCDCGSPRDCQNPCCNAATCKLTPGSQCADGECCDQCKFGRAGTVCRPANGECDVSDVCTGQSAECPTDQFQRNGHPCQNNNGYCYNGTCPILGKQCISLFGASATVAQDACFQFNRLGNEYGYCRKENGRKIPCAPQDVKCGRLYCFDNLPEHKNPCQIYYTPRDENKGMVDPGTKCGDGMACSSNGQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Zinc metalloprotease that has fibrinogenolytic and hemorrhagic activities. Cleaves insulin B chain readily at '38-Ala-|-Leu-39' bond, and at a significantly slower rate, at '40-Tyr-|-Leu-41' bond. Hydrolyzes isolated extracellular matrix (ECM) bovine fibronectin, and basal membrane (BM) proteins human collagen IV and, to a lesser extent, murine laminin, in vitro. Cleaves murine nidogen (at '350-Ser-|-Phe-351' and '380-Tyr-|-Asn-381' bonds), but not laminin, in a solubilized BM preparation. Hydrolyzes plasma proteins involved in blood coagulation in vitro. It significantly prolongs thrombin time. Has potent alpha-fibrinogenase activity cleaving human fibrinogen alpha chain at '432-Lys-|-Leu-433' bond, but does not cleave beta or gamma chains. Hydrolyzes bovine prothrombin, but does not cleave it at '366-Arg-|-Ile-367' bond, which is necessary for the formation of active alpha-thrombin, however, the cleavage of fragment 1 from it leads to reduced alpha-thrombin formation. Hydrolyzes bovine factor X heavy chain at '211-Ser-|-Leu-212', '213-Asp-|-Leu-214' and '216-Gly-|-Leu-217' bonds activating it only marginally as does not cleave at the physiological activation site. Does not cleave factor X light chain. No hydrolysis or activation of plasminogen. The alpha-fibrinogenase activity likely contributes to its hemorrhagic activity, which in rat can be completely neutralized in vivo by anti-ammodytagin antibodies, which strongly cross-react with this protein. Has very weak collagen-, ADP- and ristocetin-induced platelet aggregation inhibition activity in vitro. {ECO:0000269|PubMed:23321470}.",Metalloprotease
419,U3FAE1,3SXA_MICFL,,Fulditoxin (Micrurus fulvius dimeric neurotoxin) (SIGMA-neurotoxin) (Three-finger toxin 3a) (3FTx 3a) (Three-finger toxin 9a) (Three-finger toxin 9d) (Three-finger toxin 9e),MKTLLLTLVVVTIVCLDLGNSLKCYSSRTETMTCPEGEDKCEKYAVGLMHGSFFFIYTCTSKCHEGAYNVCCSTDLCNKSSTSG,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: Postsynaptic neurotoxin that produces potent, and completely reversible, postsynaptic neuromuscular blockade, as well as broad spectrum inhibition of human muscle and neuronal nicotinic acetylcholine receptors (nAChRs). Inhibition is potent or moderate, depending on the receptor (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE (IC(50)=2.56 uM), alpha-4-beta-2/CHRNA4-CHRNB2 (IC(50)=1.8 uM), alpha-7/CHRNA7 (IC(50)=7 uM), and alpha-3-beta-2/CHRNA3-CHRNB2 (IC(50)=12.6 uM)) (PubMed:31877243). Acts as a competitive antagonist of ACh (PubMed:31877243). Binds to chicken muscle-type nicotinic acetylcholine receptor (AChR) with high potency compared with the cloned human receptor (PubMed:31877243). Unlike short-chain alpha-3FTxs that only bind to muscle nAChRs, this toxin utilizes dimerization to expand its pharmacological targets to block neuronal nAChRs (PubMed:31877243). {ECO:0000269|PubMed:31877243}.",Neurotoxin
420,U3KRG1,VM1T1_PROMU,3.4.24.-,Snake venom metalloproteinase TM-1 (SVMP) (EC 3.4.24.-) (Zinc-dependent metalloproteinase),QQRFPQRYVMLAIVADHGMVTKYSGNSSAITTRVHQMVSHVTEMYSPLNIATTLSLLRIWSSKDLITVQSDSSVTLGSFGDWRKVVLLSQQAHDCAFLNTATALDDSTIGLAYSNGMCDPKFSVGLVQDHSSNVFMVAVTMTHELGHNLGMAHDEAGGCACSSCIMSPAASSGPSKLFSDCSKDDYQTFLTNTNPQCILNAP,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Potent fibrinogenolytic protease which cleaves mainly the Aalpha (FGA) and Bbeta (FGB) chains of fibrinogen and slightly the gamma chain (FGG) (PubMed:7488093, PubMed:8193588). Shows preference for substrates having a moderate-size and hydrophobic residue at the P1' position. Preferentially cleaves Ala-|-Leu and Tyr-|-Leu bonds (PubMed:23732127). Is more susceptible to tripeptide inhibitors than TM-3 (AC O57413) (PubMed:9703966). {ECO:0000269|PubMed:23732127, ECO:0000269|PubMed:7488093, ECO:0000269|PubMed:8193588, ECO:0000269|PubMed:9703966}.",Kunitz Family
421,U5PZ28,VM2H1_BOTLA,3.4.24.-,Zinc metalloproteinase-disintegrin BlatH1 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAALPYQGSSIILESGNVNDYEVVYPRKVTALPKGAGQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSSDGRKITTNPPVEDHCYYHGRIENDADSTGSISACNGLKGHFKLQGEMYLIEPLKLSDSEAHAIYKYENVEKEDEAPKMCGVTETNWESYEPIKKASQSNLTPEQQRFNPFKYVELVIVADHRMFTKYNGDLEKIRIKIYEIVNILNEMFRYLYIRIALVDLEIWSNRDLINVTSVAGDTLDSFGNWRETDLLKRKSHDNAQLLTGIDFNGTTIGIAYIASMCNPYLSVGIVQDHSEINFLIAVTMAHEMGHNLGMRHDTDYCTCGGYSCIMCAVLSDQPSKFFSNCSYIQYGKFIMNQNSQCILNEPLGTDIVSPPVCGNEILEVGEECDCGCPTNCQDPCCNAATCKQYSWVQCESGECCEQCRFRAAGTVCRRATDNDMDNRCTGQSADCPSNG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIc sub-subfamily","FUNCTION: Snake venom zinc metalloprotease-disintegrin that hydrolyzes azocasein, gelatin and fibrinogen (Aalpha and Bbeta chains and partially gamma-chain), and exerts a potent local and systemic hemorrhagic activity in mice. It inhibits ADP- and collagen-induced human platelet aggregation (IC(50) = 0.3 uM and 0.7 uM for ADP and collagen, respectively). This inhibition is dependent of protease activity, and probably occurs through the degradation of an unknown platelet receptor. {ECO:0000269|PubMed:24457155}.",Metalloprotease
422,V5TBK6,VMH4A_VIPAA,3.4.24.-,Zinc metalloproteinase-disintegrin-like protein H4 subunit A (EC 3.4.24.-) (Hemorrhagin 4 subunit A) (Metalloproteinase H4-A) (P-III metalloproteinase H4 subunit A) (Snake venom metalloproteinase) (SVMP) (VaH4-A),MIQPLLVVTCLVVFPYQVSSIILESGNVNDYEVVYPQKVTSLPKGAVQQPEQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGHIQNEADSTASISACNGLKGHFKLQGETYLIEPLKIPESEAHAVYKYENIEKEDEAPKMCGVTETNWESDEPIRKASQLVATSEQRRNIQKYIELVIVVDNVMFRKYTGNSTAIRTRIYEIVNTLNVVFRNVHIFVALVGIEIWNKKDQIKVKSAESVTLDLFGDWREKDLLRRKRHDNAQLLTGIDLNEQTLGIAPMSGMCKPKSSVGLIQDYCKSYLLVAIVMAHELGHNLGMDHDDGNCICREMPCIMSPEAGSKPAFYFSDCSWNQYQKFRNDIKSKCIDNKPLKTDIVSPAFCGNYFVEEGEECDCGFPGNCRNPCCNATTCKLTPGSECGDGECCDQCRIQTAGTECRPAWDECDVPEYCTGQSAECPTDVLQRNGQPCKNNNGYCYNGVCPILTNQCISLFGSSVTVAPDRCFNNNLQGTENFHCGMENGRYIKCKPQDKKCGRLFCVEPPTGGGINCKSIRSEGDPDHGMVDLGTKCADGKVCNSNRQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily","FUNCTION: Heterodimer (A and B subunits): Zinc metalloprotease that has fibrinogenolytic and hemorrhagic activities. Cleaves insulin B chain preferably at '40-Tyr-|-Leu-41' bond, but also at '28-Gln-|-His-29' and '34-His-|-Leu-35' bonds. Hydrolyzes effectively isolated extracellular matrix (ECM) bovine fibronectin, and only slightly, basal membrane (BM) proteins human collagen IV and murine laminin, in vitro. Cleaves nidogen-1 (at '350-Ser-|-Phe-351' and '380-Tyr-|-Asn-381' bonds), but not laminin, in a solubilized BM preparation. Hydrolyzes plasma proteins involved in blood coagulation in vitro. It slightly shortens prothrombin time and significantly prolongs thrombin time. Has potent alpha-fibrinogenase activity cleaving human fibrinogen alpha chain at '441-Glu-|-Leu-442' and '539-Glu-|-Phe-540' bonds, and to a lesser extent, beta chain at '52-Lys-|-Arg-53' and '48-Pro-|-Leu-49' bonds, but does not cleave gamma chain. Hydrolyzes bovine prothrombin at '200-Ser-|-Gly-201' bond, but does not activate it, however, it cleaves fragment 1 and prethrombin 1 from it. Hydrolyzes bovine factor X heavy chain, but the cleavage does not produce an activated factor Xa heavy chain. No hydrolysis or activation of plasminogen. The ability to degrade some of the ECM, BM and plasma proteins is likely the main contributor to its hemorrhagic activity. Inhibits platelet aggregation induced by collagen in vitro. Its binding to glycosaminoglycans (GAGs) may assist in concentrating it in the proximity of blood vessel walls enabling in vivo degradation of BM protein components. Cytotoxic to cultured HeLa cancer cells in a concentration- and time-dependent manner. In the solubilized BM preparation (Matrigel), it induces morphological changes in the HeLa cells and inhibits their adhesion, however, the viability of the cells is not reduced. {ECO:0000269|PubMed:24269369}.",Metalloprotease
423,W8E7D1,PDE_MACLB,3.6.1.-,Venom phosphodiesterase (PDE) (VLPDE) (EC 3.6.1.-),MIQQKVLFISLVAVALGLGLGLGLKESVEPQVSCRYRCNETFSKMASGCSCDDKCTERQACCQDYEDTCVLPTQSWSCSKLRCSEKRMANVLCSCSEDCLEKKDCCTDYKSICKGETSWLKDQCASSSAAQCPSGFEQSPLILFSMDGFRAGYLETWDSLMPNINKLKTCGTHAKYMRAVYPTKTFVNHYTIVTGLYPESHGIIDNNIYDVTLNLNFSLSAPTMTNPAWWGGQPIWHTVTYQGLKAATYFWPGSEVKINGSYPTIYKVYNKSIPFEARVTEVLKWLDLPKAERPDFVTLYIEEPDTTGHKFGPVSGEIIMALQMADRTLGMLMEGLKQRNLHNCVNLILLADHGMEQISCNRLEYMTDYFDKVDFFMYEGPAPRIRSKNVPKDFYTFDSEGIVRNLTCQKPKQYFKAYLAKDLPKRLHYVNNIRIDKVNLMVDQQWMAVRNKNYNRCNGGTHGYDNEFKSMQAIFLAHGPGFKGKNEVTSFENIEVYNLMCDLLKLKPAPNNGTHGSLNHLLKNPFYNPSPAKEQTSPLSCPFGPVPSPDVSGCKCSSITDLGKVNERLNLNNQAKTESEAHNLPYGRPQVLQNHSKYCLLHQAKYISAYSQDVLMPLWSSYTINKSPPTSVPPSASDCLRLDVRIPAAQSQTCSNYQPDLTITPGFLYPPNFGSSNFEQYDALITSNLVPMFKGFTRLWNYFHGTLLPKYARERNGLNVISGPIFDYNYDGHFDSYDTIKEYVNDTKIPIPTHFFVVLTSCENQINTPLNCPGSLKVLSFILPHRPDNSESCADTSPDNLWVEERIQTHTARVRDVELLTGLNFYSGLKQPLPETLQLKTFLPIFVNPVN,Nucleotide pyrophosphatase/phosphodiesterase family,"FUNCTION: Hydrolyzes ADP with high activity (PubMed:25079051). Shows weak or no activity on 5'-AMP, 5'-GMP, 3'-AMP, ATP, cAMP, and cGMP (PubMed:25079051). Is devoid of monophosphatase and proteinase activities (PubMed:25079051). Dose-dependently inhibits platelet aggregation induced by ADP (IC(50)=0.99 uM) and collagen (IC(50)=1.4 uM) (PubMed:25079051). {ECO:0000269|PubMed:25079051}.",Hydrolase
424,W8EFS0,V5NTD_MACLB,3.1.3.5,Snake venom 5'-nucleotidase (5'-NT) (VL5'NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (Ecto-5'-NT),AREKVGIIGYTTKETPVLSNPGPYLEFRDEVEELQIHANKLTTLGVNKIIALGHSGFFEDQRIARKVKGVDVVVGGHTNTFLYTGSPPSTEVPAGNYPFMVQSDDGRQVPVVQAYAFGKYLGYLNVVFNDKGNVIKASGNPILLNKDIPEDQVVKAQVNKMKIQLQNYYSQEIGKTIVYLNGTTQACRFHECNLGNLICDAVIYNNLRHPDDNEWNHVSMCIVNGGGIRSPIDERANNGIITLEELTSVLPFGGTFDLLQIKGSALKQAFEHSVHRHGQGTGELLQVSGIKVVYDLSQKPGSRVVSLNVLCTKCRVPTYVPLEMEKTYKVLLPSFLATGGDGYHMLKGDSSNHNSGDLDISIVGDYIKRMEKVFPAVEGRVTFLDGTLFQAQLFLTWGLCISLLFFIL,5'-nucleotidase family,"FUNCTION: Hydrolyzes nucleotides into nucleosides (PubMed:25434533). Prefers AMP as the substrate but cleaves also GMP and ADP (PubMed:25434533). Does not affect AMP, cAMP and cGMP (PubMed:25434533). Inhibits ADP- and collagen-induced platelet aggregation (PubMed:25434533). Snake venom 5'-nucleotidases are widely distributed among venomous snake taxa, but there is a lack of information about their biological activities. They have been shown to inhibit platelet aggregation. This effect may be due to the liberation of inhibitory AMP or adenosine by its action on ADP released upon initiation of aggregation. Venom 5'-nucleotidases are also known to synergistically act in vivo with other toxins like ADPases, phospholipases, and disintegrins to exert a more pronounced anti-coagulant effect (PubMed:20186872). {ECO:0000269|PubMed:25434533, ECO:0000305|PubMed:20186872}.",Phospholipase
425,X2JCV5,OXLAA_CERCE,1.4.3.2,L-amino acid oxidase (CC-LAAO) (LAO) (EC 1.4.3.2),MNVFFMFSLLFLAALESCADDKNPLEEEFFEADYEEFLLIAKNGLQQTSNPKRVVIVGAGMSGLSAAYVLAKTGHEVILLEASERVGGRVSTYRNDQEGWYANLGPMRLPERHRIVREYIRKFGLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEKGKSAPQLYRDSLQKIIEEYGRSNCSYILNKYDTYSTKDYLIKEGNLSPGAVDMVGDLLNEDSGYYVSFIESLKPDDIFAYENRFDEIVGGFDKLPTSMYQAIQEKVRLNVRVIKIQQDVKEVTVTYQTPAKNLSYVTADYVIVCTTSGAARRIKFEPPLPLKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSITDRPSRLIHYPNHNFPNGIGVLVIFTIADDADFFLALDNKTIADIVIHDLSLIHQLPKEKIRDLCYVSMIQKWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLTAARDVNRASENPSGIHLSNDNEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:25009089). Is highly active on L-Met>L-Leu>L-Phe>L-Trp=L-Ile (PubMed:25009089). Binds to the cell surface and enables the production of highly localized concentration of hydrogen peroxide in or near the binding interfaces (PubMed:26433175). Does not bind to phospholipids (PubMed:26433175). Induces platelet-rich plasma aggregation, shows cytotoxic effects on some cancer cell lines (B16-F10 (mouse melanoma), PC12 (rat pheochromocytoma), MCF-7 and MDA-MB-231 (human breast carcinoma)) and shows antibacterial activities against both Gram-positive and Gram-negative bacteria (PubMed:26433175). Also exhibits hemorrhage and edema (By similarity). Does not show cytotoxicity on erythrocytes and peripheral blood mononuclear cells (PubMed:26433175). Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:25009089, ECO:0000269|PubMed:26433175}.",Binding Protein
428,A0A1I9KNP0,VSPH1_VIPAA,,Vaa serine proteinase homolog 1 (VaaSPH-1) (Enzymatically inactive serine proteinase-like protein SPH-1) (Snake venom serine protease homolog),MVLIRVLANLLVLQLSYAQKSSELVIGGDECNINEHPFLVALHTARSKRFYCAGTLINQEWVLTAARCDRKNIRIILGVHSKNVPNEDEQMRVPKEKFFCLSSKTYTRWDKDIMLIRLKRPVNDSTHIAPLSLPSSPPSVGSVCRIMGWGTITTTKVTYPDVPHCADINMFDYSVCQKVYRKLPEKSRTLCAGILQGGIDSCKVDNGGPLICNGQIQGIVSWGGYPCAQPHKPALYTNVFDYTDWIQSIIAGNITATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: This is the first member of the serine protease family that has strong anticoagulant activity and lacks enzymatic activity. It inhibits activities of three blood coagulation complexes: (1) prothrombinase complex (composed of blood coagulation factors Va and Xa (F5 and F10)) (IC(50)=164.1 nM), (2) intrinsic tenase complex (composed of factors VIIIa and IXa (F8 and F9)), and (3) extrinsic tenase complex (composed of tissue factor and factor VIIa (F7)). The toxin has also been observed to bind prothrombin, factor FVa, non-activated and activated forms of factors FVII (F7) (FVII and FVIIa), factor FVIIIa (F8), factors FIX and FIXa (F9) and factors FX and FXa (F10). The toxin inhibits the activity of the intrinsic tenase complex mainly by competing with FIXa (F9) for binding to FVIIIa (F8). {ECO:0000269|PubMed:30235482}.",Serine Protease
429,A0A2I4HXH5,V5NTD_NAJAT,3.1.3.5,Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase),GSFELTILHTNDVHARLEQTSRDSGKCTGEDCYGGVARRATKIRQIRASHRNVLLLDAGDQYQGTIWFNYYKGREVVHFMNSLRYDAMALGNHEFDNGLNGLLDPLLKNVKFPILSANIRPKGPIASNISGYILPYKIINVGSEKVGIIGYTTKETPVLSNPGPYLEFRDEVEELQKHADKLTTLGVNKIIALGHSGFMEDCRIAQKVKGVDVVVGGHTNTFLYTGSPPSNEVAAGNYPFMQLSDDGRQVPVVQAYAFGKYLGYLNVTFDDKGKVIKASGNPILLNKSIQEDPAVKAEISRMKVQLQNYSSQEIGRTIVYLNGTTHACRFHECNLGNLICDAVVYNNLRHPDDNEWNHVSMCIVNGGGIRSPIDEQANNGIITLEELTAVLPFGGTFDLLQIKGSTLRQAFEHSVHRHGQGTGELLQVSGIKVVYDLSQKPGKRVVSLNVLCTECRVPTYVPLEMEKTYKVLLPSFLAAGGDGYYMLKGDSSNHSSGDLDISIVGDYIKRMGKVFPAMEGRMVFSAGSL,5'-nucleotidase family,"FUNCTION: Hydrolyzes nucleotides into nucleosides (By similarity). Snake venom 5'-nucleotidases are widely distributed among venomous snake taxa, but there is a lack of information about their biological activities. They have been shown to inhibit platelet aggregation. This effect may be due to the liberation of inhibitory AMP or adenosine by its action on ADP released upon initiation of aggregation. Venom 5'-nucleotidases are also known to synergistically act in vivo with other toxins like ADPases, phospholipases, and disintegrins to exert a more pronounced anti-coagulant effect. {ECO:0000250|UniProtKB:P0DJJ5, ECO:0000305|PubMed:20186872}.",Phospholipase
430,A0A346CIA0,3NBA_SPISL,,Sulditoxin subunit A (S.sulphureus dimeric toxin) (Three-finger toxin subunit B),MKTLLLALAVVVLVCLGSANQLGLGRQQIDRRQRQAIGPPYGLCFQCDRKTSPDCSTAKKCPWYHTTCYTLYKPDDACGEEWAVKGCAKTCPTAGPYERVKCCYKPECNND,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily","FUNCTION: Reptile-specific neurotoxin (tested on geckos) (PubMed:30068680). Inhibits nicotinic acetylcholine receptor (nAChR) (By similarity). Not toxic to mammals (tested on mice) (PubMed:30068680). {ECO:0000250|UniProtKB:A0S864, ECO:0000269|PubMed:30068680}.",Neurotoxin
431,A0A346CIB3,3NBB_SPISL,,Sulditoxin subunit B (S.sulphureus dimeric toxin) (Three-finger toxin subunit A),MKTLLLALAVVVLVCLGSANELGLGRQQIDRGRRQAIGPPYGICYQCNRKSCRDCFNPKRCPSYHTMCYTLYKPNENGAEEWAVKGCARKCPTAGPNERVNCCRGRDCNND,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily","FUNCTION: Reptile-specific neurotoxin (tested on geckos) (PubMed:30068680). Inhibits nicotinic acetylcholine receptor (nAChR) (By similarity). Not toxic to mammals (tested on mice) (PubMed:30068680). {ECO:0000250|UniProtKB:A0S864, ECO:0000269|PubMed:30068680}.",Neurotoxin
432,A0RZC6,VCO32_AUSSU,,A.superbus venom factor 2 (AVF-2) (CVF-like) (Complement C3 homolog) [Cleaved into: AVF-2 alpha chain; AVF-2 gamma chain; AVF-2 beta chain],MEGMALYLVAALLIGFPGSSHGALYTLITPGVLRTDTEEQILVEAHGDSAPKQPVISIHDFPRRQKILFQIRVDMNPAGGMLVTPTIKIPAKELNKESRQNQYVVVKVSGLPLELEKVVLLSSQSGFVFIQTDKGIYTPGSLVRYRVFSMDYNMHRMDKTVIVEFQTPEGVVVSSNPINPSSVLIRHYNLSELVSFGTWKAVAKYEHSPEESYTAYFDVREYVLPSFEVRLQPSDKFLYIDGNKNFHVSITARYLYGKKVEGVAFVLFGVKIDDAKKSIPDSLTRIPIIDGDGEAILKRDILRSRFQNLNELVGHTLYASVTVMTESGSDMVVTEQSGIHIVTSPYQIYFTKPPKYFKPGMPYELTVYVTNPDGSPAANVPVVSEAIHSEGTTLSDGTAKLILNTPLNTQSLPITVRTNHRDLPRERQATKSMTATAYQTQGGSGNYLHVAITSTEIKAGDNLPVSFNVRGNANSLNQIKYFTYLILTKGKIFKVGRQPRGEGQNLVTMNLRITPDLIPAFRFVAYYQVGNNEIVADSVWVDVKDTCMGMLVVKGASSRDNRIQKPGAAMKIKLEGDPGARVGLVAVDKAVYVLNDKYKISQAKIWDTIEKSDFGCTAGGGQDNLGVFEDAGLALTTSTNLNTKQRSVATCPQPTNRRRRSSVLLLDSKASKAAQFQEQNLHKCCEDGMHENPMGYTCEKRAKYTQEGDACKAAFLECCRYIKGIRDENQRESELFLARSDFEDEFFEEDNIISRSDFPDSWLWLTEDLNEPPNSQGISSKTLSFYLKDSITTWEVLAVSIAPTKGICVAEPYEITVMKDFFIDLRVPYSVVKNEQVEIRAVLYNYADEDIYVRVELLYNPAFCSASAEGQRYRVQVPVRALSSWAVPFVIVPLEQGLHDVEVKASVRGELASDGVRKKLKVVPEGERKNIVTVIELDPSVKGVGGTQEQTVVANKLDDKVPETEIETKFSVLGDPVAQIIENSIDGSKLSHLIITPSGSGEQNMITMTPSVIATYYLDATGQWENLGVDRRTEAVKQIMKGYAQQMVYKKADHSYASFVNRASSSWLTAYVVKVFAMAAKMVKDINHEIICGGVKWLILNRQQSDGVFKENAPVILGGMMGGTQGAEPEVSLTAFILVALLESRSVCNEHINILDNSINKATDYLLKKYEKLQRPYTTALTAYALAAAERLNDDRVLMAASTGRDRWEEHARTHNIEGTSYALLALLKMKKFAEAGPVVKWLIDQKYYGGTYGQTQATVMVFQALAEYEIQIPTHKDLNLNISINLPEREVPLRYSINYGNALVARTAETKLNEDFTVSASGDGKATMTILTVYNAQLREDANVCNKFHLNVSVENAQLNSKQAKGAKDTLRLKICTRYLGEVDSTMTIIDVSMLTGFLPDTEDLTRLSKGVDRYISKFEIDNNMVQKGTVVIYLDKVSHSEVECLNFKIHKHFEVGFIQPGPVKVYSYYNLDEQCTKFYHPDKGTGLLNKICHGNICRCAEQSCSLLNQQKKIDLPLRIQKACAPNVDYVYKAKLLRIEEKDGNDIYVMDVLEVIKGGTDRNPQAKARQYVSQRKCQEALNLNLNNDYLIWGLSSDLWPMKNDISYLITKNTWIERWPNEDECQDEEFQNLCDDFAQLSNTLTIFGCPT,Venom complement C3 homolog family,"FUNCTION: Complement-activating protein in snake venom. It is a structural and functional analog of complement component C3b, the activated form of C3. It binds factor B (CFB), which is subsequently cleaved by factor D (CFD) to form the bimolecular complex AVF/Bb. AVF/Bb is a C3 convertase that cleaves complement component C3, but not C5 (as do CVF/Bb) (By similarity). {ECO:0000250}.",General Toxin
433,A1IVR8,3L21_BUNCA,,Alpha-elapitoxin-Bc2a (Alpha-EPTX-Bc2a) (Alpha-delta-Bgt-1) (Alpha/delta-bungarotoxin-1) (Alpha/delta-BgTx-1),YTLLCYKTPSPINAETCPPGENLCYTKMWCDAWCSSRGKVIELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscular and neuronal nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (PubMed:30944155, Ref.2). Reversibly blocks chick and mouse muscle nicotinic acetylcholine receptors (PubMed:30944155, Ref.2). Blocks muscle type nAChR with an IC(50)=30 nM, when heterologously expressed in oocytes (PubMed:30944155). Also binds with high affinity to alpha-7/CHRNA7 nAChRs (PubMed:30944155). In addition, shows a weak inhibition of neuronal alpha-3-beta-2/CHRNA3-CHRNB2 nAChR (IC(50)=2.9 uM) (PubMed:30944155). Selectively binds to alpha-1-delta subunit interface of the mouse muscle nicotinic acetylcholine receptor, with a 10-fold higher affinity for the adult than for the fetal receptors (PubMed:30944155, Ref.2). In vivo, when intraperitoneally injected into mice, causes flaccid paralysis and respiratory distress, followed by death within 2-4 hours (PubMed:30944155). {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:30944155, ECO:0000269|Ref.2}.",Neurotoxin
435,A4FS04,PA2A_NAJAT,3.1.1.4,Acidic phospholipase A2 natratoxin (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFKNMIQCTVPSRSWWDFADYGCYCGKGGSGTPVDDLDRCCQVHDNCYNEAEKISGCWPYFKTYSYECSQGTLTCKGGNNACAAAVCDCDRLAAICFAGAPYTDANYNIDLKARCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has an effectively inhibitory effect on A-type K(+) currents (Kv/KCN) in acutely dissociated rat dorsal root ganglion (DRG) neurons. This inhibitory effect is independent of its enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18247353}.,Phospholipase
436,A6MFL5,NGFV1_DEMVE,,Venom nerve growth factor 1 (v-NGF-1) (vNGF-1),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHKALKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLENEDALNRNIRSKRENHPVNDHGEYSVCDSVSVWVNKTTATDIKGKPVTVMVDVNLNNHVYKQYFFETKCKNPNPVPSGCRGIDSRHWNSYCTTTQSFVKALTKEGNQASWRFIRIDTACVCVISRKTGNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
437,A6MFL6,NGFV2_DEMVE,,Venom nerve growth factor 2 (v-NGF-2) (vNGF-2),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATPDLSDTSCAQTHKALKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLENEDALNRNIRSKRENHPVNDHGEYSVCDSVSVWVNKTTATDIKGKPVTVMVDVNLNNHVYKQYFFETKCKNPNPVPSGCRGIDSRHWNSYCTTTQSFVKALTKEGNQASWRFIRIDTACVCVISRKTGNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
438,A6MFL7,NGFV3_DEMVE,,Venom nerve growth factor 3 (v-NGF-3) (vNGF-3),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEALKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLENEDALNRNIRSKRENHPVNDHGEYSVCDSVSVWVNKTTATDIKGKPVTVMVDVNLNNHVYKQYFFETKCKNPNPVPSGCRGIDSRHWNSYCTTTQSFVKALTKEGNQASWRFIRIDTACVCVISRKTGNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
441,A8QL48,VM3_BUNFA,3.4.24.-,Zinc metalloproteinase-disintegrin-like BfMP (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MLVVFPYQGSSIILESGNVNDYEVVYPQKVPSLPKGGVQNPQPETKYEDTMQYEFHVNGEPVVPHLEKNKGLFSEDYTETHYASDGREITTSPSVQDHCYYYGYIQNEADSSAAISACDGLKGHFKHQGETYFIEPLKLSNSEAHAIYKDENVEEEDETPKICGLTQTTWESDEPFKNTSLLIYTPEQNRYLQAKKYIEFYVAVDNRMYRHYKRNKTVIKRRVYELVNILNTIFRRLNFYIALIGLEIWSKRDKVNVQSDVKVTLKSFGKWREKKVAATQKEYNAQLLTRIDFNGNTVGLAALGALCSVKYSVAVIQDYSKRTSMVASTMAHEMGHNLGINHDRASCTSCGSNKCIMSTKRTKPAYRFSSCSVREHRRYLLRDRPQCILNKPLITDIVAPAICGNYFVEVGEECDCGSPRDCQSACCNAATCKLKHGAQCDSGECCRKCKFKKAGAKCRAVKDDCDLPERCTGRSAECPTDIFRRNGLPCQNNQGYCYNGKCPTLTNQCIAFMGPNVKVSRDSCFTLNQRGKGCGYCRMQNGAKFPCAAKDIKCGKLFCKKRNSKICNCLISPDDPNYGMVEPGTKCGDGVVCSNRKCVKLQRVY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that inhibits platelet aggregation and degrades fibrinogen. {ECO:0000250}.,Metalloprotease
442,A8QL49,VM3_BUNMU,3.4.24.-,Zinc metalloproteinase-disintegrin-like BmMP (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQALLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKVPLLPKGGVQNPQPKTKYEDTVQYEFEVNGEPVVLHLERNKGLFSEDYTEAHYAPDGREITTRPPVQDHCYYHGYIQNEADSSAAISACDGLKGHFKHQGETYFIEPLKLSDSEAHAIYKDENVEEENETPKICGLTETTWESDEPIRNASLLIYTPEQNRYLKVKKYIEFYVAVDNRMYRHYKRNKPIIKRRVYELVNILNTILRRLNFHIALIGLEIWSKRDKINVQSDVKATLKSFGKWREKKLLPRKRNDNAQLLTRIDFNGNTVGLAALGSLCSVKYSVAVIQDYSKRTSMVASTMAHEMGHNLGINHDRASCTSCGSNKCIMATKRTKPASRFSSCSVREHQRYLLRDRPQCILNKPLITDIVAPAICGNYFVEVGEECDCGSPRDCRSACCNAATCKLKHEAQCDSGECCGKCKFKKVGAKCRAAKDDCDLPERCTGRSAECPTDIFRRNGLPCQNKQGYCYNGKCPTLTNQCIALMGPNVKVSRDSCFTLNQRGKGCGYCRMQNGAKIPCAAKDIKCGKLFCKKRNSGVCNCLILPDDPNYGMVETGTKCGDGMVCSDRKCVKLQTVY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that inhibits platelet aggregation and degrades fibrinogen. {ECO:0000250}.,Metalloprotease
443,A8QL58,OXLA_NAJAT,1.4.3.2,L-amino-acid oxidase (LAO) (NA-LAAO) (EC 1.4.3.2),MNVLFIFSLLFLAALESCADDRRSPLEKCFQEADYEDFLEIARNGLKETSNPKHVVVVGAGMAGLSAAYVLAGAGHKVTLLEASERVGGRVITYHNDREGWYVNMGPMRLPERHRIVREYIRKFGLKLNEFFQENENAWYYINNIRKRVWEVKKDPSLLKYPVKPSEEGKSASQLYQESLRKVIEELKRTNCSYILNKYDSYSTKEYLIKEGNLSRGAVDMIGDLLNEDSSYHLSFMESLKSDALFSYEKRFDEIVGGFDQLPISMYQAIAEMVHLNARVIKIQYDAEKVRVTYQTPAKTFVTADYVIVCSTSRAARRIYFEPPLPPKKAHALRSIHYRSATKIFLTCSKKFWEADGIHGGKSTTDLPSRFIHYPNHNFTSGIGVIMAYVLADDSDFFQALDTKTCADIVINDLSLIHDLPKREIQALCYPSIKKWNLDKYTMGSITSFTPYQFQDYFESAAAPVGRIHFAGEYTGRFHGWIDSTIMTGLRAARDVNRASQKPSKIR,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:18180850). Shows activity on L-Leu (PubMed:18180850). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities (By similarity). This protein induces platelet aggregation by both hydrogen peroxide production and binding to platelet membrane proteins (that would enhance the sensitivity of platelets to hydrogen peroxide). Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:18180850}.",Vascular Interaction
444,A8QL59,VM3_NAJAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like NaMP (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQPLLVAICLVVFPYQGSSTILESGKVRDYEVVYPQKIPSLPKGRLQRREEKTKYENTMKYEFKVNGEPVVLNLEKNKRLFSKDYTETHYSPDGREITTSPPVQDHCYYHGHIQNDADSTAVIRACDGLNGYFKSNGEMYIIEPLKLSDSEAHAVFKYESLEKEDETPKTCGAIHNSGESDETIKKISNTFVTPEKGEEYLEAEKHIELYMVADNLVYRKYSSNITVVRMRIFEILNYVNLYYKILNIHVVLIGLEVWSDEDKILINGSSELTVRSFAAWRHSDLLKHKRNDNAQLLTGIHFDKRVLGIAFIGGMCNNFTSVGAIQDNSIHAVLIAATMTHELGHNLGMNHDTDSCTCNTGPCIMKAALNFKPPYEFSSCSYWDFQNYIMTKSAQCILNDPLTTDIVPTAICGNGFVEEGEECDCGPPEICKNECCEAATCKLKPEAQCASGACCEECQFRRAGELCRAAKDDCDLDELCTGQSAECPMNHFHMNGHPCQNNQGYCFRGTCPTLTKQCIALWGPDAEVAPDGCFMNNQKGNYYGYCKKKNGTNIPCEPENVKCGRLYCIDDSTEENSCKFHFSNENANSGMVQPGTKCGEGMVCGFGECIGLETALGINQ,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that inhibits platelet aggregation and degrades fibrinogen. {ECO:0000250}.,Metalloprotease
445,A8Y7P1,VKTB1_DABSI,,Kunitz-type serine protease inhibitor B1 (BBPTI-1) (BPTI-1) (Trypsin inhibitor 1) (Trypsin inhibitor B1),MSSGGLLLLLGLLTLWAELTPISGHDRPKFCYLPADPGECLAHMRSFYYDSESKKCKEFIYGGCHGNANKFPSRDKCRQTCGGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that has activity against chymotrypsin (Ki=4.77 nM) but not against trypsin. {ECO:0000269|PubMed:23428970}.,Serine Protease
446,B0FXM1,VSP13_CRODU,3.4.21.-,Thrombin-like enzyme gyroxin B1.3 (SVTLE gyroxin B1.3) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHNFLVALYEYWSQSFLCGGTLINGEWVLTAAHCDRKHILIYVGVHDRSVQFDKEQRRFPKEKYFFNCRNNFTKWDKDIMLIRLNKPVSYSEHIAPLSLPSSPPIVGSVCRVMGWGTIKSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATSRILCAGVLEGGIDTCHRDSGGPLICNGEFQGIVSWGDGPCAQPDKPALYSKVFDHLDWIQNIIAGSETVNCPS,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Displays a specificity similar to trypsin. Releases only fibrinopeptide A in the conversion of fibrinogen to fibrin. Reversibly increases the permeability of the blood brain barrier (BBB) in mice (PubMed:11137545, PubMed:20637222). Induces the barrel rotation syndrome in mice, which is manifested by gyroxin-like, rapid rolling motions (PubMed:11137545, PubMed:20637222). This syndrome may be due to its effect on BBB permeability, and certainly also to other actions affecting endogenous substrates present in the endothelium, nervous tissues or blood (PubMed:11137545, PubMed:20637222). Also shows a moderate inhibitory activity on the human voltage-gated potassium channel Kv10.1/KCNH1/EAG1 (58% current inhibition at 5 uM) (PubMed:32161292). It blocks Kv10.1/KCNH1/EAG1 in a time and dose-dependent manner and with a mechanism independent of its enzymatic activity (By similarity). It may have a preference in interacting with Kv10.1/KCNH1/EAG1 in its closed state, since the inhibitory effect of the toxin is decreased at more depolarized potentials (By similarity). {ECO:0000250|UniProtKB:A0A0S4FKT4, ECO:0000269|PubMed:11137545, ECO:0000269|PubMed:20637222, ECO:0000269|PubMed:32161292}.",Serine Protease
447,B0FXM2,VSP14_CRODU,3.4.21.-,Thrombin-like enzyme gyroxin B1.4 (SVTLE gyroxin B1.4) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHNFLVALYEYWSQSFLCGGTLINGEWVLTAAHCDRTHFLIYVGVHDRSVQFDKEQRRFPKEKYFFNCGNNFTKWDKDIMLIRLNKPVRNNEHIAPLSLPSSPPSVGSVCRVMGWGQTTSPQNTLPDVPHCANINLLDYEVCRTALPQLRLPATSRILCAGVLEGGIDTCNRDSGGPLICNGEFQGIVFWGPDPCAQPDKPALYSKVFDHLDWIQSIIAGNTIVNCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Displays a specificity similar to trypsin. Releases only fibrinopeptide A in the conversion of fibrinogen to fibrin. Shows coagulant, esterase and amidase activities (By similarity). Reversibly increases the permeability of the blood brain barrier (BBB) in mice. Induces the barrel rotation syndrome in mice, which is manifested by gyroxin-like, rapid rolling motions. This syndrome may be due to its effect on BBB permeability, and certainly also to other actions affecting endogenous substrates present in the endothelium, nervous tissues or blood. {ECO:0000250, ECO:0000269|PubMed:11137545, ECO:0000269|PubMed:20637222}.",Serine Protease
448,B0FXM3,VSP17_CRODU,3.4.21.-,Thrombin-like enzyme gyroxin B1.7 (SVTLE gyroxin B1.7) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRLLAIVYTNSSQCAGTLINQEWVLTAAHCDGENMDIYLGVHNESVQYDDEEGRVAAEKFFCLSSRNYTKWDKDIMLIRLNIPVRNSTHIAPLSLPSSPPSVGSVCRVMGWGTITSPNETYPDVPHCANINLFDYEVCLAAYPEFGLPATSRTLCAGIQQGGKDTCGSDSGGSLICNGQFQGIVSWGDNPCAQPHKPALYTKVLDDTEWIQSIIAGNTAVTCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Displays a specificity similar to trypsin. Releases only fibrinopeptide A in the conversion of fibrinogen to fibrin. Shows coagulant, esterase and amidase activities (By similarity). Reversibly increases the permeability of the blood brain barrier (BBB) in mice. Induces the barrel rotation syndrome in mice, which is manifested by gyroxin-like, rapid rolling motions. This syndrome may be due to its effect on BBB permeability, and certainly also to other actions affecting endogenous substrates present in the endothelium, nervous tissues or blood. {ECO:0000250, ECO:0000269|PubMed:11137545, ECO:0000269|PubMed:20637222}.",Serine Protease
449,B0VXV3,TXVE1_SISCA,,Snake venom vascular endothelial growth factor toxin 1 (svVEGF) (VEGF-F),MAAYLLAVAILFCIQGWPSGTVQGQAMPFMEVFERSVCQTREMLVSILDEHPDEVAHLFRPSCVTVLRCGGCCTDESLMCTATGKRSVGREIMRVDPRKETSKIQVMQFTEHTKCECRPRSGRVNSGKRKRNPEEGGAESQVPLGLTSF,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces angiogenesis in vitro (By similarity). Like other crotalid VEGFs, this protein interacts with VEGF receptor-1 (FLT1) with a high affinity, whereas it binds to VEGF receptor-2 (KDR) with a low affinity (By similarity). {ECO:0000250|UniProtKB:P67862, ECO:0000250|UniProtKB:P83942, ECO:0000250|UniProtKB:Q330K6}.",Vascular Interaction
450,B0VXV4,TXVE_SISCA,,Snake venom vascular endothelial growth factor toxin 2 (svVEGF) (VEGF-F),MAAYLLAVAILFCIQGWPSGTVQGQAMPFMEVFERSVCQTREMLVSILDEHPDEVAHLFRPSCVTVLRCGGCCTDESLMCTATGKRSVGREIMRVDPRKETSKIEVMQFTEHTECECRPRSGRVNSGKRKRNPEEGGAESQVPLGLTSF,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces angiogenesis in vitro (By similarity). Like other crotalid VEGFs, this protein interacts with VEGF receptor-1 (FLT1) with a high affinity, whereas it binds to VEGF receptor-2 (KDR) with a low affinity (By similarity). {ECO:0000250|UniProtKB:P67862, ECO:0000250|UniProtKB:P83942, ECO:0000250|UniProtKB:Q330K6}.",Vascular Interaction
451,B0ZT25,VSPH_PROJR,,Snake venom serine protease homolog (TjsvSPH) (Serine proteinase-like protein),MVLVRVLANLLMLQLSYAQKSSELIIGGDECNINEHRFLVALYTFRSRRFHCSGTLINEEWVLSAARCDRKNIRIQLGMHSTNVINEDVQTRVPKEKFFCLSSKTYTKWNKDIMLIRLKKPVNNSTHIAPVSLPSNPPSLGSVCRVMGWGTISATKETHPDVPYCANINILDYSVCRAAYARLPATSRTLCAGILEGGKDSCLTDSGGPLICNGQFQGIVSWGGHPCGQPRKPGLYTKVFDHLDWIKSIIAGNKDATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease homolog (PubMed:18590752). May act in the hemostasis system of the prey (Probable). {ECO:0000269|PubMed:18590752, ECO:0000305}.",Serine Protease
453,B3EWP2,HYAL_CRODU,3.2.1.35,Hyaluronidase CdtHya1 (Hya) (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor),MQAKAPMYPNEPFLVFWNAPTTQCRLRYKVDLDLNTFHIVTNAR,Glycosyl hydrolase 56 family,"FUNCTION: Snake venom endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. In venom, it is not toxic by itself, but increases the diffusion of other venom proteins such as crotoxin (a neurotoxic and myotoxic PLA2) by degrading the extracellular matrix. In addition, it displays antiedematogenic activity, since it significantly diminishes the oedematogenic activity of crotoxin (probably by direct substrate hydrolysis, since hyaluronan possesses strong water-binding capacity). {ECO:0000269|PubMed:22940594, ECO:0000269|Ref.1}.",Neurotoxin
455,B5U6Y4,PA2HS_ECHOC,,Phospholipase A2 homolog (svPLA2 homolog) (PLA2-Eoc15),MRALWIVAVWLIGVEGSVVELGKMIIQETGKSPFPSYTSYGCFCGGGEKGTPKDATDRCCFVHSCCYDKLPDCSPKTDRYKYQRENGEIICENSTSCKKRICECDKAVAVCLRENLQTYNKKYTYYPNFLCKGEPEKC,"Phospholipase A2 family, Group II subfamily, S49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Shows high myotoxin activities and displays edema-inducing activities (By similarity). Has cytotoxic activities against HUVEC cells (LC(50)=5.0 uL) and human lung adenocarcinoma A549 cells (LC(50)=5.2 uL). {ECO:0000250|UniProtKB:P48650, ECO:0000269|PubMed:23747272}.",Phospholipase
456,B5U6Z2,PA2A_MACLN,3.1.1.4,Acidic phospholipase A2 MVL-PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLMGVEGHLTQFGDMINKKTGTFGLLSYVYYGCYCGLGGKGKPQDATDRCCFVHDCCYGTVNGCDPKLSTYSYSFQNGDIVCGDDDPCLRAVCECDRVAAICFGENMNTYDKKYMLYSLFDCMEESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays an inhibitory effect, independent from its catalytic activity, on tumor cell adhesion and migration. This effect is mediated via specific inhibition of integrins alpha-5/beta-1 (ITGA5/ITGB1), alpha-v/beta-3 (ITGAV/ITGB3) and alpha-v/beta-6 (ITGAV/ITGB6). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:19351557}.",Phospholipase
457,B6EWW8,V5NTD_GLOBR,3.1.3.5,Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase),MQTPKRRRGAQGCPRSSPSPPLLLLVGAVWFCAALSVAAGSFELTILHTNDVHARVEQTSRDSGKCTGQDCYGGVARRATKIRELRANHSHVLLLDAGDQYQGTIWFSFFKGREVVKFMNSLGYDAMALGNHEFDNGLAGLLDPLLKHANFPILSANIRPKGSIASNISGYILPYKIINVGSEKVGIIGYTTKETPVLSNPGPYLEFRDEVEELQKHANKLTTLGVNKIIALGHSGFFEDQRIARKVKGVDVVVGGHTNTFLYTGSPPSTEVAAGNYPFMVKSDDGRQVPVVQAYAFGKYLGYLNVIFDDKGNVIKSSGNPILLNKNISEDQDVKAEVNKMKIQLHNYSSQEIGKTIVYLNGTTQACRFHECNLGNLICDAVIYNNVRHPDYNEWNHVSMCIVNGGGIRSPIDERANNGTITLEELTAVLPFGGTFDLLQIKGCALKQAFEHSVHRHGQGMGELLQVSGIKVVYDLSRKPGSRVVSLNVLCTECRVPTYVPLEKEKTYKLLLPSFLAGGGDGYHMLKGDSSNHSSGNLDISIVGDYIKRMGKVFPAVEGRVIFSAGTLFQAQLFLTWGLCISLLYFIL,5'-nucleotidase family,"FUNCTION: Hydrolyzes nucleotides into nucleosides (By similarity). Snake venom 5'-nucleotidases are widely distributed among venomous snake taxa, but there is a lack of information about their biological activities. They have been shown to inhibit platelet aggregation. This effect may be due to the liberation of inhibitory AMP or adenosine by its action on ADP released upon initiation of aggregation. Venom 5'-nucleotidases are also known to synergistically act in vivo with other toxins like ADPases, phospholipases, and disintegrins to exert a more pronounced anti-coagulant effect. {ECO:0000250|UniProtKB:P0DJJ5, ECO:0000305|PubMed:20186872}.",Phospholipase
458,B6RLX2,VKTCT_OPHHA,,Kunitz-type serine protease inhibitor TCI (Trypsin and chymotrypsin bi-functional serine protease inhibitor) (OH-TCI),MSSGRLLLLLGLLTLWAELTPVSGLGRPKFCELPAVSGFCKAYIPSFYYNPDASACQKFIYGGCGGNANKFKTIEECHRTCVG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that strongly inhibits chymotrypsin (Ki=84.6 nM) and trypsin (Ki=391 nM). {ECO:0000269|PubMed:18582511}.,Serine Protease
460,B7U492,VM1V1_AGKPL,3.4.24.-,Snake venom metalloproteinase VMP1 (AplVMP-I) (AplVMP1) (SVMP) (EC 3.4.24.-),MIQVLLVTICLAAFPYQGSSIILESGNVNDYEIVYPRKVTPVPRGAVQPKYEDAMQYELKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISTCNGLKGHFKLQGEMYLIEPLELSDSEAHAVYKYENVEKEDEAPKMCGVTQNWESYEPTKKAFQLNLTPEQQGFPQRYVELVIIADHRMYMKYKRDSNKITQWVHQMVNTINEIYRPLNIQFALVGLEIWSNQDLITVTSVSDDTLISFANWRETVLLRRKSHDNAQLLTAIVFDEGIIGRAPLAGMCDPNRSVGTVQDHSKINFRVAIIMAHEIGHNLGMGHDDNSCTCGGYSCIMLPRLSKQPSKLFSDCSKKDYLTFLKVKNPQCILNKPLRTDTVSTPVSGNELLEA,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: This venom zinc protease has fibrinolytic activity. The recombinant enzyme cleaves both alpha- (FGA) and beta-chains (FGB) of fibrinogen, but not the gamma-chain. The recombinant protein does not produce hemorrhage in mice and does not have effect on ADP- or collagen-stimulated platelet aggregation. {ECO:0000269|PubMed:19375443}.",Metalloprotease
461,C0HJC1,PA2_BOTLA,3.1.1.4,Acidic phospholipase A2 BlatPLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLLQFREMITKMTGKEPIFFYAFYGCYCGLGGRGKPQDATDRCCFVHDCCYGKVTGCDPKKDIYTYSEENGAFVCGGDDPCKKEICECDKNAAICFRNDLDTYDYKYLLYSPENCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Acidic phospholipase A2 (PLA2) that only causes a mild edema, when subcutaneously injected in the mice foot. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:23872034}.",Phospholipase
462,C0HJD7,3L24_DENPO,,Alpha-elapitoxin-Dpp2d (Alpha-EPTX-Dpp2d),RTCNKTFSDQSKICPPGENICYTKTWCDAFCSQRGKRVELGCAATCPKVKAGVEIKCCSTDNCNKFQFGKPR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (IC(50)=114 nM) and neuronal (alpha-7/CHRNA7) (IC(50)=58 nM) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. Competitive radioligand binding assays also demonstrate that this toxin competes with epibatidine binding to the Lymnaea stagnalis acetylcholine-binding protein (Ls-AChBP) (IC(50)=4.9 nM). {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:24867092}.",Neurotoxin
464,C0HJU2,VM11_BOTPA,3.4.24.-,Snake venom metalloproteinase BpMP-1 (SVMP) (EC 3.4.24.-) (Fibrinogenolytic metalloproteinase),YIELAVVADHGMFTKYNSNVNTIRTWVHEMVNSLNGFFRSMXVDDASLVNLEVWSKTLTSFGEWRDLLPRISHDHAQLLTTIVFDQQTIGIAYTAGMCDPSQSVAVVMDHVAVTMAHELGHNLGMDHDDTCTCGAKSCIMASTISKGLSFEFSDCSQNQYQTYVTKHNPQCILNK,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Non-hemorrhagic snake venom zinc metalloprotease that hydrolyzes the Aalpha-chain of fibrinogen, more slowly the Bbeta-chain and shows no effect on the gamma chain. Has no coagulant activity on bovine plasma and fibrinogen. {ECO:0000269|PubMed:22008900}.",Metalloprotease
465,C0HK16,PA2BD_DABRR,3.1.1.4,Basic phospholipase A2 daboxin P (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLLEFGKMILEETGKLAIPSYSSYGCYCGWGGKGTPKDATDRCCFVHDCCYGNLPDCNNKSKRYRYKKVNGAIVCEKGTSCENRICECDKAAAICFRQNLNTYSKKYMLYPDFLCKGELVC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits anticoagulant activity, probably by binding to factor X and its activated form factor Xa (F10). Shows no cytotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:27089306}.",Phospholipase
466,C0HKC1,PA2HB_AGKCN,,Basic phospholipase A2 homolog APC-K49 (svPLA2 homolog) (ApcP2),SVLELGKMILQETGKNAITSYGSYGCNCGWGHRGQPKDATDRCCFVHKCCYKKLTDCNHKTDRYSYSWKNKAIICEEKNPCLKEMCECDKAVAICLRENLDTYNKKYKAYFKLKCKKPDTC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that lacks enzymatic activity (PubMed:28633930). Is myotoxic and displays edema-inducing activities (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:28633930}.",Phospholipase
467,C0HKC2,PA2HB_AGKPL,,Basic phospholipase A2 homolog APL-K49 (svPLA2 homolog) (AplP2),MRTLWIVALLLVGVEGSVLELGKMILQETGKNAITSYGSYGCNCGWGHRGQPKDATDRCCFVHKCCYKKLTDCNHKTDRYSYSWKNKAIICEEKNPCLKEMCECDKAVAICLRENLDTYNKKYKAYFKLKCKKPDTC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that lacks enzymatic activity (PubMed:28633930). Does not show antibacterial activity (PubMed:29928892). Is myotoxic and displays edema-inducing activities (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:28633930, ECO:0000269|PubMed:29928892}.",Phospholipase
468,C0HL97,VM3_CROVE,3.4.24.-,Zinc metalloproteinase-disintegrin-like uracoina-1 (EC 3.4.24.-) (Snake venom metalloprotease) (SVMP),HQKYNPFRFVELVLVVDKAM,"Venom metalloproteinase (M12B) family, P-III subfamily","FUNCTION: Snake venom zinc metalloprotease that possesses hemorrhagic activity (minimum hemorrhagic dose, MHD=4.7 ug) when injected intradermally into mice. Degrades the alpha-chain of fibrinogen (FGA). {ECO:0000269|PubMed:11451438}.",Metalloprotease
469,C0HLA3,VSP4_LACMR,3.4.21.-,Snake venom serine protease LmrSP-4 (SVSP) (EC 3.4.21.-),VFGGDECNINEHRSLVVLFDSDGFLCAGTLINKEWVLTAAHCDSENFQMQLGV,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that has fibrinogenolytic activity. Hydrolyzes the alpha-chain of fibrinogen (FGA), without affecting the beta- and the gamma-chains. Also displays hydrolytic activity towards S-2302 (plasma kallikrein substrate) and S-2251 (substrate for plasmin), but has no hydrolytic activity with S-2238 (thrombin substrate) or S-2222 (factor Xa). {ECO:0000269|PubMed:31131000}.",Serine Protease
470,C0HLB2,VKT_PSEPC,,Kunitz-type serine protease inhibitor PPTI (Pseudocerastes persicus trypsin inhibitor) (PPTI),EDRPKFCYLPDDPGVCKAHIPRFYYNPASNKCKEFIYGGCGGNANNFETRAECRHTCVASRKGGPRRP,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that weakly inhibits trypsin (Ki=0.2 uM) (PubMed:30452896). May have potassium channel blocking activities (PubMed:30973886). {ECO:0000269|PubMed:30452896, ECO:0000305|PubMed:30973886}.",Serine Protease
471,C0HM67,VM1RI_LACMR,,Snake venom metalloproteinase rhomb-I (Hemorrhagic metalloproteinase rhomb-I),FSQKYIELVVVADHGMFTKYNGNLNTIRTRVHEIVNTLNGFYRSLNVRVSLTELEIWSNQDLINVQSAAADTLKTFGEWRERVLLNRISHDNAQLLTAIDLADNTIGIAYTGGMCYPKNSVGIVQDHSPKTLLIAVTMAHELGHNLGMKHDENHCHCSASFCIMPPSISEGPSYEFSDCSKDYYQMFLTKRKPQCILNKP,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom zinc metalloproteinase that induces hemorrhage. {ECO:0000269|Ref.1}.,Metalloprotease
474,C0K3N2,TXVE_AGKPI,,Snake venom vascular endothelial growth factor toxin apiscin (svVEGF) (VEGF-F),MAAYLLAVAILFCIQGWPSGTVQGQAMPFMEVYTRSACQTRETLVSILEEHPHEISHLFKPSCVTVLRCGGCCSDESLTCTSTGKRSVGREIMRVDPHKETSKIEVMQFTEHTDCECRPQSASG,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces angiogenesis in vitro (By similarity). Like other crotalid VEGFs, this protein interacts with VEGF receptor-1 (FLT1) with a high affinity, whereas it binds to VEGF receptor-2 (KDR) with a low affinity (By similarity). {ECO:0000250|UniProtKB:P67862, ECO:0000250|UniProtKB:P83942, ECO:0000250|UniProtKB:Q330K6}.",Vascular Interaction
475,C0K3N3,TXVE_CROAT,,Snake venom vascular endothelial growth factor toxin cratrin (svVEGF) (VEGF-F),MAVYLLAVAILFCIQGWPSGTVQGQAMSFMEVYERSVCQTREMLVSILDEYPSEVAHLFRPSCVTVLRCGGCCTDESLTCTATGKRSVGREIMRVDPRKGTSKIEVMQFTEHTECECRPRSTVNNGKRKKNPKEGEPRAKFPLV,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces angiogenesis in vitro (By similarity). Like other crotalid VEGFs, this protein interacts with VEGF receptor-1 (FLT1) with a high affinity, whereas it binds to VEGF receptor-2 (KDR) with a low affinity (By similarity). {ECO:0000250|UniProtKB:P67862, ECO:0000250|UniProtKB:P83942, ECO:0000250|UniProtKB:Q330K6}.",Vascular Interaction
478,C0LZJ5,VM3LC_MACLN,,Disintegrin-like leberagin-C,IVSPPVCGNELLENGEECDCGSPANCRNPCCDAASCRLHSWVECESGECCDQCRFVTAGTECRATRSECDLAGQCTGQSADCPIDRFHRNGQPCLQNYGYCYNGKCPIMHHQCYYLFGANATVAQDACFEENKNGIGDFYCRKQSDRLIPCAPEDVKCGRLFCEILPNTRCKHAPGDNGMVDPGTKCEDKKVCFNRKCVDVNTVY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: Inhibits platelet aggregation induced by thrombin and arachidonic acid with IC(50) of 40 and 50 nM respectively (in rabbit platetelet-rich plasma). It also inhibits the adhesion of melanoma tumor cells on fibrinogen and fibronectin, by interfering with the function of alpha-V/beta-3 (ITGAV/ITGB3) and, to a lesser extent, with alpha-V/beta-6 (ITGAV/ITGB6) and alpha-5/beta-1 (ITGA5/ITGB1) integrins. {ECO:0000269|PubMed:19808093}.",Fibrinogenolytic Enzyme
479,C1IC45,PA2A2_WALAE,3.1.1.4,Acidic phospholipase A2 PL-II (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGASSIRPLPLHLGQFNNMIKCTIPGSTPWWDFSDYGCYCGYGGSGTPVDQLDRCCQTHDNCYTEAQKFSGCSPYRRKYSYECSEGTLTCKSDNDECAAFVCNCDRLAAICFAGAPYNSNNVDIDLEARCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that may act in the hemostasis system of the prey (By similarity). Exhibits hydrolytic activities, and prefers the anionic micelles (dPPC with deoxycholate) (54 umol/mg/min) to the zwitterionic micelles (dPPC with Triton X-100) (15 umol/mg/min). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000250, ECO:0000269|PubMed:18405934}.",Phospholipase
480,C1IC46,PA2A1_WALAE,3.1.1.4,Acidic phospholipase A2 PL-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGASSIRPLPLHLGQFNNMIKCTIPGSTPWWDFSDYGCYCGYGGSGTPVDQLDRCCQTHDNCYTEAQKFSGCSPYTRKYSYECSEGTLTCKSDNDECAAFVCNCDRSAAICFARAPYNSNNVDIDLEAHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that may act in the hemostasis system of the prey (By similarity). Exhibits hydrolytic activities, and prefers the anionic micelles (dPPC with deoxycholate) (793 umol/mg/min) to the zwitterionic micelles (dPPC with Triton X-100) (591 umol/mg/min). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000250, ECO:0000269|PubMed:18405934}.",Phospholipase
481,C1IC47,3S13_WALAE,,Three-finger toxin W-III,MKTLLLTLVVVTIVCLDLGHTFVCHNQQSSQPPTTTNCSGGENKCYKKQWSDHRGSITERGCGCPTVKKGIKLHCCTTEKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000269|PubMed:960110}.",Neurotoxin
482,C1IC49,3NO25_WALAE,,Three-finger toxin W-V,MKTLLLTLVLVTIVCLDLGYTLTCLICPKKYCNQVHTCRNGENLCIKTFYEGNLLGKQFKRGCAATCPEARPREIVECCSRDKCNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily","FUNCTION: Three-finger toxin that binds and inhibits the muscular nicotinic acetylcholine receptor (nAChR). The neuromuscular block is irreversible in chick biventer cervicis, but partially reversible in the rat diaphragm preparation. {ECO:0000269|PubMed:960110}.",Neurotoxin
483,C5H5D1,VM31_CRODC,3.4.24.-,Zinc metalloproteinase-disintegrin-like crotastatin (EC 3.4.24.-) (Crotastatin-1) (Snake venom metalloprotease) (SVMP) (Vascular apoptosis-inducing protein-like) (VAP-like),EQQKYLNAKKYVKLFLVADYIMYLKYGRNLTAVRTRMYDIVNVITPIYHRMNIHVALVGLEIWSNTDKIIVQSSADVTLDLFAKWRATDLLSRKSHDNAQLLTGINFNGPTAGLGYLGGICNTMYSAGIVQDHSKIHDLVAIAIAHEMGHNLGMDHDKDTCTCGTRPCIMAGVLSCEASFLFSDCSQKDHQEFLIKNMPQCILKKPLKTDVVSPAVCGNYFVEVGEECDCGSPRTCRDPCCDAATCKLRQGAQCAEGLCCDQCRFKGAGTECRAAKDECDMADVCTGRSTECTDRFQRNGQPCKNNNGYCYNGKCPIMADQCIALFGPGATVSQDACFQFNREGNHYGYCRKEQNTKIACEPQDVKCGRLYCFPNSPENKNPCNIYYSPNDEDKGMVLPGTKCADGKACSNGQCVDVT,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that induces apoptosis in vascular endothelial cells (VEC), without degrading the extracellular matrix (it cannot cleave collagen) or inhibiting adhesion of VEC. Has also fibrinogenolytic and hemorrhagic activities (By similarity). {ECO:0000250}.",Metalloprotease
484,C5H5D2,VM31_BOTAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like batroxstatin-1 (EC 3.4.24.-) (Snake venom metalloprotease) (SVMP) (Vascular apoptosis-inducing protein-like) (VAP-like),EQQKYLNARKYIELVIVADNVMVKKYTSNSTAIRTRIYSCVNTLNLIYSAFNTHIALTGVEIWSNGDKINVQSNSSVTLDFFGTWRETVLLNRKRHDNAQLLTAIDLDGPTVGLAYVGSMCNPKGSTGLIQDHNKLDVMVAITMAHELGHNLGMNHDGNQCNCGGNPCIMSATLDFEPVYQFSDCSRDQHWRYLIDNRPPCILNIPLRTDIVSPPVCGNYFVEVGEECDCGLPANCQNQCCNAATCKLIPGAQCEDGECCERCQFKGAGTECRAARSECDIAESCTGQSPECPTDDFQRNGQPCLNNQGYCYNGNCPILDHQCHNLFGAGATVAPNACFDFNRKGQGNSYCRKQNGVTIPCARKDIKCGRLFCVQGPIGNTISCQSTSSQDDPDIGMVDLGTKCGDGRVCNSNRECVDVTTPY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that induces apoptosis in vascular endothelial cells (VEC), without degrading the extracellular matrix (it cannot cleave collagen) or inhibiting adhesion of VEC. Has also fibrinogenolytic and hemorrhagic activities (By similarity). {ECO:0000250}.",Metalloprotease
485,C5H5D4,VM33_BOTAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like batroxstatin-3 (EC 3.4.24.-) (Snake venom metalloprotease) (SVMP) (Vascular apoptosis-inducing protein-like) (VAP-like),EQQRYLNATKYIKLVIVADNVMVRKYTHNLIDIRKRIFEIVNILSLIYLSMNINVALVGVDIWTNGDKINVTSAVEPTLASFGTWRERDLLNRKTHDNAQLLTGINLNGDTVGYAYIGSMCMPKQSVGIVQDHGKTYHLVAVTMAHELGHNLGMDHDRDSCTCLANSCIMSATISPSYQFSDCSQNDHLRYLISHTPQCILNEPLRTDIVSPEVCGNYLLEEGEECDCGPLWNCQNPCCNAATCKLTPGAQCAEGLCCYQCRFIKAGNVCRPPRSECDIAESCTGQSAHCPTDRFHRNGQPCLNNHGYCYNGNCPIMLYQCIALFGAGTTVAEDVCFNYNLDGQGFFYCRRENDRIFPCAKEDVKCGRLYCKVYNDNVHPCRYQYLDNGMVDHGTKCAVGKVCSNRQCVDVNTP,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that induces apoptosis in vascular endothelial cells (VEC), without degrading the extracellular matrix (it cannot cleave collagen) or inhibiting adhesion of VEC. Has also fibrinogenolytic and hemorrhagic activities (By similarity). {ECO:0000250}.",Metalloprotease
486,C7G1G6,PA2B3_PROFL,3.1.1.4,Basic phospholipase A2 BP-III (svPLA2) (EC 3.1.1.4) (Basic protein III) (BPIII) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVDGSLVQLWKMIFQETGKEAAKNYGLYGCNCGVGRRGKPKDATDSCCYVHKCCYKKVTGCNPKMDSYSYSWKNKAIVCGENNPPCLKQVCECDKAVAICLRENLGTYNKKYTIYPKPFCKKADTC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has low phospholipase A2 activity (By similarity). Shows anticoagulant activities, strong myolytic activity, infiltration of polymorphonuclear cells, and edema in stromal tissues. Induces cell death of Jurkat cells in a concentration dependent manner. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000250, ECO:0000269|PubMed:19463843}.",Phospholipase
487,C9DPL5,PA2A1_BOTPI,3.1.1.4,Acidic phospholipase A2 BpirPLA2-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 1B),NLWQFGKLIMKIAGESGVFKYLSYGCYCGLGGQGQPTDATDRCCFVHDCCYGKVTGCDPKIDSYTYSKENGDVVCGGDDPCKKQICECDRVAATCFRDNKDTYDIKYWFYGAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen/ADP-induced platelet aggregation, and induces hypotension in rats (activity abolished in the presence of p-bromophenacyl bromide). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:21331602}.",Phospholipase
488,C9E1R7,VM2V2_CROAT,3.4.24.-,Zinc metalloproteinase-disintegrin VMP-II (CaVMP-II) (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKELFSEDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVYKYENVEKEDEAPKMCGVTQNWESHEPIKKASQSNLPPEQEELLKRYIELVVVADHRMYTIYDGDKTEISSIIYEIVNILTQIFRPLHIRVALIGLEIWSSGELSKVTLSADDTLEAFGEWRETVLMNRKRHDHAQLLTGMIFSGTIEGRTYKSRMCDPKHSVGIVRDHRTRRHFVANRMAHELGHNLGIDHDRDSCSCGANSCIMSATVSNEPSSQFSDCSLNQYLKHIIHYHYTTCLYNEPSKTDIVSPPVCGNYYTEVGEDCDCGPPANCQNPCCDAATCKVTTGSQCAEGLCCDQCKFMKEGTVCRVARGDWNNDICTGQSAECPNKGYYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIb sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that inhibits ADP-induced platelet aggregation (probably by binding integrin alpha-IIb/beta-3 (ITGA2B/ITGB3)) and degrades fibrinogen. {ECO:0000250}.,Metalloprotease
489,C9E1R8,VM3V3_CROVV,3.4.24.-,Zinc metalloproteinase-disintegrin-like VMP-III (CvvVMP-III) (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAAFPYQGSSIILESGNVNDYEIVYPRKVTALPKGAVQPKYEDAMQYELKVSGEPVVLHLEKNKQLFSKDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVYKYENVEKEDEALKMCGVTQNWESYEPIKKASQLVVTAEHQKYNPFRFVELFLVVDKAMVTKNNGDLDKIKTRMYEIVNTVNEIYRYMYIHVALVGLEIWSNEDKITVKPEAGYTLNAFGEWRKTDLLTRKKHDNAQLLTAIDLDRVIGLAYVGSMCHPKRSTGIIQDYSEINLVVAVIMAHEMGHNLGINHDSGYCSCGDYACIMRPEISPEPSTFFSNCSYFECWDFIMNHNPECILNEPLGTDIISPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYDLFGADVYEAEDSCFERNQKGNYYGYCRKENGNKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNEDEHKGMVLPGTKCADGKVCSNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
490,C9E1R9,VM2V2_CROVV,3.4.24.-,Zinc metalloproteinase/disintegrin VMP-II [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin viridistatin-2 (Disintegrin beta subunit)],MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGELYLIEPLKFPDSEAHAVFKYENVEKEDNAPKMCGVTQNWKSYEPIKKASQLNLTPEQQRFPQRYIELVIVADHRMFTKYNSNLNTIRIWVHEIVNTINVFYRSLHIVVSLTDLEIWSNQDQINVQSAAADTLEAFGEWRETVLLNRISHDNAQLLTAINFQGNIIGRAYTGSMCDPRKSVGIITDHSAINLWVAVTMAHELAHNLGISHDGNQCHCDANSCIMSEELSEELSFEFSDCSLNQYQTYLTDHNPQCMLNEPLGTDTVSRNELLEAGEECDCGSPANPCCDAATCKLRPGAQCAEGLCCDQCRFIKKGKICRRARGDNPDDRCTGQSADCPRNRFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily",FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin viridistatin-2]: This recombinant protein inhibits ADP-induced platelet aggregation in whole human blood and this effect is concentration-dependent with an IC(50) of 34 nM. {ECO:0000269|PubMed:22465495}.,General Toxin
491,C9E1S0,VM3V3_AGKPL,3.4.24.-,Zinc metalloproteinase-disintegrin-like VMP-III (AplVMP-III) (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTLCLAAFPYQGSSIILDSGNVNDYEVVYPRKVTALPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSIEDHCYYRGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVYKYENIEKEDEAPKMCGVTQTNWKSDEPIKKASQLVVTPEEQRYLNTKKYIELVIVADNVMVKKYTSNSTAIRTRIYACVNTLNLIYRAFNIYIALIGLEIWSNRDLINVQSASSVTLDLFGTWRETVLLRHKRHDNAQLLTGINFDGDTVGLAYVGSMCDPKRSAGIIQDHNKLDVMVAIAMAHELGHDLGINHDGNQCNCGGNPCIMSATLNFEPVYRFSDCSRDEHWRYLIDNRPPCILNKPSITDIVSPPVCGNYFVEVGEECDCGLPAHCQNPCCDAATCKLRPETQCEDGECCEQCQFTRAGTECRAARSECDIAESCTGQSAECPTDDFQRNGQPCLNNNGYCYNGTCPILTNQCISFFGSSATVAPDVCFDFNLQGQGNFYCRRERARIFPCAPQDKKCGRLFCVKGPIGNTISCQSTSSQSDLDIGMVDLGTKCGDGRVCNSNRQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
492,C9E1S1,VM2V2_AGKPL,3.4.24.-,Zinc metalloproteinase/disintegrin VMP-II (AplVMP2) [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin beta subunit],MIQVLLVTLCLAAFPYQGNSIILESGNVNDYEVLYPQKVTALPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSSDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKGDEAPKMCGVTQTNWKSDKPIKKASQLNLTPEQQRFPQRYIELVVVADHRMFTKYNGNLNTIRIWVHELVNTMNVFYRPLNIHVSLTDLEVWSDQDLINVQPAAADTLEAFGDWRETVLLNRISHDNAQLLTAIELDGETIGLANRGTMCDPKLSTGIVQDHSAINLWVAVTMAHEMGHNLGISHDGNQCHCDANSCIMSEELRQQLSFEFSDCSQNQYQTFLTDHNPQCMLNEPLRTDIVSTPVSGNELWETGEESDFDAPANPCCDAETCKLRPGAQCAEGLCCDQCKFMKEGTVCHRAKGDDLDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Has fibrinolytic activity. The recombinant enzyme cleaves both alpha- (FGA) and beta-chains (FGB) of fibrinogen, but not the gamma-chain. The recombinant protein does not produce hemorrhage in mice and does not have effect on ADP- or collagen-stimulated platelet aggregation. {ECO:0000269|PubMed:19375443}.; FUNCTION: [Disintegrin beta subunit]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
496,D2YVH7,LECM_OXYSU,,C-type lectin mannose-binding isoform (CTL) (Venom C-type lectin mannose-binding isoform 1),MGRFLLVTLSLLVGAFSLNEANSCCCPQDWLPKNGFCYKVFNDHKNWNDAEMFCRKFKPGCHLASIHSNADSADLAEYVSDYLKSDGNVWIGLNDPRKQRTWVWSDRSPTNYYSWNRGEPNNSKNNEYCVHLWALSGYLKWNDTPCKALYSFICQCRF,True venom lectin family,FUNCTION: Mannose-binding lectin that binds to and agglutinates rabbit (but not human) erythrocytes in a calcium-dependent manner. {ECO:0000269|PubMed:21115100}.,Binding Protein
497,D2YW39,SLEC_CALRH,,Snaclec rhodocetin subunit gamma,DFNCLPGWSAYDQHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNIKRPELYVWIGLRDRRKEQQCSSEWSMSASIIYVNWNTGESQMCQGLARWTGFRKWDYSDCQAKNPFVCKFPSEC,Snaclec family,"FUNCTION: Potent inhibitor of collagen-induced platelet aggregation. It acts by binding to the integrin alpha2A domain and blocks collagen binding to integrin alpha-2/beta-1 (ITGA2/ITGB1). The gamma/delta subunits mainly contribute to this activity. {ECO:0000269|PubMed:11121411, ECO:0000269|PubMed:12871211}.",Kunitz Family
498,D2YW40,SLED_CALRH,,Snaclec rhodocetin subunit delta,CPLHWSSYNGYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTLKYTSMWLGLNNPWKECKWEWSDDAKLDYKVWLRRPYCAVMVVKTDRIFWFNRGCEKTVSFVCKFYS,Snaclec family,"FUNCTION: Potent inhibitor of collagen-induced platelet aggregation. It acts by binding to the integrin alpha2A domain and blocks collagen binding to integrin alpha-2/beta-1 (ITGA2/ITGB1). The gamma/delta subunits mainly contribute to this activity. {ECO:0000269|PubMed:11121411, ECO:0000269|PubMed:12871211}.",Kunitz Family
499,D6MKR0,PA2A6_CROHD,3.1.1.4,Acidic phospholipase A2 CH-E6' (svPLA2) (EC 3.1.1.4) (CH-E6) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVLLLGVEGSLVQFEMMIMEVAKRSGLLWYSAYGCYCGWGGHGRPQDATDRCCFVHDCCYGKATDCNPKRVSYTYSEENGEIVCGGDDPCGTQICECDKAAAICFRDNIPSYDNKYWLFPPKNCQEEPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows high lipolytic and weak ADP-induced platelet aggregation activities. Also shows weak anticoagulant activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
500,D8VNS0,VM3_CERRY,3.4.24.-,Zinc metalloproteinase-disintegrin-like (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQALLVTICLVGFPHQGSSIILESGNVKDYEVVYPQKIPALPKGGIQRAEPETKYEDTMQYQFKVNGEPVVLHLERNKGLFSEDYSETHYSPDGREITTSPPVQDHCYYHGRIQNDADSTASISACNGLKGRFKHQGETYLIEPLKISDSEAHKIYKSENLEKEDEAPKTCGVTQTSLETDETIKMNFQSANNPEEDYVRKRKYIKLAVVVDNSMYIKYDRNLNDIRSRIYEIVNDVNVFYRLLNIHIALIFIEIWSHQDKINVQPMVRVTLDSFGTWRETDLLPRRSHDNAQLYTNVDFDGPTVGYAYVGSLCKPKHSVAIIQDHTETANMMASTVAHELGHNLGMNHDSGNCICQPTLCVMSETLSSVPFNDFSACSRVDHRNYLIRDLPQCILNKPLRTDIVAPAVCGNNFVEVGGECDCGSPQDCQSTCCDAATCRLRDGAQCDTEECCEQCRFRRAGTVCRAAKDDCDVAEFCTGRTADCPMDGLQRNGEPCQHNQGYCYNGKCPIMTNQCIALWGPDATVSQDGCFHFNENGQGDLYCRRENGVNIQCEPQDNKCGRLFCVQSTSTVQCNYRSSATDPDYGMVAIGTKCGDGRVCNNNRFCVDIRIAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloprotease that may induce platelet aggregation. {ECO:0000269|PubMed:20158271}.,Metalloprotease
502,E2ITZ3,3S11A_NAJAT,,Alpha-elapitoxin-Na1a (Alpha-EPTX-Na1a) (Three-finger toxin),MKTLLLTLLVVTIVCLDLGYTLECHNQQSSQTPTTTGCSGGETNCYKKRWRDHRGYRTERGCGCPSVQTAIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Strong post-synaptic neurotoxin that probably binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission (PubMed:32473162). Abolishes in vitro indirect twitches in a concentration- and time-dependent manner and abolishes contractile responses to exogenous acetylcholine and carbachol (PubMed:32473162). Its inhibitory effects on nerve-mediated twitches are not reversed by repeat washing, suggesting relatively strong binding of the toxin at the skeletal nAChR (PubMed:32473162). {ECO:0000269|PubMed:32473162}.",Kunitz Family
503,E9NW26,VM2P1_PROMU,3.4.24.-,Zinc metalloproteinase/disintegrin PMMP-1 [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin],MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPNRAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSETYYSPDGRKITTKPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETHLIEPLKLSGSEAHAVFKYENVEKEDEAPKMCGVTETNWESYEPIKKASKLVVTAEPLRYVELVIVADHGMVTKYNGDLDKIREWVHEMVNTVDEIYDYMYIDVILADLEIWTNEDLINVQPSAHHTLDSFGEWRERDLLKRKSHDNAQLLTATDFDGPTIGLAHVASMCDPKRSTGVVQDHSTINLRVAVTLAHEMGHNLGIHHDKGSCSCGGYACIMSPVISHDPSKYFSNCSYIQCWDFIRKHNPQCILNKPLRTDTVSTPVSGNELLEAGEDCDCGSPSNPCCDVGTCKLSPGAQCADGLCCDQCRFKKKGTICRIARGDWNDDRCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily",FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin]: Inhibits platelet aggregation. {ECO:0000250}.,General Toxin
504,E9NW27,VM2P2_PROMU,3.4.24.-,Zinc metalloproteinase/disintegrin PMMP-2 [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin trimucrin],MIQVLLVTICLAVFPYQGSSIILESGNVDDYEVVYPRRVSALPKGAVQPKYEDAMQYEFKVNGEAVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYLIEPLKLPDSEAHAVYKYENIEKEDEAPKMCGVTQNWESDESIKKASQLNLTPLQQRFLQRYVKLAIVVDYRMYIKYNRDSNKITVRAHEMVNHVNEMYKPLNITITLSLLQIWSQNDLITVQPASSITLRLFGNWRKTVLLNQQNHDNAQLLTDIVFNGRTIGKAPVAGMCQPDRSVGVVRDYSSNVFVVAVIMTHELGHNLGMEHDEDKNEKKCKCDTCIMAPAISDPPAQLFSDCSKNDYQLFLTVYNPQCILNAPLRTDTVSTPVSGNEFLEAGEECDCGSPENPCCDAATCKLRPGAQCAEGLCCDQCRFKKKRTICRRARGDNPDDRCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin trimucrin]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3). {ECO:0000250|UniProtKB:P17349}.",Fibrinogenolytic Enzyme
507,F8J2D2,PA222_DRYCN,3.1.1.4,Phospholipase A2 PS22 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASVPPQPLNLVQFGYLIQCANHGSRATWHYMDYGCYCGAGGSGTPVDDLDRCCKIHDDCYGDAEKKGCSPKMLAYDYYCGENGPYCKNIKKECQRFVCACDVQAAKCFAGAPYNDANWNIDTTKHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
510,F8RKV9,VM39_DRYCN,3.4.24.-,Zinc metalloproteinase-disintegrin-like MTP9 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIEVLLVTICFTVFPYQGSSIILESGNVNDYEVVYPQKVPALPKGGVQNPQPETKYEDTMQYEFHVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAAISACDGLKGHFKHRGETYFIEPLKLSNSESHAIYKDEHVEKEDEIPKICGVTQTTSESDEPIEKISQLTNTPEQDRYLQVKKYIELYVVVDNRMYRNYNSNRDAINERVYEMVNTLNVMYRPLNFFIALIGLEIWSNQDEINIEPEVAVTLRSFGEWRNTTLLPRKRNDNAQLLTGIDFNGATVGLAYVGTLCRPTQSVAVIQDHSKRTSMVASTMAHELGHNLGINHDSASCNCNAGPCIMSATISNQPLSEFSSCSVQEHQRYLLRVRPQCILNKPLSTDIVTPPVCGNYFVERGEECDCGSPQDCQDACCNAATCKLQHDCDSGECCEQCKFKKAGAECRAAKDDCDLPESCTGQSAECPTDSFQRNGHPCQNNQGYCYNGKCPIMTNQCIALKGPGVNVSPDECFTLKQNDPECGFCRIENGTKIPCAEKDKMCGKLLCQEGNATCICFPTTDDPDYGMVEPGTKCGDGKVCINRQCVDVQTAY,"Venom metalloproteinase (M12B) family, P-III subfamily",FUNCTION: Snake venom zinc metalloproteinase that may impair hemostasis in the prey.,Metalloprotease
511,F8RKW0,VM38_DRYCN,3.4.24.-,Zinc metalloproteinase-disintegrin-like MTP8 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIEVLLVTICFTVFPYQGSPIILESGNVNDYEVVYPQKVPALPKGGVQNPQPETKYEDTMQYEFHVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAAISACDGLKGHFKHRGETYFIEPLKLSNSESHAIYKDEHVEKEDEIPKICGVTQTTSESDETIEKISQLTNTPEQDRYLQVKKYIELYVVVDNRMYRNYNSNRDAINERVYEMVNTLNVMYRPLNFFIALIGLEIWSNQDEINIEPEVAVTLRSFGEWRNTTLLPRKRNDNAQLLTGIDFNGATVGLAYVGTLCRPTQSVAVIQDHSKRTSMVASTMAHELGHNLGINHDSASCNCNAGPCIMSATISNQPLSEFSSCSVQEHQRYLLRVRPQCILNKPLRKDIVTPPVCGNYFVERGEECDCGSPQDCQSACCNATTCKLQHEAQCDSGECCEQCKFKKAGAECRAAKDDCDLPESCTGQSAKCPTDSFQRNGHPCQNNQGYCYNGKCLIMTNQCIALKGPGVNVSPDECFTLKQNDPECGFCRIENGTKIPCAEKDKMCGKLLCQEGNATCICFPTTDDPDYGMVEPGTKCGDGKVCINRQCVDVQTAY,"Venom metalloproteinase (M12B) family, P-III subfamily",FUNCTION: Snake venom zinc metalloproteinase that may impair hemostasis in the prey.,Metalloprotease
512,F8RKW1,VM34_DRYCN,3.4.24.-,Zinc metalloproteinase-disintegrin-like MTP4 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIEVLLVTICFTVFPYQGSSIILESGNVNDYEVVYPQKVPALPKGGVQNPQPETKYEDTMQYEFHVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAAISACDGLKGHFKHRGETYFIEPLKLSNSESHAIYKDEHVEKEDEIPKICGVTQTTSESDEPIEKISQLTNTPEQDRYLQVKKYIELYVVVDNRMYRNYNSNRDAINERVYEMVNTLNVMYRPLNFFIALIGLEIWSNQDEINIEPEVAVTLRSFGEWRNTTLLPRKRNDNAQLLTGIDFNGATVGLAYVGTLCSPTQSVAVIQDHSKRTSMVASTMAHELGHNLGINHDSASCNCNAGPCIMSATISNQPFSKFSSCSVQEHQRYLLRVRPQCILNKPLSTDIVTPPVCGNYFVERGEECDCGSPQDCQSACCNATTCKPQHEAQCDSGECCEKCKFKKAGAECRAAKDDCDLPESCTGQSAKCPTDSFQRNGHPCQNNEGYCYNGKCPIMTNQCIALGGPGVNVSPDECFTLKQNVPECGFCRIENGRKIPCAEKDKMCGKLLCEKGNATCICFPTTHDPDYGMVEPGTKCGDGKVCINRQCVDVQTAY,"Venom metalloproteinase (M12B) family, P-III subfamily",FUNCTION: Snake venom zinc metalloproteinase that may impair hemostasis in the prey.,Metalloprotease
514,F8S0Z7,V5NTD_CROAD,3.1.3.5,Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase),MQTPKRRRGAQGCPRSSPSPPLLLLVRAVWFCAALSVAAGSFELTILHTNDVHARVEQTSRDSGKCTGQDCYGGVARRATKIRELRAKHRHVLLLDAGDQYQGTVWFNFFKGREVVKFMNSLRYDAMALGNHEFDNGLAGLLDPLLKHANFPILSANIRPKGSIASNISGYILPYKIINVGSEKVGIIGYTTKETPVLSNPGPYLEFRDEVEELQNHANKLTTLGVNKIIALGHSGFSEDQRIARKVKGVDVVVGGHTNTFLYTGSPPSTEVAAGNYPFMVQSDDGRQVPVVQAYAFGKYLGYLNVIFDDKGNVIKSSGNPILLNKDISEDQDIKAEVNKMKIQLHNYSSQEIGKTIVYLNGTTQACRFHECNLGNLICDAVIYNNVRHPDDNEWNHVSMCIVNGGGIRSPIDERTNNGTITLEELTAVLPFGGTFDLLQIKGSALKQAFEHSVHRHGEGMGELLQVSGIKVVYDLSRKPGSRVLSLNVLCTECRVPTYVPLEKEKTYKLLLPSFLAAGGDGYHMLKGDSSNHSSGNLDISIVGDYIKRMGKVFPAVEGRMIFSAGTLFQAQLFLTWGLCVSLLYFIL,5'-nucleotidase family,"FUNCTION: Hydrolyzes nucleotides into nucleosides (By similarity). Snake venom 5'-nucleotidases are widely distributed among venomous snake taxa, but there is a lack of information about their biological activities. They have been shown to inhibit platelet aggregation. This effect may be due to the liberation of inhibitory AMP or adenosine by its action on ADP released upon initiation of aggregation. Venom 5'-nucleotidases are also known to synergistically act in vivo with other toxins like ADPases, phospholipases, and disintegrins to exert a more pronounced anti-coagulant effect. {ECO:0000250|UniProtKB:P0DJJ5, ECO:0000305|PubMed:20186872}.",Phospholipase
515,F8S108,VM34_CROAD,3.4.24.-,Zinc metalloproteinase-disintegrin-like 4a (EC 3.4.24.-) (Snake venom metalloproteinase 7) (SVMP),MIQVLLVTISLAVFPYQGSSVILESGNVNDYEVVYPRKVTALPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPTVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPEQQRYLNAKKYVKLFLVADYIMYLKYGRNLTAVRTRMYDIVNVITPIYHRMNIHVALVGLEIWSNTDKIIVQSSADVTLNLFGNWRATDLLRRKSHDNAQLLTGINFNGPTAGLAYLGGICNTMYSAGIVQDHSKIHHLVAIAMAHEMGHNLGMDHDKDTCTCGTRPCVMAGALSCEASFLFSDCSQKDHREFLIKNMPQCILKKPLKTDVVSPAVCGNYFVEVGEECDCGSPRTCRDPCCDATTCKLRQGAQCAEGLCCDQCRFKGAGTECRAAKDECDMADVCTGRSAECTDSFQRNGQPCKNNNGYCYNGKCPIMADQCIALFGPSATVSQDACFQFNREGNHYGYCRKEQNTKIACEPQDVKCGRLYCFPNSPENKNPCNIYYSPNDEDKGMVLPGTKCADGKACSNGQCVDVTTPY,"Venom metalloproteinase (M12B) family, P-III subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
516,F8S114,VSPCR_CROAD,3.4.21.74,Thrombin-like enzyme crotalase (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Snake venom serine protease 2) (SVSP),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDYWSQSFLCGGTLINEEWVLTAKHCDRTHILIYVGVHDRSVQFDKEQRRFPKEKYFFDCSNNFTKWDKDIMLIRLNKPVSYSEHIAPLSLPSSPPIVGSVCRAMGWGQTTSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATSRTLCAGVLEGGIDTCNRDSGGPLICNGQFQGIVFWGPDPCAQPDKPGLYTKVFDHLDWIQSIIAGEKTVNCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom protein that release fibrinopeptide A from fibrinogen (FGA). Shows both kinin-releasing and coagulant activities. {ECO:0000269|PubMed:1014024, ECO:0000269|PubMed:10348716, ECO:0000269|PubMed:5132665, ECO:0000269|PubMed:7043462, ECO:0000269|PubMed:854881}.",Serine Protease
517,G3DT18,PA2A_BOTMO,3.1.1.4,Acidic phospholipase A2 BmooPLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVLLLGVEGNLWQFEMLIMKIAKTSGFLFYSSYGCYCGWGGHGRPQDATDRCCFVHDCCYGKVTGCNPKTDSYTYSEENGDVVCGGDDPCKKQICECDRVAATCFRDNKDTYDNKYWFYPAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits ADP- and collagen-induced platelet aggregation, has edema-inducing, anti-coagulant activity, antibacterial activity, and cytotoxic activity. In vivo, has a hypotensive effect. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:22571953}.",Phospholipase
518,H6VC05,VKTK1_DABRR,,Kunitz-type serine protease inhibitor DrKIn-I (Daboia russelii Kunitz Inhibitor-I),MSSGGLLLLLGLLTLWAELTPISGQDRPKFCNLAPESGRCRGHLRRIYYNPDSNKCEVFFYGGCGGNDNNFETRKKCRQTCGAPRKGRPT,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor. Inhibits activated protein C (APC) with an IC(50) of 3.5 nM in the presence of heparin (to which it strongly binds) and an IC(50) of 88.9 nM in its absence. Other targets are also significantly inhibited in presence of heparin: trypsin (PRSS1) (45%), coagulation FXIa (F11) (40%), and plasmin (PLG) (70%). In vivo, synergizes with RVV-X in promoting coagulation in mice and by extension in Russell's viper bite patients. {ECO:0000269|PubMed:22416129}.",Serine Protease
519,J3RZ81,LIPE_CROAD,3.1.1.3,Putative endothelial lipase (EC 3.1.1.3),MRACPFLLLLLLPLLLSLGRIAAVRDAAGAGPERRQDDSVSQVQKLREEPSKVRDLQVKFIVRTTPDLDDADCYITAGQDHLLDDCNFNVSAKTFFVIHGWTMGGMYERWLDTLVSALQEREKEANVVVVNWLALAQQLYTIAVNNTRVVGKELAGLLDWLEEKKDFQLKNVHLIGYSLGAHIAGYTGNYARGIIGRITGLDPAGPMFEGADPSRRLSPDDADFVDVLHTYTRETLGISIGIQMPVGHIDIYPNGGDIQPGCGLTDILGTLALGEIGDLVICEHERSVHLFVDSLVNKDKQSFAFQCTDSGRFKKGICLSCRKNRCNSIGYNIKKMRNKRNSKMYLKTRAGMPFKVFHYQLKIHVFSYKSLGETEPSFSVTFYGTSGDSEPLPLEVSDQIGLNYTNTFLVYTEEDVGDILRIKLTWESTTQSWYNFWSQMKNYWSKPDPSSKELQIRRIRVKSGETQKKAMLAVEFWELKSTCLKMVKVEKHCSRPL,"AB hydrolase superfamily, Lipase family",FUNCTION: Has phospholipase and triglyceride lipase activities. {ECO:0000250}.,Phospholipase
520,J3S829,VM32A_CROAD,3.4.24.-,Zinc metalloproteinase-disintegrin-like 2a (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGSSIILGSGNVNDYEVVYPRKVTALPKGAAQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQLNLTPEQQRYLNTKKYIELVIVADNVMVKKYTSNSTAIRTRIYACVNTLNLIYRAFNIHIALVGIEIWSNKDLINVISASNVTLDLFGNWRRRVLLRRKRHDNAQLLTAIDLDGPTIGLARVGSMCDPKCSTGIVQDHSKLDVMVAVTMAHELAHNLGINHDGNQCNCGGNPCIMSATLNFEPAYRFSDCSRDEHWRYLIDNRPPCILNKPLITDIVSPPVCGNYFVEVGEECDCGLPAHCQNPCCNAATCKLRPGTQCEDGECCEQCQFTSAGTECRAAKSECDIAESCTGQSADCPTDNFQRNGRPCLNNNGYCYNGKCPTLDHQCISFFGSSATVAPDVCFNLNLKGEGNFYCRRENTRIFPCAPQDKKCGRLFCVLGPTGNTISCQSTYSQSDLDIGMVDLGTKCGDGRVCNSTRQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
521,J3S830,VM33_CROAD,3.4.24.-,Zinc metalloproteinase-disintegrin-like 3a (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTILAVFPYQGSSIILGSGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPMVLHLEKNKQLFSKDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEIYLIEPLKLRDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQLVVTAEQQRYLNPYRYVELVIVADHGMFTKYNRNLTEVKTWVYEIVNTLNEIYRYLYIRVALVGLEIWSDGDLSNVTLSSGNTLDSFGEWRKRDLLRRKRHDNAQLLTAIDFSGNTIGRASIANMCDPKYSTGIVQDHSPINLLVAVTMAHEMGHNLGLHHDGKSCTCGDYICIMNATLSHQHSKYFSNCSYNQYWDYINTYTPKCILNEPLRTDIISPPVCGNELLEAGEECDCGSPRNCQYQCCDAATCKLHSWVECESGVCCEQCKFRTAGTECRARRSECDIAESCTGQSADCPTDDFHKNGQPCLNNFGYCYNGNCPIMYHQCYALFGSNVYEAEDSCFESNQKGDDYGYCRKENGEKIPCAPEDVKCGRLYCNDNSPGQNDPCKIFPSNEDEHKEMVLPGTKCADGKFCTNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
522,J3S836,VCO3_CROAD,,Venom factor (VF) (CVF-like) (Complement C3 homolog) [Cleaved into: VF alpha chain; VF gamma chain; VF beta chain],MEGMALYLVAALLIGFPASSFGALYTFITPGVLRTDTEEKILVEAHGDNAPKQLDISVHDFPRKQKILYQTRVDMNPAGGMLVTPTITIPAKDLNKDSRQNQYVVVQVTAPGLRLEKVVLLSYQSGFVFIQTDKGIYTPGSPVRYRVFSMDHNMHRMDKTVIVEFQTPQGIVVSSNPVNPASSLIRPYNLPELVSFGTWKAVAKYENSPEESYTALFDVREYVLPGFEVRVQPSEKFLYIDGNTDFHVSITARYLYGKRVEGVAFVLFGVKIDGNKKSIPESLTRIPIIDGDGEATLERHTLSRRFQRLNDLVGHNLYVSVTVITDSGSDMVVTEQSGIHIVTSPYQISFTKTPKYFKPGMPYELMVYVTNPDGSPAANVPVVSESIHSKGTTLSDGTAKLILNTPLNIQSLSITVKTNHRDLPRERQAMKSMTATAYQTQGGSGNYLHIAITSTEIKPGDNLPVSFNVRGNANSLNQIQYFTYLILTKGKIFKVGRQPRGAGQNLVTMTLPITPDLIPSFRFLAYYQVGNSEIVADSVWVDVKDTCMGTLVVKGASSRDNRIQKPGAAMKIKLEGDPGARVGLVAVDKAVYVLSDEYKISQTKIWDTIEKSDFGCTAGSGQNNLGVFEDAGLALATSTSLNTKQRSDAKCPQPENRRRRRSVVLLDSKASKAAQFPDQALRKCCEDGMHENPMGYSCEKREKYIQEGDACKAAFLECCRYIKGIHDENKREDELFLARSDFEDEFFGEDNIISRSDFPESWLWLTENLNAVPNNEGISSKTVPFYLRDSITTWEVLAVSITPTKGICVAEPYEITVMKDFFIDLRLPYSVVKNEQVEVRAILYNYVDDDIDVRVELLHNPAFCSVATETQRYRTQVTIKALSSWAVPFVIVPLQQGLHDIEVRASVRGQLASDGVKKKLKVVPEGMRKDIVTVIELDPSTKGVGGTQEQLVKANELDGKVPDTEIETKISVQGDRVAQIVENSIDGNKLSHLIITPSGCGEQNMITMTPSVIATYYLDTTGQWETLGVDRRTEAVQQIKKGYAQQLVYKKADHSYAAFVNRDSSSWLTAYVVKVFAMATKVVPDISHEIICGGVKWLILNRQQPDGVFKENAPVIHGEMLGGTKGAEPEVSLTAFILIALLESRSICNEHINILESSINKAADYLLKKYEKLQRPYTTALTAYALAAAGLLNDDRVLMAASTERNRWEEHNAYTYNIEGTSYALLALLKMEKFAEANPVVRWLTDQKYYGGTYGQTQATVVGFQGLAEYEIAMPSHKDLNLDIVIKLPEREVPISYRIDATNALRAQTTETKLNEDFTVSASGDGKATMTILTVYNAQLREDANVCNQFHLEVSVERIDSNLKQAKGAKETLKLKICTRYLGEVDSTMTIIDVSMLTGFLPDAEDLTRLSKGVDRYISKFEIDNNMAQKGAVIIYLDKVSHSEDECLQFRIQKHFEVGFIQPGSVKVYSYYNLDEQCTRFYHPDKGTGLLNKICHGNVCRCAEETCSLLNQQKKIDLQLRIQKACEPNVDYVYKAKLLRIEEKDASDIYVMDVLEVIKGGTDRNPQAKPRQYVSQRKCQEALNLKVNNDYLIWGLSSDLWHKKDEISYLITRNTWIERWPNEDECQDEEFQNLCNDFTQLSNTLTIFGCPN,Venom complement C3 homolog family,"FUNCTION: Complement-activating protein in venom. It is a structural and functional analog of complement component C3b, the activated form of C3. It binds factor B (CFB), which is subsequently cleaved by factor D (CFD) to form the bimolecular complex VF/Bb. VF/Bb is a C3/C5 convertase that cleaves both complement components C3 and C5. Structurally, it resembles the C3b degradation product C3c, which is not able to form a C3/C5 convertase. Unlike C3b/Bb, VF/Bb is a stable complex and completely resistant to the actions of complement regulatory factors H (CFH) and I (CFI). Therefore, VF continuously activates complement resulting in the depletion of complement activity (By similarity). {ECO:0000250}.",General Toxin
523,J3SBP3,PDE2_CROAD,3.6.1.-,Venom phosphodiesterase 2 (PDE) (EC 3.6.1.-),MIQQKVLFISLVAVTLGLGLGLGLKESVQPQAQSWSCSKLRCGEKRIANVLCSCSDDCLEKKDCCTDYKSICKGETSWLKDKCASSGATQCPAGFEQSPLILFSMDGFRAGYLENWDSLMPNINKLKTCGTHAKYMRAVYPTKTFVNHYTIATGLYPESHGIIDNNIYDVNLNLNFSLSSSTARNPAWWGGQPIWHTATYQGLKAATYFWPGSEVKINGSYPTIFKNYNKSIPFEARVTEVLKWLDLPKAKRPDFLTLYIEEPDTTGHKYGPVSGEIIKALQMADRTLGMLMEGLKQRNLHNCVNLILLADHGMEEISCDRLEYMANYFNNVDFFMYEGPAPRIRSKNVPKDFYTFDSEGIVKNLTCRKPKQYFKAYLSKDLPKRLHYANNIRIDKVNLMVDQQWMAVRDKKFTRCKGGTHGYDNEFKSMQAIFLAHGPGFNEKNEVTSFENIEVYNLMCDLLKLKPAPNNGTHGSLNHLLKNPFYTPSPAKEQSSPLSCPFGPVPSPDVSGCKCSSITELEKVNQRLNLNNQAKTESEAHNLPYGRPQVLQNHSKYCLLHQAKYISAYSQDILMPLWSSYTIYRSTSTSVPPSASDCLRLDVRIPAAQSQTCSNYQPDLTITPGFLYPPNFNSSNFEQYDALITSNIVPMFKGFTRLWNYFHTTLIPKYARERNGLNVISGPIFDYNYDGHFDSYDTIKQHVNNTKIPIPTHYFVVLTSCENQINTPLNCLGPLKVLSFILPHRPDNSESCADTSPENLWVEERIQIHTARVRDVELLTGLNFYSGLKQPLPETLQLKTFLPIFVNPVN,Nucleotide pyrophosphatase/phosphodiesterase family,"FUNCTION: Hydrolyzes ADP with high activity. Shows weak or no activity on 5'-AMP, 5'-GMP, 3'-AMP, ATP, cAMP, and cGMP. Is devoid of monophosphatase and proteinase activities. Dose-dependently inhibits platelet aggregation induced by ADP (IC(50)=0.99 uM) and collagen (IC(50)=1.4 uM). {ECO:0000250|UniProtKB:W8E7D1}.",Hydrolase
524,J3SBP9,VM28_CROAD,3.4.24.-,Zinc metalloproteinase-disintegrin 8 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAAQPKYEDAMQYEFKVNGEPVVLHLEKNKELFSEDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEASKMCGVTETNWESYEPIKKASQLNLPPEQQRFPQTYIELVVVADHRMYTKYDGDKTEISSIIYEIVNTLTQIFRPLHIRVALIGLEIWSSGELSKVTLSADDTLEAFGEWRETVLMNRKRHDNAQLLTGMIFNETIEGRTYKSGMCNPKHSVGIVRDYRTRRHFVANRMAHELGHNLGIDHDRDSCTCGANSCIMSATVSNEPSSQFSDCSLNKYLNYIVRYQSTTRCLHNEPSETDIVSPPFCGNYFKEVGEDCDCGPPANCQNPCCDAATCKLTTGSQCAEGLCCDQCKFTKKGTACRPARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily",FUNCTION: Inhibits ADP-induced platelet aggregation (probably by binding integrin alpha-IIb/beta-3 (ITGA2B/ITGB3)) and degrades fibrinogen. {ECO:0000250}.,Fibrinogenolytic Enzyme
525,J3SDW6,VM32D_CROAD,3.4.24.-,Zinc metalloproteinase-disintegrin-like 2d (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGSSIILGSGNVNDYEVVYPRKVTALPKGAAQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQLNLTPEQQRYLNTKKYIELVIVADNVMVKKYTSNSTAIRTRIYACVNTLNLIYRAFNIHIALVGIEIWSNKDLINVISASNVTLDLFGNWRRRVLLRRKRHDNAQLLTAIDLDGPTIGLARVGSMCDPKCSTGIVQDHSKLDVMVAVTMAHELAHNLGINHDGNQCNCGGNPCIMSATLNFEPAYRFSDCSRDEHWRYLIDNRPPCILNKPLITDIVSPPVCGNYFVEVGEECDCGLPAHCQNPCCNAATCKLRPGTQCEDGECCEQCQFTSAGTECRAAKSECDIAESCTGQSADCPTDNFQRNGRPCLNNNGYCYNGKCPTLDHQCISFFGSSATVAPDVCFNLNLKGEGNFYCRRENTRIFPCAPQDKKCGRLFCVLGPTGNTISCQATSSQSNVDIGMVDLGTKCGDGRVCNSNRQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
526,J3SDW8,VM38_CROAD,3.4.24.-,Zinc metalloproteinase-disintegrin-like 8 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGSSIILGSGNVNDYEVVYPRKVTALPKGAAQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQLNLTPEQQRYLNTKKYIELVIVADNVMVKKYTSNSTAIRTRIYACVNTLNLIYRAFNIHIALVGIEIWSNGDLINVTSAANVTLDLFGNWRRRVLLRHKRHDNAQLLTAIDFDGPTVGLAYGASMCDPRFATGIVQDHSKLDIMVAVTMAHELGHNLGMNHDGNQCNCGGNPCIMSATLNFEPAYQFSDCSRDEHWRYLIDNRPPCILNKPSITDIVSPPVCGNYFVEVGEECDCGLPARCQNPCCNAATCKLRPGTQCEDGECCEQCQFKGAGTECRAASSECDIAESCTGQSADCPTDDFQRNGQPCLNNNGYCYNGTCPTLDDQCISFFGSSKTVAPDVCFNLNLQGQGDFYCRRENTRIFPCAPQDKKCGRLFCVLGPTGNTISCQSTYSQSDLDIGMVDLGTKCGDGRVCNSTRQCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
527,J3SEZ3,PDE1_CROAD,3.6.1.-,Venom phosphodiesterase 1 (PDE) (EC 3.6.1.-),MIQQKVLFISLVAVTLGLGLGLGLKESVQPQVSCRYRCNETFSKMASGCSCDDKCTERQACCSDYEDTCVLPTQSWSCSKLRCGEKRIANVLCSCSDDCLEKKDCCTDYKSICKGETSWLKDKCASSGATQCPAGFEQSPLILFSMDGFRAGYLENWDSLMPNINKLKTCGTHAKYMRAVYPTKTFVNHYTIATGLYPESHGIIDNNIYDVNLNLNFSLSSSTARNPAWWGGQPIWHTATYQGLKAATYFWPGSEVKINGSYPTIFKNYNKSIPFEARVTEVLKWLDLPKAKRPDFLTLYIEEPDTTGHKYGPVSGEIIKALQMADRTLGMLMEGLKQRNLHNCVNLILLADHGMEEISCDRLEYMANYFNNVDFFMYEGPAPRIRSKNVPKDFYTFDSEGIVKNLTCRKPKQYFKAYLSKDLPKRLHYANNIRIDKVNLMVDQQWMAVRDKKFTRCKGGTHGYDNEFKSMQAIFLAHGPGFNEKNEVTSFENIEVYNLMCDLLKLKPAPNNGTHGSLNHLLKNPFYTPSPAKEQSSPLSCPFGPVPSPDVSGCKCSSITELEKVNQRLNLNNQAKTESEAHNLPYGRPQVLQNHSKYCLLHQAKYISAYSQDILMPLWSSYTIYRSTSTSVPPSASDCLRLDVRIPAAQSQTCSNYQPDLTITPGFLYPPNFNSSNFEQYDALITSNIVPMFKGFTRLWNYFHTTLIPKYARERNGLNVISGPIFDYNYDGHFDSYDTIKQHVNNTKIPIPTHYFVVLTSCENQINTPLNCLGPLKVLSFILPHRPDNSESCADTSPENLWVEERIQIHTARVRDVELLTGLNFYSGLKQPLPETLQLKTFLPIFVNPVN,Nucleotide pyrophosphatase/phosphodiesterase family,"FUNCTION: Hydrolyzes ADP with high activity. Shows weak or no activity on 5'-AMP, 5'-GMP, 3'-AMP, ATP, cAMP, and cGMP. Is devoid of monophosphatase and proteinase activities. Dose-dependently inhibits platelet aggregation induced by ADP and collagen. {ECO:0000250|UniProtKB:W8E7D1}.",Hydrolase
528,J9Z332,VM2_CROAD,3.4.24.-,Zinc metalloproteinase-disintegrin VMP-II (CamVMP-II) (EC 3.4.24.-) (Disintegrin r-Cam-dis) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQLKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLKLSDSEAHAVYKYENVEKEDEASKMCGVTETNWESYEPIKKASQSNIPPEEEAFYQRYIELVVVADHRMYTKYDGDKTEISSIIYEIVNTLTQIFRPLHIRVALIGLEIWSSGELSKVTLSADDTLEAFGEWRKTVLMNRKRHDNAQLLTGMIFNETIEGRTYKSGMCNPKHSVGIVRDYRTRRHFVANRMAHELGHNLGIDHDRDSCTCGANSCIMSATVSNEPSSQFSDCSLNKYLNYIVRYQSTTRCLHNEPSETDIVSPPFCGNYFKEVGEDCDCGPPANCQNPCCDAATCKLTTGSQCAEGLCCDQCKFTKKGTACRPARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIb sub-subfamily","FUNCTION: Zinc metalloproteinase-disintegrin VMP-II: inhibits ADP-induced platelet aggregation (probably by binding integrin alpha-IIb/beta-3 (ITGA2B/ITGB3)) and degrades fibrinogen. {ECO:0000250}.; FUNCTION: Recombinant disintegrin r-Cam-dis (413-488): this recombinant protein inhibits platelet adhesion to fibrinogen (IC(50) is 1 nM), inhibits collagen- (IC(50) is 18 nM) and ADP-induced (IC(50) is 6 nM) platelet aggregation, and also inhibits platelet function on clot retraction. May act by binding integrin alpha-IIb/beta-3 (ITGA2B/ITGB3). {ECO:0000269|PubMed:23313448}.",Metalloprotease
529,K9MCH1,3S11_MICLL,,Three-finger toxin A1 (MlatA1) (Short chain alpha-neurotoxin A1),MKTLLLTLVVVTIVCLDFGHTRICYNQQSSQPPTTKTCSEGQCYKKTWRDHRGTIIERGCACPNVKPGIQISCCTSDKCNG,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds and inhibits fetal (alpha-1-beta-1-gamma-delta/CHRNA1-CHRNB1-CHRNG-CHRND, IC(50)=1.4 nM), adult (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE, IC(50)=12 nM) and neuronal alpha-7/CHRNA7 (IC(50)=400 nM) nicotinic acetylcholine receptors (nAChR) thereby impairing neuromuscular and neuronal transmissions. {ECO:0000269|PubMed:23438486}.",Neurotoxin
531,N0AAE6,VAE1_GLOHA,3.4.21.-,Thrombin-like enzyme agkihpin-1 (TLE agkihpin-1) (EC 3.4.21.-) (Agkihpin) (Snake venom arginine esterase) (SVAE) (Snake venom thrombin-like enzyme) (SVTLE),MILGDDECNINEHRFLVALYTSRTLFCGGTLINQEWVLTAAHCNMEDIQIKLGMHSKKVPNEDEQKRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSAHIAPLSLPSSPPSVGSVCRTIGWGRISSTKETYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCVGDSGGPLICNGQFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIENIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like enzyme that shows fibrinogenolytic activity against bovine fibrinogen alpha and beta chains, but not gamma chain. Hydrolyzes fibrin. Enhances ADP-induced human platelet aggregation. Has arginine esterase activity for TAMe (tosyl-arginine methyl ester) substrate. Reduces thrombin-induced thrombosis. Does not have hemorrhagic activity. Reduces the motility of human liver cancer HepG2 cells in a wound-healing assay. {ECO:0000250|UniProtKB:N0A5N4}.",Serine Protease
532,O13069,VSP2_BOTJA,3.4.21.-,Thrombin-like enzyme KN-BJ 2 (SVTLE) (EC 3.4.21.-) (Kinin-releasing and fibrinogen-clotting serine protease 2),MVLIRVLANLLILQLSYAQKASELIIGGRPCDINEHRSLALVKYGNFQCSGTLINQEWVLSAAHCDGEKMKIHLGVHSKKVPNKDKQTRVAKEKFFCLSSKNYTKWDKDIMLIRLDSPVKNSAHIAPISLPSSPPIVGSVCRIMGWGTISTSKVILSDVPHCANINLLNYTVCRAAYPELPATSRTLCAGILQGGKDTCVGDSGGPLICNGQFQGIVSWGSDVCGYVLEPALYTKVSDYTEWINSIIAGNTTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease that clots fibrinogen (FGA) by releasing only fibrinopeptide A. Also releases bradykinin from bovine low-molecular-mass kininogen (KNG). {ECO:0000269|PubMed:9490060}.,Serine Protease
533,O42138,VM3AD_AGKCL,3.4.24.-,Zinc metalloproteinase-disintegrin-like ACLD (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) (VMP-III) (AclVMP-III),MIQVLLVTLCLAVFPYQGSSIILESGNVNDYEVVYPRKVTVLPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKQLFSKDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIDPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQLNLTPEQQAYLDAKKYVEFVVVLDHGMYTKYKDNLDKIKTRIFEIVNTMNEMFIPLNIRVALICLEIWSDKDKFNMTSAANVTSISFRNWRATDLLKRKSHDNAQLLTVIDFDGPTIGKAYMASMCDPKRSVGIIQDHSTINLMMAVTMAHEMGHNLGMDHDEKYCTCGAKSCVMAKALSRQPSKLFSNCSQEDYRKYLIKRRPKCILNEPNGTDIVSPPVCGNELLEVGEECDCGSPTNCQNPCCDAATCKLTPGSQCADGVCCDQCRFTRAGTECRQAKDDCDMADLCTGQSAECPTDRFQRNGHPCLNDNGYCYNRTCPTLKNQCIYFFGPNAAVAKDSCFKGNQKSNNHTYCRKENGKKIPCAPQDIKCGRLYCFRNLPGKKNICSVIYTPTDEDIGMVLPGTKCEDGKVCSNGHCVDVNIAYKSTTGFSQI,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Is a potent activator of prothrombin (F2). Does not elicit any hemorrhagic response. Barely inhibits collagen-induced platelet aggregation. Binds neither collagen, nor the jararhagin-monoclonal antibody MAJar3. Hydrolyzes the Aalpha-chain of fibrin and fibrinogen, without affecting the Bbeta- and gamma-chains. Is capable of triggering endothelial pro-inflammatory and procoagulant cell responses, but fails to trigger apoptosis. Induces von Willebrand factor release, and the expression of both ICAM1 and E-selectin (SELE) (without increase in VCAM1) in endothelial cells (HUVEC). Is also able to up-regulate the synthesis of the coagulation factor TF (F3). Enhances nitric oxide (NO) generation, prostacyclin production and interleukin-8 release (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
534,O42187,PA2BB_GLOHA,3.1.1.4,Basic phospholipase A2 B (svPLA2) (EC 3.1.1.4) (BPLA(2)) (Phosphatidylcholine 2-acylhydrolase) (bAhp),MRALWIVAVLLLGVEGSLLQFRKMIKKMTGKEPVVSYAFYGCYCGSGGRGKPKDATDRCCFVHDCCYEKLTGCDPKWDDYTYSWKNGTIVCGGDDPCKKEVCECDKAAAICFRDNLKTYKKRYMTYPNILCSSKSEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows potent hemolytic activity, and exhibits medium anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (IC(50) is 90 nM). It is one of the few phospholipases A2 capable of hydrolyzing the phospholipids of E.coli membranes in the presence of a bactericidal/permeability-increasing protein (BPI) of neutrophils. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:10728829, ECO:0000269|PubMed:18062812}.",Phospholipase
536,O42207,VSPE2_GLOUS,3.4.21.-,Thrombin-like enzyme CPI-enzyme 2 (SVTLE) (EC 3.4.21.-) (Capillary permeability-increasing enzyme 2),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLALVFNSSGFLCSGTLINQEWVLTAAHCDMENMRIYLGVHNESVQYDDEQTRVPEEKFFCLRSNNDTKWDKDIMLIRLDSPVNNSAHIAPLNLPFNPPMLGSVCRIMGWGAITSPNEIYSSVPHCANINVLHYSMCRAVYPGMPAQTRILCAGIQTGGIDTCSGDSGGPLICNGQFQGIVSWGRYPCAKPRAPGLYTRVFDYTDWIENIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that cleaves fibrinogen beta (FGB) releasing fibrinopeptide B. Promotes capillary permeability-increasing activity through the release of peptides from the beta-chain of fibrinogen. {ECO:0000269|PubMed:8303715, ECO:0000269|PubMed:8303716, ECO:0000269|PubMed:9133714}.",Serine Protease
537,O73795,VM2MB_GLOBR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase Mt-b (SVMP) (EC 3.4.24.-); Disintegrin],MIQVLLVIICLAAFPYQGTSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLPKNKALPSKDYIETHYSPDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYLIEPLKLSNSEAHAVYKYEDVEKEDEAPKMCGVTQNWESYEPIKYEDVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPAHQRYIELVIVADHGMFTKYNGDSDKIREWVRQMVNTVDEIYSYMYIDVALAGLQIWSNEDLINVQPAAPHTLDSFGKWRERDLLHRIHHDNAMLLTAIDFDGPTIGLAYVGTMSNPKGSTGVVQDHSTINFRVAVTMAHEIGHNLGIHHDTGSCSCGGYSCIMSPVISHEPSKYFSDCSYTQCWDFIMNQKPQCILNKPLRTDTVSTPVSGNELLEAGEECDCGSPGNPCCDAATCKLRQGAQCAEGLCCDQCRFMKEGTICRRGRGDDLDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase Mt-b]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
538,O93426,SLA_CRODU,,Snaclec convulxin subunit alpha (CVX-alpha),MGRFIFVSFGLLVLFLSLSGTGAGLHCPSDWYYYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLDLYITKCSLLKKETGFRKWFVASCIGKIPFVCKFPPQC,Snaclec family,"FUNCTION: Snake venom lectin that activates platelets by binding to the platelet collagen receptor glycoprotein VI (GP6) (PubMed:9153205). The indirect activation of integrin alpha-IIb/beta-3 (ITGA2B/ITGB3) also induced by the toxin is upstream the cytoskeletal translocation of GPIb, FcRgamma (FCER1G) and 14-3-3zeta (YWHAZ) (PubMed:16102113). {ECO:0000269|PubMed:16102113, ECO:0000269|PubMed:9153205}.",General Toxin
539,O93427,SLB_CRODU,,Snaclec convulxin subunit beta (CVX-beta),MGRFIFVSFGLLVVFLSLSGSEAGFCCPSHWSSYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGANNIWNKCNWQWSDGTKPEYKEWHEEFECLISRTFDNQWLSAPCSDTYSFVCKFEA,Snaclec family,"FUNCTION: Snake venom lectin that activates platelets by binding to the platelet collagen receptor glycoprotein VI (GP6) (PubMed:9153205). The indirect activation of integrin alpha-IIb/beta-3 (ITGA2B/ITGB3) also induced by the toxin is upstream the cytoskeletal translocation of GPIb, FcRgamma (FCER1G) and 14-3-3zeta (YWHAZ) (PubMed:16102113). {ECO:0000269|PubMed:16102113, ECO:0000269|PubMed:9153205}.",General Toxin
543,P00602,PA2A1_NAJMO,3.1.1.4,Acidic phospholipase A2 CM-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFKNMIHCTVPSRPWWHFADYGCYCGRGGKGTAVDDLDRCCQVHDNCYGEAEKLGCWPYLTLYKYECSQGKLTCSGGNNKCEAAVCNCDLVAANCFAGAPYIDANYNVNLKERCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that causes myonecrosis when injected intramuscularly, shows indirect hemolytic activity, abolishes twitches evoked by indirect stimulation earlier than those by direct stimulation (in the mouse phrenic nerve-diaphragm preparation) but does not produce complete neuromuscular block (up to 30 ug/ml) (in the chick biventer cervicis nerve-muscle preparation) (PubMed:3615669). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:3117784, ECO:0000269|PubMed:3615669}.",Phospholipase
544,P00604,PA2B3_NAJMO,3.1.1.4,Basic phospholipase A2 CM-III (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFKNMIHCTVPSRPWWHFADYGCYCGRGGKGTPVDDLDRCCQVHDNCYEKAGKMGCWPYFTLYKYKCSQGKLTCSGGNSKCGAAVCNCDLVAANCFAGARYIDANYNINFKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows several activities. It shows strong anticoagulant activity, probably by binding to coagulation factor Xa (F10) and inhibiting the formation of the prothrombinase complex (PubMed:15922780), shows direct hemolytic action, causes neuromuscular blockade with a gradual contracture and a decreased sensitivity to ACh and KCl, abolishes twitches evoked by indirect stimulation earlier than those by direct stimulation (in the mouse phrenic nerve-diaphragm preparation), and causes myonecrosis when injected intramuscularly (PubMed:3615669). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15922780, ECO:0000269|PubMed:3615669}.",Phospholipase
545,P00605,PA2B4_NAJNG,3.1.1.4,Phospholipase A2 'basic' (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme III/IV) (CM-III/CM-IV),NLYQFKNMIHCTVPSRPWWHFADYGCYCGRGGKGTPVDDLDRCCQVHDNCYEKAGKMGCWPYLTLYKYKCSQGKLTCSGGNSKCGAAVCNCDLVAANCFAGARYIDANYNINFKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows strong anticoagulant activity. Binds directly with the coagulation factor FXa (F10) and blocks the formation of the prothombinase complex. Acts by a nonenzymatic mechanism (PubMed:10462445). Also inhibits the complex composed of tissue factor (F3) and coagulation factor VIIa (F7) (TF-VIIa complex) by both enzymatic and nonenzymatic mechanisms (PubMed:8866616). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:10462445, ECO:0000269|PubMed:2271532, ECO:0000269|PubMed:2814939, ECO:0000269|PubMed:8866616}.",Phospholipase
547,P00609,PA2B5_NOTSC,3.1.1.4,Basic phospholipase A2 notechis II-5 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLVQFSYLIQCANHGRRPTRHYMDYGCYCGWGGSGTPVDELDRCCKIHDDCYSDAEKKGCSPKMSAYDYYCGENGPYCRNIKKKCLRFVCDCDVEAAFCFAKAPYNNANWNIDTKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. Notechis II-5 is less toxic than notexin but has a higher specific phospholipase activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
548,P00610,PA2B_HYDSC,3.1.1.4,Basic phospholipase A2 (svPLA2) (EC 3.1.1.4) (Myotoxin) (Phosphatidylcholine 2-acylhydrolase) (Toxin VI-5) (Toxin VI:5b),NLVQFSYVITCANHNRRSSLDYADYGCYCGAGGSGTPVDELDRCCKIHDDCYGEAEKQGCYPKMLMYDYYCGSNGPYCRNVKKKCNRKVCDCDVAAAECFARNAYNNANYNIDTKKRCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has several activities. It is myotoxic, has weak anticoagulant activity and inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:3117784}.",Phospholipase
553,P00622,PA2B_BITCA,3.1.1.4,Basic phospholipase A2 caudoxin (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLIQFGNMISAMTGKSSLAYASYGCYCGWGGKGQPKDDTDRCCFVHDCCYGKADKCSPKMILYSYKFHNGNIVCGDKNACKKKVCECDRVAAICFAASKHSYNKNLWRYPSSKCTGTAEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows anticoagulant activity and presynaptic neurotoxicity. Acts as an anticoagulant toxin by inhibiting prothrombinase complex formation. Shows about 50% of the prothrombinase complex inhibition compared to CM-IV of N.nigricollis venom. Acts as a neurotoxin by inhibiting neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:10462445, ECO:0000269|PubMed:7135414}.",Phospholipase
554,P00979,VKTH1_DENPO,,Kunitz-type serine protease inhibitor homolog dendrotoxin I (DTX-I) (Dendrotoxin-1) (Venom basic protease inhibitor 1),QPLRKLCILHRNPGRCYQKIPAFYYNQKKKQCEGFTWSGCGGNSNRFKTIEECRRTCIRK,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor homolog that blocks voltage-gated potassium channels (Kv1.1/KCNA1, Kv1.2/KCNA2, and Kv1.6/KCNA6) (IC(50)=0.13-50 nM). {ECO:0000269|PubMed:8612784}.",Serine Protease
555,P00983,MAMB7_DENPO,,Mambaquaretin-7 (MQ7) (Kunitz-type serine protease inhibitor homolog dendrotoxin B) (DTX-B) (Mambaquaretin-8) (MQ8) (Protein B) (Upsilon-Dp2b) (Upsilon-Dp2c) (Venom basic protease inhibitor B),RPYACELIVAAGPCMFFISAFYYSKGANKCYPFTYSGCRGNANRFKTIEECRRTCVV,Venom Kunitz-type family,"FUNCTION: The mixture of mambaquaretin-7 and mambaquaretin-8 interacts with vasopressin V2 receptor (V2R/AVPR2), probably in a selective manner (PubMed:35122240). This mixture inhibits vasopressin binding human V2R in the nanomolar range (Ki=3.14 nM), and also potently inhibits vasopressin-induced cAMP production (IC(50)=58 nM) (PubMed:35122240). In vivo, intraperitoneal injection of this protein into rats increases diuresis, without any loss of electrolytes (By similarity). {ECO:0000250|UniProtKB:A0A1Z0YU59, ECO:0000269|PubMed:35122240}.",Vascular Interaction
556,P00987,VKTH1_BUNMU,,"Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B1 chain, major component (Beta-1-bungarotoxin)",MSSGGLLLLLGLLTLCAELIPVSSRQRHRDCDKPPDKGNCGPVRRAFYYDTRLKTCKAFQYRGCNGNGNHFKTETLCRCECLVYP,Venom Kunitz-type family,"FUNCTION: Beta-1-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv) (By similarity). {ECO:0000250, ECO:0000269|PubMed:9693106}.",Kunitz Family
557,P00989,VKTH2_BUNMU,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B2 chain (Beta-2-bungarotoxin),MSSGGLLLLLGLLTLCAELTPVSSRKRHPDCDKPPDTKICQTVVRAFYYKPSAKRCVQFRYGGCNGNGNHFKSDHLCRCECLEYR,Venom Kunitz-type family,FUNCTION: Beta-2-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv). {ECO:0000269|PubMed:9693106}.,Kunitz Family
558,P00991,VKT1_VIPAA,,Kunitz-type serine protease inhibitor 1 (Venom basic protease inhibitor 1) (Venom trypsin inhibitor I) (cVamTi),MSSGGLLLLLGLLTLWAELTPVSGQDHPKFCYLPADPGRCKAHIPRFYYDSASNKCNKFIYGGCPGNANNFKTWDECRQTCGASAMGRPT,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that principally inhibits trypsin (Ki=0.34 nM). Also inhibits alpha-chymotrypsin (Ki=270 nM), plasmin, plasma and pancreatic kallikrein. {ECO:0000269|PubMed:6602050, ECO:0000269|PubMed:6639951}.",Serine Protease
559,P00992,VKT3_VIPAA,,Kunitz-type serine protease inhibitor 3 (Venom basic protease inhibitor 3) (Venom chymotrypsin inhibitor) (cVamChi),MSSGGLLLLLGLLTLWAELTPVSTRDRPKFCYLPADPGRCLAYMPSFYYDSASNKCKKFIYGGCRGNANNFKTWDECRHTCVASGIQPRIASN,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that principally inhibits alpha-chymotrypsin (Ki=4.3 nM). Shows weak inhibition on trypsin (Ki=5100 nM), and plasma kallikrein. {ECO:0000269|PubMed:6602050, ECO:0000269|Ref.2}.",Serine Protease
561,P01140,NGFV_NAJNA,,Venom nerve growth factor (v-NGF) (vNGF),EDHPVHNLGEHSVCDSVSAWVTKTTATDIKGNTVTVMENVNLDNKVYKEYFFETKCKNPNPEPSGCRGIDSSHWNSYCTETDTFIKALTMEGNQASWRFIRIDTACVCVITKKTGN,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
562,P01379,3L21_LATSE,,Alpha-elapitoxin-Ls2a (Alpha-EPTX-Ls2a) (Long neurotoxin Ls3) (LsIII) (Ls III) (Neurotoxin 1) (Neurotoxin alpha),MKTLLLTLVVVTIVCLDLGYTRECYLNPHDTQTCPSGQEICYVKSWCNAWCSSRGKVLEFGCAATCPSVNTGTEIKCCSADKCNTYP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (tested on Torpedo marmorata, Kd=1.6 nM) and neuronal (chimeric alpha-7/CHRNA7, Kd=3 nM) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (PubMed:9305882). Also shows a very weak inhibition on GABA(A) receptors (PubMed:26221036). The toxin (10 uM) inhibits 83% of current in channels composed of alpha-1-beta-3-gamma-2 (GABRA1-GABRB3-GABRG2) subunits, 39% of current in channels composed of alpha-2-beta-2-gamma-2 (GABRA2-GABRB2-GABRG2) subunits, and 33% of current in channels composed of alpha-5-beta-2-gamma-2 (GABRA5-GABRB2-GABRG2) subunits (PubMed:26221036). {ECO:0000269|PubMed:26221036, ECO:0000269|PubMed:9305882}.",Neurotoxin
563,P01382,3L21_NAJOX,,Alpha-elapitoxin-Nno2a (Alpha-EPTX-Nno2a) (Long neurotoxin 1) (Neurotoxin I) (NT I) (Ntx-1) (Toxin I) (NnoI),ITCYKTPIPITSETCAPGQNLCYTKTWCDAWCGSRGKVIELGCAATCPTVESYQDIKCCSTDDCNPHPKQKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (tested on Torpedo marmorata AChR, Kd=0.38 nM) and neuronal (tested on chimeric alpha-7/CHRNA7, Kd=12 nM) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (PubMed:9305882). The toxin also shows a very weak inhibition of GABA(A) receptors composed of alpha-1-beta-3-gamma-2 (GABRA1-GABRB3-GABRG2) subunits (PubMed:26221036). {ECO:0000269|PubMed:26221036, ECO:0000269|PubMed:9305882}.",Neurotoxin
566,P01443,3SA4_NAJAT,,Cytotoxin 4 (CTX-4M) (CTX4) (Cardiotoxin A4) (CTX A4) (Cardiotoxin analog IV) (CTX IV),MKTLLLTLVVVTIVCLDLGYTRKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Basic protein that bind to cell membrane and depolarizes cardiomyocytes. This cytotoxin also shows lytic activities, but 2-fold more important than that of CTX-A2. It binds to the integrin alpha-V/beta-3 with a moderate affinity. Inhibits protein kinase C. It may interact with sulfatides in the cell membrane, which induces pore formation and cell internalization and is responsible for cytotoxicity in cardiomyocytes. It may also target the mitochondrial membrane and induces mitochondrial swelling and fragmentation. {ECO:0000269|PubMed:16407244, ECO:0000269|PubMed:8448165, ECO:0000269|PubMed:9398182}.",General Toxin
571,P01476,MYX1_CROVV,,Myotoxin-A (Myotoxin-1),YKQCHKKGGHCFPKEKICIPPSSDLGKMDCRWKWKCCKKGSG,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity). It also binds to sarcoplasmic reticulum calcium-ATPase (PubMed:1329655). {ECO:0000250|UniProtKB:Q9PWF3, ECO:0000269|PubMed:1329655}.",Kunitz Family
574,P04417,PA2B_GLOBL,3.1.1.4,Basic phospholipase A2 (PA2-I) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFRKMIKKMTGKEPVISYAFYGCYCGSGGRGKPKDATDRCCFVHDCCYEKVTGCKPKWDDYTYSWKNGDIVCGGDDPCKKEICECDRAAAICFRDNLKTYKKRYMAYPDILCSSKSEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
575,P07525,3SAT_NAJAT,,Cytotoxin 5 (Cardiotoxin A4b) (CTX-A4b) (Cardiotoxin T) (Cardiotoxin analog V) (CTX V) (Cytotoxin D-1) (Membrane toxin D1),LKCNKLVPLFYKTCPAGKNLCYKMFMVSNKMVPVKRGCIDVCPKSSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Basic protein that binds to cell membrane and depolarizes cardiomyocytes. It also possesses lytic activity on many other cells, including red blood cells. Interaction with sulfatides in the cell membrane induces pore formation and cell internalization and is responsible for cytotoxicity in cardiomyocytes. It targets the mitochondrial membrane and induces mitochondrial swelling and fragmentation. Inhibits protein kinases C. It binds to the integrin alpha-V/beta-3 with a moderate affinity (By similarity). Is cardiotoxic and cytocidal to Yoshida sarcoma cells. {ECO:0000250|UniProtKB:P01443}.",Vascular Interaction
576,P08873,PA2B2_NOTSC,3.1.1.4,Basic phospholipase A2 notechis 11'2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLTVCVSLLEASSIPARPLNLYQFGNMIQCANHGRRPTLAYADYGCYCGAGGSGTPVDELDRCCKAHDDCYGEAGKKGCYPTLTLYSWQCIEKTPTCNSKTGCERSVCDCDATAAKCFAKAPYNKKNYNIDTEKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has no lethal activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
578,P0C2D3,OXLA_ERIMA,1.4.3.2,L-amino-acid oxidase (LAAO) (LNV-LAO) (EC 1.4.3.2),ADDKNPLEEAFREADYEVFLEIAKNGL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:11368308). Shows activity on L-Leu (PubMed:11368308). Exhibits diverse biological activities, such as hemolysis, edema, apoptosis, as well as induction of platelet aggregation (PubMed:11368308). Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation (By similarity). These different effects are probably due to different experimental conditions. Unlike other snake venom L-amino acid oxidases, does not induce hemorrhage (PubMed:11368308). This protein may also have antibacterial and antiparasitic activities (By similarity). {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:11368308}.",General Toxin
581,P0C578,VSP2_OVOOK,3.4.21.-,Thrombin-like enzyme okinaxobin-2 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Okinaxobin II) (Snake venom serine protease) (SVSP),VVGGDECNINEHRFLVALYY,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease. Releases both fibrinopeptides A and B from fibrinogen (FGA and FGB) to form fibrin clots. {ECO:0000269|PubMed:7725319}.,Serine Protease
582,P0C590,VSP2_GLOUS,3.4.21.-,Thrombin-like enzyme calobin-2 (SVTLE) (EC 3.4.21.-) (Calobin II) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNINEHRFLVAXY,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease that cleaves alpha-chain of fibrinogen (FGA) releasing fibrinopeptide A. Has high clotting activity. {ECO:0000269|PubMed:11024490}.,Serine Protease
583,P0C6B6,VM2AL_TRIAB,,Zinc metalloproteinase homolog-disintegrin albolatin,MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPEKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLYLEKNKELFSENYSETHYSLDGREITTYPSVEDHCYYHGRIQNDADSTASISACNGLKGHFKLRGKTYLIEPLKLPNSEAHAVFKYENVEKEDEAPQMCGVTETNWESDLPIKKTSQLNLPLLEKRCIELVMVADHRMYTKYDGDKTEISSKIYEIANNLNVDYRPMKIRVALIGTEIWSTGNLSKVTLSADETLDSFGEWRERDLLKRKSHDNVQLLTGMIFNEKIEGRAYNKSMCDPKRSVGIVRDHRTRPHLVANRMAHGLGHNLGIHHDGDSCSCGANSCIMSATVSNEPSSRFSDCSLNQYSNDIIYNPWTSYCLYNEPSKTDIVSPPVCGNYYLEVGEDCDCGPPANCQNPCCDATTCKLTPGSQCAEGLCCAQCKFIEEGTVCRVAKGDWNDDHCTGQSGDCPWIGYYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIb sub-subfamily","FUNCTION: The function of this complete protein has not been studied, but it may be similar to the function of the disintegrin domain. A recombinant protein of this domain (409-484) inhibits collagen-induced human platelet aggregation, without having effect on ADP-induced aggregation. It may act either by blocking the binding of fibrinogen to the platelet receptor GPIIb/GPIIIa (ITGA2B/ITGB3) or by blocking the binding of collagen to the integrin alpha-2/beta-1 complex (ITGA2/ITGB1). {ECO:0000269|PubMed:17870140}.",Fibrinogenolytic Enzyme
584,P0C6S0,VM1B1_BOTPA,3.4.24.-,Snake venom metalloproteinase BnP1 (SVMP) (EC 3.4.24.-),SQIKFKPSYIELAVVADHGMFTKYNSNINTIRIVHEMVNTVDGFFRTITSFGEWRERDIIPRSCIMASTISKHNPQCIINQPI,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: This protein is a zinc protease from snake venom that is devoid of significant myotoxic and hemorrhagic activities. It hydrolyzes the Aalpha-chain and more slowly the Bbeta-chain of fibrin and fibrinogen, without affecting the gamma-chains. It induces cell detachment and a apoptosis (anoikis) in endothelial cells. {ECO:0000269|PubMed:17889921}.",Metalloprotease
585,P0C6S6,VMXJ4_BOTJA,3.4.24.-,Snake venom metalloproteinase jararafibrase-4 (SVMP) (EC 3.4.24.-) (Jararafibrase IV),TPEHQRYIELFLVVDHGMFMKYNGNSDKIYYYIHQMVNIMKXAYXYL,Venom metalloproteinase (M12B) family,"FUNCTION: The metalloproteinase is a probable venom zinc protease that induces local hemorrhage in the skin of rats. Degrades type-IV collagen, gelatin, laminin and fibronectin. Has fibrinolytic activities. Has high hemagglutinating activity on red blood cells. Cleaves insulin B chain at 29-His-|-Leu-30, and 38-Ala-|-Leu-39 bonds (PubMed:8087204). {ECO:0000269|PubMed:12165326, ECO:0000269|PubMed:8087204}.",Metalloprotease
586,P0C7A9,VM1BJ_BOTJA,3.4.24.-,Snake venom metalloproteinase bothrojaractivase (SVMP) (EC 3.4.24.-),RYIELAVVADHGMFTKYRVHELVNTVNGFFRSKQDLIKVQKDKTLTSFGEWRERDLLPRI,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Prothrombin (F2) activator that is cofactor-independent. Also has fibrinolytic and fibrinogenolytic activity. It degrades the Aalpha-chain and more slowly the Bbeta-chain of fibrin and fibrinogen, while the gamma-chain is only partially and slowly affected. A dose-dependent procoagulant activity is shown in human plasma. {ECO:0000269|PubMed:18262582}.",Fibrinogenolytic Enzyme
588,P0C8I7,VM3FA_VIPAA,3.4.24.-,Factor X-activator 1 heavy chain (VAFXA-I HC) (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),LVSVSPAFNGNYFVE,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIId sub-subfamily","FUNCTION: Catalytic subunit of blood coagulation factor X-activating enzyme. Activates coagulation factor X (F10) in a calcium-dependent manner by cleaving at the '234-Arg-|-Ile-235' site. Weakly hydrolyzes insulin B chain (by cleaving at the '27-Asn-|-Gln-28' and '44-Gly-|-Glu-45' sites), fibrinogen and some components of the extracellular matrix in vitro. {ECO:0000269|PubMed:18760294}.",Fibrinogenolytic Enzyme
589,P0C932,PA2A1_LACMU,3.1.1.4,Acidic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (LM-PLA2-I) (Phosphatidylcholine 2-acylhydrolase),HLLQFGDLIDKIAGRSGFWYYGFYGCYCGLGGRGRPQDATDRCCFVHDCC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays a potent enzymatic activity as measured by indirect hemolysis of red blood cells. Is neither lethal when injected into mice nor does it present anticoagulant activity. Displays a moderate inhibitory activity on the aggregation of platelets induced by low levels of ADP, thrombin and arachidonate. In contrast, strongly inhibits platelet aggregation induced by high doses of collagen. Shows myotoxic activity, increases the plasma creatine-kinase activity and induces edema and myonecrosis of mouse skeletal muscles. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:10728833, ECO:0000269|PubMed:12007562, ECO:0000269|PubMed:9408022}.",Phospholipase
590,P0C933,PA22_LACMU,3.1.1.4,Phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (LM-PLA2-II) (Phosphatidylcholine 2-acylhydrolase),HLLQFEQLIRKIAGRGFRYYGFYGCYCGLGGQGRPQDATDRCCFVHDCC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has a high indirect hemolytic activity and a potent inhibitory effect on platelet aggregation induced by ADP and collagen. Also produces a significant paw edema reaction in rats. This edematous response is abolished by pretreatment with either indomethacin or dexamethasone, suggesting the involvement of cyclo-oxygenase. May be myotoxic. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12007562}.",Phospholipase
591,P0C943,PA2B2_LACMU,3.1.1.4,Basic phospholipase A2 LmTX-II (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLKFNKMIKFETRKNAIPFYAFYGCYCGWGGRXXXXXXXXXCCFVHDCCYGKXXXXXXXWDLYPYXXXSGYLTCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that may display neurotoxic and myotoxic activities. May induce inflammatory edema by mechanisms involving mast cell activation and arachidonic acid metabolites. May increase plasma creatine kinase activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
592,P0C944,3SAG_NAJAT,,Cytotoxin najalgesin,LKCNKLVPLFYKTCPAGKNLCYKMFMVSNK,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Analgesic toxin that is blocked by atropine and naloxone, suggesting the involvement of cholinergic and opioidergic mechanisms in its antinociceptive effect (PubMed:18765245). Shows cytolytic activity by forming pore in lipid membranes (By similarity). {ECO:0000250, ECO:0000269|PubMed:18765245}.",General Toxin
593,P0CAR8,PA2B_BOTJR,3.1.1.4,Basic phospholipase A2 BjIV (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLWSWGQMIQETGLLPSYTTY,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 has a high enzymatic activity and produces moderate myonecrosis in skeletal muscle, but shows no neuromuscular activity in mouse phrenic nerve-diaphragm preparations. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
594,P0CAS1,PA2B6_CRODM,3.1.1.4,Phospholipase A2 crotoxin basic chain (CB) (svPLA2) (EC 3.1.1.4) (Cdcum6) (Phosphatidylcholine 2-acylhydrolase),SLVQFEKMIKEVAGKNGVPWY,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces a conspicuous local myotoxic effect and moderate footpad edema. In vitro, it shows anticoagulant effects and is not cytotoxic on myoblast but is able to lyse myotubes. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:19673100}.",Phospholipase
595,P0CAS3,PA2BC_CRODR,3.1.1.4,Basic phospholipase A2 Cdr-12 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLLQFNKMIKFETRKNAIPFYAFYGCYCGWGGQGRPKDATDRCCIVHDCCYGKLAKCNTKWDFYRYSLRSGYFQCGKGTWCEQQICECDRVAAECLRRSLSTYRYGYMIYPDSRCREPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces myonecrosis and edema upon intramuscular injections in mice. In vitro, causes a potent blockade of neuromuscular transmission in young chicken biventer cervicis preparation and produces cytotoxicity in murine C2C12 skeletal muscle myotubes and lack cytolytic activity upon myoblasts in vitro. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:17203396}.",Phospholipase
596,P0CAS4,PA2BD_CRODR,3.1.1.4,Basic phospholipase A2 Cdr-13 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLVQFEKMIKEETGKNAVPFYAFYGCYCGWGGRGRPKDATDRCCIVHDCCYEKLVKCNTKWDFYRYSLRSGYFQCGKGTWCEQQICECDRVAAECLRRSLSTYRYGKMIYPDSRCREPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces myonecrosis and edema upon subcutaneous injections in mice. In vitro, causes a potent blockade of neuromuscular transmission in young chicken biventer cervicis preparation and produces cytotoxicity in murine C2C12 skeletal muscle myotubes and lack cytolytic activity upon myoblasts in vitro. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:17203396}.",Phospholipase
597,P0CAS6,PA2BF_CRODU,3.1.1.4,Basic phospholipase A2 F16 (svPLA2) (EC 3.1.1.4) (CdtF16) (Phosphatidylcholine 2-acylhydrolase),SLLQFNKMIKFETRKNAVPFYAFYGCYCGWGGRRRPKDATDRCCFVHDCCYEKVTKCNTKWDIYRYSLKSGYITCGKGTWCKEQICECDRVAAECLRRSLSTYKNGYMFYPDSRCRGPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that produces neuromuscular blockade in chick biventer cervicis preparations in the absence and presence of crotapotin. In contrast, in mouse phrenic nerve-diaphragm preparations, the neuromuscular blockade is dependent on crotapotin. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:16283546}.",Phospholipase
598,P0CJ40,OXLA_BOTMA,1.4.3.2,L-amino-acid oxidase (BmarLAAO) (LAO) (EC 1.4.3.2),AHDGNPLEECFREDDEEFFLEIAKNGLTATSNPKRVVIV,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:19944711). Shows activity on L-Leu (PubMed:19944711). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). In addition, this protein inhibits dose-dependently the growth of Gram-positive, Gram-negative bacteria and yeast, probably by the generation of hydrogen peroxide. {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:19944711}.",Vascular Interaction
599,P0CJ41,VSPAF_TRIAB,3.4.21.-,Alpha-fibrinogenase albofibrase (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHHSLVAIFNSTGFFCSGTLINQEWVVTAAHCDSKNFKMKFGAHSKKLLNEDEQIRNPKEKFICPNKKSNEILDKDIMLIKLDSPVSNSAHIAPLSLPSSPPSVGSVCRIMGWGSTTPIEVTYPDVPYCANINLLDDAECKPGYPELLPEYRTLCAGIVQGGKDTCGGDSGGPLICNEKLHGIVSYGGHPCGQSHKPGIYTNVFDYNDWIQSIIAGNTDATCLS,"Peptidase S1 family, Snake venom subfamily",FUNCTION: The recombinant protein has fibrinogenolytic activity against the Aalpha chain (FGA) of fibrinogen. Activates plasminogen (PLG) (is 4-fold less active than urokinase). Has weak thrombin-like enzyme activity. Has enzymatic activity against a trypsin-like substrate (S-3013) and shows a weaker activity on an activated protein C substrate (S-3125). {ECO:0000269|PubMed:17346761}.,Serine Protease
601,P0DI86,OXLA_BOTAL,1.4.3.2,L-amino-acid oxidase (Balt-LAAO-I) (LAO) (EC 1.4.3.2),ADVRNPLEEFRETDYEVL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:15142548). Is highly active on L-Phe > L-Tyr > L-Met > L-Leu, and is weakly or not active on other amino acids (PubMed:15142548). Exhibits diverse biological activities, such as slight hemorrhage, induction of platelet aggregation, edema in the mouse paw and bactericidal activity against both Gram-positive (S.aureus) and Gram-negative (E.coli) bacteria (PubMed:15142548). May also induce hemolysis, apoptosis of vascular endothelial cells or tumor cell lines, and may have antiparasitic activities (By similarity). Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250, ECO:0000269|PubMed:15142548}.",Vascular Interaction
602,P0DJ62,PA2A_BOTLC,3.1.1.4,Acidic phospholipase A2 (svPLA2) (EC 3.1.1.4) (Bl-PLA2) (Phosphatidylcholine 2-acylhydrolase 1B),SLWQFGKMINYVMGESGVLQYLSYGCYCGLGGQGQPTDATDRCCFVHDCCYGKVTGCDPK,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits an indirect hemolytic activity, a low myotoxicity, and induces edema. In addition, this enzyme has been shown to induce the release of some pro- and anti-inflammatory cytokines from human PBMC (IL12B, TNF-alpha, IL1B and IL6 but not variation has been observed for IL-8 and IL-10). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:21699995}.",Phospholipase
603,P0DJ87,VM3L_BOTLC,3.4.24.-,Zinc metalloproteinase-disintegrin-like leucurogin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),LGTDIISPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSECGHGDCCEQCKFTKSGTECRASMSECDPAEHCTGQSSECPADVGHK,"Venom metalloproteinase (M12B) family, P-III subfamily","FUNCTION: Snake venom zinc metalloprotease that possesses hemorrhagic activity (By similarity). The disintegrin-like domain has been expressed and named leucurogin (PubMed:21641921). This recombinant disintegrin is able to inhibit collagen-induced platelet aggregation but not ADP- or arachidonic acid-induced platelet aggregation (PubMed:21641921). Furthermore, it inhibits the adhesion of human fibroblasts to collagen type I (PubMed:30611825). It also reduces adhesion and migration of human fibroblasts and inhibits migration and proliferation of human and mouse melanoma cell lines (BLM, and B16-F10-Nex2) (PubMed:30611825). In vitro, it inhibits the vascular structures formation by endothelial cells (PubMed:30611825). In addition, it inhibits the growth of experimental Ehrlich tumor and has anti-angiogenesis effect on the sponge implant model (PubMed:21641921). In vivo, when intraperitoneally injected into mice, it inhibits lung metastasis of B16F10 Nex-2 cells. In the treatment of human melanoma, grafted intradermally in the nude mice flank, it inhibits tumor growth (PubMed:21641921). {ECO:0000250|UniProtKB:P30431, ECO:0000269|PubMed:21641921, ECO:0000269|PubMed:30611825}.",Metalloprotease
604,P0DJE8,VSPDV_BOTJR,3.4.21.-,Thrombin-like enzyme D-V (SVTLE D-V) (EC 3.4.21.-) (Clotting factor) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VVGADNCNFN,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like enzyme that induces quick formation of fibrin clots. Only degrades the Aalpha-chain of fibrinogen (FGA). {ECO:0000269|PubMed:9248003}.,Serine Protease
605,P0DJF1,VSP1_BOTPA,3.4.21.-,Thrombin-like enzyme BpSP-1 (SVTLE BpSP-1) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Thrombin-like enzyme BpSP-I) (SVTLE BpSP-I),VIGGDECDINEHPFL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like enzyme that has high clotting activity upon bovine and human plasma. Has also fibrinogenoltic activity by rapidly hydrolyzing Aalpha chain of fibrinogen (FGA), and partially consumes Bbeta chain (FGB). Has high catalytic activity upon substrates such as TAME, and specific substrates for thrombin S-2238 and S-2288. Also hydrolyzes specific substrates for kallikrein (S-2266 and S-2302), however, no release of kinin upon plasma has been determined. When administered intraperitoneally in mice, causes defibrinogenation, making the plasma incoagulable.",Serine Protease
606,P0DJF4,VSPAL_TRIAB,3.4.21.-,Thrombin-like enzyme albolabrase (SVTLE albolabrase) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VVGGDECNINE,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Releases both fibrinopeptides A and B after 90 minutes incubation, but only fibrinopeptides A after 10 minutes incubation. Clots fibrinogen with different clotting time depending on the species: bovine > dog = human > goat. Fails to clot both rabbit and cat fibrinogens. {ECO:0000269|PubMed:21983189}.",Serine Protease
607,P0DJF6,VSPC_TRIAB,3.4.21.-,Thrombin-like enzyme chitribrisin (SVTLE chitribrisin) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MMLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVVLFNSSGALCGGTLINQEYVLTAAHCDMPNMQILLGVHSASVLNDDEQARDPEEKYFCLSSNNDTKWDKDIMLIRLNRPVNNSVHIAPLTLPSSPPRLGAICRIMGWGAITSPNETYPDASQCANINILRYSLCQAVYRGMPAQSRIVCAGILRGGKGSCKGDSGGPLICNAQLQGIVSAGGDPCAQPRVPVLYIRVFDYTDWIQSIIEGNRTVTCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that activates fibrinogen by releasing both fibrinopeptides A and B. Has also fibrinogenolytic activity, with a complete digestion of alpha chain (FGA) at 30 minutes and of beta chain (FGB) at 60 minutes. {ECO:0000269|PubMed:19303445, ECO:0000269|Ref.2}.",Serine Protease
608,P0DJF7,VSPP_TRIPP,3.4.21.-,Thrombin-like enzyme purpurase (SVTLE purpurase) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VVGGDECNINDHRSLVRIF,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease. Releases only fibrinopeptides A after 2 hours incubation. Clots fibrinogen with different clotting time depending on the species: cat > human > dog > goat >> rabbit. {ECO:0000269|PubMed:19770070}.,Serine Protease
609,P0DJG5,VSPKA_GLOHA,3.4.21.-,Snake venom serine protease AHP-Ka (SVSP) (EC 3.4.21.-),VIGGDECNINEHRFL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that hydrolyzes specific chromogenic substrate S-2302 suggesting that AHP-Ka is a plasma kallikrein. Has esterase activity on alpha-N-benzoyl-L-arginine ethyl ester hydrochloride (BAEE) and amidolytic activity. {ECO:0000269|PubMed:22162083}.,Serine Protease
610,P0DJH2,VM3AL_TRIAB,3.4.24.-,Zinc metalloproteinase-disintegrin-like alborhagin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) [Cleaved into: Disintegrin-like alborhagin-C],RYIPYDQEDVKRQMVAAIGIEDKNTVTRANYYTLDLXIDTVTPDVNRNELKEK,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: [Zinc metalloproteinase-disintegrin-like alborhagin]: Induces platelet activation and glycoprotein VI (GP6)-dependent platelet aggregation. Induces ectodomain cleavage of GP6 by activating endogenous platelet metalloproteinases (probably ADAM10). Has fibrinogenolytic activity against the alpha chain of fibrinogen (FGA). Recognizes distinct binding sites as convulxin, since alborhagin has minimal effect on convulxin binding to GPVI-expressing cells. {ECO:0000269|PubMed:18064326}.; FUNCTION: Disintegrin alborhagin-C: 42 kDa fragment of alborhagin autoproteolysed that does not show platelet activation. {ECO:0000269|PubMed:18064326}.",Metalloprotease
611,P0DJH4,VM3AL_BORPO,3.4.24.-,Zinc metalloproteinase alsophinase (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),QDTYLNAKKYIEFYLVVDNGMFXKYSXXFTV,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that has potent hemorrhagic activity, fibrinogenolytic activity on the alpha-subunit of human fibrinogen (FGA) in vitro and provokes necrosis in skin, muscle and lung tissues. May contribute to local edema and ecchymosis induced by venom. Hydrolyzes model substrate (beta-chain of insulin) at Ala(14)-Leu(15). {ECO:0000269|PubMed:22349739}.",Metalloprotease
612,P0DJJ1,VM3AH_NAJAT,3.4.24.-,Zinc metalloproteinase atrahagin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),TNTPEDDRYLQDYVYI,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloprotease that causes mast cell degranulation and histamine release. Selectively degrades the alpha-chain of human fibrinogen (FGA). {ECO:0000269|PubMed:16310401}.,Metalloprotease
613,P0DJJ4,VM3_NAJOX,3.4.24.-,Zinc metalloproteinase oxiagin (EC 3.4.24.-) (Snake venom metalloprotease) (SVMP),TNTPEQQCYLQAKCYIEFYVVV,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIId sub-subfamily","FUNCTION: Snake venom metalloproteinase that inhibits the classical complement pathway dose-dependently. It acts by binding to carbohydrates of IgG within the antibody-sensitized sheep erythrocytes (EA) complex, and thus prevents interaction of component C2 with immobilized C4b. Also induces cation-independent hemagglutination that can be prevented by D-galactose pretreatment. {ECO:0000269|PubMed:15829304}.",Vascular Interaction
614,P0DJJ7,PA2A_OVOMO,3.1.1.4,Acidic phospholipase A2 Omo-E6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLMQFETLIMKIAGRSGVWIYGSYGCYCG,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits the ADP- and collagen-induced human platelet aggregation (By similarity). Exhibits strong hydrolytic activities and prefers the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000250, ECO:0000269|PubMed:22115990}.",Phospholipase
615,P0DJJ8,PA2B1_PROFL,3.1.1.4,Basic phospholipase A2 BP-I (svPLA2) (EC 3.1.1.4) (Basic protein I) (BP1) (BPI) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLLGVDGSLVQLWKMIFQETGKEAAKNYGLYGCNCGVGRRGKPKDATDSCCYVHKCCYKKVTGCDPKMDSYSYSWKNKAIVCGEKNPPCLKQVCECDKAVAICLRENLGTYNKKYTIYPKPFCKKADTC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has strong myotoxic activity with a low phospholipase A2 activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:2330604}.,Phospholipase
616,P0DJK0,SRTX1_ATRIR,,Sarafotoxin-i1 (SRTX-i1) (Sarafotoxin-i3) (SRTX-i3),MALLPRLAAGGLLLLLALAALDGKPAPPKLLQKLMDGGQRRSEDQAAAGRIIDYEDGDEPVAVSVGDTKQAARALSPLRKPQPLCSCTDMSDLECMNFCHKDVIWINRNRKPSPIQSS,Endothelin/sarafotoxin family,"FUNCTION: Vasoconstrictor activity. These toxins cause cardiac arrest probably as a result of coronary vasospasm (By similarity). {ECO:0000250}.; FUNCTION: Sarafotoxin-i3: vasoconstrictor activity. Causes cardiac arrest probably as a result of coronary vasospasm (By similarity). Displays low agonistic activities towards endothelin-2 receptor (EDNRB) (displays affinity in the micromolar range). {ECO:0000250, ECO:0000269|PubMed:21889567}.",General Toxin
617,P0DJL1,SLB_TRIAB,,Snaclec alboluxin subunit beta,NFSCPPDWYAYD,Snaclec family,"FUNCTION: Potent platelet activator that aggregates platelets via both GPIb (GP1BA/GP1BB) and GPVI (GP6). Alboluxin induces a tyrosine phosphorylation profile in platelets that resembles those produced by collagen and convulxin, involving the time dependent tyrosine phosphorylation of Fc receptor gamma chain (FCGR1A), phospholipase Cgamma2 (PLCG2), LAT and p72SYK. Inhibition of alpha-IIb/beta-3 reduces the aggregation response to alboluxin, as well as tyrosine phosphorylation of platelet proteins, showing that activation of alpha-IIb/beta-3 and binding of fibrinogen are involved in alboluxin-induced platelet aggregation and it is not simply agglutination. {ECO:0000269|PubMed:12008953}.",Phospholipase
618,P0DJM9,PA2B1_CROBA,3.1.1.4,Basic phospholipase A2 CB1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRKNAIPFYAF,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
619,P0DJN0,PA2B1_CROVE,3.1.1.4,Basic phospholipase A2 CB1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRKNAIPFYAF,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
620,P0DJN1,PA2B1_CRODM,3.1.1.4,Basic phospholipase A2 CB1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRKNAIPFYAF,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
621,P0DJN4,PA2B2_CROMT,3.1.1.4,Basic phospholipase A2 CB2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLLQFNKMIKFETRKNAIPFYAF,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
622,P0DJN6,PA2BB_CROHD,3.1.1.4,Basic phospholipase A2 canebraxin B (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETRKNAIPFYAF,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
623,P0DJN7,PA2B3_CROLL,3.1.1.4,Basic phospholipase A2 Cll-N6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMIKIMTKKNAFPFYTS,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows myotoxic activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
624,P0DJP4,PA2AC_CRAPU,3.1.1.4,Acidic phospholipase A2 Tpu-E6c (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFEMMILKMAGRSGIRWYSDYGCYCGKGGHGQPQDATDRCCFVHDCCYGKVSGCDPKDEFYKYSSDNNDIVCGGNNPCLKEICECDRDAAICFRDNLSTYNNKYWNVPSETCQVESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs hemostasis. It weakly inhibits ADP-induced platelet aggregation when tested on platelet rich plasma from human and rabbit blood (15-25% of inhibition at 5-10 ug of enzyme), and dose-dependently inhibits blood coagulation, possibly by inhibiting thrombin activation. Exhibits high hydrolytic activities toward L-dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15955061}.",Phospholipase
625,P0DJP5,PA2A_DABSI,3.1.1.4,Acidic phospholipase A2 Drs-PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLFQFARMINGKLGAFSV,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has several activities. It exhibits anticoagulant activities (by inhibiting activated coagulation factor X (F10)), it shows hemolytic and cytotoxic activities (cytotoxic concentration(50)=65.8 nM), and inhibits cell migration in human skin melanoma cells (IC(50)=25.6 nM). In addition, it reduces tumor lung colonization of B16F10 melanoma cells in BALB/c mice by 65%. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:22091349}.",Phospholipase
626,P0DKR0,VM3_BOTMO,3.4.24.-,Zinc metalloproteinase-disintegrin-like moojenin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) [Cleaved into: Disintegrin-like],LGPDIVSPPVCGNELLEVGEECDCGTPENCQNE,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: Metalloproteinase moojenin: snake venom metalloproteinase that cleaves both alpha- and beta-chains of fibrinogen, but not the gamma-chain. Shows a coagulant activity on bovine plasma about 3.1 fold lower than crude venom. Renders the blood incoagulable when intraperitoneally administered into mice. Induces necrosis in liver and muscle, but does not cause histological alterations in mouse lungs, kidney or heart. {ECO:0000269|PubMed:22975266}.",Fibrinogenolytic Enzyme
627,P0DKR3,PA2AA_PSEFE,3.1.1.4,Acidic phospholipase A2 CbIalpha (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLFQFGEMIFEKTGKEAVHSYAIYGCYCGWGGQGRAMDATDRCCFVHDCCYGRVNGCNPKMATYSTSFQNGDIVCGDNDLCLRAVCECDRAAAICLGQNVNTYNKNYEHYSISHCMEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Heterodimer: presynaptic neurotoxin.; FUNCTION: Monomer: Snake venom phospholipase A2 (PLA2) is inactive towards micellar phosphatidylcholine but is weakly active towards non-micellar dithiolecithin. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
628,P0DKR5,PA2B2_PSEFE,3.1.1.4,Basic phospholipase A2 CbII (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLFQFTKMINGKLGAFAVLNYISTGCYCGWGGQGTPKDATDRCCFVHDCCYGRVKGCNPKLAIYSYSFQKGNIVCGKNNGCLRDICECDRVAANCFHQNKNTYNRNYRFLSSSRCRQTSEQC,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Heterodimer: presynaptic neurotoxin. {ECO:0000269|PubMed:18062812}.; FUNCTION: Monomer: Snake venom phospholipase A2 (PLA2) that exhibits strong anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (IC(50) is 20 nM). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18062812}.,Phospholipase
629,P0DKT6,PA2B_BITAR,3.1.1.4,Phospholipase A2 bitanarin (svPLA2) (EC 3.1.1.4) (Bitis arietans nicotinic acetylcholine receptor inhibitor) (Phosphatidylcholine 2-acylhydrolase),SLIEFGKMITEETNRPVFPYEATIVVCDCGNGNGS,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that is the first competitive blocker of nicotinic acetylcholine receptors (nAChRs) (PubMed:21333664). Competes with alpha-bungarotoxin for binding to nAChRs and acetylcholine binding proteins (AChBPs) and blocks acetylcholine-elicited current (PubMed:21333664). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:21333664). {ECO:0000269|PubMed:21333664}.,Phospholipase
630,P0DKT7,PA2CA_OXYSA,3.1.1.4,Basic phospholipase A2 cannitoxin alpha chain (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFGYMIRCANGRSRPVW,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling. Enzymatic activity is essential for the neurotoxic effects (PubMed:16135698). May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum (By similarity). {ECO:0000250, ECO:0000269|PubMed:16135698}.; FUNCTION: Monomer (alpha chain): Snake venom phospholipase A2 (PLA2) that possesses a low level of presynaptic activity and the same high enzymatic activity than the heterotrimer. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:16135698}.",Phospholipase
631,P0DKT9,PA2HC_OXYSA,,Neutral phospholipase A2 homolog cannitoxin beta chain 2 (svPLA2 homolog),NLVQFGFMIECAIRNRQPALDFMNYGCYCGTVGRGTPVDD,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling. Enzymatic activity is essential for the neurotoxic effects (PubMed:16135698). May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum (By similarity). {ECO:0000250, ECO:0000269|PubMed:16135698}.; FUNCTION: Monomer (beta chain): Snake venom phospholipase A2 homolog that is neither toxic nor enzymatically active (PubMed:16135698). Does not bind calcium (By similarity). {ECO:0000250, ECO:0000269|PubMed:16135698}.",Phospholipase
632,P0DKU0,PA2HG_OXYSA,,Acidic phospholipase A2 homolog cannitoxin gamma chain (svPLA2 homolog),SEIPQPSLDFEQFSNMIQCTIPPGEECLAY,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling. Enzymatic activity is essential for the neurotoxic effects (PubMed:16135698). May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum (By similarity). {ECO:0000250, ECO:0000269|PubMed:16135698}.; FUNCTION: Monomer (gamma chain): Snake venom phospholipase A2 homolog that is neither toxic nor enzymatically active (PubMed:16135698). Does not bind calcium (By similarity). {ECO:0000250, ECO:0000269|PubMed:16135698}.",Phospholipase
633,P0DKU1,PA2H_GLOUS,,Basic phospholipase A2 homolog Gln49-PLA2 (svPLA2 homolog),SLLQFRKMIKKMTGKEPVVSYAFYGCYCGSGGRGKPKDATDRCCFVHQCCYEKVTGCDPKWDDYTYSWKDGDIVCGGDDPCKKEVCECDRAAAICFRDNLKTYKKIYMAYPDIFCSSKSEKC,"Phospholipase A2 family, Group II subfamily, Q49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) homolog that shows local myotoxicity, apparent anticoagulant activity (PubMed:15618013), and neurotoxicity (PubMed:17299814). Shows analgesic effect on mice due to a decrease of action potentials and nerve conduction velocity. These effects are caused by inhibition of voltage-gated ion channels (potassium (Kv) and sodium (Nav)) (PubMed:19277489). In addition, analgesic effects are antagonized by naloxone, implying the mechanism of action is correlated with opioid receptors (probably indirectly) (PubMed:17299814). Does not show detectable PLA2 activity on egg yolk phospholipids (PubMed:15618013). {ECO:0000269|PubMed:15618013, ECO:0000269|PubMed:17299814, ECO:0000269|PubMed:19277489}.",Phospholipase
634,P0DKX2,VSP1_CRODM,3.4.21.-,Thrombin-like enzyme Cdc SI (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNIN,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that coagulates human plasma and bovine fibrinogen by hydrolysis of the alpha chains (FGA) (minimum coagulation dose is 120 ug on fibrinogen). Has fibrinogenolytic activities, and degrades preferentially the Aalpha chain (FGA). Shows amidolytic activity toward N-benzoyl-L-Arg-p-nitroanilide, has a lower activity than Cdc SII. In vivo, intravenous injection induces defibrin(ogen)ation and a loss of the righting reflex and opisthotoxins, together with a typical gyroxin-like effect (18-20 minutes). Subcutaneous injection into the footpads induces moderate edema. Potentiates local hemorrhagic activity induced by metalloproteinases (BaP1). {ECO:0000269|PubMed:23178323}.",Serine Protease
635,P0DKX3,VSP2_CRODM,3.4.21.-,Thrombin-like enzyme Cdc SII (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDICNINEHNFLVALYE,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that coagulates human plasma and bovine fibrinogen by hydrolysis of the alpha chains (FGA) (minimum coagulation dose is 60 ug on fibrinogen). Has fibrinogenolytic activities, and degrades preferentially the Aalpha chain (FGA). Shows amidolytic activity toward N-benzoyl-L-Arg-p-nitroanilide, has a higher activity than Cdc SI. In vivo, intravenous injection induces defibrin(ogen)ation and a loss of the righting reflex and opisthotoxins, together with a typical gyroxin-like effect (18-20 minutes). Subcutaneous injection into the footpads induces moderate edema. Potentiates local hemorrhagic activity induced by metalloproteinases (BaP1). {ECO:0000269|PubMed:23178323}.",Serine Protease
636,P0DKY5,VSP_CRODC,3.4.21.-,Thrombin-like enzyme F202 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VVGGDECNINEHRFLVALYANSSLLCGGTLINQEWVLIAAHCDR,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that coagulates fibrinogen by inducing a fast degradation of the alpha chain (FGA) from human citrated plasma, and a slow degradation of beta chain (FGB). Potently induces platelet aggregation in both platelet rich plasma and washed platelet preparations in a concentration-dependent fashion. Shows amidolytic activities. {ECO:0000269|PubMed:16729248}.",Serine Protease
637,P0DL42,TXVE_DABSI,,Snake venom vascular endothelial growth factor toxin VR-1' (svVEGF) (VEGF-F),EVRPFLDVYQRSACQTRETLVSILQEHPDEISDIFRPSCVAVLRCSGCCTDESMKCTPVGKHTADIQIMRMNPRTHSSKMEVMKFMEHTACECRPRWKQGEPEGPKEPR,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein stimulates vascular endothelial cell proliferation (EC(50)=0.2 nM) in a similar manner than VR-1 and vammin (PubMed:15992764). This angiogenesis probably occurs through VEGF receptor (KDR/VEGFR-2) signaling. Also induces drastic hypotension mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces vascular permeability (By similarity). {ECO:0000250|UniProtKB:P83942, ECO:0000269|PubMed:15992764}.",Vascular Interaction
640,P0DM43,VSP_PROJR,3.4.21.-,Thrombin-like enzyme jerdonobin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNINEHRFLVALYDF,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that has fibrinogen-clotting activity (217 NIH units/mg). It releases fibrinopeptide A and a small amount of fibrinopeptide B from fibrinogen alpha (FGA) and beta (FGB). {ECO:0000269|PubMed:10736476, ECO:0000269|PubMed:12091097}.",Serine Protease
641,P0DM49,PA2X1_BOTPA,3.1.1.4,Phospholipase A2 neuwieditoxin-1 (NeuTX-1) (PLA2) (EC 3.1.1.4) (Neuwieditoxin-I) (NeuTX-I) (Phosphatidylcholine 2-acylhydrolase),DLVQFGQMILKVAGRSLPKSYGAYGCYCGWGGRGK,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. 10 ug/ml of this protein produce complete neuromuscular blockade up to 80 minutes, without inhibiting the responses to acetylcholine (ACh) and potassium chloride (KCl). In addition, it produces a calcium-dependent blockade of acetylcholine release and causes appearance of giant miniature end-plate potentials. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|Ref.1}.",Phospholipase
642,P0DM50,PA2X2_BOTPA,3.1.1.4,Phospholipase A2 neuwieditoxin-2 (NeuTX-2) (PLA2) (EC 3.1.1.4) (Neuwieditoxin-II) (NeuTX-II) (Phosphatidylcholine 2-acylhydrolase),SLFEFAKMILEETKRLPFPYYGAYGCYCGWGGQGQPKDAT,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. 10 ug/ml of this protein produce complete neuromuscular blockade up to 70 minutes, without inhibiting the responses to acetylcholine (ACh), but with a partial inhibition (67%) of the response to potassium chloride (KCl). {ECO:0000269|Ref.1}.",Phospholipase
643,P0DM52,PA2B2_BOTPA,3.1.1.4,Basic phospholipase A2 BnpTX-2 (BnPTx-II) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLWEFAQMILEETKRLPFPYYGAYGCYCGWGGQGQ,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2). In vitro, shows anticoagulant activity and induces cytotoxicity when tested on C2C12 myoblasts/myotubes. In vivo, when tested on mice, induces myotoxicity (intramuscular injection), edema (injection in the subplantar region) and lethality. The catalytic and anticoagulant activities of BnpTX-II are lower than those of BnpTX-I. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15302537}.",Phospholipase
644,P0DM77,VM2_DEIAC,,Disintegrin accutin,QGAQCTAGPCCWPCKFLKEGTICRRARGDDLDDYCNGISADCPRNPYY,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibit human platelet aggregation induced by ADP, collagen, thrombin or the thromboxane analog U46619 in platelet suspension with IC(50) values of 66-267 nM. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (PubMed:9838213). It also inhibits angiogenesis in vivo and in vitro by blocking integrin alpha-V/beta-3 (ITGAV/ITGB3) of endothelial cells and by inducing apoptosis (PubMed:9787163). {ECO:0000269|PubMed:9787163, ECO:0000269|PubMed:9838213}.",Fibrinogenolytic Enzyme
645,P0DM87,VM2_TRIST,3.4.24.-,Zinc metalloproteinase-disintegrin stejnitin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGNSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIQNDADLTASISACNGLKGYFKLQGETYLIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTETNWESDEPIKKASQLNLTPDEQRFIELVIVADHRMYTKYDGDETEISSKIYEIANDLNVIFRALYIHVALIGLEIWPSGELCNVTLSADDTLDSFAEWTKRDLQKRKRHDNAQLLTGMIFNEKIEGRAYKKTMCHWKRSVGIVRDHRTRPHFVANRMAHGLGHNLGINHDGDSCTCGANSCIMSATVSNDPSSRFSDCSLNQYSSDIIHNPYTSRCLYNGPWKTDIVSPPVCGNYYVEVGEDCDCGPPANCQNRCCDAATCRLTPGSQCAEGLCCEQCRFSTEGKLCREAKGDWNNDYCSGQSGDCPRNPFRA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIb sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase that inhibits ADP-induced platelet aggregation in human platelet-rich plasma (IC(50) is 175 nM) and cleaves alpha-(FGA) and subsequently the beta-chain (FGG) of bovine fibrinogen, leaving the gamma-chain unaffected. It is also able to inhibit proliferatin of ECV304 cells by inducing apoptosis of these cells. {ECO:0000269|PubMed:17403531}.",Metalloprotease
646,P0DM88,VM3_PROJR,3.4.24.-,Zinc metalloproteinase-disintegrin-like jerdohagin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),YLNNFRYLYIRHDREACTCHANSCIMSAYFSNSHVQYENYINDCKPQCILNELHSWVECESGECCEQCRSECDIAESCTNGQPLHNFGYCYNGNCPIMYHQCYLYCYNSLGNQFPCVPYYTPR,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom metalloproteinase that has high hemorrhagic activity and degrades the alpha-chain of fibrinogen (FGA), leaving the beta- and the gamma-chain intact. It may also inhibit platelet aggregation. Cleaves insulin B chain at '25-Phe-|-Val-26', '26-Val-|-Asn-27', '29-His-|-Leu-30', '30-Leu-|-Cys-31', '33-Ser-|-His-34', '35-Leu-|-Val-36', '40-Tyr-|-Leu-41', '41-Leu-|-Val-42', '42-Val-|-Cys-43', '43-Cys-|-Gly-44', '44-Gly-|-Glu-45', '46-Arg-|-Gly-47', '47-Gly-|-Phe-48', '49-Phe-|-Tyr-50' and '52-Pro-|-Lys-53' bonds. Also cleaves human prothrombin (72 kDa) and activation fragment F1 (27 kDa) of activated human prothrombin, to generate two new proteins of 68 and 23 kDa. {ECO:0000269|PubMed:15302534}.",Fibrinogenolytic Enzyme
647,P0DM97,VM25A_BITAR,3.4.24.-,Zinc metalloproteinase-disintegrin BA-5A (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MMQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKVTALPKGAVQQAEQKYEDAMQYEFEVNGQPVVLHLEKNKDLFSEDYSETHYSPDGKEITTNPPIEDHCYYHGRIQNDAHSTASISACNGLKGHFKLRGETYLIEPLKIPDSEAHAVYKYENIEKEDDAPKMCGVTQTNWESDEPIKEASQLVATSDQQRYYDHFRYIKYFIVVDHRMVEKYNGNLRTIRRRIYQLVNILNEIYLPWNIRAPLVGIEFWNQRDLINVTSSAPYTLDLFGKWRASDLLNRKIHDYTHLLTAIVFVEQILGMAHIATMCHSELSVGLVQDYMPSEHVVAAIMVHEMGHNLGISHDEKYCNCGADSCIMYPQISIPPPVYFSNCSWEQYQNFLTIYKPDCTLIRPSRTDIVSPPVCGNDILEQGEECDCGSPEKCQDPCCDAASCKLHSWIECEFGECCDQCRFKPAGTECRGIRSECDLPEYCTGQSVDCPIDHFHRNGKPCLNNNGAEKGEFQHTGGRY,"Venom metalloproteinase (M12B) family, P-II subfamily",FUNCTION: Snake venom zinc metalloprotease that possesses hemorrhagic activity and degrades alpha chain of fibrinogen (FGA) (By similarity). May inhibit alpha-2/beta-1 integrin (ITGA2/ITGB1). {ECO:0000250}.,Metalloprotease
648,P0DMD1,NGFV_ECHOC,,Venom nerve growth factor (v-NGF) (vNGF),MSMLCYTLIIAFLIGIWAAPKSEDNVSLGSPATPDISDTSCAKTHEALKTSQNTDQHSPAPKKAEDQEFGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNADSLNRNIRAKRGIHPVHNQGEFSVCDSVNVWVANKTTATDIKGNEVTVMVNVKP,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). {ECO:0000250}.",Metalloprotease
649,P0DMJ9,PA2H1_BOTMT,,Basic phospholipase A2 homolog BmatTX-I (svPLA2 homolog) (Lys49 PLA2-like),SLVELGKMILQETGKNPVTSYGAYGCNCGVLGHGKPKDATDRCCYVHKCCY,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:24724078). Shows high myotoxic activity, neutrophile activation (demonstrated by activation induction of IL-1beta production), slight cytotoxicity against Jurkat (leukemia T) and SK-BR-3 (breast adenocarcinoma) tumor cell lines, and slight antiparasitic activity against promastigote forms of Leishmania amazonensis (PubMed:24724078). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:24724078}.",Phospholipase
650,P0DMK1,PA23_BOTMT,3.1.1.4,Basic phospholipase A2 BmatTX-III (svPLA2) (EC 3.1.1.4) (Asp49 PLA2) (Phosphatidylcholine 2-acylhydrolase),DLWELAKMILKETGKNPLPSYGAYGCYCGWGG,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 that shows high myotoxic activity, slight neutrophil activation (demonstrated by activation induction of IL-1beta production), slight cytotoxicity against Jurkat (leukemia T) and SK-BR-3 (breast adenocarcinoma) tumor cell lines, and slight antiparasitic activity against promastigote forms of Leishmania amazonensis. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:24724078}.",Phospholipase
651,P0DMT1,PA2HS_ECHPL,,Phospholipase A2 homolog EPL_00195 (svPLA2 homolog),SVIELGKMIIQLTNKTPASYVSYGCFCGGGDKGKPKDATDRCCFVHSCCYDTLPDCSPKTDQYKYKWENGEIICENSTSCKKRICECDKAVAICLRDNLNTYNKKYRIYPNFLCRGDPDKC,"Phospholipase A2 family, Group II subfamily, S49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (By similarity). Shows high myotoxin activities and displays edema-inducing activities (By similarity). Has cytotoxic activities against HUVEC cells (LC(50)=2.5 uL) and human lung adenocarcinoma A549 cells (LC(50)=2.9 uL). {ECO:0000250|UniProtKB:P48650, ECO:0000269|PubMed:23747272}.",Phospholipase
652,P0DMT2,PA2HS_ECHCS,,Phospholipase A2 homolog ECS_00014 (svPLA2 homolog),SIVELGKMIIQETGKSPFPSYTSYGCFCGGGERGPPLDATDRCCLAHSCCYDTLPDCSPKTDRYKYKRENGEIICENSTSCKKRICECDKAMAVCLRKNLNTYNKKYTYYPNFWCKGDIEKC,"Phospholipase A2 family, Group II subfamily, S49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (By similarity). Shows high myotoxin activities and displays edema-inducing activities (By similarity). Has cytotoxic activities against HUVEC cells (LC(50)=12.2 uL) and human lung adenocarcinoma A549 cells (LC(50)=8.5 uL). {ECO:0000250|UniProtKB:P48650, ECO:0000269|PubMed:23747272}.",Phospholipase
653,P0DMT3,PA2HS_ECHCO,,Phospholipase A2 homolog ECO_00035 (svPLA2 homolog),SVIELGKMIVQLTNKTPASYVSYGCFCGGGDRGKPKDATDRCCFVHSCCYDTLPDCSPKTDQYKYKWENGEIICENSTSCKKRICECDKAVAICLRENLKTYNKKYKIYPNILCRGEPDKC,"Phospholipase A2 family, Group II subfamily, S49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (By similarity). Shows high myotoxin activities and displays edema-inducing activities (By similarity). Has cytotoxic activities against HUVEC cells (LC(50)=4.9 uL) and human lung adenocarcinoma A549 cells (LC(50)=3.5 uL) (PubMed:23747272). {ECO:0000250|UniProtKB:P48650, ECO:0000269|PubMed:23747272}.",Phospholipase
654,P0DMU0,VSPJN_PROJR,3.4.21.-,Snake venom serine protease jerdonase (SVSP) (EC 3.4.21.-),IIGGDECNINEHPFLVALYDA,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Multifunctional venom serine protease that has fibrino(geno)lytic activity towards the A alpha-chain of human fibrinogen (FGA) and a slow activity towards the B beta-chain (FGB). Also hydrolyzes bovine low-molecular-mass kininogen and releases bradykinin. Catalyzes the hydrolysis of BAEE, S-2238 and S-2302. {ECO:0000269|PubMed:12897962}.",Serine Protease
655,P0DMU1,VSPJF_PROJR,3.4.21.-,Beta-fibrinogenase jerdofibrase (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VIGGDECNINEHPFLVLVYY,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Fibrin(ogen)olytic serine protease degrades Bbeta-chain of human fibrinogen (FGB) and shows a lower activity on Aa-chain (FGA). Also degrades fibrin directly. Releases fibrinopeptide B and a small amount of fibrinopeptide A. Has also be shown to catalyze the hydrolysis of some chromogenic substrates such as S2238, S2160, S2302 and S2251. {ECO:0000269|PubMed:11306131}.",Serine Protease
659,P0DQP2,3SIH_DENJJ,,Venom protein SynTx (Dj_SynTx) (Synergistic-like venom 3FTx protein S2C4 homolog) (T3431),TLLLTLVVVTIVCLDLGYTLTCVTDKSFGGVITEECAAGQKICFKNWKKMGPKLYDVKRGCTATCPKADDNGCVKCCNTDKCNK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily",FUNCTION: This protein shows a synergetic toxic effect in that it enhances the toxicity of other toxins. {ECO:0000250|UniProtKB:P01407}.,General Toxin
660,P0DQP6,PA21_CERGO,3.1.1.4,Basic phospholipase A2 (svPLA2) (EC 3.1.1.4) (Myotoxin I) (Phosphatidylcholine 2-acylhydrolase),HLFQFREMIKEMTGKEPVVSYAFYGCYCGKGGRGKPDAT,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows high myotoxic activities, induces mild edema, and shows cytolytic, and anti-coagulant activities, as well as intracerebral lethal effect (PubMed:10698689, PubMed:1524423). Does not induce lethality at a dose of 5 ug/g, when intravenously injected into mice (PubMed:1524423). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:1524423). {ECO:0000269|PubMed:10698689, ECO:0000269|PubMed:1524423}.",Phospholipase
661,P0DQP9,PA2B1_BOTBZ,3.1.1.4,Basic phospholipase A2 myotoxin-I (MTX-I) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLWEFGQMILKETGKLPFPYYGAYGCYCGWGGRRGPKDATDRCCYVHDCKQICECDKAAAVCFRERKYMAYLRVLCKK,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits myotoxin and anticoagulant activity (PubMed:18602430). Displays edema-inducing activities in mouse paw (PubMed:18602430). Also displays cytotoxic activity against some cell lines and myotubes, and antimicrobial activities against E.coli, C.albicans and Leishmania (PubMed:18602430). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18602430}.",Phospholipase
662,P0DQT6,VM11_BOTMO,3.4.24.-,Snake venom metalloproteinase BmooMP-I (SVMP) (EC 3.4.24.-),AFSPRYIELAVVADNGMFTKYNSNLNTIRTRVHEMVNTVNGFYSSVNANASLANLQVWSIKDLIKVEKDSNKTLTSFGEWRERDLLPRISHDHAQLLTTIVFDNYVIGRSRSGKMCDPEQSVGVVRDHSKNNLWVAVTMAHELGHNLDMHHDDTCSCGAKSCIMASVLSKTKSYAFSTCSQNEYQTFLTKHNPQCILNEP,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Zinc metalloprotease that displays fibrinogenolytic, gelatinase and weak hemorrhagic activities (PubMed:32946987). Degrades the three chain of fibrinogen Aalpha-chain (FGA), Bbeta-chain (FGB), and gamma (FGG) (PubMed:32946987). {ECO:0000269|PubMed:32946987}.",Metalloprotease
663,P0DTS8,PA2H2_BOTBZ,,Basic phospholipase A2 homolog 2 (svPLA2 homolog) (Brazilitoxin II) (BbTX-II),SLFELGKMILQETGKNPAKSYGAYGCYCGVLGRGKPKDATDRCCYVHKCCYKKLTGCDNKKDRYSYSWKDKTIVCGENNPCLKELCECDKAVAICLRENLNTYNKKYRYHLKPLCKKADAC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Is myotoxic and displays edema-inducing activities in mouse paw (PubMed:19539640). Also displays cytotoxic activity against myotubes (PubMed:19539640). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (PubMed:24145104). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (PubMed:24145104). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (PubMed:24145104). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (PubMed:24145104). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (PubMed:24145104). {ECO:0000269|PubMed:19539640, ECO:0000305|PubMed:24145104}.",Phospholipase
664,P0DUN6,PA2H_BOTNR,,Basic phospholipase A2 homolog BnuTX-I (svPLA2 homolog) (Lys49 PLA2-like),SLFELGKMILQETGKNPAKSYGAYGCNCGVLGRGKPKDATDRCCYVHKCCYKDRYSYSWKDKTIVCGENNPCLKELCECDKAVAICLRENLGTYNKKYRYHLKPFCKK,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that lacks enzymatic inactivity, but induces myotoxicity (PubMed:26927324). Also causes an inflammatory activity that is demonstrated by mice paw edema induction and pro-inflammatory cytokine IL-1 (but not TNF-alpha) elevation (PubMed:26927324). Also shows antimicrobial activity against Gram-positive and Gram-negative bacteria (PubMed:26927324). {ECO:0000269|PubMed:26927324}.",Phospholipase
665,P0DUN7,PA2H_LACMU,,Basic phospholipase A2 homolog LmutTX (svPLA2 homolog) (LmmV toxin) (Lys49 PLA2-like),SLVELGKMILQETGKNPVTSYGAYGCNCGVLGSGKPKDATDRCCYVHKCCYKKLTDCDPKKDRYSYSWKDKTIVCGENNSCLKELCECDKAVAICLRENLDTYNKKYNYLKPFCKKADPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:29067765). Shows moderate cytotoxicity against C2C12 myotubes (activity above 200 ug/mL) (PubMed:29067765). Also shows antibacterial activity against both Gram-positive and Gram-negative bacteria (PubMed:29067765). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:29067765}.",Phospholipase
666,P0DUP1,PA2H_BOTDP,,Basic phospholipase A2 homolog Bneu-I (svPLA2 homolog) (B.neuwiedii myotoxin I) (Lys49 PLA2-like),SLVELGKMILQETGKNPVTSYGAYGCNCGVLGRGKPKDAT,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:10519651). It induces local myotoxicity and shows edema-forming effects in mice (PubMed:10519651). It is not lethal when intravenously injected at high doses (up to 4.7 mg/kg) (PubMed:10519651). {ECO:0000269|PubMed:10519651}.,Phospholipase
667,P0DUP2,PA2H2_CROOA,,Basic phospholipase A2 CoaTx-II (svPLA2 homolog) (Lys49 PLA2-like),SLVELGKMILQETGKNAIPSYGFYGCNCGWGGRGKPKDATDRCCFVHKCCYKKLTDCDPKTDIYSYSWKNKTIICDVNNPCLKEMCECDKAVAICLRENLDTYNKKYRIYPKFLCKKPDTC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that lacks enzymatic inactivity (PubMed:27530662). It shows antibacterial activity against both Gram-negative and Gram-positive bacteria, including methicillin-resistant strains (PubMed:27530662). In vivo, it causes local muscular damage, but no systemic damage (intravenous administration does not elevate plasma creatine kinase). Also causes an inflammatory activity that is demonstrated by mice paw edema induction and pro-inflammatory cytokine IL-6 elevation (PubMed:27530662). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:27530662}.",Phospholipase
668,P0DUP9,PA2H2_BOTMA,,Basic phospholipase A2 homolog BmajPLA2-II (svPLA2 homolog),NLWQLGKMILLETGKIPAKSYGAYGCNCGVLGRCCYVHKXXXXKLTGCDPKXXXYSYSWKXXTIVCGENNSCLKELCECDKAVAICLRENLDTYNKXXXYNYLKPF,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) homolog that lacks enzymatic activity (PubMed:28390830). Shows high myotoxin activities (By similarity). Also shows neurotoxicity, since it induces muscle paralysis when tested on mouse phrenic-diaphragm preparations (By similarity). Displays edema-inducing activities (By similarity). Also displays antimicrobial activity against E.coli and C.albicans, as well as antitumoral activity against some human and mice cell lines (By similarity). In addition, it is effective as parasiticidal agent against Leishmania infantum promastigotes and Trypanosoma cruzi epimastigotes (PubMed:28390830). It also disrupts negatively charged liposomes in a dose- and temperature-dependent manner and shows toxicity by intraperitoneal route (By similarity). In contrast to other phospholipase A2-like toxins, this myotoxin does not require fatty acid binding to be active (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is usually (but not here) activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:Q9I834, ECO:0000269|PubMed:28390830}.",Phospholipase
669,P0DV82,PA2_BOTIN,3.1.1.4,Acidic phospholipase A2 Bi PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLFEFGKMILKETGKNPFTSYGFYGCYCGWGGRGGPKDATDRCCF,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) induces increase of creatine kinase levels, which is an indicator or myonecrosis (PubMed:17953979). It also promotes renal alterations in the isolated perfused rat kidney (PubMed:17953979). It increases perfusion pressure (PP), renal vascular resistance (RVR), urinary flow (UF) and glomerular filtration rate (GFR). Sodium and chloride tubular reabsorption decreased at 120 minutes, without alteration in potassium transport (PubMed:17953979). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:17953979). {ECO:0000269|PubMed:17953979}.",Phospholipase
670,P0DW97,TXVE_DABPA,,Snake venom vascular endothelial growth factor toxin (svVEGF) (VEGF-F) (VpVEGF),QVRPFLDVYQRSACQARETLVSILQEYPDEISDIFRPSCVAVLRCSGCCTDESLKCTPVGKHTVDMQIMRVNPRTQSSKMEVMKFTEHTACECRPRRKQGEPDGPKEKPR,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein potently stimulates dermal human microvascular endothelial cell (dHMVEC) proliferation in a VEGFR-2 dependent manner (PubMed:17852405). This stimulatory effect is correlated with activation of the MAPK Erk1/2 signaling pathway (PubMed:17852405). It also appears to be a chemoattractant for migration of these cells and stimulates their radial migration in a collagen gel (PubMed:17852405). In vivo, it induces angiogenesis in a Japanese quail assay (PubMed:17852405). This pro-angiogenic effect may also be related to its interaction with VEGFR-2 (PubMed:17852405). In addition, it may induce an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase (By similarity). {ECO:0000250|UniProtKB:P83942, ECO:0000269|PubMed:17852405}.",Vascular Interaction
671,P10116,PA2B2_LATCO,3.1.1.4,Basic phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme II) (PLA-II),NLIQFSELIQCANKGKRATYYYMDYGCYCGKGGSGTPVDDLDRCCKTHDDCYGQAEKKGCFPFLTLYNFICFPGGPTCDRGTTCQRFVCDCDIQAAFCFARSPYNNKNYNINISKRCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
672,P14411,PA2BA_BUNFA,3.1.1.4,Basic phospholipase A2 10 (svPLA2) (EC 3.1.1.4) (KBf X) (KBf-10) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGAANIPPQPLNLYQFKNMIQCAGTQLWVAYVNYGCYCGKGGSGTPVDQLDRCCQTHDHCYHNAKRFGKCNPYFKTYEYTCNKPNLTCRGAKGSCGRNVCDCDRAAAICFAAAPYNLSNFGINKKTHCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
673,P14556,PA2B_NAJPA,3.1.1.4,Basic phospholipase A2 nigexine (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFKNMIHCTVPSRPWWHFADYGCYCGRGGKGTPIDDLDRCCQVHDNCYEKAGKMGCWPYFTLYKYKCSKGTLTCNGRNGKCAAAVCNCDLVAANCFAGAPYINANYNIDFKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows anticoagulant activity, has cytotoxic activity and affects neuromuscular transmission in vitro. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:2048150, ECO:0000269|PubMed:2753914}.",Phospholipase
674,P15503,VM2TA_CRAGM,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin trigramin-alpha (Platelet aggregation activation inhibitor)],MIQVLLITICLAVFPYQGSSIILESGNLNDYEVVYPEKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSEIHYSPDGREITAYPSVEDHCYYHGRIENDADSTASISACDGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEPPKMCGVTQNWESYESTKKASQLNVTPEQQRFPQRYIKLGIFVDHGMYTKYSGNSERITKRVHQMINNINMMCRALNIVTTLSVLEIWSEKDLITVQASAPTTLTLFGAWRETVLLNRTSHDHAQLLTATIFNGNVIGRAPVGGMCDPKRSVAIVRDHNAIVFVVAVTMTHEMGHNLGMHHDEDKCNCNTCIMSKVLSRQPSKYFSECSKDYYQTFLTNHNPQCILNAPLRTDTVSTPVSGNELLEAGEDCDCGSPANPCCDAATCKLIPGAQCGEGLCCDQCSFIEEGTVCRIARGDDLDDYCNGRSAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin trigramin-alpha]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3).",Fibrinogenolytic Enzyme
675,P17497,VM2_BITAR,,Disintegrin bitistatin (Arietin) (Bitan-alpha) (Bitistatin D1) (Platelet aggregation activation inhibitor) (Venom protein CM-2),SPPVCGNKILEQGEDCDCGSPANCQDRCCNAATCKLTPGSQCNYGECCDQCRFKKAGTVCRIARGDWNDDYCTGKSSDCPWNH,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen. {ECO:0000269|PubMed:2600082}.",Fibrinogenolytic Enzyme
676,P17934,PA2A4_BUNMU,3.1.1.4,Acidic phospholipase A2 beta-bungarotoxin A4 chain (Beta-BuTX A4 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MNPAHLLVLSAVCVSLLGAANIPPQHLDLYQFKEMIRYTIPCEKTWGEYADYGCYCGAGGSGTPIDALDRCCYVHDNCYGDAANIRDCDPKTQSYSYKLTKRTIICYGAAGTCARVVCDCDRTAALCFGNSEYIEGHKNIDTARFCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
678,P18619,VM2FL_PROFL,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin flavoridin],MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKRAVQQKYEDAMQYELKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYLIEPLKLSDSEAHAVYKYENIEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYIELAIVVDHGMYKKYNHDSDKIKVRVHQMVNHINEMYRPLNIAITLSLLQIWSNKDLITVKSASNVTLNLFGNWRETVLLKRRSHDCAHLLTDINFTGNIIGLAYKQGMCNPKLSVGLVQDYSSNVFVVAVIMTHELGHNLGMEHDEEKNGKKCNCKTCIMSPAISDPPAQLFSDCSKNDYHTFLTNRNPQCILNAPLRTDTVSTPVSGNEFLEAGEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRIARGDFPDDRCTGLSNDCPRWNDL,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin flavoridin]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
679,P18998,PA2HA_CROSS,,Phospholipase A2 homolog mojave toxin acidic chain (Mtx-a) [Cleaved into: Mojave toxin acidic chain A; Mojave toxin acidic chain B; Mojave toxin acidic chain C],MRALWIVAVLLVGVEGSLVEFETLIMKIAGRSGISYYSSYGCYCGAGGQGWPQDASDRCCFEHDCCYAKLTGCDPTTDVYTYRQEDGEIVCGGDDPCGTQICECDKAAAICFRDSMNTYDYKYLRFSPENCQGESQPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini.,Phospholipase
681,P20005,VSP1_OVOOK,3.4.21.-,Thrombin-like enzyme okinaxobin-1 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Okinaxobin I) (Snake venom serine protease) (SVSP),VIGGDECNINEHRFLAALYD,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that releases specifically fibrinopeptide B from fibrinogen (FGB) to form fibrin clots. Shows a preferential cleavage at Arg-|-Gly bonds in fibrinogen beta chains. Cleaves fibrinogen beta chains preferentially to alpha chains. {ECO:0000269|PubMed:1964457, ECO:0000269|PubMed:7725319}.",Serine Protease
693,P20476,PA2A1_CRAGM,3.1.1.4,Acidic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme I) (PLA2-I),MRTLWIMAVLLVGVEGHLMQFETLIMKVAGRSGVWYYGSYGCFCGAGGQGRPQDASDRCCFVHDCCYGKVNGCDPKKDFYTYSEENGAIVCGGDDPCKKEICECDKDAAICFRDNKDTYDNKYWFFPAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has high lipolytic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
694,P21789,PA2A_CERCE,3.1.1.4,Acidic phospholipase A2 Cc1-PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFGKMIFKMTGKSPIFSYGDYGCYCGWGGKGTPVDATDRCCFVHDCCYGRVNSCNPKRSTYSYSFQNGGIVCDDQNLCKRAVCECDRVAAICFGENVNTYDKKYKDYPTSQCTETEQ,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: This non-toxic acidic phospholipase A2 hydrolyzes monolayers of different short chain phospholipids (PubMed:2402760). It exhibits anticoagulant effects upon human plasma in vitro (PubMed:30239061). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (PubMed:2402760). {ECO:0000269|PubMed:2402760, ECO:0000269|PubMed:30239061}.",Phospholipase
695,P22028,VM3B_BOTJA,3.4.24.-,Zinc metalloproteinase-disintegrin-like botrocetin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP) (von Willebrand factor-dependent platelet coagglutinin) [Cleaved into: Disintegrin-like botrocetin],IISPPVCGNELLEEGEECDCGTPEN,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIb sub-subfamily","FUNCTION: Metalloproteinase that binds to von Willebrand factor (VWF) and induces its interaction with GPIb (GP1BA), resulting in platelet aggregation.",Vascular Interaction
696,P22640,PA2H_PROMU,,Basic phospholipase A2 homolog (svPLA2 homolog) (TMV-K49),SLIELGKMIFQETGKNPVKNYGLYLCNCGVGNRGKPVDATDRCCFVHKCCYKKVTGCDPKKDRYSYSWENKAIVCGEKNPPCLKQVCECDKAVAICLRENLQTYDKKHRVTVKFLCKAPESC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has almost no phospholipase A2 activity. Is myotoxic (By similarity). Displays edema-inducing activities (PubMed:2029535). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:2029535}.",Phospholipase
697,P23027,PA2HB_PSETE,,Basic phospholipase A2 homolog textilotoxin B chain (svPLA2 homolog),DLVEFGFMIRCANRNSQPAWQYMDYGCYCGKRGSGTPVDDVDRCCQTHNECYDEAAKIPGCKPKWTFYFYQCGSGSQFTCRKSKDVCRNVVCDCDFKAALCLTGARYNSANYNIDIKTHCR,"Phospholipase A2 family, Group I subfamily, N49 sub-subfamily","FUNCTION: Snake venom oligomeric phospholipase A2 that has potent presynaptic neurotoxicity. Chain B is not itself neurotoxic, but it is essential for the neurotoxicity of textilotoxin. Subunit B possesses a very low phospholipase activity. {ECO:0000269|PubMed:8431471}.",Phospholipase
699,P25660,VKT9_BUNFA,,Kunitz-type serine protease inhibitor IX (Bungarus fasciatus fraction IX) (BF9) (Venom basic protease inhibitor IX) [Cleaved into: Kunitz-type serine protease inhibitor VIIIB (Venom basic protease inhibitor VIIIB)],KNRPTFCNLLPETGRCNALIPAFYYNSHLHKCQKFNYGGCGGNANNFKTIDECQRTCAAKYGRSS,Venom Kunitz-type family,"FUNCTION: Dual-function toxin that inhibits both serine proteases (high activity on chymotrypsin (Ki = 18 nM), and low activity on elastase) and voltage-gated potassium channels Kv1.3/KCNA3 (IC(50) = 120.0 nM). {ECO:0000269|PubMed:11562364, ECO:0000269|PubMed:24243656}.",Serine Protease
700,P26324,VSPF1_CALRH,3.4.21.74,Thrombin-like enzyme ancrod (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Venombin A),VIGGDECNINEHRFLVAVYEGTNWTFICGGVLIHPEWVITAEHCARRRMNLVFGMHRKSEKFDDEQERYPKKRYFIRCNKTRTSWDEDIMLIRLNKPVNNSEHIAPLSLPSNPPIVGSDCRVMGWGSINRRIDVLSDEPRCANINLHNFTMCHGLFRKMPKKGRVLCAGDLRGRRDSCNSDSGGPLICNEELHGIVARGPNPCAQPNKPALYTSIYDYRDWVNNVIAGNATCSP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that acts as an anticoagulant. It cleaves fibrinogen (FGA) to split off the A-fibrinopeptides (A, AY and AP), but not the B-fibrinopeptide. The resulting fibrin polymers are imperfectly formed and much smaller in size (1 to 2 um long) than the fibrin polymers produced by the action of thrombin. These ancrod-induced microthrombi are friable, unstable, urea-soluble and have significantly degraded alpha chains. They do not cross-link to form thrombi. They are markedly susceptible to digestion by plasmin and are rapidly removed from circulation by either reticuloendothelial phagocytosis or normal fibrinolysis, or both. Anticoagulation through the removal of fibrinogen from the blood is rapid, occurring within hours following its administration. It does not activate plasminogen and does not degrade preformed, fully cross-linked thrombin fibrin. It also reduces the level of plasminogen activator inhibitor (PAI) and may stimulate the release of tissue plasminogen activator (PLAT) from the endothelium. The profibrinolytic effect of these 2 actions appears to be limited to local microthrombus degradation.",Serine Protease
701,P30811,PA2HC_PSETE,,Acidic phospholipase A2 homolog textilotoxin C chain (svPLA2 homolog),MHPAHLLVLLGVYVSLLGAARIPPLPLNLIQFSNMIKCTIPGSQPLLDYANYGCYCGPGNNGTPVDDVDRCCQAHDECYDEASNHGCYPELTLYDYYCDTGVPYCKARTQCQVFVCGCDLAVAKCLAGATYNDENKNINTGERCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom oligomeric phospholipase A2 that has potent presynaptic neurotoxicity. Chain C is not itself neurotoxic, but it is essential for the neurotoxicity of textilotoxin. Chain C possesses a very low phospholipase activity. {ECO:0000269|PubMed:8431471}.",Phospholipase
702,P30894,NGFV_DABRR,,Venom nerve growth factor (v-NGF) (vNGF),HPVHNQGEFSVCDSVSVWVANKTTATDMRGNVVTVMVDVNLNNNVYKQYFFETKCKNPNPVPSGCRGIDAKHWNSYCTTTDTFVRALTMERNQASWRFIRINTACVCVISRKNDNFG,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
703,P31854,PA2B_VIPBB,3.1.1.4,Basic phospholipase A2 Pla2Vb (VbbPLA2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVWLMGVEGNLFQFGNMINHMVGKHAVWSYLSYGCYCGWGGQGKPQDATDRCCFVHDCCYGRANGCDPKLSTYSYNFQNGNIVCGNKYGCLRHICECDRVAAICFQKNMNTYNKKYKNYSSSNCQENSDKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits medium anticoagulant effects by binding to factor Xa (F10) and inhibiting the prothrombinase activity (IC(50) is 90 nM). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:18062812}.,Phospholipase
704,P31989,VM2JC_BOTJA,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin jararacin (Platelet aggregation activation inhibitor); Disintegrin jararacin-AGEEC; Disintegrin jararacin-GEEC; Disintegrin jararacin-EC],ERDLLVAVTMDHELGHNLGIRHDTGSCSCGGYSCVMSPVISHDISKYFSDCSYIQCWDFIMKENPQCILNKHLRTDTVSTPVSGNELLEAGEECDCGTPGNPCCDAATCKLRPGAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: Disintegrin: inhibit platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
705,P33588,VSPCA_AGKBI,3.4.21.-,Protein C activator (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VVGGDECNINEHRSLALMYA,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that selectively cleaves the heavy chain of protein C (PROC). This activation is thrombomodulin-independent. {ECO:0000269|PubMed:2385829}.,Serine Protease
706,P34180,PA2N2_VIPAA,3.1.1.4,Neutral phospholipase A2 ammodytin I2 (AmI2) (AmdI1) (AtnI2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLIGVEGNLYQFGNMIFKMTKKSALLSYSNYGCYCGWGGKGKPQDATDRCCFVHDCCYGRVNGCDPKLSIYSYSFENGDIVCGGDDPCLRAVCECDRVAAICFGENLNTYDKKYKNYPSSHCTETEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has enzymatic activity but is non-toxic. Displays low binding affinity and enzymatic activity on phosphatidylserine-containing vesicles and HEK-293 plasma membranes, in contrast to ammodytoxins that have high activity on these phospholipids. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:16156665}.",Phospholipase
707,P47797,VSPF2_CALRH,3.4.21.74,Thrombin-like enzyme ancrod-2 (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Venombin A),MVLIRVLANLVILQLSYAQKSSELVIGGDECNINEHRFLVALYDSTTRNFLCGGVLIHPEWVITAKHCNKKSMVLYLGKHKQSVKFDDEQERFPKEKHFIRCNKPRTRWGEDIMLIRLNKPVNNSEHIAPLSLPSNPPIVGSVCRVMGWGSINKYIDVLPDEPRCANINLYNYTVCRGVFPRIPKKSKILCAGDLQGRLDSCHCDSGGPLICSEEFHGIVYRGPNPCAQPDKPALYTNIFDHLHWILSIMAGNATCYP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Cleaves fibrinogen (FGA) to split of fibrinopeptides AM, AO, and AY; the aberrant fibrinogen is then incapable of being cross-linked, forming easily dispersible clots.",Serine Protease
708,P48650,PA2HS_ECHCA,,Basic phospholipase A2 homolog ecarpholin S (Ecs-S49) (svPLA2 homolog),SVVELGKMIIQETGKSPFPSYTSYGCFCGGGERGPPLDATDRCCLAHSCCYDTLPDCSPKTDRYKYKRENGEIICENSTSCKKRICECDKAVAVCLRKNLNTYNKKYTYYPNFWCKGDIEKC,"Phospholipase A2 family, Group II subfamily, S49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Shows high myotoxin activities and displays edema-inducing activities (PubMed:18586854). {ECO:0000269|PubMed:18586854}.,Phospholipase
709,P58464,PA2H3_BOTPI,,Basic phospholipase A2 homolog piratoxin-3 (svPLA2 homolog) (MP-III 4R) (Piratoxin-III) (PrTX-III),DLWQFGQMILKETGKLPFPYYTYGGCYCGVGGRRGLGTKDDRCCYVHDCCYKKLTGCPKTDDRYSYSWLDLTIVCGEDDPCKELCECDKAIAVCFRENLGTYNKKYRYHLKPCKKADKPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that lacks enzymatic activity. Shows high myotoxin activities (PubMed:10395455). Also has anticoagulant activity (PubMed:10395455). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:10395455}.",Phospholipase
710,P59018,PA2B5_BUNMU,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A5 chain (Beta-BuTX A5 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGAANIPPQHLNLYQFKEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAEKKHKCNPKTQSYSYKLTKRTIICYGAAGTCGRIVCDCDRTTALCFGNSEYIEGHKNIDTARFCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
711,P59067,PA2SA_AUSSU,3.1.1.4,Phospholipase A2 superbin a (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFKNMIQCANHGRRATWHYLDYGCYCGPGGLGTPVDELDRCCKTHDDCYIEAGKKGCFP,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. In terms of inhibition of platelet aggregation, superbin a is more potent as superbin b, c, and d. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
712,P59068,PA2SB_AUSSU,3.1.1.4,Phospholipase A2 superbin b (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFKNMIQCANRGSRHWLAYADYGCYCGWGGSGTPVDELDRCCKTHDDCYTEAGK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. In terms of inhibition of platelet aggregation, superbin b is more potent as superbin c, and d. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
713,P59069,PA2SC_AUSSU,3.1.1.4,Phospholipase A2 superbin c (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLIQLSNMIKCAIPGSRPLLHYTDYGCYCGKGGSGTPVDELDRCCK,"Phospholipase A2 family, Group I subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. In terms of inhibition of platelet aggregation, superbin c is more potent as superbin d. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
714,P59070,PA2SD_AUSSU,3.1.1.4,Phospholipase A2 superbin d (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLVQFSNMIQCANHGSRPTRHYVDYGCYCGWGGSGTPVDELDRCCQTH,"Phospholipase A2 family, Group I subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. In terms of inhibition of platelet aggregation, superbin d is less potent as superbin a, b, and c. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
715,P59276,3S1C_NAJKA,,Cobrotoxin-c (CBT-c) (Short neurotoxin II) (NT2),LECHNQQSSQAPTTKTCSGETNCYKKWWSDHRGTIIERGCGCPKVKPGVNLNCCRTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Binds to the nicotinic acetylcholine receptor. {ECO:0000269|PubMed:12039691, ECO:0000305|PubMed:12039691}.",Neurotoxin
717,P60301,3SA3_NAJAT,,Cytotoxin 3 (Cardiotoxin 3) (CTX-3) (CTX3) (Cardiotoxin A3) (CTX A3) (Cardiotoxin III) (Cardiotoxin analog III) (CTX III),MKTLLLTLVVVTIVCLDLGYTLKCNKLVPLFYKTCPAGKNLCYKMFMVATPKVPVKRGCIDVCPKSSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Basic protein that binds to cell membrane and depolarizes cardiomyocytes. This cytotoxin also possesses lytic activity on many other cells, including red blood cells (PubMed:8182052). Interaction with sulfatides in the cell membrane induces pore formation and cell internalization. Cytotoxicity is due to pore formation, and to another mechanism independent of membrane-damaging activity. When internalized, it targets the mitochondrial membrane and induces mitochondrial swelling and fragmentation. It inhibits protein kinases C. It binds to the integrin alpha-V/beta-3 (ITGAV/ITGB3) with a moderate affinity (PubMed:16407244). It also binds with high affinity to heparin (PubMed:17685633). {ECO:0000269|PubMed:15922335, ECO:0000269|PubMed:16263708, ECO:0000269|PubMed:16407244, ECO:0000269|PubMed:17714752, ECO:0000269|PubMed:8182052, ECO:0000269|PubMed:8448165, ECO:0000269|PubMed:9245415}.",Vascular Interaction
719,P60304,3SA1_NAJAT,,Cytotoxin 1 (CX1) (Cardiotoxin 1) (CTX-1) (CTX1) (Cardiotoxin A1) (CTX A1) (Cardiotoxin I) (Cardiotoxin analog I) (CTX I),MKTLLLTLVVVTIVCLDLGYTLKCNKLIPIASKTCPAGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Basic protein that binds to cell membrane and depolarizes cardiomyocytes. It also shows lytic activities on many other cells, including red blood cells. Interaction with sulfatides in the cell membrane induces pore formation and cell internalization and is responsible for cytotoxicity in cardiomyocytes. It targets the mitochondrial membrane and induces mitochondrial swelling and fragmentation (By similarity). It binds to the integrin alpha-V/beta-3 (ITGAV/ITGB3) with a moderate affinity and inhibits protein kinases C (PubMed:8448165). It also binds with high affinity to heparin (PubMed:17685633). It also causes skeletal muscle necrosis after intramuscular injection into mice (PubMed:8342169). {ECO:0000250|UniProtKB:P01443, ECO:0000250|UniProtKB:P60301, ECO:0000269|PubMed:8342169, ECO:0000269|PubMed:8448165}.",Vascular Interaction
720,P60616,3L21V_BUNMU,,Alpha-bungarotoxin isoform V31 (Alpha-BTX V31) (Alpha-Bgt(V31)) (BGTX V31) (Long neurotoxin 1),MKTLLLTLVVVTIVCLDLGYTIVCHTTATSPISAVTCPPGENLCYRKMWCDVFCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:10497260}.",Neurotoxin
721,P62375,3SOF5_NAJAT,,Cytotoxin A5 (CTX A5) (CT A5) (Cardiotoxin A5) (Cardiotoxin V) (CTX V) (CTXV) (Cardiotoxin-like basic polypeptide) (CLBP),MKTLLLTMVVVTIVCLDLGYTLKCHNTQLPFIYKTCPEGKNLCFKATLKKFPLKFPVKRGCADNCPKNSALLKYVCCSTDKCN,"Snake three-finger toxin family, Short-chain subfamily, Orphan group XV sub-subfamily","FUNCTION: Non-cytotoxic protein that does not show lytic and hemolytic activities, but can induce aggregation and fusion of sphingomyelin vesicles (PubMed:8182052). It binds to integrin alpha-V/beta-3 (ITGAV/ITGB3) with high affinity, and it inhibits osteoclast differentiation and bone resorption in mice, probably due to binding to integrin alpha-V/beta-3 (PubMed:16407244). {ECO:0000269|PubMed:14743531, ECO:0000269|PubMed:16407244, ECO:0000269|PubMed:8182052, ECO:0000269|PubMed:8703922}.",Binding Protein
722,P68520,VM2IC_CROAT,,Disintegrin crotatroxin (Platelet aggregation activation inhibitor) [Cleaved into: Disintegrin crotatroxin-2; Disintegrin crotatroxin-4; Disintegrin crotatroxin-5],AGEECDCGSPANPCCDAATCKLRPGAQCADGLCCDQCRFIKKGTVCRPARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Disintegrin crotatroxin]: Inhibits fibrinogen interaction with platelets. Acts by binding to the alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.; FUNCTION: [Disintegrin crotatroxin-2]: Inhibits ADP-induced platelet aggregation (IC(50) = 17.5nM), cancer cell migration in vitro, and experimental lung tumor colonization of cancer cells.",Fibrinogenolytic Enzyme
723,P70088,PA2A6_CRAGM,3.1.1.4,Acidic phospholipase A2 6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme VI) (PLA2-VI),MRTLWIMAVLLVGVEGHLMQFENMIKKVTGRSGIWWYGSYGCYCGKGGQGLPQDASDRCCFVHDCCYGKVNGCDPKDDFYVYSSENRDIVCGEDNPCTKEICECDKAAAICFRDNMDTYQNKYWFYPSSNCNEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has high lipolytic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
724,P70090,PA2H5_CRAGM,,Basic phospholipase A2 homolog 5 (svPLA2 homolog) (Phospholipase A2 isozyme V) (PLA2-V),MRTLWIMAVLLLGVEGSVIELGKMIFQETGKNPATSYGLYGCNCGPGGRRKPKDATDRCCYVHKCCYKKLTDCDPIKDRYSYSWVNKAIVCGEDNPCLKEMCECDKAVAICFRENLDTYDKKKKINLKLFCKKTSEQC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (By similarity). Is myotoxic and displays edema-inducing activities (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:Q90249}.",Phospholipase
725,P80245,3SAN_NAJAT,,Cytotoxin 6 (Cardiotoxin 6) (CTX6) (Cardiotoxin A6) (CTX A6) (Cardiotoxin N) (CTXN) (Ctx-N) (Cytotoxin N),MKTLLLTLVVVTIVCLDLGYTLKCNQLIPPFYKTCAAGKNLCYKMFMVAAPKVPVKRGCIDVCPKSSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Basic protein that bind to cell membrane and depolarizes cardiomyocytes. This cytotoxin also shows lytic activities, on many other cells including red blood cells. Interaction with sulfatides in the cell membrane induces pore formation and cell internalization and is responsible for cytotoxicity in cardiomyocytes. It targets the mitochondrial membrane and induces mitochondrial swelling and fragmentation. Inhibits protein kinases C (By similarity). It binds to the integrin alpha-V/beta-3 with a moderate affinity (PubMed:16407244). {ECO:0000250|UniProtKB:P01443, ECO:0000269|PubMed:16407244}.",Vascular Interaction
727,P81038,VSPA_CERCE,3.4.21.-,Thrombin-like enzyme cerastotin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGAECNINEHRSLVLLYYSSRLFGGGTLINKEWVLSAAHCDGENMKIIYXXXXXXXXXXKDRQIRVAKKYFCRDRKKSVIDKDIMLIKKPVNGSTH,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease that preferentially cleaves the alpha-chain of fibrinogen (FGA). Induce platelet aggregation in the presence of exogenous fibrinogen. Possesses esterase and amidolytic activities. {ECO:0000269|PubMed:9249017}.,Serine Protease
728,P81111,SLA1_TRIAB,,Snaclec alboaggregin-A subunit alpha (50-kDa alboaggregin) (Alboaggregin-A subunit 1) (AL-A subunit 1),DCPSDWSSYDQYCYRVFKRIQTWEDAERFCSEQANDGHLVSIESAGEADFVTQLVSENIRSEKHYVWIGLRVQGKGQQCSSEWSDGSSVHYDNLQENKTRKCYGLEKRAEFRTWSNVYCGHEYPFVCKFXR,Snaclec family,"FUNCTION: Potent platelet activator that aggregates platelets via both GPIbalpha (GP1BA) and GPVI (GP6). Induces a tyrosine phosphorylation profile in platelets that resembles this produced by collagen, involving the time dependent tyrosine phosphorylation of Fc receptor gamma chain (FCGR1A), phospholipase Cgamma2 (PLCG2), and LAT. {ECO:0000269|PubMed:11159519, ECO:0000269|PubMed:11389045, ECO:0000269|PubMed:8823201, ECO:0000269|PubMed:9531050}.",Phospholipase
729,P81166,PA2BA_MICNI,3.1.1.4,Basic phospholipase A2 nigroxin A (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQLKNMIKCTNTRHWVSFTNYGCYCGYGGSGTPVDELDKCCQVHDKCYDTAKHVCKCSPSMTMYSYDCSEGKLTCKDNNTKCKDFVCNCDRTAALCFAKAPYNNKNFKIDPTKGCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has only a weak enzymatic activity. It has a myotoxic activity in vivo (dystrophic effect). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8603741}.,Phospholipase
730,P81167,PA2BB_MICNI,3.1.1.4,Basic phospholipase A2 nigroxin B (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLIDFKNMIKCTNTRHWVSFTNYGCYCGYGGSGTPVDELDKCCQVHDKCYDTAKHVCKCSPSMTMYSYDCSEGKLTCKDNNTKCKDFVCNCDRTAALCFAKAPYNNKNFKIDPTKGCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has only a weak enzymatic activity. It has a myotoxic activity in vivo (dystrophic effect). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8603741}.,Phospholipase
731,P81176,VSP1_GLOBL,3.4.21.-,Thrombin-like enzyme halystase (SVTLE) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),IIGGDECNINEHRFLVALYTPRSRTLFCGGTLINQEWVLTAAHCDRKNFRIKLGMHSKKVPNKDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSTHIEPFSLPSSPPSVGSVCRIMGWGRISPTEETFPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCRGDSGGPLICNGQFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIKSIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Cleaves fibrinogen (beta chain of fibrinogen (FGB) and more slowly alpha chain (FGA)) without inducing fibrin clotting and cleaves kininogen to produce bradykinin (KNG), resulting in the reduction of blood pressure. {ECO:0000269|PubMed:9546675}.",Serine Protease
732,P81236,PA2B1_ACAAN,3.1.1.4,Basic phospholipase A2 acanthin-1 (svPLA2) (EC 3.1.1.4) (Acanthin I) (Phosphatidylcholine 2-acylhydrolase),DLFQFGGMIGCANKGARSWLSYVNYGCYCGWGGSGTPVDELDRCCQIHDNCYGEAEKKQCGPKMTSYSWKCANDVPVCNDSKSACKGFVCDCDAAAAKCFAKAPYNKNNIGIGSKTRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that potently inhibits ADP-(IC(50)=10 nM) and collagen-induced (IC(50)=7 nM) platelet aggregation when tested on human whole blood. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:9637731}.,Phospholipase
733,P81237,PA2B2_ACAAN,3.1.1.4,Basic phospholipase A2 acanthin-2 (svPLA2) (EC 3.1.1.4) (Acanthin II) (Phosphatidylcholine 2-acylhydrolase),NLYQFGGMIQCANKGARSWLSYVNYGCYCGWGGSGTPVDELDRCCQIHDNCYGEAEKKRCGPKMTLYSWECANDVPVCNSKSACEGFVCDCDAAAAKCFAKAPYNKNNIGIGSKTRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that potently inhibits ADP-(IC(50)=12 nM) and collagen-induced (IC(50)=4 nM) platelet aggregation when tested on human whole blood. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:9637731}.,Phospholipase
734,P81243,PA2A_BOTJA,3.1.1.4,Acidic phospholipase A2 (svPLA2) (EC 3.1.1.4) (BJ-PLA2) (Phosphatidylcholine 2-acylhydrolase),DLWQFGQMMNDVMREYVVFNYLYYGCYCGWGGIGKPRDATDRCCFVHDCCYGKVTGCNPKTDSYTYTYSEENGDVVCGGDDLCKKQICECDRVAATCFRDNKDTYDTKYWLYGAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen- and ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:10375395}.,Phospholipase
735,P81397,SLEA_CALRH,,Snaclec rhodocetin subunit alpha,DCPDGWSSTKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQRSNLEWSDGSSISYENLYEPYMEKCFLMDHQSGLPKWHTADCEEKNVFMCKFQLPR,Snaclec family,"FUNCTION: Potent inhibitor of collagen-induced platelet aggregation. It acts by binding to the integrin alpha2A domain and blocks collagen binding to integrin alpha-2/beta-1 (ITGA2/ITGB1). The gamma/delta subunits mainly contribute to this activity. {ECO:0000269|PubMed:10360956, ECO:0000269|PubMed:11121411, ECO:0000269|PubMed:12871211}.",Kunitz Family
736,P81398,SLEB_CALRH,,Snaclec rhodocetin subunit beta,DFRCPTTWSASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLTERNLKWTNGASVSYENLYEPYIRKCFVVQPWEGKSKWYKADCEEKNAFLCKFPKPH,Snaclec family,"FUNCTION: Potent inhibitor of collagen-induced platelet aggregation. It acts by binding to the integrin alpha2A domain and blocks collagen binding to integrin alpha-2/beta-1 (ITGA2/ITGB1). The gamma/delta subunits mainly contribute to this activity. {ECO:0000269|PubMed:10360956, ECO:0000269|PubMed:11121411, ECO:0000269|PubMed:12871211}.",Kunitz Family
737,P81458,PA2B_DABRR,3.1.1.4,Basic phospholipase A2 RVV-VD (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (R1),NLFQFAEMIVKMTGKNPLSSYSDYGCYCGWGGKGKPQDATDRCCFVHDCCYEKVKSCKPKLSLYSYSFQNGGIVCGDNHSCKRAVCECDRVAATCFRDNLNTYDKKYHNYPPSQCTGTEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has low enzymatic activity, is devoid of lethal activity but has strong anticoagulant activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8835338}.",Phospholipase
738,P81661,VSPA_BOTJA,3.4.21.74,Thrombin-like enzyme bothrombin (SVTLE) (EC 3.4.21.74) (Factor VIII activator) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Venombin A),VIGGDECDINEHPFLAFMYYSPQYFCGMTLINQEWVLTAAHCDKTYMRIYLGIHTRSVANDDEVIRYPKEKFICPNKKKNVITDKDIMLIRLNRPVKNSTHIAPISLPSNPPSVGSVCRIMGWGAITTSEDTYPDVPHCANINLFNNTVCREAYNGLPAKTLCAGVLQGGIDTCGGDSGGPLICNGQFQGILSWGSDPCAEPRKPAFYTKVFDYLPWIQSIIAGNKTATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that clots fibrinogen by releasing fibrinopeptide A from the alpha chain of fibrinogen (FGA), induces platelet aggregation through its interaction with GPIb (GP1BA/GP1BB), and activates factor VIII (F8). {ECO:0000269|PubMed:8110787}.",Serine Protease
739,P81743,VM2AB_ERIMA,,Disintegrin EMF10B (EMF-10B) (Eristocophin II) (Platelet aggregation activation inhibitor),ELLQNSGNPCCDPVTCKPRRGEHCVSGPCCDNCKFLNAGTVCWPAMGDWNDDYCTGISSDCPRNPVFK,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily","FUNCTION: Extremely potent and selective inhibitor of integrin alpha-5/beta-1 (ITGA5/ITGB1). Partially inhibits adhesion of cells expressing alpha-IIb/beta-3 (ITGA2B/ITGB3), alpha-V/beta-3 (ITGAV/ITGB3), and alpha-4/beta-1 (ITGA4/ITGB1) to appropriate ligands only at concentration higher than 500 nM. Weakly inhibits ADP-induced platelet aggregation. {ECO:0000269|PubMed:10529205}.",Kunitz Family
740,P81783,3NO4_BUNCA,,Candoxin,MKTLLLTLVVVTIVCLDLGYTMKCKICNFDTCRAGELKVCASGEKYCFKESWREARGTRIERGCAATCPKGSVYGLYVLCCTTDDCN,"Snake three-finger toxin family, Ancestral subfamily, Orphan group IV sub-subfamily",FUNCTION: Binds and inhibits muscular and neuronal nicotinic acetylcholine receptors (nAChR). Is a reversible antagonist of muscle nAChR (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) (IC(50)=10 nM) and a potent and poorly reversible antagonist of the neuronal alpha-7/CHRNA7 nAChR (IC(50)=50 nM). May exhibit differential affinities for the two binding sites on the muscle nAChR. {ECO:0000269|PubMed:11884390}.,Neurotoxin
741,P81824,VSP1_BOTJA,3.4.21.-,Platelet-aggregating proteinase PA-BJ (EC 3.4.21.-) (Snake venom serine protease) (SVSP),NSLVIVVGGRPCKINVHRSLVLLYNSSSLLCSGTLINQEWVLTAAHCDSKNFKMKLGVHSIKIRNKNERTRHPKEKFICPNRKKDDVLDKDIMLIRLNRPVSNSEHIAPLSLPSSPPSVGSVCYVMGWGKISSTKETYPDVPHCAKINILDHAVCRAAYTWWPATSTTLCAGILQGGKDTCEGDSGGPLICNGLQGIVSGGGNPCGQPRKPALYTKVFDYLPWIESIIAGTTTATCP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that induces platelet aggregation through activation of protease-activated platelet receptors (PAR1/F2R and PAR4/F2RL3). On F2R, the cleavage occurs at Arg41-Ser42 (like thrombin cleavage), and Arg46-Asn47. In normal condition of hemostasis, the cleavage of the Arg41-Ser42 bond liberates a new N-terminus that functions as an agonist. However after envenomation, the cleavage of Arg46-Asn47 bond degrades this potential agonist. This may explain why the snake protease is less potent than thrombin in causing platelet aggregation and release reaction. On F2RL3, a thrombin-like activity has also been proven by calcium release from lung fibroblasts transfected with this receptor. Possesses amidolytic activities. {ECO:0000269|PubMed:10908720, ECO:0000269|PubMed:7766629}.",Serine Protease
742,P81882,VSPT1_BOTJA,3.4.21.-,Thrombin-like enzyme TL-BJ 1 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme TL-BJ isoform 1) (Snake venom serine protease) (SVSP),VIGGDECNINEHRSLALVY,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Causes the specific clotting of fibrinogen (FGA) with release of fibrinopeptide A. The aberrant fibrinogen is then incapable of being cross-linked, forming easily dispersible clots. {ECO:0000269|PubMed:10744151}.",Serine Protease
743,P81883,VSPT2_BOTJA,3.4.21.-,Thrombin-like enzyme TL-BJ 2 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme TL-BJ isoform 2) (Snake venom serine protease) (SVSP),VVGGDECNINEHRSLVAIF,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Causes the specific clotting of fibrinogen (FGA) with release of fibrinopeptide A. The aberrant fibrinogen is then incapable of being cross-linked, forming easily dispersible clots. {ECO:0000269|PubMed:10744151}.",Serine Protease
744,P81884,VSPT3_BOTJA,3.4.21.-,Thrombin-like enzyme TL-BJ 3 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme TL-BJ isoform 3) (Snake venom serine protease) (SVSP),VVGGDECNINEHRSLVAIF,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Causes the specific clotting of fibrinogen (FGA) with release of fibrinopeptide A. The aberrant fibrinogen is then incapable of being cross-linked, forming easily dispersible clots. {ECO:0000269|PubMed:10744151}.",Serine Protease
745,P82287,PA2H2_BOTPI,,Basic phospholipase A2 homolog piratoxin-2 (svPLA2 homolog) (Piratoxin-II) (PrTX-II),SLFELGKMILQETGKNPAKSYGAYGCNCGVLGRGKPKDATDRCCYVHKCCYKKLTGCNPKKDRYSYSWKDKTIVCGENNPCLKELCECDKAVAICLRENLGTYNKKYRYHLKPFCKKADDC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) homolog that lacks enzymatic activity (PubMed:10863008). Shows myotoxic activity and edema-inducing activities in vivo (PubMed:10863008). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:10863008}.",Phospholipase
746,P82662,3L26_OPHHA,,Alpha-elapitoxin-Oh2b (Alpha-EPTX-Oh2b) (Alpha-neurotoxin) (LNTX3) (Long neurotoxin OH-6A/OH-6B) (OH-3),MKTLLLTLVVMTIVCLDLGYTLICFISSHDSVTCAPGENVCFLKSWCDAWCGSRGKKLSFGCAATCPKVNPGIDIECCSTDNCNPHPKLRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (By similarity). Recombinant LNTX1 leads to a functional block of the muscle-type acetylcholine receptors. Has a cytotoxic activity. This neurotoxin is lethal (PubMed:16689684). {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:16689684}.",Neurotoxin
747,P82893,PA2B2_TRIST,3.1.1.4,Basic phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (PLA2-II) (Phosphatidylcholine 2-acylhydrolase),SLLQLRKMIKKMTNKEPILSYSKYGCNCGMAGRGKPVDATDXCCXXHDCCYGKVTSCSTKADSYSYSWEE,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits strong myotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|Ref.1}.,Phospholipase
748,P82942,VM3K_NAJKA,3.4.24.-,Hemorrhagic metalloproteinase-disintegrin-like kaouthiagin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),TNTPEQDRYLQAEKYIEFYVIVDNRMYRYYNYDKPAIKIRVYEMINAVNTKFRPLKIHIALIGLEIWSNEDKFEVKPAASVTLKSFREWRQTVLLPRKRNDNAQLLTGINLNGTAVGIAYPGSLCTQRSVFVVQDYNRRMSLVASTMTHELGHNLGIHHDEASCICIPGPCIMLKKRTAPAFQFSSCSIRDYQEYLLRDRPQCILNKPLSTDIVSPAICGNYFVEEGEECDCGSPAACQSACCDAATCKFNGAGAECRAAKHDCDLPELCTGQSAECPTDSLQRNGHPCQNNQGYCYNGKCPTLTNQCIALLGPHFTVSPKGCFDLNMRGDDGSFCRMEDGTKIPCAAKDVKCGRLYCTEKNTMSCLIPPNPDGIMAEPGTKCGDGMVCSKGQCVDVQTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc protease that inhibits hemostasis by binding and cleaving the vWF in humans. Has also and inhibitory effect on the collagen-induced platelet aggregation. {ECO:0000269|PubMed:11284707}.,Metalloprotease
749,P82950,PA2HB_METNM,,Basic phospholipase A2 homolog (svPLA2 homolog) (Myotoxin II),NLYQLWKMILQETGKNAAPSYGFYGCNCGVGSRGKPKDATDRCCFVHKCCYKALTDCSPKTDSYSYSWKDKTIVCGKNNPCLKQECECDKAVAICLRDNLDTYNKNYKIYPKPLCKKADDC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity, but has myotoxic and cytolytic activities. {ECO:0000269|PubMed:12127577}.",Phospholipase
750,P82966,VKTCI_OPHHA,,Kunitz-type serine protease inhibitor (Oh11-1) (Venom chymotrypsin inhibitor),MSSGRLLLLLGLLTLWAELTPVSGLGRPKFCELPPEPGLCNARKTFFYYSLHSHACQKFIYGGCGGNANKFKTIDECHRTCVG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits chymotrypsin (Ki=3520 nM). {ECO:0000269|PubMed:11350064}.,Serine Protease
751,P83228,VNPB_OXYSC,,Natriuretic peptide TNP-b (Taipan natriuretic peptide) (Venom natriuretic peptide OxsSNPb),MVGLSRLAGGGLLLLLLLALLPLALDGKPAPLPQALPEALAGGTTALRRDVTEEQQQQLVAEESSGPAAGRSDPKIGDGCFGLPLDHIGSVSGLGCNRPVQNRPKQIPGGS,Natriuretic peptide family,FUNCTION: Snake venom natriuretic peptide that exhibits vasoactive and probable hypotensive activity (PubMed:15652496). Is only weakly active on natriuretic peptide receptor-C (NPR3) (PubMed:15652496). {ECO:0000269|PubMed:15652496}.,General Toxin
752,P83230,VNPC_OXYMI,,Natriuretic peptide TNPc (TNP-c) (Taipan natriuretic peptide) (Venom natriuretic peptide OxsSNPc),SDSKIGNGCFGFPLDRIGSVSGLGCNRIMQNPPKKFSGE,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that exhibits vasoactive and hypotensive activity (By similarity). Produces a near complete relaxation in pre-contracted aortae by activating the natriuretic peptide receptor 1 (NPR1) (PubMed:15652496). Stimulates cGMP production through the natriuretic peptide receptor 1 (NPR1) with high potencies for the rat NPR1 (EC(50)=100 nM), and very weak potencies over human NPR1 (28% activation at 10 uM) (PubMed:37049825). In vivo, reduces both systolic and diastolic blood pressure with no effect on heart rate, when intravenously injected in conscious rabbits (PubMed:37049825). Also enhances the bradycardia due to cardiac afferent stimulation (Bezold-Jarisch reflex) (PubMed:37049825). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000269|PubMed:15652496, ECO:0000269|PubMed:37049825}.",General Toxin
753,P83254,DID1B_MACLB,,Disintegrin lebein-1-beta (MS-II) (Platelet aggregation activation inhibitor),NSGNPCCDPVTCKPRRGWHCVSNPCCDNCKFMRAGTICNRARGDDMNDYCTGISSDCPRNPYKD,"Disintegrin family, Dimeric disintegrin subfamily","FUNCTION: Strongly inhibits ADP-induced platelet aggregation on human platelet-rich plasma. Also avidly binds to the laminin-binding beta-1 integrins (alpha-3/beta-1, alpha-6/beta-1, and alpha-7/beta-1) in an RGD-independent manner. {ECO:0000269|PubMed:11343790, ECO:0000269|PubMed:12719418}.",Binding Protein
754,P83469,DIS_MACLO,,Disintegrin obtustatin,CTTGPCCRQCKLKPAGTTCWKTSLTSHYCTGKSCDCPLYPG,"Disintegrin family, Short disintegrin subfamily","FUNCTION: Is a potent and selective inhibitor of alpha-1/beta-1 (ITGA1/ITGB1) integrin. It blocks the adhesion of alpha-1/beta-1-expressing K562 cells to immobilized collagens IV and I with IC(50) of 2 and 0.5 nM, respectively. Potently inhibits angiogenesis in chicken and in mouse model and reduces tumor development by half. Is 25-fold less potent than viperistatin. {ECO:0000269|PubMed:12538900, ECO:0000269|PubMed:12727812}.",Kunitz Family
761,P84788,VSP1_PROEL,3.4.21.-,Thrombin-like enzyme elegaxobin-1 (SVTLE) (EC 3.4.21.-) (Elegaxobin I) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNINEHPFLVLVYYDDYQCGGTLINEEWVLTAAHCNGKNMEIYLGVHSKKVPNKDVQRRVPKEKFFCDSSKTYTKWNKDIMLIRLDRPVRKSAHIAPLSLPSSPPSVGSVCRVMGWGTITSPQETYPDVPHCAKINLLDYSECRAAYPGLPPKSRTLCAGVLEGGKDTCGGDSGGPLICNGQFQGIVSWGGDPCAQPHEPGSYTNVFDHLDWIKGIIAGNTDATCPL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that clots rabbit fibrinogen. Only the beta chain of fibrinogen (FGB) is cleaved, releasing fibrinopeptide B. Incubation with human fibrinogen alpha and beta resulted in cleavage of both fibrinogen chains but generated neither fibrinopeptide A nor fibrinopeptide B. Promotes clotting of rabbit fibrinogen, but not bovine or human fibrinogen. {ECO:0000269|PubMed:10708800}.",Serine Protease
765,P85060,PA22_ACASS,3.1.1.4,Phospholipase A2 acanmyotoxin-2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFGGMIGCANKGTRSWLSYVNYGCYCG,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has myotoxic activity but no significant neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:16242671}.,Phospholipase
766,P85061,PA23_ACASS,3.1.1.4,Phospholipase A2 acanmyotoxin-3 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFAFMIRQANKRRRPVIPYEEYGLYYM,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has myotoxic activity but no significant neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:16242671}.,Phospholipase
767,P85062,PA21_ACASE,3.1.1.4,Phospholipase A2 acanmyotoxin-1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQIGIMKRCANKRRRPVFHYRDYGCYC,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has myotoxic activity but no significant neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12540524}.,Phospholipase
768,P85103,VMXP_PHIPA,3.4.24.-,Snake venom metalloproteinase patagonfibrase (SVMP) (EC 3.4.24.-),LSTDIVAPPV,Venom metalloproteinase (M12B) family,"FUNCTION: Snake venom zinc metalloprotease that hydrolyzes the alpha chain of fibrinogen (FGA) but not the beta or gamma chains. Has caseinolytic activity. Induces hemorrhage after intradermal injection into mice. Intramuscular injection into the gastrocnemius muscle of mice causes hemorrhage, edema, myonecrosis, increase in serum creatine kinase levels and multifocal lung hemorrhage. Inhibits collagen-induced platelet aggregation, but not thrombin- or ristocetin-induced platelet aggregation. {ECO:0000269|PubMed:17306461}.",Metalloprotease
769,P85162,BPPCC_BOTJA,,Bradykinin-potentiating peptide 12c (BPP-12c) [Cleaved into: Bradykinin-potentiating peptide 9a (BPP-9a) (BPP-a) (Bradykinin-potentiating peptide V-6-I) (BPPV-6-I) (Teprotide); Bradykinin-potentiating peptide 9a-F (BPP-9a-F) (Bradykinin-potentiating peptide 5b) (BPP-5b)],QWAQWPRPQIPP,Bradykinin-potentiating peptide family,FUNCTION: [Bradykinin-potentiating peptide 9a]: Inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain. May also potentiate the hypotensive effects of bradykinin.; FUNCTION: [Bradykinin-potentiating peptide 9a-F]: Has much lower activity than BPP-9a.,Vascular Interaction
771,P86193,MYXC2_CRODM,,Crotamine-IV-2,YKRCHIKGGHCFPKEKLICIPPSSDIGKMDCPWKRKCCKKRS,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, and hind limb paralysis (By similarity). It also induces potent blockade of neuromuscular transmission in young chicken biventer cervicis preparation and potent myotoxic effect. In vivo, induces myonecrosis, upon intramuscular or subcutaneous injections into mice (PubMed:17828447). {ECO:0000250|UniProtKB:Q9PWF3, ECO:0000269|PubMed:17828447}.",Kunitz Family
772,P86194,MYXC3_CRODM,,Crotamine-IV-3,YKQCHKKGGHCFPKEVLICIPPSSDFGKMDCRWKRKCCKKRS,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, and hind limb paralysis (By similarity). It also induces potent blockade of neuromuscular transmission in young chicken biventer cervicis preparation and potent myotoxic effect. In mice, it induces myonecrosis, upon intramuscular or subcutaneous injections (PubMed:17828447). {ECO:0000250|UniProtKB:Q9PWF3, ECO:0000269|PubMed:17828447}.",Kunitz Family
774,P86419,3SI1B_DENAN,,Rho-elapitoxin-Da1b (Rho-Da1b) (Rho-EPTX-Da1b),LTCVTKDTIFGITTQNCPAGQNLCFIRRHYINHRYTEITRGCTATCPKPTNVRETIHCCNTDKCNE,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Non-competitive antagonist of alpha-2 adrenergic receptors (ADRA2) in smooth muscles, and partial antagonist of D3 dopamine receptors (DRD3) (inhibits 25% of methylspiperone binding to this receptor) (PubMed:20659106). Also shows a low antagonism on D2 dopamine receptors (DRD2) (short isoform) (PubMed:24793485). Shows high affinity to adrenergic receptors (Ki=14 nM (ADRA2A), Ki=73 nM (ADRA2B), and Ki=38 nM (ADRA2C)) (PubMed:20659106). Increases heart rate and blood catecholamine concentrations (PubMed:21419153). {ECO:0000269|PubMed:20659106, ECO:0000269|PubMed:21419153, ECO:0000269|PubMed:24793485}.",Binding Protein
775,P86456,PA2A4_BOTAL,3.1.1.4,Acidic phospholipase A2 SpII RP4 (Ba SpII RP4) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLVQFKTLIMKIAGRSVVYKYFYGCYCGWGGIGQPRDATDRCCFVHDCCYGKVTNCNPKTATYSYTEENGALVCGGDDPCKKQVCECDRVAAMCFRDNKDTYDNKYWFLPPKNCQEDSEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) which exhibits indirect hemolysis, induces mild edema inflammation in the foot pads of mice and slightly delays anticoagulant activities. In mice, not lethal, even at the highest dose, and exhibits low to moderate myotoxicity on muscular fibers. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:20331996}.",Phospholipase
776,P86497,VSPR1_BITRH,3.4.21.-,Snake venom serine protease rhinocerase (SVSP rhinocerase) (EC 3.4.21.-) (Rhinocerase 1),VIGGAECDINEHPSLALIYSTSMRFHCAGTLLNQEWVSFTMWDKDIMLIRTLCAGVLEGGKDTCLAHPCAQPLLPAFYTKVFDYIPWIK,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that cleaves fibrinogen alpha and beta chains (FGA and FGB), but not gamma chains. Exhibits fibrinolytic and kininogenolytic. Preferentially cleaves after Arg and Lys residues. {ECO:0000269|PubMed:20300193}.",Serine Protease
777,P86524,PA2HB_ACAAN,,Phospholipase A2 homolog P-elapitoxin-Aa1a beta chain (P-EPTX-Aa1a beta chain) (svPLA2 homolog),DLFQFGKMIECANKGSRPSLDYMNYGCYCGK,"Phospholipase A2 family, Group I subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) that has presynaptic neurotoxicity. Inhibits nerve-evoked twitch contractions but not responses to cholinergic agonists acetylcholine and carbachol and to depolarizing agonist KCl. Causes a fade in tetanic contractions. Displays a triphasic mode of action with depression, enhancement and blockade of neurotransmission. Does not display myotoxic activity such as changes in baseline muscle tension or inhibition of directly stimulated muscle twitches. All subunits are necessary for maximum toxicity. {ECO:0000269|PubMed:20361942}.; FUNCTION: Monomer: The beta chain has no enzymatic activity and is not toxic by itself. {ECO:0000269|PubMed:20361942}.",Phospholipase
778,P86525,PA2HC_ACAAN,,Phospholipase A2 homolog P-elapitoxin-Aa1a gamma chain (P-EPTX-Aa1a gamma chain) (svPLA2 homolog),SIPLPSLNFEQFGNMIQCTI,"Phospholipase A2 family, Group I subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) that has presynaptic neurotoxicity. Inhibits nerve-evoked twitch contractions but not responses to cholinergic agonists acetylcholine and carbachol and to depolarizing agonist KCl. Causes a fade in tetanic contractions. Displays a triphasic mode of action with depression, enhancement and blockade of neurotransmission. Does not display myotoxic activity such as changes in baseline muscle tension or inhibition of directly stimulated muscle twitches. All subunits are necessary for maximum toxicity. {ECO:0000269|PubMed:20361942}.; FUNCTION: Monomer: the gamma chain has no significant enzymatic activity and is not toxic by itself. {ECO:0000269|PubMed:20361942}.",Phospholipase
780,P86974,PA2BD_BOTLC,3.1.1.4,Basic phospholipase A2 (blD-PLA2) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DLWQFGQMILKETGKLPFPYYTTYGCYCGWGGQGQPKDATDRCCFVHDCCYGKLTNCKPKTDRYSYSRENGVIICGEGTPCEKQICECDKAAAVCFRENLRTYKXXYMAYPDVLCKKPAEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that does not inhibit platelet aggregation. Exhibits cytotoxic and anticoagulant activity. Induces Ehrlich tumor growth but not angiogenesis. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:17110015}.,Phospholipase
782,Q0NZX5,VM2JA_BOTJA,,Disintegrin jarastatin (JT) (Platelet aggregation activation inhibitor) [Cleaved into: Disintegrin jarastatin; Disintegrin jarastatin-AGEEC; Disintegrin jarastatin-GEEC; Disintegrin jarastatin-EC],RTDTVSTPVSGNELLEAGEECDCGTPGNPCCDAATCKLRPGAQCAEGLCCDQCRFMKEGTVCRRARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Binds alpha-5/beta-1 (ITGAV/ITGB1), alpha-V/beta-3 (ITGAV/ITGB3) and alpha-M/beta-2 (ITGAM/ITGB2) integrins. Is a potent inhibitor of platelet aggregation induced by ADP, collagen, and thrombin. Induces neutrophil chemotaxis and inhibits the chemotaxis of human neutrophils toward fMLP, IL-8, and jarastatin itself. Directly activates an integrin-coupled signaling and modulate the MAPK pathway in different ways, leading the neutrophils to express different functional response. Jarastatin-treated neutrophils accumulates F-actin at the plasmalemma. Induces PTK2/FAK1 and phosphoinositide 3-kinase (PI3K) activation. Induces Erk-2 translocation to nucleus and a delay of the spontaneous apoptosis of neutrophils. Increases the IL-8 mRNA levels in neutrophils. When injected simultaneously with melanoma cells in mice, jarastatin, flavoridin (FL) and kistrin (KR), significantly reduce tumor lung colonization. Jarastatin inhibits B16F10 cell growth in vitro. When it interacts with melanoma cells, it induces actin cytoskeleton rearrangement, increasing actin polymerization and PTK2/FAK1 phosphorylation. Interferes with NF-kappaB translocation in melanoma cells. {ECO:0000269|PubMed:10471323, ECO:0000269|PubMed:14697344, ECO:0000269|PubMed:17854854}.",Kunitz Family
783,Q0ZZJ6,VCO31_AUSSU,,A.superbus venom factor 1 (AVF-1) (CVF-like) (Complement C3 homolog) [Cleaved into: AVF-1 alpha chain; AVF-1 gamma chain; AVF-1 beta chain],MEGMALYLVAALLIGFPGSSHGALYTLITPGVLRTDTEEQILVEAHGDSVPKQAVISIHDFPRRQKTLFQTRVDMNPAGGMLVTPTIKIPAKELNKESRQNQYVVVKVSGLPLELEKVVLLSYQSGFVFIQTDKGIYTPGSPVRYRVFSMDYNMHRMDKTVIVEFQTPEGVVVSSNPVNPSSVLIRPYNLPELVSFGTWKAVAKYEHSPEESYTAYFDVREYVLPSFEVRLQPSDKFLYIDGNKNFHVSITARYLYGKKVEGVAFVLFGVKIDDAKKSIPDSLTRIPIIDGDGEAILKRDTLRSRFQNLNELVGHTLYASVTVMTESGSDMVVTEQSGIHIVTSPYQIYFTKTPKYFKPGMPYELTVYVTNPDGSPAANVPVVSEAIRSEGTTLSDGTAKLILNTPLNTQSLPITVRTNHRDLPSERQATKSMTATAYQTQGGSGNYLHVAITSAEIKAGDNLPVNFNVRGNANSLNQIKYFTYLILTKGKIFKVGRQPKGEGQNLVTMNLRITPDLIPAFRFVAYYQVGNNEIVADSVWVDVKDTCMGTLVVKGASSRDNRIQKPGAAMKIKLEGDPGARVGLVAVDKAVYVLNDKYKISQAKIWDTIEKSDFGCTAGGGQNNLGVFEDAGLALTTSTNLNTKQRSVATCPQPTNRRRRSSVLLLDSKANKAAQFQDQNLRKCCEDGMHENPMGYTCEKRAKYIQEGDACKAAFLECCRYIKGIRDENQRESELFLARSDFEDELFGEDNIISRSDFPESWLWLTEDLKEPPNSQGISSKTLSFYLRDSITTWEVLAVSIAPTKGICVAEPYEITVMKDFFIDLRVPYSVVKNEQVEIRAVLYNYADEDIYVRVELLYNPAFCSASTEGQRYRVQVPVKALSSWAVPFVIVPLEQGLHDVEVKASVRGELASDGVRKKLKVVPEGERKNIVTVIELDPSVKGVDGTQEQTVIANKLDDKVPETEIETKISVLGDPVAQIIENSIDGSKLNHLIITPSGCGEQNMITMTPSVIATYYLDATGQWENLGVDRRTEAVKQIMKGYAQQMVYKKADHSYAAFPNRASSSWLTAYVVKVFAMAAKIVKDIKHEIICGGVKWLILNRQQPDGVFKENAPVIHGEMLGGTKGAEPEVSLTAFILTALLESRSVCNEHINILDSSINKAIDYLLKKYEKLQRPYTTALTAYALAAAERLNDDRVLMAASTGRDRWEEHNARTHNIEGTSYALLALLKMKKFAEAGPVVKWLIDQKYYGGTYGQTQATVMVFQALAEYEIQIPTHKDLNLDISINLPEREVPLRYSINYGNALVARTAETKLNEDFTVSASGDGKATMTILTVYNAQLREDANVCNKFHLDVSVENAQLNSKQAKGAKDTLRLKICTRYLGEVDSTMTIIDVSMLTGFLADAEDLTRLSKGVDRYISKFEIDNNMVQKGTVVIYLDKVSHSEVECLHFKIHKHFEVGFIQPGSVKVYSYYNLDEQCTKFYHPDKGTGLLNKICHGNICRCAEESCSLLNQQKKIDLQLRIQKACAPNVDYVYKTKLLQIEEKDGNDIYVMDVLEVIKGGTDRNPQAKARQYVSQRKCQEALNLKLNNDYLIWGLSSDLWPRKNDISYLITKNTWIERWPNEDECQDEEFQNLCDDFAQLSNTLTIFGCPT,Venom complement C3 homolog family,"FUNCTION: Complement-activating protein in snake venom. It is a structural and functional analog of complement component C3b, the activated form of C3. It binds factor B (CFB), which is subsequently cleaved by factor D (CFD) to form the bimolecular complex AVF/Bb. AVF/Bb is a C3 convertase that cleaves complement component C3, but not C5 (as does CVF/Bb). {ECO:0000269|PubMed:17412383}.",General Toxin
784,Q10754,PA2H_VIPAZ,,Acidic phospholipase A2 inhibitor vaspin A chain (VaspA) (svPLA2 homolog) (PLA2-I complex chain A),MRTLWIVAVCLIGVEGNLFQFGDMILQKTGKEAVHSYAIYGCYCGWGGQGRAQDATDRCCFAQDCCYGRVNDCNPKMATYTYSFENGDIVCGDNDLCLRAVCECDRAAAICLGENVNTYDKNYEYYSISHCTEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Heterodimer: postsynaptic neurotoxin. {ECO:0000250}.; FUNCTION: Monomer: the acidic chain inhibits the basic phospholipase A2 of the complex. {ECO:0000250}.,Phospholipase
785,Q10755,PA2B_VIPAZ,3.1.1.4,Basic phospholipase A2 B chain (svPLA2) (EC 3.1.1.4) (PLA2-I complex B chain) (Phosphatidylcholine 2-acylhydrolase),NLFQFAKMINGKLGAFSVWNYISYGCYCGWGGQGTPKDATDRCCFVHDCCYGRVRGCNPKLAIYSYSFKNGNIVCGKNLGCLRDICECDRVAANCFHQNKNTYNKNYRFKSSSRCRQTSEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Heterodimer: postsynaptic neurotoxin. {ECO:0000250}.; FUNCTION: Monomer: snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
787,Q1PBD1,VM2DI_GLOHA,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin halystatin (Disintegrin brevicaudin-1b)],MIQVLLVIICLAVPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKGLFSKDYIETHYSPDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYLIEPLKLSNSEAHAVYKYEDVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPAHQRYIELVIVADHGMFTKYDSNLDTIRTWVHELVNSINEFYRSLNIDVSLTELEIWSNEDLINVQPAAPHTLDSFGKWRERDLLHRIHHDNAMLLTAIDFDEPTIGLAYVGTMCNPKGSTGVVQDHSTINLRVAVTMAHEIGHNLGIHHDTGSCSCGGYSCIMSPVISHEPSKYFSDCSYTQCWDFIMNQKPQCILNKPLRTDTVSTPVSGNELLEAGEECDCGSPGNPCCDAATCKLRQGAQCAEGLCCDQCRFMKKGTVCRIARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin halystatin]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
788,Q1PS45,VM3AK_DEIAC,3.4.24.-,Zinc metalloproteinase-disintegrin-like agkihagin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVTALPEGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIQNDADLTASISACNGLKGHFMLQGEMYLIEPLKLSDSEAHAVFKYENVEKEDEAPKMCGVTQNWKSYEPIKKASQSNLTPEQQRYLNAPKFVKLFLVADNIMYLKYGRSLTNVRTRMYDMANILNLIFRRMNIHVAVTDLEIWSDKDKIIVQPSADDTLKSFATWRESVLLKHKSHDNAQLLTGINFNGPTAGLAYLGGICDPMYSTAIVQDHNKIHHLVAIAMAHEMGHNLGIDHDKDTCTCAAKSCVMAGTLSCEASYLFSDCSRKEHRAFLIKNMPQCILKKPSKTDVVSPPVCGNYFVEMGEDCDCGSPATCRDPCCDAATCKLKQGAQCAEGLCCDQCRFKGAGTQCRAAMDECDMADLCTGQSADCTDRFQKNGQPCQNNNGYCYNGTCPTMIKQCTVFFGSNAAVSQDACFQFNLQGNNYGYCRKEQNTKIACEPQNVKCGRLYCTSPEKQNPCNIYYSPSNEDKGMVLPGTKCADGKACSNGQCVDVTTPY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Strongly inhibits the collagen-induced human platelet aggregation. Hydrolyzes the Aalpha-chain of fibrinogen (FGA), without cleavage of Bbeta- and gamma-chains. Induces apoptosis and strongly inhibits proliferation of endothelial cells as well as adhesion of the cells to extracellular matrix proteins (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
789,Q1W7Q6,NGFV_CRYNI,,Venom nerve growth factor (v-NGF) (vNGF),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPTTSDLSDTSCAQTHEGLKTSRNTDQRHLAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRTKRETHPVHNLGEHSVCDSISVWVTNKTKATDIKDNMVTVMVDINLNNEVYKQYFFETKCRNPNPVPSGCRGTDSRHWNSYCTTTQTFVKALTMEGNRASWRFIRIDTACVCVISRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
790,Q1ZY03,PA2B_DEIAC,3.1.1.4,Basic phospholipase A2 DAV-N6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVLLVSVEGHLLQFNKMIKIMTRKNAFPFYTSYGCYCGWGGRGWPKDATDSCCFVHDCCYQKLTGCSPKWDIYPYSWKTGVIICGEGTPCEKEICECDRAAAVCLGENLRTYKTKYMFYPDFLCKKPSKQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
791,Q2EI26,VM1PA_DEIAC,3.4.24.-,Snake venom metalloproteinase AaPA (SVMP) (EC 3.4.24.-) (Agkistrodon acutus prothrombin activator),MIQVLLVTICLAAFPYQGSSIILESGKVNDYEVVYPQRLAPLPEGAVQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGRRITTHPLVEDHCYYRGHIRNDADSTASISACHGLKGHFKLRGETYLIEPMKISNSEAHAVYKYENVEKEDEAHKMCGVTQNWESYEPIKKASQLIVSTEFQRYMEIVIVVDHSMVKKYNGDSDKIKAWVYEMINTITESYSYLYIDIILSGLEIWSEKDLINVETSAENTLKSFGEWRAKDLIHRISHDNAQLLTATDFDGPTIGLAYVASMCDPKRSVGVVQDHSSVNRLVAITLAHEMAHNLGVRHDEGSCSCGSGYTCIMSPVINSEVIKYFSDCSYIQCREYISKENPPCILNKPLRTDTVSTPVSGNELLEAEKDYD,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom zinc metalloprotease that may activate prothrombin.,Metalloprotease
792,Q2HZ28,PA2A_BOTER,3.1.1.4,Acidic phospholipase A2 BE-I-PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVEGSLVQFETLIMKIAGRSGVWYYGSYGCYCGSGGQGRPQDASDRCCFVHDCCYGKVTDCDPKADVYTYSEENGVVVCGGDDPCKKQICECDRVAATCFRDNKDTYDNKYWFFPAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 that shows a potent inhibition of human platelet aggregation. This inhibition is concentration-dependent when aggregation is induced by collagen, and concentration-independent when aggregation is induced by arachidonic acid. In human umbilical-cord vein endothelial cells, this toxin stimulates endothelial cells to release prostaglandin I(2), suggesting an increase of its potential anti-platelet activity in vivo. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:16750518}.",Phospholipase
793,Q2PG81,PA2B1_PROEL,3.1.1.4,Basic phospholipase A2 PeBP(R)-I/II (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLLGVEGSLVELWKMVFQETGKEAVKNYGLYGCNCGVGKRGKPVDATDRCCFVHRCCYKKVTGCDPKKDRYSYSWENKAIVCGEKNPCLKQVCECDKAVAICLRENLGTYNKNHRVTVKFLCKAPESC,"Phospholipase A2 family, Group II subfamily, R49 sub-subfamily","FUNCTION: Snake venom phospholipases A2 that have myotoxic, and edema-inducing activity, as well as extremely weak lipolytic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:16962627}.",Phospholipase
794,Q2QA02,VM3_CRODD,3.4.24.-,Zinc metalloproteinase-disintegrin-like (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAALPYQGSSIILESGNVNDYEIVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLYLEKNKQLFSKDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLKLSNSEAHAVYKYENVEKEDEAPKMCGVTQNWKSYEPIKKASQLVVTAEHQKYNPFRFVELVLVVDKAMVTKNNDDLDKIKTRMYELANTVNEIYRYMYIHVALVGLEIWSNEDKITVKPEAGYTLNAFGEWRKTDLLTRKKHDNAQLLTAIDLDRVIGLAYVGSMCHPKRSTGIIQDYSPINLVVAVIMAHEMGHNLGIHHDSGYCSCGDYACIMRPEISPEPSTFFSNCSYFDCWDFIMNQNPECIVNEPLGTDIISPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYDLFGADVYEAEDSCFERNQKGNYYGYCRKENGNKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNEDEHKGMVLPGTKCADGKVCSNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: This protein is a zinc metalloprotease from snake venom that possesses hemorrhagic activity. {ECO:0000269|PubMed:18621072}.,Metalloprotease
795,Q2UXR0,VM3E1_ECHOC,3.4.24.-,Zinc metalloproteinase-disintegrin-like Eoc1 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MQVLLITISLAVLPYLGSSIILESGIVNDYEVVNPQKVTAMLKGAVKQPEQKYEDTMQYEFKVKGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADSSASISACNGLKGHFKLRGEMYFIEPLKIPDSEAHAVYKYENIEEEDEAPKMCGVKHTNRESDKSIKKASQLNLTPEQQRYLNTPKHIKVAIVADYLIFRKYGRNLFTIRAKIYEILNILNEIYKAFNIHVALVFLEIWSNGDKINLFPAANVTLDLFGKWRERDLMNRKNHDNTQLLTGMNFDGPTAGLGYVGTMCHPQFSAAVVQDHNKINFLVALAMAHELGHNLGMTHDEQFCTCGAKSCIMSATLSCEGSYRFSNCSREENRRYLINKMPQCILIKPSRTDIVSPPVCGNSLVEVGEDCDCGSPGYCRNPCCNAATCKLTPGSQCADGECCDQCRFTRAGTECRPARDECDKADLCTGQSAECPADQFQRNGQPCQNNSGYCYNGICPVMRNQCISLFGSRAIVAEDACFQFNSLGIDYGYCRKENGRKIPCAPEDVKCGRLYCFDNLPEHKNPCQIFYTPRDEDKGMVDPGTKCENGKVCINGKCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: This metalloproteinase hydrolyzes azocasein, and oxidized insulin B-chain. Also hydrolyzes the alpha-chain (FGA) and more slowly the beta-chain of fibrinogen (FGB), without affecting the gamma-chain. Does not cleave fibrin. Inhibits endothelial cell adhesion to extracellular matrix proteins such as fibrinogen, fibronectin, vitronectin, collagen I, and collagen IV. Induces apoptosis in vascular endothelial cells (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
796,Q2XXL6,NGFV1_AZEFE,,Venom nerve growth factor 1 (v-NGF-1) (vNGF-1) (NGF-AZE1),GEDNVPLGSPATSDLSDTSCAKTHEALKTSRNTDQHYPAPKKAEDQEFGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNADSLNRNIRAKRGTHPVHNQGEYSVCDSVSVWVANKTTATDIRGNLVTVMVDINLNNNVYKQYFFETKCRNPNPVPSGCRGIDARHWNSYCTTTHTYVRALTKEGNQASWRFIRIDTACVCVISRITENFG,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
797,Q2YHJ5,PA2AB_CRAPU,3.1.1.4,Acidic phospholipase A2 Tpu-E6b (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLMQFETMIMKVAGRSGVWWYGSYGCYCGKGGQGQPQDASDRCCFVHDCCYGKVNGCDPKDDFYTYSSENGDVVCEEDNPCTKEICECDKAAAICFRDNMDTYQNKYWFYPTKYCKEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that weakly inhibits ADP-induced platelet aggregation when tested on platelet rich plasma from human and rabbit blood (15-25% of inhibition at 5-10 ug of enzyme). Exhibits moderate hydrolytic activities toward L-dipalmitoyl phosphatidylcholine. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15955061}.,Phospholipase
798,Q3BER1,DIS_ECHOC,,Disintegrin ocellatusin (Short ocellatusion precursor Eo10c-10),MIPVLLVTICLAVFPFQGSSIILESGNINDYEIVYPKKVAVLPTGAMNSAHPCYDPVTCQPKEKEDCESGPCCDNCKFLKEGTICKMARGDNMHDYCNGKTCDCPRNPYKGEHDPMEWPAPAKGSVLM,"Disintegrin family, Short disintegrin subfamily","FUNCTION: The disintegrin ocellatusin-10c1 is a poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of cells expressing the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. Inhibition on alpha-2b/beta-3 (ITGA2B/ITGB3) is low, and there is no inhibition on alpha-1/beta-1 (ITGA1/ITGB1), alpha-2/beta-1 (ITGA2/ITGB1) and alpha-6/beta-1 (ITGA6/ITGB1) (By similarity). {ECO:0000250}.; FUNCTION: The short monomeric disintegrin ocellatusin inhibits ADP-induced platelet aggregation (IC(50)=168 nM). Inhibits alpha-5/beta-1 (ITGA5/ITGB1) integrin and induces the expression of a ligand-induced binding site epitope on beta-1 integrin subunit. Has a direct chemotactic stimulus on human neutrophils in vitro. {ECO:0000269|PubMed:11852062}.",Kunitz Family
799,Q3BER3,DID4A_ECHOC,,Disintegrin EO4A (Dim-3 SP6) (Eo-10) (Eo-10c1),MIPVLLVTICLAVFPFQGSSIILESGNINDYEIVYPKKVNVLPTGAMNSAHPCCDPVTCQPKQGEHCISGPCCRNCKFLNSGTICKRARGDNLHDYCTGISSDCPRNPYKGKYDPMKWPAAAKGSVLM,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of cells expressing the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. Inhibition on alpha-2b/beta-3 (ITGA2B/ITGB3) is low. {ECO:0000269|PubMed:12667142}.,Kunitz Family
800,Q3BER4,DID5A_ECHOC,,Disintegrin EO5A (Eo-12),MIPVLLVTICLAVFPFQGSSIILESGNINDYEIVYPKKVAVLPTGAMNSAHPCCDPVTCQPKQGEHCISGPCCRNCKFLNSGTICKKTMLDGLNDYCTGVTSDCPRNPYKGKEDD,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of the alpha-4/beta-1 (ITGA4/ITGB1) integrin to VCAM-1. Inhibition on alpha-IIb/beta-3 (ITGA2B/ITGB3) is low. {ECO:0000269|PubMed:12667142}.,Kunitz Family
801,Q3BK13,DID2A_MACLB,,"Disintegrin lebein-2-alpha (ML-(2,8,15)) (MS-I) (VLDA) (ml-G2)",MIQVLLVTICLAVFPFHGSSIILESGNVNDYEVVYPKKVTLLPTGAMNSANPCCDPITCKPRKGEHCVSGPCCRNCKFLNPGTICKRTMLDGLNDYCTGITSDCPRNPWKSEEDEMKWSATAKGSVLM,"Disintegrin family, Dimeric disintegrin subfamily","FUNCTION: Inhibits ADP-induced human platelet aggregation. Antagonist of alpha-IIb/beta-3 (ITGA2B/ITGB3) (By similarity). Also avidly binds to the laminin-binding beta-1 integrins (alpha-3/beta-1 (ITGA3/ITGB1), alpha-6/beta-1 (ITGA6/ITGB1), and alpha-7/beta-1 (ITGA7/ITGB1)) in an RGD-independent manner. {ECO:0000250, ECO:0000269|PubMed:12719418}.",Binding Protein
802,Q3BK14,DIS_MACLB,,"Disintegrin lebestatin (ML-(6,9,10)) (ML-4)",MIQVLLVIICLAVFPFQGSSKTLKSGNVNDYEVVNPGTVTGLPKGAVEEKHEPMKGNTLQKFPLCTTGPCCRQCKLKPAGTTCWKTSRTSHYCTGKSCDCPSYPGNG,"Disintegrin family, Short disintegrin subfamily",FUNCTION: Specifically interacts with the alpha-1/beta-1 integrin (ITGA1/ITGB1). Exhibits highly inhibitory effects on cell adhesion and cell migration to collagens I and IV. Also shows in vivo anti-angiogenic activity. {ECO:0000269|PubMed:16200076}.,Kunitz Family
803,Q3HLQ4,PA2HB_PROMU,,Basic phospholipase A2 homolog TM-N49 (svPLA2 homolog),MRTLWIMAVLLLGVEGNLLQFRKMIKKMTGKEPILSYATYGCNCGMAGVGQPVDGTDRCCFVHNCCYEKVTSCSPKWDQYIYSWENGNIVCGEKNPCKKQICECDKAAAMCFRDNVKTYKKRNIFYPKSSCTEPTDTC,"Phospholipase A2 family, Group II subfamily, N49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits potent myotoxic activity causing inflammatory cell infiltration, severe myoedema, myonecrosis and myolysis in the gastrocnemius muscles of BALB/c mice. {ECO:0000269|PubMed:16413680}.",Phospholipase
804,Q3HTN1,VM3SA_TRIST,3.4.24.-,Zinc metalloproteinase-disintegrin-like stejnihagin-A (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTTLPKGALQQNYEDAMQYEFKVNGEPVVLHLEKNKELFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIQNEADSTASISACNGLKGHFKLQGETYLIEPLKLPDSEAHAVFKYENVVKEDEAPKMCGVTETNWKSDEPIKKASQLVVTAEQQRFPRRYVKLAIVADRRMYMKHQKNLKPWVFQMVNSVHQIYRSMNVLIALVYLNIWKKNDKITVQSASDVTLDLFAEWRETVLLRRKKHDCAHLLTAIDFDGPTIGRAHIASMCNSKLSVGIVQNYTEINLVNAIVMAHELGHNLGISHDGNQCNCHTCIMSAVISNPPSERFSNCSEDYHQSFLTAYNPQCILNAPSKTDIITPPVCGNELLEEGEECDCGSPENCQYQCCDAASCKLHSWVKCESGECCDQCRFTSAGTECRAARSECDIAESCTGQSADCPTDDFHRNGQPCLSNHGYCYNGNCPVMHYQCIALFGSNAIVGQDECFDFNMKGEQYFYCRKEYEKYIPCAQEDVKCGRLFCFYTNNMDICRYNYSDIGIVDHGTKCADGKVCNSNRHCVDVTTVY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: This metalloproteinase-disintegrin-like impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
805,Q3HTN2,VM3SB_TRIST,3.4.24.-,Zinc metalloproteinase-disintegrin-like stejnihagin-B (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTAVPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKELFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIQNEADSTASISACNGLKGHFKLQGETYLIEPLKLPDSEAHAVFKYENVEKEEEAPKMCGVTETNWKSDEPIKKASQLVVTAEQQRFPRRYVKLAIVADHRMYTKHKKNLKPWVFQMVNSVHQIYRSMNVLIALVYLNIWKKNDKITAQSASNVTLDLFGNWRETVLLKRKRHDCAQLLTAIDFDGPTIGRAHVSSVCDPKRSTGIVQNYTEINLVNAVIMAHELGHNLGMDHDGNQCNCHACIMSAVINNPPSERFSGCSMGYYQTFLTAYNPQCILNALSKRDIITPPVCGNELLEEGEECDCGSPENCQYQCCNATTCKLHSWVECESGECCEQCRFKKAGAVCRAARTECDIPENCTDQSADCPTDSFHRNGQPCLYNHGYCYNGNCPVMHYQCYGLFGPNATVGQDGCFDANDRGDEYFYCRKENEKYIPCAQEDVKCGRLFCTYIYDINLCRYDYSANGMVAQGTKCADGKVCNSNRQCADVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: This metalloproteinase-disintegrin-like impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
806,Q3HXX4,NGFV5_TROCA,,Venom nerve growth factor 5 (v-NGF-5) (vNGF-5),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSVANIIVDPKLFQKRRFQSPRVLFSIQPPPLSRDEQSVEFLDNEDTLNRNIRTKRETHPVYNRGEHSVCDSVSVWVTNKTKATDIKGNMVTVMVDINLNNEVYKQYFFETKCRNPNPVPSGCRGTDSRHWNSYCTTTQTFVRALTMEGNQASWRFIRIDTACVCVIIRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
807,Q3HXX5,NGFV4_TROCA,,Venom nerve growth factor 4 (v-NGF-4) (vNGF-4),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSSRVLFSTQPPPLSRGEQSVEFLDNEDTLNRNIRAKRENHPVHNQGEHSVCDSVSDWVIKTTATDIRGNVVTVMEDINLNNEVYKQYFFETKCRNPNPNPVQSECRGIDSRLWNSYCTTTQTFVRALTMEGNQASWRFIRIDTACVCVIIRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
808,Q3HXX6,NGFV3_TROCA,,Venom nerve growth factor 3 (v-NGF-3) (vNGF-3),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSVANIIVDPKLFQKRRFQSSRVLFSTQPPPLSRDEQSVEFLDNEDALNRNIRAKRETHPVHNRGEHSVCDSISVWVANKTNATDIKGNMVTVMVDVNLNNEVYKQYFFETKCRNPNPVPSGCRGIDSRHWNSYCTTTQAYVRALTMEGNRASWRFIRIDTACVCVIIRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
809,Q3HXX7,NGFV2_TROCA,,Venom nerve growth factor 2 (v-NGF-2) (vNGF-2),MSMLCYTLIIAFLIGTWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSVANIIVDPKLFQKRRFQSSRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRENHPVHNQGEHSVCDSVSDWVIKTTATDIRGNVVTVMEDINLNNEVYKQYFFETKCRNPSPNPVQSECRGIDSRLWNSYCTTTQTFVRALTMEGNQASWRFIRIDTACVCVIIRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
810,Q3HXX8,NGFV1_TROCA,,Venom nerve growth factor 1 (v-NGF-1) (vNGF-1),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSSRVLFSTQPPPLSRDEQSVEFLDNEDALNRNIRAKRETHPVHNRGEHSVCDSISVWVANKTNATDIKGNMVTVMVDVNLNNEVYMQYFFETKCRNPNPNPVPSGCRGIDSRHWNSYCTTTQAYVRALTMEGNRASWRFIRIDTACVCVIIRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
811,Q3HXX9,NGFV2_HOPST,,Venom nerve growth factor 2 (v-NGF-2) (vNGF-2),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVNPKLFQKRRFQSPRALFSTQPPPLSRDEQSVEFLDNEDALNRNIRAKRENHPVHNRGEHSVCDSISVWVTNKTKATDIKGNMVTVMVDVNLNNEVYKQYFFETKCRNPNPNLLQSECRGIDSRLWNSYCTRTQTFVKALTMEGNQASWRFIRIDTACVCVIIRKTDNL,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
812,Q3HXY0,NGFV1_HOPST,,Venom nerve growth factor 1 (v-NGF-1) (vNGF-1),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVNPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDALNRNIRAKRENHPVHNRGEHSVCDSISVWVTNKTKATDIKGNMVTVMVDVNLNNEVYKQYFFETKCRNPNPVPSGCRGTDSRHWNSYCTTTQTFVRALTMEGNRASWRFIRIDTACVCVIIRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
813,Q3HXY1,NGFV3_PSEAU,,Venom nerve growth factor 3 (v-NGF-3) (vNGF-3),MSMLCYTLIIAFLIGIWAAPQSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKVDDQEPGSVANIIVDPKLFQKRQFQSSRVLFSTQPPPLSRDEQSVEFLNNEDALNRNIQAKRQNHPVHDLGEHSVCDSISEWVTKTTATDIKGNTVTVEVDVNLNNEVYKQYFFETKCRNPNPVPSGCRGIDSRLWNSYCTTTQTFVKALTMEGNQASWRFIRIDTACVCVITKKTDNL,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
814,Q3HXY2,NGFV2_PSEAU,,Venom nerve growth factor 2 (v-NGF-2) (vNGF-2),MSMLCYTLIIAFLIGIWAAPQSEDNVPLGSPATSDLSDTSCAQTHEDLKTSRNTDQRHPAPKKADDQELGSAANIIVDPKLFQKRQFQSSRVLFSTQPPPLSRDEQSVEFLDNEDALNRNIQAKRQNHPVHDLGEHSVCDSISEWVTKTTATDIKGNTVTVKVDVNLNNHVYKQYFFETKCRNPNPVPSGCRGIDSRLWTSYCTKTQTFVRALTMEGNQASWRFIRIDTACVCVITKKTDNL,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
815,Q3HXY3,NGFV1_PSEAU,,Venom nerve growth factor 1 (v-NGF-1) (vNGF-1),MSMLCYTLIIAFLIGIWAAPQSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKVDDQELGSVANIIVDPKLFQKRQFQSSRVLFSTQPPPLSRDEQSVEFLDNEDALNRNIQAKRQNHPVHDLGEHSVCDSISEWVTKTTATDIKGNTVTVEVDVNLNNEVYKQYFFETKCRNPNPVPSGCRGIDSRLWNSYCTTTQTFVKALTMEGNQASWRFIRIDTACVCVITKKTDNL,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
816,Q3HXY4,NGFV_PSEPO,,Venom nerve growth factor (v-NGF) (vNGF),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKADDQELGSVANIIVDPKLFQKRQFQSPRVLFSTQPPPLSRDEQSVEFLDNEDALNRNIQAKRQNHPVHDLGEQSVCDSISEWVTKTTATDIKGNTVTVKVDVNLNNQVYKQYFFETKCRNPNPVPSGCRGIDSSHWNSYCTTTQTFVRALTMEGNQASWRFIRIDTACVCVISKKT,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
817,Q3HXY5,NGFV3_NOTSC,,Venom nerve growth factor 3 (v-NGF-3) (vNGF-3),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSVANIIVDPKLFQKRRFQSSRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRENHPVHNQGEHSVCDSVSDWVIKTTATDIRGNMVTVMVDINRDNEVYKQYFFETKCRNPNPNPVQSECRGIDSRLWNSYCTTTRTFVRALTMEGNQASWRFIRIDTACVCVIIRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
818,Q3HXY6,NGFV2_NOTSC,,Venom nerve growth factor 2 (v-NGF-2) (vNGF-2),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRENHPVHNQGEHSVCDSVSDWVIKTTATDIRGNMVTVMVDINRNNEVYKQYFFETKCRNPNPNPVQSERRGIDSRLWNSYCTTTQTFVRALTMEGNQASWRFIRIDTACVCVIIRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
819,Q3HXY7,NGFV1_NOTSC,,Venom nerve growth factor 1 (v-NGF-1) (vNGF-1),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSVANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRENHPVHNQGEHSVCDSVSDWVIKTTATDIRGNMVTVMVDINRNNEVYKQYFFETKCRNPNPNPVQSECRGIDSRLWNSYCTTTQTFVRALTMEGNQASWRFIRIDTACVCVIIRKTDNF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
820,Q3HXY8,NGFV2_PSETE,,Venom nerve growth factor 2 (v-NGF-2) (vNGF-2),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELASAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRETHPVHNRGEYSVCDSISVWVANKTKAMDIKGKPVTVMVDVNLNNHVYKQYFFETKYRNPNPVPSGCRGIDSGHWNSYCTTTQTYVRALTMEGNQASWRFIRIDAACVCVISRKTENF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
821,Q3HXY9,NGFV1_PSETE,,Venom nerve growth factor 1 (v-NGF-1) (vNGF-1),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRETHPVHNRGEYSVCDSISVWVANKTKAMDIKGKPVTVMVDVNLNNHVYKQYFFETKCRNPNPVPSGCRGIDSRHWNSYCTTTHTFVKALTMEGNRASWRFIRIDTACVCVISRKTENF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
822,Q3HXZ0,NGFV2_OXYMI,,Venom nerve growth factor 2 (v-NGF-2) (vNGF-2),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQHHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRETHPVHNLGEYSVCDSISVWVANKTKAMDIKGKPVTVMVDVNLNNHVFKQYFFETKCRNPNPVPSGCRGIDSGHWNSYCTTTQTFVRALTMEGNQASWRFIRIDTACVCVISRKTENF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
823,Q3HXZ1,NGFV1_OXYMI,,Venom nerve growth factor 1 (v-NGF-1) (vNGF-1),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNEDTLNRNIRAKRETHPVHNLGEYSVCDSISVWVANKTKAMDIKGKPVTVMVDVNLNNHVFKQYFFETKCRNPNPVPSGCRGIDSGHWNSYCTTTQTFVRALTMEGNQASWRFIRIDTACVCVISRKTENF,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
824,Q3SAE9,VNPA_TROCA,,Natriuretic peptide TcNPa (TcNP-a),SGSETAKIGDGCFGLPIDRIGSASGMGCGSVPKPTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 (EC(50)=1080.0 nM) and NPR2 (EC(50)=328.60 nM) (PubMed:25735823). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000269|PubMed:25735823}.",General Toxin
825,Q45Z11,3S11_OXYSC,,Short neurotoxin 1 (SNTX-1) (Toxin 3),MKTLLLTLVVVTIVCLDLGYTMTCYNQQSSEAKTTTTCSGGVSSCYKKTWSDGRGTIIERGCGCPSVKKGIERICCRTDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000269|PubMed:17906946, ECO:0000269|PubMed:8672493}.",Neurotoxin
832,Q45Z42,PA2PA_OXYMI,3.1.1.4,Basic phospholipase A2 paradoxin-like alpha chain (svPLA2) (EC 3.1.1.4) (PLA-4) (Phosphatidylcholine 2-acylhydrolase),MHPAHLLVLLAVCVSLLGASDIPPLPLNLAQFGFMIKCANHRSRPVSHYMDYGCYCGKGGSGTPVDELDRCCQVHDECYGEAEKRFKCVPYMTLYSWKCYGTAPSCNTKTDCQRFVCNCDAKAAECFARSPYQNKNWNINTKARCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling (PubMed:17313963). May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum (By similarity). {ECO:0000250, ECO:0000269|PubMed:17313963}.; FUNCTION: Monomer (alpha chain): Snake venom phospholipase A2 (PLA2) alpha chain that possesses the same high enzymatic activity than the heterotrimer. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.",Phospholipase
833,Q45Z46,PA2HB_OXYMI,,Neutral phospholipase A2 paradoxin-like beta chain (svPLA2) (Beta paradoxin-like),MHPAHLLVLLAVCVSLLGASDIPPLPLNLLQFGFMIECAIRNRQPALDFMNYGCYCGTVGHGTPVDDLDRCCKTRNECYAEAEKHGCYPSLTTYRWQCGRVGLHCNSKTQCEVFVCACDLAAAKCLAQEDYNPAHFNINTKARCR,"Phospholipase A2 family, Group I subfamily, N49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling (PubMed:17313963). May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum (By similarity). {ECO:0000250, ECO:0000269|PubMed:17313963}.; FUNCTION: Monomer (beta chain): Snake venom phospholipase A2 homolog that is neither toxic nor enzymatically active. Does not bind calcium (By similarity). {ECO:0000250}.",Phospholipase
834,Q4JHE1,OXLA_PSEAU,1.4.3.2,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2),MNVFFMFSLLFLAALGSCADDRRRPLEECFREADYEEFLEIAKNGLQRTSNPKRVVVVGAGMAGLSAAYVLAGAGHQVTLLEASERVGGRVNTYRNEKDGWYVNLGPMRLPERHRIIREYIRKFGLELNEFIQENDNAWYFIKNIRKRVSEVKKDPGVFKYPVKPSEEGKSASQLYRESLQKVIEELKRTNCSYILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSSYYLSFIESLKSDDIFSYEKRFDEIVGGFDQLPRSMYQAIAEKVHLNAQVIKIQQNAEDVRVTYQTPAKTLSYVIADYVIVCSTSRAARRIHFEPPLPPKKAHALRSIHYRSSTKIFLTCSQKFWEADGIHGGKSTTDLPSRFIYYPNHSFTSGIGVIVAYTLADDTDFFQALDIETSADIVINDLSLIHQLPKEQIQALCYPSKIQKWSLDEYAMGAITSFTPYQFQDFFEIVAAPVGRIYFAGEYTASVHGWLDSTIKSGLTAARDVNLASQKPSRIQLSNDNEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). This protein has antibacterial activities (PubMed:1796476). {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:1796476}.",Vascular Interaction
835,Q56EB0,SLAB_BOTJA,,Snaclec bothrojaracin subunit beta (BJC subunit beta),MGRFIFVSFGLLVVFLSLSGTAADCPPDWSSYEGSCYRVFEQKMNWEDAEKFCTQQQTGGHLVSFQSSEEADFVVSLTSPILRDSFVWTGLSDVWKECSFEWSDGSDLSYKDNYQFVFSEYECVASKTKNNKWRIIPCTKLEYFVCEFQA,Snaclec family,"FUNCTION: This potent antithrombotic agent acts in a calcium-independent manner. Exerts its anticoagulant effect by two distinct mechanisms. It binds to activated thrombin through exosite 1, blocking fibrinogen clotting, platelet activation, factor V activation and other effects, and it interacts with prothrombin (F2), decreasing its proteolytic activation -especially in the presence of factor Va. In vivo, intravenous injection before thrombosis induction causes a significant decrease in thrombus weight. Furthermore, BJC shows a prolonged effect by remaining in the plasma bound to prothrombin for at least 12 hours. {ECO:0000269|PubMed:11051105, ECO:0000269|PubMed:11514680, ECO:0000269|PubMed:11858489, ECO:0000269|PubMed:11910195, ECO:0000269|PubMed:16707920, ECO:0000269|PubMed:8399228, ECO:0000269|PubMed:8703912, ECO:0000269|PubMed:9346315, ECO:0000269|PubMed:9657441}.",Fibrinogenolytic Enzyme
836,Q56EB1,SLAA_BOTJA,,Snaclec bothrojaracin subunit alpha (BJC subunit alpha),MGRFLFVSFGLLVVFLSLSGTAADCPSDWSSHEGHCYKFFQQKMNWADAERFCSEQAKGGHLVSFQSDGETDFVVNLVTEKIQSTDLYAWIGLRVQNKEKQCSSKWSDGSSVSYENVVGRTVKKCFALEKEQEFFVWINIYCGQQNPFVCKSPPP,Snaclec family,"FUNCTION: This potent antithrombotic agent acts in a calcium-independent manner. Exerts its anticoagulant effect by two distinct mechanisms. It binds to activated thrombin through exosite 1, blocking fibrinogen clotting, platelet activation, factor V activation and other effects, and it interacts with prothrombin (F2), decreasing its proteolytic activation -especially in the presence of factor Va. In vivo, intravenous injection before thrombosis induction causes a significant decrease in thrombus weight. Furthermore, BJC shows a prolonged effect by remaining in the plasma bound to prothrombin for at least 12 hours. {ECO:0000269|PubMed:11051105, ECO:0000269|PubMed:11514680, ECO:0000269|PubMed:11858489, ECO:0000269|PubMed:11910195, ECO:0000269|PubMed:16707920, ECO:0000269|PubMed:8399228, ECO:0000269|PubMed:8703912, ECO:0000269|PubMed:9346315, ECO:0000269|PubMed:9657441}.",Fibrinogenolytic Enzyme
839,Q5YF89,NGFV2_NAJSP,,Venom nerve growth factor 2 (v-NGF-2) (vNGF-2) (Nerve growth factor II),MSMLCYTLITAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPQKAEDQELRTAANIIVDPKLFQKRQFQSPRVLFSTQPPLLSRDEESVEFLDNEDSLNRNIRAKREDHPVHNLGEHSVCDSVSAWVTKTTATDIKGNTVTVMENVNLDNKVYKQYFFETKCKNPNPVPSGCRGIDSSHWNSYCTETDTFIKALTMEGNQASWRFIRIDTACVCVITKKTGN,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
840,Q5ZPJ7,VKT_NAJAT,,Kunitz-type serine protease inhibitor NACI (Naja atra chymotrypsin inhibitor) (ACI) (NA-CI),MSSGGLLLLLGLLTLWAELTPVSGRPRFCELAPSAGSCFAFVPSYYYNQYSNTCHSFTYSGCGGNANRFRTIDECNRTCVG,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that inhibits chymotrypsin (Ki=25 nM) (PubMed:14990218, PubMed:15698956). Also interacts with vasopressin V2 receptor (V2R/AVPR2) (PubMed:35122240). Inhibits vasopressin binding human V2R in the nanomolar range (Ki=112 nM), and also moderately inhibits vasopressin-induced cAMP production (IC(50)=138 nM). In vivo, intraperitoneal injection of this protein into rats increases diuresis by 2.2-fold, without any loss of electrolytes (PubMed:35122240). {ECO:0000269|PubMed:14990218, ECO:0000269|PubMed:15698956, ECO:0000269|PubMed:35122240}.",Serine Protease
842,Q69CK0,3SDC7_OPHHA,,Beta-cardiotoxin CTX27 (OH-27),MKTLLLTLVVVTIVCLDLGYTRKCLNTPLPLIYTTCPIGQDKCVKMTIKKLPSKYDVIRGCIDICPKSSADVEVLCCDTNKCNK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Acts as a beta-blocker by binding to beta-1 and beta-2 adrenergic receptors (ADRB1 and ADRB2). It dose-dependently decreases the heart rate (bradycardia), whereas conventional cardiotoxins increases it. At 100 mg/kg, intraperitoneal injection into mice provokes labored breathing, impaired locomotion, lack of response to external stimuli, and death (after 30 minutes). {ECO:0000269|PubMed:17616557}.",General Toxin
843,Q6EER5,PA2B_CERGO,3.1.1.4,Basic phospholipase A2 Ceg-N6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMIKIMTKKNAVPFYTSYGCYCGWGGRGKPKDATDRCCFEHDCCYEKLTDCSPKTDIYSYSWKSGVIICGEGTPCEKQICECDRVAAVCFGTNLRTYKKRYMFYPDFLCTDPSEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows myotoxic activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
844,Q6EER6,PA2B_SISMS,3.1.1.4,Basic phospholipase A2 Sms-N6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMIKIMTKKNAIPSYTSYGCYCGWGGRGRPKDATDRCCFVHDCCYEKLTDCSPKTDIYSYSWKSGVITCGEGTPCEKQICECDRAAAVCFGENLPTYKKRYMFYPDFLCTDPSEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows myotoxic activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
845,Q6H3C5,PA2BB_TRIST,3.1.1.4,Basic phospholipase A2 Ts-G6D49 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLLEFGRMIKEETGKNPLSSYISYGCYCGWGGQGEPKDDTDRCCFVHDCCYGKLWGCSPKTDIYFYFRKNGAIVCGRGTWCEKQICECDKAAAICFRENLATYKEEYHSYGKSGCTEKSPKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 that induces fast and sustaining local edema a few hours after injection (5-10 ug) in the hind paw, and prolongs the coagulation time of human plasma. Exhibits moderate hydrolytic activities and prefers the zwitterionic micelles (dPPC with Triton X-100) to the anionic micelles (dPPC with deoxycholate). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12959640}.",Phospholipase
846,Q6H3C6,PA2AI_TRIST,3.1.1.4,Acidic phospholipase A2 CTs-A3 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLIQFETLIMKVAKKSGMFSYSAYGCYCGWGGQGQPQDPTDRCCFVHDCCYGKVTGCDPKMDIYTYSEENGDIVCGGDDPCRKAVCECDKAAAICFRDNKDTYDWKKYWRFPTKNCQESVPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows a moderate inhibition of ADP-induced human platelet aggregation when tested on platelet rich plasma. Exhibits moderate hydrolytic activities and prefers the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12959640}.,Phospholipase
848,Q6H3C9,PA2AC_TRIST,3.1.1.4,Acidic phospholipase A2 Ts-A3 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLLGVEGSLIQFETLIMKVAKKSGMFSYSAYGCYCGWGGQGQPQDATDRCCFVHDCCYGKVTGCDPKMDIYTYSEENGDIVCGGDDPCRKAVCECDKAAAICFRDNKDTYDWKKYWRFPTKNCQESVPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows a moderate inhibition of ADP-induced human platelet aggregation when tested on platelet rich plasma. Exhibits high hydrolytic activities and prefers the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12959640}.,Phospholipase
849,Q6H3D1,PA2HJ_TRIST,,Basic phospholipase A2 homolog CTs-K49b (svPLA2 homolog),SVIELGKMIFQETGKNPATSYGLYGCNCGPGGRRKPKDATDRCCFLHKCCYKKLTDCDPIRDSYSYSWVNKAIVCGGDDPHLKEMCECDKAMAICFRENLDTYDKKKKITLKLSCKKTSEQC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks catalytic activity (PubMed:12959640). It shows myotoxic and weak anticoagulant activities (PubMed:12959640). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:12959640}.",Phospholipase
850,Q6H3D2,PA2HF_TRIST,,Basic phospholipase A2 homolog Ts-K49b (svPLA2 homolog),MRTLWIMAVLLVGVEGGVIELTKMFVQEMGKNALTSYSLYGCNCGPGGRRKPMDATDSCCHVHKCCYKKLTDCDPIKDRYSYSWVNKAIVCGEDNPCLKEMCECDKAVAIRFRENLDTYDKKKKINLKLFCKKTSEQC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks catalytic activity (PubMed:12959640). It shows myotoxic and weak anticoagulant activities (PubMed:12959640). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:12959640}.",Phospholipase
851,Q6H3D3,PA2HG_TRIST,,Basic phospholipase A2 homolog Ts-K49c (svPLA2 homolog),MRTLWIMAVLLLGVEGSVIELGKMIFQETGKNPATSYGLYGCNCGPGGRRKPKDATDRCCYVHKCCYKKLTDCDPIKDRYSYSWVNKAIVCGEDNPCPKEMCECDKAVAICFRENLDTYDKKKKINLKLFCKKTSEQC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks catalytic activity (PubMed:12959640). It shows myotoxic and weak anticoagulant activities and induces local edema a few hours after injection (5-10 ug) in the hind paw (PubMed:12959640). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:12959640}.",Phospholipase
852,Q6H3D4,PA2HE_TRIST,,Basic phospholipase A2 homolog Ts-K49a (svPLA2 homolog),MRTLWIMAVLLLGVEGSVIELGKMIFQETGKNPATSYGLYGCNCGPGGRRKPKDATDRCCYVHKCCYKKLTDCDPIKDRYSYSWVNKAIVCGEDNPCLKEMCECDKAVAICFRENLDTYDKKKKINLKLFCKKTSEQC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks catalytic activity (PubMed:12959640). It shows myotoxic and weak anticoagulant activities and induces local edema a few hours after injection (5-10 ug) in the hind paw (PubMed:12959640). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:12959640}.",Phospholipase
853,Q6H3D5,PA2HI_TRIST,,Basic phospholipase A2 homolog CTs-K49a (svPLA2 homolog) (PLA2-III),MRTLWIMAVLLVVVEGSLVQLGKMIFQETGKNPATSYGLYGCNCGPGGRRKPKDATDRCCFLHKCCYKKLTDCDPIKDSYSYSWVNKAIVCGGDDPHLKEMCECDKAMAICFRENLDTYDKKKKINLKLFCKKTSEQC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks catalytic activity (PubMed:12959640). It shows myotoxic and weak anticoagulant activities (PubMed:12959640). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:12959640}.",Phospholipase
854,Q6H3D6,PA2HD_TRIST,,Basic phospholipase A2 homolog Ts-R6 (svPLA2 homolog) (CTs-R6) (PLA2-I),MRTLWIMAVLLLGVEGHLLQLRKMIKKMTNKEPILSYGKYGCNCGMAGRGQPVDGTDRCCSIHNCCYGKVNGCSPKWDYYTYSEENGDIVCEEKHPCKDVCECDKAVATCFRDNLDTYKKRNIFHPKSSCVKVSTPC,"Phospholipase A2 family, Group II subfamily, N49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 homolog that induces local edema a few hours after injection (5-10 ug) in the hind paw and shows weak anticoagulant and myotoxic activities. {ECO:0000269|PubMed:12959640}.,Phospholipase
855,Q6H3D7,PA2HH_TRIST,,Basic phospholipase A2 homolog CTs-R6 (svPLA2 homolog),MRTLLIMAVLLLGVEGSLLQLRKMIKKMTNKEPILSYSKYGCNCGMAGRGKPVDATDTCCSIHNCCYGKVTSCSTKWDSYSYSWENGDIVCDEKHPCKDVCECDKAVATCFRDNLDTYKKRNIFHPTSSCVKVSTPC,"Phospholipase A2 family, Group II subfamily, N49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that induces local edema a few hours after injection (5-10 ug) in the hind paw, and shows weak anticoagulant and myotoxic activities. {ECO:0000269|PubMed:12959640}.",Phospholipase
856,Q6J936,TXVE_BOTER,,Snake venom vascular endothelial growth factor toxin (svVEGF) (VEGF-F),MAAYLLAVAILFCIQGWPLGTVQGQVMPFMEVYRHSVCQPRETLVSILEEYPGEIAHIFRPSCVTALRCGGCCTDESLECTATGKRSVGREIMRLSPHKGTSEKEVMQFTEHTDCECRPRSASGVNSRKHKRNPEEGEQRAKFPFV,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces angiogenesis in vitro (By similarity). Like other crotalid VEGFs, this protein interacts with VEGF receptor-1 (FLT1) with a high affinity, whereas it binds to VEGF receptor-2 (KDR) with a low affinity (By similarity). {ECO:0000250|UniProtKB:P67862, ECO:0000250|UniProtKB:P83942, ECO:0000250|UniProtKB:Q330K6}.",Vascular Interaction
857,Q6QX33,LECG_BOTIN,,C-type lectin BiL (BiLec) (CTL),MGRFIFVSFGLLVVFLSLSGAKGNNCPQDWLPMNGLCYKIFDELKAWKDAEMFCRKYKPGCHLASFHLYGESPEIAEYISDYHKGQSEVWIGLWDKKKDFSWEWTDRSCTDYLSWDKNQPDHYQNKEFCVELVSDTGYRLWNDQVCESKNAFLCQCKF,True venom lectin family,"FUNCTION: Lectin with a hemagglutinating activity that is inhibited by galactose, lactose and EDTA (PubMed:15519291). Is calcium-dependent (PubMed:15519291). Shows effects on the renal function of isolated perfused rat kidneys by increasing both perfusion pressure (PP) and renal vascular resistance (RVR) (PubMed:16730365). In addition, the urinary flow and glomerular filtration rate (GFR) decreases significantly (PubMed:16730365). The changes observed may reflect direct injury to the glomerular and tubular renal cells, and the rise in permeability in the glomerular endothelial cells, may be the effect of interactions of C-type lectin with endothelial cells or due to release of other mediators by mesangial, tubular and endothelial cells (PubMed:16730365). {ECO:0000269|PubMed:15519291, ECO:0000269|PubMed:16730365}.",Vascular Interaction
858,Q6SLM0,PA2B3_BUNCE,3.1.1.4,Basic phospholipase A2 3 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),LVAVCVSLLGAANIPPQPLNLQQFKNMIQCAGTRTWTAYINYGCYCGKGGSGTPVDKLDRCCYTHDHCYNQADSIPGCNPNIKTYSYTCTQPNITCTRTADACAKFLCDCDRTAAICFASAPYNINNIMISASNSCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows anticoagulant and neurotoxic activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
859,Q6T5L0,VSPSH_GLOSH,3.4.21.-,Alpha-fibrinogenase shedaoenase (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VIGGDECNINEHRFLVALYTSRFRTLFCGGTLINQEWVLTAAHCDRKNFRIKLGIHSKKVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSTHIAPFSLPSSPPSVGSVCRIMGWGRISPTEETYPDVPHCVNINLLEYEMCRVPYPEFGLPATSRTLCAGILEGGKDTCRGDSGGPLICNGQFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIKSIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom protease that shows fibrinogenolytic activities. Preferentially degrades the alpha-chain of human fibrinogen (FGA) and slowly degrades the beta-chain (FGB). Has no effect on the gamma-chain. Can hydrolyze fibrinogen without forming fibrin clots and also can degrade fibrin. Hydrolyzes the substrate of plasmin more potently than the substrate of thrombin. Shows a preferential cleavage at Lys-|-Xaa instead of Arg-|-Xaa bonds. {ECO:0000269|PubMed:16331328}.,Fibrinogenolytic Enzyme
860,Q6T6T3,DID1_BITGA,,Disintegrin gabonin-1 (Bitisgabonin-1),MIQVLLVIICLAVFPYQGSSIILESGNVNDYEIVYPKKVTVLPTGAMNSAHPCCDPVTCKPKRGEHCISGPCCRNCKFLNAGTICKRGRGDSLHDYCTGVTPDCPRNPNKGESDELEWSAAATGSVLM,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: The heterodimer bitisgabonin-1 is a potent inhibitor of the adhesion of the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. {ECO:0000269|PubMed:17203976}.,Kunitz Family
861,Q6TPH0,SLOA_PROMU,,Snaclec mucrocetin subunit alpha,MGRFIFVSFGLLVVFLSLSGTGADFDCIPGWSAYDRYCYQAFSEPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLYKQSSKKCYALKKGTELRTWFNVYCGRENPFVCKYTPEC,Snaclec family,FUNCTION: Platelet-agglutinating factor that acts in a vWF-independent manner. Binds specifically to platelet GPIbalpha (GP1BA) to a distinct binding site from that of flavocetin-A.,Binding Protein
862,Q6WP39,OXLA_TRIST,1.4.3.2,L-amino-acid oxidase (LAAO) (TSV-LAO) (EC 1.4.3.2),MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARNGLKATSNPKHVVIVGAGMSGLSAAYVLAGAGHEVTVLEASERAGGRVRTYRNDEEGWYANLGPMRLPEKHRIVREYIRKFNLQLNEFSQENDNAWHFVKNIRKTVGEVKKDPGVLKYPVKPSEEGKSAEQLYEESLRKVEKELKRTNCSYILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLMNEDAGYYVSFIESMKHDDIFAYEKRFDEIVDGMDKLPTSMYRAIEEKVHFNAQVIKIQKNAEEVTVTYHTPEKDTSFVTADYVIVCTTSRAARRIKFEPPLPLKKAHALRSVHYRSGTKIFLTCTKKFREDEGIHGGKSTTDLPSRFIYYPNHNFTSGVGVIIAYGIGDDANFFQALDLKDCGDIVINDLSLIHQLPREEIQTFCYPSMIQKWSLDKYAMGGITTFTPYQFQHFSEALTSHVDRIYFAGEYTAHAHGWIDSSIKSGLTAARDVNRASENPSGIHLSNDDEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). Displays dose-dependent inhibition on HIV-1 infection and replication (PubMed:12963032). {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:12963032}.",Vascular Interaction
863,Q6X1T6,VM3E6_ECHOC,3.4.24.-,Zinc metalloproteinase-disintegrin-like EoMP06 (EC 3.4.24.-) (Prothrombin activator EoMP06) (Snake venom metalloprotease) (SVMP),VEDHCYYHGRVQNDAESTASISACNGLKGHFKLQGETYFIEPLKIPNSEAHAVYKYENIEKEDEAPKMCGVTQTNWESDEPIKKTLGLIVPPHGQKFEKKFIELIIVVDHSMVTKYNNDLTAVRTEIYERLNTVNEIYLPLNIHVALVGIVFWSNRDLINVTSSAADTLHSFGEWRGSDLLNQKRHDHAQLLTNVTLDGTTLGITFVFGMCKSDRSVELIRDYSNITFNMAYIMAHEMGHSLGMLHDTKSCTCGDKPCIMFSKESVPPPKEFSSCSYDQYNKYLLKYNPKCIVDPPLRKDIASPAVCGNGVWEEGEECDCGSPEDCENPCCDAATCKLKPGAECGNGECCDNCKIRKAGTECRPARDDCDVAEHCTGQSAECPRNEFQRNGQPCLNNSGYCYNGDCPIMLNQCIALFSPSATVAQDSCFQRNLQGSYYGHCRKEIGHYGKRFPCAAQDVKCGRLYCLDNSFKKNMRCKKDFSYSDENKGIVEPGTKCEDGKVCINRKCVDVNTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that catalyzes the conversion of prothrombin (F2) to alpha-thrombin. {ECO:0000250}.,Metalloprotease
864,Q6YIJ3,PA2A_BUNCA,3.1.1.4,Acidic phospholipase A2 beta-bungarotoxin A chain (Beta-BuTX A chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAANIRDCNPKTQSYSYKLTKRTIICYGAAGTCARVVCDCDRTAALCFGDSEYIEGHKNIDTARFCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Beta bungarotoxin is a presynaptic neurotoxin. The A chain has phospholipase activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
865,Q6YNQ0,PA2A3_BUNCA,3.1.1.4,Acidic phospholipase A2 beta-bungarotoxin A3 chain (Beta-BuTX A3 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYTNYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAANIRDCNPKTQSYSYKLTKRTIICYGAAGTCARVVCDCDRTAALCFGDSEYIEGHKNIDTARFCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Beta bungarotoxin is a presynaptic neurotoxin. The A chain has phospholipase activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
867,Q75S51,PA2B4_BUNCA,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A4 chain (Beta-BuTX A4 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MNPAHLLVLSAVCVSLLGAANIPPHPLNLKNFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAETKHKCNPKTQSYSYKLTKRTIICYGAAGTCGRIVCDCDRTAALCFGDSEYIERHKNIDTKRHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. The A chain has phospholipase activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
869,Q7LZG2,PA2T_OXYSC,3.1.1.4,Phospholipase A2 taicatoxin (TCX) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLAQFGFMIRCANGGSRSALDYADYGC,"Phospholipase A2 family, Group I subfamily","FUNCTION: Heterotrimer: blocks the voltage-dependent L-type calcium channels from the heart, and the small conductance calcium-activated potassium channels in the chromaffin cells and in the brain. Is very toxic to mice.; FUNCTION: Monomer: Snake venom phospholipase A2 (PLA2) that has neurotoxic activities. Voltage-dependently affects ionic currents in chick (Gallus domesticus) dorsal root ganglion cells. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
870,Q7LZG3,PA2_PSEPP,3.1.1.4,Phospholipase A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLIQFSNMIQLDRCCETHDNEAEKKGCYPKLTLY,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that strongly inhibits platelet aggregation and has a strong anticoagulant activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:7632717}.,Phospholipase
871,Q7SZE0,VM2SA_GLOIT,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase saxin (SVMP) (EC 3.4.24.-); Disintegrin],MIQVLLVTICLVIFPYQGSSIILESGNVNDYEVVYPQKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKHQGEMYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTQTNWKSDEPIKKASQLVVTPEQQRFPQRYIELVVVADQGMFTKYNSNLDTIRTWVHELVDTINEFYRSLNVRVSLTELEIWSNEDLINVQPAAPHTLDSFGEWRQRDLLHRISHDNAMLLTSTDFDGDTIGFAHVGTMCDPKRSVGIVQDHSAINLLVAVTMAHELGHNLGTDHDGNQCHCSANSCIMGDVLREGLSYEFSDCSQNQYQTYLTDHNPQCILNEPLRTDTVSTPVSGNELLETGEECDCGTPANPCCDAATCKLRPGAQCAEGLCCDQCKFTRAGKICRRARGDNPDDRCTGQSSDCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IId sub-subfamily",FUNCTION: [Snake venom metalloproteinase saxin]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin]: Binds and inhibits integrins. {ECO:0000250}.,General Toxin
874,Q7T1K6,CRVP1_NAJAT,,Cysteine-rich venom protein natrin-1 (Cysteine-rich venom protein 1) (NA-CRVP1) (Protein G2a),MIAFSLLCFAAVLQQSFGNVDFNSESTRRKKKQKEIVDLHNSLRRRVSPTASNMLKMEWYPEAASNAERWANTCSLNHSPDNLRVLEGIQCGESIYMSSNARTWTEIIHLWHDEYKNFVYGVGANPPGSVTGHYTQIVWYQTYRAGCAVSYCPSSAWSYFYVCQYCPSGNFQGKTATPYKLGPPCGDCPSACDNGLCTNPCTIYNKLTNCDSLLKQSSCQDDWIKSNCPASCFCRNKII,CRISP family,"FUNCTION: Inhibits calcium-activated potassium channels (KCa1.1/KCNMA1), voltage-gated potassium channel Kv1.3/KCNA3, and the calcium release channel/ryanodine receptor (RyR). Binds specifically to type 1 RyR (RyR1) from skeletal muscle. Inhibit both the binding of ryanodine to RyR1, and RyR1's calcium-channel activity. Inhibits carbachol-induced muscle contraction and weakly blocks muscle contraction evoked by potassium. {ECO:0000269|PubMed:15581679, ECO:0000269|PubMed:16042391, ECO:0000269|PubMed:17070778, ECO:0000269|PubMed:18658224}.",Binding Protein
875,Q7T1R1,PA2B2_BUNFL,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A2 chain (Beta-BuTX A2 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MNPAHLLVLSAVCVSLLGASNIPPQSLNLLQFKDMIRCTIPCERTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAEKRNCNPKVVSYSSKCDKRTLFCYDAPGSCARFVCDCDRTAALCFGDSEYIGRHKNIDTKRYCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:11738240}.,Phospholipase
876,Q7T2I5,3S1EC_LATSE,,Erabutoxin c (ETXC) (Ec) (Short neurotoxin 1c),MKTLLLTLVVVTIVCLDLGYTRICFNHQSSQPQTTKTCSPGESSCYHKQWSDFRGTIIERGCGCPTVKPGINLSCCESEVCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. Binds to Torpedo marmorata nAChR (Kd=0.14 nM) (PubMed:7721859). {ECO:0000269|PubMed:7721859}.",Neurotoxin
877,Q7T2Q1,SLA_ECHML,,Snaclec EMS16 subunit alpha (EMS16A),MGRFISVSFGLLVVFLSLSGTGADFDCPSDWTAYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQGLTKWTNFHDWNNINCEDLYPFVCKFSAV,Snaclec family,"FUNCTION: EMS16 is a potent and selective inhibitor of alpha-2/beta-1 (ITGA2/ITGB1) integrin and acts as a potent antagonist of platelet aggregation and cell migration. Binds specifically to the I domain of the alpha-2 subunit, in a metal ion-independent fashion. {ECO:0000269|PubMed:10933804}.",Kunitz Family
880,Q7T3J2,3L2A_BUNCA,,"Alpha-bungarotoxin, isoform A31 (Alpha-BgTx (A31)) (Alpha-bungarotoxin (A31))",MKTLLLTLVVVTIVCLDLGYTIVCHTTATSPISAVTCPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (tested on Torpedo marmorata, Kd=0.4 nM) and neuronal (tested on chimeric alpha-7/CHRNA7, Kd=0.95 nM) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. It also shows an activity on GABA(A) receptors. It antagonises GABA-activated currents with high potency when tested on primary hippocampal neurons. It inhibits recombinantly expressed GABA(A) receptors composed of alpha-2-beta-2-gamma-2 (GABRA2-GABRB2-GABRG2) subunits with high potency (62.3% inhibition at 20 uM of toxin). It also shows a weaker inhibition on GABA(A) receptors composed of alpha-1-beta-2-gamma-2 (GABRA1-GABRB2-GABRG2) subunits, alpha-4-beta-2-gamma-2 (GABRA4-GABRB2-GABRG2) subunits, and alpha-5-beta-2-gamma-2 (GABRA5-GABRB2-GABRG2) subunits. A very weak inhibition is also observed on GABA(A) receptor composed of alpha-1-beta-3-gamma-2 (GABRA1-GABRB3-GABRG2). It has also been shown to bind and inhibit recombinant GABA(A) receptor beta-3/GABRB3 subunit (Kd=about 50 nM). In addition, it blocks the extracellular increase of dopamine evoked by nicotine only at the higher dose (4.2 uM). In vivo, when intraperitoneally injected into mice, induces flaccid paralysis of the limbs and respiratory distress, and causes death in a dose-dependent manner (PubMed:14505938). {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:14505938}.",Neurotoxin
884,Q800C3,PA2AF_CROVV,3.1.1.4,Acidic phospholipase A2 Cvv-E6f (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVLLLGVEGSLVQFEMMIIKVAKRSGLFWYGAYGCYCGWGGQGRPQDATDRCCFVHDCCYGKATDCNPKTVSYTYSVKNGEIICEDDDPCKKQVCECDRVAAVCFRDNIPSYNNNYKRFPAENCREEPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows very low inhibition of ADP-induced platelet aggregation in platelet-rich plasma of human, rabbit and guinea pig. In vivo, shows efficient edema-inducing activities in rat paws. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12623078}.",Phospholipase
886,Q8AV97,SLAA_PROFL,,Snaclec flavocetin-A subunit alpha (FL-A subunit alpha),MERLIFVSFGLLVVILSLSGTGADFDCIPGWSAYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLVKQFSKKCYALKKGTELRTWFNVYCGTENPFVCKYTPEC,Snaclec family,"FUNCTION: Strong platelet aggregation inhibitor. Binds specifically to platelet glycoprotein Ibalpha (GP1BA) with high affinity and inhibits vWF-dependent platelet aggregation (PubMed:7599152). Has also been observed to induce small agglutinates in washed platelets by binding to GPIb (PubMed:10688335). {ECO:0000269|PubMed:10688335, ECO:0000269|PubMed:7599152}.",Kunitz Family
887,Q8AV98,SLAB_PROFL,,Snaclec flavocetin-A subunit beta (FL-A subunit beta),MGQFIFVSFGFLVVATSLSGTEAGFCCPLGWSSYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLSNVWNECTKEWSDGTKLDYKAWSGGSDCIVSKTTDNQWLSMDCSSKRYVVCKFQA,Snaclec family,"FUNCTION: Strong platelet aggregation inhibitor. Binds specifically to platelet glycoprotein Ibalpha (GP1BA) with high affinity and inhibits vWF-dependent platelet aggregation (PubMed:7599152). Has also been observed to induce small agglutinates in washed platelets by binding to GPIb (PubMed:10688335). {ECO:0000269|PubMed:10688335, ECO:0000269|PubMed:7599152}.",Kunitz Family
888,Q8AVA3,CRVP_PSEPO,,Cysteine-rich venom protein pseudecin (CRVP Pdc),MIAFIVLLSLAAVLQQSSGTVDFASESSNKKNYQKEIVDKHNALRRSVKPTARNMLQMKWNSHAAQNAKRWADRCTFAHSPPNTRTVGKLRCGENIFMSSQPFPWSGVVQAWYDEIKNFVYGIGAKPPGSVIGHYTQVVWYKSHLIGCASAKCSSSKYLYVCQYCPAGNIRGSIATPYKSGPPCADCPSACVNRLCTNPCNYNNDFSNCKSLAKKSKCQTEWIKKKCPASCFCHNKII,CRISP family,FUNCTION: Blocks olfactory (CNGA2) and retinal (CNGA1) CNG channel currents. Is really less potent that Pseudechetoxin. Does not affect neither depolarization- nor caffeine-induced contraction of smooth muscle. {ECO:0000269|PubMed:12234174}.,General Toxin
890,Q8AWX7,VM2AG_GLOHA,3.4.24.-,Zinc metalloproteinase-disintegrin agkistin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKVPALPKRAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPPVEDHCYYHGRIENDADSTTSISACNGLKGHFKLQGETYFIESLKLPDSEAHAVFKYENVEKEDGAPKMCGVTQNWESYEPVKKASQLNFPPDGRIEFLQRYIELVIVADHRMYTKYDGDKTEISSIIYEIVNILTQNYRPMHIRVALTGLEIWSSGELSNVTLSADDTLDSFGEWRERDLLNRKRHDNAQSLTGMIFSENIEGRAYKESMCDLKRSVGIVRDYRTRRHFVANIMAHEMGHNLGIDHDRDSCTCDASSCIMSATVSNEPSSRFSDCSLNQYLSDIIHNPLASYCLYNEPSKTDIVSPPVCGNYYLEVGEDCDCGPPANCQNPCCDAATCRLTPGSQCAEGLCCEQCSFMKEGTVCRIARGDDLDDYCNGISAGCPRNPSHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIb sub-subfamily","FUNCTION: Inhibits ADP-induced human platelet aggregation, inhibits bovine aortic endothelial cells (BAEC) migration, has anti-angiogenic activity and induces BAEC and human micro-vascular endothelial cell (HMEC) apoptosis. The metalloproteinase domain may act in hemorrhage. {ECO:0000269|PubMed:12565859, ECO:0000269|PubMed:16924676}.",Vascular Interaction
892,Q8AY47,PA2B2_BUNCA,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A2 chain (Beta-BuTX A2 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGAANIPPHPFNLINFMKMIRYTIPCEKTWGEYVDYGCYCGVGGSGRPIDALDRCCYVHDNCYGDAEKKHKCNPKMQSYSYKLTKRTTSAMVPQVLVHVLSVIVTARQPSASAILNTSSGTRILTPRDIADDI,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
893,Q8AY48,PA2B1_BUNCA,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A1 chain (Beta-BuTX A1 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAEKKHKCNPKTQSYSYKLTKRTIICYGAAGTCARIVCDCDRTAALCFGDSEYIERHKNIDTARFCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. The A chain has phospholipase activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
894,Q8AY79,VSPS2_TRIST,3.4.21.-,Beta-fibrinogenase stejnefibrase-2 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MELIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVAIFNSTGFFCSGTLINQEWVVTAAHCDSKNFKMKFGAHSKKLLNEDEQIRNPKEKFICPNKKNNDVLDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSVGSDCRIIGWGSITPIEVTYPDVPYCANINLLDDAECKPGYPELLPEYRTLCAGIVEGGKDTCGGDSGGPLICNGQFHGIVSYGGHPCGQSLKPGIYTKVFDYNDWMKSIIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that degrades preferentially beta-chain of fibrinogen (FGB). {ECO:0000269|PubMed:9637365}.,Serine Protease
895,Q8AY80,VSPS1_TRIST,3.4.21.-,Alpha- and beta-fibrinogenase stejnefibrase-1 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MELIRVLANLLILQLSYAQKSSELIIGGDECNIDEHRFLVALYKSGRFRCGGTLINQEWVLTAAHCDRRNMEIKLGMHSKNVPNEDEQRRVPKEKFFCDSNKNYTQWNKDIMLIRLNSPVNNSTHIAPLSLPSSPPIVGSVCRIMGWGTITSPNETYPDVPHCANINLFNYTVCHGAHAGLPATSRTLCAGVLEGGKDTCKGDSGGPLICNGQFQGIVSWGGHPCAQPREPGVYTKVFDHLDWIQNIIAGSTTATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease. Degrades concomitantly alpha- (FGA) and beta-chains of fibrinogen (FGB). {ECO:0000269|PubMed:9637365}.,Serine Protease
896,Q8AYA3,SLB2_DEIAC,,Snaclec agglucetin subunit beta-2 (Antithrombin 1 chain B),MGRFIFVSFGLLVVFLSLRGTGAGFCCPLRWSSYEGHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPILDLSLIWMGLSNMWNDCKREWSDGTKLDFKAWAKTSDCLIGKTDGDNQWLNMDCSKKHYFVCKFKL,Snaclec family,"FUNCTION: Agglucetin specifically causes platelet aggregation and surface exposure of integrin alpha-IIb/beta-3 with a GPIb-(GP1BA-) dependent manner in washed platelets. It binds to human platelets in a saturable manner, and its binding is specifically blocked by anti-GP Ib mAb. It regulates endothelial cell survival and promotes angiogenesis by activating integrin alpha-v/beta-3 signaling through FAK/phosphatidylinositol 3-kinase (PI3K)/Akt pathway. {ECO:0000269|PubMed:11686327, ECO:0000269|PubMed:18312855}.",Binding Protein
897,Q8JFG0,PA2B_VIPAP,3.1.1.4,Basic phospholipase A2 vaspin B chain (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Vaspin toxic component),MRILWIVAVCLIGVEGNLFQFAKMINGKLGAFSVWNYISYGCYCGWGGQGTPKDATDRCCFVHDCCYGRVRGCNPKLAIYSYSFKKGNIVCGKNNGCLRDICECDRVAANCFHQNKNTYNKNYRFLSSSRCRQTSEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Heterodimer: postsynaptic neurotoxin. {ECO:0000250}.; FUNCTION: Monomer: snake venom phospholipase A2 (PLA2) that shows postsynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
898,Q8JFX7,3NOHE_BUNMU,,Muscarinic toxin BM14,MKTLLLTLVVVTIICLDLGYTEMCNMCVRPYPFMSSCCPEGQDRCYKSYWVNENGKQKKYHGKYPVILERGCVTACTGPGSGSIYNLYTCCPTNRCGSSSTSG,"Snake three-finger toxin family, Ancestral subfamily, Orphan group XVII sub-subfamily",FUNCTION: This toxin inhibits the binding of [3H]quinuclidinyl benzilate to the M2 muscarinic acetylcholine (mAchR) receptor subtype (CHRM2). {ECO:0000269|PubMed:12437132}.,General Toxin
899,Q8JGT6,SLEB_PROMU,,Snaclec mucetin subunit beta (Trimeresurus mucrosquamatus venom activator subunit beta) (TMVA subunit beta),MGRFIFVSFGLLVVFISLSGTEAGFCCPLGWSSYDEHCYQVFQQKMNWEDAEKFCTQQHTGSHLVSYESSEEVDFVVSKTLPILKASFVWIGLSNVWNACRLQWSDGTELMYNAWTAESECIASKTTDNQWWSMDCSSKRYVVCKF,Snaclec family,"FUNCTION: Potent platelet activator that acts via GPIb (GP1BA/GP1BB) (PubMed:15175804). After activation by the toxin, the receptor is redistributed on platelet surface thanks to cytoskeletal translocation. The indirect activation of integrin alpha-IIb/beta-3 (ITGA2B/ITGB3) also induced by the toxin is downstream the cytoskeletal translocation of GPIb (PubMed:16102113). {ECO:0000269|PubMed:12220719, ECO:0000269|PubMed:15175804, ECO:0000269|PubMed:15501291, ECO:0000269|PubMed:16102113}.",General Toxin
900,Q8JGT7,SLEA_PROMU,,Snaclec mucetin subunit alpha (Trimeresurus mucrosquamatus venom activator subunit alpha) (TMVA subunit alpha),MGRFTFVSFGLLVVFLSLSGTGADFDCIPGWSAYDRYCYQAFSEPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLFKQSSKKCYALKKGTELRTWFNVYCGRENPFVCKYTPEC,Snaclec family,"FUNCTION: Potent platelet activator that acts via GPIb (GP1BA/GP1BB) (PubMed:15175804). After activation by the toxin, the receptor is redistributed on platelet surface thanks to cytoskeletal translocation. The indirect activation of integrin alpha-IIb/beta-3 (ITGA2B/ITGB3) also induced by the toxin is downstream the cytoskeletal translocation of GPIb (PubMed:16102113). {ECO:0000269|PubMed:12220719, ECO:0000269|PubMed:15175804, ECO:0000269|PubMed:15501291, ECO:0000269|PubMed:16102113}.",General Toxin
903,Q8JIV9,SLA1_DEIAC,,Snaclec agglucetin subunit alpha-1 (Agkisacucetin subunit alpha),MGRFIFVSFGLLVVFLSLSGTGADVDCLPGWSAYDQSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSENKQTDNVWLGLKIQSKGQQCSTEWTDGSSVSYENFSEYQSKKCFVLEKNTGFRTWLNLNCGSEYAFVCKSPP,Snaclec family,"FUNCTION: Agglucetin specifically causes platelet aggregation and surface exposure of integrin alpha-IIb/beta-3 with a GPIb-(GP1BA-) dependent manner in washed platelets. It binds to human platelets in a saturable manner, and its binding is specifically blocked by anti-GP Ib mAb. It regulates endothelial cell survival and promotes angiogenesis by activating integrin alpha-v/beta-3 signaling through FAK/phosphatidylinositol 3-kinase (PI3K)/Akt pathway. {ECO:0000269|PubMed:11686327, ECO:0000269|PubMed:18312855}.",Binding Protein
904,Q8JIW1,SLUB_DEIAC,,Snaclec agkisacutacin subunit B (Agk-B),MGRFIFVSFGLLVVFLSLSGTAADCPSDWSSYEGHCYKPFDEPKTWADAEKFCTQQHKGSHLASFHSSEEADFVVTLTTPSLKTDLVWIGLKNIWNGCYWKWSDGTKLDYKDWREQFECLVSRTVNNEWLSMDCGTTCSFVCKFQA,Snaclec family,"FUNCTION: Anticoagulant protein which binds to the gamma-carboxyglutamic acid-domain regions of factor IX (F9) and factor X (F10) in the presence of calcium with a 1 to 1 stoichiometry. Also inhibits platelet aggregation by binding to platelet glycoprotein Ibalpha (GP1BA) and functioning as a blocker of von Willebrand factor (VWF). Is devoid of hemorrhagic and lethal activities. Possesses antithrombotic and thrombolytic activities. Also hydrolyzes the Aalpha-chain of fibrinogen (FGA). Does not affect the Bbeta-chain (FGB) and the gamma chain (FGG). {ECO:0000269|PubMed:10558903, ECO:0000269|PubMed:12058182, ECO:0000269|PubMed:15925567}.",Fibrinogenolytic Enzyme
905,Q8JIY9,PA2A_PROJR,3.1.1.4,Acidic phospholipase A2 jerdoxin (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVEGHLWQFREMIKEATGKEPLTTYLFYACYCGWGGRGEPKDATDRCCFVHDCCYGKLTACSPKLDIYSYSQKNEDIVCGGGTECEKQICECDKAAAICFLDNLGTYNKEYNNYSKSRCIEESPKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities, exhibits indirect hemolytic activity, and inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
906,Q8QFW3,PA2B2_BUNCE,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A2 chain (Beta-BuTX A2 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLSAVCVSLLGAANIPPYPLNLINFMEMIRYTIPCDKTWGHYADYGCYCGAGGSGTPVDALDRCCYVHDNCYGVAENKHKCNPKTQSCSYKLTKRTIICYGAAGTCGRIVCDCDRTAALCFGDSEYIGAHKNIDTKRHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
907,Q8QFW4,PA2B1_BUNCE,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A1 chain (Beta-BuTX A1 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLILSAVCVSLLGAANIPPHPLNLINFMNMIRYTIPCEKTWGEYTNYGCYCGAGGSGTPIDALDRCCYVHDNCYGDAEKIHKCSPKTQSYSYKLTRRTIICYGAAGTCARIVCDCDRTAALCFGDSEYIEGHKRIDTKRYCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
908,Q8QG87,PA2A_BOTIN,3.1.1.4,Acidic phospholipase A2 BITP01A (svPLA2) (EC 3.1.1.4) (BinTX-I) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVEGNLWQFGKMMNYVMGQSVVYKYFYYGCYCGWGGIGQPRDATDRCCFVHDCCYGKVTGCDPKTDSYTYSKENGDVVCGGDDPCKKQICECDRVAATCFRDNKDTYDMKYWLYGAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that induces edema in mice, produces neuromuscular blockade in chick biventer cervicis, increases CK release and produces myonecrosis. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:17140721}.",Phospholipase
909,Q8QG88,VM36A_BOTIN,3.4.24.-,Zinc metalloproteinase-disintegrin-like BITM06A (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGREITTYPAVEDHCYYHGRIENDADSTASISACNGLKGHFKLQRETYFIEPLKLSNSEAHAVFKYENVEKEDEAPKMCGVTQNWKSYEPIKKASQLVVTAEQQKYNPFRYVELFIVVDQEMVTKNNGDLDKIKARMYELANIVNEILRYLYMHAALVGLEIWSNGDKITVKPDVDYTLNSFAEWRKTDLLTRKKHDNAQLLTAIDFNGPTIGYAYIGSMCHPKRSVAIVEDYSPINLVVAVIMAHEMGHNLGIHHDTDFCSCGDYPCIMGPTISNEPSKFFSNCSYIQCWDFIMKENPQCILNEPLGTDIVSPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYALFGADVYEAEDSCFKDNQKGNYYGYCRKENGKKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNDDEHKGMVLPGTKCADGKVCSNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
910,Q8QHK2,VSP2_CROAT,3.4.21.-,Snake venom serine protease catroxase-2 (SVSP) (EC 3.4.21.-) (Catroxase II) (Kallikrein-like EI),MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVAIFNSTEFFCSGTLINQEWVVTAAHCDSTNFKMKLGVHSKKVPNEDEQTRNPKEKFFCPNKKKDDVLDKDIMLIKLDSPVSNSEHIAPLSLPSSPPSVGSVCHIMGWGSITPIEKTLPDVPYCANIKLLDDAVCQPPYPELPATSRTLCAGIPEGGKDTCGGDSGGPLICNGQFQGIVFYGAHPCGQALKPGVYTKVFDYNDWIQSIIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
911,Q8QHK3,VSP1_CROAT,3.4.21.-,Snake venom serine protease catroxase-1 (SVSP) (EC 3.4.21.-) (Catroxase I),MVLIRVLANLLILQLSYAQKSSEPIIGGDECNRNEHRFLALVSSDGNQCGGTLINEEWVLTAAHCEGNKMKIHLGVHSKKVPNKDKQTRVAKEKFFCVSSKNYTFWDKDIMLIRLDRPVSNSEHIAPLSLPSSPPSVGSVCRIMGWGTISPTKVILPDVPHCVNINLLNYSVCRAAYPEYGLPATSRTLCAGILEGGKDTCVGDSGGPLICNGQFQGIASWGSPNCGYVREPALYTKVFDHLDWIQSIIAGNTDATCPFVNF,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
912,Q8UVU7,PA2HB_CERGO,,Basic phospholipase A2 homolog Pgo-K49 (svPLA2 homolog),MRTLLIVAVLLVGVEGSVYELGKMILQETGKNAATSYGFYGCNCGVGRRGKPKDATDRCCFVHKCCYKKLTDCNSKTDRYSYSWKDKTIVCGDNNPCLQEMCECDKAVAICLRENLNTYNKKYKIHMKFFCKKPDAC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (By similarity). Is myotoxic (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:Q6JK69}.",Phospholipase
913,Q8UVZ7,PA2H_CROAT,,Basic phospholipase A2 homolog Cax-K49 (svPLA2 homolog),MRTFWIVAMLLVGVEGSLVELGKMILQETGKNPITSYGIYGCNCGVGSRHKPKDGTDRCCFVHKCCYKKLTDCDPKMDGYTYSFKDKTIICDVNNPCLKEMCECDKAVAICLRENLDTYNKKYKIYPKFLCKKPDTC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:11594738). Displays edema-inducing activities and may be myotoxic (PubMed:11594738). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:11594738}.",Phospholipase
915,Q90220,VM2H1_GLOHA,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin halystatin (Disintegrin adinbitor) (Disintegrin brevicaudin-1b)],MIQVLLITICLAVFPFQGSSIVLDSGNLNEFEVVYPEKVTALPRAAVKNKYEDAMQYEFKVNGEPLLLHLERNKGLFSDDYSEIHYSPDAREISAYPSVEDHCFYHGRVENDADSTASLSACDGLKAHFKIQGEMYLIEPLEVSDTDAHAVFKYENVEKEDEPPKMCGVTQNWESYESTKKASQLNVSPDQQRFPQRFIKLAIYVDHGMYTKYAGNSERITKRVHQMINNINMMCRALNIVTSLSVLRIWSEKDLITVNASAPSSLTLFGAWRETVLLNRTSHDHAQLMTATIFNGNVIGRAPVGGMCDPKRSVAIVRDHNAILFIVAVTMTHEMGHNLGMHHDEDKCNCNTCIMSKVLSRQPSYEFSDCNENEYQTYVTDHSPQCILNDPLRPDTVSTPVSGNELLEAGEECDCGSPGNPCCDAATCKLRQGAQCAEGLCCDQCRFMKKGTVCRIARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily",FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin halystatin]: Inhibits platelet aggregation and bone resorption. {ECO:0000269|Ref.1}.,General Toxin
916,Q90391,VM1AB_CROAT,3.4.24.41,Snake venom metalloproteinase atrolysin-B (SVMP) (EC 3.4.24.41) (Hemorrhagic toxin B) (HT-B) (Metalloendopeptidase B),MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKELFSKDYSETHYSPDGRKITTNPSVEDHCYYRGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASDLNLNPDQQNLPQRYIELVVVADHRVFMKYNSDLNIIRKRVHELVNTINGFYRSLNIDVSLTDLEIWSDQDFITVQSSAKNTLNSFGEWREADLLRRKSHDHAQLLTAINFEGKIIGRAYTSSMCNPRKSVGIVKDHSPINLLVGVTMAHELGHNLGMNHDGDKCLRGASLCIMRPGLTPGRSYEFSDDSMGYYQSFLNQYKPQCILNKPLRIDPVSTPVSGNELLEAGEE,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
917,Q90VW1,3S1EB_LATSE,,Erabutoxin b (ETXB) (Eb) (Short neurotoxin 1b),MKTLLLTLVVVTIVCLDLGYTRICFNHQSSQPQTTKTCSPGESSCYHKQWSDFRGTIIERGCGCPTVKPGIKLSCCESEVCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular nicotinic acetylcholine receptors (nAChRs) (tested on Torpedo marmorata, Kd=0.07 nM), and with low affinity to neuronal alpha-7/CHRNA7 nAChRs (tested on chimeric alpha-7/CHRNA7, Kd=22 uM) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission (PubMed:7721859). Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. {ECO:0000269|PubMed:9305882}.",Neurotoxin
920,Q90X23,TXVE_BOTJA,,Snake venom vascular endothelial growth factor toxin (svVEGF) (VEGF-F),MAVYLLAVAILFCIQGWPLGTVQGQVMPFMEVYRHSVCQPRETLVSILEEYPGEISHIFRPSCVTALRCGGCCTDESLECTATGKRSVGREIMRLSPHKGTSEKEVMQFTEHTDCECRPRSASGVNSRKHKRNPEEGEPRAKFPFV,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability after intradermal injection, as well as a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces angiogenesis in vitro (By similarity). Like other crotalid VEGFs, this protein interacts with VEGF receptor-1 (FLT1) with a high affinity, whereas it binds to VEGF receptor-2 (KDR) with a low affinity (By similarity). {ECO:0000250|UniProtKB:P67862, ECO:0000250|UniProtKB:P83942, ECO:0000250|UniProtKB:Q330K6}.",Vascular Interaction
921,Q90X24,TXVE_BOTIN,,Snake venom vascular endothelial growth factor toxin (svVEGF) (VEGF-F),MAAYLLAVAILFCIQGWPLGTVQGQVMPFMEVYRHSVCQTRETLVSILEEHPDEVSHIFRPSCVTALRCGGCCTDESLKCTATGKRSVGREIMRVDPHKGTSKTEVMQFTEHTDCECRPRSASGVNSRKHKRNPEEGEPRAKFPFV,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces vascular permeability probably through VEGF (VEGFR) signaling (PubMed:11517227). This protein also induces a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase (By similarity). Also induces angiogenesis in vitro (By similarity). Like other crotalid VEGFs, this protein interacts with VEGF receptor-1 (FLT1) with a high affinity, whereas it binds to VEGF receptor-2 (KDR) with a low affinity (By similarity). {ECO:0000250|UniProtKB:P67862, ECO:0000250|UniProtKB:P83942, ECO:0000250|UniProtKB:Q330K6, ECO:0000269|PubMed:11517227}.",Vascular Interaction
923,Q90Y77,PA2BY_PROFL,3.1.1.4,Basic phospholipase A2 PL-Y (PLA-Y) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIMAVLLVGVEGHLLQFRKMIKKMTGKEPIVSYAFYGCYCGKGGRGKPKDATDRCCFVHDCCYEKVTGCDPKWDYYTYSLENGDIVCGGDNPCTKVVCECDKAAAICFRDNLKTYKKRYMTFPDIFCTDPTEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that can cleave arachidonate at the sn-2 position from phospholipides in the micellar state or in bilayer membranes. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12612832}.,Phospholipase
924,Q91507,VSP1_PROMU,3.4.21.-,Beta-fibrinogenase mucrofibrase-1 (EC 3.4.21.-) (Snake venom serine protease) (SVSP) (Tm-VIG),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVLVYYDDYQCGGTLLNEEWVLTAAHCNGKDMEIYLGVHSKKVPNKDVQRRVPKEKFFCDSSKTYTKWNKDIMLIRLDRPVRKSAHIAPLSLPSSPPSVGSVCRVMGWGTITSPQETYPDVPHCANINLLDYEVCRAAYAGLPATSRTLCAGILEGGKDSCVGDSGGPLICNGQFQGIVSWGGDPCAQPREPGVCTNVFDHLDWIKGIIAGNTDVTCPL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease with strong beta-fibrinogenolytic activities, angiotensin I (AGT)-degrading activities and strong kallikrein-like activities in vitro, releasing bradykinin from kininogen (KNG1). Intravenous injection strongly lowers blood pressure in experimental rats, which may be explained by the action on angiotensin I and kininogen. {ECO:0000269|PubMed:11237764, ECO:0000269|PubMed:7811255}.",Serine Protease
925,Q91508,VSP2_PROMU,3.4.21.-,Beta-fibrinogenase mucrofibrase-2 (EC 3.4.21.-) (Snake venom serine protease) (SVSP) (Trimubin),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVLVYYDDYQCGGTLLNEEWVLTAAHCNGKDMEIYLGVHSKKVPNKDVQRRVPKEKFFCDSSKTYTKWNKDIMLIRLDRPVRKSAHIAPLSLPSSPPSVGSVCRVMGWGTITSPQVTLPDVPRCANINLLDYEVCRAAYPELPATSRTLCAGILEGGKDSCGGDSGGPLICNGQFQGIVSWGGDPCAQPHEPGLYTNVFDHLDWIKGIIAGNTDVTCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease with fibrinogenolytic activities. Cleaves beta-chain of fibrinogen (FGB) efficiently and shows relatively lower activity on alpha-chain. {ECO:0000269|PubMed:7811255}.,Serine Protease
926,Q91509,VSP3_PROMU,3.4.21.-,Beta-fibrinogenase mucrofibrase-3 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVLVYYDDYQCGGTLLNEEWVLTAAHCNGKDMEIYLGVHSKKVPNKDVQRRVPKEKFFCDSSKTYTKWNKDIMLIRLDRPVRKSAHIAPLSLPSSPPSVGSVCRVMGWGTITSPQETYPDVPHCANINLLDYEVCRAAYAGLPATSRTLCAGILEGGKDSCVGDSGGPLICNGQFQGIVSWGGDPCAQPREPGVYTNVFDHLDWIKGIIAGNTDVTCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease with fibrinogenolytic activities. Cleaves beta-chain of fibrinogen (FGB) efficiently and shows relatively lower activity on alpha-chain. {ECO:0000269|PubMed:7811255}.,Serine Protease
927,Q91510,VSP4_PROMU,3.4.21.-,Beta-fibrinogenase mucrofibrase-4 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVLVYYDDYQCGGTLINEEWVLTAAHCNGENMEIYLGMHSKKVPNKDRRRRVPKEKFFCDSSKTYTKWNKDIMLIRLDRPVRKSAHIAPLSLPSSPPSVGSVCRVMGWGTITSPQVTLPDVPRCANINLLDYEVCRAAYPELPATSRTLCAGILEGGKDSCGGDSGGPLICNGQFQGIVSWGGDPCAQPHEPGLYTNVFDHLDWIKGFIAGNTDVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease with fibrinogenolytic activities. Cleaves beta-chain of fibrinogen (FGB) efficiently and shows relatively lower activity on alpha-chain. {ECO:0000269|PubMed:7811255}.,Serine Protease
928,Q91511,VSP5_PROMU,3.4.21.-,Beta-fibrinogenase mucrofibrase-5 (EC 3.4.21.-) (Snake venom serine protease) (SVSP) (Tm-5) (Tm-IIG),MVLIRVLANLLILQLSYAQKSSELIIGGDECNINEHPFLVLVYYDDYQCGGTLINEEWVLTAAHCNGENMEIYLGMHSKKVPNKDRRRRVPKEKFFCDSSKNYTKWNKDIMLIRLNRPVRKSAHIAPLSLPSSPPSVGSVCRIMGWGTISPTKVTLPDVPRCANINLLDYEVCRAAYAGLPATSRTLCAGILEGGKDSCGGDSGGPLICNGQFQGIVSWGGDPCAQPHEPGLYTNVFDHLDWIKGIIAGNTDATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease with strong beta-fibrinogenolytic activities, angiotensin I (AGT)-degrading activities and strong kallikrein-like activities in vitro, releasing bradykinin from kininogen (KNG1). Intravenous injection mildly lowers blood pressure in experimental rats, which may be explained by the action on angiotensin I and kininogen. Exhibits amidase activity against N-benzoyl-Pro-Phe-Arg-p-nitroanilide in vitro (PubMed:10973823). {ECO:0000269|PubMed:10973823, ECO:0000269|PubMed:11237764, ECO:0000269|PubMed:7811255}.",Serine Protease
929,Q92031,VM1A_AGKCL,3.4.24.-,Snake venom metalloproteinase ACLF (SVMP) (EC 3.4.24.-) (ACLF-I) (Metalloproteinase VMP-I) (AclVMP-I),MIQVLLVTLCLAAFPYQGSSIILESGNVNDYEVVYPRKVTPVPRGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVYKYENVEKEDEAPKMCGVTQNWESYEPIKKAFQLNLTPEQQGFPQRYVELVIVADHRMNTKYNGDSDKIRQWVHQIVNTINEIYRPLNIRFALVGLEIWSNQDLITVTSVSHDTLASFGNWRETDLLRRQRHDNAQLLTAIDFDGDTVGLAYVGGMCQLKHSTGVIQDHSAINLLVALTMAHELGHNLGMNHDGNQCHCGANSCVMPSVLSDQPSKLFSDCSKKDYQTFLPVNNPQCILNKPLRTDTASTPVSGNELLEA,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloprotease that has fibrinolytic activity. The recombinant enzyme cleaves both alpha- and beta-chains of fibrinogen, but not the gamma-chain. The recombinant protein does not produce hemorrhage in mice. Cleaves the peptide substrate Abz-LVEALYQ-EDDnp at the Ala-Leu bond in vitro (PubMed:12651104). {ECO:0000269|PubMed:10833388, ECO:0000269|PubMed:12651104}.",Metalloprotease
930,Q92043,VM3AA_CROAT,3.4.24.1,Zinc metalloproteinase-disintegrin-like atrolysin-A (EC 3.4.24.1) (Alpha-proteinase) (Hemorrhagic toxin A) (HT-A) (Snake venom metalloproteinase) (SVMP),ERLTKRYVELVIVADHRMFTKYNGNLKKIRKWIYQIVNTINEIYIPLNIRVALVRLEIWSNGDLIDVTSAANVTLKSFGNWRVTNLLRRKSHDNAQLLTAIDLDEETLGLAPLGTMCDPKLSIGIVQDHSPINLLVAVTMAHELGHNLGMVHDENRCHCSTPACVMCAVLRQRPSYEFSDCSLNHYRTFIINYNPQCILNEPLQTDIISPPVCGNELLEVGEECDCGSPRTCRDPCCDAATCKLHSWVECESGECCQQCKFTSAGNVCRPARSECDIAESCTGQSADCPTDDFHRNGKPCLHNFGYCYNGNCPIMYHQCYALWGSNVTVAPDACFDINQSGNNSFYCRKENGVNIPCAQEDVKCGRLFCNVNDFLCRHKYSDDGMVDHGTKCADGKVCKNRQCVDVTTAYKSTSGFSQI,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase-disintegrin that causes hemorrhage by provoking the degradation of the sub-endothelial matrix proteins (fibronectin, laminin, type IV collagen, nidogen, and gelatins) and disturbances in platelet function. The recombinant cysteine-rich domain interacts with the alpha-2/beta-1 integrin (ITGA2/ITGB1) (collagen receptor), and inhibits the platelet aggregation induced by collagen. {ECO:0000269|PubMed:10620350, ECO:0000269|PubMed:12914938, ECO:0000269|PubMed:2817904}.",Metalloprotease
932,Q98996,PA2A_DABPA,3.1.1.4,Acidic phospholipase A2 VpaPLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLMGVEGHLTQFGDMINKKTGTFGLLSYVYYGCYCGLGGKGKPQDATDRCCFVHDCCYGTVNGCDPKLSTYSYSFQNGDIVCGDDDPCLRAVCECDRVAAICFGENMNTYDKKYMLYSFFDCMEESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that causes a sudden decrease of arterial blood pressure when injected into rat, but is not lethal. When co-injected with an uncharacterized basic protein (which did not show any enzymatic activity, but also causes a drop in blood pressure), this synergistical mixture is lethal. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.",Phospholipase
933,Q98UF9,VM3H3_BOTJA,3.4.24.-,Zinc metalloproteinase-disintegrin-like HF3 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYARKVTALPKGAVQPKYEDTMQYELKVNGEPVVLHLEKNKQLFSKDYSETHYSPDGREITTYPPVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYFIEPLKLPNSEAHAVFKYENVEKEDEVPKMCGVTQTNWESDEPIKKASQLVVTAEQQRYNHYKYIELVILADYRMVTKNNGDLGKIRTKIYEIVNILNEIFRYLYIRIALVGIEIWSNADLSNVTLSADDTLASFGTWRGTVLLKRKSHDNAQLLTAIDFDGQTIGIANIASMCNQNKSVGVVMDYSPINLVVAVIMAHEMGHNLGINHDTGSCSCGGYSCIMAPEISDQPSKLFSNCSKQAYQRYINYYKPQCILNEPLRTDIVSPPVCGNELLEMGEECDCGSPRNCRDPCCDAATCKLHSWVECESGECCDQCRFKGAGTECRAARSECDIAESCTGQSADCPTDDFKRNGQPCLHNYGYCYNGNCPIMYHQCYALFGSNATVAEDGCFEFNENGDKYFYCRKQSGVNIPCAQEDVKCGRLFCHTKKHPCDYKYSEDPDYGMVDNGTKCADGKVCSNGHCVDVATAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: The metalloproteinase-disintegrin-like HF3 is a potent hemorrhagic toxin that activates macrophages for phagocytosis through integrin alpha-M/beta-2 (ITGAM/ITGB2). It inhibits collagen-induced platelet aggregation. This protein shows cleavage specificity for substrate for leucine at P1' position, followed by hydrophobic residues in P2' (PubMed:27020778). {ECO:0000269|PubMed:15336556, ECO:0000269|PubMed:27020778, ECO:0000269|PubMed:3136558}.",General Toxin
934,Q9DEF8,SLAB_DEIAC,,Snaclec anticoagulant protein subunit B (AaACP-B) (ACF 1/2 B-chain) (Agkisasin-b),MGRFIFVSFGLLVLFLSLSGTAADCPSDWSSYEGHCYKPFNEPKNWADAENFCTQQHTGSHLVSFQSTEEADFVVKLAFQTFDYGIFWMGLSKIWNQCNWQWSNAAMLKYTDWAEESYCVYFKSTNNKWRSITCRMIANFVCEFQA,Snaclec family,FUNCTION: Anticoagulant protein which binds to the gamma-carboxyglutamic acid-domain regions of factors IX and factor X in the presence of calcium with a 1 to 1 stoichiometry. Also inhibits platelet aggregation by binding to platelet glycoprotein Ibalpha (GP1BA) and functioning as a blocker of vWF. Is devoid of hemorrhagic and lethal activities. Possesses antithrombotic and thrombolytic activities. Also hydrolyzes the Aalpha-chain of fibrinogen. Does not affect the Bbeta-chain and the gamma chain (By similarity). {ECO:0000250}.,Fibrinogenolytic Enzyme
935,Q9DEF9,SLAA_DEIAC,,Snaclec anticoagulant protein subunit A (AaACP-A),MGRFIFVSFGLLVVYLSLSGTAADCSSSWSSYEGHCYKAFKQSKTWADAESFCTKQVNGGHLVSIESSGEADFVAHLIAQKIKSAKIHVWIGLRAQNKEKQCSIEWSDGSSISYENWIEEESKKCLGVHKATGFRKWENFYCEQRDPFVCEA,Snaclec family,"FUNCTION: Anticoagulant protein which binds to the gamma-carboxyglutamic acid-domain regions of factors IX and factor X in the presence of calcium with a 1 to 1 stoichiometry. Also inhibits platelet aggregation by binding to platelet glycoprotein Ibalpha (GP1BA) and functioning as a blocker of vWF. Is devoid of hemorrhagic and lethal activities. Possesses antithrombotic and thrombolytic activities. Also hydrolyzes the Aalpha-chain of fibrinogen. Does not affect the Bbeta-chain and the gamma chain (By similarity). {ECO:0000250, ECO:0000269|PubMed:12175618}.",Fibrinogenolytic Enzyme
936,Q9DEZ9,NGFV_CRODU,,Venom nerve growth factor (v-NGF) (vNGF),MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAKTHEALKTSRNIDQHYPAPKKAEDQEFGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVDNANSLNRNIRAKREDHPVHKRGEYSVCDSVNVWVANKTTATDIRGNLVTVMVDVNINNNVYKQYFFETKCRNPNPVPTGCRGIDARHWNSYCTTTNTFVKALTMEGNQASWRFIRIDSACVCVISRKNENFG,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
938,Q9DF67,VSP2_PROJR,3.4.21.-,Snake venom serine protease 2 (SP2) (SVSP) (EC 3.4.21.-) (Jerdonobin-II),MVLIRVLANLLILQLSYAQKSSELVFGGRPCNINEHRSLVVLFNSSGFLCGGTLINQDWVVTAAHCDSENFQLLFGVHSKKILNEDEQTRDPKEKFFCPNRKNDDEVDKDIMLIKLDSSVSNSTHIAPLSLPSSPPSVGSVCRIMGWGKTIPTKEIYPDVPHCANINILDHAVCRAAYSWRTVANTTLCAGILQGGKDTCHADSGGPLICNGQVQGIVSWGGHPCGQPREPGVYTKVLDYNDWVQSIIAGNTEATCPP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey (By similarity). Has weak fibrinogen clotting activity. Possesses amidolysis activity towards S-2251 (substrate for plasmin) but has no hydrolytic activity with S-2302 (plasma kallikrein substrate) or S-2238 (thrombin substrate). {ECO:0000250, ECO:0000269|PubMed:15683874}.",Serine Protease
939,Q9DGH6,VM2_GLOHA,,Disintegrin saxatilin,EAGEECDCGAPANPCCDAATCKLRPGAQCAEGLCCDQCRFMKEGTICRMARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3). Also inhibits ADP-induced platelet aggregation. Inhibits basic fibroblast growth factor (bFGF)-induced proliferation of human vascular endothelial cell (HUVEC), and vitronectin-induced migration of smooth muscle cells (SMC). It also regulates platelet activation associated with HUVEC migration and invasion, suppresses TNF-alpha-induced ovarian cancer cell proliferation and invasion, and inhibits angiogenesis and tumor progression. {ECO:0000269|PubMed:11864711, ECO:0000269|PubMed:16410825, ECO:0000269|PubMed:16806476, ECO:0000269|PubMed:17215584, ECO:0000269|PubMed:17394781, ECO:0000269|PubMed:17562297}.",Fibrinogenolytic Enzyme
940,Q9I840,SLYB_CALRH,,Snaclec rhodocytin subunit beta (Aggretin beta chain) (Rhodoaggretin subunit beta),MGRFIFVSFGLLVVFLSLSGTGADCPSGWSSYEGHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRPRLKANLVWMGLSNIWHGCNWQWSDGARLNYKDWQEQSECLAFRGVHTEWLNMDCSSTCSFVCKFKA,Snaclec family,"FUNCTION: Elicits platelet aggregation by the binding to the C-type lectin domain family 1 member B (CLEC1B/CLEC2). Binding leads to tyrosine phosphorylation in the cytoplasmic tail of CLEC1B, which promotes the binding of spleen tyrosine kinase (Syk), subsequent activation of PLCgamma2, and platelet activation and aggregation. Binding to GPIbalpha (GP1BA) and alpha2/beta-1 (ITGA2/ITGB1) may also induce aggregation, but this is controversial. {ECO:0000269|PubMed:11287424, ECO:0000269|PubMed:11352922, ECO:0000269|PubMed:11453648, ECO:0000269|PubMed:11728470, ECO:0000269|PubMed:14630793, ECO:0000269|PubMed:16174766, ECO:0000269|PubMed:7639679, ECO:0000269|PubMed:9588185}.",Binding Protein
941,Q9I841,SLYA_CALRH,,Snaclec rhodocytin subunit alpha (Aggretin alpha chain) (Rhodoaggretin subunit alpha),GLEDCDFGWSPYDQHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQKDELADEDYVWIGLRAQNKEQQCSSEWSDGSSVSYENLIDLHTKKCGALEKLTGFRKWVNYYCEQMHAFVCKLLPY,Snaclec family,"FUNCTION: Elicits platelet aggregation by the binding to the C-type lectin domain family 1 member B (CLEC1B/CLEC2). Binding leads to tyrosine phosphorylation in the cytoplasmic tail of CLEC1B, which promotes the binding of spleen tyrosine kinase (Syk), subsequent activation of PLC-gamma-2, and platelet activation and aggregation. Binding to GPIbalpha (GP1BA) and alpha-2/beta-1 (ITGA2/ITGB1) may also induce aggregation, but this is controversial. {ECO:0000269|PubMed:11287424, ECO:0000269|PubMed:11352922, ECO:0000269|PubMed:11453648, ECO:0000269|PubMed:11728470, ECO:0000269|PubMed:14630793, ECO:0000269|PubMed:16174766, ECO:0000269|PubMed:7639679, ECO:0000269|PubMed:9588185}.",Binding Protein
942,Q9I8X2,VSP1_DEIAC,3.4.21.-,Thrombin-like enzyme acutobin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVIGGVECDINEHRFLVALYELTSMTFLCGGTLINQEWVVTAAHCDRLQLYLYIGMHDKYVKFDDEQGREPIEKYFYNCSNNLTTRDKDIMLIRLDRPVDNSTHIAPLSLPSRPPSVGSVCRVMGWGAISPSRDVLPDVPHCVNINLVNNAECRRAYPRLPATSRTLCAGVMQGGIDSCNRDSGGPLICDGQFQGVVNWGGNPCAQPNMPALYTKVYDYNDWIRSITAGNTTAACPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease that coagulates human fibrinogen by hydrolysis of the alpha chains (FGA). {ECO:0000269|PubMed:11171091}.,Serine Protease
944,Q9I9R4,VM1N_BOTPA,3.4.24.-,Snake venom metalloproteinase neuwiedase (SVMP) (EC 3.4.24.-),QQRFFPQRYIELVIVADRRMYTKYNSDSNKIRTRVHELVNTVNGFFRSMNVDASLANLEVWSKKDLIKVEKDSSKTLTSFGEWRERDLLRRKSHDNAQLLTAIDFNGNTIGRAYLGSMCNPKRSVGIVQDHSPINLLVGVTMAHELGHNLGMEHDGKDCLCGASLCIMSPGLTDGPSYEFSDCSKDYYQTFLTNHNPQ,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: This metalloprotease hydrolyzes the Aalpha chain of fibrin and fibrinogen first followed by the Bbeta chain and shows no effect on the gamma chain. It is also able to degrade type I collagen, fibronectin, laminin and induces inflammatory reaction. It is devoid of hemorrhagic and thrombotic activities, except in lung where it induces pulmonary bleeding. It also induces a mild myotoxic reaction. It is not able to inhibit platelet aggregation, but it induces decrease of platelets and plasma fibrinogen. It contributes to local tissue damage by inducing edema, inflammatory infiltrate and mild myotoxicity, and by degrading extracellular matrix components. {ECO:0000269|PubMed:11032408, ECO:0000269|PubMed:11506891, ECO:0000269|PubMed:14505822}.",Metalloprotease
945,Q9IAM1,SLUA_DEIAC,,Snaclec agkisacutacin subunit A (Agk-A),MGRFIFVSFGLLVVFLSLSGTAADCSSGWSSYEGHCYKVFKQSKTWTDAESFCTKQVNGGHLVSIESSGEADFVGQLIAQKIKSAKIHVWIGLRAQNKEKQCSIEWSDGSSISYENWIEEESKKCLGVHIETGFHKWENFYCEQQDPFVCEA,Snaclec family,"FUNCTION: Anticoagulant protein which binds to the gamma-carboxyglutamic acid-domain regions of factors IX (F9) and factor X (F10) in the presence of calcium with a 1 to 1 stoichiometry. Also inhibits platelet aggregation by binding to platelet glycoprotein Ibalpha (GP1BA) and functioning as a blocker of von Willebrand factor (VWF). Is devoid of hemorrhagic and lethal activities. Possesses antithrombotic and thrombolytic activities. Also hydrolyzes the Aalpha-chain of fibrinogen (FGA). Does not affect the Bbeta-chain (FGB) and the gamma chain (FGG). {ECO:0000269|PubMed:10558903, ECO:0000269|PubMed:12058182, ECO:0000269|PubMed:15925567}.",Fibrinogenolytic Enzyme
946,Q9IAX6,VM2M2_DEIAC,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase MD2 (SVMP) (EC 3.4.24.-) (DaMD2); Disintegrin],FPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGRRITTHPLVEDHCYYRGRIRNDADSTASISACNGLKGHFKLRGETYLIEPMKISNSEAHAVYKYENVEKEDEAHKMCGVTQNWESYEPIKKASQLIVTPEHQRYMEIVIVVDHSMYTKYNGDSDKIKTWIYEMSNTIRESYRYLYIDTSVAAIEIWSEKDLINVETSAKNTLESFGEWRARDLIHRISHDNAQLLTATDLDGPTIGLAYVASMCDPKRSVGVVQDHSSVNHLVAITLAHEIAHNLGVRHDEGSCSCGSGYTCIMSPVINPDAMKYFSDCSYIQCWDYIMKENPPCILNKPLRTDTVSTPVSGNELLEAGKDYDRDSSANPCYDAATCKLNQGAQCTAGPCCDQGRFKEEGTICRRARGDDLDDYCNGISGDCPRNPYHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase MD2]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
947,Q9IAY2,VM1H5_DEIAC,3.4.24.-,Snake venom metalloproteinase H5 (SVMP) (EC 3.4.24.-),FPYQGSSIMLESGKVNDYEVVYPQRLAPLPEGAVQQKYEDTMQYEFKVNGETIGLHMEKSKGLFSKDYSETHYSPDGRKITTYPSVEDHCYYHGRIENYEDSTASISACNGLKGHFKIQGETYFIESLKLSDSEAHAVFKYENVEKEDETHKMCGVTQNWKSYDPIKKPSWVNLTPKQQTWPQTSVNLQLVVDRSMYAKYNSDSEKITQTLQERVNIMKEIFKPLNLDITLSVIEMWDKKDLITVKTAATDTLKLFPKWRQTDLLKRIDNDNAQLQTAVDFDGETVGLAFKGTMCDKRYSAGIIQDHSAIPLLMAVTMAHELGHNLGMDHDDTYKCNCNVCIMPPRLNTNPSKTFSDCSNNDYQKFLTDKKPKCIHKKSLKTDTVSTSVSGNEPLDDNVDGFHA,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: This probable venom zinc protease is not hemorrhagic when 3 ug are injected onto the back skin of guinea pig. {ECO:0000269|PubMed:10691973}.,Metalloprotease
948,Q9PRG0,PA2A1_AUSSU,3.1.1.4,Acidic phospholipase A2 S1-11 (svPLA2) (EC 3.1.1.4) (ASPLA1) (ASPLA3) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASDMPPQPLNLVQFSNMIQCANHGRRPTSNYMDYGCYCGKGGSGTPVDELDRCCKIHDDCYGEAEKSQKCAPYWTWYTWKCGSDGPQCDDSETGSRRFVCGYDATAAKCFAKAPYNKENYNIETRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
949,Q9PRM8,VSPAA_CERCE,3.4.21.-,Snake venom serine protease Afaacytin alpha/beta/beta' chains (SVSP) (EC 3.4.21.-),VIGGAECNINEHRSLVLLYXSSSXFGE,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that exhibits alpha-fibrinase and beta-fibrinogenase activities. It replaces missing factors VIII (F8) and IX (F9) in deficient plasmas by activating purified human factor X (F10) into factor Xa. It releases serotonin from platelets and induces platelet aggregation in human (but not in rabbit). Has caseinolytic, arginine-esterase and amidase activities. {ECO:0000269|PubMed:8521839}.",Serine Protease
951,Q9PRW2,VSP3_CROAT,3.4.21.-,Alpha-fibrinogenase A3 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VIGGDECNINEHRSL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that cleaves fibrinogen Aalpha chain (FGA), partially cleaves Bbeta chain (FGB) and has no activity on gamma chain. Is less potent than A1 and A2 alpha-fibrinogenases. {ECO:0000269|PubMed:8024586}.",Serine Protease
952,Q9PRW3,VSPA2_CROAT,3.4.21.-,Alpha-fibrinogenase A2 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VPGGDECNINEHRSL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that cleaves fibrinogen Aalpha chain (FGA), partially cleaves Bbeta chain (FGB) and has no activity on gamma chain. Is more potent than A3 alpha-fibrinogenases and less potent than A1. {ECO:0000269|PubMed:8024586}.",Serine Protease
953,Q9PRW4,VSPA1_CROAT,3.4.21.-,Alpha-fibrinogenase A1 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VIGGDECNINEHRSLVAIFDS,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that completely cleaves fibrinogen Aalpha chain (FGA), partially cleaves Bbeta chain (FGB) and has no activity on gamma chain. Is more potent that A2 and A3 alpha-fibrinogenases. Very active within 5 minutes. {ECO:0000269|PubMed:8024586}.",Serine Protease
954,Q9PS48,VMXCA_CROAT,3.4.21.-,Snake venom metalloproteinase catroxase (SVMP) (EC 3.4.21.-),TPDHQRYVELFIVVDHGMYTKYNGD,Venom metalloproteinase (M12B) family,FUNCTION: Metalloprotease that is highly active against alpha-(FGA) and beta-chains (FGB) of fibrinogen molecules. {ECO:0000269|PubMed:1520324}.,Metalloprotease
955,Q9PSN3,VSP2_AGKBI,3.4.21.-,Thrombin-like enzyme bilineobin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),IIGGDECNINEHRFLVALYDVWSGSFLCGGTLINQEWVLTAAHCNMSNIYIYLGMHNQSVQFDDEERRYPKEKYLFRCSKNFTKWDKDIMLIRLNKPVRNSEHIAPLSLPSSPPIVGSVCRVMGWGTITSPNETLPDVPRCVNINLFNYTVCRGVFPRLPERSRILCAGVLEGGIDTCKRDSGGPLICNGQFQGIVSWGPKRCAQPRKPALYSKVFDHLDWIQSIIAGNKTVNCP,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that has coagulant activity by releasing fibrinopeptides A and B from fibrinogen alpha (FGA) and beta (FGB), with a preference for beta chain. {ECO:0000269|PubMed:8470131}.",Serine Protease
956,Q9PSN5,PA2AE_NOTSC,3.1.1.4,Acidic phospholipase A2 HTe (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFGNMIQCANHGRRPTRHYMDYGCYCGKGGSGTPVDELDRCCQTHDDCYGEAEKLPACNYMMSGPYYNTYSYECNEGELTCKDNNDECKAFICNCDRTAAICFARAPYNDANWNIDTKTRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that blocks neuromuscular transmission, but that does not produce blockade by virtue of a selective action on nerve endings. Instead, the toxin acts both on nerve and on muscle. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:7733680}.",Phospholipase
957,Q9PSN7,VM3H1_CRORU,3.4.24.-,Snake venom metalloproteinase HT-1 (SVMP) (EC 3.4.24.-) (Hemorrhagic metalloproteinase HT-1) (Hemorrhagic toxin I),LGTDIISPPVCGNELLEVGEECDCGFPRNCRDPCCDATTCKLHSWVECESGECCGQCKFTSAGNECRPARSECDIAESCTGQSADCPMDDFHRNGQPCLNNFGYCYNGNCPILYHQCYALFGSNVYEAEDSCFERNQKGDDDGYCRKENGEKIPCAPEDVKCGRLYCKDNSPGPNDSCKTFNSNEDDHKEMVLPGTKCADGKVCSNGHCVDVASAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Zinc protease from snake venom that induces hemorrhage. {ECO:0000250}.,Metalloprotease
958,Q9PTA1,PA2BA_BUNMU,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A-AL1 chain (Beta-BuTX A-AL1 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (SP III-A),LAVCVSLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRYCYVHGNCYGDAEKKHKCNPKTQSYSYKLTKRTIICYGAAGTCGRIVCDCDRTAALCFGNSEYIEGHKNIDTARFCQ,"Phospholipase A2 family, Group I subfamily, G49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
959,Q9PUG7,PA2AH_AUSSU,3.1.1.4,Acidic phospholipase A2 S17-58 (svPLA2) (EC 3.1.1.4) (ASPLA17) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASNIPLPSLDFEQFGKMIQCTIPCEESCLAYMDYGCYCGPGGSGTPSDELDRCCQTHDNCYAEAGKLPACKAMLSEPYNDTYSYSCIERQLTCNDDNDECKAFICNCDRAAVICFSGAPYNDSNYDIGTIEHCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
960,Q9PUG8,PA2AG_AUSSU,3.1.1.4,Acidic phospholipase A2 S16-19 (svPLA2) (EC 3.1.1.4) (ASPLA16) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASNIPLPSLDFEQFGKMIQCTIPCEESCLAYMDYGCYCGPGGSGTPLDELDRCRQTHDNCYAEAGKLPACKAMLSEPYNDTYSYGCIERQLTCNDDNDECKAFICNCDRAAVICFSGAPYNDSNYDIGTIEHCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
961,Q9PVK7,VM3_NAJKA,3.4.24.-,Zinc metalloproteinase-disintegrin-like cobrin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQLSWSSIILESGNVNDYEVVYPQKVPALLKGGVQNPQPETKYEDTMQYEFQVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYFQNEADSSAVISACDGLKGHFKLQGEIYFIEPLKISDSEAHAIYKDENVEEEDETPKICGVTDTTWESDEPIKKTSLLTNTPEQDRYLQAEKYIEFYMVVDNIMYRHYKRNQLVIKRKVYEMINTMNMIYRRLNFHIALIGLEIWSNINEINVQSDVKATLDLFGEWREKKLLPRKRNDNAQLLTGIDFNGTPVGLAYIGSICNPKTSAAVVQDYSKSTRMVAITMAHEMGHNLGMNHDKGFCTCGFNKCVMSTRRTKPAYQFSSCSVREHQRYLLRDRPQCILNKPLSTDIVSPPICGNYFVEVGEECDCGSPADCQSACCNATTCKLQHEAQCDSEECCEKCKFKGAGAECRAAKDDCDLPELCTGQSAECPTDVFQRNGLPCQNNGYCYNGKCPIMTNQCIALRGPGVKVSRDSCFTLNQRTRGCGLCRMEYGRKIPCAAKDVKCGRLFCKKRNSMICNCSISPRDPSYGMVEPGTKCGDGMVCSNRQCVDVKTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that may cleave complement protein C3 into C3c-like (C3o). {ECO:0000269|PubMed:3045125}.,Metalloprotease
962,Q9PVK9,VM2MD_GLOBR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase Mt-d (SVMP) (EC 3.4.24.-); Disintegrin],MIQVLLVTICLAAFPYQGSSMILESGNVNDYEVVYPQKVPALPKGAVPQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGRKITTNPPVEDHCYYHGHIQNDADSTASISACNGLKGHFKHQGEMYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTQTNWKSDEPIKASQLVVTAEQQRFPQRYIELVVVADHGMFTKYDSNLDTITTWVHELVNNINEFYRSLNVRVSLTELEIWSNQDLINVQSAAADTLEAFGDWRETDLLNRISHDNAQLLTTIDLDGNTIGLAHVGTMCDPKYSVGIVQDHSAINLLVAVTMAHELGHNLGMDHDGNQCHCGANSSVMGDVLRVGVSYEFSDCNENEYQTYVTDHNPQCILNEPLRTDTVSTPVSGNELLEAGVECDCGAPANPCCDAATCKLRPGAQCAEGLCCDQCRFMKEGTICRMARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IId sub-subfamily","FUNCTION: [Snake venom metalloproteinase Mt-d]: This recombinant protein hydrolyzes fibronectin, but has no effect on type I gelatin and type I to V collagens. Selectively hydrolyzes the Aalpha-chain of fibrinogen (FGA), but has no effect on fibrin. {ECO:0000269|PubMed:10406963}.; FUNCTION: [Disintegrin]: Inhibits ADP-induced platelet aggregation. {ECO:0000250}.; FUNCTION: Recombinant metalloproteinase-disintegrin Mt-d-I (393-408): hydrolyzes type I gelatin, type III and V collagens, but has no effect on type I, II, IV collagens and fibronectin. Selectively hydrolyzes the Aalpha-chain of fibrinogen, but has no effect on fibrin. May induce hemorrhage in vascular tissue. Strongly inhibits ADP-induced platelet aggregation. When concentrated, Mt-d-I undergoes autoproteolytic processing into metalloproteinase and disintegrin. {ECO:0000269|PubMed:10406963}.",Fibrinogenolytic Enzyme
963,Q9PW36,VM1AC_DEIAC,3.4.24.-,Snake venom metalloproteinase acutolysin-C (SVMP) (EC 3.4.24.-),MIQVLLVTICLAALPYQGSSIMLESGKVNDYEVVYPQRLAPLPEGAVQQKYEDTMQYEFKVNGETIVLHLEKNKGLFSKDYSETHYSPDGRKITTYPSVEDHCYYHGRIENYEDSTASISACNGLKGHFKIQGETYFIESLKLSDSEAHAVLKYENVGKEDETHQICGVTLNWKSYDPIKRPSRLNLTPKQQTWPQTSVNLQLIVDHSMYAKYNSNSEKITKTVQERVNIMKEIFKPLNFDITLSGIEMWDKKDLITVKTAATDTLKLFAKWRQTDLLKRIDNDNAQLQTAVDFDGETVGLAFKSTMCDKRYSAGIIQDHSAIPLLMAVTIAHELGHNLGMDHDDTSKCNCNVCIMAPRLNTNPSKTFSDCSNNDYQKFLTDKKPKCIHKKSLKTDTVSTSVSGNEPLDDNVDGFHA,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: This protein is an alkaline zinc metalloprotease from snake venom that possesses weak hemorrhagic activity. {ECO:0000250}.,Metalloprotease
964,Q9PWJ0,VM2A2_DEIAC,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase aculysin-2 (SVMP) (EC 3.4.24.-) (DaMD1) (Metalloproteinase MD1); Disintegrin acugrin],MIQVLLVTICLAAFPYQGSSIILESGKVNDYEVVYPQRLAPLPEGAVQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGRRITTHPLVEDHCYYRGHIRNDADSTASISACHGLKGHFKLRGETYLIEPMKISNSEAHAVYKYENVEKEDEAHKMCGVTQNWESYEPIKKASQLIVSTEQQRYMEIVIVVDHSMVKKYNGDSDKIKAWVYEMINTITESYRYLYIDIILSGLEIWSEKDLINVETSAENTLKSFGEWRAKDLIHRISHDNAQLLTATDLDGPTIGLAYVASMCDPKRSVGIVQDHSSVNRLVAITLAHEMAHNLGVRHDEGSCSCGSGYTCIMSPVINPDAMKYFSDCSYIQCWDYIMKENPPCILNKPLRTDTVSTPVSGNELLEAGKDYDRDSSANPCYDAATCKLNQGAQCTAGPCCDQGRFKEEGTICRRARGDDLDDYCNGISADCPRNPYHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase aculysin-2]: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin acugrin]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
965,Q9W7S2,VM11_DEIAC,3.4.24.-,Snake venom metalloproteinase aculysin-1 (SVMP) (EC 3.4.24.-),MIQVLLVTICLAAFPYQGSSIMLESGKVNDYEVVYPQRLAPLPEGAVQQKYEDTMQYEFKVNGETIVLHLEKNKGLFSKDYSETHYSPDGRKITTYPSVEDHCYYHGRIENYEDSTASISACNGLKGHFKIQGETYFIESLKLSDSEAHAVFKYENVEKEDETHKICGVTQNWKSYDPIKKPSWLNLTPKQQTWPQTSVNLQLIVDHSMYAKYNSNSEKITKTLQERVNIMKEIFKPLNLDITLSGIEMWDKKDLITVKTAATDTLKLFAKWRQTDLLKRIDNDNAQLQTAVDFDGETVGLAFKSTMCDKRYSAGIIQDHSAIPLLMAVTMAHELGHNLGMDHDDTSKCNCNVCIMAPRLNTNPSKTFSDCSNNDYQKFLTDKKPKCIHKKSLKTDTVSTSVSGNEPLDDNVDGFHA,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: This protein is an alkaline zinc metalloprotease from snake venom that possesses weak hemorrhagic activity. {ECO:0000250|UniProtKB:P60244}.,Metalloprotease
967,Q9YGJ0,3NO5I_BUNMU,,Gamma-bungarotoxin (Long neurotoxin homolog NTL2I),MKTLLLTLVVVTIVCLDLGYTMQCKTCSFYTCPNSETCPDGKNICVKRSWTAVRGDGPKREIRRECAATCPPSKLGLTVFCCTTDNCNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group V sub-subfamily","FUNCTION: Exhibits M2 muscarinic acetylcholine receptor (CHRM2)-blocking activity, but has a weak binding activity toward nicotinic AChR. Moreover, it inhibits collagen-induced platelet aggregation. {ECO:0000269|PubMed:12168693}.",Binding Protein
968,Q9YGJ8,VSPPA_GLOBR,3.4.21.-,Venom plasminogen activator Haly-PA (EC 3.4.21.-),MALIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVVLFNSSGLICSGTLINQEWVLTAAHCDSKNFQMLFGVHSKKILNEDEQTRDPKEKFICPNKKKDDEKDKDIMLIRLDSPVSNSEHIAPLSLPSSSPTVDSVCRIMGWGTIKPADETYPDVPHCANINILDHTVCRAAYPVLLAGSSTLCAGTQQGGKDTCVGDSGGPLICNGQIQGIVSWGAHPCGQGSKPGVYTKVFDHLDWIKSIIAGNTAVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that activates plasminogen. Displays indirect fibrino(geno)lytic activity through conversion of plasminogen to plasmin. Shows a preferential cleavage at Arg-|-Xaa instead of Lys-|-Xaa bonds. {ECO:0000269|PubMed:9839665}.,Serine Protease
969,Q9YGN4,SLB_GLOBR,,Snaclec salmorin subunit B,MGRFIFVSFGLLVVFVSLSGTGADCPSGWSSYEGHCYKLFNQQSQWAHAEKFCTLQHTGGHLVSFHSTEEADFVVKLAFQNFGHGIFWMGLSNVWNQCSWQWSNAAKLKYEAWAEIYCVYFKSTNNKWRSRACRMEAYFVCEFQA,Snaclec family,FUNCTION: Inhibits thrombin-induced fibrinogen clotting and factor Xa-induced prothrombin activation. Binds to thrombin and prothrombin exosites. {ECO:0000269|PubMed:10963789}.,Fibrinogenolytic Enzyme
970,Q9YGN5,SLA_GLOBR,,Snaclec salmorin subunit A,MGRFIFVSFGLLVVFLSLSGTGADFFCPSGWGSNNGHCYQAFNQRMTWEDAERFCSAQAKGGHLVSIETRAEADFVAHVVAERIETSFPHVWIGLRDEGKEQQCSSEWSDGSSVSYENWIEAESKTCLGLELDSNYHKWVNVYCGQRNPFVCEA,Snaclec family,FUNCTION: Inhibits thrombin-induced fibrinogen clotting and factor Xa-induced prothrombin activation. Binds to thrombin and prothrombin exosites. {ECO:0000269|PubMed:10963789}.,Fibrinogenolytic Enzyme
971,Q9YGS1,VSPA_DEIAC,3.4.21.-,Thrombin-like enzyme acutin (SVTLE acutin) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Thrombin-like defibrase 1) (DFA1),MVIGGDECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTNFQMQLGVHSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPLSLPSSPPSVGSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQTGYPSCWRNTTLCAGFLEGGKDTCGGDSGGPLICNGQFQGIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRNIAGNTDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease. Has arginyl esterase and fibrinogen clotting activities. {ECO:0000269|PubMed:10049722}.,Serine Protease
977,W5XCJ6,SLCIB_MACLB,,Snaclec lebecin subunit beta,MGRIIFVSFGLLVVFLSLSGTGADCPSDWSSDEEHCYYVFFLLFTWEEAAKFCTQQANGGHLVSIESVEEAEFVAQLISENIKTSADYVWIGLWNQRKAPYCVSKWTDGSSVIYKNVIERFIKNCFGLEKETNYRTWFNLSCGDDYPFVCKSPA,Snaclec family,"FUNCTION: Inhibits human breast cancer cells (MDA-MB231) migration and proliferation, as well as their adhesion to fibrinogen and fibronectin. This inhibition may be due to the binding to receptors of the integrin family, probably alpha-v/beta-3 (ITGAV/ITGB3) (40% inhibition of cell adhesion) and alpha-5/beta-1 (ITGA5/ITGB1) (by comparison with lebectin). {ECO:0000269|PubMed:24814013}.",Fibrinogenolytic Enzyme
978,W5XDM0,SLCIA_MACLB,,Snaclec lebecin subunit alpha,MGRSISVSFGLLVVFLSLSGTGADQDCLPGWSFYEGGCYYVFDVKTWEDAEKFCQKQSNGKHLATIEWLGKANFVADLVTLNSDPRLDWIGLRVEDKRQQCSSHWTDGSAVSYENVVHNTKCFGLDQKTGYRTWVALRCELAYHFICSRVPR,Snaclec family,"FUNCTION: Inhibits human breast cancer cells (MDA-MB231) migration and proliferation, as well as their adhesion to fibrinogen and fibronectin. This inhibition may be due to the binding to receptors of the integrin family, probably alpha-v/beta-3 (ITGAV/ITGB3) (40% inhibition of cell adhesion) and alpha-5/beta-1 (ITGA5/ITGB1) (by comparison with lebectin). {ECO:0000269|PubMed:24814013}.",Fibrinogenolytic Enzyme
979,X5ICI2,TXVE1_GLOTS,,Vascular endothelial growth factor isoform GtVF,MAAYLLAVAILFCIQGWPSGTVQGQVMPFMEVFKRSVCQTRETLVPVLEEHPSEIADLFKPSCATVLRCGGCCSDESLACTAVGKRSVGREILRVDPRKGTSKIEVMQFTEHTDCECRPRSRSGVDSGKRKRNPEEGEPRAKFPFV,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily","FUNCTION: Snake venom VEGFs that may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces an increase in capillary permeability after intradermal injection, in a VEGFR-2 (KDR) dependent manner (PubMed:24857790). In addition, it provokes a drastic hypotensive effect after intravenous injection (By similarity). The hypotension is mediated by nitric oxide (NO), which is produced by VEGF-activated endothelium NO synthase. Also induces angiogenesis in vitro (By similarity). Unlike other crotalid VEGFs, this protein probably interacts with VEGF receptor-2 (KDR) (PubMed:24857790). {ECO:0000250|UniProtKB:P83942, ECO:0000269|PubMed:24857790}.",Vascular Interaction
980,A0A0U5AUY6,3SA9_NAJNA,,Cytotoxin 9 (CTX9),VVTIVCLDLGYTLKCNKLVPLFYKTCPAGKNLCYKMYMVATPKVPVKRGCIDVCPKSSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Shows cytolytic activity on many different cells by forming a pore in lipid membranes. In vivo, increases heart rate or kills the animal by cardiac arrest. In addition, it binds to heparin with high affinity, interacts with Kv channel-interacting protein 1 (KCNIP1) in a calcium-independent manner, and binds to integrin alpha-V/beta-3 (ITGAV/ITGB3) with moderate affinity (By similarity). Preferentially binds acidic phospholipids like phosphatidylserine, phosphatidic acid and phosphatidyl glycerol (PubMed:26456928). Has hemolytic activity towards human erythrocytes (EC(50)=0.171 uM) and cytolytic activity towards various cell lines (PubMed:26456928). {ECO:0000250|UniProtKB:P60301, ECO:0000250|UniProtKB:P60304, ECO:0000269|PubMed:26456928}.",Serine Protease
981,A0A346CIB0,3NB2_SPISL,,Sulmotoxin 2 (S.sulphureus monomeric toxin 2) (Three-finger toxin 11) (Three-finger toxin 14),MKTLLLALAVVAFMCLDSVYPLNCFQCNRETWWKCSEAKRCRLGNKCYNLYNSDGKWTVKGCAQTCPTAGPDERVKCCYISECNRY,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily",FUNCTION: Probable neurotoxin. Is not toxic to mice and geckos. {ECO:0000269|PubMed:30068680}.,Neurotoxin
982,A0A346CIB2,3NB1_SPISL,,Sulmotoxin 1 (S.sulphureus monomeric toxin) (Three-finger toxin 2),MKTLLLALAVVVLVCLGSANELGLGRQRVDRRRRQAVGAPYGLCFQCNQKSSRDCLNPKRCPYFHRTCYTLYNSGGQWTVKGCAKMCPTAGPNERVKCCYKPECNND,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily",FUNCTION: Mammal-specific neurotoxin (tested on mice) (PubMed:30068680). Not toxic to lizards (tested on geckos) (PubMed:30068680). {ECO:0000269|PubMed:30068680}.,Neurotoxin
984,A0A7T7DMY7,3SA1_NAJSU,,Cytotoxin 1 (CX1) (Cardiotoxin-1) (CTX-1) (CTX1),MKTLLLTLVVVTIVCLDLGYTLKCNKLVPLFYKTCPAGKNLCYKMYMVATPKVPVKRGCIDVCPKSSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Shows cytolytic activity on many different cells by forming pores in lipid membranes (By similarity). Exhibits concentration-dependent growth inhibitory effects in the lung cell lines A549 (IC(50)= 0.88) and NL20 (IC(50)= 1.91), in the prostate cell lines PC-3 (IC(50)= 3.13 ug/ml) and RWPE-1 (IC(50)=0.35 ug/ml), and in the breast cell lines MCF-7 (IC(50)= 9.10 ug/ml) and 184B5 (IC(50)=6.21 ug/ml), with high selectivity for the lung cancer cell line A549 (selectivity index=2.17) (PubMed:33263003). Induces primarily necrosis in the A549 lung cancer cell line, and mainly caspase-independent late apoptosis in the breast cancer cells line MCF-7 and in the prostate cancer cell line PC-3 (PubMed:33263003). {ECO:0000250|UniProtKB:P01470, ECO:0000269|PubMed:33263003}.",Kunitz Family
985,A1IVR9,3L22_BUNCA,,Alpha-elapitoxin-Bc2b (Alpha-EPTX-Bc2b) (Alpha-delta-Bgt-2) (Alpha/delta-bungarotoxin-2) (Alpha/delta-BgTx-2),YTLLCYKTPIPINAETCPPGENLCYTKMWCDIWCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPD,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscular and neuronal nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (PubMed:30944155). Blocks muscle type nAChR (PubMed:30944155). Also binds with high affinity to alpha-7/CHRNA7 nAChRs (By similarity). In addition, shows a weak inhibition of neuronal alpha-3-beta-2/CHRNA3-CHRNB2 nAChR (By similarity). Selectively binds to alpha-1-delta subunit interface of the mouse muscle nicotinic acetylcholine receptor, with a 10-fold higher affinity for the adult than for the fetal receptors (By similarity). In vivo, when intraperitoneally injected into mice, causes flaccid paralysis and respiratory distress, followed by death within 2-4 hours (By similarity). {ECO:0000250|UniProtKB:A1IVR8, ECO:0000269|PubMed:30944155}.",Neurotoxin
986,A2CJE2,VM3S_CROSS,3.4.24.-,Zinc metalloproteinase-disintegrin-like scutiarin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),NPCCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYDLFGADVYEAEDSCFERNQKGNYYGYCRKENGNKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNEDEHKGMVLPGTKCADGKVCSNRQ,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
987,A2CJE3,VM3V_CROVV,3.4.24.-,Zinc metalloproteinase-disintegrin-like viristiarin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),NPCCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYDLFGADVYEAEDSCFERNQKGNYYGYCRKENGNKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNEDEHKGMVLPGTKCADGKVCSNRQ,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
988,A2CJE4,VM3C_CROAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like catroriarin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),NPCCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYDLFGADVYEAEDSCFERNQKGNYYGYCRKENGNKIPCAPEDVKCGRLYSKDNSPGQNNPCKMLCSNEDEHKGRFLEQTGRGKVCSNRQ,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
989,A2CKF6,3NO28_BUNFA,,Neurotoxin 3FTx-8a (3FTx-VIIIa),MKTLLLTLVVVTIVCLDLGYTLTCLICPERYCQKVHTCRGEEKLCVKRFYDEKALGWRAKRGCAATCPEAKPKETVECCSTDKCNK,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
990,A2CKF7,3NO2_BUNFA,,Neurotoxin 3FTx-LT,MKTLLLTLVVVTIVCLDLGYTLTCLICPEKYCQKVHTCRDGENLCVKRFYEGKRFGKKYPRGCAATCPEAKPHEIVECCSTDKCNK,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
991,A3FM55,LECM1_HYDHA,,C-type lectin 1 (CTL),MGRFLFASLGLLVVAFSLSGTGANLYCPFDWLSYNVSCYKLFYSLVTWDQAQRFCVEQQENSQLASIHDVGESVKLSNYISQRWGFFDVWMGLRLSKRNGIWEWSDGSNLTYTSWKEGEPNNLFNMEFCAVLSAGTRYLQWNDKKCTLLHPFLCQFQPRSEANG,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
992,A3QVN2,HYAL_ECHOC,3.2.1.35,Hyaluronidase (Hy) (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor),MYHLWIKCLAAWIFLKRFNGVHVMHAKAPMYPNEPFLVFWNAPTTQCRLRYKVDLDLKTFHIVANANDTLSGSAVTIFYPTHLGIYPHIDDRGHFFHGIIPQNESLTKHLDKSKSDINRIIPLKTFHGLGVIDWENWRPQWDRNWGNKNVYRNRSIQFARDLHPELSENKIRRLAKAEYEKAAKSFMRDTLLLAEEMRPDGYWGYYLYPDCQNYDYKTKGDQYTGKCPDIEMSRNDQLLWLWRESTALFPNVYLEIILRSSDNALKFVHHRLKESMRIASMAREDYALPVFVYARPFYAYTFEPLTQEDLVTTVGETAAMGAAGIVFWGSMQYASTVDSCQKVKKYMNGPLGRYIINVTTAAKICSHALCRKNGRCVRKHSDSNAFLHLFPESFRIMVHANATEKKVIVKGKLELENLIYLRENFMCQCYQGWQGLYCEEYSIKDIRKI,Glycosyl hydrolase 56 family,"FUNCTION: Snake venom endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. In venom, it is not toxic by itself, but increases the diffusion of other venom proteins by degrading the extracellular matrix. In addition, it displays antiedematogenic activity (By similarity). {ECO:0000250}.",General Toxin
993,A3QVN3,HYAL1_CERCE,3.2.1.35,Hyaluronidase-1 (Hy-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1) (Venom spreading factor),MYHIWIKFLAAWIFLKRFNGVHVMQAKAPMYRNEPFLVFWNAPTTQCRLRYKVDLDLKTFHIVSNANDSLSGSAVTIFYPNHLGVYPHIDDRGHFFHGIIPQNESLTKHLNKSKSDINRIIPLKAFHGLGVIDWENWRPQWDRNWGSKNVYRNRSIQFARDLHPELSEDKIRRLAKKEYEKAAKSFMRDTLLLAEEMRPDGYWGYYLYPDCQNYDYKTKGDQYTGKCPEIEMSRNDQLLWLWRDSTALFPNVYLEIILRSSDNALKFVHHRLKEAMRIASMAREDYALPVFAYARPFYAYTFEPLTQEDLVTTVGETAAMGAAGIVFWGSMQYASTVDSCQKVKKYMNGPLGRYIVNVTTAAKICSRVLCRKNGRCVRKHSDSNAFLHLFPESFRIMVYANATEKKVIVKGKLELENLIYLRENFMCQCYQGWKGLYCEEYSIKDIRKI,Glycosyl hydrolase 56 family,"FUNCTION: Snake venom endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. In venom, it is not toxic by itself, but increases the diffusion of other venom proteins by degrading the extracellular matrix. In addition, it displays antiedematogenic activity (By similarity). {ECO:0000250}.",General Toxin
994,A3QVN4,HYAL3_CERCE,3.2.1.35,Hyaluronidase-3 (Hy-3) (EC 3.2.1.35) (Hyaluronoglucosaminidase-3) (Venom spreading factor),MYHIWIKFLAAWIFLKKFNGVHVMQAKAPMYRNEPFLVFWNAPTTQCRLRYKVDLDLKTFHIVSNANDSLSGSAVTIFYPNHLGVYPHIDDRGHFFHGIIPQNESLTKHLNKSKSDINRIIPLKAFHGLGVIDWENWRPQWDRNWGSKNVYRNRSIQFARDLHPELSEDKIRRLAKKEYEKAAKSFMRDTLLLAEEMRPDGYWGYYLYSDCQNYDYKTKGDQYTGKCPEIEMSRNDQLLWLWRDSTALFPNVYLEIILRSSDNALKFVHHRLKEAMRIASMAREDYALPVFAYARPFYAYTFEPLTQEDLVTTVGETAAMGAAGIVFWGSMQYASTVDSCQKVKKYMNGPLGRYIVNVTTAAKICSRVLCRKNGRCVRKHSDSNAFLHLFPESFRIMVYANATEKKVIVKGKLELENLIYLRENFMCQCYQGWKGLYCEEYSIKDIRKI,Glycosyl hydrolase 56 family,"FUNCTION: Snake venom endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. In venom, it is not toxic by itself, but increases the diffusion of other venom proteins by degrading the extracellular matrix. In addition, it displays antiedematogenic activity (By similarity). {ECO:0000250}.",General Toxin
995,A3QVN5,HYAL4_CERCE,3.2.1.35,Hyaluronidase-4 (Hy-4) (EC 3.2.1.35) (Hyaluronoglucosaminidase-4) (Venom spreading factor),MYHIWIKFLAAWIFLKRFNGVHVMQAKAPMYRNEPFLVFWNAPTTQCRLRYKVDLDLKTFHIVSNANDSLSGSAVTIFYPNHLGVYPHIDDRGHFFHGIIPQNESLTKHLNKSKSDINRIIPLKAFHGLGVIDWENWRPQWDRNWGSKNVYRNRSIQFARDLHPELSEDKIRRLAKKEYEKAAKSFMRDTLLLAEEMRPDGYWGYYLYPDCQNYDYKTKGDQYTGKCPEIEMSRNDQLLWLWRDSTALFPNVYLEIILRSSDNALKFVHHRLKEAMRIASMAREDYALPVFAYARPFYAYTFEPLTQEDLVTTVGETAAMGAAGIVFWGSVQYASTVDSCQKVKKYMNGPLGRYIVNVTTAAKICSRVLCRKNGRCVRKHSDSNAFLHLFPESFRIMVYANATEKKVIVKGKLELENLIYLRENFMCQCYQGWKGLYCEEYSIKDIRKI,Glycosyl hydrolase 56 family,"FUNCTION: Snake venom endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. In venom, it is not toxic by itself, but increases the diffusion of other venom proteins by degrading the extracellular matrix. In addition, it displays antiedematogenic activity (By similarity). {ECO:0000250}.",General Toxin
996,A3QVN6,HYAL_ECHPL,3.2.1.35,Hyaluronidase (Hy) (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor),MYHIWIKFLAAWIFLKRFNGVHVMQAKAPMYRNEPFLVFWNAPTTQCRLRYKVDLDLKTFHIVSNANDSLSGSAVTIFYPNHLGVYPHIDDRGHFFHGIIPQNESLTKHLNKSKSDINRIIPLKAFHGLGVIDWENWRPQWDRNWGSKNVYRNRSIQFARDLHPELSEDKIRRLAKKEYEKAAKSFMRDTLLLAEEMRPDGYWGYYLYPDCQNYDYKTKGDQYTGKCPEIEMSRNDQLLWLWRDSTALFPNVYLEIILRSSDNALKFVHHRLKEAMRIASMAREDYALPVFAYARPFYAYTFEPLTQEDLVTTVGETAAMGAAGIVFWGSMQYASTVDSCQKVKKYMNGPLGRYIVNVTTAAKICSRVFCRKNGRCVRKHSDSNAFLHLFPESFRIMVYANATEKKVIVKGKLELENLIYLRENFMCQCYQGWKGLYCEEYSIKDIRKI,Glycosyl hydrolase 56 family,"FUNCTION: Snake venom endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. In venom, it is not toxic by itself, but increases the diffusion of other venom proteins by degrading the extracellular matrix. In addition, it displays antiedematogenic activity (By similarity). {ECO:0000250}.",General Toxin
997,A3QVN9,HYAL1_BITAR,3.2.1.35,Hyaluronidase-1 (Hy-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1) (Venom spreading factor),MYHLWIKCLAAWIFLKRCNGVHAMPAKAPMYPNEPFIVLWNAPTTQCPLRYKVDLDLKTFHIVANPNDSLSGSVVTIFYPNHLGVYPHIDERGHFFHGIIPQNESLTKHLNKSKSDINRMIPLKTFHGLGVIDWENWRPQWDRNWGSKNVYRNRSIQFAKELHPELSEDKIKRLAKKEYEKAAKSFMRDTLLLAEEMRPNGYWGYYLYPDCQNYDYKTKGDQYTGKCPDIEMSRNDQLLWLWRDSTALFPNVYLEIILRSSDNALKFVHHRLKESMRIASMAREDYALPVFVYARPFYAYTFEPLTQEDLVTTVGETAAMGAAGIVFWGSMQYASTVDSCQKVKTYMNGPLGRYIVNVTTAAKICSHALCRKNGRCVRKHSDSNAFLHLFPESFRIMVHANATEKKAIVKGKLELKDLIYLRKNFMCQCYQGWKGLYCEEYSIKDIRKI,Glycosyl hydrolase 56 family,"FUNCTION: Snake venom endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. In venom, it is not toxic by itself, but increases the diffusion of other venom proteins by degrading the extracellular matrix. In addition, it displays antiedematogenic activity (By similarity). {ECO:0000250}.",General Toxin
998,A3QVP0,HYAL2_BITAR,3.2.1.35,Hyaluronidase-2 (Hy-2) (EC 3.2.1.35) (Hyaluronoglucosaminidase-2) (Venom spreading factor),MYHLWIKCLAAWIFLKRCNGVHAMPAKAPMYPNEPFIVLWNAPTTQCPLRYKVDLDLKTFHIVANANDSLSGSVVAIFYPNHLGVYPHIDERGHFFHGIIPQNESLTKHLNKSKSDINRMIPLKTFHGLGVIDWENWRPQWDRNWGSKNVYRNRSIQFAKKLHPELSEDKIKRLAKKEYEKAAKSFMRDTLLLAEEMRPNGYWGYYLYPDCQNYDYKTKGDQYTGKCPDIEMSRNDQLLWLWRDSTALFPNVYLEIILRSSDNALKFVHHRLKESMRIASMAREDYALPVFVYARPFYAYTFEPLTQEDLVTTVGETAAMGAAGIVFWGSMQYASTVDSCQKVKTYMNGPLGRYIVNVTTAAKICSHALCRKNGRCVRKHSDSNAFLHLFPESFRIMVHANATEKKAIVKGKLELKDLIYLRKNFMCQCYQGWKGLYCEEYSIKDIRKI,Glycosyl hydrolase 56 family,"FUNCTION: Snake venom endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. In venom, it is not toxic by itself, but increases the diffusion of other venom proteins by degrading the extracellular matrix. In addition, it displays antiedematogenic activity (By similarity). {ECO:0000250}.",General Toxin
999,A6MFL0,OXLA_DEMVE,1.4.3.2,L-amino-acid oxidase (DvLAAO) (LAO) (EC 1.4.3.2),MNVFFMFSLLFLAALESCADDRRNPLGECFREADYEEFVDIATNGLKQTSNPKRVVVVGAGMAGLSAAYVLAGAGHNVMLLEASERVGGRVNTYRNEQEGWYVNLGPMRLPERHRIVREYIKKFGLQLNQFFQEDEDAWYFIKNIRKKVREVKENPSIFPYPVKPSEKGKSAPQLYRDSLQKIIEEYGRSNCSYILNKYDTYSTKDYLIKEGNLSPGAVDMIGDLLNEGSSYYLSFIESLKSDDIFSYENRFDEIVGGFDLLPKAMYKAIEEKVHLNARVIQIQQNAEGVRVTYQTPAKNLSYVTADYVIVCSTSRAARRIYFEPPLPPEKAHALQSIHYRSATKIFLTCTKKFWEDDGIHGGKSITDRPSRLIHYPNHNFPNGIGVLVIYTIADDADFFLALDNKTIADIVIHDLSLIHQLPKEKIRDLCYVSMIKKWSLDKYSMGSITTFAPYQFQEYFETVAAPVGRIYFAGEYTARAHGWIDSTIKSGLKAARDVNRASQKPSRIQLSNDNEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
1002,A7LAC6,VSP1_TRIAB,3.4.21.-,Thrombin-like enzyme 1 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Green pit viper thrombin-like enzyme 1) (GPV-TL1) (Snake venom serine protease) (SVSP),MVLITVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDVWSGDFLCGGTLINKEYVLTAAHCETRNMYIYLGMHNKNVQFDDEQRRYPKKKYFFRCSNNFTRWDKDIMLIRLNRPVRNSEHIAPLSLPSSPPSVGSVCRVMGWGTITSPNETLPDVPRCANINLLNYTVCRGVFPRLPARSRTLCAGVLQGGIDTCKRDSGGPLICNGQLQGVVFWGPKPCAQPRKPALYTKVFNHLDWIQSIIAGNTTVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease. {ECO:0000250}.,Serine Protease
1003,A7LAC7,VSP2_TRIAB,3.4.21.-,Thrombin-like enzyme 2 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Green pit viper thrombin-like enzyme 2) (GPV-TL2) (Snake venom serine protease) (SVSP),MMLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDVWSGDFLCGGTLINKEYVLTAAHCETRNMYIYLGMHNKMYQFDDEQRRYPKKKYFFRCSNNFTRWDKDIMLIRLNRPVRNSEHIAPLSLPSSPPSVGSVCRVMGWGTITSPNETLPDVPRCANINLLNYTVCRGVFPRLPARSRTLCAGVLQGGIDTCKRDSGGPLICNGKLQGVVFWGPKPCAQPRKPALYTKVFDHLDWIQSIIAGNTTVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease. {ECO:0000250}.,Serine Protease
1004,A7X3X0,LECM3_PSEPL,,C-type lection lectoxin-Enh3 (CTL),MGQFTVVSLGLLAMFLSLSGAKGDNCPASWISRNGVCNKLFPDRKTWLEAEMYCRALKPGCHLASLHRDSDSTVLAWYISDHFKGAGHVWIGLRDTNRKRTWKWSDRTSTNYFSWNQGEPNNVQDNENCVHLWAPSGYLKWNDEPCASLHPFICQYKL,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1005,A7X3X3,LECM4_PSEPL,,C-type lectin lectoxin-Enh4 (CTL),MGQFTVVSLGLLAMFLSLSGAKGDNCPASWISRNGVCNKLFPDRKTWLEAEMYCRALKPGCHLASLHRDSDSTVLAWYISDHFKGAGHVWIGLRDTNRKRTWKWSDRTSTNYFSWNQGEPNNVQDDENCVHLWAPSGYLKWNDEPCASLHPFICQYKL,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1006,A7X3X8,LECM5_PSEPL,,C-type lectin lectoxin-Enh5 (CTL),MGQFTVVSLGLLAVFLSLSGAKGDNCPANWISRNGVCNKLFPDRKTWLEAEMYCRALKPGCHLASLHRDSDSTVLAWYISDHFKGAGHVWIGLRDTNRKRTWKWSDRTSTNYFSWNQGEPNNVQDNENCVHLWAPSGYLKWNDEPCASLHPFICQYKL,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1007,A7X3Y2,LECM6_PSEPL,,C-type lectin lectoxin-Enh6 (CTL),MGQFTVVSLGLLAVFLSLSGAKGDNCPANWISRNGVCNKLFPDRKTWLEAEMYCRALKPGCHLASLHRDSDSTVLAWYISDHFKGAGHVWIGLRDTNRKRTWKWSDRTSTNYFSWNQGEPNNVQDNENCVHLWAPSGYLKWNDEPCASLHPSICQYKL,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1008,A7X3Y6,LECM7_PSEPL,,C-type lectin lectoxin-Enh7 (CTL),MGQFTVVSLGLLAVFLSLSGAKGDNCPANWISRNGVCNKLFPDRKTWLEAEMYCRALKPGCHLASLHRDSDSTVLAWYISDHFKGAGHVWIGLRDTNRKRTWKWSDRTSTNYFSWNQGEPNNVQDNENCVHPWAPSGYLKWNDEPCASLHPFICQYKL,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1009,A7X401,LEC1_LEIMD,,C-type lectin lectoxin-Lei1 (CTL),MRRFLFLSLGVLVVAFSLNGIGADHHCPWDWFSFDRFCYKVIKQRKNWQDAERFCGQLQNGSHLASIQSWAESKYVAMLLSNNAFLDTVWIGLFEPEKNRSLEWSDGSGFCYTGWERRKRNNVDNKKYCVELSWMSDYLEWNNVKCESRNIFICKI,True venom lectin family,FUNCTION: Lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1010,A7X406,LECM1_PHIOL,,C-type lectin lectoxin-Phi1 (CTL),MGRFIFVSLGLLVLAFSLSGIGADQHCPSGWFSHNVSCYKLINDWKTWDEAQRFCMDEQENGQLASINDVGESVKLSDEISKTWSIIDVWIGLRLSKRKSIWEWIDGSNVTQTRWEEGEPNNFLKKEFCVVLTSRSRYLKWNDKDCNRRHRFLCKF,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1011,A7X409,LECM2_PHIOL,,C-type lectin lectoxin-Phi2 (CTL),MGRFIFVSLGLLVLAFSLSGIGADQHCPSGWFSHNVSCYKLINDWKTWDEAQRFCMDEQENGQLASINDVGESVKLSDEFSKTWSIIDVWIGLRLSKRKSIWEWIDGSNVTQTRWEEGEPNNFLKKEFCVVLTSRSRYLKWNDKDCNRRHRFLCKF,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1012,A8CG84,PA2BS_DABSI,3.1.1.4,Basic phospholipase A2 DsM-S1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLIGVEGSLLEFGKMILEETGKLAIPSYSSYGCYCGWGGKGTPKDATDRCCFVHDCCYGNLPDCNPKSDRYKYKRVNGAIVCEKGTSCENRICECDKAAAICFRQNLNTYSKKYMLYPDFLCKGELRC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that is neurotoxic. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1013,A8CG87,PA2A2_DABRR,3.1.1.4,Acidic phospholipase A2 Drk-a2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLIGVEGNLYQFGEMINQKTGNFGLLSYVYYGCYCGWGGKGKPQDATDRCCFVHDCCYGRVKGCDPKTATYSYSFENGDIVCGGDDPCLRAVCECDRVAAICFRENMNTYDKKYMLYSIFDCKEESDQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that is neurotoxic. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1015,A8HDJ4,3S11_PSEPO,,Alpha-elapitoxin-Ppr1 (Short neurotoxin 1) (SNTX-1),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTTCAGGESSCYKKTWSDHRGSRTERGCGCPHVKPGIKLTCCETDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily",FUNCTION: Bird-specific neurotoxin (tested on chicken) that acts as a pseudo-irreversible antagonist at the nicotinic acetylcholine receptor (nAChR) of the skeletal neuromuscular junction. Has no significant effect on the electrically-induced twitches of the rat isolated phrenic nerve-diaphragm preparation. {ECO:0000269|PubMed:23545348}.,Neurotoxin
1016,A8N286,3SO8_OPHHA,,Haditoxin (Muscarinic toxin-like protein 3 homolog) (MTLP-3 homolog),MKTLLLTLVVVTIVYLDLGYTTKCYNHQSTTPETTEICPDSGYFCYKSSWIDGREGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ,"Snake three-finger toxin family, Short-chain subfamily, Orphan group VIII (haditoxin) sub-subfamily","FUNCTION: Antagonist of muscle (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and neuronal (alpha-7/CHRNA7, alpha-3-beta-2/CHRNA3-CHRNB2, alpha-4-beta-2/CHRNA4-CHRNB2) nicotinic acetylcholine receptors (nAChR) (PubMed:20071329). The highest affinity is for human alpha-7/CHRNA7 nAChRs (IC(50)=180 nM), compared to human alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE nAChR (IC(50)= 550 nM), alpha-3-beta-2/CHRNA3-CHRNB2 nAChR (IC(50)=500 nM), and alpha-4-beta-2/CHRNA4-CHRNB2 nAChR (IC(50)=2.6 uM). {ECO:0000269|PubMed:20071329}.",Neurotoxin
1017,A8QL51,OXLA_BUNMU,1.4.3.2,L-amino-acid oxidase (Bm-LAAO) (LAO) (EC 1.4.3.2),MNVFSIFSLVFLAAFGSCADDRRSPLEECFREADYEEFLEIARNGLKKTSNPKHVVVVGAGMAGLSAAYVLEKAGHRVTLLEASDRVGGRANTYRDEKEGWYVNMGPMRLPERHRIVRTYIAKFGLKLNEFFQENENAWYFIRNIRKRVWEVKKDPGVFKYPVKPSEEGKSASQLYRESLKKIIEELKRTNCSYILDKYDSYSTKEYLIKEGNLSRGAVDMIGDLLNEDSSYYLSFIESLKNDDLFSYEKRFDEISGGFDQLPKSMHQDIAEMVHLNAQVTKIQHDAEKVRVAYQTPAKTLSYVTADYVIVCATSRAVRRISFEPPLPSKKAHALRSIHYKSATKIFLTCTQKFWEADGIHGGKSTTDLPSRFIYYPNHNFTSGVGVIVAYVLADDSDFFQALDIKTSADIVINDLSLIHQLPKNEIQALCYPSLIKKWSLDKYTMGALTSFTPYQFQDYSETVAAPVGRIYFAGEYTARVHGWLDSTIKSGLTAARDVNRASQKPSRIHLISDNQL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
1018,A8QL53,VSP1_NAJAT,3.4.21.-,Snake venom serine protease NaSP (SVSP) (EC 3.4.21.-),MVLIRVLASLLILQLSYSKSLDDGAKESAYDDEIQQSSWGNSTVNTTLTETVVIQLIMGGSECYKSKHPFLVYLYNSAGFFCSGTLLNHEWVLTAAHCNRDDIQLKLGVHNVHVHYEDEQIRVPKEKLCCLSTKNCTQWSQDIMLIRLNSSVNNSKHIEPLSLPSRPPSMGSDCTVMGWGTITSPKVTYPKVPHCVDIKILHNPVCQAAYPTMSRKNILCAGVLEGGKDSCKGDSGGPLICDGQIQGIVSWGRFPCAQLLEPGVYTKVFDYIDWIRGIIAGN,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1019,A8QL57,VSP1_BUNMU,3.4.21.-,Snake venom serine protease BmSP (SVSP) (EC 3.4.21.-),MVLIGVLASLLILQLSYSKSLDDGAKESAYDDEIQQSSWGNSTVNTTLTETVVIQLIMGGSECYKSKHPFLVYLYNSAGFFCSGTLLNHEWVLTAAHCNRDDIQLKLGVHNVHVHYEDEQIRVPKEKLCCLSTKNCTQWSQDIMLIRLNSSVNNSKHIEPLSLPSRPPSMGSDCTVMGWGTITSPKVTYPKVPHCVDIKILHNPVCQAAYPTMSRKNILCAGVLEGGKDSCKGDSGGPLICDGQIQGIVSWGRFPCAQLLEPGVYTKVFDYIDWIKGIIAGN,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1020,A8Y7N4,VKTC1_DABSI,,Kunitz-type serine protease inhibitor C1 (BPTI-1) (Trypsin inhibitor 1) (Trypsin inhibitor C1),MSSGGLLLLLGLLTLWAELTPISGQDRPKFCNLAPESGRCRGHLRRIYYNPDSNKCEVFFYGGCGGNDNNFETRKKCRQTCGAPRKGRPT,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin. {ECO:0000250}.,Serine Protease
1021,A8Y7N5,VKTC2_DABSI,,Kunitz-type serine protease inhibitor C2 (BPTI-2) (Trypsin inhibitor 2) (Trypsin inhibitor C2),MSSGGLLLLLALLTLWAELTPISGHDRPTFCNLAPESGRCRAHLRRIYYNLESNKCEVFFYGGCGGNDNNFSSWDECRHTCVGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits plasmin and trypsin. {ECO:0000250}.,Serine Protease
1022,A8Y7N6,VKTC3_DABSI,,Kunitz-type serine protease inhibitor C3 (BPTI-3) (Trypsin inhibitor 3) (Trypsin inhibitor C3),MSSGGLLLLLGLLTLWAELTPISGHDRPKFCYLPADPGECMAYIRSFYYDSESKKCKEFIYGGCHGNANNFPTRDKCRQTCRGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1023,A8Y7N7,VKTC4_DABSI,,Kunitz-type serine protease inhibitor C4 (BPTI-4) (Trypsin inhibitor 4) (Trypsin inhibitor C4),MSSGGLLLLLGLLTLWAELTPISGHDRPKFCYLPADPGECMAYIRSFYYDSESKKCKEFIYGGCHGNANNFPTRDKCRQTCRAPRKGRHT,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1024,A8Y7N8,VKTC5_DABSI,,Kunitz-type serine protease inhibitor C5 (BPTI-5) (Trypsin inhibitor 5) (Trypsin inhibitor C5),MSSGGLLLLLALLTLWAELTPISGHDRPTFCNLAPESGRCRGHLRRIYYNPDSNKCEVFFYGGCGGNDNNFETRKKCRQTCGAPRKGRPT,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin. {ECO:0000250}.,Serine Protease
1025,A8Y7N9,VKTC6_DABSI,,Kunitz-type serine protease inhibitor C6 (BPTI-6) (Trypsin inhibitor 6) (Trypsin inhibitor C6),MSSGGLLLLLGFLTLWAELTPISGQNRPMFCHLPADSGRCKAHIPRFYYNPASNQCQGFTYGGCGGNANNFETRDQCRHTCGASGNVGPRPRIASN,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1026,A8Y7P0,VKTB7_DABSI,,Kunitz-type serine protease inhibitor 7 (BPTI-7) (Trypsin inhibitor 7) (Trypsin inhibitor B7) (Trypsin inhibitor C7),MSSGGLLLLLGLLTLWAELTPISGHDRPTFCNLAPESGRCRGHLRRIYYNLESNKCKVFFYGGCGGNANNFETRDECRQTCGGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin. {ECO:0000250}.,Serine Protease
1027,A8Y7P2,VKTB2_DABSI,,Kunitz-type serine protease inhibitor B2 (BPTI-2) (Trypsin inhibitor 2) (Trypsin inhibitor B2),MSSGGLLLLLGLLTLWAELTPISGHDRPTFCNLAPESGRCRGHLRRIYYNLESNKCNVFFYGGCGGNDNNFETRDECRQTCGGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin. {ECO:0000250}.,Serine Protease
1028,A8Y7P3,VKTB3_DABSI,,Kunitz-type serine protease inhibitor B3 (BPTI-3) (Trypsin inhibitor 3) (Trypsin inhibitor B3),MSSGGLLLLLGLLTLWAELTPISGHDRPTFCNLAPESGRCRGHLRRIYYNLESNKCEVFFYGGCGGNDNNFSTRDECRHTCVGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits plasmin and trypsin. {ECO:0000250}.,Serine Protease
1029,A8Y7P4,VKTB4_DABSI,,Kunitz-type serine protease inhibitor B4 (BPTI-4) (Trypsin inhibitor 4) (Trypsin inhibitor B4),MSSGGLLLLLGLLTLWAELTPISGHDRPTFCNLAPESGRCRGHLRRIYYNLESNKCEVFFYGGCGGNDNNFSTWDECRHTCVGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits plasmin and trypsin. {ECO:0000250}.,Serine Protease
1030,A8Y7P5,VKTB5_DABSI,,Kunitz-type serine protease inhibitor B5 (BBPTI-5) (BPTI-5) (Trypsin inhibitor 5) (Trypsin inhibitor B5),MSSGGLLLLLGLLTLWAELTPISGHDRPKFCYLPADPGECLAHMRSFYYDSESKKCKEFIYGGCHGNANKFPSRDKCRQTCGASAKGRPT,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1031,A8Y7P6,VKTB6_DABSI,,Kunitz-type serine protease inhibitor B6 (BPTI-6) (Trypsin inhibitor 6) (Trypsin inhibitor B6),MSSGGLLLLLGLLTLWAELTPISSHDRPKFCNLAPESGRCRGHLRRIYYNLESNKCKVFFYGGCGGNANNFETRDECRQTCGGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin. {ECO:0000250}.,Serine Protease
1033,B0VXW0,OXLA_SISCA,1.4.3.2,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2),MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIAKNGLTATSNPKRVVIVGAGMSGLSAAYVLAGAGHQVTVLEASERVGGRVRTYRKEDWYANLGPMRLPTKHRIVREYIKKFGLELNEFFQENDNAWYFIKNIRKRVQEVKNNPGLLKYPVKPSETGKSAGQLYEESLRKVVEELRSTNCKYILDKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFGYEKRFDEIVGGMDQLPTSMYEAIKEKVQVHFNARVIEIQQNDREATVTYQTSANEMSSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDEGIHGGKSTTDLPSRSIYYPNHNFTSGVGVIIAYGIGDDANFFQALDFKDCADIVINDLSLIHQLPKEDIQTFCHPSKIQRWSLDRYAMGGITTFTPYQFQHFSEALTAPFNRIYFAGEYTAQFHGWIDSTIKSGLTAARDVNRASENPSGIHLSNDNEF,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
1034,B2BRQ5,3L21_AUSLA,,Alpha-elapitoxin-Al2b (Alpha-EPTX-Al2b),MKTLLLTLVVVTIVCLDFGGGLICYMGPKTPRTCPPGQNLCYTKTWCDGFCGSRGKVVVLGCAATCPTVKPGVDITCCATDKCNPFPKTKAPWERP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily",FUNCTION: Potent long-chain postsynaptic neurotoxin. Pseudo-irreversibly inhibits the nicotinic acetylcholine receptor through competitive antagonism. {ECO:0000269|Ref.3}.,Neurotoxin
1035,B2KTG1,VKT_BUNFA,,Kunitz-type serine protease inhibitor bungaruskunin,MSSGGLLLLLGLLTLWTELTPVSSLGGPAYCKLPPEPGPCHEYKHAFYYNPDARECEEFIYGGCKGNKNNFKTRHECHRVCVR,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that inhibits trypsin, chymotrypsin and elastase, but does not inhibit thrombin. {ECO:0000269|PubMed:18164783}.",Serine Protease
1036,B3EWG8,PA2A_PORNA,3.1.1.4,Acidic phospholipase A2 PnPLA2 (svPLA2) (EC 3.1.1.4),DLLQFXDMMK,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that has antibacterial activity against S.aureus ATCC 25923 and ATCC 29213, acts by inducing bacterial membrane breakage. Displays a potent inhibitory effect on collagen-induced human platelet aggregation and has indirect hemolytic activity. Does not show cytotoxicity to murine skeletal muscle myoblasts. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:22251437}.",Phospholipase
1040,B3EWR3,3SAW_NAJNA,,Cytotoxin NN-32,LKCNKLVPLF,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Shows cytotoxic activity against Ehrlich ascites carcinoma (EAC) model in mice. Also shows effect on apoptotic features such as nuclear fragmentation, caspase activity, pro- and anti-apoptotic protein levels on treated EAC cells. Increased levels of antioxidant enzymes and cytokine levels observed in toxin-treated EAC mice. Cardiotoxic towards guinea pig auricle. Has no cytotoxicity towards macrophages in vivo in EAC bearing mice or in vitro in normal human lymphocytes. {ECO:0000269|PubMed:21530568}.",General Toxin
1041,B3EWY2,BNPL2_CROOA,,Natriuretic peptide Coa_NP2,SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP,"Natriuretic peptide family, Snake NP subfamily","FUNCTION: Snake venom natriuretic peptide that exhibits hypotensive and vasorelaxant effects. Produces a dose-dependent hypotension in rats, followed by significant increases in concentrations of markers of nitric oxide (NO) formation measured in the plasma and vasorelaxation in a thoracic aortic ring bath. The peptide may exert its hypotensive action, at least in part, through stimulation of NO production. The vasorelaxant effect is endothelium-dependent and does not appear to be mediated by the natriuretic peptide receptor-A, as its action is not modified by isatin (a potent NPR1 antagonist). May act by activating the natriuretic peptide receptor-B (NPR2). {ECO:0000269|PubMed:22617223}.",General Toxin
1042,B3EWY3,BNPL1_CROOA,,Natriuretic peptide Coa_NP1,SKRLSNGCFGLKLDRIGAMSGLGCWRLINESK,"Natriuretic peptide family, Snake NP subfamily",FUNCTION: Snake venom natriuretic peptide that exhibits hypotensive and vasodepressor activity in rats. {ECO:0000269|Ref.1}.,General Toxin
1043,B4ESA2,VKT1L_BUNMU,,Kunitz-type serine protease inhibitor PILP-1 (Protease inhibitor-like protein 1),MSSGSLLLLLGLLTLWAELTPISTKDRPSCDKAPDTERCKRNVYAFYYNPSARDCLQFVYGGCDGNGKHFRSKALCLFHCHR,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin (Ki=55.62 nM). {ECO:0000269|PubMed:18471842}.,Serine Protease
1044,B4ESA3,VKT2L_BUNMU,,Kunitz-type serine protease inhibitor PILP-2 (Protease inhibitor-like protein 2),MSSGGLLLLLGLLTLWMELTPVSSKNRPPFCNLLPEPGRCNAIVRAFYYNSRPRKCLEFPYGGCGGNANNFKTIEECQRTCAG,Venom Kunitz-type family,"FUNCTION: Shows weak binding and inhibition of MMP-2 and shows an activity in inhibiting migration and invasion of neuroblastoma. {ECO:0000269|PubMed:18471842, ECO:0000269|PubMed:19706303}.",Neurotoxin
1045,B4ESA4,VKT3L_BUNMU,,Kunitz-type serine protease inhibitor PILP-3 (Protease inhibitor-like protein 3),MSSGGLLLLLGLLTLWAELTPVSSRKRHQFCNVPPEPGRCNANVRAFYYNPRLRKCIEFSYGGCGGNANNFKSRGECKRTCAE,Venom Kunitz-type family,"FUNCTION: Binds and inhibits MMP-2 and shows an activity in inhibiting migration and invasion of neuroblastoma. Intact C-terminus is crucial to the activities of this protein (PubMed:19706303). {ECO:0000269|PubMed:18471842, ECO:0000269|PubMed:19706303}.",Neurotoxin
1050,B5U6Y3,VSP_ECHOC,3.4.21.-,Serine protease sp-Eoc49 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLVLQLSYAQMSSELVVGGGECNRNRHRSLALLYNSSGTLCGGTLIHEEWVLSAAHCDMENMKIYLGLHNLSLPNKDQQKREPRETHFCLPSRNYTLWDKDIMLIKLNRPVNNSPHIAPISLPSNPPRLRSVCHIMGWGAITSPNETYPDVPHCANINILRYSVCRAAFGRLPAQSRTLCAGILRGGIDTCLGDSGGPLICNGQIQGIVSWGAEVCAKPHAPGLYTKVSDYTDWIQSIIAGNTTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1051,B5U6Y8,OXLA_ECHOC,1.4.3.2,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2),MNIFFMFSLLFLATLGSCADDKNPLEECFREADYEEFLEIAKNGLKKTSNPKDIVVVGAGMSGLSAAYVLAGAGHKVTVLEASQLVGGRVRTHRNAKEGWYANLGPMRIPEKHRIVREYIRKFGLELNEFVQETDNGWYFVKNIRKRVGEVKKDPGLLKYPVKPSEAGKSAGQLYQEALGKAVEELKRTNCSYMLNKYDTYSTKEYLIKEGNLSTGAVDMIGDLMNEDSGYYVSFVESMKHDDIFAYEKRFDEIVGGMDQLPTSMYRAIEKSVLFKARVTKIQQNAEKVRVTYQTAAKTLSDVTADYVIVCTTSRAARRINFKPPLPPKKAHALRSVHYRSATKIFLTCTKKFWEDDGIQGGKSTTDLPSRFIYYPNHNFTSGVGVIIAYGIGDDSNFFLSLTLNECADIVFSDLSSIHQLPKNDIQKFCNPSVIQKWSLDRYAMGAITTFTPYQFQDYSKALTAPAGRVYFAGEYTANAHGWIDSTIKSGLTAARDVNQASEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
1053,C0HJB0,3SX3_DENAN,,Mambalgin-3 (Mamb-3),LKCYQHGKVVTCHRDMKFCYHNIGMPFRNLKLILQGCSSSCSETENNKCCSTDRCNK,"Snake three-finger toxin family, Short-chain subfamily, Mambalgin sub-subfamily","FUNCTION: This three-finger toxin inhibits ASIC channels (Ref.1). It acts as a gating modifier toxin by decreasing the apparent proton sensitivity of activation and by slightly increasing the apparent proton sensitivity for inactivation. It binds more tightly to the closed state and to a much lesser extent the inactivated/desensitized state of ASIC1a (By similarity). It interacts directly with the outside surface of the thumb domain of chicken ASIC1a (ASIC1a), but does not insert into the acidic pocket as suggested previously (By similarity). This binding leads to relocation of the thumb domain that could disrupt the acidic pocket of cASIC1a (By similarity). The peptide exerts both stimulatory and inhibitory effects on ASIC1a (By similarity). It reversibly inhibits rASIC1a (IC(50)=17 nM), rASIC1b (IC(50)= 44 nM) and rASIC1a-rASIC2a (IC(50)=252 nM) channels (Ref.1). In vivo, it shows a potent naloxone-resistant analgesic effect against acute and inflammatory pain upon central and peripheral injection. In addition, it also has an opioid-independent effect on both thermal and mechanical inflammatory pain after systemic administration and is effective against neuropathic pain (By similarity). {ECO:0000250|UniProtKB:P0DKR6, ECO:0000250|UniProtKB:P0DKS3, ECO:0000269|Ref.1}.",Kunitz Family
1054,C0HJI9,3S11B_BUNFA,,Alpha-elapitoxin-Bf1b (Alpha-EPTX-Bf1b),RICLNQQSSEPQTTEICPDGEDTCY,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000269|PubMed:24440452}.",Neurotoxin
1060,C0HJR6,VSP2_CRODO,3.4.21.-,Thrombin-like enzyme collinein-2 (SVTLE collinein-2) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),TALPQLRLPATSRILCAGVLEGGIDTCNR,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease. {ECO:0000250|UniProtKB:A0A0S4FKT4}.,Serine Protease
1061,C0HJT4,3NOJ_DENAN,,Toxin Tx7335,LECHRRGSFISDGKITCSAKKTFCCKMYEKIFGIYWYGCAKTYTEKNTWNVYSKCCTTNLCNT,"Snake three-finger toxin family, Ancestral subfamily, Orphan group XIX sub-subfamily","FUNCTION: Activates bacterial pH-gated potassium channel KcsA by binding to its extracellular domain, probably at a site different from channel inhibitors. Increases both mean open time and open probability of KscA. {ECO:0000269|PubMed:27044983}.",Kunitz Family
1062,C0HJT5,3SO1_HEMHA,,Ringhalexin,RLCLSDYSIFSETIEICPEGHNYCFKKFPKGITRLPWVIRGCAATCPKPEAQVYVDCCARDKCNR,"Snake three-finger toxin family, Short-chain subfamily, Orphan group I sub-subfamily","FUNCTION: Has anticoagulant activity, since it is able to inhibit the activation of coagulation factor X (F10) by coagulation factor VIIa (F7) (IC(50)=123.8 nM) (PubMed:27173146). Also shows weak irreversible neurotoxicity (PubMed:27173146). {ECO:0000269|PubMed:27173146}.",Neurotoxin
1063,C0HJW8,PA2HA_BOTNI,,Phospholipase A2 homolog nigroviriditoxin acidic subunit A,SPENCQGESQPCGCYCDAEGQGWPQDAEENGDIVCGEXTPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Heterodimer A-B: Nigroviriditoxin possesses phospholipase A2 (PLA2) activity. It consists of a non-covalent association of a basic PLA2 subunit B with a non-enzymatic subunit A. {ECO:0000269|PubMed:25434534}.; FUNCTION: Subunit A: The acidic subunit of nigroviriditoxin probably is a heterotrimer of three disulfide-linked chains generated by post-translational maturation of a PLA2-like precursor (PubMed:20590130). It appears to have no PLA2 activity of its own, instead inhibiting the catalytic activity of subunit B (PubMed:25434534). It is not toxic to mice by itself but increases toxicity of subunit B (PubMed:25434534). {ECO:0000269|PubMed:20590130, ECO:0000269|PubMed:25434534}.",Phospholipase
1066,C0HK50,VM2_CROTA,,Disintegrin tzabcanin,GEECDCGSPANPCCDAATCKLRPGAQCADGLCCDQCRFIKKGTICRRARGDNPDDRCTGQSADCPRNHFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen (By similarity). Inhibits cell adhesion to vitronectin, probably by blocking its receptor integrin alpha-V/beta-3 (ITGAV/ITGB3), and to fibronectin in vitro (PubMed:26163300, PubMed:27060015). Shows little to no cytotoxicity in vitro (PubMed:26163300, PubMed:27060015). {ECO:0000250|UniProtKB:P18618, ECO:0000269|PubMed:26163300, ECO:0000269|PubMed:27060015}.",Fibrinogenolytic Enzyme
1069,C0HKZ8,3NOJ_WALAE,,Actiflagelin,MECYKCGVSGCHLKITCSAEEKFCYKWRDKISNERWLGCAKTCTEENTWRVYNSCCTTNLCNP,"Snake three-finger toxin family, Ancestral subfamily, Orphan group XIX sub-subfamily","FUNCTION: Unknown. In vitro, this toxin activates sperm motility when tested on OF1 male mice. {ECO:0000269|PubMed:29410678}.",General Toxin
1070,C0HL51,KTIL_BOTSC,,Kazal-type inhibitor-like protein (KTIL),MKVNCKGYPTKFCFGKPLPHCASDGKTYPNRCRFCNAFVKSHGLITLRYYGKCK,,FUNCTION: Partially inhibits trypsin in vitro at slightly acidic pH and concentrations in excess of 0.3 mM. Has no protease inhibitory activity at neutral or basic pH. Has no antibacterial activity. Shows no toxicity in vertebrates apart from transient paw edema in mouse. {ECO:0000269|PubMed:26973135}.,Kunitz Family
1071,C0HLA5,MAMB2_DENVI,,Mambaquaretin-2 (MQ2) (Upsilon-Dv2a),RPSFCNLPVKPGPCNGFFSAFYYSQKTNKCHSFTYGGCRGNANRFSTIEECRRTCVG,Venom Kunitz-type family,"FUNCTION: Interacts with vasopressin V2 receptor (V2R/AVPR2), probably in a selective manner. Inhibits vasopressin binding human V2R in the nanomolar range (Ki=8.16 nM), and also moderately inhibits vasopressin-induced cAMP production (IC(50)=224 nM). In vivo, intraperitoneal injection of this protein into rats increases diuresis by 5.5-fold, without any loss of electrolytes. {ECO:0000269|PubMed:35122240}.",Vascular Interaction
1072,C0HLA6,MAMB3_DENPO,,Mambaquaretin-3 (MQ3) (Upsilon-Dp2a),RPSFCNLPVKPGPCNGFFSAFYYSQKKNKCHSFTYGGCKGNANRFSTIEECRRTCVG,Venom Kunitz-type family,"FUNCTION: Interacts with vasopressin V2 receptor (V2R/AVPR2), probably in a selective manner (PubMed:35122240). Inhibits vasopressin binding human V2R in the nanomolar range (Ki=13.3 nM), and also moderately inhibits vasopressin-induced cAMP production (IC(50)=453 nM). In vivo, intraperitoneal injection of this protein into rats increases diuresis by 4.5-fold, without any loss of electrolytes (PubMed:35122240). {ECO:0000269|PubMed:35122240}.",Vascular Interaction
1073,C0HLA7,MAMB4_DENVI,,Mambaquaretin-4 (MQ4) (Upsilon-Dv2c),RPSFCNLPVKPGPCSGFFSAFYYSQKTNKCHSFTYGGCRGNGNRFRTIEECRRTCVG,Venom Kunitz-type family,"FUNCTION: Interacts with vasopressin V2 receptor (V2R/AVPR2), probably in a selective manner. Inhibits vasopressin binding human V2R in the nanomolar range (Ki=7.34 nM), and also potently inhibits vasopressin-induced cAMP production (IC(50)=26 nM). In vivo, intraperitoneal injection of this protein into rats increases diuresis by 8.6-fold, without any loss of electrolytes. {ECO:0000269|PubMed:35122240}.",Vascular Interaction
1074,C0HLA8,MAMB5_DENJA,,Mambaquaretin-5 (MQ5) (Upsilon-Dj2a),RPSFCNLPVKPGPCSGFFSAFYYSQKTNKCHSFTYSGCRGNGNRFRTIEECRRTCVG,Venom Kunitz-type family,"FUNCTION: Interacts with vasopressin V2 receptor (V2R/AVPR2), probably in a selective manner (PubMed:35122240). Inhibits vasopressin binding human V2R in the nanomolar range (Ki=3.50 nM), and also potently inhibits vasopressin-induced cAMP production (IC(50)=21 nM). In vivo, intraperitoneal injection of this protein into rats increases diuresis by 6-fold, without any loss of electrolytes (PubMed:35122240). {ECO:0000269|PubMed:35122240}.",Vascular Interaction
1075,C0HLA9,MAMB6_DENVI,,Mambaquaretin-6 (MQ6) (Upsilon-Dv2d),RPSFCNLPVKPGPCSGFFSAFYYSQKTNKCHSFTYGGCRGPGNRFRTIEECRRTCVG,Venom Kunitz-type family,"FUNCTION: Interacts with vasopressin V2 receptor (V2R/AVPR2), probably in a selective manner (PubMed:35122240). Inhibits vasopressin binding human V2R in the nanomolar range (Ki=21.5 nM), and also moderately inhibits vasopressin-induced cAMP production (IC(50)=574 nM). In vivo, intraperitoneal injection of this protein into rats increases diuresis by 2-fold, without any loss of electrolytes (PubMed:35122240). {ECO:0000269|PubMed:35122240}.",Vascular Interaction
1076,C0HLB0,MAMB9_DENVI,,Mambaquaretin-9 (MQ9) (Upsilon-Dv2b),RPYACELTVAAGPCLRFSAFYYSKGANQCYPFNYSGCGGNANRFSTNQKCRRTCVV,Venom Kunitz-type family,"FUNCTION: Interacts with vasopressin V2 receptor (V2R/AVPR2), probably in a selective manner (PubMed:35122240). Inhibits vasopressin binding human V2R in the nanomolar range (Ki=45.1 nM), and also potently inhibits vasopressin-induced cAMP production (IC(50)=111 nM) (PubMed:35122240). In vivo, intraperitoneal injection of this protein into rats increases diuresis, without any loss of electrolytes (By similarity). {ECO:0000250|UniProtKB:A0A1Z0YU59, ECO:0000269|PubMed:35122240}.",Vascular Interaction
1078,C0HLK3,3S11_MICTC,,Three-finger toxin Tschuditoxin-I,MICYNQQSSEPPTTKTCSEGQCYKKTWSDHRGTIIERGCACPNVKPGVKISCCSSDK,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site (By similarity). Binds to and inhibits the endogenous nicotinic acetylcholine receptors (nAChR) (By similarity). This neurotoxin is lethal to mice by intraperitoneal or intravenous injection (PubMed:31211957). {ECO:0000250|UniProtKB:P86095, ECO:0000269|PubMed:31211957}.",Neurotoxin
1080,C0HM08,3S12_NAJNA,,Alpha-elapitoxin-Nn2a (Short neurotoxin 2) (Short-chain alpha-neurotoxin Nn2a),LECHNQQSSQTPTTTDCSGGETNCYKKWWSDHRGTIIERGCGCPTVKKGIELNCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Nicotinic acetylcholine receptor antagonist (PubMed:35418867). Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission (PubMed:35418867). Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site (PubMed:35418867). Induces concentration-dependent inhibition of indirect twitches and abolishes contractile responses of tissues to exogenous acetylcholine and carbachol, in the chick biventer cervicis nerve-muscle preparation at 100-300 nM (in vitro) (PubMed:35418867). Prior incubation of tissues with Indian polyvalent antivenom (1 ml/0.6 mg) prevents the neurotoxic effects at 100 nM (in vitro) (PubMed:35418867). Addition of Indian polyvalent antivenom (1 ml/0.6 mg) at the t90 time point does not reverse the neurotoxic effects (in vitro) (PubMed:35418867). Displays non-competitive antagonism of concentration-response curves to carbachol, with a pA2 of 8.01 (in vitro) (PubMed:35418867). {ECO:0000269|PubMed:35418867}.",Neurotoxin
1081,C0HM09,3L27_NAJNA,,Alpha-elapitoxin-Nn3a (Long neurotoxin 7) (Long-chain alpha-neurotoxin Nn3a),IRCFITPDITSKDCPNGHVCYTKTWCDGFCSIRGERVDLDGCAATCPTVTGVDIQCCSTDNCNPFPTRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Nicotinic acetylcholine receptor antagonist (PubMed:35418867). Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission (PubMed:35418867). Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site (PubMed:35418867). Induces concentration-dependent inhibition of indirect twitches and abolishes contractile responses of tissues to exogenous acetylcholine and carbachol, in the chick biventer cervicis nerve-muscle preparation at 100-300 nM (in vitro) (PubMed:35418867). Prior incubation of tissues with Indian polyvalent antivenom (1 ml/0.6 mg) prevents the neurotoxic effects at 100 nM (in vitro) (PubMed:35418867). Addition of Indian polyvalent antivenom (1 ml/0.6 mg) at the t90 time point partially restores the neurotoxic effects (in vitro) (PubMed:35418867). Displays a reversible antagonism of concentration-response curves to carbachol, with a pA2 of 8.17 (in vitro) (PubMed:35418867). {ECO:0000269|PubMed:35418867}.",Neurotoxin
1082,C1IC48,3S14_WALAE,,Three-finger toxin W-IV,MKTLLLTLVVVTIVCLDLGHTLLCHNQQSSTSPTTTCCSGGESKCYKKRWPTHRGTITERGCGCPTVKKGIELHCCTTDQCNL,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000269|PubMed:960110}.",Neurotoxin
1083,C1IC50,VKT1_WALAE,,Protease inhibitor 1 (Kunitz inhibitor KIn-I),MSSGGLLLLLGLLTLWAELTPVSGRPGLCELPAETGPCKARIRAFYYNPHSHKCLEFTYGGCKGNANNFKTIDECNRTCVG,Venom Kunitz-type family,FUNCTION: Snake venom serine protease inhibitor. {ECO:0000250}.,Serine Protease
1084,C1IC52,VKT2_WALAE,,Kunitz-type serine protease inhibitor spermatin (Kunitz inhibitor KIn-II) (Protease inhibitor 2),MSSGCLLLLLGLLTLWAELTPVSGRPRLCELPAESGLCNAYIPSFYYNPHSHKCQKFMYGGCGGNANNFKTIDECHRTCVG,Venom Kunitz-type family,FUNCTION: Snake venom serine protease inhibitor. {ECO:0000250}.,Serine Protease
1085,C1IC53,VKT4_WALAE,,Protease inhibitor 4 (Kunitz inhibitor IV),MSSGCLLLLLGLLTLWAELTPISGLGGPKYCHLPADPGPCSNYRPAYYYNPASRKCEEFMYGGCKGNKNNFKTRHECHRVCVR,Venom Kunitz-type family,FUNCTION: Snake venom serine protease inhibitor. {ECO:0000250}.,Serine Protease
1086,C5H5D3,VM32_BOTAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like batroxstatin-2 (EC 3.4.24.-) (Snake venom metalloprotease) (SVMP) (Vascular apoptosis-inducing protein-like) (VAP-like),EQQRYLNAKKYVKLVLVADYIMYLKYGRSLTTLRTRMYDIVNIINLIFQRMNIHVALVGLEIWSNRDKIIVQSSADVTLDLFAKWRETDLLKRKSHDNAQLLTGINFNGPTAGLAYLSGICKPMYSAGIVQDHNKVHHLVAIAMAHEMGHNLGMDHDKDTCTCGARSCVMAGTLSCEPSYLFSDCSRRGHRAFLIKDMPQCILEKPLRTDVVSPPVCGNYFVEVGEECDCGSPATCRDTCCDAATCKLRQGAQCAEGLCCDQCRFKGAGTECRAAKDECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNGTCPIMRDQCIALFGPNAAVSQDACFQFNLQGNHYGYCRKEQNTKIACEPQDVKCGRLYCFPSSPATKNPCNIHYSPNDEDKGMVLPGTKCADGKACSNGRCVDVT,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that induces apoptosis in vascular endothelial cells (VEC), without degrading the extracellular matrix (it cannot cleave collagen) or inhibiting adhesion of VEC. Has also fibrinogenolytic and hemorrhagic activities (By similarity). {ECO:0000250}.",Metalloprotease
1087,C5H5D5,VM31_LACMR,3.4.24.-,Zinc metalloproteinase-disintegrin-like lachestatin-1 (EC 3.4.24.-) (Snake venom metalloprotease) (SVMP) (Vascular apoptosis-inducing protein-like) (VAP-like),EQQRYLNAKKYVKLVLVADYIMYLKYGRSLTTLRTRMYDIVNIINLIFQRMNIHVALVGLEIWSNRDKIIVQSSADVTLDLFAKWRETDLLKRKSHDNAQLLTGINFNGPTAGLAYLSGICKPMYSAGIVQDHNKVHHLVAIAMAHEMGHNLGMDHDKDTCTCGARSCVMAGTLSCEPSYLFSDCSRREHRAFLIKDMPQCILEKPLRTDVVSPPVCGNYFVEVGEECDCGFSATCRDTCCDAATCKLRQGAQCAEGLCCDQCRFKGAGTECRAAKDECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNGTCPIMRDQCIALFGPNAAVSQDACFQFNLQGNHYGYCRKEQNTKIACEPQDVKCGRLYCFPSSPATKNPCNIHYSPNDEDKGMVLPGTKCADGKACSNGRCVDVNTPY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that induces apoptosis in vascular endothelial cells (VEC), without degrading the extracellular matrix (it cannot cleave collagen) or inhibiting adhesion of VEC. Has also fibrinogenolytic and hemorrhagic activities (By similarity). {ECO:0000250}.",Metalloprotease
1088,C5H5D6,VM32_LACMR,3.4.24.-,Zinc metalloproteinase-disintegrin-like lachestatin-2 (EC 3.4.24.-) (Snake venom metalloprotease) (SVMP) (Vascular apoptosis-inducing protein-like) (VAP-like),EQQKYLNAKKYVKLVLVADYIMYLKYGRSLTTLRTRMYDIVNIINLIFQRMNIHVALVGLEIWSNRDKIIVQSSADVTLDLFAKWRETDLLKRKSHDNAQLLTGINFNGPTAGLAYLSGICKPMYSAGIVQDHNKVHHLVAIAMAHEMGHNLGMDHDKDTCTCGARSCVMAGTLSCEPSYLFSDCSRREHRAFLIKDMPQCILEKPLRTDVVSPPVCGNYFVEVGEECDCGSPATCRDTCCDAATCKLRQGAQCAEGLCCDQCRFKGAGTECRAAKDECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNGTCPIMRDQCIALFGPNAAVSQDACFQFNLQGNHYGYCRKEQNTKIACEPQDVKCGRLYCFPSSPATKNPCNIHYSPNDEDKGMVLPGTKCADGKACSNGRCVDVTTPY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that induces apoptosis in vascular endothelial cells (VEC), without degrading the extracellular matrix (it cannot cleave collagen) or inhibiting adhesion of VEC. Has also fibrinogenolytic and hemorrhagic activities (By similarity). {ECO:0000250}.",Metalloprotease
1089,C6JUN9,LEC1_MICCO,,C-type lectin (CTL),MGHFTFISLCLMPIFLSLSGAECYTCPIDWLSRNGLCYKLFDDTKTWPDAEIFCRKHKPGCHLTSIHSEAESADLAEYIYDYLKSEKNVWIGLNDPQKERIWEWTDRSSTNYTSWNEGEPNNSWNKEYCVHLLASQGYLKWNDTPCESLFAFICRCQF,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1090,C6JUP3,3SX3_MICCO,,Three-finger toxin MicTx3 (MCOR0100C) (Three-finger toxin 3FTx-3),MKTLLLTLVVVTIMCLDLGYTLVCYTNVLEPPGTLETCPDDFTCVKKWEGGGRRVTQYCSHACAIPASYEFVHCCQTDKCNG,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: Has been described to inhibit nicotinic acetylcholine receptor (nAChR) alpha-7/CHRNA7 subunits and to bind acetylcholine binding protein (AChBP) (Kd=29.5 nM) (PubMed:21214917). {ECO:0000269|PubMed:21214917}.,Binding Protein
1091,C9E1S2,DIDA_AGKPL,,Disintegrin subunit alpha,MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKITPLPKGAVQPKNPCCDAATCKLTPGAQCAEGLCCDQCKFIKAGKICRRARGDNPDYRCTGQSGDCPRKHFYA,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits both ADP-induced platelet aggregation and platelet aggregate dissociation in human platelet-rich plasma. {ECO:0000250}.,Binding Protein
1092,D1MZV3,VNP_RHATT,,C-type natriuretic peptide (CNP),MFASRLAALGLLLLALVLDGKPAPPPQPLRKAPAGGTTALQRQLTEQQQQQQQAEGSSGPAAGGGGGRSGSKTANAAPTAPKSKGAAASAASRLLRDLRPDGKQSRAAWGRMVHPEHHAGGGGGGGGGGSRRLKGLPKKGLGSGCFGLKLDRIGSMSGLGC,Natriuretic peptide family,FUNCTION: Snake venom natriuretic peptide that has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.,General Toxin
1093,D2YVI2,LECG_PSEAU,,C-type lectin galactose-binding isoform (CTL) (Venom C-type lectin galactose binding isoform),MGRFLLVTLSLLVMAFFLNGANSCCCPQDWLPRNGFCYKVFNDLKTWDDAEMYCRKFKPGCHLASLHSNADAVEFSEYITDYLTGQGHVWIGLRDTKKKYIWEWTDRSRTDFLPWRKDQPDHFNNEEFCVEIVNFTGYLQWNDDSCTALRPFLCQCKY,True venom lectin family,FUNCTION: Galactose-binding lectin that binds to and agglutinates erythrocytes in a calcium-dependent manner. {ECO:0000250}.,Binding Protein
1094,D2YVJ6,LECG_PSEPO,,C-type lectin galactose-binding isoform (CTL) (Venom C-type lectin galactose binding isoform),MGRFLLVTLSLLVVAFSLNGANSCCCPQDWLPRNGFCYKVFNHLKNWNDAEMYCRKFKPGCHLASLHSNADAVEFSEYITDYLTGQGHVWIGLRDTKKKYIWEWTDRSRTDFLPWRKDQPDHFNNEEFCVETVNFTGYLQWNDDSCTALRPFLCQCKY,True venom lectin family,FUNCTION: Galactose-binding lectin that binds to and agglutinates erythrocytes in a calcium-dependent manner. {ECO:0000250}.,Binding Protein
1095,D2YVJ8,LECM_TROCA,,C-type lectin mannose-binding isoform (CTL) (Venom C-type lectin mannose binding isoform 1),MGRFLLVTLSLLVGAFSLNEANSCCCPQDWLPKNGFCYKVFNDHKNWNDAEMFCRKFKPGCHLASIHSNADSADLAEYASDYLKSDGNVWIGLNDPRKQRTWVWSDRSSTNYLAWNQGEPNNSKNIEYCVHLWALTGYLKWNDTPCKALYSFICQCRF,True venom lectin family,FUNCTION: Mannose-binding lectin that binds to and agglutinates erythrocytes in a calcium-dependent manner. {ECO:0000250}.,Binding Protein
1096,D2YVK1,LECG_HOPST,,C-type lectin galactose-binding isoform (CTL) (Venom C-type lectin galactose binding isoform),MGRFLLVTLSLLVVAFSLNGANNCCCPQDWLPKNGYCYKVFKDHKSWDDAEMFCRKLKPGCHLASLHSNADAFDFSEYITDYLTGHDHVWIGLRDTEKNYIWEWTDRSRTDFLPWKKDQPDHHNNDEFCVEIVSFTGYLQWNDDSCTALRPFLCQCKH,True venom lectin family,FUNCTION: Galactose-binding lectin that binds to and agglutinates erythrocytes in a calcium-dependent manner. {ECO:0000250}.,Binding Protein
1097,D2YVK5,LECM_NOTSC,,C-type lectin mannose-binding isoform (CTL) (Venom C-type lectin mannose binding isoform 1),MGRFLLVTLSMLVVTFSLNEANSCCCPQDWLPKNGFCYKVFNDLKNWNDAEMFCRKFKPGCHLASIHSNADSADLAEYISDYLKSDGHVWIGLNDPRKQRTWVWSDRSSTNYLAWNQGEPNNSKNIEYCVHLWALTGYLKWNDTPCEALYHFICQCKF,True venom lectin family,FUNCTION: Mannose-binding lectin that binds to and agglutinates erythrocytes in a calcium-dependent manner. {ECO:0000250}.,Binding Protein
1099,D5LMJ3,VM3A_NAJAT,3.4.24.-,Zinc metalloproteinase-disintegrin-like atrase-A (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),MIQALLVIICLAVFPHQGSSIILESGNVNDYEVVYPQKVPALLKGGVQNPQPETKYEDTMRYEFQVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAVISACNGLKGHFKHQGETYFIEPLELSESEAHAIYKDENVEKEDETPKICAVTQTTWESDESIEKTSQLTNTPEQDRYLQVKKYIEFYLVVDNKMYKNHTSNQELRTRVYEMVNYLNTKYRRLNFHIALIGLEIWSNQDKVDMDPGANVTLKSFAEWRAKLPPHKRNDNAQLLTGIDFNGTTVGLAYTGTLCTWGSVAVVQDYSRRTILMASTMAHELGHNMGIHHDKANCRCSHSPCIMSDTISDEPFYEFSSCSVREHQEYLLRERPQCILNKPSRKAIVSRPVCGNNFVEVGEQCDCGSLQDCQSTCCNATTCKLQPHAQCDSEECCEKCKFKGAETECRAAKDDCDLPEFCTGQSAECPTDSLQRNGHPCQNNQGYCYNGKCPTMENQCITLLGPNYTVGPAGCFKNNRKGDDVSHCRKENGAKIPCAAKDEKCGTLYCTEIKKTGCIVPVSPRDPDSRMVEPGTKCEDKKVCSKSQCVKV,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase that inhibits platelet aggregation by cleaving platelet glycoprotein Ib alpha (GP1BA) at Glu-298/Asp-299, and abolishes binding of von Willebrand factor (VWF) to GPIBA. {ECO:0000250}.",Metalloprotease
1100,D8MIA0,VSPH2_BITRH,,Snake venom serine protease homolog rhinocerase 2 (BG-RHIN2) (Venom serine proteinase-like protein 2),VLIRVLANLLLLQLSYAQESSELVIGGDECDINEHPFLVALHTARSKRFHCAGTLLNKEWVLTAARCDRKNIRIKFGVHNKNVQNEDEEMRVPKEKHFCVSSKTYTRWDKDIMLIRLKRPVNDGTHIAPLSLPSNPPSVGSVCRIMGWGSITTTKVTYPDVPHCANIKLFDYSVCRDAYKGLPEKSRTLCAGILEGGIDSCKVDNGGPLICNGQFQGIGSWEGHPCAQPLKPALYTNVFEYTDWIEGIIARNTTVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1101,D8MIA1,VSPH3_BITRH,,Snake venom serine protease homolog rhinocerase 3 (BG-RHIN3) (Venom serine proteinase-like protein 3),VLIRVLANLLLLQLSYAQESSELVIGGDECDINEHPFLVALHTARSKRFHCAGTLLNKEWVLTAARCDMENMQIYLGLHNISRPNQDQKRRVPKEKHFCVSSKTYTRWDKDIMLIRLKRPVNDGTHIAPLSLPSNPPSVGSVCRIMGWGSITTTKVTYPDVPHCANIKLFDYSVCRDAYKGLPEKSRTLCAGILEGGIDSCKVDNGGPLICNGQFQGIGSWEGHPCAQPLKPALYTNVFEYTDWIEGIIARNTTVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1102,D8MIA2,VSPR4_BITRH,3.4.21.-,Snake venom serine protease rhinocerase 4 (BG-RHIN4) (SVSP) (EC 3.4.21.-),VLIRVLANLLVLQLSYAQKSSELVIGGAECNINEHRSLALVYNSSGLLCCGILINQEWVLSAAHCDMENMQIYLGLHNISRPNQDQKRRVPKQKFFCLSNKTYTRWDKDIMLIKLNSPVPYSTHIAPLSLPSSPPIVGSVCRIMGWGATKSPNENVPHVPHCANINILHYSVCRATYGRLPAKSRTLCAGIPRRRIGSCLGDSGGPLICNGQVEGIVSWASKPCVHNGAPGMYTKVYDYTDWIRSIIGGNTSATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1103,D8MIA3,VSPR5_BITRH,3.4.21.-,Snake venom serine protease rhinocerase 5 (BG-RHIN5) (SVSP) (EC 3.4.21.-),VLIRVLANLLLLQLSYAQESSELVIGGDECDINEHPFLVALHTARSKRFHCAGTLLNKEWVLTAAHCDMENMQIYLGLHNISRPNQDQKRRVPKQKFFCLSNKTYTRWDKDIMLIKLNSPVPYSTHIAPLSLPSSPPIVGSVCRIMGWGATKSPNENVPHVPHCANINILHYSVCRATYGRLPAKSRTLCAGIPRRRIGSCLGDSGGPLICNGQVEGIVSWASKPCVHNGAPGMYTKVYDYTDWIRSIIGGNTSATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1104,D8VNS6,LECM_CERRY,,C-type lectin (CTL),MWQFTVVSLGWLAVFLSLSGAKGNSCPASWISRNGVCNKLFPDRKTWLEAEMYCRALKPGGHLASLHKDSDSTVLAWYISDHFKGAGHVWIGLRDTNKKRSWKWSDRTSTNYFSWNQGEPNNVQDNENCVHLWAPSGYLKWNDEPCASLHPFICQYKL,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1109,E0Y418,VSP1_MACLB,3.4.21.-,Serine protease VLSP-1 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLVLHLSYAQKSSELVIGGDECNINEHPFLALMYNSTSMKFHCSGTLLNEEWVLTAAHCDMENMQIYLGVHDKKNPNKDQQTRVPKEMFFCLSNKSYTPWDKDIMLIRLNSPVTYSTHIAPFSLPSSPPTVGSVCRIMGWGAITSPNETYPDVPHCANIEIYDYSVCRKAYGGLPEKSRTLCAGVLQGGIDTCLADSGGPLICNGQFQGIVAWGRHPCAQPQLPAFYTKVFDYSDWIQSIIAGNTAATCPS,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1110,E0Y420,VSP3_MACLB,3.4.21.-,Serine protease VLSP-3 (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLVLQLSYAQKSSELVIGGDECNINEHRSLVYLYNDSNFQCGGTLINQEWVLSAAHCDMENMEIYLGVHNLSLPNKDQKRRDPKEKFFCLSSKNYTKWDKDIMLIKLNRPVKTSTHIAPLSLPSSPPSVGSVCRIMGWGTVTSPNETLLDVPHCANINILNYTVCRAASPRLPTQSRTLCAGILQGGIDACKGDSGGPLICNGQIQGIVSWGNHPCAQPLKPGHYTHVFDYTDWIQSIIAGNTTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1113,E3P6N3,CYT_AUSSU,,AsCystatin (AsCys) (Cystatin),MVHSQLPVAAPLRLLCALLLLPLATMIPGGLSPRSVTDPDVQEAAEFAVQEYNALSANAYYYKQLRIVEAQSQVVTGAKYYLTMELMKTKCAKTTGKPKVYKEIQNCELPPKAQQEKLTCRFQVWSCPWLQKIELTKMSCN,Cystatin family,"FUNCTION: Recombinant AsCystatin inhibits various C1 cysteine proteases including cathepsin L (Ki is 0.89 pM), papain (Ki is 1.74 pM) and cathepsin B (Ki is 0.69 nM). This activity has also been observed in the crude venom. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein. {ECO:0000269|PubMed:21172403}.",General Toxin
1114,E5AJX2,VSP_VIPNI,3.4.21.-,Snake venom serine protease nikobin (SVSP) (EC 3.4.21.-),MVLIRVLANLLLLQLSYAQKSSELVIGGDECNINEHPFLAFVTSDRRRCAGTLINQEWVLTAAHCNGKYMKIELGVHDKMVRNEDKQTRVPKQKFFCLSSKEYTMWDKDIMLIRLNTPVNNSTHIAPVSLASRPPVVGSVCRIMGWGTISSPKVILPDVPHCANIEIIKYSKCQGVHPELPAKGRVVCAGIWQGGKDSCHGDSGAPLICNGQLQGLLSWGGDPCAQPLQPGLYTDIFDYSDWIQSIIAGNTTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1115,E5L0E3,VSPAF_DABSI,3.4.21.-,Alpha-fibrinogenase-like (RVAF) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLVLQLSYAQKSSELVVGGHPCNIYEHHFLAFMYNSSGFMCSGTLINQQWVLSAAHCDMENMHIYLGLHSFKLPNKDQKKRVAKEKFFCLSSKSYTKWDKDIMLIKLNKPVTYSTHIASLSLPSNPPRVGSVCRIMGWGSITSPKKILPFVPHCANINIVPYTVCRVIYRPLPEQSRTLCAGVSGRRIGSCLGDSGGPLICNGQIQGIVSWGSDPCVNRGAPSIYTKVFDYTDWIHSIIAGNTAATCPS,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Degrades alpha chain of fibrinogen (FGA), and has strong caseinolytic activity. Cleaves oxidized insulin B-chain at '40-Tyr-|-Leu-41', '48-Phe-|-Phe-49' and '49-Phe-|-Tyr-50', and glucagon at the bonds '62-Tyr-|-Ser-63', 66-Leu-|-Asp-67' and '78-Leu-|-Met-79' bonds. {ECO:0000250|UniProtKB:Q8JH85}.",Fibrinogenolytic Enzyme
1116,E5L0E4,VSPB_DABSI,3.4.21.-,Beta-fibrinogenase-like (RVBF) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIKVLANLLVLQLSYAQKSSELVVGGDECNINEHRSLVFLYNNSFGCSGTLINQQWVLSAVHCDMENVRIYLGVHNLTLRNNAEIRLPEERFFCLSNKNYTKWDKDIMLIKLDRPVKTSTYIAPLSLPSSPPRVGSVCRIMGWGAITSPNETFPGVTHCANINILPYSVCRAAYKGLPAQSRTLCGGILEGGIGSCMGDSGGPLICNGEMHGIVAWGDDTCAQPHKPVHYTKVYDYTDWIQSIIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that has fibrinogenolytic activities by hydrolyzing the beta chain of fibrinogen (FGB). Typical arginine esterase which hydrolyzes esters and amides of arginine. {ECO:0000250|UniProtKB:E0Y419}.,Serine Protease
1117,E5L0E5,VSPPA_AGKPL,3.4.21.-,Venom plasminogen activator (APL-PA) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVVFFNSSGFLCGGTSINQEWVLTAAHCDSKNFQMLFGVHSKKILNEDEQTRDPKEKFICPNRKKDDERDKDIMLIRLDSPVSNSEHIAPLSLPSSPPSVGSVCRIMGWGTISPTKVTYPDVPHCANINILDHAVCRAAYPTLLAESSTVCAGTQQEGKDTCGGDSGGPLICNGQIQGIVSWRAHPCGQGLKPGVYTKVFDYTDWIQSIISGNTDVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that activates plasminogen. Shows a preferential cleavage at Arg-|-Xaa instead of Lys-|-Xaa bonds. {ECO:0000250|UniProtKB:Q9YGJ8}.,Serine Protease
1118,E5L0E6,VSPCA_AGKPL,3.4.21.-,Protein C activator (APL-C) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),MVLIRVLANLLILHLSYAQKSSELVIGGDECNINEHRFLALVYANGSLCGGTLINQEWVLTARHCDRGNMRIYLGMHNLKVLNKDALRRFPKEKYFCLNIRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLPSNPPSVGSVCRVMGWGTITSPNATLPDVPHCANINILDYAVCQAAYRGLAATTLCSGILEGGKDTCKGDSGGPLICNGQFQGILSVGGNPCAQPRKPGVYTKVFDYTDWIQSIISGNTDAACPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that selectively cleaves the heavy chain of protein C (PROC). This activation is thrombomodulin-independent. {ECO:0000250|UniProtKB:P09872}.,Serine Protease
1120,E7FL12,VKT2_PSERS,,Kunitz serine protease inhibitor Pr-mulgin 2,MSSGGLLLLLGLLTLWEGLTPVSSKDRPHFCHLPHDPGPCKGNFQAFYYHPVRRTCLEFIYGGCQGNPNNFKTIDECKRTCAA,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that acts against trypsin (EC(50)=10 nM, Ki=5nM), chymotrypsin (EC(50)=100 nM, Ki=40 nM), and plasmin (EC(50)=100 nM, Ki=40 nM). {ECO:0000269|PubMed:22024014}.",Serine Protease
1121,E7FL13,VKT3_PSERS,,Kunitz serine protease inhibitor Pr-mulgin 3,MSSGGLFLLLGLLTLWEVLTPVSSKDRPKFCELPADSGSCKGNFQAFYYHPVHRTCLEFIYGGCEGNDNNFKTIDECKRTCAT,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that acts against trypsin (EC(50)=10 nM, Ki=5nM), and plasmin (EC(50)=200 nM, Ki=100 nM). {ECO:0000269|PubMed:22024014}.",Serine Protease
1122,E9NW28,VM2P3_PROMU,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase PMMP-3 (SVMP) (EC 3.4.24.-)],MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVSALPKGAVQPKYEDTMQYELKENGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGQTYLIEPLKLPDSEAHAVFKYENIEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYVKLAIVVDYRMYIKYNRDSNKITVRVHEMVNHVNEMYKPLNVAITLSLLRIWSTRDLITVQSDSKVTLGSFGDWRKTVLLKQQSHDCAHLLTDITFTKNVIGVAYKKGMCDPKLSVGLVQDYSSNVFVVAAIMTHELGHNLGMEHDEDENGKKCKCDTCIMSPAISDPPAQLFSDCSKNDYHTFLTNSKPQCILNAPLRTDTVSTPVSGNEPL,"Venom metalloproteinase (M12B) family, P-II subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1124,F5CPD5,3S151_MICAT,,Three-finger toxin MALT0051C (MALT0051C),MKTLLLTLVVVTVVCLDFGHTMICYNQQSSQPPTTTTCSEGQCYKKTWSDHRGTIIERGCACPNVKPGVKISCCSSDKCNG,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1125,F5CPD6,3S152_MICAT,,Three-finger toxin MALT0052C (MALT0052C),MKTLLLTLVVVTIVCLDFGHTLICYNDHGYIGKTTETCENGMTTCYEERWREARGTRIERGCGCYKVKPGVQMNCCKTDRCNG,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1126,F5CPD8,3S157_MICAT,,Three-finger toxin MALT0057C (MALT0057C),MKTLLLTLVVVTIVCLDFGHTMICYNQQSSQPPTTTTCSEGQCYKQRWRDHRGWRTERGCGCPKAIPEVKLNCCKTDRCNG,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1127,F5CPD9,3S158_MICAT,,Three-finger toxin MALT0058C,MKTLLLTLVVVTIVCLDFGHTLICYNDHGFIGKTTETCENGMTTCYEKRWTEARGTRIDRGCGCPNVKPGVNLNCCKTDRCNG,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1128,F5CPE0,3SX9_MICAT,,Three-finger toxin MALT0059C (3FTx MALT0059C),MRTLLLTLVVVTIVCLDLGNSLICYVTRDGKTATCPPGQKCEKYAVSASHTGHWFHRWHCTSTCHEGPYNVCCSTDFCNR,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: Neurotoxin. Blocks muscular nicotinic acetylcholine receptors (nAChR). {ECO:0000250|UniProtKB:P86421}.,Neurotoxin
1131,F5CPE4,3S166_MICAT,,Three-finger toxin MALT0066C (MALT0066C),MKTLLLTLVVVTIVCLDFGHTLICYNYETPLDKTTECCGNGVTTCFAKSWRDHRGLRTDRGCGCPNVKPGVTINCCKTDRCNG,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1132,F8J2D0,PA214_DRYCN,3.1.1.4,Phospholipase A2 147 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASVPPQPLNLVQFGYLIQCANHGSRATWHYMDYGCYCGAGGSGTPVDDLDRCCKIHDDCYGDAEKKGCSPKMLAYDYYCGENGPYCKNIKKECQRFVCDCDVKAAKCFAGAPYNDANWNIDTTKHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1133,F8J2F6,VKT18_DRYCN,,Kunitz-type serine protease inhibitor 18 (SPI-18),MSSGGLLLLLGLLTLWEVLTPVSSKDRPHFCHLPADPGRCNALSEAFYYNPVQRKCLKFRYGGCKANANTFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1134,F8QN50,PA2HS_VIPRE,,Basic phospholipase A2 homolog Vur-S49 (svPLA2 homolog),MRALWIVAVCLIGVEGSMIEFGKMIQEETEKNPITSYSLYGCHCGLGSKGKPKDATDRCCFVHSCCYAKLSDCSPKTNRYEYHRENGTIVCGSSTFCKKQICECDRAAAICFRENLKTYNKKYKVYLRFKCKGVPEKC,"Phospholipase A2 family, Group II subfamily, S49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:25522251). Is able to suppress the acetylcholine (ACh)-evoked current mediated by alpha-7 (CHRNA7)-similar nAChRs in L.stagnalis neurons (IC(50)=2.18 uM) (PubMed:25522251). This activity is only partially reversible and seems to be non-competitive (PubMed:25522251). {ECO:0000269|PubMed:25522251}.,Phospholipase
1136,F8S116,VSP5_CROAD,3.4.21.-,Snake venom serine proteinase 5 (SVSP) (EC 3.4.21.-) (Serine proteinase 4),MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVAIFNSTEFFCSGTLINQEWVVTAAHCDSTNFKMKLGVHSKKVPNEDEQTRNPKEKFFCPNKKKDDVLDKDIMLIKLDSPVSNSEHIAPLSLPSSPPSVGSVCHIMGWGSITPIEKTLPDVPYCANINLLDDAVCRPPYPELPATSRTLCAGILEGGKDTCVVDSGGPLICNGQFQGIVFYGAHPCGQALKPGVYTKVFDYNDWIQSIIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1137,F8S122,VESP_CROAD,,Vespryn,MSPSAGLQFSLYFLQTKKVLWKLTDKEKGLCYILLFTLCFFADQENGGKALASPPGIWKRADVTFDSNTAFSSLVVSANKKTVKNVGVPQVVPDNPERFNSSPCVLGSPGFRSGKHYFEVKYGTQREWAVGIAGKSVKRKGNLMLVPEERIWQMGLWWLRHLETDPGRVHSTSGKITVFVDYNGGNVIFDLNRINTTLKANFNGEEVVPFFYLGGTVSLTTL,Ohanin/vespryn family,"FUNCTION: Neurotoxin that produces dose-dependent hypolocomotion and hyperalgesia in mice. May directly act on the central nervous system, as it is 6500-fold more potent when administered intracerebroventricularly than intraperitoneal. {ECO:0000250|UniProtKB:P83234}.",Neurotoxin
1138,H6VC06,VKTK2_DABRR,,Kunitz-type serine protease inhibitor DrKIn-II (Daboia russelii Kunitz Inhibitor-II),MSSGGLLLLLGLLTLWAELTPISGHDRPTFCNLAPESGRCRAHLRRIYYNLESNKCEVFFYGGCGGNDNNFSTWDECRHTCVGK,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that inhibits plasmin (90%) (Ki=0.19 nM), trypsin (70%), FXIa/F11 (37%) (Ki=6 nM) and FXa/F10 (20%), and prolonges the activated partial thromboplastin time. This antifibrinolytic property has been confirmed by a fibrin plate assay. Shows less antifibrinolytic activity that aprotinin. In vivo, reduces the bleeding time in a murine bleeding model, and prevents the increase of fibrin(ogen) degradation products in coagulation-stimulated mice. {ECO:0000269|PubMed:22416129, ECO:0000269|PubMed:23999090}.",Serine Protease
1140,I7ICN3,SLRB_BITRH,,Snaclec rhinocetin subunit beta (C-type lectin like protein 2),MGRFIFLSSGLLVVFLSLSGTGADQGCLPDWTLYEGYCYKVFKEKKTWADAEKFCKEQANGGHLVSLQSSEEVDFMVHQTFPILRYDFVWIGLSDFSRDCQWKWSDYSKLFYKAWNNEPNCFVCKTTDNQWLRRDCNRQQYFVCKSRVPR,Snaclec family,"FUNCTION: Antagonist of the alpha-2 subunit of the integrin alpha-2/beta-1 (ITGA2/ITGB1) on human platelets and endothelial cells. This protein inhibits collagen-stimulated activation of human platelets in a dose-dependent manner. In addition, it antagonizes the binding of monoclonal antibodies against the alpha-2 subunit of integrin alpha-2/beta-1 to platelets and it coimmunoprecipitates with this integrin. {ECO:0000269|PubMed:22689571}.",Binding Protein
1141,I7JUQ0,SLRA_BITRH,,Snaclec rhinocetin subunit alpha (C-type lectin like protein 1),MGRFIFLSSGWLVVFLSLSGTGADEGCLPGWSLYEGHCYKFFFIFKTWENAEKFCQEQSNGKNLASIEWLGKANFVAELVSQALTKTKYHVWIGLRREDEKQQCSSFWTDGSSVSYENVIRYTKCVGLNKNTGHRTWIALHCGDNYPFVCMSRLPH,Snaclec family,"FUNCTION: Antagonist of the alpha-2 subunit of the integrin alpha-2/beta-1 (ITGA2/ITGB1) on human platelets and endothelial cells. This protein inhibits collagen-stimulated activation of human platelets in a dose-dependent manner. In addition, it antagonizes the binding of monoclonal antibodies against the alpha-2 subunit of integrin alpha-2/beta-1 to platelets and it coimmunoprecipitates with this integrin. {ECO:0000269|PubMed:22689571}.",Binding Protein
1142,J3RY93,VSPC_CROAD,3.4.21.-,Snake venom serine proteinase 12 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDPDRFLCSGILLNEEWVLTAAHCDRRNIRIKLGMHSKTVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVSNSEHIAPLSLPSSPPSVGSVCRIMGWGRISPSKETYPDVPHCANINLLDYEVCLAAYPEFGLPATSKTLCAGILEGGKDTCVGDSGGPLICNGQFQGILSWGNDVCGYILQPALYTRVFDHLDWIQSIIAGNTDVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1143,J3RYA3,VSP9_CROAD,3.4.21.-,Snake venom serine proteinase 9 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNIDEHRFLVALYHSRSKTFLCGGTLLNEEWVLTAAHCNRVFMYIRLGMHNKNVKFDDEQIRYAKEKYFFRCHNNFTRWDKDIMLIRLNKPVSYSEHIAPLSLPFSPPSVGSVCRAMGWGQTTSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATSRTLCAGVLEGGIDTCNRDSGGPLICNGQFQGIVFWGPDPCAQPDKPGLYTKVFDHLDWIQSIIAGEKTVNCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1144,J3S3W5,VSP1_CROAD,3.4.21.-,Snake venom serine proteinase 1 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDYWSQSFLCGGTLINEEWVLTAKHCDRTHILIYVGVHDRSVQFDKEQRRFPKEKYFFDCSNNFTKWDKDIMLIRLNKPVSYSEHIAPLSLPSSPPIVGSVCRAMGWGQTTSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATSRTLCAGVLEGGIDTCNRDSGGPLICNGQFQGIVFWGPDPCAQPDKPGLYTKVFDHLDWIQSIIAGEKTVNCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1145,J3S820,HYAL_CROAD,3.2.1.35,Hyaluronidase (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor),MYHLWIKCLAAWIFLKRFNGVHVMQAKAPMYPNEPFLVFWNAPTTQCRLRYKVDLDLNTFHIVTNANDSLSGSAVTIFYPTHLGFYPHIDGRGHFFNGIIPQNESLAKHLNKSKSDINRMIPLRTFHGLGVIDWENWRPQWDRNWGSKNVYRNRSIQFARDLHPELSEDEIKRLAKQEYEKAAKSFMRDTLLLAEEMRPYGYWGYYLYPDCQNYNYKTKPDQYTGECPDIEITRNNQLLWLWRDSTALFPNIYLETVLRSSDNALKFVHHRLKESMRIASMARKDYALPVFPYARPFYAYTFEPLTEEDLVNTVGETAAMGAAGIVFWGSMQYASTVDSCRKVKDYIDGPLGRYIVNVTTAAKICSHFLCKKHGRCVRKHSDSNAFLHLFPDSFRILVHGNATEKKVIVKGKLELENLIFLINNFMCQCYQGWKGLYCEKHSIKDIRKI,Glycosyl hydrolase 56 family,"FUNCTION: Snake venom endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. In venom, it is not toxic by itself, but increases the diffusion of other venom proteins by degrading the extracellular matrix. In addition, it displays antiedematogenic activity (By similarity). {ECO:0000250}.",General Toxin
1146,J3S832,VSPB_CROAD,3.4.21.-,Snake venom serine proteinase 11 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVLVYSDGIQCGGTLINQEWMLTAAHCDGKKMKLQFGLHSKKVPNKDKQTRVPKEKFFCLSSKNNKEWDKDIMLIRLNRPVNNSKHIAPLSLPSKPPSQDTVCNIMGWGTISPTEETYPDVPHCANINILDHAVCRAIYPGLLEKSRVLCAGILEGGKDTCGGDSGGPLICNGEIQGLLSVGGDPCAQPHVPALYIKVFDYTEWIQSIITGNTAATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1147,J3S833,VSP2_CROAD,3.4.21.-,Snake venom serine proteinase 2 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELIFGGRPCNRNEHRFLALVYSDGNQCSGTLINEEWVLTAAHCEGNKMKIHLGVHSKKVPNKDKQTRVPKEKFFCVSSKTYTKWNKDIMLIRLDRPVSNSKHIAPLNLPSSSPSVGSVCRIMGWGTISPTEVILPDVPQCANINLLSYSVCRAAYPEYGLPATSRTLCAGILEGGKDTCAGDSGGPLICNGQFQGIASWGSTLCGYVREPALYTKVFDHLDWIQSIIAGNTDATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1148,J3S835,VSP8_CROAD,3.4.21.-,Snake venom serine proteinase 8 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVAIFNSTKFFCSGTLINQEWVVTAAHCDSTNFKMKLGVHSKKVPNENEQTRNPKEKFFCPNKKKDDVLDKDIMLIKLDSPVSNSEHIAPLSLPSSPPSVGSVCHIMGWGSITPIEKTLPDVPYCANINLLDDAVCRPPYPELPATSRTLCAGILEGGKDTCRGDSGGPLICNGQFQGIVFYGAHPCGQALKPGVYTKVFDYNDWIQSIIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1151,J3SDW9,VSPE_CROAD,3.4.21.-,Snake venom serine proteinase 14 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLAIVHTDISLCTGTLINQEWVLTAAHCDRGDILVLLGVHRLKDVQTRVAKEKFICPNRKKDNEKDKDIMLIRLDSPVNNSTHIAPLSLPSNPPSVGSVCRIMGWGAITSPNVTFPGVPHCADINIFDYEVCRAAKPELPATSRTLCAGILEGGKGSCDGDSGGPLICNGEIQGIVSWGGDICAQPREPGHYTKVFDYTDWIQSIIAGNTDVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1152,J3SDX0,VSP4_CROAD,3.4.21.-,Snake venom serine proteinase 4a (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQMSSELVTGGDECNRNEHRFLVALYDPDRFLCGGTLLNEEWVLTAAHCDRRNMWIKLGMHSKTVPNEDEQRRVPKEKFFCLSTKNYTLWDKDIMLIRLDSPVSNSEHIAPLSLPSSPPSVGSVCRIMGWGTISSNKETYPNVPHCANINILDYEVCLAAYPEFVLPATSRTLCAGILEGGKDSCKGDSGGPLICNGQFQGILSWGNDVCGYILQPALYTRVFDHLDWIQRIIAGNTDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1153,J3SDX8,LICH_CROAD,3.1.1.13,Putative lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase),MWRLIIIAILFQGLVNSAMLERRKRGVDPETAMNISEIILFRGYPSEEYEVVTGDGYILCLNRIPYGKISQKTKEPKPAVFLQHGLLADGSNWVTNLDYNSLGFALADAGFDVWLGNSRGNTWSQKHINYTIKQKEFWMFSFNEMAMYDIPASVNFVLNKTGQEQLFYVGHSQGTTIGFIAFSVLPELAKKIKMFFGLAPVMTVKFSSGGLVKLGELPEFLLKEIFGTKQIFPQNAVIKWLATHVCGQVLIDELCGNFFFLLCGFNEKNLNMSRVEIYSTHCPAGTSVQNMLHWSQAVKSGEVRAFDWGSRKENMAHYKQPTPPPYKMERMLVPTALWTGGHDWLSDRKDIAILLTLIPNLIYHKEIPEWEHLDFIWGLDAPQRMFRDMIQMMHKVQYAH,"AB hydrolase superfamily, Lipase family","FUNCTION: In physiological conditions, is crucial for intracellular hydrolysis of cholesteryl esters and triglycerides that have been internalized via receptor-mediated endocytosis of lipoprotein particles. In venom, the biological contribution is unknown.",General Toxin
1154,J3SE80,CYT2_CROAD,,Cystatin-2,MALLRGFLVCSLLLLSCICKEALGTRLLGGLENASPEEPGVARALQFAMNEYNRGSNDMYSSRVSEVVEAQKQIVSGIKYYFTVKIGRTVCRKGATDLENCAFHNAPKLAQTMTCTFEVYNIPWRNFISLEKSSCT,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
1155,O13057,VSP2_PROFL,3.4.21.-,Snake venom serine protease 2 (SVSP 2) (EC 3.4.21.-),MVLIRVLANLLILQLFYAQKSSELIIGGDECNINEHRFLVALYTFRSRRLHCGGILINQEWVLSAARCNRKNIRIQLGMHSTNVINEDVQTRVPKEKFFCLSSKTHTRWNKDIMLIRLNSPVNNSTHIAPVSLPSNPPSLGSVCRVMGWGTISATKETHPDVPHCANINILDYSVCRAAYARLPATSRTLCAGILEGGKDSCKADSGGPLICNGEIQGIVSRGGHSCGQPRKPGLYTKVFDHLDWIKSIIAGNKDAICPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1156,O13058,VSP3_PROFL,3.4.21.-,Snake venom serine protease 3 (SVSP 3) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVVLFNSSGALCGGTLINQEWVLTAAHCDMPNMQIYLGVHSASVPNDDEQARDPEEKYFCLSSNNDTEWDKDIMLIRLNRSVRNSKHIAPLSLPSSPPSVGSVCRIMGWGAITSPNETYPDVPYCANIKLLRYSLCRVYQRMPAQSRILCAGILQGGKGICKGDSGGPLICNGQFQGIVHGGGKTCAQPYEPGLYIKVFDYTDWIQNIIAGNTTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1157,O13059,VSP1_CRAGM,3.4.21.-,Snake venom serine protease 1 (SVSP 1) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVAIFNSTGFFCSGTLINQEWVVTAAHCDSNNFKMKFGAHSQKVLNEDEQIRNPKEKFICPNKKNNEVLDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSVGSVCRIMGWGSITPTKVTYPDVPYCANINLLDDAECKPGYPELLPEYRTLCAGIVQGGKDTCGGDSGGPLICNGQFHGIVSYGAHPCGQSLKPGIYTTVFDYNDWIKSIIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1158,O13060,VSPHA_CRAGM,,Snake venom serine protease homolog 2A (SVSP 2A) (Serine proteinase-like protein 2A),MVLIRVLANLLILQLSYAQKSSELIIGGDECNINEHRFLVALYTFRSRRFHCGGTLINQEWVLSAARCDRKNIRIKLGMHSTNVTNEDVQTRVPKEKFFCLSSKTYTKWNKDIMLIRLKRPVNNSTHIAPVSLPSNPPSLGSVCRVMGWGTISATKETHPDVPHCANINILDYSVCRAAYARLPATSRTLCAGILEGGKDTCHGDSGGPLICNGQVQGIVSWGGHPCGQPRKPGLYTKVFDHLDWIKSIIAGNKDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1159,O13061,VSPB_CRAGM,3.4.21.-,Snake venom serine protease 2B (SVSP 2B) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRFLVALYEYTSMTFICGGTLINQEWVLTAAHCDRDTIYIYIGMHDKYVKFDDEQGRHPKEKYIFNCSNNFTKWDKDIMLIKLDYPVNYSEHIAPLSLPSSPPSMGSVCRVMGWGAITPTNETLPDVPHCANINILDHALCRAVFPGLPATSRTLCAGVLQGGTDTCNRDSGGPLICNGQFQGIVFWGWYPCAQPRVPALYTKVFDHLDWIQSIIAGNTDAACPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1160,O13062,VSPC_CRAGM,3.4.21.-,Snake venom serine protease 2C (SVSP 2C) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGHPCNINEHPFLVLVYHDGYQCGGTLINEEWVLTAAHCDGKKMKLQFGLHSKNVPNKDKQTRVPKEKFFCLSSKNFIKWGKDIMLIRLNRSVNNSTHIAPLSLPSSPPSQNTVCNIMGWGTISPTKEIYPDVPHCANINILDHAVCRAFYPGLLEKSKTLCAGILQGGKDICQGDSGGPLICNGQIQGIVSVGGNPCAEPRVPAIYTKVFDHLDWIKSIIAGNTAATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1161,O13063,VSP3_CRAGM,3.4.21.-,Snake venom serine protease 3 (SVSP 3) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVVLFNSSGVLCGGTLINQEYVLTAAHCDMPNMQILLGVHSASVLNDDEQARDPEEKYFCLSSNNDTEWDKDIMLIRLNRSVNNSVHIAPLSLPSSPPRLGSVCRVMGWGAITSPNETYPDVPHCANINILRYSLCRAVYLGMPVQSRILCAGILRGGKDSCKGDSGGPLICNGQLQGIVSAGSDPCAKPRVPNLYIKVFDYTDWIQSIIAGNTTVTCPQ,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1165,O42257,3L27_NAJSP,,Long neurotoxin 7 (LNTX7),MKTLLLTLVLVTIMCLDLGYTIRCFITPDVTSTDCPNGHVCYTKTWCDGFCSSRGRRVELGCAATCPTVKPGVDIQCCSTDNCNPFPTRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1166,O73800,VSPSN_GLOHA,3.4.21.-,Snake venom serine protease salmobin (SVSP) (EC 3.4.21.-),MVLIKVLANHLILQLSYAQKSSELVIGGDECNINEHRFLVALYHSRSRTFLCGGTLINQEWVLTAAHCDRFLMYIRLGMHNKNVKFDDEQRRFPKEKYFFACSNNFTKWDKDIMLIRLNRPVNNSEHIAPLSLPSNPPSVGSVCRVMGWGTITSPNETLPDVPHCANINLLHYSVCQAAYPKLPVTRRLLCAGILEGGIDSCHRDSGGPLICNGQFQGIVSWGRYPCAQPRVPGIYIKVFDYTDWIQSIIAGNTAVNCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1171,O93421,VSPPE_GLOHA,3.4.21.-,Snake venom serine protease pallase (SVSP pallase) (EC 3.4.21.-),VIGGDECNINEHRFLVALYTSRTLFCGGTLINQEWVLTAAHCNMEDIQIKLGMHSKKVPNEDEQKRVPKEKFFCLSSKKLYLWDKDIMLIRLDSPVKNSAHIAPLSLPSSPPSVGSVCRTMGWGRISSTKETYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCVGDSGGPLICNGQFQGIASWGDHPCAQPHKPAAYTKVFDHLDWIENIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1175,O93515,VM2S3_GLOBR,3.4.24.-,Zinc metalloproteinase-disintegrin salmosin-3 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),SCPCDANSCIMSATLSNEPSSRFSDCSFSLPSRFSDCSFNQYSSDIIHYHECLLNEPSRTDIVSPPVCGNYYPEVGEDCDCGPPANCQNPCCDAATCGLTTGSQCAEGLCCDQCRLKKAGTICRKARGDNPDDRCTGQSGVCPRNT,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIb sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that inhibits ADP-induced platelet aggregation (probably by binding integrin alpha-IIb/beta-3 (ITGA2B/ITGB3)) and degrades fibrinogen. {ECO:0000250}.,Metalloprotease
1176,O93516,VM2S2_GLOBR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin salmosin-2],NEYQTYLTDRNPQCILNEPLRTDTVSTPVSGNELLEAGKECDCGAPANPCCDAATCKLRPGEQCAEGLCCDQCRFMKEGTICQEAKGDWNDDTCTGQSADCPRNGFYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin salmosin-2]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
1177,O93517,VM3S4_GLOBR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin-like salmosin-4],DEPLKTDLVSPPVCGNYFVEVGEDCDCGSPATCRDSCCDAATCKLRQGAQCREGLCCDQCRFKGAGTECRAATDECDMADLCTGRSAECTDRFQRNGQPCQNNNG,"Venom metalloproteinase (M12B) family, P-III subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin-like salmosin-4]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
1178,O93518,VM3S5_GLOBR,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin-like salmosin-5],NHNPECIVNEPLGTDIVSPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRESMSECDPAEHCSGQCSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYALWGADVYEAEDSCFESNKKGNYYYGYCRKENGKKIPCAPEDVKCGRLYCKDNSPGQNGPC,"Venom metalloproteinase (M12B) family, P-III subfamily","FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin-like salmosin-5]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
1180,P00603,PA2B2_NAJMO,3.1.1.4,Basic phospholipase A2 CM-II (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFKNMIHCTVPSRPWWHFADYGCYCGRGGKGTAVDDLDRCCQVHDNCYGEAEKLGCWPYLTLYKYECSQGKLTCSGGNNKCAAAVCNCDLVAANCFAGARYIDANYNINLKERCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that causes myonecrosis when injected intramuscularly, causes neuromuscular blockade with a gradual contracture and a decreased sensitivity to ACh and KCl (in the chick biventer cervicis nerve-muscle preparation), abolishes twitches evoked by indirect stimulation earlier than those by direct stimulation (in the mouse phrenic nerve-diaphragm preparation), shows indirect hemolytic activity (PubMed:3615669), and shows weak anticoagulant activity (PubMed:3117784). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:3117784, ECO:0000269|PubMed:3615669}.",Phospholipase
1182,P00984,VKTE_DENPO,,Kunitz-type serine protease inhibitor dendrotoxin E (DTX-E) (Protein E) (Venom basic protease inhibitor E),LQHRTFCKLPAEPGPCKASIPAFYYNWAAKKCQLFHYGGCKGNANRFSTIEKCRHACVG,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that inhibits trypsin (PubMed:668688). May also inhibit voltage-gated potassium channels (Kv) (Probable). Binds transition metal ions such as copper and cobalt (PubMed:668688). {ECO:0000269|PubMed:668688, ECO:0000305}.",Serine Protease
1183,P00985,VKT2_HEMHA,,Kunitz-type serine protease inhibitor 2 (Venom basic protease inhibitor 2),RPDFCELPAETGLCKAYIRSFHYNLAAQQCLQFIYGGCGGNANRFKTIDECRRTCVG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000269|PubMed:950337}.,Serine Protease
1184,P00986,VKT2_NAJNI,,Kunitz-type serine protease inhibitor 2 (Venom basic protease inhibitor 2) (Venom basic protease inhibitor II),RPRFCELPAETGLCKARIRSFHYNRAAQQCLEFIYGGCGGNANRFKTIDECHRTCVG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor.,Serine Protease
1185,P00990,VKT2_DABSI,,Kunitz-type serine protease inhibitor 2 (RVV-II) (Venom basic protease inhibitor 2) (Venom basic protease inhibitor II),HDRPTFCNLAPESGRCRGHLRRIYYNLESNKCKVFFYGGCGGNANNFETRDECRETCGGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000269|PubMed:4436285}.,Serine Protease
1186,P01380,3L21_HYDST,,Alpha-elapitoxin-Ast2a (Alpha-EPTX-Ast2a) (Long neurotoxin 1) (Toxin B),LSCYLGYKHSQTCPPGENVCFVKTWCDGFCNTRGERIIMGCAATCPTAKSGVHIACCSTDNCNIYAKWGS,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1187,P01381,3L22_HYDST,,Alpha-elapitoxin-Ast2b (Alpha-EPTX-Ast2b) (Long neurotoxin 2) (Toxin C),LSCYLGYKHSQTCPPGENVCFVKTWCDAFCSTRGERIVMGCAATCPTAKSGVHIACCSTDNCNIYTKWGSGR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1188,P01383,3L21_NAJME,,Long neurotoxin 1 (Neurotoxin 3.9.4),KRCYRTPDLKSQTCPPGEDLCYTKKWCADWCTSRGKVIELGCVATCPKVKPYEQITCCSTDNCNPHPKMKP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1189,P01384,3L21_NOTSC,,Alpha-elapitoxin-Nss2a (Alpha-EPTX-Nss2a) (Long neurotoxin 1) (LNTX-1) (Notechis III-4),MKTLLLTLVVVTIVCLDLGDSLICYMGPKTPRTCPRGQNLCYTKTWCDAFCSSRGKVVELGCAATCPIAKSYEDVTCCSTDNCNPFPVRPRPHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1190,P01385,3L21_ACAAN,,Alpha-elapitoxin-Aa2b (Alpha-EPTX-Aa2b) (Long neurotoxin 1),VICYRGYNNPQTCPPGENVCFTRTWCDAFCSSRGKVVELGCAATCPIVKSYNEVKCCSTDKCNPFPVRPRRPP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1191,P01386,3L22_OPHHA,,Long neurotoxin 2 (Neurotoxin B),TKCYVTPDATSQTCPDGQDICYTKTWCDGFCSSRGKRIDLGCAATCPKVKPGVDIKCCSTDNCNPFPTWKRKH,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1192,P01387,3L21_OPHHA,,Long neurotoxin 1 (Neurotoxin A),TKCYVTPDVKSETCPAGQDICYTETWCDAWCTSRGKRVDLGCAATCPIVKPGVEIKCCSTDNCNPFPTWRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1193,P01388,3L22_NAJME,,Long neurotoxin 2 (Neurotoxin B) (Tx-NM4),IRCFITPDVTSQICADGHVCYTKTWCDNFCASRGKRVDLGCAATCPTVKPGVNIKCCSTDNCNPFPTRNRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1-beta-1-gamma-delta/CHRNA1-CHRNB1-CHRNG-CHRND) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (PubMed:33672715). Ranges of nAChR inhibition are in nanomolar (competitive binding with alpha-bungarotoxin gives Ki=2.17 nM on muscle nAChR and Ki=26.9 nM on alpha-7) (PubMed:33672715). Also shows low inhibition on GABA(A) receptors (IC(50)~10 uM on all receptors tested: alpha-1-beta-3-gamma-2 (GABRA1-GABRB3-GABRG2), alpha-1-beta-2-gamma-2 (GABRA1-GABRB2-GABRG2), and alpha-3-beta-2-gamma-2 (GABRA3-GABRB2-GABRG2)) (PubMed:33672715). {ECO:0000269|PubMed:33672715}.",Neurotoxin
1194,P01389,3L21_NAJAC,,Long neurotoxin 1 (Toxin III),IRCFITPDVTSQACPDGQNICYTKTWCDNFCGMRGKRVDLGCAATCPTVKPGVDIKCCSTDNCNPFPTRERS,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1195,P01390,3L21_NAJNI,,Long neurotoxin 1 (Neurotoxin alpha),IRCFITPDVTSQACPDGHVCYTKMWCDNFCGMRGKRVDLGCAATCPKVKPGVNIKCCSRDNCNPFPTRKRS,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1196,P01393,3L21_DENJA,,Alpha-elapitoxin-Djk2a (Alpha-EPTX-Djk2a) (Long neurotoxin 1) (Toxin V-III-N1),RTCYKTYSDKSKTCPRGEDICYTKTWCDGFCSQRGKRVELGCAATCPKVKTGVEIKCCSTDYCNPFPVWNPR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1197,P01394,3L21_DENVI,,Alpha-elapitoxin-Dv2b (Alpha-EPTX-Dv2b) (Long neurotoxin 1) (Neurotoxin 4.7.3/4.9.3),RTCYKTPSVKPETCPHGENICYTETWCDAWCSQRGKREELGCAATCPKVKAGVGIKCCSTDNCDPFPVKNPR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1198,P01395,3L22_DENVI,,Alpha-elapitoxin-Dv2a (Alpha-EPTX-Dv2a) (Long neurotoxin 2) (Toxin I/V),RTCYKTPSVKPETCPHGENICYTETWCDAWCSQRGKRVELGCAATCPKVKAGVGIKCCSTDNCNPFPVWNPRG,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1199,P01396,3L21_DENPO,,Alpha-elapitoxin-Dpp2a (Alpha-EPTX-Dpp2a) (Long neurotoxin 1) (Neurotoxin gamma) (Toxin VN1),RTCNKTFSDQSKICPPGENICYTKTWCDAWCSQRGKRVELGCAATCPKVKAGVEIKCCSTDDCDKFQFGKPR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1200,P01409,3SIY4_DENAN,,"Synergistic-type venom protein C9S3, chain 2",LTCVTGKSIGGISTEECAAGQKICNKKWTKMGPKLYDVSRGCTATCPKADEYGCVKCCNTDRN,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily",FUNCTION: This protein shows a synergetic toxic effect in that it enhances the toxicity of other D.angusticeps toxins.,General Toxin
1203,P01416,3S11_DENPO,,Short neurotoxin 1 (Neurotoxin alpha),RICYNHQSTTRATTKSCEENSCYKKYWRDHRGTIIERGCGCPKVKPGVGIHCCQSDKCNY,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1204,P01417,3S11_DENJA,,Short neurotoxin 1,RICYNHQSTTPATTKSCGENSCYKKTWSDHRGTIIERGCGCPKVKQGIHLHCCQSDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1205,P01418,3S11_DENVI,,Short neurotoxin 1 (Neurotoxin 4.11.3),RICYNHQSTTPATTKSCGENSCYKKTWSDHRGTIIERGCGCPKVKRGVHLHCCQSDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1206,P01419,3S110_DENJA,,Toxin S5C10,RICYNHQSNTPATTKSCVENSCYKSIWADHRGTIIKRGCGCPRVKSKIKCCKSDNCNL,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1207,P01420,3S13_NAJHA,,Short neurotoxin 3 (Toxin CM-10) (Toxin V-NH-I1),MICYKQQSLQFPITTVCPGEKNCYKKQWSGHRGTIIERGCGCPSVKKGIEINCCTTDKCNR,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1208,P01421,3S14_NAJHA,,Short neurotoxin 4 (Toxin CM-12) (Toxin V-NH-I2),MICYKQRSLQFPITTVCPGEKNCYKKQWSGHRGTIIERGCGCPSVKKGIEINCCTTDKCNR,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1209,P01422,3S12_NAJHA,,Short neurotoxin 2 (Toxin CM-14) (Toxin V-N-I2),MICHNQQSSQPPTIKTCPGETNCYKKRWRDHRGTIIERGCGCPSVKKGVGIYCCKTNKCNR,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1210,P01423,3S12_NAJNI,,Short neurotoxin 2 (Neurotoxin beta),MICHNQQSSQRPTIKTCPGETNCYKKRWRDHRGTIIERGCGCPSVKKGVGIYCCKTDKCNR,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1211,P01425,3S11_HEMHA,,Short neurotoxin 1 (Toxin II),LECHNQQSSQPPTTKSCPGDTNCYNKRWRDHRGTIIERGCGCPTVKPGINLKCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1212,P01426,3S11_NAJPA,,Short neurotoxin 1 (Neurotoxin alpha) (Toxin alpha),LECHNQQSSQPPTTKTCPGETNCYKKVWRDHRGTIIERGCGCPTVKPGIKLNCCTTDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular nicotinic acetylcholine receptors (nAChRs) (tested on Torpedo marmorata AChR, Kd=0.07 nM) and with low affinity to neuronal alpha-7/CHRNA7 nAChRs (tested on chimeric receptor, Kd=3 uM) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission (PubMed:9305882). Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. {ECO:0000269|PubMed:9305882}.",Neurotoxin
1213,P01427,3S11_NAJOX,,Short neurotoxin 1 (Neurotoxin II) (NT II) (NTII) (NTX II) (Neurotoxin alpha),LECHNQQSSQPPTTKTCSGETNCYKKWWSDHRGTIIERGCGCPKVKPGVNLNCCRTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1214,P01431,3S11_NAJMO,,Short neurotoxin 1 (NMM I) (Neurotoxin I),LECHNQQSSEPPTTTRCSGGETNCYKKRWRDHRGYRTERGCGCPTVKKGIELNCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1215,P01432,3S13_NAJMO,,Short neurotoxin 3 (NMM III) (Neurotoxin III),LNCHNQMSAQPPTTTRCSRWETNCYKKRWRDHRGYKTERGCGCPTVKKGIQLHCCTSDNCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1216,P01433,3S12_HEMHA,,Short neurotoxin 2 (Toxin IV),LECHNQQSSQTPTTQTCPGETNCYKKQWSDHRGSRTERGCGCPTVKPGIKLKCCTTDRCNK,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1217,P01434,3S11_ACAAN,,Short neurotoxin 1 (Toxin Aa c),MQCCNQQSSQPKTTTTCPGGVSSCYKKTWRDHRGTIIERGCGCPRVKPGIRLICCKTDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1218,P01437,3S11_HYDLA,,Short neurotoxin 1 (Neurotoxin A),MTCCNQQSSQPKTTTNCAESSCYKKTWRDFRGTRIERGCGCPQVKPGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission (By similarity). The recombinant protein also barely blocks voltage-gated potassium channel Kv1.3/KCNA3 (2.71% inhibition at 60 nM of toxin) (PubMed:30648553). {ECO:0000250|UniProtKB:P60775, ECO:0000269|PubMed:30648553}.",Neurotoxin
1220,P01441,3SA2_NAJOX,,Cytotoxin 2 (Cytotoxin II) (CTII),LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: This three-finger cytotoxin is a basic protein that interacts and penetrates into the cell membrane, with the tips of all the three loops. Cytotoxins which have a Pro-30 (P-type) interacts with membrane stronger that those which have a 'Ser-28' (S-type). CTII interacts with membrane stronger than CTI. {ECO:0000269|PubMed:11357394, ECO:0000269|PubMed:12709064, ECO:0000269|PubMed:15584897}.",General Toxin
1222,P01451,3SA1_NAJOX,,Cytotoxin 1 (Cytotoxin I) (CTI),LKCNKLVPIAYKTCPEGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: This three-finger cytotoxin is a basic protein that interacts and penetrates into the cell membrane, with the tips of all the three loops. Cytotoxins which have a 'Pro-30' (P-type) interacts with membrane stronger that those which have a Ser-28 (S-type). CTI interacts with membrane weaker than CTII.",General Toxin
1237,P01468,3SA1_NAJPA,,Cytotoxin 1 (CTX-1) (Cardiotoxin gamma),LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Basic protein that binds to cell membrane and depolarizes cardiomyocytes. This cytotoxin also possesses lytic activity on many other cells, including red blood cells. Interaction with sulfatides in the cell membrane induces pore formation and cell internalization and is responsible for cytotoxicity in cardiomyocytes. It targets the mitochondrial membrane and induces mitochondrial swelling and fragmentation. Inhibits protein kinases C. It binds to the integrin alpha-V/beta-3 with a moderate affinity. {ECO:0000250|UniProtKB:P01443}.",Vascular Interaction
1241,P01477,MYXC_CROHE,,Myotoxin (Crotamine-4) (Toxic peptide C),MKILYLLFAFLFLAFLSEPGNAYKRCHKKGGHCFPKTVICLPPSSDFGKMDCRWKWKCCKKGSVNNAISI,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity). {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
1246,P08935,CYT_BITAR,,Cystatin,IPGGLSPRDVTDPDVQEAAAFAVEKYNAGSKNDYYFKERRVVEAQSQVVSGVKYYLMMELLKTTCKKTVGRPKGYQEIQNCNLPPENQQEEITCRFEVWSRPWLPSTSLTK,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
1247,P0C1Y9,3SE1_DENAN,,Fasciculin-1 (Fas-1) (Fas1) (Fasciculin-I) (FAS-I) (Toxin TA1),TMCYSHTTTSRAILTNCGENSCYRKSRRHPPKMVLGRGCGCPPGDDYLEVKCCTSPDKCNY,"Snake three-finger toxin family, Short-chain subfamily, Acn-esterase inhibitor sub-subfamily","FUNCTION: Interferes with neuromuscular transmission by inhibiting the enzyme acetylcholinesterase (AChE) present at the neuromuscular junction. It selectively binds and inhibits with a 1:1 stoichiometry the mammalian and electric fish AChE at picomolar concentrations. It is highly specific for the peripheral site of AChE and blocks the entry of acetylcholine into the active site of the enzyme, thereby preventing its breakdown. It has been called fasciculin since after injection into mice it causes severe, generalized and long-lasting (5-7 hours) fasciculations. {ECO:0000269|PubMed:6530667}.",Phosphodiesterase
1253,P0C5H4,3SA1_DABRR,,Cytotoxin drCT-1 (drCT-I),LKCNKLVPLFYKTCPAGKNL,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: This three-finger cytotoxin has antiproliferative, cytotoxic and apoptotic activities. Both in vivo and in vitro experimental results suggests that this protein possess anticancer potential. Also shows neurotoxicity, cardiotoxicity and myotoxicity. {ECO:0000269|PubMed:16511326, ECO:0000269|PubMed:17055549}.",Neurotoxin
1254,P0C603,3NBA_BOIDE,,Boigatoxin-A,QAIGLPHTACIQCNRKTSSKCLSGQICLPYHMTCYTLYKPDENGELK,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily",FUNCTION: This toxin may inhibit nicotinic acetylcholine receptor (nAChR). It has poorly reversible postsynaptic blocking activity in a chick muscle preparation and readily reversible inhibitory activity at a presynaptic site in the rat vas deferens prostatic segment most likely to prevent the release of neurotransmitters. {ECO:0000269|PubMed:15683871}.,Kunitz Family
1255,P0C616,PA2HA_BOTAS,,Basic phospholipase A2 homolog 4a (svPLA2 homolog) (Myotoxin IVa) (MT-IVa),MRTLWIVTVLLVGVEGSLVELGKMILQETGKNPLTSYGVYGCNCGVGGRHKPKDGTDRCCYVHKCCYKKMTDCDPKKDRYSYSWKDKTIVCDENNPCLKELCECDKAVAICLRENLDTYNKKYKIYPKFFCKKAEPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (By similarity). Is myotoxic and displays edema-inducing activities (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:Q90249}.",Phospholipase
1256,P0C6A3,DIDBA_ECHML,,Disintegrin EMS11A,NSAHPCCDPVKCEPREGEHCISGPCCRNCKFLNAGTICKKAMLDGLNDYCTGISSDCPRNRYKGKEDD,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of both the alpha-4/beta-1 (ITGA4/ITGB1) and the alpha-5/beta-1 (ITGA5/ITGB1) integrins to VCAM-1 and fibronectin respectively with almost the same degree of specificity. Inhibition on alpha-IIb/beta-3 (ITGA2B/ITGB3) is low. {ECO:0000269|PubMed:12667142}.,Kunitz Family
1257,P0C6A4,DID5B_ECHOC,,Disintegrin EO5B (EO4B),NSAHPCCDPVTCQPKKGEHCISGPCCRNCKFLNSGTVCKRAVGDDMDDYCSGITTDCPRNPYKGKD,"Disintegrin family, Dimeric disintegrin subfamily","FUNCTION: Poor inhibitor of platelet aggregation. When it dimerizes with EO4A, it inhibits the adhesion of cells expressing the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. When it dimerizes with EO5A, it inhibits the adhesion of the alpha-4/beta-1 (ITGA4/ITGB1) integrin to VCAM-1. When it dimerizes either with EO4A or EO5A, the inhibition on alpha-IIb/beta-3 (ITGA2B/ITGB3) is low. {ECO:0000269|PubMed:12667142}.",Kunitz Family
1258,P0C6A5,VM2A6_VIPAA,,Disintegrin VA6,NSANPCCDPVTCKPRRGEHCVSGPCCRNCKFLNAGTICRYARGDDMNDYCTGVTSDCPRNPYKS,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IId sub-subfamily","FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of cells expressing the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. Inhibition on alpha-IIb/beta-3 (ITGA2B/ITGB3) is low, and there is no inhibition on alpha-1/beta-1 (ITGA1/ITGB1), alpha-2/beta-1 (ITGA2/ITGB1) and alpha-6/beta-1 (ITGA6/ITGB1). {ECO:0000269|PubMed:12667142}.",Kunitz Family
1259,P0C6A6,DID7A_VIPBB,,Disintegrin VB7A,NSGNPCCDPVTCKPRRGEHCVSGPCCRNCKFLNAGTICKYARGDDMNDYCTGISSDCPRNPYKD,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of cells expressing the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. Inhibition on alpha-2b/beta-3 (ITGA2B/ITGB3) is low. {ECO:0000269|PubMed:12667142}.,Kunitz Family
1260,P0C6A7,VM27B_VIPBB,,Disintegrin VB7B,ELLQNSGNPCCDPVTCKPREGEHCISGPCCRNCKFKRAGTVCLDAKGDWMNNYCTGISSDCPRN,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily",FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of cells expressing the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. Inhibition on alpha-IIb/beta-3 (ITGA2B/ITGB3) is low. {ECO:0000269|PubMed:12667142}.,Kunitz Family
1261,P0C6A8,DID4_MACLO,,Disintegrin VLO4,MNSGNPCCDPVTCKPRRGEHCVSGPCCRNCKFLNAGTICKRARGDDMNDYCTGISPDCPRNPWKG,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of cells expressing the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. Inhibition on alpha-2b/beta-3 (ITGA2B/ITGB3) is low. {ECO:0000269|PubMed:12667142}.,Kunitz Family
1262,P0C6A9,VM25A_MACLO,,Disintegrin VLO5A,NSGNPCCDPVTCQPRRGEHCVSGKCCRNCKFLRAGTVCKRAVGDDMDDYCTGISSDCPRNPYKD,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily",FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of the alpha-4/beta-1 (ITGA4/ITGB1) integrin to VCAM-1. Inhibition on alpha-IIb/beta-3 (ITGA2B/ITGB3) is low. {ECO:0000269|PubMed:12667142}.,Kunitz Family
1263,P0C6B0,DID5B_MACLO,,Disintegrin VLO5B,MNSANPCCDPITCKPRRGEHCVSGPCCRNCKFLNPGTICKRTMLDGLNDYCTGVTSDCPRNPWKSEEED,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of the alpha-4/beta-1 (ITGA4/ITGB1) integrin to VCAM-1. Inhibition on alpha-2b/beta-3 (ITGA2B/ITGB3) is low. {ECO:0000269|PubMed:12667142}.,Kunitz Family
1266,P0C6E2,DIS_DABPA,,Disintegrin viperistatin,CTTGPCCRQCKLKPAGTTCWKTSRTSHYCTGKSCDCPVYQG,"Disintegrin family, Short disintegrin subfamily","FUNCTION: Potent and highly selective inhibitor of alpha-1/beta-1 (ITGA1/ITGB1) integrin binding to collagen I and IV. Is about 25-fold more potent than obtustatin inhibiting the binding of this integrin to collagen IV. {ECO:0000269|PubMed:15556632, ECO:0000269|PubMed:19502781}.",Kunitz Family
1267,P0C6S1,VM1B2_BOTPA,3.4.24.-,Snake venom metalloproteinase BnP2 (SVMP) (EC 3.4.24.-),YIELAVVADHGMFTKYNSNIDTIRVHEMVNTVDGFFRSMNVDASIANIEVWSKTITSFGEWRERDIIPR,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: This protein is a zinc protease from snake venom that is devoid of significant myotoxic and hemorrhagic activities. It hydrolyzes the Aalpha-chain and more slowly the Bbeta-chain of fibrin and fibrinogen, without affecting the gamma-chains. It induces cell detachment and a apoptosis (anoikis) in endothelial cells (By similarity). {ECO:0000250}.",Metalloprotease
1276,P0C7N3,VM3CR_CROVV,3.4.24.-,Zinc metalloproteinase-disintegrin-like crovidisin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),AMVTKNNGDLDKSGTECRLYCKDNSPGQNNSCKMFYSNEDEHKGMVLPGTK,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase-disintegrin-like that blocks the interaction between platelets and collagen fibers through its binding to collagen fibers, resulting in the blockade of collagen-mediated platelet functions such as adhesion, release reaction, thromboxane formation, and aggregation. Binds selectively to collagen type I with high affinity. Also exerts proteolytic activity to matrix. {ECO:0000269|PubMed:15037024, ECO:0000269|PubMed:9395771}.",Metalloprotease
1281,P0C7S4,BPP9A_BOTNU,,Bradykinin-potentiating peptide 9a (BPP-9) (BPP-9a) (BPP-a),QWPRPQIPP,Bradykinin-potentiating peptide family,FUNCTION: This peptide inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain. May also potentiate the hypotensive effects of bradykinin. {ECO:0000269|PubMed:11994001}.,Vascular Interaction
1285,P0C7X6,VM212_CROHD,,Disintegrin horridistatin-2 [Cleaved into: Disintegrin horridistatin-1],GEECDCGSPANPCCDAATCKLRPGAQCADGLCCDQCRFIKKGTVCRPARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily",FUNCTION: [Disintegrin horridistatin-1]: Inhibits ADP-induced platelet aggregation (IC(50) is 16.2 nM) by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3). {ECO:0000269|Ref.1}.; FUNCTION: [Disintegrin horridistatin-2]: Inhibits ADP-induced platelet aggregation (IC(50) is 16.2 nM) by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3). {ECO:0000269|Ref.1}.,Binding Protein
1286,P0C7X7,VM212_CROSS,,Disintegrin mojastin-2 [Cleaved into: Disintegrin mojastin-1],EAGEECDCGSPANPCCDAATCKLRPGAQCADGLCCDQCRFIKKGTVCRPARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Disintegrin mojastin-1]: Inhibits the three processes involved in platelet function (adhesion, activation and aggregation). It inhibits platelet adhesion to fibronectin with an IC(50) of 58.6 nM. It inhibits ATP release from platelet induced by ADP with an IC(50) of 19.5 nM on platelet-rich plasma, probably by binding to ADP receptors (P2RY1 and P2RY12). Finally, it inhibits ADP-induced platelet aggregation with IC(50) of 44.7 nM on platelet-rich plasma and 19.3 nM on whole blood, probably by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) (PubMed:20598348). {ECO:0000269|PubMed:20598348}.; FUNCTION: [Disintegrin mojastin-2]: Inhibits ADP-induced platelet aggregation (IC(50) = 13.8 nM) probably by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) located on the platelet surface. {ECO:0000269|PubMed:16084550}.",Binding Protein
1287,P0C8I8,SL2_BITAR,,Snaclec bitiscetin-2,DEGCLPDDSSRT,Snaclec family,"FUNCTION: Snaclec that binds to von Willebrand factor (VWF) and induces its interaction with GPIbalpha (GP1BA), resulting in platelet aggregation. In contrary to bitiscetin, it does not bind to the A1 domain. Instead, it interacts with the collagen-binding A3 domain of vWF. Also interferes with the binding of vWF to collagen. {ECO:0000269|PubMed:10068669, ECO:0000269|PubMed:12069583, ECO:0000269|PubMed:16839359}.",Vascular Interaction
1288,P0C8I9,SLAB_BOTAL,,Snaclec bothroalternin subunit alpha/beta (Bothrojaracin-like protein),DCPSDWSNHEGHCYRVFNEWMNWAD,Snaclec family,FUNCTION: Thrombin (F2) inhibitor that inhibits aggregation of rabbit platelets induced by alpha-thrombin. {ECO:0000269|PubMed:9839674}.,Kunitz Family
1291,P0C8J2,SL1C1_VIPAA,,Snaclec factor X-activator 1 light chain 1 (VAFXA-I LC1),DFDCPXDWVXYDQ,Snaclec family,"FUNCTION: Regulatory subunit of the blood coagulation factor X-activating enzyme. Activates coagulation factor X (F10) in a calcium-dependent manner by cleaving the Arg-Ile bond at position 234. Weakly hydrolyzes insulin B chain, fibrinogen and some components of the extracellular matrix in vitro, but does not activate prothrombin or plasminogen.",Fibrinogenolytic Enzyme
1292,P0C8J3,SL1C2_VIPAA,,Snaclec factor X-activator 1 light chain 2 (VAFXA-I LC2),LFDPPDSXPXY,Snaclec family,"FUNCTION: Regulatory subunit of the blood coagulation factor X-activating enzyme. Activates coagulation factor X (F10) in a calcium-dependent manner by cleaving the Arg-Ile bond at position 234. Weakly hydrolyzes insulin B chain, fibrinogen and some components of the extracellular matrix in vitro, but does not activate prothrombin or plasminogen.",Fibrinogenolytic Enzyme
1293,P0C8J4,SL2C1_VIPAA,,Snaclec factor X-activator 2 light chain 1 (VAFXA-I LC1),DFDCPPDWSAYDXQCYYAF,Snaclec family,"FUNCTION: Regulatory subunit of the blood coagulation factor X-activating enzyme. Activates coagulation factor X (F10) in a calcium-dependent manner by cleaving the Arg-Ile bond at position 234. Weakly hydrolyzes insulin B chain, fibrinogen and some components of the extracellular matrix in vitro, but does not activate prothrombin or plasminogen.",Fibrinogenolytic Enzyme
1294,P0C8J5,SL2C2_VIPAA,,Snaclec factor X-activator 2 light chain 2 (VAFXA-II LC2),AFCCPSGWSAYDQNCY,Snaclec family,"FUNCTION: Regulatory subunit of the blood coagulation factor X-activating enzyme. Activates coagulation factor X (F10) in a calcium-dependent manner by cleaving the Arg-Ile bond at position 234. Weakly hydrolyzes insulin B chain, fibrinogen and some components of the extracellular matrix in vitro, but does not activate prothrombin or plasminogen.",Fibrinogenolytic Enzyme
1295,P0C929,SLA_BOTIN,,Snaclec bothroinsularin subunit alpha (BIN),DCPSDWSPYGQYCYKFFQQKMNWADAERFCSEQAKGGHLVSFQSDGETDFVVNLVTEKIQSSDLYAWIGLRVQNKEKQCSSKWSDGSSVSYENVVGRTVKKCFALEKEQEFFVWINIYCGQQNPFVCKSPPP,Snaclec family,"FUNCTION: Thrombin and prothrombin (F2) inhibitor. The IC(50) of thrombin-induced platelet aggregation and fibrinocoagulation is 62 and 35 nM, respectively. Its inhibitory activity is at least 10-fold lower than that observed for other thrombin inhibitors. {ECO:0000269|PubMed:18221976}.",Kunitz Family
1296,P0C930,SLB_BOTIN,,Snaclec bothroinsularin subunit beta (BIN),DCPPDWSSYEGSCYRVFEQKMNWEDAEKFCTQQQTGGHLVSFQSSEEADFVVSLTSPILRDSFVWTGLSDVWKGCRFEWSDGSDLSYKDNYQFVFSEYECVASKTKNNKWRIIPCTKLEYFVCEFQA,Snaclec family,"FUNCTION: Thrombin and prothrombin (F2) inhibitor. The IC(50) of thrombin-induced platelet aggregation and fibrinocoagulation is 62 and 35 nM, respectively. Its inhibitory activity is at least 10-fold lower than that observed for other thrombin inhibitors. {ECO:0000269|PubMed:18221976}.",Kunitz Family
1297,P0CAR0,VKTG1_MICPY,,Kunitz-type serine protease inhibitor G1,KVPAYCKLPPDSGPCKGHFPAFYYDPVSSYCQKFI,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1298,P0CAR1,3S1D1_MICPY,,Short neurotoxin D1,MICYNQQSSQPPTTKTCSEGQCYKKTWSDHRGTISERGCACPNVKPGVKISCCSSDKCNG,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1299,P0CAR4,3S12B_MICPY,,Weak neurotoxin D2B,LICYNDHGYIGETSESCKNGETTCYEEXWTEARXXIIERACGCXKVKPGVQMKCCKTQ,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:F5CPD6}.",Neurotoxin
1300,P0CAR7,3SX_MICPY,,Venom protein E2 (Three-finger toxin) (3FTx),LICYVSRDGKTATCPPQGKCEKYAVSASHTXHXFYVYGCTSXC,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: Neurotoxin. Blocks muscular nicotinic acetylcholine receptors (nAChR). {ECO:0000250|UniProtKB:P86421}.,Neurotoxin
1301,P0CAS9,PA2B1_MICPY,3.1.1.4,Phospholipase A2 B1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKVIKFETRKNAIPFYAFYGCYCGWGGRG,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1304,P0CB06,3S12_OXYSC,,Short neurotoxin 2 (SNTX-2),MTCYNQQSSEAKTTTTCSGGVSSCYKKTWSDIRGTIIERGCGCPSVKKGIERICCRTDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000269|PubMed:8672493}.",Neurotoxin
1305,P0CG02,3S1A_HYDTO,,Toxin aagardi,MTCCNQQSSQPKTTTNCAGNSCYKKTWSDHRGTIIERGCGCPQVKSGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1307,P0CJ33,TXVE1_MACLB,,Snake venom vascular endothelial growth factor toxin IC1 (svVEGF) (Increasing capillary-1) (VEGF-F),EVRPFPEVYERIA,"PDGF/VEGF growth factor family, Snake venom VEGF subfamily",FUNCTION: Snake venom VEGFs may contribute to venom dispersion and prey subjugation by inducing vascular permeability and hypotension. This protein induces vascular permeability through VEGF receptor (KDR/VEGFR-2) signaling. May also induce angiogenesis through VEGF receptor (KDR/VEGFR-2) signaling. {ECO:0000269|PubMed:19695228}.,Vascular Interaction
1309,P0CV87,BNP_CROAT,,C-type natriuretic peptide (CNP) (NAP),AKKRAGNGCFGLKLDRIGSMSGLGC,Natriuretic peptide family,FUNCTION: Snake venom natriuretic peptide that has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.,General Toxin
1310,P0CV89,PA23_CROAT,3.1.1.4,Phospholipase A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMIKIMTKKNAFPFYTSYGCYCGWGGRCCFVHDCCYEKTDIYSYSWKRQICECDR,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1311,P0CV91,PRDX4_CROAT,1.11.1.24,Peroxiredoxin-4 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 4),GLFIIDDKQITMNDLPVGRSVDETLRLVQAFQYTDK,"Peroxiredoxin family, AhpC/Prx1 subfamily",FUNCTION: Venom peroxiredoxin enzyme that may play a role as part of a redox pathway leading to the structural/functional diversification of toxins through a disulfide bond engineering mechanism.,General Toxin
1313,P0DI85,OXLA8_DEIAC,1.4.3.2,L-amino-acid oxidase ACTX-8 (LAAO) (LAO) (EC 1.4.3.2),ADDRNPLEEFRENNYEEFL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). Induces apoptosis in HeLa cervical cancer cells. Both the caspase-dependent and the mitochondrial pathways seem to be involved in apoptosis (PubMed:17275856). {ECO:0000250, ECO:0000269|PubMed:17275856}.",Vascular Interaction
1314,P0DI87,OXLA_BOTIN,1.4.3.2,L-amino-acid oxidase (BiLAO) (LAAO) (EC 1.4.3.2),ADDKNPLEECFREDDYEGFLEIAKNGLSTTSNPKRVVIVGAGMSGLAAY,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme (PubMed:17983639). Shows activity on L-Leu (PubMed:17983639). Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). In addition, this protein induces apoptosis and necrosis and has inhibitory effects on rat kidney function (decrease of blood flow and glomerular filtration). {ECO:0000250|UniProtKB:P0CC17, ECO:0000269|PubMed:17983639}.",Kunitz Family
1315,P0DI92,PA2H_BOTMA,,Phospholipase A2 homolog BmarPLA2 (svPLA2 homolog),SLLELGKMILQETGKMPSKSYGAYGCNCGVLGR,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake phospholipase A2 homolog that lacks enzymatic activity (PubMed:19944711, PubMed:20036276). May display myotoxin activity (Probable). In isolated heart decreases cardiac frequency (PubMed:20036276). Also decreases mean arterial pressure (PubMed:19944711). Does not show antimicrobial activity (PubMed:19944711). Does not change renal parameters (such as perfusion pressure, renal vascular resistance, urinary flow, glomerular filtration rate and sodium tubular transport) (PubMed:20036276). {ECO:0000269|PubMed:19944711, ECO:0000269|PubMed:20036276, ECO:0000305}.",Phospholipase
1316,P0DJ63,VKT_OXYMI,,Kunitz-type serine protease inhibitor OMI,KDFCHLPPKPGPCRAAI,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that inhibits plasma kallikrein (Ki=1.7 nM), and plasmin (Ki=33.0 nM). {ECO:0000269|PubMed:21843588}.",Serine Protease
1317,P0DJC8,SLA_BOTAS,,Snaclec aspercetin subunit alpha,DCPSGWSSYEGHCYRFFHPPKDWADAERFCTEQAKGGALVSIQRFGEEDFVSNLITKNLQRG,Snaclec family,"FUNCTION: Snaclec that binds to von Willebrand factor (VWF) and induces its interaction with GPIbalpha (GP1BA) (via the vWF A1 domain), resulting in platelet aggregation. Intravenous injection in mice induces a dose-dependent drop in platelet count (thrombocytopenia). Pretreatment by intravenous injection by this protein in mice potentiates the hemorrhagic lesion in the skin provoked by the metalloproteinase BaP1 intradermally injected. This result is not observed when both BaP1 and this protein are injected simultaneously. {ECO:0000269|PubMed:11341509}.",Vascular Interaction
1318,P0DJC9,SLB_BOTAS,,Snaclec aspercetin subunit beta,DCPSDWSSYEGHCYRVFKPPKDWADAERFCSQQAKGGHLVSIERFGREDFVSNLITKNLQRG,Snaclec family,"FUNCTION: Snaclec that binds to von Willebrand factor (VWF) and induces its interaction with GPIbalpha (GP1BA) (via the vWF A1 domain), resulting in platelet aggregation. Intramuscular and intravenous injections in mice induce a dose-dependent drop in platelet count (thrombocytopenia). Pretreatment by intravenous injection by this protein in mice potentiates the hemorrhagic lesion in the skin provoked by the metalloproteinase BaP1 intradermally injected. This result is not observed when both BaP1 and this protein are injected simultaneously. {ECO:0000269|PubMed:11341509}.",Vascular Interaction
1319,P0DJF5,VSPPA_TRIAB,3.4.21.-,Venom plasminogen activator GPV-PA (EC 3.4.21.-) (Green pit viper plasminogen activator) (GPV-PA) (Snake venom serine protease) (SVSP),MVLIRVLANLLILQLSYAQKSSELVFGGRPCNINEHRSLVVLFNSSGFLCGGTLINQDWVVTAAHCDSNNFQLLFGVHSKKTLNEDEQTRDPKEKFFCPNRKKDDEVDKDIMLIKLDSSVNNSEHIAPLSLPSSPPSVGSVCRIMGWGKTIPTKDIYPDVPHCANINILDHAVCRTAYSWRQVANTTLCAGILQGGKDTCHFDSGGPLICNEQFHGIVSWGGHPCGQPREPGVYTNVFDYTDWIQSIIAGNKDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that activates plasminogen. {ECO:0000250}.,Serine Protease
1320,P0DJG6,VSP_CROVV,3.4.21.-,Snake venom serine protease (SVSP) (EC 3.4.21.-),VIGGDECNINEHRFLVALYDPDGFLSGGIL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that catalyzes the hydrolysis of arginine esters, kallikrein substrates Pro-Phe-Arg-MCA and Z-Phe-Arg-MCA. Cleaves kininogen analogs to release bradykinin. Induces contraction of the isolated rat uterus directly at high concentrations, but provokes more forceful contractions when injected in presence of bovine plasma. Shows capillary permeability-increasing activity and hypotensive activity on the anesthetized rat. {ECO:0000269|PubMed:3167099}.",Serine Protease
1321,P0DJJ5,V5NTD_GLOBB,3.1.3.5,Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase),SFELTILHTNDVHARVEIINVGSEKSDDGRQVPVVQAYAFGIQLHNYSSQEIGK,5'-nucleotidase family,"FUNCTION: Hydrolyzes nucleotides into nucleosides (PubMed:18384831). Snake venom 5'-nucleotidases are widely distributed among venomous snake taxa, but there is a lack of information about their biological activities. They have been shown to inhibit platelet aggregation. This effect may be due to the liberation of inhibitory AMP or adenosine by its action on ADP released upon initiation of aggregation. Venom 5'-nucleotidases are also known to synergistically act in vivo with other toxins like ADPases, phospholipases, and disintegrins to exert a more pronounced anti-coagulant effect. {ECO:0000269|PubMed:18384831, ECO:0000305|PubMed:20186872}.",Phospholipase
1322,P0DJK1,SRTX2_ATRIR,,Sarafotoxin-i2 (SRTX-i2),MALLPRLAAGGLLLLMALAALDGKPAPPKLLQKLMDGGQRRSEDQAAAGRIIDYEDGDEPVAVSVGDTKQAARALSPLRKPQPLCSCADMSDLECMNFCRLDVMWVNRNRKPSPIQSS,Endothelin/sarafotoxin family,FUNCTION: Vasoconstrictor activity. These toxins cause cardiac arrest probably as a result of coronary vasospasm. Acts by displaying agonistic activities towards endothelin-1 and -2 receptors (EDNRA and EDNRB) (By similarity). {ECO:0000250}.,General Toxin
1329,P0DJL2,SLA_TRIPP,,Snaclec purpureotin subunit alpha,DCPSDWSSFKQYCYQIIKQLKTWEDAERFCLDQMKGAHLVSIESYREAVFVAELLSENVKTTKYHVWIGLSVQNKGQQCSSEWSDGSTVSYENLVKPNPKKCFVLKKESEFRTWSNVYCEQKHIFMCKFLGSR,Snaclec family,"FUNCTION: Snaclec that induces platelet aggregation without any cofactor in a dose-dependent manner. Its platelet aggregation effect is blocked by echicetin, suggesting it is a GPIb-binding protein which binds to the same or a closely related GPIb site on platelets as echicetin. {ECO:0000269|PubMed:15019836}.",Binding Protein
1330,P0DJL3,SLB_TRIPP,,Snaclec purpureotin subunit beta,DCPSDWSSYDLYCYKVFQQRMNWEDAEKFCRQQHTGSHLLSFHSSEEVDFVVSKTLPILKADFVWIGLTDVWSACRLQWSDGTELKYNAWTAESECIASKTTDNQWWTRSCSRTYPFVCKLEV,Snaclec family,"FUNCTION: Snaclec that induces platelet aggregation without any cofactor in a dose-dependent manner. Its platelet aggregation effect is blocked by echicetin, suggesting it is a GPIb-binding protein which binds to the same or a closely related GPIb site on platelets as echicetin. {ECO:0000269|PubMed:15019836}.",Binding Protein
1333,P0DJM5,PA2AC_CROVV,3.1.1.4,Acidic phospholipase A2 Cvv-E6c (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLVQFELLIMKVAKRSGLLSYSA,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that significantly inhibits ADP-induced platelet aggregation in platelet-rich plasma of human, rabbit and guinea pig. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12623078}.",Phospholipase
1334,P0DJM6,PA2B_PROMB,3.1.1.4,Basic phospholipase A2 mangshantoxin (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMIKIMTKKNAIPFYSS,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that displays presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
1335,P0DJM7,PA2B_PROTO,3.1.1.4,Basic phospholipase A2 Pto-N6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMIKIMTKKNAIPFYSS,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities, as well as presynaptic neurotoxicity and myotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.",Phospholipase
1336,P0DJM8,PA2BI_GLOIT,3.1.1.4,Basic phospholipase A2 intermexin (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMIKVETGKNAIPFYAF,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity and low myotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
1337,P0DJN3,PA2B2_CRODM,3.1.1.4,Basic phospholipase A2 CB2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLLQFNKMIKFETRKNAIPFYAF,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
1338,P0DJN5,PA2B3_CRODU,3.1.1.4,Phospholipase A2 crotoxin basic chain 3 (CB3) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFNKMIKFETGKNAIPFYAF,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows presynaptic neurotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:15032748}.,Phospholipase
1339,P0DJN8,PA2B3_SISMB,3.1.1.4,Basic phospholipase A2 Smb-N6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFNKMIKIMTKKNAFPFYTS,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows myotoxic activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1341,P0DJP7,PA2AE_TRIST,3.1.1.4,Acidic phospholipase A2 Ts-A5 (svPLA2) (EC 3.1.1.4) (CTs-A5) (Phosphatidylcholine 2-acylhydrolase),NLMQFETLIMKVAGRSGVWYYGS,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows a moderate inhibition of ADP-induced human platelet aggregation when tested on platelet rich plasma. Exhibits high hydrolytic activities and prefers the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12959640}.,Phospholipase
1342,P0DJP8,PA2AG_TRIST,3.1.1.4,Acidic phospholipase A2 CTs-A1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLIQFETLIMKVAGQSGMFSYSA,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows a moderate inhibition of ADP-induced human platelet aggregation when tested on platelet rich plasma. Exhibits moderate hydrolytic activities and prefers the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12959640}.,Phospholipase
1343,P0DJP9,PA2AH_TRIST,3.1.1.4,Acidic phospholipase A2 CTs-A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLMQFELLIMKVAGRSGIVWYSD,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows a moderate inhibition of ADP-induced human platelet aggregation when tested on platelet rich plasma. Exhibits moderate hydrolytic activities and prefers the anionic micelles (dPPC with deoxycholate) to the zwitterionic micelles (dPPC with Triton X-100). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12959640}.,Phospholipase
1344,P0DJQ0,PA2BA_TRIST,3.1.1.4,Basic phospholipase A2 CTs-G6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLVQLGKMIFQETGKNPATSYGL,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that induces local edema a few hours after injection (5-10 ug) in the hind paw. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12959640}.,Phospholipase
1345,P0DJQ2,PA2HK_TRIST,,Basic phospholipase A2 homolog CTs-K49c (svPLA2 homolog),SVIELGKMILQETGKNPVTHYGA,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks catalytic activity (By similarity). Shows myotoxic activities (By similarity). Induces local edema a few hours after injection (5-10 ug) in the hind paw (PubMed:12959640). {ECO:0000250|UniProtKB:Q6H3D1, ECO:0000269|PubMed:12959640}.",Phospholipase
1346,P0DJR1,PA2AA_CROHD,3.1.1.4,Acidic phospholipase CHA-E6a (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLVQFEMMIMEVAKRSGLLWYSA,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows high lipolytic (1048 umol/mg/min) and weak ADP-induced platelet aggregation activities. Also shows weak anticoagulant activity (IC(50) is less than 1.0 uM). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:20347857}.,Phospholipase
1347,P0DJR2,PA2AB_CROHD,3.1.1.4,Acidic phospholipase A2 CHA-E6b (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLLQFEMMIMEVAKRSGIFWYSA,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that shows high lipolytic (1200 umol/mg/min) and weak ADP-induced platelet aggregation activities. Also shows weak anticoagulant activity (IC(50) of about 1.0 uM). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:20347857}.,Phospholipase
1348,P0DKL8,VKT_VIPRE,,"Kunitz-type serine protease inhibitor Vur-KIn [Cleaved into: Kunitz-type serine protease inhibitor Vur-KIn, truncated]",QDHPVFCYLPADPGICKAHKPRFYYNPASNKCKEFFYGGCGGNANNFKTRDECHHTCVASAMGRPT,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1349,P0DKR4,PA2AB_PSEFE,3.1.1.4,Acidic phospholipase A2 CbIbeta (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),DCCYGRVNGCNPKMADKNYE,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Heterodimer: presynaptic neurotoxin.; FUNCTION: Monomer: Snake venom phospholipase A2 (PLA2) is inactive towards micellar phosphatidylcholine but is weakly active towards non-micellar dithiolecithin. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1350,P0DKS3,3SX2_DENPO,,Mambalgin-2 (Ma-2) (Mamb-2) (Pi-Dp2),LKCFQHGKVVTCHRDMKFCYHNTGMPFRNLKLILQGCSSSCSETENNKCCSTDRCNK,"Snake three-finger toxin family, Short-chain subfamily, Mambalgin sub-subfamily","FUNCTION: This three-finger toxin inhibits ASIC channels. It acts as a gating modifier toxin by decreasing the apparent proton sensitivity of activation and by slightly increasing the apparent proton sensitivity for inactivation (PubMed:24695733). It binds more tightly to the closed state and to a much lesser extent the inactivated/desensitized state of ASIC1a isoform of ASIC1 (PubMed:24695733). It interacts directly with the outside surface of the thumb domain of chicken ASIC1a (ASIC1a), but does not insert into the acidic pocket as suggested previously (By similarity). This binding leads to relocation of the thumb domain that could disrupt the acidic pocket of cASIC1a (By similarity). The peptide exerts both stimulatory and inhibitory effects on ASIC1a (PubMed:24695733). It reversibly inhibits rat ASIC1a (IC(50)=21-55 nM), rat ASIC1b (IC(50)=103-192 nM), rat ASIC1a-ASIC1b (IC(50)=72 nM), rat ASIC1a-ASIC2a (IC(50)=246-252 nM) and rat ASIC1a-ASIC2b (IC(50)=61 nM) (PubMed:23034652, PubMed:23624383, PubMed:24323786, PubMed:24695733, PubMed:26991634). In vivo, it shows a potent naloxone-resistant analgesic effect against acute and inflammatory pain upon central and peripheral injection (By similarity). In addition, it also has an opioid-independent effect on both thermal and mechanical inflammatory pain after systemic administration and is effective against neuropathic pain (By similarity). {ECO:0000250|UniProtKB:P0DKR6, ECO:0000269|PubMed:23034652, ECO:0000269|PubMed:23624383, ECO:0000269|PubMed:24323786, ECO:0000269|PubMed:24695733, ECO:0000269|PubMed:26991634}.",Kunitz Family
1351,P0DKT8,PA2HB_OXYSA,,Neutral phospholipase A2 homolog cannitoxin beta chain 1 (svPLA2 homolog),NLVQFGKMIE,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily","FUNCTION: Heterotrimer: Snake venom phospholipase A2 (PLA2) heterotrimer that acts as a potent presynaptic neurotoxin by blocking synaptic transmission and synaptic vesicle recycling. Enzymatic activity is essential for the neurotoxic effects (PubMed:16135698). May act by binding in a calcium-dependent fashion to neurotonal pentraxin-1 (NPTX1) and neurotonal pentraxin-2 (NPTX2), but not to neuronal pentraxin receptor (NPTXR). Also binds to taipoxin-associated calcium binding protein 49 (RCN2), a protein localized in the lumen of endoplasmic reticulum (By similarity). {ECO:0000250, ECO:0000269|PubMed:16135698}.; FUNCTION: Monomer (beta chain): Snake venom phospholipase A2 homolog that is neither toxic nor enzymatically active. Does not bind calcium (By similarity). {ECO:0000250}.",Phospholipase
1352,P0DKU3,PA2B1_NAJNG,3.1.1.4,Basic phospholipase A2 CM-I (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme I),NLYQFKNMIHCTVPSRPWWHFADYGCYCGR,"Phospholipase A2 family, Group I subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows weak anticoagulant activity. Is more catalytically active than the strong anticoagulant protein CM-IV found in this venom. Acts by inhibiting the complex composed of tissue factor (F3) and coagulation factor VIIa (F7) (TF-VIIa complex) by only enzymatic mechanism (PubMed:8866616). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:2271532, ECO:0000269|PubMed:2814939, ECO:0000269|PubMed:8866616}.",Phospholipase
1353,P0DKU4,PA2B2_NAJNG,3.1.1.4,Basic phospholipase A2 CM-II (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme II),NLYQFKNMIHCTVPSRPWWHFADYGCYCGR,"Phospholipase A2 family, Group I subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows weak anticoagulant activity. Is more catalytically active than the strong anticoagulant protein CM-IV found in this venom. Acts by inhibiting the complex composed of tissue factor (F3) and coagulation factor VIIa (F7) (TF-VIIa complex) by only enzymatic mechanism (PubMed:8866616). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:2271532, ECO:0000269|PubMed:2814939, ECO:0000269|PubMed:8866616}.",Phospholipase
1354,P0DKW9,3L22E_ACAAN,,Alpha-elapitoxin-Aa2e (Alpha-EPTX-Aa2e) (Aa el/Aa e2),VICYVGYNNPQTCPPGGNVCFTKTWCDARCHQLGKRVEMGCATTCPKVNRGVDIKCCSTDKCNPFPKTTPPWKRPRGKP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (By similarity). Produces paralysis, clear dyspnea and lethality on mice (PubMed:9133710). {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:9133710}.",Neurotoxin
1355,P0DKX1,PA2N_DABRR,3.1.1.4,Neutral phospholipase A2 RVV-PFIIc' (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLFQFAEMIVKMTGKEAVH,"Phospholipase A2 family, Group II subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows enzymatic, indirect hemolytic and anticoagulant activities. Interestingly, anti-PFIIc'serum completely inhibits anticoagulant activity, partially inhibits the indirect hemolytic activity, but does not inhibit enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:12236591}.",Phospholipase
1356,P0DKY6,ANF_CRODC,,Natriuretic peptide NP2 (NP2_Casca),VSTSRGSQGCFGLKLDRIGAASGLGCWRRIVDS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that shows an increase in perfusion pressure, urinary flow and glomerular filtration rate. Reduces total and proximal tubular transport of sodium. In the aortic ring assay, causes a relaxant effect in endothelium-intact thoracic aortic rings precontracted with phenylephrine in the presence and absence of isatin, a natriuretic receptor antagonist. {ECO:0000269|PubMed:18835291}.",General Toxin
1372,P0DL30,LECG_BOTPI,,C-type lectin BPL (CTL) (Galactose-specific lectin),NNCPGDWLPMNGLCYKIFNELKAWEDAEMFCRKYKPGCHLASIHIYGESLEIAEYISDYHKGQAEVWIGLWDKKKDFSWEWTDRSCTDYLSWDKNQPDHYENKEFCVELVSLTGYRLWEDQVCESKNAFLCQCKF,True venom lectin family,"FUNCTION: Galactose-binding protein which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. Calcium-dependent lectin. Shows high hemagglutinating activity in the presence of human erythrocytes, which are agglutinated with a minimum hemagglutination concentration (MHC) of 2.5-0.35 ug/ml. Causes indirect nephrotoxicity. Causes reductions in perfusion pressures, renal vascular resistance, urinary flow, glomerular filtration rate, sodium, potassium and chloride tubular transport. Its effects may be caused by the release of inflammatory mediators. {ECO:0000269|PubMed:15381156}.",Vascular Interaction
1373,P0DL82,3SXNA_CALBG,,Delta-elapitoxin-Cb1a (Delta-EPTX-Cb1a) (Calliotoxin) (Three-finger toxin) (3FTx),LECYDTIFKWHTMTCPEGQNLCFYYFTWRIFLVRGCTATCPVGYSHTHCCDTDKCNN,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: This toxin shifts the voltage-dependence of Nav1.4/SCN4A activation to more hyperpolarised potentials, inhibits inactivation, and produces large ramp currents, consistent with its profound effects on contractile force in an isolated skeletal muscle preparation (PubMed:27763551). This toxin produces large muscle contractions and fasciculations in the indirectly stimulated chick biventer cervicis nerve-muscle assay, which are significantly inhibited by the addition of the sodium channel antagonist tetrodotoxin (PubMed:27763551). {ECO:0000269|PubMed:27763551}.",General Toxin
1375,P0DM46,VM3A_MICCO,3.4.24.-,Zinc metalloproteinase-disintegrin-like (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),TVTPEQDRYLQVKKY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1378,P0DMG8,OXLA_BOTCO,1.4.3.2,L-amino-acid oxidase Bco23 (LAAO) (LAO) (EC 1.4.3.2),ADDRNPLEECFRETD,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
1379,P0DMG9,OXLA_BOTFO,1.4.3.2,L-amino-acid oxidase Bfon20 (LAAO) (LAO) (EC 1.4.3.2),ADPRNPLEECFRETD,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
1380,P0DMH0,PA2A_BOTFO,3.1.1.4,Basic phospholipase A2 Bfon11 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLWQFGMMIQHTTRENPLFKYFSYGCYCGWGGGGPLDATDRCCFVHDCCYG,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that impairs hemostasis. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1381,P0DMH6,VSP_BOTFO,3.4.21.-,Snake venom serine protease (SVSP) (EC 3.4.21.-),IIGGDECNINEHRFL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1382,P0DMJ6,VKT12_DENAN,,Kunitz-type serine protease inhibitor dendrotoxin DaE1 [Cleaved into: Kunitz-type protease inhibitor dendrotoxin DaE2],LQHRTFCKLPAEPGPCKASIPAFYYNWAAKKCQLFHYGGCKGNANRFSTIEKCRRACVG,Venom Kunitz-type family,FUNCTION: DaE1 and DaE2 are serine protease inhibitors that inhibit voltage-gated potassium channels Kv1.1/KCNA1 channels (IC(50)=300 nM). {ECO:0000269|PubMed:11240130}.,Serine Protease
1383,P0DMK0,PA2H2_BOTMT,,Basic phospholipase A2 homolog BmatTX-II (svPLA2 homolog) (Lys49 PLA2-like),SLFELGKMILQETGKNPAQSYGAYGCNC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:24724078). Shows high myotoxic activity, neutrophil activation (demonstrated by activation induction of IL-1beta production), and slight cytotoxicity against Jurkat (leukemia T) and SK-BR-3 (breast adenocarcinoma) tumor cell lines (PubMed:24724078). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:24724078}.",Phospholipase
1384,P0DMM6,SLA_TROWA,,Snaclec trowaglerix subunit alpha,FKCMSEWYW,Snaclec family,"FUNCTION: Potently induces platelet aggregation of washed human platelet and platelet-rich plasma in a concentration-dependent manner. It acts by binding to GPVI (GP6), leading to kinases-dependent exposure of functional alpha-IIb/beta-3 and platelet aggregation, and also induces metalloproteinase-dependent GP6 shedding from platelets. {ECO:0000269|PubMed:18221359}.",Binding Protein
1385,P0DMM7,SLB_TROWA,,Snaclec trowaglerix subunit beta,ELCCPMERSS,Snaclec family,"FUNCTION: Potently induces platelet aggregation of washed human platelet and platelet-rich plasma in a concentration-dependent manner. It acts by binding to GPVI (GP6), leading to kinases-dependent exposure of functional alpha-IIb/beta-3 and platelet aggregation, and also induces metalloproteinase-dependent GP6 shedding from platelets. {ECO:0000269|PubMed:18221359}.",Binding Protein
1387,P0DMV6,3SA12_DABRR,,7.2 kDa cytotoxin RVV-7,LECNKLVDIAYITCPAGKNL,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: This three-finger cytotoxin shows cytotoxicity and direct nephrotoxicity. The cytotoxicity has been observed on B16F10 melanoma cells (EC(50)=2.56 uM) (PubMed:16997639) and on kidney proximal tubular epithelium LLCPK1 cells (EC(50)=4.79 uM); it is due to necrotic cell death and not to apoptosis. Direct nephrotoxicity has been deduced from binding to LLCPK1 cell line and to kidney membranes. In addition, after intravenous injection into mice tail vein, the toxin principally accumulates in kidney, but only minimally in blood, liver and brain (PubMed:17499831). {ECO:0000269|PubMed:16997639, ECO:0000269|PubMed:17499831}.",General Toxin
1389,P0DQQ1,3L23_NAJME,,Long neurotoxin Tx-NM2,KRCYRTPDLKSQTCPPGEDLCYTKKWCADWCTSRGKVIELGCVATCPTVKPYEEITCCSTDNCNPHPKMPKP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1-beta-1-gamma-delta/CHRNA1-CHRNB1-CHRNG-CHRND) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (PubMed:33672715). Ranges of nAChR inhibition are in nanomolar (competitive binding with alpha-bungarotoxin gives Ki=8.66 nM on muscle nAChR and Ki=9.47 nM on alpha-7) (PubMed:33672715). Also shows moderate inhibition on GABA(A) alpha-1-beta-3-gamma-2 receptor (GABRA1-GABRB3-GABRG2) (IC(50)=1.25 uM), and a lower inhibition on alpha-1-beta-2-gamma-2 (GABRA1-GABRB2-GABRG2) and alpha-3-beta-2-gamma-2 (GABRA3-GABRB2-GABRG2) (PubMed:33672715). {ECO:0000269|PubMed:33672715}.",Neurotoxin
1390,P0DQQ2,3L24_NAJME,,Long neurotoxin Tx-NM3-1,IRCFITPDVTSQICADGHVCYTKTWCDAWCTSRGKRVDLGCAATCPTVKTGVDIKCCSTDNCNPFPTRNRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1-beta-1-gamma-delta/CHRNA1-CHRNB1-CHRNG-CHRND) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (PubMed:33672715). Ranges of nAChR inhibition are in nanomolar (competitive binding with alpha-bungarotoxin gives Ki=1.66 nM on muscle nAChR and Ki=4.84 nM on alpha-7) (PubMed:33672715). Also shows moderate inhibition on GABA(A) alpha-1-beta-3-gamma-2 receptor (GABRA1-GABRB3-GABRG2) (IC(50)=0.68 uM), and a lower inhibition on alpha-1-beta-2-gamma-2 (GABRA1-GABRB2-GABRG2) and alpha-3-beta-2-gamma-2 (GABRA3-GABRB2-GABRG2) (PubMed:33672715). {ECO:0000269|PubMed:33672715}.",Neurotoxin
1392,P0DSN0,3SX_NAJKA,,Nakoroxin (Naja kaouthia orphan toxin) (Three-finger toxin) (3FTx),MECYRMSNIVTCQPWEKFCYKEVTMFFPNHPVHLSGCASECTETNSKFCCTTDKCNGAGSG,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: Shows no cytotoxicity and does not inhibit the binding of alpha-bungarotoxin to nicotinic acetylcholine receptors of muscle and alpha-7/CHRNA7 types. However, it potentiates the binding of alpha-bungarotoxin to the acetylcholine-binding protein from Lymnaea stagnalis. {ECO:0000269|PubMed:28864897}.",General Toxin
1393,P0DTB7,VM2A_CROAT,3.4.24.-,Snake venom metalloproteinase CatroxMP-II (SVMP) (EC 3.4.24.-) (Fibrinogenolytic metalloproteinase),NPEHQRYVELFI,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Snake venom zinc metalloproteinase that cleaves both alpha- and beta-chains of fibrinogen, but not the gamma-chain (PubMed:29761254). {ECO:0000269|PubMed:29761254}.",Metalloprotease
1394,P0DUK7,3SOF1_NAJAT,,Mu-elapitoxin-Na1a (Mu-EPTX-Na1a),LKCHNTQLPFIYKTCPEGKNLCFKATLKKFPLKFPFKRGCADNCPKNSALLKYVCCSTDKCN,"Snake three-finger toxin family, Short-chain subfamily, Orphan group XV sub-subfamily","FUNCTION: Potent inhibitor of hNav1.8/SCN10A (IC(50)=141-380 nM) (PubMed:30804211). Is highly selective for this channel and acts in a reversible manner (PubMed:30804211). Shows a depolarizing shift of activation and hyperpolarizing shift of inactivation (PubMed:30804211). In contrast to the very similar cytotoxin A5 (AC P62375), does not seem to bind integrin alpha-V/beta-3, since it does not promote or inhibit the proliferation of HUVECs and C-PAE cells (PubMed:30804211). In vivo, in rodent models of inflammatory and neuropathic pain, it alleviates nociceptive behaviors more potently than does morphine (PubMed:30804211). It displays no evident cytotoxic, hemolytic and cardiotoxic activities and produces no obvious adverse responses in mice even at a dose 30-fold higher than that producing a significant analgesic effect (PubMed:30804211). {ECO:0000269|PubMed:30804211}.",Kunitz Family
1395,P0DUN8,PA2H4_BOTMT,,Basic phospholipase A2 homolog BmatTX-IV (svPLA2 homolog) (Lys49 PLA2-like),SLVELGKMILQETGKNPVTSYGAYGCNCGVLGRGKPKDATDRCCYVHKCCY,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:31340737). Shows cytotoxic activity (IC(50)=81.2 ug/mL) against murine fibroblasts (PubMed:31340737). Shows high myotoxic activity, neutrophile activation, slight cytotoxicity against tumor cell lines, and slight antiparasitic activity against promastigote forms of Leishmania amazonensis (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:P0DMJ9, ECO:0000269|PubMed:31340737}.",Phospholipase
1396,P0DUP0,PA2H1_BOTDP,,Basic phospholipase A2 homolog BdipTx-I (svPLA2 homolog),SLFELGKMILQETGKNPAKSYGAYGCNCGVLGRGKPKEATQRCCYVHKCCYKKLTGCDPKKDRYSYSW,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that lacks enzymatic activity. Is myotoxic, induces edema, and causes systemic effects (renal changes that lead to proteinuria) on mice (PubMed:29170054). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:29170054}.",Phospholipase
1399,P10456,3S1D_LATCO,,Short neurotoxin D,MKTLLLTLVVVTMVCLDLGYTRRCFNQQSSQPKTTKSCPPGENSCYNKQWRDHRGSITERGCGCPKVKPGIKLRCCESEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1400,P10457,3S12_LATCO,,Short neurotoxin II,MKTLLLTLVVVTVVCLDLGYTRRCYNQQSSQPKTTKSCPPGENSCYNKQWRDHRGSITERGCGCPTVKPGIKLRCCESEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1401,P10458,3S1C_LATCR,,Short neurotoxin C,RRCFNQQSSQPQTNKSCPPGENSCYRKQWRDHRGTIIERGCGCPTVKPGIKLRCCQSEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission.",Neurotoxin
1402,P10459,3S1B_LATLA,,Short neurotoxin B,MKTLLLTLVVVTIVCLDLGYTRRCFNHPSSQPQTNKSCPPGENSCYNKQWRDHRGTITERGCGCPQVKSGIKLTCCQSDDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission.",Neurotoxin
1403,P10460,3S1C_LATLA,,Short neurotoxin C,RRCFNQQSSQPQTNKSCPPGENSCYRKQWRDHRGTIIERGCGCPTVKPGVKLRCCQSEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission.",Neurotoxin
1404,P12029,MYX2_CROCL,,Myotoxin-2 (Myotoxin II),YKRCHKKGGHCFPKEKICTPPSSDFGKMDCRWKWKCCKKGSVN,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
1405,P13211,SRTXD_ATREN,,Sarafotoxin-D (SRTX-D) (S6D),CTCKDMTDKECLYFCHQDIIW,Endothelin/sarafotoxin family,FUNCTION: Vasoconstrictor activity. These toxins cause cardiac arrest probably as a result of coronary vasospasm. May act by displaying agonistic activities towards endothelin-1 and -2 receptors (EDNRA and EDNRB). {ECO:0000269|PubMed:2509240}.,General Toxin
1406,P13495,3L2B_PSETE,,Pseudonajatoxin b (Long neurotoxin B),RTCFITPDVKSKPCPPGQEVCYTETWCDGFCGIRGKRVELGCAATCPTPKKTGIDIQCCSTDDCNTFPLRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1408,P14612,3L2H_PSEAU,,Long neurotoxin homolog Pa ID (LNTX-ID),MKTLLLTLVVVTIMCLDLGYTLTCYKGRDRSSETCRSEQELCCTKTWCDQWCQDRGPRLEMGCTATCPRRMPGLDFTCCTTDNCNPVPT,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1409,P15815,3LKF_BUNFL,,Kappa-flavitoxin (Kappa-ftx) (Kappa-fvt) (Long neurotoxin 2),RTCLISPSSTSQTCPKGQDICFTKAFCDRWCSSRGPVIEQGCAATCPEFTSRYKSLLCCTTDNCNH,"Snake three-finger toxin family, Long-chain subfamily, Kappa-neurotoxin sub-subfamily","FUNCTION: Postsynaptic neurotoxin that binds and inhibits neuronal nicotinic acetylcholine receptors (nAChR) with high affinity (IC(50)<100 nM). Is a selective, and slowly reversible antagonist of alpha-3/CHRNA3-containing and some alpha-4/CHRNA4-containing AChRs. {ECO:0000269|PubMed:3828786, ECO:0000269|PubMed:8334127}.",Neurotoxin
1410,P15816,3LK2_BUNMU,,Kappa-2-bungarotoxin (Kappa-neurotoxin CB1),MKTLLLTLVVVTIVCLDLGYTKTCLKTPSSTPQTCPQGQDICFLKVSCEQFCPIRGPVIEQGCAATCPEFRSNDRSLLCCTTDNCNH,"Snake three-finger toxin family, Long-chain subfamily, Kappa-neurotoxin sub-subfamily","FUNCTION: Postsynaptic neurotoxin that binds and inhibits neuronal nicotinic acetylcholine receptors (nAChR) with high affinity (IC(50)<100 nM). Is a selective, and slowly reversible antagonist of alpha-3/CHRNA3-containing and some alpha-4/CHRNA4-containing AChRs. {ECO:0000250|UniProtKB:P01398, ECO:0000269|PubMed:2322821}.",Neurotoxin
1411,P15817,3LK3_BUNMU,,Kappa-3-bungarotoxin (K3Bgt) (Kappa-neurotoxin) (Long neurotoxin CR1),MKTLLLSLVVVTIVCLDLGYTRTCLISPSSTPQTCPNGQDICFRKAQCDNFCHSRGPVIEQGCVATCPQFRSNYRSLLCCRTDNCNH,"Snake three-finger toxin family, Long-chain subfamily, Kappa-neurotoxin sub-subfamily","FUNCTION: Postsynaptic neurotoxin that binds and inhibits neuronal nicotinic acetylcholine receptors (nAChR) with high affinity (IC(50)<100 nM). Is a selective, and slowly reversible antagonist of alpha-3/CHRNA3-containing and some alpha-4/CHRNA4-containing AChRs. {ECO:0000250|UniProtKB:P01398, ECO:0000269|PubMed:2322821}.",Neurotoxin
1413,P16338,VM2_AGKPI,,Disintegrin applaggin (Applagin) (Platelet aggregation activation inhibitor),EAGEECDCGSPENPCCDAATCKLRPGAQCAEGLCCDQCKFMKEGTVCRARGDDVNDYCNGISAGCPRNPFH,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen. {ECO:0000269|PubMed:2510158}.",Fibrinogenolytic Enzyme
1414,P17495,VM2B_CRAGM,,Disintegrin trigramin-beta-2 (Platelet aggregation activation inhibitor) [Cleaved into: Disintegrin trigramin-beta-1],EAGKDCDCGSPANPCCDAATCKLLPGAQCGEGPCCDQCSFMKKGTICRRARGDDLDDYCNGRSAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to the alpha-IIb/beta-3 receptor (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen. {ECO:0000269|PubMed:2320569}.",Fibrinogenolytic Enzyme
1415,P18328,3SIM2_DENAN,,Muscarinic toxin 2 (MT2) (MTx2),MKTLLLTLVVVTIVCLDLGYTLTCVTTKSIGGVTTEDCPAGQNVCFKRWHYVTPKNYDIIKGCAATCPKVDNNDPIRCCGTDKCND,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Binds irreversibly to M1 (CHRM1) muscarinic acetylcholine receptors, and reveals a slightly weaker effect on M3 (CHRM3) receptors. The mechanism of toxin-receptor interaction comprises at least two steps. The first step is fast with no competition between the toxin and the antagonist. The second step is slow with formation of a more stable toxin-receptor complex and inhibition of the antagonist binding. {ECO:0000269|PubMed:7778123}.",Vascular Interaction
1416,P18618,VM2_BOTAT,,Disintegrin batroxostatin (Disintegrin colombistatin) (Platelet aggregation activation inhibitor),EAGEECDCGAPENPCCDAATCKLRPGAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFY,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to the glycoprotein IIb-IIIa receptor (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Also inhibits T24 and SK-Mel-28 cell adhesion to fibronectin with IC(50) of 4.4 uM and 33 nM, respectively. {ECO:0000269|PubMed:18830584, ECO:0000269|PubMed:2207176}.",Fibrinogenolytic Enzyme
1417,P18692,VSPCE_CERVI,3.4.21.-,Thrombin-like enzyme cerastobin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGAKCNINEHRSIVLLYSSRLFGHTLINKEWVL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease, that cleaves both alpha-chain (FGA) and beta-chain (FGB) of fibrinogen. Partially degrades factor X (F10), and release bradykinin from kininogen (KNG). Potently induces platelet aggregation. Shows a proteolytic activity towards protein constituents of the platelets cytoskeleton. Hydrolyzes actin, actin-binding protein, and P235. Shows a preferential cleavage at Arg-|-Xaa bonds. {ECO:0000269|PubMed:1963167, ECO:0000269|PubMed:2539861}.",Serine Protease
1418,P18997,PA2B_GLOHA,3.1.1.4,Basic phospholipase A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLLQFRKMIKKMTGKEVVWYAFYGCYCGGGGK,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1419,P18999,PA2_DABSI,3.1.1.4,Phospholipase A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLFQFARMINKKLGAFXFXNYI,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1420,P19859,VKTCI_NAJNA,,Kunitz-type serine protease inhibitor (Venom chymotrypsin inhibitor),RPRFCELAPSAGSCFGFVSSYYYNRYSNTCHSFTYSGCGKNANRFRTIDECNRTCVV,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that inhibits chymotrypsin (By similarity). Also interacts with vasopressin V2 receptor (V2R/AVPR2) (PubMed:35122240). Inhibits vasopressin binding human V2R in the nanomolar range (Ki=7.87 nM), and also moderately inhibits vasopressin-induced cAMP production (IC(50)=208 nM). In vivo, intraperitoneal injection of this protein into rats increases diuresis by 1.6-fold, without any loss of electrolytes (PubMed:35122240). {ECO:0000250|UniProtKB:Q5ZPJ7, ECO:0000269|PubMed:35122240}.",Serine Protease
1421,P19958,3S13_AIPLA,,Short neurotoxin C,LTCCNQQSSQPKTTTDCADNSCYKKTWKDHRGTRIERGCGCPQVKPGIKLECCKTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1422,P19959,3S12_AIPLA,,Short neurotoxin B,MKTLLLTLVVVTIVCLDLGYTLTCCNQQSSQPKTTTDCADNSCYKMTWRDHRGTRIERGCGCPQVKPGIKLECCKTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1423,P20229,VKTTI_NAJNA,,Kunitz-type serine protease inhibitor (Venom trypsin inhibitor),RPGFCELPAAKGLCKAHKPAFYYNKDSHRCQKFIYGGCGGNANRFRTIDECNRTCVG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin (Ki=0.0035 nM). {ECO:0000269|PubMed:1702708}.,Serine Protease
1426,P20416,VMXBN_BOTJA,3.4.24.50,Snake venom metalloproteinase bothrolysin (SVMP) (EC 3.4.24.50) (Hemorrhagic metalloproteinase J) (Zinc metalloproteinase bothrolysin),TPEHQRYIELFLVVDSGMFMKYNGNSDKI,Venom metalloproteinase (M12B) family,FUNCTION: Snake venom zinc metalloproteinase that impairs hemostasis in the envenomed animal.,Metalloprotease
1427,P21790,PA21_MICNI,3.1.1.4,Phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFKNMIQCTTKRSVLEFMEYGCYC,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1428,P21791,PA22_MICNI,3.1.1.4,Phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLQYLKNMIKCTNTRHWLSFTNYGCYCG,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1429,P21792,PA23_MICNI,3.1.1.4,Phospholipase A2 3 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLYQFKNMIKCTNTRMWWSFTNAGCYDG,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1430,P21858,VM2_GLOBL,,Disintegrin halysin (Platelet aggregation activation inhibitor),EAGEECDCGSPGNPCCDAATCKLRQGAQCAEGLCCDQCRFMKKGTVCRIARGDDMDDYCNGISAGCPRNPF,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen. {ECO:0000269|PubMed:1888330}.",Fibrinogenolytic Enzyme
1431,P21859,VM2T_PROFL,,Disintegrin triflavin (Platelet aggregation activation inhibitor) (RGD-containing peptide) (Trimestatin),GEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRIARGDFPDDRCTGQSADCPRWNGL,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1432,P22029,SLEA_BOTJA,,Snaclec botrocetin subunit alpha (Platelet coagglutinin),DCPSGWSSYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEKQCSSEWSDGSSVSYENVVERTVKKCFALEKDLGFVLWINLYCAQKNPFVCKSPPP,Snaclec family,"FUNCTION: Snaclec that binds to von Willebrand factor (VWF) and induces its interaction with GPIbalpha (GP1BA) (via the vWF A1 domain), resulting in platelet aggregation.",Vascular Interaction
1433,P22030,SLEB_BOTJA,,Snaclec botrocetin subunit beta (Platelet coagglutinin),DCPPDWSSYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLSDVWNKCRFEWTDGMEFDYDDYYLIAEYECVASKPTNNKWWIIPCTRFKNFVCEFQA,Snaclec family,"FUNCTION: Snaclec that binds to von Willebrand factor (VWF) and induces its interaction with GPIbalpha (GP1BA) (via the vWF A1 domain), resulting in platelet aggregation.",Vascular Interaction
1434,P22826,VM2TI_ERIMA,,Disintegrin eristicophin (Platelet aggregation activation inhibitor),QRQEEPCATGPCCRRCKFKRAGKVCRVARGDWNNDYCTGKSCDCPRNPWNG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen. {ECO:0000269|PubMed:2033037}.",Fibrinogenolytic Enzyme
1435,P22827,VM2I_SISMB,,Disintegrin barbourin (Platelet aggregation activation inhibitor),EAGEECDCGSPENPCCDAATCKLRPGAQCADGLCCDQCRFMKKGTVCRVAKGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibitor of ligand binding to the integrins alpha-IIb/beta-3 (ITGA2B/ITGB3). Competition with fibrinogen for the RGD recognition sites on the alpha-IIb/beta-3 integrin results in the inhibition of platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Kunitz Family
1436,P22828,VM2I_SISTE,,Disintegrin tergeminin (Platelet aggregation activation inhibitor),EAGEECDCGSPANPCCDAATCKLRPGAQCADGLCCDQCRFMKKGTVCRVARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1437,P22947,3SLS_DENPO,,Calciseptin (Calciseptine) (CaS) (L-type calcium channel blocker),RICYIHKASLPRATKTCVENTCYKMFIRTQREYISERGCGCPTAMWPYQTECCKGDRCNK,"Snake three-finger toxin family, Short-chain subfamily, L-type calcium blocker sub-subfamily",FUNCTION: This specific blocker of the L-type calcium channel (Cav1/CACNA1) is a smooth muscle relaxant and an inhibitor of cardiac contractions. {ECO:0000269|PubMed:1848702}.,Kunitz Family
1440,P24330,MYX_CROAD,,Myotoxin (CAM-toxin),MKILYLLFAFLFLAFLSEPGNAYKRCHKKGGHCFPKTVICLPPSSDFGKMDCRWRWKCCKKGSVNNAISI,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
1441,P24541,VKT_ERIMA,,Kunitz-type serine protease inhibitor (Venom trypsin inhibitor),FCYLPDDPGVCKAHIPRFYYNPASNKCKNFIYGGCGGNANNFETRAECRHTCVASGKGGPRP,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that inhibits trypsin (PubMed:1743283). The recombinant protein also barely blocks voltage-gated potassium channel Kv1.3/KCNA3 (3.70% inhibition at 60 nM of toxin) (PubMed:30648553). {ECO:0000269|PubMed:1743283, ECO:0000269|PubMed:30648553}.",Serine Protease
1442,P24644,PA21_CALBG,3.1.1.4,Phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme I),NLYQFGNMIQCTIPKRLSWSSFVDYGCYCGKGGSGTPV,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1443,P24645,PA22_CALBG,3.1.1.4,Phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme II),NLYQFGNMIKCTIPKRLSWRSFVDYGCYCGKGGSGTPV,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1444,P24776,3SB2_HEMHA,,Cytotoxin 2 (Toxin 12A),LKCHNKVVPFLSKTCPEGKNLCYKMTLKKVPKIPIKRGCTDACPKSSLLVNVMCCKTDKCN,"Snake three-finger toxin family, Short-chain subfamily, Type IB cytotoxin sub-subfamily","FUNCTION: This protein lyses red blood cells, has cytotoxic activity and induces hypotension, but is not neurotoxic. In addition, it induces direct paralysis of the muscle fiber. {ECO:0000303|PubMed:404150}.",Neurotoxin
1446,P24778,3SOE_HEMHA,,Cytotoxin homolog (Toxin 9B/9BB),LICHNRPLPFLHKTCPEGQNICYKMTLKKTPMKLSVKRGCAATCPSERPLVQVECCKTDKCNW,"Snake three-finger toxin family, Short-chain subfamily, Orphan group XIV sub-subfamily",FUNCTION: This toxin has a very low toxicity. {ECO:0000269|PubMed:404150}.,General Toxin
1449,P25497,3S11_PSEAU,,Short neurotoxin 1 (Neurotoxin PA A),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTICAGGESSCYKKTWSDHRGSRTERGCGCPHVKPGIKLTCCKTDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000269|PubMed:4091794}.",Neurotoxin
1453,P25667,3L23_DENPO,,Alpha-elapitoxin-Dpp2b (Alpha-EPTX-Dpp2b) (Long neurotoxin 3) (Toxin VN2),RTCNKTFSDQSKICPPGENICYTKTWCDAWCSRRGKIVELGCAATCPKVKAGVGIKCCSTDNCNLFKFGKPR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1454,P25668,3L21_NAJNA,,Long neurotoxin 1 (Toxin A),IRCFITPDITSKDCPNGHVCYTKTWCDGFCSIRGKRVDLGCAATCPTVRTGVDIQCCSTDDCDPFPTRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1455,P25670,3L21_ASPSC,,Long neurotoxin 1 (Toxin S4C6),RICYIAPYDHKTCAAGENICYLKAWCDAWCSSRGKKLEFGCAATCPTVKPGVDISCCDTDNCNPHPKL,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1456,P25671,3L23_NAJNA,,Long neurotoxin 3 (Toxin C),IRCFITPDITSKDCPNGHVCYTKTWCDAFCSIRGKRVDLGCAATCPTVKTGVDIQCCSTDDCDPFPTRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1457,P25672,3L24_NAJNA,,Long neurotoxin 4 (Toxin D),IRCFITPDITSKDCPNGHVCYTKTWCDGFCRIRGERVDLGCAATCPTVKTGVDIQCCSTDDCDPFPTRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1458,P25674,3L21_NAJHH,,Long neurotoxin 1 (Toxin CM-5),IRCFITPDVTSQACPDGHVCYTKMWCDNFCGMRGKRVDLGCAATCPTVKPGVDIKCCSTDNCNPFPTRKRS,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1459,P25675,3S12_NAJHH,,Short neurotoxin 2 (Toxin CM-10a),MICHNQQSSQPPTIKTCPGETNCYKKQWRDHRGTIIERGCGCPSVKKGVGIYCCKTDKCNR,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1460,P25683,3SL8_DENJA,,Toxin S4C8,RICYTHKSLQAKTTKSCEGNTCYKMFIRTSREYISERGCGCPTAMWPYQTECCKGDRCNK,"Snake three-finger toxin family, Short-chain subfamily, L-type calcium blocker sub-subfamily",FUNCTION: This specific blocker of the L-type calcium channel (Cav1/CACNA1) is a smooth muscle relaxant and an inhibitor of cardiac contractions. {ECO:0000250|UniProtKB:P01414}.,Kunitz Family
1461,P25684,3SL2_DENAN,,Toxin C10S2C2,RICYSHKASLPRATKTCVENSCYKMFIRTSPDYISDRGCGCPTAMWPYQTACCKGDRCNK,"Snake three-finger toxin family, Short-chain subfamily, L-type calcium blocker sub-subfamily",FUNCTION: This specific blocker of the L-type calcium channel (Cav1/CACNA1) is a smooth muscle relaxant and an inhibitor of cardiac contractions. {ECO:0000250|UniProtKB:P01414}.,Kunitz Family
1464,P29601,PA2HA_BUNFA,,Acidic phospholipase A2 homolog (svPLA2 homolog),NMVQFKSMVQCTSTRPWLDYVDYGCNCDIGGTGTPLDELDRCCQTHANCYTEARKFPECAPYYKTYSYTCSGGTITCNADNDECAASVCNCDRTAALCFAGAPYNQNNFDVDLETRCQ,"Phospholipase A2 family, Group I subfamily, A49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) homolog that lacks both catalytic and neurotoxicity activities. {ECO:0000269|PubMed:1478931}.,Phospholipase
1468,P31981,VM2I_CROBA,,Disintegrin basilicin (Basicilin) (Platelet aggregation activation inhibitor),AGEECDCGSPANPCCDAATCKLRPGAQCAEGLCCDQCRFIKKGKICRRARGDNPDDRCTGQSADCPRNHFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1469,P31982,VM2I_CROCC,,Disintegrin cerastin (Platelet aggregation activation inhibitor),EAGEECDCGTPENPCCDAATCKLRPGAQCADGLCCDQCRFMKKGTVCRVARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1470,P31984,VM2I_CROMM,,Disintegrin molossin (Platelet aggregation activation inhibitor),EAGIECDCGSPENPCCDAATCKLRPGAQCADGLCCDQCRFIKKGKICRRARGDNPDDRCTGQSADCPRNRFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1471,P31985,VM2I_CROCE,,Disintegrin cereberin (Platelet aggregation activation inhibitor),EAGEECDCGSPANPCCDAATCKLRPGAQCAEGLCCDQCRFIKKGKICRRARGDNPDDRCTGQSADCPRNRFH,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelet. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1472,P31986,VM2I_CROLT,,Disintegrin lutosin (Platelet aggregation activation inhibitor),EAGEECDCGSPANPCCDAATCKLRPGAQCADGLCCDQCRFIKKGTVCRVARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1473,P31987,VM2I_CROVV,,Disintegrin viridin (Platelet aggregation activation inhibitor),AGEECDCGSPANPCCDAATCKLRPGAQCADGLCCDQCRFIKKGKICRRARGDNPDDRCTGQSADCPRNRFH,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1474,P31988,VM2_BOTCO,,Disintegrin cotiarin (Platelet aggregation activation inhibitor),EAGEECDCGAPENPCCDAATCKLRPGAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFH,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1475,P31990,VM2I_LACMU,,Disintegrin lachesin (Platelet aggregation activation inhibitor),EAGEECDCGAPANPCCDAATCKLRPGAQCAEGLCCDQCRFIKKGKICRRARGDNPDDRCTGQSADCPRNGYYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1476,P32879,3S11_AIPLA,,Short neurotoxin A,LTCCNQQSSQPKTTTDCADNSCYKKTWQDHRGTRIERGCGCPQVKPGIKLECCKTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1477,P34074,3L221_NAJAN,,Long neurotoxin 1 (NXL1),IRCFITPRVSSQACPDGHVCYTKTWCDNFCGINGKRVDLGCAATCPTVKPGVDIKCCSTDNCNPFPTRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and hinders acetylcholine binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:1814007}.",Neurotoxin
1478,P34075,3S11_NAJAN,,Short neurotoxin 1,KICYNQPSSQHPTTKACPGEKNCYRKQWSDHRGTIIERGCGCPTVKPGVKLHCCTTEKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1479,P34076,3S11_NAJCH,,Short neurotoxin 1,MECHNQQSSQPPTTTHCSGGETNCYEKRWHDHRGTIIERGCGCPTVKPGVKLNCCTTDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1481,P58930,WAG24_TROWA,,Waglerin-4 (SL-Waglerin-2) [Cleaved into: Waglerin-2 (Lethal peptide II) (Waglerin II)],SLGGKPDLRPCYPPCHYIPRPKPR,Waglerin family,"FUNCTION: Waglerin-2 selectively blocks the epsilon subunit of muscle nicotinic acetylcholine receptor (nAChR). Has also effects on rodent ionotropic GABA(A) receptors (GABR), since it potentiates I(GABA) in some neurons and depresses I(GABA) in others. In mice, it elicits tachypnea, ocular proptosis, rapid collapse and spasms, whereas no toxic effects on respiration and blood pressure are observed in rats (By similarity). {ECO:0000250}.; FUNCTION: Waglerin-4 selectively blocks the epsilon subunit of muscle nicotinic acetylcholine receptor. It elicits tachypnea, ocular proptosis, rapid collapse and spasms in mice. It causes death by respiratory failure (By similarity). {ECO:0000250}.",Neurotoxin
1482,P59066,PA2_AUSSU,3.1.1.4,Phospholipase A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),NLIQFANMIGCANHGSR,"Phospholipase A2 family, Group I subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-, ADP-, thrombin-, ionophore-, adrenaline-, ristocetin-, and arachidonic acid-induced platelet aggregation. Inhibits serotonin release. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8362372}.",Phospholipase
1483,P59072,3S331_PSETE,,Short neurotoxin N1 (Alpha-neurotoxin),LTCYKGYRDTV,"Snake three-finger toxin family, Short-chain subfamily, Type III alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and hinders acetylcholine binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:10518793}.",Neurotoxin
1484,P59073,3S332_PSETE,,Short neurotoxin N2 (Alpha-neurotoxin),LTCYKGYHDTVVCKP,"Snake three-finger toxin family, Short-chain subfamily, Type III alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and hinders acetylcholine binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:10518793}.",Neurotoxin
1488,P59264,PA2BA_PROFL,3.1.1.4,Basic phospholipase A2 PLA-A (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFRKMIKKMTGKEPIVSYAFYGCYCGKGGRGKPKDATDRCCFVHDCCYEKVTGCDPKWSYYTYSLEDGDIVCEGDPYCTKVKCECDKKAAICFRDNLKTYKNRYMTFPDIFCTDPTEGC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities. PLA-A is three times less active than PLA-B in edema-inducing activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1489,P59265,PA2BB_PROFL,3.1.1.4,Basic phospholipase A2 PLA-B (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),HLLQFRKMIKKMTGKEPIVSYAFYGCYCGKGGRGKPKDATDRCCFVHDCCYEKVTGCDPKWSYYTYSLENGDIVCEGDPYCTKVKCECDKKAAICFRDNLKTYKNRYMTFPDIFCTDPTEGC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities. PLA-B is three times more active than PLA-A in edema-inducing activities. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1490,P59275,3S1B_NAJKA,,Cobrotoxin-b (CBT-b) (Short neurotoxin III) (NT3),LECHNQQSSQTPTTKTCSGETNCYKKWWSDHRGTIIERGCGCPKVKPGVNLNCCRRDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Binds to the nicotinic acetylcholine receptor. {ECO:0000269|PubMed:12039691, ECO:0000305|PubMed:12039691}.",Neurotoxin
1491,P59359,PA2B_AUSSU,3.1.1.4,Basic phospholipase A2 S2-22 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASDIPPQPLNLVQFSNMIQCANHGRRPTSNYMDYGCYCGKGGSGTPVDELDRCCKIHDDCYGEAEKSQKCAPYWTWYTWKCGSDGPQCDDSKTGCQRFVCDCDATAAKCFAKAPYNKENYNIKTRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1492,P60234,3SI12_DENAN,,Muscarinic m1-toxin2,LTCVKSNSIWFPTSEDCPPGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Binds irreversibly and specifically to M1 (CHRM1) muscarinic acetylcholine receptors, blocking further binding of antagonists and preventing the action of agonists. {ECO:0000269|PubMed:10665800}.",Binding Protein
1493,P60235,3SI13_DENAN,,Muscarinic m1-toxin3,LTCVKSDSIWFPTSEDCPDGQNLCFKKWQYISPRMYDFTR,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Binds irreversibly and specifically to M1 (CHRM1) muscarinic acetylcholine receptors, blocking further binding of antagonists and preventing the action of agonists. {ECO:0000269|PubMed:10665800}.",Binding Protein
1494,P60236,3SI14_DENAN,,Muscarinic m1-toxin4,LTCVKSNSIWFITSENCPAGQNLCFKRWQYISPRMYDFTR,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Binds irreversibly and specifically to M1 (CHRM1) muscarinic acetylcholine receptors, blocking further binding of antagonists and preventing the action of agonists. {ECO:0000269|PubMed:10665800}.",Binding Protein
1499,P60771,3S1CB_NAJKA,,Cobrotoxin (CBT) (Short neurotoxin I) (NT1),MKTLLLTLLVVTIVCLDLGYTLECHNQQSSQTPTTTGCSGGETNCYKKRWRDHRGYRTERGCGCPSVKNGIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1500,P60772,3S15_NAJSP,,Neurotoxin 5 (Toxin 5),LECHNQQSSQAPTTKTCSGETNCYKKWWSDHRGTIIERGCGCPKVKPGVKLNCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1501,P60773,3S11_NAJPH,,Short neurotoxin 1 (NTX I),LECHNQQSSQAPTTKTCSGETNCYKKWWSDHRGTIIERGCGCPKVKPGVKLNCCRTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1502,P62376,3S12_HYDCY,,Short neurotoxin 2 (Hydrophitoxin b),PLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTNCAESSCYKKTWSDHRGTRIERGCGCPQVKSGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1504,P62383,VM2G_CRAGM,,Disintegrin trigramin-gamma (Platelet aggregation activation inhibitor),EAGEDCDCGSPANPCCDAATCKLLPGAQCGEGLCCDQCSFMKKGTICRRARGDDLDDYCNGISAGCPRNPLHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen. {ECO:0000269|PubMed:2320569}.",Fibrinogenolytic Enzyme
1505,P62384,VM2G_TRIAB,,Disintegrin albolabrin (Platelet aggregation activation inhibitor),EAGEDCDCGSPANPCCDAATCKLLPGAQCGEGLCCDQCSFMKKGTICRRARGDDLDDYCNGISAGCPRNPLHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelet receptors. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1506,P62388,3S1A_HYDPL,,Pelamitoxin a,MTCCNQQSSQPKTTTNCAESSCYKKTWSDHRGTRIERGCGCPQVKSGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1509,P63175,MYX2_CROVV,,Myotoxin-2 [Cleaved into: Myotoxin-4],YKRCHKKEGHCFPKTVICLPPSSDFGKMDCRWKWKCCKKGSVNNA,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
1510,P63176,MYX3_CROVV,,Myotoxin-3,YKRCHKKGGHCFPKTVICLPPSSDFGKMDCRWKWKCCKKGSVNNA,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
1511,P63327,MYX_CRODR,,Crotamine Ile-19 (CRO_Ile-19),YKQCHKKGGHCFPKEKICIPPSSDFGKMDCRWRWKCCKKGSG,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor, it induces severe muscle necrosis by a non-enzymatic mechanism and exhibits antimicrobial activities (By similarity). It also elicits a short-lasting hyperextension of the hind limb (Ref.1). It does not cause observable tissue damage (whereas the whole venom causes severe myonecrosis accompanied by edema and hemorrhage) (Ref.1). {ECO:0000250|UniProtKB:Q9PWF3, ECO:0000269|Ref.1}.",Kunitz Family
1512,P68412,3S11_HYDST,,Short neurotoxin 1 (Toxin A),MTCCNQQSSQPKTTTNCAGNSCYKKTWSDHRGTIIERGCGCPQVKSGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1513,P68415,3S11_HYDSC,,Short neurotoxin 1 (Toxin 4),MTCCNQQSSQPKTTTNCAESSCYKKTWSDHRGTRIERGCGCPQVKPGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1514,P68416,3S11_HYDHA,,Short neurotoxin 1 (SN12) (Toxin 4),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTNCAESSCYKKTWSDHRGTRIERGCGCPQVKPGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1515,P68417,3S11_NAJHA,,Short neurotoxin 1 (Neurotoxin alpha),LECHNQQSSQPPTTKTCPGETNCYKKRWRDHRGSITERGCGCPSVKKGIEINCCTTDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission.; FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Binds to the muscular nicotinic acetylcholine receptor.",Neurotoxin
1516,P68418,3S11_NAJHH,,Short neurotoxin 1 (Toxin CM-6),LECHNQQSSQPPTTKTCPGETNCYKKRWRDHRGSITERGCGCPSVKKGIEINCCTTDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission.",Neurotoxin
1517,P68419,3S11_NAJNI,,Short neurotoxin 1 (Neurotoxin delta),LECHNQQSSQPPTTKTCPGETNCYKKRWRDHRGSITERGCGCPSVKKGIEINCCTTDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission.",Neurotoxin
1518,P68521,VM2I_CRODD,,Disintegrin durissin (Platelet aggregation activation inhibitor),AGEECDCGSPANPCCDAATCKLRPGAQCADGLCCDQCRFIKKGTVCRPARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen.",Fibrinogenolytic Enzyme
1519,P70089,PA2H7_CRAGM,,Basic phospholipase A2 homolog 7 (svPLA2 homolog) (Phospholipase A2 isozyme VII) (PLA2-VII),MRTLWLMAVLLVGVEGGVIELTKMIVQEMGKNALTSYSLYGCNCGPGGRRKPMDATDSCCYVHKCCYKKLTDCDPIKDRYSYSWVNKAIVCGEKNPHLKELCECDKAVAICFRENMDTYDKKKKINLKLFCKKTSEKC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (By similarity). Is myotoxic and displays edema-inducing activities (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:Q90249}.",Phospholipase
1520,P79799,VNP32_MICCO,,Natriuretic peptide Mc-NP (Micrurus natriuretic peptide) (MNP),MVGLSRLRGGGLLLVLALLPLALDGKPLEEAPTAPSRIIPFSRPVRKQSQAVLDPMVHPERPAGSGDDGDSRRLEGLAKEALGDGCFGQRIDRICNVSGMGCNHVRTDPAPTALARIIPFSRPVRKESRAALDRMQQPG,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that dose-dependently induces the rapid relaxation of rat aortic strips phenylephrine-precontracted. Acts by stimulating cGMP production in a dose-dependent manner (by probably activating NPR1 and/or NPR2). May also show potent hypotensive effects (By similarity). A synthetic peptide (AA 77-108, where the Cys-95 is replaced by a Ser) increases sodium excretion and urinary volume in rat kidneys. {ECO:0000250|UniProtKB:D9IX97, ECO:0000269|PubMed:9432002}.",General Toxin
1523,P80494,3SIMA_DENPO,,Muscarinic toxin alpha (MT-alpha),LTCVTSKSIFGITTENCPDGQNLCFKKWYYLNHRYSDITWGCAATCPKPTNVRETIHCCETDKCNE,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Selectively binds with high-affinity to the a2B-adrenoceptor subtype (ADRA2B) (PubMed:20466015). The toxin reversibly binds to ADRA2B, and its mode of inhibition is non-competitive (PubMed:20466015). The toxin has also been described to bind with high affinity to all muscarinic receptor subtypes (Ki=23 nM (on CHRM1), Ki=44 nM (on CHRM2), Ki=3 nM (on CHRM3), Ki=5 nM (on CHRM4), and Ki=8 nM (on CHRM5)) but no other data support these affinity values (PubMed:8536706). {ECO:0000269|PubMed:10978757, ECO:0000269|PubMed:20466015, ECO:0000269|PubMed:21557730, ECO:0000269|PubMed:8536706}.",General Toxin
1524,P80548,3S11_MICNI,,Three-finger toxin Mnn I (Neurotoxin alpha) (Nicotinic acetylcholine receptor-binding protein Mnn-9) (Short neurotoxin 1),MICHNQQSSQPPTIKTCSEGQCYKKTWRDHRGTISERGCGCPTVKPGIHISCCASDKCNA,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1525,P80965,3L25_OPHHA,,Long neurotoxin OH-5 (Alpha-neurotoxin),TKCYKTGDRIISEACPPGQDLCYMKTWCDVFCGTRGRVIELGCTATCPTVKPHEQITCCSTDNCDPHHKMLQ,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1526,P81030,3SIM1_DENAN,,Muscarinic toxin 1 (MT1) (MTx1),LTCVTSKSIFGITTENCPDGQNLCFKKWYYIVPRYSDITWGCAATCPKPTNVRETIRCCETDKCNE,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Shows a non-competitive interaction with adrenergic and muscarinic receptors. Binds to alpha-2b (ADRA2B) (IC(50)=2.3 nM), alpha-1a (ADRA1A), alpha-1b (ADRA1B), and alpha-2c (ADRA2C) adrenergic receptors. Reversibly binds to M1 (CHRM1) muscarinic acetylcholine receptors, probably by interacting with the orthosteric site (PubMed:12488533, PubMed:24793485, PubMed:7778123). Also reveals a slightly weaker effect at M3 (CHRM3) and M4 (CHRM4) receptors (PubMed:12488533, PubMed:24793485, PubMed:7778123). The order of potency is ADRA2B>>CHRM1>ADRA1A>ADRA1B>ADRA2C/CHRM4 (PubMed:24793485). {ECO:0000269|PubMed:12488533, ECO:0000269|PubMed:21557730, ECO:0000269|PubMed:24793485, ECO:0000269|PubMed:7778123}.",Vascular Interaction
1527,P81112,SLA2_TRIAB,,Snaclec alboaggregin-A subunit alpha' (Alboaggregin-A subunit 2) (AL-A subunit 2),DFHCLPGWSAYDQYCYRVFNEPKNWEDAERFCAKQADSGHLVSIETMGEADFVAQLISENIQSEKHYVWIGLKVQNKEQQCSSEWSDGSSVTYENLIKLYMRKCGALEQESGFRKWINLGCIQLNPFVCKFPPQ,Snaclec family,"FUNCTION: Potent platelet activator that aggregates platelets via both GPIbalpha (GP1BA) and GPVI (GP6). Induces a tyrosine phosphorylation profile in platelets that resembles this produced by collagen, involving the time dependent tyrosine phosphorylation of Fc receptor gamma chain (FCGR1A), phospholipase Cgamma2 (PLCG2), and LAT. {ECO:0000269|PubMed:11159519, ECO:0000269|PubMed:11389045, ECO:0000269|PubMed:8823201, ECO:0000269|PubMed:9531050}.",Phospholipase
1528,P81113,SLA3_TRIAB,,Snaclec alboaggregin-A subunit beta (Alboaggregin-A subunit 3) (AL-A subunit 3),GFDCPFGWSSYEGYCYKVYNKKMNWEDAESFCREQHKRSHLVSFHSSGEVDFVVSKTFPILRYDFVWMGLSDIWKECTKEWSDGARLDYKAWSGKSYCLVSKTTNNEWLSMDCSRTRYPVCKFXG,Snaclec family,"FUNCTION: Potent platelet activator that aggregates platelets via both GPIbalpha (GP1BA) and GPVI (GP6). Induces a tyrosine phosphorylation profile in platelets that resembles this produced by collagen, involving the time dependent tyrosine phosphorylation of Fc receptor gamma chain (FCGR1A), phospholipase Cgamma2 (PLCG2), and LAT. {ECO:0000269|PubMed:11159519, ECO:0000269|PubMed:11389045, ECO:0000269|PubMed:8823201, ECO:0000269|PubMed:9531050}.",Phospholipase
1529,P81114,SLA4_TRIAB,,Snaclec alboaggregin-A subunit beta' (Alboaggregin-A subunit 4) (AL-A subunit 4),DCPSDWSSYEGHCYRVFNEPQNWADAEKFCTQQHKGSHLVSFQSSEEADFVVQMTRPILNANLVWIGLSNLWNQCNSQWSDGTXLDYKXWREQFECLVSRTTNNEWLSMDCSSTHSFVCEFQA,Snaclec family,"FUNCTION: Potent platelet activator that aggregates platelets via both GPIbalpha (GP1BA) and GPVI (GP6). Induces a tyrosine phosphorylation profile in platelets that resembles this produced by collagen, involving the time dependent tyrosine phosphorylation of Fc receptor gamma chain (FCGR1A), phospholipase Cgamma2 (PLCG2), and LAT. {ECO:0000269|PubMed:11159519, ECO:0000269|PubMed:11389045, ECO:0000269|PubMed:8823201, ECO:0000269|PubMed:9531050}.",Phospholipase
1530,P81115,SLBA_TRIAB,,Snaclec alboaggregin-B subunit alpha (AL-B subunit alpha) (25-kDa alboaggregin),MGRFIFVSFGLLVVFLSLSGTGADCPSDWSSFKQYCYQIVKELKTWEDAEKFCSEQANDGHLVSIESYREAVFVAELLSENVKTTKYNVWIGLSVQNKGQQCSSEWSDGSSVSYENLVKPNPKKCFVLKKESEFRTWSNVYCEQKHIFMCKFLGSR,Snaclec family,FUNCTION: Weakly agglutinates platelets at high doses by binding to GPIbalpha (GP1BA). {ECO:0000269|PubMed:1747371}.,Binding Protein
1531,P81116,SLBB_TRIAB,,Snaclec alboaggregin-B subunit beta (AL-B subunit beta) (25-kDa alboaggregin),MGRFIFGSFGLLVLFLSLSGTGADCPSDWSSYDLYCYKVFQQRMNWEDAEQFCRQQHTGSHLLSFHSSEEVDFVVSKTLPILKADFVWIGLTDVWSACRLQWSDGTELKYNAWTAESECIASKTTDNQWWTRSCSRTYPFVCKLEV,Snaclec family,FUNCTION: Weakly agglutinates platelets at high doses by binding to GPIbalpha (GP1BA). {ECO:0000269|PubMed:1747371}.,Binding Protein
1532,P81478,PA2A2_CRAGM,3.1.1.4,Acidic phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme II) (PLA2-II),NLLQFENMIRNVAGRSGIWWYSDYGCYCGKGGHGRPQDASDRCCFVHDCCYGKVNGCNPKKAVYIYSLENGDIVCGGDDPCRKEVCECDKAAAICFRDNKDTYDNKYWNIPSENCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has high lipolytic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1533,P81479,PA2A4_CRAGM,3.1.1.4,Acidic phospholipase A2 4 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme IV) (PLA2-IV),HLMQFETLIMKVAGRSGVWYYGSYGCFCGAGGQGRPQDASDRCCFVHDCCYGKVNGCDPKKDFYTYSEENGDIVCGGDDPCKKEICECDKDAAICFRDNKDTYDNKYWFFPAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has high lipolytic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1534,P81480,PA2A3_CRAGM,3.1.1.4,Acidic phospholipase A2 3 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme III) (PLA2-III),NLMQFETLIMKVAGRSGVWYYGSYGCFCGAGGQGRPQDASDRCCFVHDCCYGKVNGCDPKKDFYTYSEENGAIVCGGDDPCKKEICECDKDAAICFRDNKDTYDNKYWFFPAKNCQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has high lipolytic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.,Phospholipase
1535,P81508,SLA_CROHD,,Snaclec CHH-B subunit alpha,DLECPSGWSSYDRYCYKPFKQEMTWADAERFCSEQAKGRHLLSVETALEASFVDNVLYANKEYLTRYIWIGLRVQNKGQPCSSIYSENLVDPFDCFMVSRDTRLREWFKVDCEQQHSFICKFTRPRR,Snaclec family,FUNCTION: Binds to the subunit GPIbalpha (GP1BA) of the platelet GPIb/V/IX receptor system. It inhibits ristocetin- and vWF-induced platelet aggregation in platelet-rich plasma by inhibiting the binding of vWF to GPIbalpha. {ECO:0000269|PubMed:8823201}.,Binding Protein
1536,P81509,SLB_CROHD,,Snaclec CHH-B subunit beta,DCPSDWSSYEGHCYRVFQQEMTWDDAEKFCTQQHTGGHLVSFRSSEEVDFLVSILKFDLFWMGWRDIWNERRLQWSDGTKVNYKAWSAEPECIVCRATDNQWLSTSCSKTHNVVCKF,Snaclec family,FUNCTION: Binds to the subunit GPIbalpha (GP1BA) of the platelet GPIb/V/IX receptor system. It inhibits ristocetin- and vWF-induced platelet aggregation in platelet-rich plasma by inhibiting the binding of vWF to GPIbalpha.,Binding Protein
1537,P81630,VM23A_ECHCA,,Disintegrin EC3A,NSVHPCCDPVKCEPREGEHCISGPCCRNCYFLRAGTVCKRAVGDDVDDYCSGITPDCPRNRYKGKED,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily",FUNCTION: Inhibits adhesion of cells expressing alpha-4/beta-1 (ITGA4/ITGB1) and alpha-4/beta-7 (ITGA4/ITGB7) integrins to the natural ligands vascular cell adhesion molecule 1 (VCAM-1) and mucosal addressin cell adhesion molecule 1 (MADCAM-1). It is also a weaker inhibitor of alpha-5/beta-1 (ITGA5/ITGB1) and alpha-2b/beta-3 (ITGA2B/ITGB3) integrins. The inhibitory activity of EC3 towards alpha-4 integrins is associated with the MLD sequence of EC3B subunit. The ability of EC3 to inhibit ITGA5/ITGB1 resides in both subunits A and B. {ECO:0000269|PubMed:10212222}.,Kunitz Family
1538,P81631,VM23B_ECHCA,,Disintegrin EC3B,NSVHPCCDPVKCEPREGEHCISGPCCRNCKFLNAGTICKRAMLDGLNDYCTGISTDCPRNRYKGKED,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIe sub-subfamily",FUNCTION: Inhibits adhesion of cells expressing alpha-4/beta-1 (ITGA4/ITGB1) and alpha-4/beta-7 (ITGA4/ITGB7) integrins to the natural ligands vascular cell adhesion molecule 1 (VCAM-1) and mucosal addressin cell adhesion molecule 1 (MADCAM-1). It is also a weaker inhibitor of alpha-5/beta-1 (ITGA5/ITGB1) and alpha-2b/beta-3 (ITGA2B/ITGB3) integrins. The inhibitory activity of EC3 towards alpha-4 integrins is associated with the MLD sequence of EC3B subunit. The ability of EC3 to inhibit ITGA5/ITGB1 resides in both subunits A and B. {ECO:0000269|PubMed:10212222}.,Kunitz Family
1540,P81714,CYT_NAJAT,,Cystatin,IPGGLSPRSVSDPDVQKAAAFAVQEYNAGSANAHYYKELRVVEAQSQSVAGEKYFLMMELVKTKCAKTAGKPKVYKEIQNCELPPIKQQEEKLCGFQVW,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L (Ki is 0.1 nM), papain (Ki is 0.19 nM), cathepsin S (Ki is 1.2 nM), and cathepsin B (Ki is 2.5 nM). This protein has no toxic activity and its function in the venom is unknown. It may play a role as housekeeping or regulatory protein. {ECO:0000269|PubMed:9512485}.",General Toxin
1541,P81742,DIDAA_ERIMA,,Disintegrin EMF10A (EMF-10A) (Eristocophin I) (Platelet aggregation activation inhibitor),MNSANPCCDPITCKPKKGEHCVSGPCCRNCKFLNPGTICKKGRGDNLNDYCTGVSSDCPRNPWKSEEED,"Disintegrin family, Dimeric disintegrin subfamily","FUNCTION: Extremely potent and selective inhibitor of integrin alpha-5/beta-1 (ITGA5/ITGB1). Partially inhibits adhesion of cells expressing alpha-IIb/beta-3 (ITGA2B/ITGB3), alpha-V/beta-3 (ITGAV/ITGB3), and alpha-4/beta-1 (ITGA4/ITGB1) to appropriate ligands only at concentration higher than 500 nM. Weakly inhibits ADP-induced platelet aggregation. {ECO:0000269|PubMed:10529205}.",Kunitz Family
1542,P81782,3NOJ_BUNCA,,Bucandin,MECYRCGVSGCHLKITCSAEETFCYKWLNKISNERWLGCAKTCTEIDTWNVYNKCCTTNLCNT,"Snake three-finger toxin family, Ancestral subfamily, Orphan group XIX sub-subfamily","FUNCTION: This toxin is described as enhancing presynaptic acetylcholine release, but neither experimental results, nor references to other sources are available. {ECO:0000303|PubMed:11053837}.",General Toxin
1550,P82849,3S1B2_NAJKA,,Cobrotoxin II (CBT II) (CBT2) (Short neurotoxin 1) (Short neurotoxin 5),LECHNQQSSQTPTTTGCSGGENNCYKKEWRDNRGYRTERGCGCPSVKKGIGINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1555,P83224,VNPA_OXYMI,,Natriuretic peptide TNPa (TNP-a) (Taipan natriuretic peptide) (Venom natriuretic peptide OxsSNPa),SDSKIGDGCFGLPLDHIGSVSGLGCNRPVQNRPKK,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that exhibits vasoactive and probable hypotensive activity (PubMed:15652496). Is only weakly active on natriuretic peptide receptor-C (NPR3) (PubMed:15652496). Stimulates cGMP production through the natriuretic peptide receptor 1 (NPR1) with moderate potencies for the rat NPR1 (EC(50)=2020 nM), and very weak potencies over human NPR1 (15% activation at 10 uM) (PubMed:37049825). In vivo, does not impact systolic and diastolic blood pressure, as well as heart rate, when intravenously injected in conscious rabbits (PubMed:37049825). Does not affect the bradycardia due to cardiac afferent stimulation (Bezold-Jarisch reflex) (PubMed:37049825). {ECO:0000269|PubMed:15652496, ECO:0000269|PubMed:37049825}.",General Toxin
1556,P83225,VNPA_OXYSC,,Natriuretic peptide TNP-a (Taipan natriuretic peptide) (Venom natriuretic peptide OxsSNPa),SDSKIGDGCFGLPLDHIGSVSGLGCNRPVQNRPKK,Natriuretic peptide family,FUNCTION: Snake venom natriuretic peptide that exhibits vasoactive and probable hypotensive activity (PubMed:15652496). Is only weakly active on natriuretic peptide receptor-C (NPR3) (PubMed:15652496). {ECO:0000269|PubMed:15652496}.,General Toxin
1557,P83226,VNPA_OXYSA,,Natriuretic peptide TNP-a (Taipan natriuretic peptide) (Venom natriuretic peptide OxsSNPa),SDSKIGDGCFGLPLDHIGSVSGLGCNRPVQNRPKK,Natriuretic peptide family,FUNCTION: Snake venom natriuretic peptide that exhibits vasoactive and probable hypotensive activity (PubMed:15652496). Is only weakly active on natriuretic peptide receptor-C (NPR3) (PubMed:15652496). {ECO:0000269|PubMed:15652496}.,General Toxin
1558,P83227,VNPB_OXYMI,,Natriuretic peptide TNPb (TNP-b) (Taipan natriuretic peptide) (Venom natriuretic peptide OxsSNPb),SDPKIGDGCFGLPLDHIGSVSGLGCNRPVQNRPKK,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that exhibits vasoactive and probable hypotensive activity (PubMed:15652496). Is only weakly active on natriuretic peptide receptor-C (NPR3) (PubMed:15652496). Stimulates cGMP production through the natriuretic peptide receptor 1 (NPR1) with moderate potencies for the rat NPR1 (EC(50)=1200 nM), and very weak potencies over human NPR1 (30% activation at 10 uM) (PubMed:37049825). In vivo, does not impact systolic and diastolic blood pressure, as well as heart rate, when intravenously injected in conscious rabbits (PubMed:37049825). Does not affect the bradycardia due to cardiac afferent stimulation (Bezold-Jarisch reflex) (PubMed:37049825). {ECO:0000269|PubMed:15652496, ECO:0000269|PubMed:37049825}.",General Toxin
1559,P83229,VNPB_OXYSA,,Natriuretic peptide TNP-b (Taipan natriuretic peptide) (Venom natriuretic peptide OxsSNPb),SDPKIGDGCFGLPLDHIGSVSGLGCNRPVQNRPKK,Natriuretic peptide family,FUNCTION: Snake venom natriuretic peptide that exhibits vasoactive and probable hypotensive activity (PubMed:15652496). Is only weakly active on natriuretic peptide receptor-C (NPR3) (PubMed:15652496). {ECO:0000269|PubMed:15652496}.,General Toxin
1561,P83234,VESP_OPHHA,,Ohanin,MLLFTLCFFADQENGGKALASPPGNWQKADVTFDSNTAFESLVVSPDKKTVENVGVPKGVPDSPERFSSSPCVLGSPGFRSGKHFFEVKYGTQREWAVGLAGKSVKRKGYLRLVPEERIWQKGLWWLRRLETDSDKLQKGSGKIIVFLDYDEGKVIFDLDGEVTTIQANFNGEEVVPFYYIGARVSLANL,Ohanin/vespryn family,"FUNCTION: Neurotoxin that produces dose-dependent hypolocomotion and hyperalgesia in mice. May directly act on the central nervous system, as it is 6500-fold more potent when administered intracerebroventricularly than intraperitoneal. {ECO:0000269|PubMed:15668253}.",Neurotoxin
1564,P83490,3NBB_COERA,,Alpha-colubritoxin,QAIGPPYGLCFQCNQKTSSDCTEARRCSPFHEKCYTLYQPDENWMKSSGLSHFGCGKQCPTAGPEGRVTCCLTPRCN,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily",FUNCTION: Potent postsynaptic neurotoxin. Displays readily reversible competitive antagonism at the nicotinic acetylcholine receptor (nAChR). {ECO:0000269|PubMed:14708577}.,Neurotoxin
1566,P84470,VKTH8_BUNCA,,Kunitz-type serine protease inhibitor homolog T2 B chain (Neurotoxin T2 B chain),RQRHRDCDKPPDKTN,Venom Kunitz-type family,FUNCTION: Neurotoxin T2 is a presynaptic neurotoxin of the venom that exhibits indirect hemolytic activity against human erythrocytes. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and is non-toxic. {ECO:0000269|PubMed:14769867}.,Kunitz Family
1567,P84471,VKTH1_BUNCA,,Kunitz-type serine protease inhibitor homolog T1-1 B chain (Neurotoxin T1-1 B chain),RKRHPDCDKAADTRI,Venom Kunitz-type family,FUNCTION: Neurotoxin T1-1 is a presynaptic neurotoxin of the venom that exhibits indirect hemolytic activity against human erythrocytes. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and is non-toxic. {ECO:0000269|PubMed:14769867}.,Kunitz Family
1568,P84472,PA2BT_BUNCA,3.1.1.4,Basic phospholipase A2 T1-2 A chain (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase T1-2 A),NLYQFKEMIRYTIP,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini and exhibits indirect hemolytic activity against human erythrocytes. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:14769867}.,Phospholipase
1569,P84473,VKTH2_BUNCA,,Kunitz-type serine protease inhibitor homolog T1-2 B chain (Neurotoxin T1-2 B chain),RQRHPDCDKPPDTGN,Venom Kunitz-type family,FUNCTION: Neurotoxin T1-2 is a presynaptic neurotoxin of the venom that exhibits indirect hemolytic activity against human erythrocytes. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and is non-toxic. {ECO:0000269|PubMed:14769867}.,Kunitz Family
1570,P84474,PA2BU_BUNCA,3.1.1.4,Basic phospholipase A2 T2 A chain (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase T2 A),NLINFMEMIRYTIP,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini and exhibits indirect hemolytic activity against human erythrocytes. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:14769867}.,Phospholipase
1571,P84475,PA2BA_BUNCA,3.1.1.4,Basic phospholipase A2 T1-1 A chain (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase T1-1 A),NLYQFKEMIRYTIP,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini and exhibits indirect hemolytic activity against human erythrocytes. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:14769867}.,Phospholipase
1572,P84745,VVP2_BOTJR,,1095.6 Da venom vasodilator peptide,PPPPPGPPPNP,,FUNCTION: Toxin. Induces vasodilation in mice and rabbits. {ECO:0000269|Ref.1}.,General Toxin
1573,P84747,VVP1_BOTMO,,1370.6 Da venom vasodilator peptide,PKVSPRWPPIPP,,FUNCTION: Toxin. Induces vasodilation in mice and rabbits. {ECO:0000269|Ref.1}.,General Toxin
1579,P85024,BKIP_CROVV,,Bradykinin inhibitor peptide (BIP),TPPAGPDVGPR,Bradykinin inhibitor peptide family,FUNCTION: Bradykinin inhibitor peptide antagonizes the vasodilatory actions of bradykinin at the B2 bradykinin receptor (BDKRB2). {ECO:0000269|PubMed:16277978}.,Kunitz Family
1580,P85025,BKIP_AGKBI,,Bradykinin inhibitor peptide (BIP),TPPAGPDVGPR,Bradykinin inhibitor peptide family,FUNCTION: Bradykinin inhibitor peptide antagonizes the vasodilatory actions of bradykinin at the B2 bradykinin receptor (BDKRB2). {ECO:0000269|PubMed:16277978}.,Kunitz Family
1581,P85039,VKTC8_DABSI,,Kunitz-type serine protease inhibitor C8 (BPTI-8) (Chymotrypsin inhibitor 8) (Chymotrypsin inhibitor B8) (Chymotrypsin inhibitor C8),HDRPKFCYLPADPGECLAHMRSF,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits chymotrypsin. {ECO:0000269|Ref.1}.,Serine Protease
1582,P85040,VKTC9_DABSI,,Kunitz-type serine protease inhibitor C9 (BPTI-9) (Chymotrypsin inhibitor 9) (Chymotrypsin inhibitor C9),HDRPKFCYLPADPGECMA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits chymotrypsin. {ECO:0000269|Ref.1}.,Serine Protease
1583,P85041,VKT10_DABSI,,Kunitz-type serine protease inhibitor C10 (BPTI-10) (Trypsin inhibitor 10) (Trypsin inhibitor C10),YNPASNQCQGF,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin. {ECO:0000269|Ref.1}.,Serine Protease
1584,P85140,3L2N3_BUNCA,,Alpha-bungarotoxin N3 (AlphaN3),IVCHTTATSPISAVTCPPGENLCYRKMCDAICSSRGKVVELGCAATCPSKKPYEEVTCCSNDKCNPHPKQRPG,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (By similarity). Mice injected with this toxin develop flaccid paralysis followed by death. Irreversibly inhibits twitches in a concentration-dependent manner in rat phrenic nerve-hemidiaphragm and chick biventer cervicis muscle (PubMed:19728988). {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:19728988}.",Neurotoxin
1590,P85520,3NO2_NAJOX,,Oxiana weak toxin (OWT),LTCLICPEKYCNKVHTCRNGEKICFKKFDQRKLLGKRYIRGCAATCPEAKPREIVECCSTDKCNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds to muscle and neuronal nicotinic acetylcholine receptors (nAChR) (Ref.1). It binds to extracellular domain of rat alpha-7/CHRNA7 nAChR (IC(50)=2.2 uM) and to Torpedo californica membranes (IC(50)=30 uM) (Ref.1). {ECO:0000269|Ref.1}.,Neurotoxin
1591,P86094,3SX_MICSU,,Short neurotoxin MS11 (Three-finger toxin) (3FTx),LKCYGIFRKIMTCPQGQNICEKFAYSPMHNGWMYSWGCTSNCHKGPLDKCCSTDLCNY,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Binds to and inhibits the endogenous nicotinic acetylcholine receptors (nAChR) in the human rhabdomyosarcoma TE 671 cell line with an IC(50) of 266 mM. Not toxic to mice by intraperitoneal injection or to zebrafish by injection at the back dorsolateral region. {ECO:0000269|PubMed:18384102}.,Neurotoxin
1592,P86095,3S11_MICSU,,Three-finger toxin MS1 (Short neurotoxin MS1),MICYNQQSTEPPTTKTCSEGQCYKKTWSDHRGTIIERGCACPNVKPGVKISCCSSDKCR,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily",FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Binds to and inhibits the endogenous nicotinic acetylcholine receptors (nAChR) in human rhabdomyosarcoma TE 671 cell line with an IC(50) of 48.2 mM. This neurotoxin is lethal to mice by intraperitoneal injection and to zebrafish by injection at the back of the dorsolateral region. {ECO:0000269|PubMed:18384102}.,Neurotoxin
1593,P86096,3NX2_MICSU,,Long neurotoxin MS2,LTCHTCPYNTCANSETCPAGKNICYQKKWEEHQGERIERRCVANCPKLGSNDKSLLCCRRDDCN,"Snake three-finger toxin family, Ancestral subfamily",FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Very weak inhibitor of the endogenous nicotinic acetylcholine receptors (nAChR) in the human rhabdomyosarcoma TE 671 cell line. Not toxic to mice by intraperitoneal injection or to zebrafish by injection at the back of the dorsolateral region. {ECO:0000269|PubMed:18384102}.,Kunitz Family
1594,P86097,3S13_MICSU,,Three-finger toxin MS3 (Short neurotoxin MS3),LICYSQMYNEIIKTCENGETTCYSKTWRDHRGTRLEKGCGCPPVKYDMIVKCCKTDRCGN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily",FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Binds to and inhibits the endogenous nicotinic acetylcholine receptors (nAChR) in human rhabdomyosarcoma TE 671 cell line with an IC(50) of 346 mM. This neurotoxin is lethal to mice by intraperitoneal injection and to zebrafish by injection at the back of the dorsolateral region. {ECO:0000269|PubMed:18384102}.,Neurotoxin
1595,P86098,3NX4_MICSU,,Long neurotoxin MS4,LTCKTCPFNTCANSETCPAGKNICYQKKWEEHRGERIERRCVANCPKLGSNDKSLLCCRRDDCN,"Snake three-finger toxin family, Ancestral subfamily","FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Weak inhibitor of the endogenous nicotinic acetylcholine receptors (nAChR) in the human rhabdomyosarcoma TE 671 cell line with an IC(50) of 690 mM. This neurotoxin is lethal to zebrafish by injection at the back of the dorsolateral region, but is not toxic to mice by intraperitoneal injection. {ECO:0000269|PubMed:18384102}.",Kunitz Family
1596,P86099,3NX5_MICSU,,Long neurotoxin MS5,LTCHTCPYNTCANSETCPAGKNICYQKKWEEHRGERIERSCVANCPEFESSHTSLLCCTTANCD,"Snake three-finger toxin family, Ancestral subfamily","FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Very weak inhibitor of the endogenous nicotinic acetylcholine receptors (nAChR) in the human rhabdomyosarcoma TE 671 cell line. This neurotoxin is lethal to zebrafish by injection at the back of the dorsolateral region, but is not toxic to mice by intraperitoneal injection. {ECO:0000269|PubMed:18384102}.",Kunitz Family
1598,P86382,3SA7_NAJNA,,Cytotoxin 7 (CTX7),LKCNKLIPLAYKTCPAGKDLCYKMYMVSNKTVPVKRGCIDVCPKNSLLVKYECCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Shows cytolytic activity on many different cells by forming pore in lipid membranes. In vivo, increases heart rate or kills the animal by cardiac arrest. In addition, it binds to heparin with high affinity, interacts with Kv channel-interacting protein 1 (KCNIP1) in a calcium-independent manner, and binds to integrin alpha-V/beta-3 (ITGAV/ITGB3) with moderate affinity (By similarity). Preferentially binds acidic phospholipids like phosphatidylserine, phosphatidic acid and phosphatidyl glycerol (PubMed:26456928). Has hemolytic activity towards human erythrocytes (EC(50)=0.171 uM) and cytolytic activity towards various cell lines (PubMed:26456928). {ECO:0000250|UniProtKB:P60301, ECO:0000250|UniProtKB:P60304, ECO:0000269|PubMed:26456928}.",Serine Protease
1599,P86420,3S11_MICFR,,Frontoxin I (FTx I),MICYNHQSSEPPTTKTCSEGQCYKKSWSDHRGTIIERGCACPNVKPGVKIICCRSC,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1600,P86421,3SX2_MICFR,,Frontoxin II (FTx II) (Three-finger toxin) (3FTx),LICYVSKDGETATCPPGQKCEKYAVSASHTGHWFYMYDCTSTCHIGPYNVCCSTDLCNR,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: Neurotoxin. Blocks muscular nicotinic acetylcholine receptors (nAChR). {ECO:0000305|PubMed:20331995}.,Neurotoxin
1601,P86422,3S13_MICFR,,Frontoxin III (FTx III),LTCFNDFSPTAHTVEDCQRGITTCYMKTWRVHRETVIERGCGCPKVKPGIRLKCCTGNTCNY,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000269|PubMed:20331995}.",Neurotoxin
1602,P86423,3NX4_MICFR,,Frontoxin IV (FTx IV),MTCKTCPFETCANSEYCPAGNDICYQKKWNDHREEMIERGCVANCPQMESHHTSLLCCRRDNCN,"Snake three-finger toxin family, Ancestral subfamily",FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Binds to the muscular nicotinic acetylcholine receptor (nAChR). {ECO:0000269|PubMed:20331995}.,Neurotoxin
1603,P86424,3NX5_MICFR,,Frontoxin V (FTx V),LTCNTCAFKTCANSETCAAGKNICYQRKWNEHHGERIERKCVANCPELGSHDTSLLCCRIPDCN,"Snake three-finger toxin family, Ancestral subfamily",FUNCTION: Produces peripheral paralysis by blocking neuromuscular transmission at the postsynaptic site. Binds to the muscular nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:P86099}.,Neurotoxin
1604,P86425,3S16_MICFR,,Frontoxin VI (FTx VI),LICYNDHGYTGKTTETCENGETTCYEKSR,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:F5CPD6}.",Neurotoxin
1605,P86522,3L2A2_ACAAN,,Alpha-elapitoxin-Aa2a (Alpha-EPTX-Aa2a),VICYRGYNYAQPCPPGENVCFTKTWCDARCYQLGK,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscular nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby potently impairing neuromuscular transmission. Pseudo-irreversibly inhibits the nAChR through competitive antagonism. In contrast to other long-chain alpha-neurotoxins, lacks affinity for neuronal alpha-7 nicotinic acetylcholine receptor. {ECO:0000269|PubMed:20950587}.",Neurotoxin
1606,P86536,VM3CX_DABRR,3.4.24.58,Coagulation factor X-activating enzyme heavy chain (EC 3.4.24.58) (Coagulation factor X-activating enzyme chain alpha) (RVV-X heavy chain) (Snake venom metalloproteinase) (SVMP),VATSEQFNKTFIELVIVVD,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIId sub-subfamily","FUNCTION: Catalytic subunit of coagulation factor X-activating enzyme, a zinc-protease enzyme that acts in hemostasis. Activates coagulation factor X (F10) by cleaving the Arg-Ile bond at position 234 and is also able to activate coagulation factor IX (F9) and protein C (PROC) by specific cleavage of Arg-Ile and Arg-Val bonds (By similarity). {ECO:0000250}.",Metalloprotease
1607,P86538,3SA2A_NAJNA,,Cytotoxin 2a (CTX2a) (Cytotoxin 2) (CTX2),LQCNKLVPIASKTCPPGKNLCYKMFMVSDLTIPVKRGCIDVCPKNSLLVKYECCNTDRCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Shows cytolytic activity on many different cells by forming pore in lipid membranes. In vivo, increases heart rate or kills the animal by cardiac arrest. In addition, it binds to heparin with high affinity, interacts with Kv channel-interacting protein 1 (KCNIP1) in a calcium-independent manner, and binds to integrin alpha-V/beta-3 (ITGAV/ITGB3) with moderate affinity (By similarity). Preferentially binds acidic phospholipids like phosphatidylserine, phosphatidic acid and phosphatidyl glycerol (PubMed:26456928). Has hemolytic activity towards human erythrocytes (EC(50)=1.024 uM) and cytolytic activity towards various cell lines (PubMed:26456928). {ECO:0000250|UniProtKB:P60301, ECO:0000250|UniProtKB:P60304, ECO:0000269|PubMed:26456928}.",Serine Protease
1610,P86545,VSP_NAJNA,3.4.21.-,Thrombin-like enzyme TLP (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),IGGFECNEHEHRSLVYLYNSAGFFCAGTLLNHEWVV,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Shows strong hydrolytic activity towards Boc-Asp(oBzl)-Pro-Arg-MCA, a synthetic substrate for thrombin. {ECO:0000269|PubMed:20203422}.",Serine Protease
1612,P86975,PA2HB_BOTLC,,Basic phospholipase A2 homolog blK-PLA2 (svPLA2 homolog),SLFELGKMILQETGKNSVKSYGVYGCNCGVGGRGKPKDATDRCCYVHKCCYKKLTGCDPKKDRYSYSWKDKTIVCGENNPCLKELCECDKAVAICLRENLGTYNKKYRYHLKPFCKKADPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) homolog that lacks enzymatic activity (By similarity). Shows myotoxic and edema-inducing activities in vivo (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:P82287}.",Phospholipase
1614,Q072L7,VSP_LACST,3.4.21.-,Snake venom serine protease (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLALVYITSGFLCGGTLINQQWVLTAAHCDRGNMLIFFDVHSLKGLNKDVQSRVAKEKFICPNRKKDDEKDKDIMLIKLDSPVSNSEHIAPLSLPSNPPSVGSVCRIMGWGAITSPNVTLPGVPHCANINILDYEVCRKAYTGLPATSRTLCAGILEGGKDSCKGDSGGPLICNGQFQGIVSWGAHPCGQSLKPGVYTKVFDYTEWIQSILAGNADATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1615,Q076D1,VM31_CRODU,3.4.24.-,Zinc metalloproteinase-disintegrin-like crotastatin (EC 3.4.24.-) (Snake venom metalloprotease) (SVMP) (Vascular apoptosis-inducing protein-like) (VAP-like),EQQRYLNAKKYVKLFLVADYIMYLKYGRNLTAVRTRMYDIDNVITPIYHRMNIHVALVGLEIWSNTDKIIVQSSADVTLDLFAKWRATDLLSRKSHDNAQLLTGINFNGPTAGLGYLGGICNTMYSAGIVQDHSKIHDLVAIAIAHEMGHNLGMDHDKDTCTCGTRPCIMAGALSCEASFLFSDCSQKDHQEFLIKNMPQCILKKPLKTDVVSPAVCGNYFVEVGEECDCGPPRTCRDPCCDAATCKLRQGAQCAEGLCCDQCRFKGAGTECRAAKDECDMADVCTGRSTECTDRFQRNGQPCKNNNGYCYNGKCPIMADQCIALFGPGATVSQDACFQFNREGNHYGYCRKEQNTKIACEPQDVKCGRLYCFPNSPENKNPCNIYYSPNDEDKGMVLPGTKCADGKACSNGQCVDVNTPY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIc sub-subfamily","FUNCTION: Snake venom zinc metalloprotease that induces apoptosis in vascular endothelial cells (VEC), without degrading the extracellular matrix (it cannot cleave collagen) or inhibiting adhesion of VEC. Has also fibrinogenolytic and hemorrhagic activities (By similarity). {ECO:0000250}.",Metalloprotease
1618,Q09GK1,VSP_PHIOL,3.4.21.-,Snake venom serine protease (SVSP) (EC 3.4.21.-),MALIGVLANLLILCLSYARTAPDRIIGGLECNQNEHRSLVLLYNSGGFFCSGTLINHEWVLTAAHCNRENIQIKLGVHNIHVPNEDEQIRVPKEKVCCLGTMNCTQWNQDIMLIRLNSSVNYSTHIAPLSLPSNPPSVGSVCRVMGWGTITSPEVTYPEVPHCVNIQILHKELCEAAYPILLGNSNILCAGKLLGDKDSCKGDSGGPLICNGQIQGIVSWGGFPCAQILEPGVYTKVFDYIDWIQDIMAGNANVICPGDNF,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1619,Q09GK2,VNP_PHIOL,,C-type natriuretic peptide (CNP),MVASRLAAGGLLLLALLALALDGKPAPPQPLRKAPAGGTTAWRRELTEQPEGASRPAAGGGGGGGRSGSKAANAAPTAPKSKGGAAAAAAAAARLMRDLRPDSKQARAAWGRMVHPEHHAGGGGGGGGGGGASRRLKGVAKKGLGKGCFGLKLDRIGSMSGLGC,Natriuretic peptide family,FUNCTION: Snake venom natriuretic peptide that has a vasorelaxant activity in rat aortic strips and a diuretic potency in anesthetized rats (By similarity). May act by activating natriuretic receptors (NPR1 and/or NPR2). {ECO:0000250|UniProtKB:P0C7P5}.,General Toxin
1620,Q0NZX6,VM2JR_BOTJA,3.4.24.-,Zinc metalloproteinase-disintegrin jararin (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),FVANRMAHELGHNLGIDNDRDSCSCGANSCIMSATVSNEPSSRFSDCSLNQYSSDLINYYGCLLNEPLRTDIVSPPFCGNYYPEVGEDCDCGPPANCQNPCCDAATCKLTTGSQCAEGLCCDQCKFIKARQICRKGRGDNPDDRCTGQSGDCPRNS,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIb sub-subfamily",FUNCTION: Snake venom zinc metalloproteinase that inhibits ADP-induced platelet aggregation (probably by binding integrin alpha-IIb/beta-3 (ITGA2B/ITGB3)) and degrades fibrinogen. {ECO:0000250}.,Metalloprotease
1621,Q0NZX7,VM3B4_BOTJA,3.4.24.-,Zinc metalloproteinase-disintegrin-like bothrojarin-4 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),IVSPPVCGNYFVEVGEECDCGLPRNCQNQCCNATTCKLIPGAQCEDGECCERCQFKGAGNVCRPRRSKCDIAESCTGQSPDCPTDRFRRNGVSCLNN,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: The hemorrhagic metalloproteinase-disintegrin-like bothrojarin-1 is a potent inhibitor of collagen-induced platelet aggregation by blockage of alpha-2/beta-1 (ITGA2/ITGB1) integrin. It does not present any fibrinogen-clotting activity (By similarity). {ECO:0000250}.,Kunitz Family
1622,Q0NZX8,VM3B3_BOTJA,3.4.24.-,Zinc metalloproteinase-disintegrin-like bothrojarin-3 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),SPPVCGTELLEVGEECDCGSPTNCRNPCCDATTCKLHSWVECESGECCEQCRFIKAGNVCRPQRSECDIAESCTGQSADCPTDDIQRNGQPCLNNFGYCYNGMCPIMYHQCIALFGASATVSPDSCFDSNLDGQGLFYCRRERARIFPCAKEDVKCGRLFCNYFQSSCLYQYSGDIDFGMVDDGTKCAEGKVCNSN,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: The hemorrhagic metalloproteinase-disintegrin-like bothrojarin-1 is a potent inhibitor of collagen-induced platelet aggregation by blockage of alpha-2/beta-1 (ITGA2/ITGB1) integrin. It does not present any fibrinogen-clotting activity (By similarity). {ECO:0000250}.,Kunitz Family
1623,Q0NZX9,VM3B2_BOTJA,3.4.24.-,Zinc metalloproteinase-disintegrin-like bothrojarin-2 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),RQNRHEASCRIVSPPVCGNELLEKGEECDCGSPRNCRDPCCDAATCKLHSWVECESGECCDQCRFIKAGNVCRPQRSECDIAESCTGQSAQCPTDDFHKNGQPCLSNYGYCYNGNCPIMHHQCYALFGSGAIVAQDGCFKFNDRGDKFFYCRKENVIITPCAQEDVKCGRLFCHTKKSECDFDYSEDPDYGMVDHGTKCADGKVCNSNRQCVDVTTAY,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: The hemorrhagic metalloproteinase-disintegrin-like bothrojarin-1 is a potent inhibitor of collagen-induced platelet aggregation by blockage of alpha-2/beta-1 (ITGA2/ITGB1) integrin. It does not present any fibrinogen-clotting activity (By similarity). {ECO:0000250}.,Kunitz Family
1624,Q0NZY0,VM3B1_BOTJA,3.4.24.-,Zinc metalloproteinase-disintegrin-like bothrojarin-1 (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP),DIVSPPVCGNYFVEVGEECDCGRPGKCQNPCCNATTCKLTPGSQCADGLCCDQCRFKGAGTECRAARSECDIAESCTGQSPECPTDDFQRNGQPCLNNQGYCYNGNCPILDHQCHNLFGAGATVAPDACFNFNRRGQGIYYCRKQNGVTIPCARKDIKCGRLFCVQ,"Venom metalloproteinase (M12B) family, P-III subfamily, P-IIIa sub-subfamily",FUNCTION: The hemorrhagic metalloproteinase-disintegrin-like bothrojarin-1 is a potent inhibitor of collagen-induced platelet aggregation by blockage of alpha-2/beta-1 (ITGA2/ITGB1) integrin. It does not present any fibrinogen-clotting activity (By similarity). {ECO:0000250}.,Kunitz Family
1625,Q1RPS9,VKTH5_BUNMU,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B5 chain,MSSGGLLLLLGLLTFCAELTPVSSRKRHPYCNLPPDPGPCHDNKFAFYHHPASNKCKEFVYGGCGGNDNRFKTRNKCQCTCSG,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxins are presynaptic neurotoxins of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv) (By similarity). {ECO:0000250}.,Kunitz Family
1626,Q1RPT0,VKTH4_BUNMU,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B4 chain,MSSGGLLLLLGLLTLCAELTPVSSRKRHPDCDKPPDTKICQTVVRAFYYKPSAKRCVQFRYGGCNGNGNHFKSDHLCRCECLEYS,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxins are presynaptic neurotoxins of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv) (By similarity). {ECO:0000250}.,Kunitz Family
1627,Q2ES46,VKT5_DABRR,,Kunitz-type serine protease inhibitor 5 (Kunitz protease inhibitor 5) (Kunitz protease inhibitor V),MSSGGLLLLLGLLTLWAELTPISGQDRPKFCHLPVDSGICRAHIPRFYYNPASNQCQGFIYGGCEGNANNFETRDQCRHTCGASGKEGPRPRIASN,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1628,Q2ES47,VKT4_DABRR,,Kunitz-type serine protease inhibitor 4 (Kunitz protease inhibitor 4) (Kunitz protease inhibitor IV),MSSGGLLLLLGLLTLWAELTPISGQDRPKFCHLPVDSGICRAHIPRFYYNPASNQCQGFIYGGCGGNANNFETRDQCRHTCGGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1630,Q2QA04,VSP_CRODD,3.4.21.-,Snake venom serine protease (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLALVYITSGFLCGGTLINKEWVLTAAHCDRGDILVLLGVHRLKDVQTGVSKDVQTRVAKEKFICPNRKKDDEKDKDIMLIRMDSPVNISTHIAPLSLPSNPPSVGSVCRIMGWGAITSPNVTLPGVPHCADINIFDYEVCRAAKPELPVTSRTLCAGILEGGKGSCDGDSGGPLICNGEIQGIVSWGGDICAQPREPEPYTKVFDYTEWIQSIIAGNTDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1631,Q2VBP8,3L2X1_OPHHA,,Long neurotoxin LNTX1,MKILLLTLVVVTIMCLDLGYTTKCYKTGERIISETCPPGQDLCYMKTWCDVFCGSRGRVIELGCTATCPTVKPHEQITCCSTDNCNPHPKMKQR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (By similarity). Recombinant LNTX1 leads to a functional block of the muscle-type acetylcholine receptors. Has a cytotoxic activity (PubMed:16689684). {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:16689684}.",Neurotoxin
1632,Q38L02,SLA_DABSI,,Snaclec dabocetin subunit alpha (C-type lectin-like 8),MGRFISVSFGLLVVFLSLSGTGADCPSEWSSHEGHCYKVFKLLKTWEDAEKFCTQQANGWHLASIESVEEANFVAQLASETLTKSKYHAWIGLRDQSKRQQCSSHWTDGSAVSYETVTKYTKCFGLNKETKYHEWITLPCGDKNPFICKSWVLH,Snaclec family,FUNCTION: Inhibits ristocetin-induced platelet aggregation via binding to platelet glycoprotein Ibalpha (GP1BA).,Binding Protein
1633,Q3BER2,DID1_ECHOC,,Disintegrin Eo1 subunit 1 (Eo1-1),MIQVLLVIICLAVFPYQGSSIILESGNVNDFELVYPKKVTVLPTGAMNSAHPCCDPVMCKPKRGEHCISGPCCRNCKFLSPGTICKKAWGDDMNDYCTGISSDCPRNPWKD,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Poor inhibitor of platelet aggregation. The disintegrin inhibits the adhesion of cells expressing the RGD-dependent integrin alpha-5/beta-1 (ITGA5/ITGB1) to immobilized fibronectin. Inhibition on alpha-IIb/beta-3 (ITGA2B/ITGB3) is low (By similarity). {ECO:0000250}.,Kunitz Family
1635,Q3SAF6,VNPA_PSETE,,Natriuretic peptide PtNP-a,SGSKIGNGCFGLPLDRISNTSGMGCRNPIQNRPKSTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets NPR1 and possibly NPR2 (By similarity) (PubMed:16908092). Exhibits hypotensive and vasodepressor activities (By similarity). Recombinant PtNP-a demonstrates a dose-dependent stimulation of cGMP production via the natriuretic peptide receptor 1 (NPR1) (EC(50)=563 nM) in Madine Darby Canine Kidney (MDCK) cells (PubMed:16908092). It also inhibits the angiotensin converting enzyme (ACE) (PubMed:16908092). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9, ECO:0000269|PubMed:16908092}.",General Toxin
1636,Q3SAF7,VNPE_OXYMI,,Natriuretic peptide TNPe (Natriuretic peptide OmNP-e),SDSKIGDGCFGLPLDHIGSVSGLGCNRPVQNRPKQIPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that exhibits vasoactive and hypotensive activity (By similarity). Stimulates cGMP production through the natriuretic peptide receptor 1 (NPR1) with moderate potencies for the rat NPR1 (EC(50)=1800 nM), and very weak potencies over human NPR1 (5% activation at 10 uM) (PubMed:37049825). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000269|PubMed:37049825}.",General Toxin
1637,Q3ZD74,VM1L4_MACLB,3.4.24.-,Snake venom metalloproteinase lebetase-4 (Le-4) (Le4) (EC 3.4.24.-),SCRKKASQLNLTPEQQRFDPRYIELVIVADHSMVTKYDGDLAAIRTWAHQLVNNIIVFYRDLNVHITLSAVEVWTNGDLINVQPAASVTLNLFGEWRERDLLNRRMHDHAQLLTAINLDDNTIGLAYNEGMCDPKYSVGIVQDHSAINRMVAATMAHEIGHNLGMDHDGNQCNCGANGCVMSAVITQQRSYQFSDCSKNKYQTYLTNHNPQCILNQP,"Venom metalloproteinase (M12B) family, P-I subfamily","FUNCTION: Snake venom zinc metalloprotease that hydrolyzes the Aalpha-chain and more slowly the Bbeta-chain of fibrin and fibrinogen. Also hydrolyzes casein and B-chain of oxidized insulin. Its fibrinolytic activity is direct, without any plasminogen activation. Inhibits ADP-induced and collagen-induced platelet aggregation. Shows low hemorrhagic activity. Cleaves the plasma proteinase inhibitors alpha(2)-macroglobulin (A2M) and alpha(2)M-related pregnancy zone protein (PZP), and is inhibited by them (By similarity). {ECO:0000250}.",Metalloprotease
1638,Q4JHE2,OXLA_NOTSC,1.4.3.2,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2),MNVFFMFSLLFLAALESCADDRRRPLEECFQEADYEEFLEIARNGLNETSNPKHVVVVGAGMAGLSAAYVLAGAGHNVTLLEASERVGGRVNTYRNETEGWYVNLGPMRLPERHRIIREYIRKFGLKLNEFLQENENAWYFIRNIRKRVWEVKKDPGVFKYPVEPSEEGKSASQLYRESLEKVIEELKRTNCSYILNKYDTYSTKEYLIKEGNLSRGAVDMIGKLPNEDSSYYLSFIESLKSDDLFSYEKRFDEIVGGFDQLPISMYQAIAEMVHLNAQVIKIQHNAEEVRVAYQTPAKTLSYVTADYVIVCSTSRAARRIYFEPPLPPKKAHALRSIHYRSGTKIFLTCTRKFWEADGIHGGKSTTDLPSRFIYYPNHNFTSDVGVIVAYTLADDADFFQALDIKTSADIVINDLSLIHQLPKEEIQALCYPSMIKKWSLDKYAMGAITSFTPYQFQDFIETVAAPVGRIYFAGEYTARVHGWLDSTIKSGLTAARDVNRASQKPSRRQLSNDNEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
1639,Q4JHE3,OXLA_OXYSC,1.4.3.2,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2),MNVFFMFSLLFLAALESCADVRRNPLEECFREADYEEFLEIARNGLKKTSNPKHVVVVGAGMAGLSAAYVLAGAGHKVTLLEASERVGGRVHTYRNEKEGWYVNLGPMRLPERHRIIREYIRKFGLKLNEFFQENENAWYFIRNIRKRVWEVKKDPGVFKYPVKPSEEGKSASQLYRESLKKVIEELKRTNCSYILNKYDTYSTKEYLIKEGNLSRGAVDMIGDLLNEDSSYYLSFIESLKSDDLFSYEKRFDEIVGGFDQLPISMYQAIAEMVHLNAQVIKIQHNAEKVRVAYQTPAKTLSYVTADYVIVCSSSRAARRIYFEPPLPPKKAHALRSIHYKSGTKIFLTCSKKFWEADGIHGGKSTTDLPSRFIYYPNHNFTSGVGVIVAYTISDDADFFQSLDIKTSADIVINDLSLIHQLPKKEIQALCYPSMIKKWSLDKYAMGSITSFAPYQFQDFIERVAAPVGRIYFAGEYTARVHGWLDSTIKSGLTAARDVNRASQKPSRRQLSNDNEL,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
1640,Q53B47,3SX5_OPHHA,,Short neurotoxin OH-5 (Three-finger toxin) (3FTx),MKNLLLTFLVVTIVCLDLGYTLICHRVHGLQTCEPDQKFCFRKTTMFFPNHPVLLMGCTYSCPTEKYSVCCSTDKCNK,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: This three-finger toxin binds and inhibits the nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:P83302}.,General Toxin
1641,Q53B52,3SXZ_OPHHA,,Short neurotoxin OH-26 (Three-finger toxin) (3FTx),MKNLLLTFLVVTIVCLDLGYTLICHQRHGLQTCEPAQKFCFAQTVMPFPNHPLTLMGCTYSCPTEKNAVCCSTDKCNR,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: This three-finger toxin binds and inhibits the nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:P83302}.,General Toxin
1642,Q53B53,3L234_OPHHA,,Long neurotoxin OH-34,KTLLLTLVVVTILCLDLGYTTKCYITPDVKSETCPDGENICYTKTWCDVWCGSRGRRVDLGCAATCPIVKPGVNINCCSTDNCNPFPKRS,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1643,Q53B59,3L237_OPHHA,,Long neurotoxin OH-37,MKTLLLTLVVMTIVCLDLGYSLICFISPHDSVTCAPGENVCFLKSWCDAWCGSRGKKLSFGCAATCPKVNPGIDIECCSTDNCNPHPKLRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1644,Q58G94,VSP21_CRODU,3.4.21.-,Thrombin-like enzyme gyroxin B2.1 (SVTLE gyroxin B2.1) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VIGGDECNINERNFLVALYEYWSQSFLCGGTLINGEWVLTAAHCDRKHILIYVGVHDRSVQFDKEQRRFPKEKYFFNCRNNFTKWDKDIMLIRLNKPVSYSEHIAPLSLPSSPPIVGSVCRVMGWGTIKSPQETLPDVPHCANINLLDYGVCRTAHPQFRLPATSRILCAGVLEGGIDTCHRDSGGPLICNGEFQGIVSWGDGSCAQPDKPALYSKVFDHLDWIQNIIAGSETVNCPS,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Displays a specificity similar to trypsin. Releases only fibrinopeptide A in the conversion of fibrinogen (FGA) to fibrin (By similarity). Shows coagulant, esterase and amidase activities. Reversibly increases the permeability of the blood brain barrier (BBB) in mice. Induces the barrel rotation syndrome in mice, which is manifested by gyroxin-like, rapid rolling motions. This syndrome may be due to its effect on BBB permeability, and certainly also to other actions affecting endogenous substrates present in the endothelium, nervous tissues or blood. {ECO:0000250, ECO:0000269|PubMed:11137545, ECO:0000269|PubMed:19341755, ECO:0000269|PubMed:20637222}.",Serine Protease
1645,Q5EE07,DID_ECHCA,,Disintegrin,NSVHPCCDPVKCEPREGEHCISGPCCRNCKFLNAGTICKRAMLDGLHDYCTGVTSDCPRNRYNH,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Inhibits adhesion of cells expressing alpha-4/beta-1 (ITGA4/ITGB1) and alpha-4/beta-7 (ITGA4/ITGB7) integrins to the natural ligands vascular cell adhesion molecule 1 (VCAM-1) and mucosal addressin cell adhesion molecule 1 (MADCAM-1). {ECO:0000250}.,Vascular Interaction
1646,Q5FZI5,SLTB_PROMU,,Snaclec trimecetin subunit beta,MGRFIFVSFGLLVVFLSLSGTAADCPSDWSSFRRYCYQVFQQKMNWEDAEKFCTQQHRGSHLVSFHSSEEVDFVVSKTLPILKANFVWMGLSNVWNECAKEWSDGTKLDYKAWSGQSDCITSKTTDNQWLSMDCSSKRYVVCKF,Snaclec family,"FUNCTION: Snaclec that induces platelet aggregation in either human platelet rich plasma (PRP) or washed platelet suspensions. It causes aggregation in a dose-dependent manner even in the absence of various platelet agonists such as ADP or von Willebrand factor (vWF). Interestingly, it does not induce aggregation in rabbit PRP. A monoclonal antibody against the platelet GPIb receptor blocks the aggregation induced by trimecetin, suggesting that it acts by binding to GPIb (GP1BA/GP1BB). {ECO:0000269|PubMed:19931300, ECO:0000269|PubMed:8968958}.",Binding Protein
1647,Q5FZI6,SLTA_PROMU,,Snaclec trimecetin subunit alpha,MGRFIFVSFGLLVVFLSLSGTGADCPSDWSSFRRYCYKPFKQLKTWEDAERFCWEQVKGAHLVSIESSGEGDFVAQLLSENIKTTKYHVWIGLSIQNKRQQCRSIWSDGSSVSYENLVKPFSKKCFVLKKESEFHKWFNIYCGERNLFMCKFLQPR,Snaclec family,"FUNCTION: Snaclec that induces platelet aggregation in either human platelet rich plasma (PRP) or washed platelet suspensions. It causes aggregation in a dose-dependent manner even in the absence of various platelet agonists such as ADP or von Willebrand factor (vWF). Interestingly, it does not induce aggregation in rabbit PRP. A monoclonal antibody against the platelet GPIb receptor blocks the aggregation induced by trimecetin, suggesting that it acts by binding to GPIb (GP1BA/GP1BB). {ECO:0000269|PubMed:19931300, ECO:0000269|PubMed:8968958}.",Binding Protein
1648,Q5UFR8,3S11_HYDPR,,Short neurotoxin 1 (Major/minor neurotoxin),MKTLLLSPVVVTIVCLDLGYTMTCCNQQSSQPKTTTNCAGNSCYKKTWSDHRGTIIERGCGCPQVKSGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1649,Q5W958,VSPH_BOTJA,,Snake venom serine protease homolog HS120 (Venom serine proteinase-like HS120),MVLIRVIANLLILQLSYAQKSSELVIGGDECNINEHPFLAFLYTGWIFCSGTLINKEWVLTVKQCNNRRPMRIYLGMHTRSVPNDDEEIRYPKEMFICPNKKKNDIMLIRLNRPVNNSEHIAPLSLPSNPPSVGSVCRIMGWGTITPSKATYPDVPHCANINLFNYTVCRGAHAGLPVTSRKLCAGVLEGGIDTCSADSGGPLICNGQLQGIVSWRGGSCAQPHKPGLYTKVFDYLPWIQSIIAGSTTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1650,Q5W960,VSP12_BOTJA,3.4.21.-,Snake venom serine protease HS112 (SVSP) (EC 3.4.21.-),MVLIRVIANLLILQLSYAQKSSELVIGGDECDINEHRFLAFLYAGGYYCGGTLINQEWVLSAAHCDKRIIRIYLGMHTRSVPNDDEEIRYPKEKFICPNKKKNVITHKDIMLIRLNRPVKNSEHIAPLSLPSNPPSVGSVCRIMGWGSITTPDETSPNVPHCANINLFNNTVCREAYNGLPAKTLCAGVLQGGIDTCGGDSGGPLICNGQFQGILSWGGIPCAQPRKPAFYTKVFDYLPWIQSIIAGNKTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1651,Q6EAN6,PA2HA_SISTE,,Acidic phospholipase A2 homolog sistruxin A (SA) (svPLA2) [Cleaved into: Sistruxin chain A; Sistruxin chain B; Sistruxin chain C],MRALWIVAVLLLGVEGSLVEFETLIMKIAGRSGVWYYSSYGCYCGTGGQGWPQDASDRCCFEHDCCYAKLTGCDPITDVYTYRQEDGEIVCGGEDPCGTQICECDKAAAICFRDSMDTYNHKYWRFSLENCQGESQPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. {ECO:0000250}.,Phospholipase
1652,Q6EER3,PA2B2_SISTE,3.1.1.4,Basic phospholipase A2 Sct-N6 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTFWIVAVLLVGVEGNLLQFNKMIKIMTKKNAIPSYSSYGCYCGWGGRGRPKDATDRCCFVHDCCYEKLTDCSPKTDTYSYSLKSGVIICGGNDPCKKQICECDKAAAVCFGENLSTYKKRYMFYPDFLCTDPSETC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities, as well as presynaptic neurotoxicity and low myotoxicity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.",Phospholipase
1653,Q6IWF1,VSPTL_BOTAL,3.4.21.-,Snake venom serine protease BthaTL (SVSP) (EC 3.4.21.-),VIGGDECDINEHRFLAFLYPGRFFCSGTLINQEWVLTVAHCDTISMRIYLGLHTRSVPNDDEEIRYPMEKFKCPNRKRSYIKDKDIMLIRLNRPVNDSPHIAPLSLPSNPPSVGSVCHVMGWGTTSPSKATYPDVPHCANINLVNDTMCHGAYNGLPVTSRKFCAGVLQGGIDTCVGDSGGPLICNGQFQGIVSWGGKVCARLPRPALYTKVFEYLPWIQSIIAGNTTATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1654,Q6T627,OXLA_BITGA,1.4.3.2,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2),GPMRIPEKHRIVREYIRKFGLQLNEFVQETENAWYYIKNIRKKVHEVKKDPGLLKYPVKP,"Flavin monoamine oxidase family, FIG1 subfamily","FUNCTION: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. {ECO:0000250|UniProtKB:P0CC17}.",Vascular Interaction
1655,Q6T6S5,VKT2_BITGA,,Kunitz-type serine protease inhibitor bitisilin-2 (BG-15) (Kunitz protease inhibitor 2),MSSGGLLLLLGLLTLWAELTPVSGKKRPDFCYLPADTGPCMANFPRFYYDSASKKCKKFTYGGCHGNANNFETREECRKKCFASAARRPT,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1656,Q6T6S7,VSPH1_BITGA,,Snake venom serine protease homolog 1 (Venom serine proteinase-like protein 1),MVLIRVLANLLLLQLSYAQESSELVIGGDECDINEHPFLVALHTARSKRFHCAGTLLNKEWVLTAARCDRKNIRIKFGVHNKNVQNEDEEMRVPKEKHFCVSSKTYTRWDKDIMLIRLKRPVNDGTHIAPLSLPSNPPSVGSVCRIMGWGSITTTKVTYPDVPHCANIKLFDYSVCRDAYKGLPEKSRTLCAGILEGGIDSCKVDNGGPLICNGQFQGIGSWEGHPCAQPLKPALYTNVFEYTDWIEGIIARNTTVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1658,Q6T6T4,CYT_BITGA,,Bitiscystatin (Cystatin),MHSRLLVAAPHCLLLLLLLPSALPALKVGGLYPRDVMDPEVQEAAAFAVENYNAQSTNDNYFKARRIVEAQSQVVSGVKYYLKMELAKTTCKKIAGKPKLYQEIQNCNLPPENQQEEITCHFEVWSRPWLQKTVLTKDEL,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
1659,Q6T6T5,VKT1_BITGA,,Kunitz-type serine protease inhibitor bitisilin-1 (BG-11) (Kunitz protease inhibitor 1),MSSGGLLLLLGLLTLWAELTPVSGKNRPEFCNLPADTGPCKAYEPRFYYDSVSKECQKFTYGGCKGNSNNFESMDECRKTCVASATRRPT,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1660,Q6T7B7,LEC1_BITGA,,C-type lectin 1 (CTL),MGRFIFISFGLLVVFFFLSGAKGSTCPFHWLPMYGLCYKIFDKLKTWNDAEMFCRKYKPGCHLASLHSKRDSIEFAEYISDYRKGWGNVWIGMWGRKEGLTCEWTDGSSTTYVAWKQNLTDHYLNKDLFCAEIVSYTGYRLWNKQDCKVKNAFLCQCGF,True venom lectin family,FUNCTION: Lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1661,Q6TPG9,SLOB_PROMU,,Snaclec mucrocetin subunit beta,MGRFIFVSFGLLVVFLSLSGTEAGFCCPLGWSSYDEHCYQVFQQKINWEDAEKFCTQQHRGSHLVSFHSSEEVDFVVSKTSPILKHDFVWMGLSNVWNECAKEWSDGTKLDYKAWSGQSDCITSKTTDNQWLSMDCSSKRYVVCKFQA,Snaclec family,FUNCTION: Platelet-agglutinating factor that acts in a vWF-independent manner. Binds specifically to platelet GPIbalpha (GP1BA) to a distinct binding site from that of flavocetin-A.,Binding Protein
1666,Q6X5T4,LECM2_BITAR,,C-type lectin 2 (CTL-2),MGRFIFVSFGLLVVFLSLSGIGADQECLPGWSFYEGHCYKVFDEYKNWTDAEQYCTEQENGGHLVSFHNREEVDFVVKLGYTILKADIVWIGLRDFWRECHWGWSNGAQLDYKGWNDEPNCFIAYTVGNKWLRRKCSSTQQFVCKSPA,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1667,Q71QH5,VSP08_TRIST,3.4.21.-,Snake venom serine protease KN8 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVVGGLPCNINEHRFLVLVYSDGIQCGGTLINKEWMLTAAHCDGKKMKLQFGLHSKNVPNKDKQTRVPKKKYFFPCSKNFTKWDKDIMLIRLNHPVNNSTHIAPLSLPSKPPSQDTVCNIMGWGTISPTKEIYPDVPHCAYINIVDHAVCRAFYPGLLEKSKTLCAGILEGGKDTCQGDSGGPLICNGQIQGIVSVGGDPCAEPRVSVLYTKVFDHLDWIKSIIAGNTAATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1668,Q71QH6,VSP13_TRIST,3.4.21.-,Snake venom serine protease KN13 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQRSSELVIGGDECNINEHRFLVALYKSGRFRCGGTLINQEWVLTAAHCDRRNMEIKLGMHSKNVPNEDEQRRVPKEKFFCDSNKNHTQWNKDIMLIRLNSPVNNSTHIAPLSLPSNPPIVGSVCRIMGWGTITSPNETYPDVPHCANINLFNYTVCHGAHAGLPATSRTLCAGVLEEGKDTCKGDSGGPLICNGQFQGIVSWGGDPCAQPREPGVYTKVFDHLDWIQNIIAGNTTATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1669,Q71QH7,VSPP_TRIST,3.4.21.-,Snake venom serine protease PA (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSPELVVGGDECNINEHRSLVAIFNSTGFFCSGTLINQEWVVTAAHCDSNNFKMKFGAHSQKVLNEDEQIRNPKEKFICPNKKNNEVLDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSVGSVCRIMGWGSITPTKVTYPDVPYCANINLLDDAECKPGYPELLPEYRTLCAGIVQGGKDTCGGDSGGPLICNGQFHGIVSYGAHPCGQSLKPGIYTTVFDYNDWIKSIIAGNTAATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1670,Q71QH9,VSP14_TRIST,3.4.21.-,Snake venom serine protease KN14 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDVSSGDFRGSGTLINPEWVLTAAHCETEEMKLQFGLHSKRVPNKDKQTRVSKEKFFCESNENYTKWNKDIMLIKLNRPVKNSAHIEPLSLPSSPPSVGSVCRIMGWGTLSDTEMILPDVPHCANINLLNYSDCQAAYPELPAKSRTLCAGILEGGKDTCSGDSGGPLICNGTFQGIASWGGTLCGYVREPGSYTKVFDHLDWIQSIIAGNTNVTCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1671,Q71QI0,VSPH7_TRIST,,Snake venom serine protease homolog KN7 (Serine proteinase-like protein KN7),MVLIRVLANLLILQLSYAQKSSELIIGGDECNINEHRFLVALYTFRSRRFHCGGTLINQEWVLSAARCDRKNIRIKLGMHSTNVTNEDVQTRVPKEKFFCLSSKTYTKWNKDIMLIRLKRPVNNSTHIAPVSLPSNPPSLGLVCRVMGWGTISATKETHPDVPHCANINILDYSVCRAAYARLPATSRTLCAGILEGGKDTCHGDSGGPLICNGQVQGIVSWGGHPCGQPRKPGLYTKVFDHLDWIKSIIAGNKDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1672,Q71QI1,VSP12_TRIST,3.4.21.-,Snake venom serine protease KN12 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQRSSELVIGGDECNINEHRFLVALYKSGRFRCGGTLINQEWVLTAAHCDRRNMEIKLGMHSKNVPNEDEQRRVPKEKFFCDSNKNYTQWNKDIMLIRLNSPVNNSTHIAPLSLPSNPPIVGSVCRIMGWGTITSPNETYPDVPHCANINLFNYTVCHGAHAGLPATSRTLCAGVLEGGKDTCKGDSGGPLICNGQFQGFVSWGGDPCAQPREPGVYTKVFDHLDWIQNIIAGNTTATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1673,Q71QI2,VSP2_TRIST,3.4.21.-,Snake venom serine protease CL2 (SVSP) (EC 3.4.21.-),MVLIRVLANLLIIQLSYAQKSSELVIGGDECNINEHRSLVVLFNSSGALCGGTLINQEYVLAAAHCDMPNMQILLGVHSASVLNDDEQARDPEEKYFCLSSNNDTKWDKDIMLIRLNRPVNNSVHIAPLSLPSSPPSVGSVCRIMGWGKTIPTQETHPDVPHCANIKLFHYSLCRAVYVGMPAQSRILCAGILQGGIGSCQGDSGGPLICNGQFQGIVSATSKPCAHSLMPALYIKVFDYTDWIKSIIAGNTTVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1674,Q71QI3,VSP5_TRIST,3.4.21.-,Snake venom serine protease CL5 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQRSSELVIGGDECNINEHRFLALVYTDRFQCGGTLINPEWVLTAAHCDRRYMHIYLGVHNESVQYDDEQRRFPKKKYFCLSSKNYTRWDKDIMLIRLNRPVRNSAHIAHLSLPSKPPSVGSVCRVMGWGTITSPNETLPDVPRCANINLFNYTVCRGVFPWLPARSRILCAGVLQGGIDTCKRDSGGPLICNGQFQGIVSWGPKPCAQPREPALYTKVFDHLDWIQSIIAGNTTVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1675,Q71QI4,VSP05_TRIST,3.4.21.-,Snake venom serine protease KN5 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDVSSGDFRGSGALINPEWVLTAAHCETEEMKLQFGLHSKRVPNKDKQTRVSKEKFFCESNKNYTKWNKDIMLIKLNRPVKNSTHIAPLSLPSNPPSVGSVCRIMGWGTLSDTEMILPDVPHCANINLLNYSDCQAAYPELPAKSRTLCAGILEGGKDTCSGDSGGPLICNGTFQGIASWGSTLCGYVREPGSYTKVFDHLDWIQSIIAGNTNVTCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1676,Q71QI5,VSP03_TRIST,3.4.21.-,Snake venom serine protease KN3 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSKLVVGGDECNINEHPFLVLVYHDGYQCGGTLINEEWVLTAAHCDGKKMKLRFGLHSKNVPNKDKQTRVPKEKFFCLSSKYFIKWGKDIMLIRLNRPVNNSTHIAPLSLPSSPPSQNTVCNIMGWGTISPTKEIYPDVPHCANISILDHAVCRAFYPGLLEKSKTLCAGILEGGKDICQGDSGGPLICNGQIQGIVSVGGNPCAEPRVPAIYTKVFDHLDWIKSIIAGNTAATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1677,Q71QI7,VSP11_TRIST,3.4.21.-,Snake venom serine protease KN11 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVTGGHPCNINEHPFLVLVYHDGYQCGGTLINEEWVLTAAHCDGKKMKLQFGLHSKNEPNKDKQTRVPKEKFFCLSSKNFIKWGKDIMLIRLNRPVNNSTHIAPLSLPSSPPSQNTVCNIMGWGTISPTKEIYPDVPHCANINILDHAVCRAFYPGLLEKSKTLCAGILQGGKDICQGDSGGPLICNGQVQGIVSVGGNPCAEPRVPAIYTKVFDHLDWIKSIIAGNTAATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1678,Q71QI8,VSP10_TRIST,3.4.21.-,Snake venom serine protease KN10 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRFLVLVYTDGIQCGGTLINKEWMLTAAHCDGKKMKLQFGLHSKNVPNKDKQTRVPKKKYFFPCSKNFTKWDKDIMLIRLNHPVNNSTHIAPLSLPSKPPSQDTVCNIMGWGTISPTKEIYPDVPHCANINIVDHAVCRAFYPGLLEKSKTLCAGILEGGKDTCQGVSGGPLICNGQIQGIVSVGGDPCAEPRVPALYTKVFDHLDWIKSIIAGNTAATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1679,Q71QJ0,VSP02_TRIST,3.4.21.-,Snake venom serine protease KN2 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGHPCNINEHPFLVLVYHDGYQCGGTLINEEWVLTAAHCDGKKMKLQFGLHSKNVPNKDKQTRVPKEKFFCLSSKNFIKWGKDIMLIRLNRPVNNSTHIAPLSLPSSPPSQNTVCNIMGWGTISPTKEIYPDVPHCANINILDHAVCRAFYPGLLEKSKTLCAGILQGGKDICQGDSGGPLICNGQIQGIVSVGGDPCAEPRVPAIYTKVFDHLDWIKSIIAGNTAATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1680,Q71QJ1,VSP09_TRIST,3.4.21.-,Snake venom serine protease KN9 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRFLVLVYTDGIQCGGTLINKEWMLTAAHCDGKKMKLQFGLHSKNVPNKDKQTRVPKKKYFFPCSKNFTKWDKDIMLIRLNHPVNNSTHIAPLSLPSKPPSQDTVCNIMGWGTISPTKEIYPDVPHCANINIVDHAVCRAFYPGLLEKSKTLCAGILEGGKDICQGDSGGPLICNGQIQGIVSVGGNPCAEPRVPAIYTKVFDHLDWIKSIIAGNTAATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1681,Q71QJ2,VSP06_TRIST,3.4.21.-,Snake venom serine protease KN6 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDVSSGDFRGSGTLINPEWVLTAAHCETEEMKLQFGLHSKRVPNKDKQTRVSKEKFFCESNKNYTKWNKDIMLIKLNRPVKNSAHIEPLSLPSSPPSVGSVCRIMGWGTLSDTEMILPDVPHCANINLLNYSDCQAAYPELPAKSRTLCAGILEGGKDTCSGDSGGPLICNGTFQGIASWGSTLCGYVREPGSYTKVFDHLDWIQSIIAGNTNVTCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1682,Q71QJ3,VSP01_TRIST,3.4.21.-,Snake venom serine protease KN1 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVVGGHPCNINEHRFLVLVYSDGIQCGGTLINKEWMLTAAHCDGKKMKLQFGLHSKNVPNKDKQTRVPKKKYFFPCSKNFTKWDKDIMLIRLNHPVNNSTHIAPLSLPSKPPSQDTVCNIMGWGTISPTKEIYPDVPHCANINIVDHAVCRAFYPGLLEKSKTLCAGILEGGKDTCQGDSGGPLICNGQIQGIVSVGGDPCAEPRVPALYTKVFDHLDWIKSIIAGNTAATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1683,Q71QJ4,VSPH4_TRIST,,Snake venom serine protease homolog KN4 (Serine proteinase-like protein KN4),MVLIRVLANLLILQLSYAQKSSELIIGGDECNINEHRFLVALYTFRSRRFHCGGTLINQEWVLSAARCDRKNIRIKLGMHSTNVTNEDEQRRVPKEKFFCLSSKTYTQWNKDIMLIRLNSPVNNSTHIAPLSLPSNPPFVGSVCRIMGWGTITSPNETYPDVPHCANINLFNYTVCHGAHAGLPATSRTLCAGVLEGGKDTCKGDSGGPLICNGQFQGIVSWGGDPCAQPREPGVYTKVFDHLDWIQNIIAGNTTATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1687,Q75S50,VKTH3_BUNCA,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B3 chain,MSSGGLLLLLGLLTLWAELTPVSSRKRHPDCDKPPDTRICQTVVRAFYYKPSEKRCVQFRYGGCKGNGNHFKSDHLCRCECLEYR,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and is non-toxic (By similarity). {ECO:0000250}.,Kunitz Family
1688,Q7LZ24,SLLC2_VIPAP,,Snaclec coagulation factor X-activating enzyme light chain 2 (Factor X activator LC2),AFCCPSGWSAYDQ,Snaclec family,"FUNCTION: Regulatory subunit of coagulation factor X-activating enzyme, a zinc-protease enzyme that impairs hemostasis in envenomed animal. Activates coagulation factor X (F10) in a calcium-dependent manner probably by cleaving the Arg-Ile bond at position 234.",Metalloprotease
1689,Q7LZE3,VKTHE_DENAN,,Kunitz-type serine protease inhibitor long epsilon-dendrotoxin His55 [Cleaved into: Kunitz-type serine protease inhibitor short epsilon-dendrotoxin His55],LQHRTFCKLPAEPGPCKASIPAFYYNWAAKKCQLFHYGGCKGNANRFSTIEKCRHACVG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin. {ECO:0000250|UniProtKB:P00984}.,Serine Protease
1690,Q7LZF4,VSP4A_CERCE,3.4.21.-,Snake venom serine protease IVa (SVSP) (EC 3.4.21.-) (Basic proteinase IVa),VIGGAEENINEHRSL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Snake venom serine protease that potently induces platelet aggregation. Its aggregatory activity is partially inhibited by monoclonal antibodies against GPIb and the thrombin receptor. Its ability to induce intracellular Ca(2+) release is blocked by pretreating platelets with thrombin. Hydrolyzes thrombin chromogenic substrate CBS 34.47, but shows very weak coagulant activity. Can hydrolyze fibrinogen alpha-chains. {ECO:0000269|PubMed:7612660}.",Serine Protease
1691,Q7LZF5,VSPC1_CROAT,3.4.21.-,Thrombin-like enzyme catroxobin-1 (SVTLE) (EC 3.4.21.-) (Catroxobin I) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),VVGGDECNINEHRSLVAIFVSTEFDCGGDLINVEWVLTAAHCTLCAGIPEGGLDTCGGDSGGPLICDGKPDGITS,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease. Clots fibrinogen (FGA and FGB) very slowly, releasing fibrinopeptide A and a small amount of fibrinopeptide B. {ECO:0000269|PubMed:2617466}.",Serine Protease
1693,Q7LZG1,ACES_NAJOX,3.1.1.7,Acetylcholinesterase (AChE) (EC 3.1.1.7),SELKVATQTGFVRGLSLPVLAGHVSAHLGVPFAEPFLRPEPVKPGAEMWNPNLNIWVPSGRVGAFXFLTVTLFGESAGAASVGMXLLSTQRAILQSGAPNAPWAQVQPAESRFPFVPVIDGEFFPLGVNKDEGSFGVPGFSKXXESLINQAVPHANDIYTDWQDQDNGGLPLTGNPTXPHN,Type-B carboxylesterase/lipase family,"FUNCTION: In venom, its toxic role is unclear: it could result in less musculatory control by rapidly hydrolyzing acetylcholine, or that it works synergistically with alkaline phosphatase (ALP) in paralyzing prey through hypotension. In muscle, it terminates signal transduction at the neuromuscular junction by rapid hydrolysis of the acetylcholine released into the synaptic cleft. In liver, its function is unclear: it could serve as a safeguard against any diffusion of acetylcholine from synapses into the circulation.",Neurotoxin
1694,Q7LZG5,PA2_NOTSC,3.1.1.4,Phospholipase A2 II-5b (svPLA2) (EC 3.1.1.4) (Notechis II-5b non-toxic venom protein) (Phosphatidylcholine 2-acylhydrolase),NLIQLSNMIKCAIPGSQPLF,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that exhibits weak enzymatic activity. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:1814009}.,Phospholipase
1695,Q7LZI5,VM2I1_GLOUS,,Disintegrin ussuristatin-1 (US-1),GEECDCGSPGNPCCDAATCKLRPGAQCAEGLCCEQCRFIKAGTVCRVARGDWNDDKCTGQSADCPRNGFYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Strongly suppress platelet aggregation induced by ADP, collagen, thrombin, and epinephrine (IC(50)=17-33 nM). Also dose-dependently inhibits the adhesion of human melanoma cells to fibrinogen and fibronectin. {ECO:0000269|PubMed:9880793}.",Fibrinogenolytic Enzyme
1696,Q7LZI6,SLB_PROTO,,Snaclec tokaracetin subunit beta,DCPSDWSSYDEHCYRVFQQKMNWEDAEKFCTQQHKGXHLX,Snaclec family,FUNCTION: Platelet antagonist that specifically and reversibly binds to a site on platelet glycoprotein Ibalpha (GP1BA) close to or identical with the site for vWF binding. It inhibits the binding of vWF to platelets and vWF-dependent shear-induced platelet aggregation. {ECO:0000269|PubMed:8948455}.,Binding Protein
1697,Q7LZJ1,VM1_CROMN,3.4.24.-,Snake venom metalloproteinase (SVMP) (EC 3.4.24.-) (Proteinase E),FAKRYVELVIVA,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1699,Q7LZK5,SLA_BITAR,,Snaclec bitiscetin subunit alpha,DPGCLPDWSSYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDEPTKCFGLDVHTEYRTWTDLPCGEKNPFICKSRLPH,Snaclec family,"FUNCTION: Snaclec that binds to von Willebrand factor (VWF) and induces its interaction with GPIbalpha (GP1BA) (via the vWF A1 domain), resulting in platelet aggregation. {ECO:0000269|PubMed:12069583, ECO:0000269|PubMed:8806626}.",Vascular Interaction
1700,Q7LZK6,SLA_PROTO,,Snaclec tokaracetin subunit alpha,DCPSGWSSFKQYCYKPFKQLKTWEDAERFCLEQVKGAHLV,Snaclec family,FUNCTION: Platelet antagonist that specifically and reversibly binds to a site on platelet glycoprotein Ibalpha (GP1BA) close to or identical with the site for vWF binding. It inhibits the binding of vWF to platelets and vWF-dependent shear-induced platelet aggregation. {ECO:0000269|PubMed:8948455}.,Binding Protein
1701,Q7LZK8,SLB_BITAR,,Snaclec bitiscetin subunit beta,DEGCLPDWSSYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLSHFWRICPLRWTDGARLDYRALSDEPICFVAESFHNKWIQWTCNRKKSFVCKYRV,Snaclec family,"FUNCTION: Snaclec that binds to von Willebrand factor (VWF) and induces its interaction with GPIbalpha (GP1BA) (via the vWF A1 domain), resulting in platelet aggregation. {ECO:0000269|PubMed:12069583, ECO:0000269|PubMed:8806626}.",Vascular Interaction
1702,Q7LZQ4,PA2A_GLOUS,3.1.1.4,Acidic phospholipase A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),SLIQFETLIMKVAKKSGMFWYSNYGCYCGWGGQGRPQDATDRCCFVHDCCYGKVTGCDPKMDVYSFSEENGDIVCGGDDPCKKEICECDRAAAICFRDNLNTYNDKKYWAFGAKNCPQEESEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|Ref.1}.,Phospholipase
1703,Q7LZQ6,PA2BD_BUNFA,3.1.1.4,Basic phospholipase A2 13 (svPLA2) (EC 3.1.1.4) (Cytotoxin XIII) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 XIII),NLYQFKNMIECAGTRTWIAYVKYGAYTYAYT,"Phospholipase A2 family, Group I subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1704,Q7LZS8,VKTRE_DENAN,,Kunitz-type serine protease inhibitor long epsilon-dendrotoxin Arg55 [Cleaved into: Kunitz-type serine protease inhibitor short epsilon-dendrotoxin Arg55],LQHRTFCKLPAEPGPCKASIPAFYYNWAAKKCQLFHYGGCKGNANRFSTIEKCRRACVG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor that inhibits trypsin. {ECO:0000250|UniProtKB:P00984}.,Serine Protease
1705,Q7LZS9,VM1A_DEIAC,3.4.24.-,Snake venom metalloproteinase Ac1 (SVMP) (EC 3.4.24.-) (Ac1-proteinase),STEFQRYMEIVIVVDHSMVKKYNGDSPKIKAWVYEMINTITEGYRDLYIDIILSGLEIWSEKDLINVEASAGNTLKSFGEWRAKDLIHRISHDNAQLLTATDFDGPTIGLAYVASMCEPKLSVGVIQDHSSVNRLVAITLAHEMAHNLGVRHDEKDCVGVVYLCIMRIPVVEDKRSYFSDCSYIQCREYISKENPPCILNKP,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1706,Q7LZT4,VM2I2_GLOUS,,Disintegrin ussuristatin-2 (US-2),EAGEECDCGAPANPCCDAATCKLRPGAQCAEGDCCEQCRFVKEGTVCREAKGDWNDDSCTGQSADCPRNGF,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IId sub-subfamily","FUNCTION: Suppress platelet aggregation induced by ADP, collagen, thrombin, and epinephrine (IC(50)=170-330 nM). Also dose-dependently inhibits the adhesion of human melanoma cells to fibrinogen but not to fibronectin. {ECO:0000269|PubMed:9880793}.",Fibrinogenolytic Enzyme
1707,Q7SZD9,VM2US_GLOUS,3.4.24.-,Zinc metalloproteinase/disintegrin ussurin [Cleaved into: Snake venom metalloproteinase ussurin (SVMP) (EC 3.4.24.-); Disintegrin ussurin],MIQVLLVTICLAAFPYQGSSIILESGNVNDYEIVYPRKVTALPKGAVQPKYEDTMQYELKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLKLSDSEAHAVFKYEHIEKEDEDPKMCGVTETNWESYEPIKKASPLVVTTYQRYVELVVVADHRMVTKYNGNLIIIRTWVYEIFNTINEIYQRMNIHVALVGLEIWSNGDKIIVQSSADVTLDLFGTWGEIDLLKRKSHDNAQLLTPTDFDGPTIGLAYVGTMCDPKRSTGVVQDFSPINLLVAVTMAHEIGHNLGMNHDENYCSCGGFACIMSPVISPQPSKLFSYCSYIHYWTYINYRNPQCILNKPLRTDIVSTPVSGNELLEAGEECDCDSPGNPCCDAATCKLRPGAQCAEGLCCEQCRFMKEGTVCRIARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: [Snake venom metalloproteinase ussurin]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin ussurin]: Inhibits platelet aggregation induced by ADP, thrombin, platelet-activating factor and collagen. Acts by inhibiting fibrinogen interaction with platelet receptors GPIIb/GPIIIa (ITGA2B/ITGB3) (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
1708,Q7T229,VSPH_BOTJR,,Snake venom serine protease homolog (Serine proteinase-like protein),MVLIRVLANLLILQLSYAQKASELIIGGDECNINEHRFLVALYTSRSRRFHCSGTLINQEWVLTAANCDRKNIRIKLGMHSKNVTNEDEQTRVPKEKFFCLSSKTYTKWDKDIMLIRLKRPVNDSPHIAPISLPSSPPSVGSVCRIMGWGTISPTKVSYPDVPHCANINLLDYEVCRAAHGGLPATSRTLCAGILEGGKDSCQGDSGGPLICNGQFQGILSWGVHPCGQRLKPGVYTKVSDYTEWIRSIIAGNTDVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1709,Q7T247,SLB_ECHCA,,Snaclec echicetin subunit beta,MGRFISVSFGLLVLLLSLSGTGANCLPDWSVYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLTDYWRDCNWEWSDGAQLDYKAWDNERHCFIYKNTDNQWTRRDCTWTFSFVCKCPA,Snaclec family,"FUNCTION: Binding of echicetin to glycoprotein Ibalpha (GP1BA) receptor on platelets alone results in inhibition of platelet aggregation, while binding to both GPIba receptor and IgMk promotes platelet aggregation and signal transduction. {ECO:0000250}.",Binding Protein
1710,Q7T248,SLA_ECHCA,,Snaclec echicetin subunit alpha,GADEMCPPGWSSNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLSERSKEQHCSSRWSDGSFFRSYEIAIRYSECFVLEKQSVFRTWVATPCENTFPFMCKYPVPR,Snaclec family,"FUNCTION: Binding of echicetin to GPIbalpha (GP1BA) receptor on platelets alone results in inhibition of platelet aggregation, while binding to both GP1BA receptor and IgMk promotes platelet aggregation and signal transduction. {ECO:0000250}.",Binding Protein
1711,Q7T2Q6,VKTHB_BUNFL,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B chain,MSSGSLLLLLGLLTLLAELTPVSSRKRHPDCDKPPNKKRCTGHIPAFYYNPQRKTCERFSYGGCKGNGNHFKTPQLCMCHCHE,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and is non-toxic. {ECO:0000269|PubMed:11738240}.,Kunitz Family
1715,Q800C1,PA2AH_CROVV,3.1.1.4,Acidic phospholipase A2 Cvv-E6h (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVLLLGVEGSLVQFETLIMKIAGRSGLLWYSAYGCYCGWGGHGLPQDATDRCCFVHDCCYGKATDCNPKTVSYTYSVKNGEIICEDDDPCKRQVCECDRVAAVCFRDNIPSYNNNYKRFPAENCREEPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows very low inhibition of ADP-induced platelet aggregation in platelet-rich plasma of human, rabbit and guinea pig. In vivo, shows efficient edema-inducing activities in rat paws. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.",Phospholipase
1716,Q800C2,PA2AG_CROVV,3.1.1.4,Acidic phospholipase A2 Cvv-E6g (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVLLLGVEGSLVQFEMMIIKVAKRSGLFWYGAYGCYCGWGGQGRPQDATDRCCFVHDCCYGKATDCNPKTVSYTYSVKNGEIICEDDDPCKKQVCECDRVAAVCFRDNIPSYNNNYKRFPAENCRGDPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that shows very low inhibition of ADP-induced platelet aggregation in platelet-rich plasma of human, rabbit and guinea pig. In vivo, shows efficient edema-inducing activities in rat paws. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.",Phospholipase
1717,Q801Z4,VM2_BOTAL,,Disintegrin DisBa-01,GNELLEAGEECDCGTPGNPCCDAATCKLRPGAQCAEGLCCDQCRFMKEGTVCRIARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: This recombinant disintegrin antagonizes integrins alpha-IIb/beta-3 (ITGA2B/ITGB3) and alpha-V/beta-3 (ITGAV/ITGB3). On ITGA2B/ITGB3, it interferes with the outside/-in phosphorylation of the focal adhesion kinase (PTK2 / FAK) downstream of the integrin. It strongly inhibits platelet aggregation induced by ADP, thrombin, and collagen, abolishes and reverses dynamic platelet recruitment to immobilized fibrinogen. In vivo, it induces a dramatic increase in the tail bleeding time, and has a strong antithrombotic activity (PubMed:18508682). On ITGAV/ITGB3, it inhibits the adhesion of ITGAV/ITGB3-expressing human microvascular endothelial cell line and murine melanoma cell line to vitronectin (IC(50) are 555 nM and 225 nM, respectively), and transiently inhibits their proliferation without direct cell toxicity. In vivo, it potently inhibits angiogenesis and metastasis (PubMed:17952617), probably due to its capability to strongly inhibit the expression of VEGF and its receptors in endothelial cells (PubMed:22561350). It also inhibits tumor cell migration in vitro (PubMed:22069567). {ECO:0000269|PubMed:17952617, ECO:0000269|PubMed:18508682, ECO:0000269|PubMed:22069567, ECO:0000269|PubMed:22561350}.",Fibrinogenolytic Enzyme
1718,Q802F0,VSPP1_GLOHA,3.4.21.-,Snake venom serine protease PTLE1 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLALVFNSSGFLCSGTLINQEWVLTAAHCDMENMRIYLGVHNESVQYDDEQTRVPEEKFFCLRSNNDTKWDKDIMLIRLDSPVNNSAHIAPLNLPFNPPMLGSVCRIMGWGAITSPNEIYPDVPHCANINLLHYSMCQAVYPGMPAQSRILCAGIQTGGIDTCSGDSGGPLICNGQFQGILHAGGNPCALPRAPGLYTRVFDYTDWIENIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1719,Q805F5,DIDA_AGKPI,,Disintegrin piscivostatin-alpha (PVS-alpha),MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKITPLPKGAVQPKNPCCDAATCKLTPGSQCAEGLCCDQCKFIKAGKICRRARGDNPDYRCTGQSGDCPRKHFYA,"Disintegrin family, Dimeric disintegrin subfamily",FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits both ADP-induced platelet aggregation and platelet aggregate dissociation in human platelet-rich plasma.,Fibrinogenolytic Enzyme
1720,Q8AY41,VKTC_BUNCA,,Kunitz-type serine protease inhibitor C (Kunitz inhibitor C),MSSGGLLLLLGLLTLWTELTPVSSKNRPPFCNLLPEPGRCNAIVRAFYYNSRLRKCLEFPYGGCGGNANNFKTIDECQRTCAG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1721,Q8AY42,VKTB_BUNCA,,Kunitz-type serine protease inhibitor B (Kunitz inhibitor B),MSSGGLLLLVGLLTLCAELTPVSSKDRPKFCNVPPEPGRCNANVRAFYYNPRLRKCIEFTYGGCGGNANNFKSGGECKRACGE,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1722,Q8AY43,VKTA_BUNCA,,Kunitz-type serine protease inhibitor A (Kunitz inhibitor A),MSSGGLLLLLGLLTLCAELTPVSSKDRPKFCNVPPEPGRCNANVRAFYYNPRLRKCIEFTYGGCGGNANNFKSRGECKRTCAE,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1723,Q8AY44,VKTH7_BUNCA,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B2b chain,MSSGGLLLLLGLLTLWAELTPVSSRKRHPDCDKPPDTRICQTVVRAFYYKPSEKRCVQFRYGGCKGNGNHFKSDHLCRCECLEYR,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and is non-toxic (By similarity). {ECO:0000250}.,Kunitz Family
1724,Q8AY45,VKBH2_BUNCA,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B2a chain,MSSGGLLLLLGLLTLWAELTPVSSRKRHPDCDKPPDTKICQTVVRAFYYKPSAKRCVQFRYGGCNGNGNHFKSDHLCRCECLEYP,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and is non-toxic (By similarity). {ECO:0000250}.,Kunitz Family
1725,Q8AY78,VSP5M_TRIST,3.4.21.-,Snake venom serine protease 5 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVVGGRPCNINEHRSLVVLFNSSGFLCGGTLINQDWVVTAAHCDSNNFQMIFGVHSKNVPNEDEQRRVPKEKFFCDSNKNYTQWNKDIMLIRLNSPVNNSTHIAPLSLPSSPPIVGSVCRIMGWGTITFPNETYPDVPHCANINLFNYTVCHGAHAGLPATSRTLCAGVLEGGKDTCKGDSGGPLICNGQFQGIVSWGGHPCAQPREPGVYTKVFDHLDWIQNIIAGNTTATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1726,Q8AY82,VSPH1_TRIST,,Snake venom serine protease homolog 1 (Serine proteinase-like protein 1),MVLIRVLANLLILQLSYAQKSSELIIGGDECNINEHRFLVALYTFRSRRFHCSGTLINQEWVLSAARCDRKNIRIKLGMHSTNVTNEDVQTRVPKEKFFCLSSKTYTKWNKDIMLIRLKRPVNNSTHIAPVSLPSNPPSLGSVCRVMGWGTISATKETHPDVPHCANINILDYSVCRAAYARLPATSRTLCAGILEGGKDTCHGDSGGPLICNGQVQGIVSWGGHPCGLPRKPGLYTKVFDHLDWIKSIIAGNKDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1727,Q8AYA4,SLB1_DEIAC,,Snaclec agglucetin subunit beta-1,MGRVIFVSFGLLVVFLSLSGTAADCPSEWSSYEGHCYKAFKQSKTWADAEKFCTQQHKGSHLASFHSSEEADFVVTLTTPSLKTDLVWIGLKNIWNGCYWKWSDGTKLDYKDWREQFECLVSRTVNNEWLSMDCGTTYSFVCKFQA,Snaclec family,"FUNCTION: Agglucetin specifically causes platelet aggregation and surface exposure of integrin alpha-IIb/beta-3 with a GPIb-(GP1BA-) dependent manner in washed platelets. It binds to human platelets in a saturable manner, and its binding is specifically blocked by anti-GP Ib mAb. It regulates endothelial cell survival and promotes angiogenesis by activating integrin alpha-v/beta-3 signaling through FAK/phosphatidylinositol 3-kinase (PI3K)/Akt pathway. {ECO:0000269|PubMed:11686327, ECO:0000269|PubMed:18312855}.",Binding Protein
1728,Q8AYA5,SLA2_DEIAC,,Snaclec agglucetin subunit alpha-2 (Antithrombin 1 chain A),MGRFIFVSFGLLVVFLSLSGTGADFNCPPGWSAYDQYCYQVIKEPKNWDDAERFCTEQADGGHLVSIESKGERDFVAQLVSQNIESVEDHVWTGLRVQNKEKQCSTEWSDGSSVSYENLLELYMRKCGALERETGFHKWINLGCIQLNPFVCKFPPQC,Snaclec family,"FUNCTION: Agglucetin specifically causes platelet aggregation and surface exposure of integrin alpha-IIb/beta-3 with a GPIb-(GP1BA-) dependent manner in washed platelets. It binds to human platelets in a saturable manner, and its binding is specifically blocked by anti-GP Ib mAb. It regulates endothelial cell survival and promotes angiogenesis by activating integrin alpha-v/beta-3 signaling through FAK/phosphatidylinositol 3-kinase (PI3K)/Akt pathway. {ECO:0000269|PubMed:11686327, ECO:0000269|PubMed:18312855}.",Binding Protein
1729,Q8JFG1,PA2H_VIPAP,,Acidic phospholipase A2 inhibitor vaspin A chain (svPLA2 homolog) (Vaspin non-toxic component),MRTLWIVAVCLIGVEGNLFQFGDMILQKTGKEAVHSYAIYGCYCGWGGQGRAQDATDRCCFAQDCCYGRVNDCNPKMATYTYSFENGDIVCGDNDLCLRAVCECDRAAAICLGENVNTYDKNYEYYSISHCTEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Heterodimer: postsynaptic neurotoxin. {ECO:0000250}.; FUNCTION: Monomer: the acidic chain inhibits the basic phospholipase A2 of the complex. {ECO:0000250}.,Phospholipase
1732,Q8JI40,CRVP_GLOBL,,Cysteine-rich venom protein ablomin,MIVFIVLPILAAVLQQSSGNVDFDSESPRKPEIQNEIVDLHNSLRRSVNPTASNMLKMEWYPEAAANAERWAYRCIEDHSSPDSRVLEGIKCGENIYMSPIPMKWTDIIHIWHDEYKNFKYGIGADPPNAVSGHFTQIVWYKSYRAGCAAAYCPSSEYSYFYVCQYCPAGNMRGKTATPYTSGPPCGDCPSACDNGLCTNPCTQEDVFTNCNSLVQQSNCQHNYIKTNCPASCFCHNEIK,CRISP family,"FUNCTION: Blocks contraction of smooth muscle elicited by high potassium-induced depolarization, but does not block caffeine-stimulated contraction. Since high potassium-treatment activates voltage-gated channels and caffeine exposure activates ryanodine receptors, this toxin may target L-type voltage-gated calcium channels (Cav) (and not ryanodine receptors) on smooth muscle (PubMed:12047379). This toxin also shows a little inhibition on cyclic nucleotide-gated CNGA1 channel (PubMed:12646276). {ECO:0000269|PubMed:12047379, ECO:0000269|PubMed:12646276}.",General Toxin
1733,Q8JJ51,VM1_CROMM,3.4.24.-,Snake venom metalloproteinase (SVMP) (EC 3.4.24.-),MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKELFSKDYSETHYSPDGRKITTNPSVEDHCYYRGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLVLSDSEAHAVFKLENVEKEDGGPKMCGVTQNWESYEPIKKASDLNFNSDQQRFAKRYVELVIVADHRMFMKYKSDLFSICSRVHDIVNFINWFYRSLNIRVSLTDLGIWSDQDYITVQSSAENTLHSFGEWGKSVLLKQKRHDNAQLLTAIVLDEDTLGLAYLSSMCNPWTSVEIIQDHSPINLLMGVTMAHELGHNLGMKHDEKDCLRGATLCIMRPGLTPGRSYEFSDDSMGYYQSFLDQYKPQCILNKPLRIDPVSTPVSGNELLEAGEE,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1734,Q8QG86,VSP_BOTIN,3.4.21.-,Snake venom serine protease BITS01A (SVSP) (EC 3.4.21.-),MVLIRVIANLLILQVSYAQKSSELVVGGDECDINEHPFLAFLYSHGYFCGLTLINQEWVLTAAHCDRRFMRIYLGIHARSVANDDEVIRYPKEKFICPNKNMSDEKDKDIMLIRLNRPVKNSTHIAPISLPSNPPSVGSVCRVMGWGSITIPNDTYPDVPHCANINLVNDTVCRGAYKRFPAKSRTLCAGVLQGGKDTCVGDSGGPLICNGTFQGIVSWGGKVCARPRKPALYTKVFDYLPWIQSIIAGNKTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1735,Q8QG89,VM1B_BOTIN,3.4.24.-,Snake venom metalloproteinase BITM02A (SVMP) (EC 3.4.24.-),MIEVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGREITTYPPVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVFKFENVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPEHQRYIELFIVVDHGMFMKYNGNSDKIRRRIHQMVNIMKEAYRYLYIDIALTGVEIWSNKDMINVQPAAPQTLDSFGEWRKTDLLNRKSHDNAQLLTNTDFDGPTIGLAYVGTMCDPKLSTGVIQDHSPINLLVAVTMAHELGHNLGISHDTDSCSCGGYSCIMAPEISHEPSKYFSDCSYIQCWDFIMKENPQCILNKRLRTDTVSTPVSGNELLEAGE,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1736,Q8UUH7,PA2BK_LATCO,3.1.1.4,Basic phospholipase A2 PC20 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASAISPRPLNLIQFSQLIQCANKGKRATYHYMDYGCYCSKGGSGTPVDALDRCCKTHDDCYGQAEKKGCFPLLSLYNFACFPGAPQCGKGNTCQRFVCACDLKAALCFAKSPYNNNYNIDIKKKCQTLIYMRLQTQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1737,Q8UUH8,PA2BH_LATCO,3.1.1.4,Basic phospholipase A2 PC17 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASAISNQPRNLVQFSELIQCVNKGKRATYHYMDYGCYCGKGGSGTPVDALDRCCKTHDDCYGQAEKKGCFPFLTLYNFGCFPGGPTCGKGNTCQRFVCDCDLKAALCFAKSPYNNNNYNIDTKKRCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1738,Q8UUH9,PA2B9_LATCO,3.1.1.4,Basic phospholipase A2 PC9 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASAISPRPLNLIQFSQLIQCANKGKRPTLHYMDYGCYCGKGGSGTPVDALDRCCKTHDDCYGQAGKKGCIPFVTLYNFGCFPGAPQCGKGNTCQRFVCACDLKAALCFAKSPYNNNNYNIDTKKKCQTLIYARLQTQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1739,Q8UUI0,PA2B1_LATCO,3.1.1.4,Basic phospholipase A2 PC1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASAISNRPRNLVQFSELIQCVNKGKRATYHYMDYGCYCGKGGSGTPVDALDRCCKTHDDCYGQAEKKGCFPLLSLYNFACFPGAPQCGKGNTCQRFVCACDLKAALCFAKSPYNNNNYNIDIKKKCQTLIYMRLQTQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1740,Q8UUJ1,VSPUA_GLOUS,3.4.21.-,Snake venom serine protease ussurase (SVSP) (EC 3.4.21.-),VIGGVECNINEHGFLALLYSRRFQCGGTLINEEWVLTAAHCDMRNMYIYLGVHNVSVQYDDEQRRYPKKKYFCLSSRNYNQWDKDIMLIRLNRPVRNSAHIAPLSLPSNPPSVGSVCRVMGWGTITSPQETLPDVPHCANINILDYEVCRAAYPELPVTRRTLCAGILEGGKDSCNGDSGGPLICNGQFQGIAYWGADTCAQPREPGLYTKVFDYTDWIQSIISGNTDATCPQ,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1741,Q8UUJ2,VSPUI_GLOUS,3.4.21.-,Snake venom serine protease ussurin (SVSP) (EC 3.4.21.-),VIGGVECNINEHRFLVALYTSRSRRFYCGGTLINQEWVLTAAHCDRKNIRIKLGMHSEKVPNEDAQTRVPKEKFFCLSSKTYTKWDKDIMLMRLKRPVNNSTHIAPVSLPSNPPSVGSVCRVMGWGTITSSQETHPDVPHCANINILDYEVCRAAYPELPVTRRTLCAGILEGGKDSCNGDSGGPLICNGQFQGIAYWGADTCAQPREPGLYTKVFDYTDWIQSIISGNTDATCPQ,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1742,Q8UUK2,VSPS1_CROAD,3.4.21.-,Snake venom serine proteinase Sp1 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELIFGGRPCNRNEHRFLALVYSDGNQCSGTLINEEWVLTAAHCEGNKMKIHLGVHSKKVPNKDKQTRVPKEKFFCVSSKTYTKWNKDIMLIRLDRPVSNSKHIAPLNLPSSSPSVGSVCRIMGWGTISPTEVILPDVPQCANINLLSYSVCRAAYPEYGLPATSRTLCAGILEGGKDTCAGDSGGPLICNGQFQGIASWGSTLCGYVREPALYTKVFDHLDWIQSIIAGNTDATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1743,Q8UVX1,VSPG_GLOUS,3.4.21.-,Snake venom serine protease gussurobin (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELIIGGDECNINEHRFLVALYTSRSRRFYCGGTLINQEWVLTAAHCDRKNIRIKLGMHSEKVPNEDAQTRVPKEKFFCLSSKTYTKWDKDIMLMRLKRPVNNSTHIAPVSLPSNPPSVGSVCRVMGWGTITSPQETYPDVPHCANINILDYEVCQAAHGGLPATSRTLCAGILKGGKDSCKGDSGGPLICNGQFQGIASWGAHPCGQSLKPGVYTKVFDYTEWIQSTIAGNTDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1744,Q8UW08,PA2B0_HYDHA,3.1.1.4,Basic phospholipase A2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASIPPLPLNLVQFSYVITCANHGRRSSLDYADYGCYCGAGGSGTPVDELDRCCQIHDDCYGEAEKQGCYPKMLIYDYYCGSDGPYCRNVKKKCNRMVCDCDVAAAKCFARNAYNNANYNIDTNKRCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1745,Q8UW26,3S12_HYDHA,,Short neurotoxin 2 (SN36),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTNCAESSCYKKTWSDHRGTRIERGCGCPQVKHGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1746,Q8UW30,PA2B7_HYDHA,3.1.1.4,Basic phospholipase A2 73 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASIPPLPLNLVQFSYVITCANHNRRSSLDYADYGCYCGAGGSGTPVDELDRCCKIHDDCYGEAEKQGCYPKMLIYDYDCGSNGPYCKNVTKKCNRKVCDCDVAAAKCFARNAYNNANYNIDTKKRCK,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1747,Q90221,VM2H2_GLOHA,3.4.24.-,Zinc metalloproteinase/disintegrin [Cleaved into: Snake venom metalloproteinase (SVMP) (EC 3.4.24.-); Disintegrin halystatin-2],SYEFSDCNENEYQTYVTDHSPQCILNDPLRPDTVSTPVSGNELLEAGEDCDCGAPANPCCDAATCKLRPGAQCAEGLCCDQCRFMKEGTICRMARGDDMDDYCNGISAGCPRNPFHA,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily",FUNCTION: [Snake venom metalloproteinase]: Impairs hemostasis in the envenomed animal. {ECO:0000250}.; FUNCTION: [Disintegrin halystatin-2]: Inhibits platelet aggregation and bone resorption. {ECO:0000250}.,General Toxin
1748,Q90251,PA2A6_BUNMU,3.1.1.4,Acidic phospholipase A2 beta-bungarotoxin A6 chain (Beta-BuTX A6 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGAANIPPQHLNLYQFKEMIRYTIPCEKTWGEYADYGCYCGAGGSGTPIDALDRCCYVHDNCYGDAAKIRGCDPKTQSYSYKLTQRTIICYGAAGTCARVVCDCDRTAALCFGNSEYIEGHKNIDTKRHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1749,Q90W98,VKT4_PSETT,,Kunitz-type serine protease inhibitor textilinin-4 (Txln-4),MSSGGLLLLLGLLTLWEVLTPVSSKDHPKFCELPADTGSCKGNVPRFYYNADHHQCLKFIYGGCGGNANNFKTIEECKSTCAA,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor (By similarity). Does not inhibit plasmin, and does not reduce blood loss in the mouse tail vein blood loss model. {ECO:0000250}.",Serine Protease
1750,Q90W99,VKT3_PSETT,,Kunitz-type serine protease inhibitor textilinin-3 (Txln-3),MSSGGLLLLLGLLTLWEVLTPVSSKDRPNFCKLPAETGRCNAKIPRFYYNPRQHQCIEFLYGGCGGNANNFKTIKECESTCAA,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor (By similarity). Does not inhibit plasmin, and does not reduce blood loss in the mouse tail vein blood loss model. {ECO:0000250}.",Serine Protease
1751,Q90WA0,VKT2_PSETT,,Kunitz-type serine protease inhibitor textilinin-2 (Txln-2),MSSGGLLLLLGLLTLWEVLTPVSSKDRPELCELPPDTGPCRVRFPSFYYNPDEQKCLEFIYGGCEGNANNFITKEECESTCAA,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor that inhibits plasmin (Ki=2.2 nM), and reduces blood loss in the mouse tail vein blood loss model. {ECO:0000269|PubMed:10847427, ECO:0000269|PubMed:12406072}.",Serine Protease
1752,Q90WA7,PA2B1_BUNFA,3.1.1.4,Basic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 isozyme I),MNPAHLLVLLAVCVSLLGAANIPPQPLNLLQFKNMIQCAGSRLWVAYVKYGCYCGPGGTGTPLDQLDRCCQTHDHCYDNAKKFGNCIPYFKTYEYTCNKPDLTCTDAKGSCARNVCDCDRAAAICFAAAPYNLANFGINKETHCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1754,Q90WI7,LECM2_BUNFA,,C-type lectin BfL-2 (CTL),MGHFTFIGLCLLAMFLSLSGAECYTCPIDWLPKNGLCYKVFSNPKSWLDAEMFCRKFKPGCHLASIHRDADSADLAEYVSDYLKDDGNVWIGLNDPQKKRTWVWSDRSSSNYFSWNQGEPNNSKNKEYCVHLWAPTGYLKWNDAPCETLHPFICQCKY,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1755,Q90WI8,LECG1_BUNFA,,C-type lectin BfL-1 (CTL),MGHFTFIGLCLLAMFLSLSGAECYTCPIDWLPKNGLCYKVFSKHKTWFDAEMYCRKFKPGCHLASLHSNADAVEFSEYISDYLTGQGHVWIGLRDTKKKYIWEWTDRSRTDFLPWRKKQPDHFNNNEFCVEIVNFTGYLQWNDDNCAALRPFLCQCKY,True venom lectin family,FUNCTION: Galactose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1757,Q910A1,PA2A1_VIPAA,3.1.1.4,Acidic phospholipase A2 ammodytin I1 (AmI1) (AmdI1) (AtnI1) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRILWIVAVCLIGAEGHLSQFGDMINKKTGIFGIMSYIYYGCYCGWGGKGKPLDATDRCCFVHDCCYGRVNGCDPKMGTYSYSFQNGDIVCGGDDPCLRAVCECDRVAAICFGENMNTYDKKYMLYSLFDCKEESEQC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that has enzymatic activity but is non-toxic. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1765,Q92152,PA2H_OVOOK,,Phospholipase A2 homolog PLA2-03 (svPLA2 homolog),MRTLWIVAVLLVGVEGSLIQLGEMIFQEMGKGAAKKYGLYGCNCGMGRRGRPQDATDRCCSVHKCCYKKLTDCDPKTDRYSYSWENGDIVCGGDDPCTKEVCECDKAATICFRDNLDTYDKKYKIFPKFLCKKPEPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (By similarity). Is myotoxic and displays edema-inducing activities in mouse paw (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6}.",Phospholipase
1773,Q9DEA1,SLCB_DEIAC,,Snaclec agkicetin-C subunit beta (Antithrombin A subunit B),MGRFIFVSFGLLVVFLSLSGTGADCPPDWSSYEGNCYLVVKEKKTWAEAQKFCTEQRKECHLVSFHSAEEVDFVVSKTFPILSYDLVWIGLNNIWNDCMLEWSDGTKLTYKAWSGIPECIISKTSDNQWLSRACSRTQPFVCKFQA,Snaclec family,"FUNCTION: Is a potent glycoprotein Ibalpha (GP1BA) antagonist. Concentration-dependently inhibits botrocetin-, ristocetin- and low dose thrombin-induced platelet aggregation. Inhibits platelet adhesion only through inhibiting the vWF interaction with GP1BA, but has minimal effect on other platelet receptors, such as alpha-IIb/beta-3 (ITGA2B/ITGB3) or alpha-2/beta-1 (ITGA2/ITGB1). Causes an instant severe thrombocytopenia in rats and is not lethal to mice. {ECO:0000269|PubMed:15777951}.",Vascular Interaction
1774,Q9DEA2,SLCA_DEIAC,,Snaclec agkicetin-C subunit alpha (Antithrombin A subunit A),MGRFIFVSFGLLVVFLSLSGTAADCLPGWSSYIRFCYQPFKLLKTWEDAERFCTEQANGGHLVSFESAREADFVAGVLSENIKIKPYVWIGLRVQNEGQQCSSKWSDSSKVSYENLVEPFSKKCFVLKKDTGFRTWENVYCGLKHVFMCKYLKPR,Snaclec family,"FUNCTION: Is a potent glycoprotein Ibalpha (GP1BA) antagonist. Concentration-dependently inhibits botrocetin-, ristocetin- and low dose thrombin-induced platelet aggregation. Inhibits platelet adhesion only through inhibiting the vWF interaction with GP1BA, but has minimal effect on other platelet receptors, such as alpha-IIb/beta-3 (ITGA2B/ITGB3) or alpha-2/beta-1 (ITGA2/ITGB1). Causes an instant severe thrombocytopenia in rats and is not lethal to mice. {ECO:0000269|PubMed:15777951}.",Vascular Interaction
1775,Q9DF66,VSP3_PROJR,3.4.21.-,Snake venom serine protease 3 (SP3) (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELIIGGHPCNINEHRSLVVLFNSSGLLCSGTLINKEWVLTAAHCDSNNFQLLFGVHSKKVLNEDEQTRDPKEKFICPNKKKDDEKDKDIMLIRLDSSVSNSEHIAPLSLPSSPPSVGSACRVMGWGKTIPTKDTYPDVPHCANINILDHAVCRAAYSNLLEKSKTLCAGILQGGKDTCQFDSGGPLICNGQVQGIVSWGGHPCGQPHALGVYTNVFNYTDWIQSIIAGNTDATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1776,Q9DF68,VSPH1_PROJR,,Snake venom serine protease homolog (SP1) (Venom serine proteinase-like protein),MVLVRVLANLLMLQLSYAQKSSELIIGGDECNINEHRFLVALYTFRSRRFHCSGTLINEEWVLSAARCDRKNIRIQLGMHSTNVINEDVQTRVPKEKFSCLSSKTYTKWNKDIMLIRLKKPVNNSTHIAPVSLPSNPPTLGSVCRVMGWGTISATKETHPDVPLCANINILDYSVCRAAYARLPATSRTLCAGILEGGIDTCKGDPGGPLICNGQFQGIVSWGSDPCAKPHEPGSYTKVFDHLNWIQSIIAGNTTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1779,Q9DG83,VSP6_PROMU,3.4.21.-,Snake venom serine protease serpentokallikrein-1 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQRTSELVIGGDECNINEHRFLVALHDALSGRFLCGGTLIHPEWVLTAAHCNTHFIIIYLGAHNQSVEFDYEETRYPEKKYFFPCSKNYTKWDKDIMLIRLYSPVRNSKHIAPISLPSSPPSVGSVCRIMGWGAITSPNETFPDVPHCANINLFNYTVCRAAYPELPATSRTLCAGILEGGIDTCHGDSGGPLICNGQFQGIVQAGGKTCARPRKPAVYTNVFDHLDWIKSIIAGNTAVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1780,Q9DG84,VSP7_PROMU,3.4.21.-,Snake venom serine protease serpentokallikrein-2 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVLVYYDDYQCGGTLINEEWVLTAAHCNGENMEIYLGMHSKKVPNKDRRRRVPKEKFFCDSSKNYTKWNKDIMLIRLNRPVRKSAHIAPLSLPSSPPSVGSVCRIMGWGTISPTKVTLPDVPRCANINLLDYEVCRAVYPELPATSRTLCAGILEGGKDSCGGDSGGPLICNGQFQGIVSWGGDPCAQPHEPGLYTNVFDHLDWIKGIIAGNTDVTCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1789,Q9I8W9,VSP4_DEIAC,3.4.21.-,Snake venom serine protease Dav-X (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGVECDINEHRFLAAFFKYQPWTFQCAGTLIHEQWVLGAAHCYKRGLNIYLGMHNQSIQFDDEQRRYAIEEHYYRCDEKLTKWEKDVMLLKLNKPVRNSTHIAPLSLPSSPPSIGSFCRVMGWGIMSSTKDILPDVPHCANIKLVNYTECVAPYPNIPVTTRLWCAGVLEGGIDTCHQDSGGPLICDGQFQGIVAFGRYPCAQPRVPALYTKVSNYTDWIQNIIAGKTTTACPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1790,Q9I8X0,VSP3_DEIAC,3.4.21.-,Snake venom serine protease Dav-KN (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVLVYYDDYQCGGTLLNEEWVLTAAHCNGKDMEIYLGVHSKKVPNKDVQRRVPKEKFFCDSSKTYTKWNKDIMLIRLDRPVRKSAHIAPLSLPSSPPSVGSVCRIMGWGSITPVEVTFPDVPYCANINLLDDVECKPGYPELLPEYKTLCAGILEGGIDTCGFDSGAPLISNGQFQGIVSWGGDPCAQPREPGVYTNVFDHLDWIKGIIAGNTDVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1791,Q9I968,PA2A2_PROMU,3.1.1.4,Acidic phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVLLLGVEGNLWQFREMIKEATGKEPLTTYLFYACYCGWGGRGEPKDATDRCCFVHDCCYGKLTACSPKLDMYTYSQKNEDIVCGGDDPCKKEICECDKAAAICFLNNLGTYNEEYNNYRKSRCIEESPKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that displays edema-inducing activities, exhibits indirect hemolytic activity, and inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.",Phospholipase
1792,Q9IAY0,VM1H3_DEIAC,3.4.24.-,Snake venom metalloproteinase H3 (SVMP) (EC 3.4.24.-),FPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGRRITTHPLVEDHCYYRGHIRNDADSTASISACNGLKGHFKLRGETYLIEPMKISNSEAHAVYKYENVEKEDEAHKMCGVTQNWESYEPIKKASQLIVSTEFQKYMEIVIVVDHSMYTKHKGDSDKIKAWVYEMINTISESYRYLYIDIIVSALEMWSEKDLINVETSAENTLKSFGEWRAKDLIHRISHDNAQLLTATDFDGPTIGLAYVASMCDPKRSVGVVQDHSSVNHLVAITLAHEIAHNLGVHHDKSSCSCGSGYTCIMSPVINSEVIKYFSDCSYIQCREYISKENPPCILNKPLRTDTVSTPVSGNELLEAGKDYD,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1793,Q9IAY1,VM1H2_DEIAC,3.4.24.-,Snake venom metalloproteinase H2 (SVMP) (EC 3.4.24.-),FPYQGSSTILESGNVNDYEVVYPRKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGRRITTHPLVEDHCYYRGHIRNDADSTASISACNGLKGHFKLRGETYLIEPMKISNSEAHAVYKYENVEKEDEAHKMCGVTQNWESYEPIKKASQLIVSTEFQRYMEIVIVVDHSMYTKYKGDSDKIKAWVYEMINTISESYRYLYIDIIVSALEMWSEKDLINVETSAENTLKSFGEWRAKDLIHRISHDNAQLLTATDFDGPTIGLAYVASMCDPKRSVGVVQDHSSVNHLVAITLAHEIAHNLGVHHDKSSCSCGSGYTCIMSPVINSEVIKYFSDCSYIQCREYISKENPPCILNKPLRTDTVSTPVSGNELLEAGKDYD,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1794,Q9IAY3,VM1H1_DEIAC,3.4.24.-,Snake venom metalloproteinase H1 (SVMP) (EC 3.4.24.-),FPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGRRITTHPLVEDHCYYRGHIRNDADSTASISACNGLKGHFKLRGETYLIEPMKISNSEAHAVYKYENVEKEDEAHKMCGVTQNWESYEPIKKASQLIVSTEFQRYMEIVIVVDHSMYTKYKGDSDKIKAWVYEMINTISESYRYLYIDIIVSALEMWSEKDLINVETSAENTLKSFGEWRAKDLIHRISHDNAQLLTATDFDGPTIGLAYVASMCDPKRSVGVVQDHSSVNHLVAITLAHEIAHNLGVHHDEGSCSCGSGYTCIMSPVINSEVIKYFSDCSYIQCREYISKENPPCILNKPLRTDTVSTPVSGNELLEAGKDYD,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1795,Q9IAY4,VM1H4_DEIAC,3.4.24.-,Snake venom metalloproteinase H4 (SVMP) (EC 3.4.24.-),FPYQGSSIMLESGKVNDYEVVYPRKVTALPKGAVQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGRRITTHPLVEGHCYYRGHIRNDADSTASISACNGLKGHFKIQGETYFIESLKLSDSEAHAVFKYENVEKEDEAHKMCGVTQNWESYEPIKKASQLIVSTEFQRYMEIVIVVDHSMYTKYKGDSDKIKAWVYEMINTISESYRYLYIDIIVSALEMWSEKDLINVETSAENTLKSFGEWRAKDLIHRISHDNAQLLTATDFDGPTIGLAYVASMCDPKRSVGVVQDHSSVNHLVAITLAHEIAHNLGVHHDEGSCSCGSGYTCIMSPVINSEVIKYFLDSK,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
1799,Q9PRY9,VSP_BITAR,3.4.21.-,Snake venom serine proteinase (SVSP) (Kallidin-releasing enzyme) (EC 3.4.21.-),VIGGDECDINEHRFLVFLTXASGLACGGTLIN,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Cleaves a kininogen analog with the release of kallidin (lysyl-bradykinin). Completely cleaves fibrinogen Aalpha chain, partially cleaves Bbeta chain and has no activity on gamma chain. {ECO:0000269|PubMed:8274016}.",Fibrinogenolytic Enzyme
1802,Q9PS28,VSPF_CERCE,3.4.21.74,Thrombin-like enzyme RP34 (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Venombin A),VIGGDEXDINEHRSLALMYXSWSHRFIXXGXLI,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Thrombin-like snake venom serine protease that displays clotting activity on fibrinogen. Shows both arginine-ester hydrolase and amidase activities on synthetic substrates. Also shows proteolytic activity toward casein. {ECO:0000269|PubMed:1485336}.,Serine Protease
1803,Q9PSF9,PA2B2_AGKBI,3.1.1.4,Basic phospholipase A2 2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 II) (PLA2-II),SLLELGKMILQETGKIAITSYGSYGCNCGWGHRGRPKDA,"Phospholipase A2 family, Group II subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. {ECO:0000269|PubMed:8138046}.,Phospholipase
1804,Q9PSM5,SL1B_BOTJA,,Snaclec GPIB-binding protein subunit beta (GPIb-BP subunit beta),DCPSDWSPYGGHCYKLFKQRMNWADAENLCAQQRKESHLVSFHSSEEVDFLVLLTFPILGPDLYWTGLSNIWNGCSFEWSDGTKVNYNAWASESECVASKTTDNQWWSFPCTRLQYFVCEFQA,Snaclec family,"FUNCTION: Binds to platelet GPIb (subunit alpha) (GP1BA) and functions as a receptor blocker for vWF binding to GPIb. The platelet GPIb-binding site resides on the GPIB-BP subunit beta and not on the alpha subunit. At a final concentration of 104 nM totally abolishes vWF-dependent shear-induced platelet aggregation (SIPA) at a high shear stress, but had no effect on SIPA at a low shear stress. {ECO:0000269|PubMed:8585016}.",Binding Protein
1805,Q9PSM6,SL1A_BOTJA,,Snaclec GPIB-binding protein subunit alpha (GPIb-BP subunit alpha),DTPFECPSDWSTHRQYCYKFFQQKESWDDRSEYDAERFCSEQAKGGHLVSIESDEEADFVAQLVAPNIGKSKYYVWIGLRIENKKQQCSSKWSDYSSVSYENLVRGNVKKCFALEKKQGFRKWVNIDCVEGNPFVCKFIRPR,Snaclec family,"FUNCTION: Binds to platelet GPIb (subunit alpha) (GP1BA) and functions as a receptor blocker for vWF binding to GPIb. The platelet GPIb-binding site resides on the GPIB-BP subunit beta and not on the alpha subunit. At a final concentration of 104 nM totally abolishes vWF-dependent shear-induced platelet aggregation (SIPA) at a high shear stress, but had no effect on SIPA at a low shear stress. {ECO:0000269|PubMed:8585016}.",Binding Protein
1809,Q9PSN6,3S13_NAJSP,,Neurotoxin 3 (Toxin 3),LECHDQQSSQTPTTTGCSGGETNCYKKRWRDHRGYRTERGCGCPSVKNGIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1812,Q9PT40,VSPH2_MACLB,,Snake venom serine protease homolog 2 (Venom serine proteinase-like protein 2) (VLP2),MVLIRVLANLLVLQLSYAQKSSELVIGGDECNINEHPFPVALHTARSKRFYCAGTLINQEWVLTAARCDRKNIRIILGVHSKNVPNEDQQIRVPKEKFFCLSSKTYTRWDKDIMLIRLKKPVNDSTHIVPLSLPSSPPSVGSVCRIMGWGTITTTKVTYPDVPHCANINMFDYSVCRKVYRKLPEKSRTLCAGILQGGIDSCKVDNGGPLICNGQIQGIVSWGGHPCAQPHKPALYTNVFDYTDWIQSIIAGNITATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
1813,Q9PTA5,PA2BD_BUNMU,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A-AL4 chain (Beta-BuTX A-AL4 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),LAVCVSLLGAANIPPQHLNLCQFKEMIRYTIPCEKTWLEYTHYGCYCGYGGSGTPVDALDRCCYVHDNCYGDAEKKHKCNPKTQSYSYKLTKRTIICYDAAGTCARIVCDCDRTAALCFGNSEYIGAHKNIDTARYC,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1814,Q9PTA6,PA2BC_BUNMU,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A-AL3 chain (Beta-BuTX A-AL3 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),LAVCVSLIGAANIPPQHLNLYQFKEMIRYTIPCEKTWLEYTDYGCYCGYGGSGTPVDALDRCCYVHDNCYGDAEKKHKCNPKMQLYSYKLTKRTIICYGAAGTCERIVCDCDRTAALCFGNSEYIERHKNIDTKRYCR,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1815,Q9PTA7,PA2B_BUNMU,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A-AL2 chain (Beta-BuTX A-AL2 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),FLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAANIRDCNPKTQSYSYKLTKRTIICYGAAGTCARIVCDCDRTAALCFGNSEYIERHKNIDTKRHCR,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1816,Q9PTL3,VSPSA_GLOBR,3.4.21.-,Snake venom serine protease salmonase (SVSP) (EC 3.4.21.-),MVLIRVLVNFLILQLSYAQKSSELVIGGDECNINEHRFLALLYSERFQCGGTLINEEWVLTAAHCDMRNMYIYLGVHNVSVQYDDEQRRYPKKKYFRLSSRNYNQWDKDIMLIRLNRPLRNSAHIAPLSLPSNPPSVGSVCRIMGWGTITSPQVTFPDVLHCANINIFDYEVCRAAYPELPATRRTLCAGILEGGKDSCNGDSGGPLICNGQFQGIAYWGADTCAQPREPGLYTKVFDYIDWIQSIIAGNTAVTCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1817,Q9PTT0,3S1CB_NAJNA,,Cobrotoxin homolog (Short neurotoxin),METLLLTLLVVTIVCLDLGYTLECHNQQSSQTPTTTGCSGGETNCYKKRWRDHRGYRTERGCGCPSVKNGIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1818,Q9PU97,PA2B7_BUNMU,3.1.1.4,Basic phospholipase A2 beta-bungarotoxin A7 chain (Beta-BuTX A7 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),AVCVSLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGEAEKIPGCNPKTKTYSYKLTKRTIICYGAAGTCGRIVCDCDRTAALCFGNSEYIEGHKNIDTKRHCR,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits neuromuscular transmission by blocking acetylcholine release from the nerve termini. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1819,Q9PUG9,PA2AF_AUSSU,3.1.1.4,Acidic phospholipase A2 S12-65J (svPLA2) (EC 3.1.1.4) (ASPLA15) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASIPPQPLNLVQFSYLIQCANHGSRATWHYTDYGCYCGSGGSGTPVDELDRCCQTHDNCYGEAEKKGCYPKMLAYDYYCGGDGPYCRDIKKECQRFVCDCDVEAAKCFAKAPYDKENYNIKTRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1820,Q9PUH0,PA2AE_AUSSU,3.1.1.4,Acidic phospholipase A2 S8-51 (svPLA2) (EC 3.1.1.4) (ASPLA14) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASIPPQPLNLVQFSYLIQCANHGSRATWHYTDYGCYCGSGGSGTPVDELDRCCQTHDNCYGEAEKKGCYPKMSAYDYYCGGDGPYCRNIRKECQRFVCDCDAIAAKCFARAPYNDANWDIDTETRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1821,Q9PUH1,PA2AD_AUSSU,3.1.1.4,Acidic phospholipase A2 S14-72F (svPLA2) (EC 3.1.1.4) (ASPLA13) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASIPPQPLNLVQFSYLIQCANHGSRATWHYTDYGCYCGSGGSGTPVDELDRCCQTHDNCYGEAEKKGCYPKMLAYDYYCGGDGPYCRNIKKECQRFVCDCDVEAAKCFARAPYNDANWNIDTKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1822,Q9PUH2,PA2AC_AUSSU,3.1.1.4,Acidic phospholipase A2 S4-30 (svPLA2) (EC 3.1.1.4) (ASPLA12) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASIPPQPLNLVQFSYLIQCANHGSRATWHYTDYGCYCGSGGSGTPVDELDRCCQTHDNCYAEAEKKGCYPKMSAYDYYCGGDGPYCRNIKKECQRFVCDCDVEAAKCFARAPYNDANWNIDTKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1823,Q9PUH3,PA2AB_AUSSU,3.1.1.4,Acidic phospholipase A2 S13-69J (svPLA2) (EC 3.1.1.4) (ASPLA11) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASIPPQPLNLVQFSYLIQCANHGSRATWHYTDYGCYCGSGGSGTPVDELDRCCQTHDNCYAEAEKKGCYPKMSAYDYYCGENGPYCRNIKKECQRFVCDCDVEAAKCFARAPYNDANWNIDTKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1824,Q9PUH4,PA2AA_AUSSU,3.1.1.4,Acidic phospholipase A2 S5-32M (svPLA2) (EC 3.1.1.4) (ASPLA10) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASIPPQPLNLVQFSYLIQCANHGSRATWHYTDYGCYCGKGGSGTPVDELDRCCKIHDDCYGEAEKKGCYPKMSAYDYYCGENGPYCRNIKKECQRFVCDCDVEAAKCFARAPYNDANWNIDTKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1825,Q9PUH5,PA2B9_AUSSU,3.1.1.4,Basic phospholipase A2 S11-61 (svPLA2) (EC 3.1.1.4) (ASPLA9) (Phosphatidylcholine 2-acylhydrolase),MYPVHLLVLLAVCVSLLGASNIPPQPLNLYQFGNMIQCANHGRRPTQHYTDYGCYCGKGGSGTPVDELDRCCKTHDDCYTEAGKKGCYPKLTLYSWKCTGKAPTCNSKTGCKRTVCDCDATAAKCFAKAPYNNKNYNIDTKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1826,Q9PUH6,PA2B8_AUSSU,3.1.1.4,Basic phospholipase A2 S10-58F (svPLA2) (EC 3.1.1.4) (ASPLA8) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGAASIPPQPLNLVQFSYLIQCANHGSRATWHYTDYGCYCGKGGSGTPVDELDRCCKTHDDCYTEAGKKGCYPKLTLYSWKCTGKAPTCNSKTGCKRTVCDCDATAAKCFAKAPYNNKNYNIDTKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1827,Q9PUH7,PA2A7_AUSSU,3.1.1.4,Acidic phospholipase A2 S15-109 (svPLA2) (EC 3.1.1.4) (ASPLA7) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASDIPPQPLNLYQFGNMIQCANHGRRPTQHYTDYGCYCGKGGSGTPVDELDRCCKTHDDCYTEAGKKGCYPKLTLYSWKCGSDGPQCDDSETGCQRFVCDCDATAAKCFAKAPYNKENYNIKTPCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1828,Q9PUH8,PA2A6_AUSSU,3.1.1.4,Acidic phospholipase A2 S3-24 (svPLA2) (EC 3.1.1.4) (ASPLA6) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASDMPPQPLNLVQFSNMIQCANHGRRPTSNYMDYGCYCGKGGSGTPVDALDRCCKIHDDCYGEAEKSQNCAPYWTWYTWKCGSDGPQCDDSETGCKRIVCDCDVEAADCFAGAPYNNANWNIDTKKRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1829,Q9PUH9,PA2A5_AUSSU,3.1.1.4,Acidic phospholipase A2 S9-53F (svPLA2) (EC 3.1.1.4) (ASPLA5) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASDIPPQPLNLYQFSNMIQCANRGRRPTKHYMDYGCYCGKGGSGTPVDELDRCCKVHDDCYGEAEKSQNCAPYWTWYTWKCGSDGPQCDDSETGCQRSVCECDAIAAKCFAKAPYNDANWDIDTETRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1830,Q9PUI0,PA2A4_AUSSU,3.1.1.4,Acidic phospholipase A2 S7-48J (svPLA2) (EC 3.1.1.4) (ASPLA4) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASDIPPQPLNLYQFSNMIQCANHGRRPTKHYMDYGCYCGKGGSGTPVDELDRCCKIHDDCYGEAEKSQNCAPYWTWYTWKCGSDGPQCDDSETGCQRSVCECDAIAAKCFAKAPYNDANWDIDTETRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1831,Q9PUI1,PA2B2_AUSSU,3.1.1.4,Basic phospholipase A2 S6-45 (svPLA2) (EC 3.1.1.4) (ASPLA2) (Phosphatidylcholine 2-acylhydrolase),MYPAHLLVLLAVCVSLLGASDIPPQPLNLVQFSSMIQCANHGRRPTSNYMDYGCYCGKGGSGTPVDELDRCCKIHDDCYGEAEKSQKCAPYWTWYTWKCGSDGPQCDDSKTGCQRFVCDCDATAAKCFAKAPYNKENYNIKTRCQ,"Phospholipase A2 family, Group I subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits collagen-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1832,Q9PVE3,PA2H3_BOTAS,,Basic phospholipase A2 homolog M1-3-3 (svPLA2 homolog),MRTLWIMAVLLVGVEGSLVELGKMILQETGKNPVTSYGAYGCNCGVLGRGKPKDATDRCCYVHKCCYKKLTGCNPKKDRYSYSWKDKTIVCGENNSCLKELCECDKAVAICLRKNLDTYNKKYKNNYLKPFCKKADPC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity. Is myotoxic (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:Q90249}.",Phospholipase
1833,Q9PVE9,PA2AC_CALRH,3.1.1.4,Acidic phospholipase A2 S1E6-c (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWILAVLLVGVEGSLVQFETMIMKLAKRSGFFWYSFYGCYCGWGGHGLPQDPTDRCCFVHDCCYGKVTNCNPKTATYSYTEENDGIVCGGDDPCKKQVCECDRVAAMCFRDNKDTYDGDKYWKLPPQKCQEDPEPC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily",FUNCTION: Snake venom phospholipase A2 (PLA2) that inhibits ADP-induced platelet aggregation. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.,Phospholipase
1834,Q9PVF3,PA2HB_CALRH,,Basic phospholipase A2 homolog G6K49 (svPLA2 homolog) (CRV/TMV/DAV-K49),MRTLWIMAVLLLGVEGSLIELGKMIFQETGKNPVKNYGLYGCNCGVGNRGKPVDATDRCCFVHKCCYKKVTGCDPKKDRYSYSWENKAIVCGEKNPPCLKQVCECDKAVAICLRENLGTYDKKHRVTVKFLCKAPESC,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that lacks enzymatic activity. Displays myotoxic activities (By similarity). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000250|UniProtKB:Q2PWA3}.",Phospholipase
1835,Q9PW19,3NOH_BUNMU,,Toxin BMLCL (BM8),MKTLLLTLVVVTIICLDLGYTEMCNMCVRPYPFMSSCCPEGQDRCYKSYWVNENGKQEAYHGKYPVILERGCVTACTGPGSGSIYNLYTCCPTNRCGSSSTSG,"Snake three-finger toxin family, Ancestral subfamily, Orphan group XVII sub-subfamily","FUNCTION: Interacts with high efficiency with both neuronal alpha-7/CHRNA7 and muscle type nicotinic acetylcholine receptors (nAChRs). Tested on human alpha-7/CHRNA7 nAChR (IC(50)=42 nM), T.californica muscle receptor (IC(50)=31 nM), L.stagnalis and A.californica acetylcholine-binding proteins (IC(50)=333 nM and 3.4 uM, respectively). {ECO:0000269|PubMed:26518551}.",Neurotoxin
1836,Q9PWR6,PA2A7_DABPA,3.1.1.4,Acidic phospholipase A2 VP7 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRTLWIVAVCLMGVEGHLTQFGDMINKKTGTFGLLSYVYYGCYCGLGGKGKPQDATDRCCFVHDCCYGTVNGCDPKLSTYSYSFQNGDIVCGDDDPCLRAVCECDRVAAICFGENMNTYDTKYMLHSLFDCMEESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that is not toxic by itself, but the synergistical mixture of a basic and this acidic protein is lethal. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.",Phospholipase
1839,Q9W728,VKTH3_BUNMU,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B3 chain,MSSGGLLLLLGLLTLCAELIPVSSRQRHRDCDKPPDKGNCGPVRRAFYYDTRLKTCKAFQYRGCNGNGNHFKSDHLCRCECLEYS,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxins are presynaptic neurotoxins of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv) (By similarity). {ECO:0000250}.,Kunitz Family
1840,Q9W7J5,3L2P_PSETE,,Pseudonajatoxin b homolog (Pt-bp),MKTLLLTLVVVTIVCLDLGYTRTCFITPDVKSKPCPPGQEVCYTKTWCDGFCGIRGKRVDLGCAATCPTPKKTGIDIICCSTDDCNTFPLRPRGRLSSIKDHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1841,Q9W7J6,3S37_PSETE,,Short neurotoxin 7 (SNTX7) (Alpha-neurotoxin 7),MKTLLLTLVMVTIMCLDLGYTLTCYKRYFDTVVCKPQETICYRYIIPATHGNAITYRGCSTSCPSGIRLVCCSTDLCNK,"Snake three-finger toxin family, Short-chain subfamily, Type III alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscle nicotinic acetylcholine receptor (nAChR) and hinders acetylcholine binding to the receptor, thereby impairing neuromuscular transmission. Competes with the binding of alpha-bungarotoxin on muscle AChR (from Torpedo) (IC(50)=0.30 uM). In vivo, causes muscle paralysis, spasms and increased respiration. {ECO:0000269|PubMed:10518793}.",Neurotoxin
1842,Q9W7J7,3S36_PSETE,,Short neurotoxin 6 (SNTX6) (Alpha-neurotoxin 6),MKTLLLTLVMVTIMCLDLGYTLTCYKSLSGTVVCKPHETICYRRLIPATHGNAIIDRGCSTSCPGGNRPVCCSTDLCNK,"Snake three-finger toxin family, Short-chain subfamily, Type III alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscle nicotinic acetylcholine receptor (nAChR) and hinders acetylcholine binding to the receptor, thereby impairing neuromuscular transmission. Competes with the binding of alpha-bungarotoxin on muscle AChR (from Torpedo) with an IC(50) of 0.18 uM. Causes muscle paralysis, spasms and increased respiration. {ECO:0000269|PubMed:10518793}.",Neurotoxin
1843,Q9W7K0,3S33_PSETE,,Short neurotoxin 3 (SNTX3) (Alpha-neurotoxin 3),MKTLLLTLVMVTIMCLDLGYTLTCYKGYHDTVVCKPHETICYRYLVPATHGNAIPARGCGTSCPGGNHPVCCSTDLCNK,"Snake three-finger toxin family, Short-chain subfamily, Type III alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscle nicotinic acetylcholine receptor (nAChR) and hinders acetylcholine binding to the receptor, thereby impairing neuromuscular transmission. Competes with the binding of alpha-bungarotoxin on muscle AChR (from Torpedo) with an IC(50) of 0.30 uM. Causes muscle paralysis, spasms and increased respiration. {ECO:0000269|PubMed:10518793}.",Neurotoxin
1844,Q9W7K1,3S32_PSETE,,Short neurotoxin 2 (SNTX2) (Alpha-neurotoxin 2),MKTLLLTLVMVTIMCLDLGYTLTCYKGYHDTVVCKPHETICYRYLIPATHGNAIPARGCGTSCPGGNHPVCCSTDLCNK,"Snake three-finger toxin family, Short-chain subfamily, Type III alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscle nicotinic acetylcholine receptor (nAChR) and hinders acetylcholine binding to the receptor, thereby impairing neuromuscular transmission. Competes with the binding of alpha-bungarotoxin on muscle AChR (from Torpedo) with an IC(50) of 0.30 uM. Causes muscle paralysis, spasms and increased respiration. {ECO:0000269|PubMed:10518793}.",Neurotoxin
1845,Q9W7K2,3S31_PSETE,,Short neurotoxin 1/5 (SNTX1) (SNTX5) (Alpha-neurotoxin 1/5),MKTLLLTLVMVTIMCLDLGYTLTCYKGYHDTVVCKPHETICYEYFIPATHGNAILARGCGTSCPGGIRPVCCRTDLCNK,"Snake three-finger toxin family, Short-chain subfamily, Type III alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. Compete with the binding of alpha-bungarotoxin on muscle AChR (from Torpedo) with an IC(50) of 0.31 uM (SNTX1) and 3.1 uM (SNTX5). Is able of exerting muscle paralysis, spasms and increased respiration. {ECO:0000269|PubMed:10518793}.",Neurotoxin
1847,Q9YGI4,3NO22_NAJAT,,Probable weak neurotoxin NNAM2 (TA-N9),MKTLLLTLVVVTIVCLDLGYTLTCLNCPEMFCGKFQICRNGEKICFKKLHQRRPFSLRYIRGCAATCPETKPRDMVECCSTDRCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
1848,Q9YGI6,VSP2_GLOHA,3.4.21.-,Snake venom serine protease pallabin-2 (SVSP) (EC 3.4.21.-),MVLIKVLANLLILQLSYAQKSSELIIGGDECNINEHRFLVALYTSRTLFCGGTLINQEWVLTAAHCNMEDIQIKLGMHSKKVPNEDEQKRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSAHIAPLSLPSSPPSVGSVCRTMGWGRISSTKETYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCVGDSGGPLICNGQFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIENIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1849,Q9YGJ2,VSP1_GLOHA,3.4.21.-,Snake venom serine protease pallabin (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSKLVIGGDECNINEHRFLVALYTSRTLFCGGTLINQEWVLTAAHCNMEDIQIKLGMHSKKVPNEDEQKRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSAHIAPLSLPSSPPSVGSDCRTMGWGRISSTKETYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCVGDSGGPLICNGQSQGIASWGDDPCAQPHRPAAYTKVFDHLDWIENIIAGNTDASCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1850,Q9YGJ7,PA2A8_DABPA,3.1.1.4,Acidic phospholipase A2 VP8 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),MRILWIVAVCLIGVEGNLYQFGKMIFKMTRKSALSYSDYGCYCGWGGKGKPQDATDRCCFVHDCCYGTVNGCDPKLSTYSYSFQNGDIVCGGDDPCLRAVCECDRVAAICFGENMNTYDTKYMLHSLFDCMEESEKC,"Phospholipase A2 family, Group II subfamily, D49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 (PLA2) that is not toxic by itself, but the synergistical mixture of a basic and this acidic protein is lethal. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides (By similarity). {ECO:0000250}.",Phospholipase
1851,Q9YGJ9,VSPH2_GLOBR,3.4.21.-,Snake venom serine protease Haly-2 (SVSP) (EC 3.4.21.-),MVLIRVLANLLILQLSYAQKSSELIIGGDECNINEHRSLVLMYYDGHQCDGTLINEEWVLTAAHCDGENMEIQLGVHSKKVPNEDVQTRVPKEKFFCDSNKTYARWNKDIMLIRLDRPVSNSAHIAPLSLPSSPPSVGSVCRIMGWGTFSTTQETYPDVPHCANINIHDFEVCQAAYPGLPATNRILCAGILEGGKDTCKGDSGGPLICNGEIQGIVSWGGHLCGNVLEPGIYTKVFDHLEWIRSIIAGNTDATCPL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
1853,U3EPL2,3SXB_MICFL,,Three-finger toxin 3b (3FTx 3b) (Micrurus fulvius dimeric neurotoxin b) (SIGMA-neurotoxin),MKTLLLTLVVVTIVCLDLGNSLKCYSSRTETMTCPEGEDKCEKYAAGLMHGSFFFIYTCTSKCHEGAYNVCCSTDLCNKSSTSG,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: Postsynaptic neurotoxin that produces potent, and completely reversible, postsynaptic neuromuscular blockade, as well as broad spectrum inhibition of human muscle and neuronal nicotinic acetylcholine receptors (nAChRs). Inhibition is potent or moderate, depending on the receptor (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE (IC(50)=2.56 uM), alpha-4-beta-2/CHRNA4-CHRNB2 (IC(50)=1.8 uM), alpha-7/CHRNA7 (IC(50)=7 uM), and alpha-3-beta-2/CHRNA3-CHRNB2 (IC(50)=12.6 uM)). Acts as a competitive antagonist of ACh. Binds to chicken muscle-type nicotinic acetylcholine receptor (AChR) with high potency compared with the cloned human receptor. Unlike short-chain alpha-3FTxs that only bind to muscle nAChRs, this toxin utilizes dimerization to expand its pharmacological targets to block neuronal nAChRs. {ECO:0000250|UniProtKB:U3FAE1}.",Neurotoxin
1857,U5YCR8,VSP_BOTPC,3.4.21.-,Snake venom serine protease pictobin (SVSP) (EC 3.4.21.-),ANLLILQVSYAQKSSELVIGGDECNINEHRFLAFTYSRGFFCGGTLINQEWVLTATHCDRIFMRIYLGLHNQSVRYDDQQIRYPKEKYFFPCSKNFTKWDKDIMLIRLDRPVKNSEHIAPLSLPSNPPSVGSVCRVMGWGTITAPNDTYPDVPHCANINLFNYTVCRGAYKGLPATSRTLCAGVLQGGIDTCVGDSGGPLICNGQFQGIVFWGGDPCAQPRKPALYTKVFDHLHWILSIIAGNTTATCPP,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may impair the hemostatic system of the prey. {ECO:0000250}.,Serine Protease
1858,A0A2P1BSS8,3SX4_MICMP,,Mipartoxin-4 (Mipartoxin-IV) (Three-finger toxin-05) (3FTx-05),MKTLLLTLVVVTIVCLDLGYTRKCHTKNSPGRETSQACPTGQNICFKKWKKGEIISKGCAVTCPKPKKDETFQCCLKNNCNR,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: Snake venom neurotoxin that blocks neuromuscular transmission, presenting a postsynaptic action through the nicotinic acetylcholine receptor (nAChR). Has no cytotoxic activity. {ECO:0000250|UniProtKB:B3EWF8}.",Neurotoxin
1859,A0A2P1BSS9,3SX2_MICMP,,Mipartoxin-2 (Mipartoxin-II) (Three-finger toxin-03) (3FTx-03),MKTLLLTLVVVTIVCLDLGNSLICYVSREGQTQTCPEGMNLCEKYAVSYFHDGRYFFTYECTSTCHRGDRNVCCSTDLCNK,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: Snake venom neurotoxin that blocks neuromuscular transmission, presenting a postsynaptic action through the nicotinic acetylcholine receptor (nAChR). Has no cytotoxic activity. {ECO:0000250|UniProtKB:B3EWF8}.",Neurotoxin
1860,A0A2P1BST7,3SX1A_MICMP,,Mipartoxin-1A (Mipartoxin-IA) (Three-finger toxin-02) (3FTx-02),MKTLLLTLVVVTIVCLDLGNSLKCYVSREGETQTCPEGEKLCEKYAVSYFHDGRWRYRYECTSACHRGPYNVCCSTDLCNK,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: Snake venom neurotoxin that blocks neuromuscular transmission, presenting a postsynaptic action through the nicotinic acetylcholine receptor (nAChR). Has no cytotoxic activity. {ECO:0000250|UniProtKB:B3EWF8}.",Neurotoxin
1861,A0A2P1BSU3,3SX3_MICMP,,Mipartoxin-3 (Mipartoxin-III) (Three-finger toxin-04) (3FTx-04),MKTLLLTLVVVTIVCLDLGNSLKCYDKLKKEVTCPEGMKFCHKDVLPATHGNSVLVMGCTYSCGLGPRNMCCSTDLCNK,"Snake three-finger toxin family, Short-chain subfamily","FUNCTION: Snake venom neurotoxin that blocks neuromuscular transmission, presenting a postsynaptic action through the nicotinic acetylcholine receptor (nAChR). Has no cytotoxic activity. {ECO:0000250|UniProtKB:B3EWF8}.",Neurotoxin
1862,A1IVR7,3L23_BUNCA,,Alpha-elapitoxin-Bc2c (Alpha-EPTX-Bc2c) (Alpha-delta-Bgt-3) (Alpha/delta-bungarotoxin-3) (Alpha/delta-BgTx-3),YTLLCYKTPSPINAETCPPGENLCYTKMWCDAWCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPD,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscular and neuronal nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission (By similarity). Blocks muscle type nAChR (By similarity). Also binds with high affinity to alpha-7/CHRNA7 nAChRs (By similarity). In addition, shows a weak inhibition of neuronal alpha-3-beta-2/CHRNA3-CHRNB2 nAChR (By similarity). Selectively binds to alpha-1-delta subunit interface of the mouse muscle nicotinic acetylcholine receptor, with a 10-fold higher affinity for the adult than for the fetal receptors (By similarity). In vivo, when intraperitoneally injected into mice, causes flaccid paralysis and respiratory distress, followed by death within 2-4 hours (By similarity). {ECO:0000250|UniProtKB:A1IVR8}.",Neurotoxin
1863,A2CJE5,VM2IA_CROAT,,Disintegrin atroxatin,NPCCDAATCKVTPGSQCAEGLCCDQCKFMKEGTVCRPARGDWNDDTCTGQSADCPRKGIYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
1864,A2CJE6,VM2IV_CROVV,,Disintegrin viridistatin,NPCCDAATCKVRTGSQCAEGLCCDQCKFIKKGTVCRPARGDWNDDTCTGQSADCPRNGLYG,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
1865,A3FM53,3L22_HYDHA,,Long neurotoxin 2,MKILLLTLVVVTIVCLDLAYTRTCYRTHPYKPETCPPGQNLCYKKSWCDAFCSSRGKVIELGCTAKCPTVKHGKDINCCATDNCNTVANWKSR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1868,A6MFK4,3L21_DEMVE,,Long neurotoxin LNTX-1,MKTLLLTLVVVTIVCLDFGYARTCLKTPEVKSEPCPPGQEVCYTKAWCDRMCSFRGKVIELGCAATCPRQEPGKEITCCSTDDCNTHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1869,A6MFK5,3L22_DEMVE,,Long neurotoxin LNTX-2,MKTLLLTLVVVTIVCLDFGYARTCLKTPEVKSEPCPPGQEVCYTKAWRDRMCSFRGKVIELGCAATCPRQEPGKEITCCSTDDCNTHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular nicotinic acetylcholine receptors (nAChRs), whereas it binds with a low affinity to neuronal alpha-7/CHRNA7 nAChRs. {ECO:0000250|UniProtKB:P0C8R6}.",Neurotoxin
1870,A6MFK6,3S11_DEMVE,,Short neurotoxin SNTX-1,MKTLLLILVVVTIVCLDLVCCSRTCCNQQSSQPKTTTVCPDGEKSCYKKSWRDHRGTRSERGCGCPTVKPGVNRECCDTDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1872,A6MFL1,VKT1_DEMVE,,Kunitz-type serine protease inhibitor vestiginin-1 (Vestiginin-6),MSSGGLLLLLGLLTLWAELTPVSSKDRPEFCELPPDRGTCMGFLQAFYYNPSQNKCLPFMFGGCKANPNNFKTLEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1873,A6MFL2,VKT2_DEMVE,,Kunitz-type serine protease inhibitor vestiginin-2,MSSGGLLLLLGLLTLWAELTPVSSKDRPEFCELPPDRGTCMGYSQAFYYNPSQNKCLPFMFGGCKANPNNFKTLEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1874,A6MFL3,VKT3_DEMVE,,Kunitz-type serine protease inhibitor vestiginin-3,MSSGGLLLLLGLLTLWAELTPVSSKDLPEICKLPKEPGPCRSYLLYFYYNSVEHKCQTFHYGGCEGNENRFHTIEECKSTCAE,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1875,A6MFL4,VKT4_DEMVE,,Kunitz-type serine protease inhibitor vestiginin-4,MSSGGLLLLLGLLTLWEVLTPVSSTDRPEFCELPEDSGPCKGLFHVFYYNSDQNQCLEFIYGGCYGNANNFKAIEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1876,A6MGX9,VKT5_DEMVE,,Kunitz-type serine protease inhibitor vestiginin-5 (Vestiginin-3),MSSGGLLLLLGLLTLWAELTPVSSKDRPEFCELPPDRGTCMGFLQAFYYNPSQKGCLPFMFGGCKANPNNFKTLEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1877,A6MGY1,VKT7_DEMVE,,Kunitz-type serine protease inhibitor vestiginin-7,MSSGGLLLLLGLLTLWAELTPVSSKDRPEICKLPKEPGPCRSYLLYFYYNSVEHKCQTFHYGGCEGNENRFHTIEECKSTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1881,A7X3S0,3NB2_TRIBI,,Toxin 3FTx-Tri2,MKTLLLALVVLAFVCLGSADQVGLGKEQIDRGRRQAIGPPFTRCSQCNRNRSPQCFIEDRCTPGDFTCYTVYKPNGNGGEDWVVKGCAKTCPTAGPGERVKCCYSPRCNKN,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily",FUNCTION: Potent postsynaptic neurotoxin. Displays readily reversible competitive antagonism at the nicotinic acetylcholine receptor (nAChR). {ECO:0000250}.,Neurotoxin
1882,A7X3S2,3NB3_TRIBI,,Toxin 3FTx-Tri3,MKTLLLALVVVAFMCLGSADEVGLGNEQIDRGRRQAIGPPFTRCSKCNRNWSPPFPLGLYTVSHVKSCGGHLSSIGQCGEDWVVKGCAKTCPTAGPGERVKCCYSPRCNKN,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily",FUNCTION: Potent postsynaptic neurotoxin. Displays readily reversible competitive antagonism at the nicotinic acetylcholine receptor (nAChR). {ECO:0000250}.,Neurotoxin
1883,A7X3V0,3NB4_TELDH,,Toxin 3FTx-Tel4,MKTLLLALVVVAFMCLGSADQLGLGSQRIDWEQGQAIGPPHGLCVQCDRKTCKNCFKSERCQPYNRICYTLYKPDENGEMKWAVKGCAKTCPSAKPGERVKCCSSPRCNEV,"Snake three-finger toxin family, Ancestral subfamily, Boigatoxin sub-subfamily",FUNCTION: Potent postsynaptic neurotoxin. Displays readily reversible competitive antagonism at the nicotinic acetylcholine receptor (nAChR). {ECO:0000250}.,Neurotoxin
1884,A7X3V4,VKT1_TELDH,,Kunitz-type serine protease inhibitor kunitoxin-Tel1,MSSGGLLLLLGLLTLWAELTPVSGQDRPKYCDLPADSGPCRARKRHFYYNSRSNQCEEFTYGGCRGNENNFETKDKCHYTCVAPPRRRPL,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1885,A7X3V7,VKT1_PHIOL,,Kunitz-type serine protease inhibitor kunitoxin-Phi1,MWARVLLLGVLLSLLADLHAASGGDAGGQKTWNPRISDCELPPEKGPCNNLELRWFYNLKSKRCERFFYGGCYGNANNFKEINECDRRCVSPDINKPG,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1886,A7X3W1,LECM1_PSEPL,,C-type lectin lectoxin-Enh1 (CTL),MGQFTVVSLGLLAMFLSLSGAKGDNCPASWISRNGVCNKLFPDRKTWLEAEKRTWKWSDRTSANYFSWNQGEPNDVQDNENCVHLWAPSGYLKWNDEPCASLHPFICQYKL,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1887,A7X3W6,LECM2_PSEPL,,C-type lectin lectoxin-Enh2 (CTL),MGQFTVVSLGLLAMFLSLSGAKGDNCPASWISRNGVCNKLFPDRKTWLEAEKRTWKWSDRTSTNYFSWNQGEPNNVQDNENCVHLWAPSGYLKWNDEPCASLHPFICQYKL,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1888,A7X3Z0,LECM_THRJA,,C-type lectin lectoxin-Thr1 (CTL),MGRFIFATLGLLLVAFSINGAKGCCCPHDWLTLKGFCYKVFNEHKTWNDAEMFCRKYKPGCHLASIHSGEESTDLAEYVSDYLKSGGNVWIGLNDPQKKRSWQWTDRSQNNFYPWKQGEPNNRANNENCVELWSPLGYKNWNDESCASTRAYLCKCRF,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1889,A7X3Z4,LECM1_ERYPO,,C-type lectin lectoxin-Lio1 (CTL),MERFIFAALLVVALSLSGTGADPQCLPGWSSSDGYCYKVFKEYKRWDDAEMFCRQEVEGGHLVSIHSKTEAKFLARLVFRKFILLNVWIGLSSPGKHGIWRWSDGSSFYYTSWAFGEPNNFLWNEYCVGLMSITGHRKWSDQNCRSKRYFICKAQPQGEGSTW,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1890,A7X3Z7,LECM2_ERYPO,,C-type lectin lectoxin-Lio2 (CTL),MERFIFAALLVVALSLSGTGADPQCLPGWSSSDGYCYKVFKEYKRWDDAEMFCRQEVEGGHLVSIHSKTEAKFLARLVFRKFILLNVWIGLSSPGKHGIWRWSDGSSFYYTSWAFGEPNNFLWNEYCVGLMSITGHRKWSDQNCRSKRYFICKAQPQSEGSTW,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1891,A7X413,LECM3_ERYPO,,C-type lectin lectoxin-Lio3 (CTL),MRRFIFMSLGLLVLAFSLSGIGANQNCPSGWFPHNISCYKLFTERKNWDQAQRTCMEEQENGQLASITDADTAVKLSNKLSGNWNFFDIWFGLSLSKTRGFWLWPDGSMVTFTNWGKGEPNNFWDMESCAALTAASGYLSWNDKNCGLLHYFICQTQSRGG,True venom lectin family,FUNCTION: Mannose-binding lectin which recognizes specific carbohydrate structures and agglutinates a variety of animal cells by binding to cell-surface glycoproteins and glycolipids. May be a calcium-dependent lectin (By similarity). {ECO:0000250}.,Binding Protein
1899,A7X4Q3,3L2O1_OXYMI,,Long neurotoxin 3FTx-Oxy1,MKTLLLTLVVVTIVCLDLGYTRRCFITPDVRSERCPPGQEVCYTKTWCDGFCGSRGKRVDLGCAATCPTPKKKGIDIICCSKDNCNTFPKWP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1900,A7X4R0,3L2O2_OXYMI,,Long neurotoxin 3FTx-Oxy2,MKTLLLTLVVVTIVCLDLGYTRRCFTTPSVRSERCPPGQEVCYTKTWTDGHGGSRGKRVDLGCAATCPTPKKKDIKTICCSKDNCNTFPKWP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1901,A7X4R5,3S13_OXYMI,,Short neurotoxin 3FTx-Oxy3,MKTLLLTLVVVTIVCLDLGYTMTCYNQQSSQAKTTTTCSGGVSSCYRKTWSDIRGTIIERGCGCPSVKKGIERICCGTDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1902,A7X4S0,3S14_OXYMI,,Short neurotoxin 3FTx-Oxy4,MKTLLLTLVVVTIVCLDLGYTMTCYNQQSSEAKTTTTCSGGVSSCYKETWYDGRGTRIERGCGCPRAKKGIERICCGTDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1908,A8HDJ5,3S11_TROCA,,Short neurotoxin 1 (SNTX-1),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTPCAESSCYKKTWKDNRGTIIERGCGCPNVKPGIDLMCCKTDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1909,A8HDJ6,3S12_TROCA,,Short neurotoxin 2 (SNTX-2),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTPCAESSCYKKTWKDHRGTIIERGCGCPNVKPGIDLMCCRTDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1910,A8HDJ7,3S11_CRYNI,,Short neurotoxin 1 (SNTX-1),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTITTCAESSCYKKTWKDHHGTRIERGCGCPPRKPLIDLICCETDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1911,A8HDJ8,3S12_CRYNI,,Short neurotoxin 2 (SNTX-2),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTITTCAESSCYKKTWKDHHGTRIERGCGCPKVKPGVGLECCKTDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1912,A8HDJ9,3S11_HOPST,,Short neurotoxin 1 (SNTX-1),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTKTCAESSCYKKTWRDHRGTITERGCGCPSVKPGIQLECCKTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1913,A8HDK0,3S11_NOTSC,,Short neurotoxin 1 (SNTX-1),MKTLLLTLVVVTIVFLDLGYTMTCCNQQSSQPKTTTTCAESSCYKKTWRDHRGTITERGCGCPNVKPGVQINCCKTDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1914,A8HDK1,3S38_PSETE,,Short neurotoxin 8 (SNTX8),MKTLLLTLVMVTIMCLDLGYTLTCYKGYHDTVVCKPHETICYEYFIPATHGNVITTRGCSTSCPGGIRPVCCSTDLCNN,"Snake three-finger toxin family, Short-chain subfamily, Type III alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscle nicotinic acetylcholine receptor (nAChR) and hinders acetylcholine binding to the receptor, thereby impairing neuromuscular transmission. Causes muscle paralysis, spasms and increased respiration. {ECO:0000250|UniProtKB:Q9W7K2}.",Neurotoxin
1916,A8HDK4,3L21_TROCA,,Long neurotoxin 1 (LNTX-1),MKTLLLTLVVVTIVCLDLGNSFSCYKTPHVKSEPCAPGQNLCYTKTWCDAFCFSRGRVIELGCAATCPPAEPKKDISCCSTDNCNPHPAHQSR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1917,A8HDK6,3L21_PSETE,,Long neurotoxin 1 (LNTX-1),MKTLLLTLVVVTIVCLDLGDSLICYLDFSVPHTCAPGEKLCYTRTWNDGRGTRIERGCAATCPIPKKPEIHVTCCSTDRCNPHPKQKPH,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor (By similarity), thereby impairing neuromuscular and neuronal transmission (PubMed:17906946). {ECO:0000250|UniProtKB:P60615, ECO:0000269|PubMed:17906946}.",Neurotoxin
1918,A8HDK7,3L21_OXYMI,,Long neurotoxin 1 (LNTX-1),MKTLLLTLVVVTIVCLDLGYTRRCFITPDVRSERCPPGQEVCYTKTWCDGFCGSRGKRVDLGCAATCPTPKKKDIKIICCSKDNCNTFPKWP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1919,A8HDK8,3L22_OXYMI,,Long neurotoxin 2 (LNTX-2),MKTLLLTLVVVTIVCLDLGYTRRCFITPDVRSERCPPGQEVCYTKTWCDGFCSSRGKRVDLGCAATCPTPKKKGIDIICCSKDNCNTFPKWP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1920,A8HDK9,3L21_OXYSC,,Long neurotoxin 1 (LNTX-1),MKTLLLTLVVVTIVCLDLGYTRRCFTTPSVRSERCPPGQEVCYTKTWTDGHGGSRGKRVDLGCAATCPTPKKKDIKIICCSTDNCNTFPKWP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1921,A8N285,3L22H_OPHHA,,Long neurotoxin LNTX-2 homolog,MKTLLLTLVVVTIVCLDLGYTTKCYVTPDATSQTCPDGENICYTKSWCDVFCSSRGKRIDLGCAATCPKVKPGVDIKCCSTDNCNPFTPWKRH,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1922,A8S6A4,3S11_AUSSU,,Short neurotoxin 1 (SNTX-1),MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTTCAESSCYKKTWRDHRGTIIERGCGCPNVKPGIQLVCCETNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
1923,A8S6A8,3L21_AUSSU,,Long neurotoxin 1 (LNTX-1),MKTLLLTLVVVTIVCLDVGNSFSCYKTPDVKSEPCAPGENLCYTKTWCDRFCSIRGKVIELGCAATCPPAEPRKDITCCSTDNCNPHPAH,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1924,A8S6B0,3L22_AUSSU,,Alpha-elapitoxin-As2a (Alpha-EPTX-As2a) (Long neurotoxin 2) (LNTX-2),MKTLLLTLVVVTIVCLDLGDGLICYVDSKTSRTCPPGENVCFTETWCDARCSLLGKRVDLGCAATCPTAKPGVDITCCSTDKCNPFPTQKHR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1925,A8S6B3,VNPA_AUSSU,,Natriuretic peptide AsNP-a,SGSKTAKIGDGCFGVRIDRIGSTSGMGCGSVPKPTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
1930,B2BRQ6,3L22A_AUSLA,,Alpha-elapitoxin-Al2a (Alpha-EPTX-Al2a) (Putative long neurotoxin),MKTLLLTLVVVTIVCLDLGDSLRCYMGPKTPRTCPPGENLCFTKTWCDPRCSLLGKLVKLGCAATCPIPKSYEDVTCCSTDNCNRFPKWERSRPRPRGLLSSIMDHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
1931,B2BS84,VKT_AUSLA,,Putative Kunitz-type serine protease inhibitor,MTREKSLALLITLAAALAAAESPPGRCHSPKTVGPCRASFHRWRYNATSQMCQEFIFGGCKGNANNFVSKQDCFQTCIRGGAAEATVVPSGPATEVATPRAGHLPEAYENRPGFREFCAAPRVVGPCRASFLRWYFDLESRMCKMFIYGGCRGNKNNYLFEEHCWSQCTGDGEITEEPGDAGAQPPLPSEPFSFSTRAVVLAVLPAILVTILLGSMGVFFVKICRKNPELSVGTVWSTLDDKEYLMSNAYTL,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1932,B2KTG2,VKTH1_BUNFA,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin BF B1 chain,MSSGGLLLLLGLLTLWTELTPVSSRERHPDCDKPPDTGRCRKNVRAFYYKPSAKRCVQFIYGGCNANGNHFKSDHLCRCECLEYP,Venom Kunitz-type family,FUNCTION: Beta-1-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv) (By similarity). {ECO:0000250}.,Kunitz Family
1933,B2KTG3,VKTH2_BUNFA,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin BF B2 chain,MSSGGLLLLLGLLTLWAELTPISSRERHPDCDKPPDTGRCGNNVRAFYYKPSTNKCVQFIYGGCNANGNHFKSDHLCRCQCREND,Venom Kunitz-type family,FUNCTION: Beta-1-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv) (By similarity). {ECO:0000250}.,Kunitz Family
1954,B5G6G6,VKT2_PSEPO,,Kunitz-type serine protease inhibitor blackelin-2,MSSGGLLLLLGLLTLWEGLTPVSSKDRPDFCELPDDRGPCRGIFHAFYYNPDQRQCLEFIYGGCYGNANNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1964,B5KF94,VKT1_HOPST,,Kunitz-type serine protease inhibitor stephenin-1,MSSGGLLLLLGLLTLWEVLTPVSSKDRPEFCELPADPGPCNALSQAYYYNPVQHKCLKFRYGGCKANPNTFKTIEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1965,B5KF95,VKT1_CRYNI,,Kunitz-type serine protease inhibitor nigrescinin-1,MSSGGLLLLLGLLTLWEALTPVSSTDRPEFCELPEDSGPCKGLFHVFYYNSDQNQCLEFIYGGCYGNANNFKTIEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1966,B5KF96,VKT2_CRYNI,,Kunitz-type serine protease inhibitor nigrescinin-2,MSSGGLLLLLGLLTLWEALTPVSSTDRPEFCELPEDSGPCKGLFHVFYYNPDQSQCLEFIYGGCYGNANNFKTIEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1968,B5KL27,VKT3_OXYMI,,Kunitz-type serine protease inhibitor microlepidin-3,MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELPADIGPCEDFTGAFHYSPREHECIEFIYGGCEGNANNFNTLEECESACAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1969,B5KL28,VKT4_OXYMI,,Kunitz-type serine protease inhibitor microlepidin-4,MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELPADIGPCEDFTGAFHYSPREHECIEFIYGGCEGNANNFNTLEGCESACAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1970,B5KL29,VKT3_OXYSC,,Kunitz-type serine protease inhibitor scutellin-3,MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELPADIGPCEDFTGAFHYSPREHECIEFIYGGCKGNANNFNTLEECESACAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1971,B5KL30,VKT4_OXYSC,,Kunitz-type serine protease inhibitor scutellin-4,MSSGGLLLLLGLLTLWAELTPVSSKDHPEFCELPADSGPCRGILHAFYYHPVHRTCLGFIYGGCYGNANNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1972,B5KL31,VKT3_PSEPO,,Kunitz-type serine protease inhibitor blackelin-3,MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELPADPGPCNGLFQAFYYNPVQRKCLKFRYGGCKANPNTFKTIEECKRICAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1973,B5KL32,VKT3_NOTSC,,Kunitz-type serine protease inhibitor tigerin-3,MSSGGLLLLLGLLTLWEILTPVSSKDRPHFCHLPHDTGPCNRNTQAFYYNPVYHTCLKFIYGGCQGNSNNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1974,B5KL33,VKT2_TROCA,,Kunitz-type serine protease inhibitor carinatin-2,MSSGGLLLLLGLLTLWEILTPVSSKDHPEFCELPADSGPCRGILHAFYYHPVHRTCLEFIYGGCYGNANNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1975,B5KL34,VKT3_CRYNI,,Kunitz-type serine protease inhibitor nigrescinin-3,MSSGGLLLLLGLLTLWEALTPVSSTDRPEFCELPEDSGPCKGLFHVFYYNSDQNQRLEFIYGGCYGNANNFKTIEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1976,B5KL35,VKT4_CRYNI,,Kunitz-type serine protease inhibitor nigrescinin-4,MSSGGLLLLLGLLTLWEVLTPVSSTDRPEFCELPEDSGPCKGLFHVFYYNSDQNQCLEFIYGGCYGNANNFKTIEECKLTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1977,B5KL36,VKT5_CRYNI,,Kunitz-type serine protease inhibitor nigrescinin-5,MSSGGLLLLLGPLTLWEVLTPVSSTDRPEFCELPEDSGPCKGLFHVFYYNSDQNQCLEFIYGGCYGNANNFKTIEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1978,B5KL37,VKT6_CRYNI,,Kunitz-type serine protease inhibitor nigrescinin-6,MSSGGLLLLLGLLTLWEVLTPVSSTDRPDFCELPEDSGSCKGNFEAFYYNSDQHQCLEFIYGGCDGNANNFKTIEECKLTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1979,B5KL38,VKT1_AUSSU,,Kunitz-type serine protease inhibitor superbin-1 (Superbinin-1),MSSGGLLLLLGLLTLWEVLTPVSSKDRPEFCKLPADTGRCKGKFPAFYYHPVHRTCLEFIYGGCKGNPNNFKTIDECERTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1980,B5KL39,VKT2_AUSSU,,Kunitz-type serine protease inhibitor superbin-2,MSSGGLLLLLGLLTLWEVLTPISSKDRPKFCELPADTGPCKAIFQAFYYHPVHRTCLKFIYGGCEGNANNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1981,B5KL40,VKT3_AUSSU,,Kunitz-type serine protease inhibitor superbin-3,MSSGGLLLLLGLLTLWEVLTPVSSKDRPEFCELPADSGSCKGNFQAFYYNPVQHQCLEFIYGGCDGNANNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1982,B5KL41,VKT4_AUSSU,,Kunitz-type serine protease inhibitor superbin-4 (Superbinin-4),MSSGGLLLLLGLLTLWEVLTPVSSKDRPNFCHLPHDTGPCKRNTQAFYYNPVYHTCLKFIYSGCEGNANNFKTIDECKRTCAT,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1998,B5L5Q1,VKT7_PSETT,,Kunitz-type serine protease inhibitor textilinin-7 (Txln-7),MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELLPDTGSCEDFTGAFHYSTRDRECIEFIYGGCGGNANNFKTLEECESTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
1999,B5L5Q6,VKT5_OXYMI,,Kunitz-type serine protease inhibitor microlepidin-5,MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFYELPADIGPCEDFTGAFHYSPREHECIEFIYGGCEGNANNFNTLEECET,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2000,B5L5Q8,VKT5_PSEAU,,Kunitz-type serine protease inhibitor mulgin-5,MSSGGLLLLLGLLTLWEGLTPVSSKDRPNFCHLPHDPGPCKGNFQAFYYHPVRRTCLEFIYGGCQGNPNNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2001,B5L5R7,VKT2_HOPST,,Kunitz-type serine protease inhibitor stephenin-2,MSSGGLLLLLGLLTLLEILTPVSSKDRPKFCELPADSGSCKGNFQAFYYNPDQHQCLEFIYGGCDGNANNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2007,C0HL88,SL_CROVE,,Snaclec uracolectin,DLPSGWSSYEGH,Snaclec family,"FUNCTION: Inhibits coagulant activity in human plasma, possibly by interfering with one step of hemostasis (modulation of platelet aggregation, or coagulation cascade, for example) (Ref.1). Does not show fibrinogen-clotting activity and does not inhibit ADP-induced platelet aggregation (Ref.1). Also does not show hemorrhagic activity in mice (Ref.1). {ECO:0000269|Ref.1}.",Fibrinogenolytic Enzyme
2008,C0HLA1,VSP2_LACMR,3.4.21.-,Thrombin-like enzyme LmrSP-2 (SVTLE) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VIGGDECNINEHRFLVALYDPDGFFCGGTL,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that cleaves alpha-chain of fibrinogen (FGA) releases only fibrinopeptide A. Shows coagulant, esterase and amidase activities. {ECO:0000250|UniProtKB:P33589}.",Serine Protease
2009,C0HLA2,VSP3_LACMR,3.4.21.-,Thrombin-like enzyme LmrSP-3 (SVTLE) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),IVGGDECNINEHRFLVALYDPDGFFC,"Peptidase S1 family, Snake venom subfamily","FUNCTION: Thrombin-like snake venom serine protease that cleaves alpha-chain of fibrinogen (FGA) releases only fibrinopeptide A. Shows coagulant, esterase and amidase activities. {ECO:0000250|UniProtKB:P33589}.",Serine Protease
2011,C0HLL1,VM2CD_CRODU,,Zinc metalloproteinase/disintegrin-like CdtV1 (SVMP) [Cleaved into: Zinc metalloproteinase/disintegrin-like CdtV2; Zinc metalloproteinase/disintegrin-like CdtV3],ARIECDCGSIENPCCYATTCKLRPGSQCAEGM,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250|UniProtKB:P34182}.,General Toxin
2012,C1IC51,VKT3_WALAE,,Protease inhibitor 3 (Kunitz inhibitor KIn-III),MSSGCLLLLLGLLTLWAELTPVSGRPRLCELPAESGLCNAYIPSFYYNPHSHKCQKFMYGGCGGNANNFKTIVECHRTCVG,Venom Kunitz-type family,FUNCTION: Snake venom serine protease inhibitor. {ECO:0000250}.,Serine Protease
2013,C5ILC5,3L22A_OPHHA,,Alpha-elapitoxin-Oh2a (Alpha-EPTX-Oh2a) (Long chain neurotoxin),MKTLLLTLVVVTIVCLDLGYTLLCYKTPSPINAETCPPGENLCYTKMWCDAWCSSRGKVIELGCAATCPSKKPYEEVDCCSTDNCNPHPKLRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2015,C6JUP2,3NO22_MICCO,,Three-finger toxin 3FTx-2 (3FTx),MKTLLLTLVVVTIVCLDLGNTANTLFCDNSNVPSIRTRKRCLKNQKLCYKMTFFTPGFGWTQIKGCIHRCPESTPNEKYQCCSTDNCI,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2016,D2N116,3L2A_BUNCE,,Alpha-delta-bungarotoxin-4 (Alpha-delta-Bgt-4),YTLLCHTTSTSPISTVTCPSGENLCYTKMWCDAFCSSRGKVIELGCVATCPQPKPYEEVTCCSTDKCNPHPKQRPG,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2017,D5J9Q8,VKT5_BUNFL,,Kunitz-type serine protease inhibitor isoform 5,MSSGGLLLLLGLLTLWAELTPVSSKDRPKYCNLPPEPGPCHGRKFAFYYHPASNKCKEFVYGGCGGNDNNFKTKDKCQRACSG,Venom Kunitz-type family,FUNCTION: Snake venom serine protease inhibitor. {ECO:0000250}.,Serine Protease
2020,E3P6N4,CYT_PSETE,,Cystatin,MVHSQLPVAAPLRLLCALLLLPSATMIPGGLSPRSVTDPDVQKAAEFAVQEYNSLSTNAYYYKQLRIVEAQSQVVAGAKYYLTMELMKTKCAKATGKPKVYKEIQNCELPPKAQQEKLTCHFQVWSRPWLEKMELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2021,E3P6N5,CYT_OXYMI,,Cystatin,MVHSQLPVAAPLRLLCALLLLPSATMIPGGISPRSVTDPDVQKAAEFAVQEYNALSTNAYYYKQLRIVEAQSQVVAGAKYYLTMELMKTKCAKTTGKPKVYKEIQNCELPPKAQQEKLTCHFQVWSRPWLEKMELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2022,E3P6N6,CYT_OXYSC,,Cystatin,MVHSQLPVAAPLRLLCALLLLPSATMIPGGLSPRSVTDPDVQKAAEFAVQEYNALSTNAYYYKQLRIVEAQSQVVAGAKYYLTMELMKTKCAKTTGKPKVYKEIQNCELPPKAQQEKLTCHFQVWSRPWLEKVELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2023,E3P6N7,CYT_PSEPO,,Cystatin,MVHSQLPVAGPLRLLCALLLLPSATMIPGGLSPRSVTDPDVQEAAEFAVQEYNALSANAYYYKQLRIVEAQSQVVSGAKYYLTMELMKTKCAKTTGKPKVYKEIQNCELPPKAQQEKLNCRFQVWSRPWLEKMELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2024,E3P6N8,CYT_PSEAU,,Cystatin,MVHSQLPVAGPLRLLCALLLLPSATMIPGGLSPRSVTDPDVQEAAEFAVQEYNALSANAYYYKQLRIVEAQSQVVSGAKYYLTMELMKTKCAKTTGKPKVYKEIQNCELPPKAQQEKLTCHFQVWSRPWLGKIELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2025,E3P6N9,CYT_TROCA,,Cystatin,MVHSQLPVAAPLRLLCALLLLPSATMIPGGLYPRSVTDPDVQEAAECAVQEYNALSANAYYYKQLRIVEAQSQVVTGAKYYLTMELMKTKCAKTTGKPKVYKEIQNCELPPKAQQEKLTCHFQVWSRPWLQKIELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2026,E3P6P0,CYT_HOPST,,Cystatin,MLHSQLPVAAPLRLLCALLLLPSVTMIPGGLSPRSVTDPDVQEAAEFAVQEYNALSANAYYYKQLRIVEAQSQVVTGAKYYLTMELMKTKCAKTTGKPKVYKEIQNCELPPKAQQEKLTCRFQVWSRPWLEKIELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2027,E3P6P1,CYT_CRYNI,,Cystatin,MVHSQLPVAASLRLLCALLLLPSATMIPGGLSPRSVTDPDVREAAEFAVQEYNALSANAYYYKQLRIVEAQSQVVAGAKYYLTMELMKTKCAKTTGKPKVYKEIQNCELPPKAQQEKLTCRFQVWSRPWLKKTELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2028,E3P6P2,CYT_NOTSC,,Cystatin,MVHSQLPVVALLRLLCALLLLPSATMIPGGLSPRSVTDPDVQEAAEFAVQEYNALSANAYYYKQLRIVEAQSQVVAGAKYYLTMELMKTKCAKTTGKPKVYKEIQNCELPPKAQQEKLTCRFQVWSRPWLQKIELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2029,E3P6P3,CYT_MICIK,,Cystatin,MVRSQLPVAAPLRLLCALLLLPSATMIPGGLSPRSVTDPDVQEAAAFSVQEYNALSANAYYYKELRIVEAQSQVVSGAKYYLTMELMKTKCAKATSKPKVYKEIQNCELPPKAQQEKLTCHFQVWSRPWLEKMELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2030,E3P6P4,CYT_NAJKA,,Cystatin,MVHFQLPVAAPLCLLCALLLLPSATMIPGGLSPRSVSDPDVQKAAAFAVQEYNARSANAHYYKELRVVEAQSQVVAGEKYYLMMELVKTKCAKTAGKPKVYKEIQNCELPPKAQQEKLTCHFQVWSRPWLDKTELTKMSCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as a housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2031,E5AJX3,VKT_VIPNI,,Kunitz-type serine protease inhibitor ki-VN,MSSGGLLLLLGLLTLWAELTPVSSRDRPKFCYLPAEPGECNAYMPSFYYDSASNKCKKFIYGGCRGNANNFKTRDECHHTCVASGKGIQPRIGSN,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2032,F5CPD7,3S154_MICAT,,Three finger toxin MALT0054C (MALT0054C),MKTLLLTLVVVTIVCLDFGHTLICYNYWTPLDKTTECCGNGVTTCFAKSWNDHRGRRTDRGCGCPNVKPGIHLNCCKTDRCNG,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2035,F8J2B3,3L213_DRYCN,,Long neurotoxin 13 (LNTX-13),MKTLLLTLVVVTIVCLDLAYTRKCYKTHPYKSEPCASGENLCYTKTWCDFRCSQLGKAVELGCAATCPTTKPYEEVTCCSTDDCNRFPNWERPRPRPRGLLSSIMDHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2038,F8J2D7,3L243_DRYCN,,Long neurotoxin 43 (LNTX-43),MKTLLLTLVVVTIVCLDLAYTRKCYKTHPYKSEPCAPGENLCYTKTWCDFRCSQLGKAVELGCAATCPTTKPYEEVTCCSTDDCNRFPNWERPRPRPRGLLSSIMDHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2039,F8J2E1,3L273_DRYCN,,Long neurotoxin 73 (LNTX-73),MKTLLLTLVVVTIVCLDLGDSLICYQAYNTPQTCAPGENLCYTKTWCDYWCHVKGKRIDLGCAATCPTAKPGEDVTCCSRDKCNPHPLQRPR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2040,F8J2E2,3L277_DRYCN,,Long neurotoxin 77 (LNTX-77),MKTLLLTLVVVTIVCLDLGDSLICYMGPKTPRTCPPGENLCYTKTWCDAFCSIRGRRVDLGCAATCPTAKPGVDITCCSTDKCNPHPAHQSR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2041,F8J2E5,3L246_DRYCN,,Long neurotoxin 469 (LNTX-469),MKTLLLTLVVVTIVCLDLGDSLICYLGYNNPQTCAPGQNLCYTKKWCDAFCLQRGKVIQLGCAATCPTTKPYEEVTCCSRDKCNPHPAQRSR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2042,F8J2E6,3L231_DRYCN,,Long neurotoxin 31 (LNTX-31),MKTLLLTLVVVTIVCLDLGNSFSCYKTPYVKSEPCAPGENLCYTKSWCDAFCSIRGKVIELGCAATCPPAEPKKDITCCSTDNCNTHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2043,F8J2F2,3L220_DRYCN,,Long neurotoxin 20 (LNTX-20) (Long neurotoxin 193R),MKTLLLTLVVVTIVCLDLGNSFSCYKTPYVKSEPCAPGENLCYTKSWCDRFCSIRGKVIELGCAATCPPAEPKKDITCCSTDNCNTHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2044,F8J2F3,VKT28_DRYCN,,Kunitz-type serine protease inhibitor 28 (SPI-28),MSSGGLLLLLGLLTLWAELTPVSSKDRPHFCHLPADTGPCKARFQAFYYHPVHRKCLEFIYGGCEGNANNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2045,F8J2F4,VKT16_DRYCN,,Kunitz-type serine protease inhibitor 161 (SPI-161),MSSGGLLLLLGLLTLWAELTPVSSKDRPDFCHLPADSGSCKGNFQAFYYHPVHRTCLEFIYGGCEGNANNFKTMDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2046,F8J2F5,VKT87_DRYCN,,Kunitz-type serine protease inhibitor 87 (SPI-87),MSSGGLLLLLGLLTLWAELTPVSSKDRPDFCHLPHETGPCKAKIQAFYYNPIYDTCLKFIYGGCEGNANNFKTMDECKRTCAE,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2047,F8J2G3,3S12A_DRYCN,,Short neurotoxin 2 (SNTX-2),MKTLLLTLVVVTIVCLDLGYTMTCYNQQSSQPQTTTTCAESSCYKKTWRDHRGTIIERGCGCPTVKPGIQRVCCATDKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2048,F8J2G5,3S134_DRYCN,,Short neurotoxin 342 (SNTX-342),MKTLLLTLVVLTIVCLDLGYTMTCYNQQLSQPQTTTTCAESFCYKKTWSGTIIERGCGCPPMKPPIRLKCCRTEKCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2049,F8RKW2,VESP_DRYCN,,Vespryn-21,MLLFTLCFFADLENGGKALASPPGKWQKADVRFDSSTAFKSLVVSPDKKTVENVGVPQVVPDNPERFSSSPCVLGSPGFRSGRHFFEVRYGTQREWAVGLAGKSVKRKGYLRLVPEELIWQRGLWFLQRLETDSDKLQKGSGKIVVFLDYSEGKVIFDQDGEVTTVQANFNGEEVVPFYYLGGGVSLTNL,Ohanin/vespryn family,"FUNCTION: Neurotoxin that produces dose-dependent hypolocomotion and hyperalgesia in mice. May directly act on the central nervous system, as it is 6500-fold more potent when administered intracerebroventricularly than intraperitoneal. {ECO:0000250|UniProtKB:P83234}.",Neurotoxin
2052,J3RYX9,CYT1_CROAD,,Cystatin-1,MHSRLPVPASLCLLLLLPSVLPASMPGGLSPRDVTDPEVQEAAVFAVEEYNARSTNSNYFKALRLVQAESQVVSGAKYYLTMELVKTSCRKTNGNPKGYQEIQNCRLPPRNQQEKLTCHFEVWSRPWLNKTLLTKVTCN,Cystatin family,"FUNCTION: Inhibits various C1 cysteine proteases including cathepsin L, papain and cathepsin B. This protein has no toxic activity and its function in the venom is unknown. It may play a role as housekeeping or regulatory protein (By similarity). {ECO:0000250}.",General Toxin
2056,J3SFJ3,TCTP_CROAD,,Translationally-controlled tumor protein homolog (TCTP),MIIYRDCISQDEMFSDIYKITEVANGLCLEVEGKMVSRKEGEIDDALIGGNASAEGPEGDGTEATVITGVDIVMNHHLQETSFTKESYKKYIKDYMKSIKARLEETKPERVKPFMTGAAEQVKHILGNFKNYQFFVGENMNPDGMVGLLDFREDGVTPYMIFFKDGLEMEKC,TCTP family,"FUNCTION: Venom protein that causes edema, enhances vascular permeability and is likely related to the inflammatory activity of the venom. {ECO:0000250}.",Vascular Interaction
2058,O12961,3LK4_BUNMU,,Kappa-4-bungarotoxin,MKTLLLTLVVVTIVCLDLGYTRTCLISPSSPPQTCPKGEDICIVKARCDEWCLRRGPLIERGCAATCPEFRSNYRSLLCCTTDNCNH,"Snake three-finger toxin family, Long-chain subfamily, Kappa-neurotoxin sub-subfamily","FUNCTION: Postsynaptic neurotoxin that binds and inhibits neuronal nicotinic acetylcholine receptors (nAChR) with high affinity (IC(50)<100 nM). Is a selective, and slowly reversible antagonist of alpha-3/CHRNA3-containing and some alpha-4/CHRNA4-containing AChRs. {ECO:0000250|UniProtKB:P01398}.",Neurotoxin
2059,O12962,3LK5_BUNMU,,Kappa-5-bungarotoxin,MKTLLLTLVVVTIVCLDLGYTKTCLISPSSTPQTCPQGQDTCFLKALCDKLCPIRGPVIEQGCAATCPEFRSNYRSLLCCTTDNCNH,"Snake three-finger toxin family, Long-chain subfamily, Kappa-neurotoxin sub-subfamily","FUNCTION: Postsynaptic neurotoxin that binds and inhibits neuronal nicotinic acetylcholine receptors (nAChR) with high affinity (IC(50)<100 nM). Is a selective, and slowly reversible antagonist of alpha-3/CHRNA3-containing and some alpha-4/CHRNA4-containing AChRs. {ECO:0000250|UniProtKB:P01398}.",Neurotoxin
2060,O12963,3NO56_BUNMU,,Long neurotoxin homolog TA-bm16 (Delta-protein),MKTLLLTLVVVTIVCLDLGYTMQCKTCSFYTCPNSETCPDGKNICVKRSWTAVAGDGLKREIRRECAATCPPSKLGLTVFCCTTDNCNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group V sub-subfamily","FUNCTION: Exhibits M2 muscarinic acetylcholine receptor (CHRM2)-blocking activity, but has a weak binding activity toward nicotinic AChR. Moreover, it inhibits collagen-induced platelet aggregation. {ECO:0000250|UniProtKB:Q9YGJ0}.",Binding Protein
2062,O42255,3NO25_NAJSP,,Weak neurotoxin 5 (Wntx-5),MKTLLLTLVVVTIVCLDLGYTLTCLNCPEMFCGKFQTCRNGEKICFKKLQQRRPFSLRYIRGCAATCPGTKPRDMVECCSTDRCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000269|PubMed:12199703}.,Neurotoxin
2063,O42256,3NO26_NAJSP,,Weak neurotoxin 6 (Wntx-6),MKTLLLTLVVVTIVCLDLGYTLTCLNCPEMFCGKFQTCRDGEKICFKKLQQRRPFSLRYIRGCAATCPGTKPRDMVECCSTDRCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2064,O57326,3S1A3_NAJSP,,Alpha-neurotoxin NTX-3 (NTX3),MKTLLLTLLVVTIVCLDLGYTLECHNQQSSETPTTTGCSGGETNCYKKRWRDHRGYRIERGCGCPSVKKGIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2065,O57327,3S1A4_NAJSP,,Alpha-neurotoxin NTX-4 (NTX4),MKTLLLTLLVVTIVCLDLGYTLECHNQQSSQAPTTTGCSGGETNCYKKGWRDHRGYRIERGCGCPSVKKGIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2066,O57540,MYC1_CRODU,,Crotamine CRO1,MKILYLLFAFLFLAFLSEPGNAYKQCHKKGGHCFPKEKICIPPSSDFGKMDCRWRWKCCKKGSGK,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
2067,O73799,MYC3_CRODU,,Crotamine CRO3,MILYLLFAFLFLAFLSEPGNAYKQCHKKGGHCFPKEKICIPPSSDFGKMDCRWRWKCCKKGSGK,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
2069,P01397,3L22_DENPO,,Alpha-elapitoxin-Dpp2c (Alpha-EPTX-Dpp2c) (Long neurotoxin 2) (Neurotoxin delta) (Toxin TN2),RTCNKTPSDQSKICPPGENICYTKTWCDAWCSQRGKIVELGCAATCPKVKAGVEIKCCSTDNCNKFKFGKPR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2070,P01399,3NO2D_NAJHA,,Weak toxin CM-13b,LTCFNCPEVYCNRFHTCRNGEKICFKRFNERKLLGKRYTRGCAATCPVAKPREIVECCSTDRCNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2071,P01400,3NO2B_NAJME,,Weak toxin S4C11,LTCLICPEKYCNKVHTCRNGENICFKRFYEGNLLGKRYPRGCAATCPEAKPREIVECCSTDKCNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2072,P01401,3NO2B_NAJHH,,Weak toxin CM-11,LTCLICPEKYCNKVHTCRNGENQCFKRFNERKLLGKRYTRGCAATCPEAKPREIVECCTTDRCNK,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2076,P01407,3SIY_DENJA,,Synergistic-type venom protein S2C4,LTCVTDKSFGGVNTEECAAGQKICFKNWKKMGPKLYDVKRGCTATCPKADDDGCVKCCNTDK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily",FUNCTION: This protein shows a synergetic toxic effect in that it enhances the toxicity of other toxins. {ECO:0000269|PubMed:437703}.,General Toxin
2077,P01408,3SIY3_DENAN,,"Synergistic-type venom protein C9S3, chain 1",LTCVTGKSIGGISTEECAAGQKICFKKWTKMGPKLYDVSRGCTATCPKADEYGCVKCCKTDRN,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily",FUNCTION: This protein shows a synergetic toxic effect in that it enhances the toxicity of other toxins. {ECO:0000269|PubMed:511106}.,General Toxin
2078,P01410,3SIY1_DENAN,,"Synergistic-type venom protein C8S2, chain 1",LTCVTGKSIGGISTEECAAGQKRCFKKWTKMGPKLYDVSRGCTATCPKADEYGCVKCCNIDK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily",FUNCTION: This protein shows a synergetic toxic effect in that it enhances the toxicity of other toxins. {ECO:0000269|PubMed:511106}.,General Toxin
2079,P01411,3SIY2_DENAN,,"Synergistic-type venom protein C8S2, chain 2",LTCVTGKSIGGISTEECAAGQKRCNKKWTKMGPKLYDVSRGCAATCPTADEYGCVKCCNTDK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily",FUNCTION: This protein shows a synergetic toxic effect in that it enhances the toxicity of other toxins. {ECO:0000269|PubMed:511106}.,General Toxin
2080,P01413,3SP1_DENJA,,Toxin S5C1,RICYNHLGTKPPTTECTQEDSCYKNIWRNITFDNIRRGCGCFTPRGDMPGPYCCESDKCNL,"Snake three-finger toxin family, Short-chain subfamily, Antiplatelet toxin sub-subfamily",FUNCTION: Inhibits ADP-induced platelet aggregation and inhibits the binding of purified platelet fibrinogen receptor alpha-IIb/beta-3 (ITGA2B/ITGB3) to immobilized fibrinogen. {ECO:0000250|UniProtKB:P28375}.,Fibrinogenolytic Enzyme
2082,P01424,3S11_NAJME,,Short neurotoxin 1 (Neurotoxin D),MECHNQQSSQPPTTKTCPGETNCYKKQWSDHRGTIIERGCGCPSVKKGVKINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2084,P07526,3L23_OPHHA,,Long neurotoxin 3 (Neurotoxin CM-9),TKCYVTPDVKSETCPAGQDLCYTETWCVAWCTVRGKRVSLTCAAICPIVPPKVSIKCCSTDACGPFPTWPNVR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2085,P0C555,3S1RI_BUNFA,,Neurotoxin 3FTx-RI,MKTLLLTLVVLTIVCLDLGHTRICLNQQSSEPQTTETCPNGEDTCYNKTWNTHRGSRTDRGCGCPKVKPGINLRCCKTDKCNQ,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2086,P0C6R5,VM2MU_ECHML,,Disintegrin multisquamatin,EGEECESGPCCRNCKFLKEGTICKRARGDDMDDYCNGKTCDCPRNPHKGPAT,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits ADP-induced human, canine and rabbit platelet aggregation by binding with high affinity to alpha-IIb/beta-3 (ITGA2B/ITGB3). {ECO:0000269|PubMed:11275562, ECO:0000269|PubMed:8178312}.",Binding Protein
2092,P0C7K4,SVMI1_ATHSQ,,Poly-His-poly-Gly peptide 1 (pHpG-1),EDDHHHHHHHHHGVGGGGGGGGGG,PHpG family,"FUNCTION: May serve as a metalloproteinase inhibitor during glandular storage. Their inhibition may be instantly disengaged, by dilution or physiochemical change, when venom is injected into tissue of the victim. {ECO:0000250|UniProtKB:A8YPR6}.",Kunitz Family
2093,P0C7K5,SVMI1_ATHCH,,Poly-His-poly-Gly peptide 1 (pHpG-1),EDDHHHHHHHHHGVGGGGGGGGGG,PHpG family,"FUNCTION: May serve as a metalloproteinase inhibitor during glandular storage. Their inhibition may be instantly disengaged, by dilution or physiochemical change, when venom is injected into tissue of the victim. {ECO:0000250|UniProtKB:A8YPR6}.",Kunitz Family
2094,P0C7K6,SVMI2_ATHNI,,Poly-His-poly-Gly peptide 2 (pHpG 2),EDDHDHHHHHHHHHHHHGVGGGGGGGGGGA,PHpG family,"FUNCTION: May serve as a metalloproteinase inhibitor during glandular storage. Their inhibition may be instantly disengaged, by dilution or physiochemical change, when venom is injected into tissue of the victim. {ECO:0000250|UniProtKB:A8YPR6}.",Kunitz Family
2099,P0C8R6,3L21_LATCO,,Alpha-elapitoxin-Lc2c (Alpha-EPTX-Lc2c) (Long neurotoxin 1),RICYLAPRDTQICAPGQEICYLKSWDDGSGSIKGKRLEFGCAATCPTVKPGIDIKCCSTDKCNPHPKLA,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular nicotinic acetylcholine receptors (nAChRs), whereas it binds with a low affinity to neuronal alpha-7/CHRNA7 nAChRs. {ECO:0000269|PubMed:9305882}.",Neurotoxin
2100,P0C8R7,3L2A_LATCO,,Toxin Lc a,RICYLAPRDTQICAPGQEICYLKSWDDGTGFLKGNRLEFGCAATCPTVKPGIDIKCCSTDKCNPHPKLA,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular nicotinic acetylcholine receptors (nAChRs), whereas it binds with a low affinity to neuronal alpha-7/CHRNA7 nAChRs. {ECO:0000250|UniProtKB:P0C8R6}.",Neurotoxin
2101,P0C8R8,3L2B_LATCO,,Toxin Lc b,RICYLAPRDTQICAPGQEICYLKSWDDGTGSIRGNRLEFGCAATCPTVKRGIHIKCCSTDKCNPHPKLA,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular nicotinic acetylcholine receptors (nAChRs), whereas it binds with a low affinity to neuronal alpha-7/CHRNA7 nAChRs. {ECO:0000250|UniProtKB:P0C8R6}.",Neurotoxin
2103,P0CAR3,3S1E1_MICPY,,Short neurotoxin E1,MICYNHQSSEPPTTXTCSEGQ,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2104,P0CAR5,3S1E3_MICPY,,Weak neurotoxin E3,LICFNDFSPTARTLEYCQIGITTYNPS,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2106,P0CJ34,BKIP_CROAT,,Bradykinin inhibitor peptide (BIP),TPPAGPDVGPR,Bradykinin inhibitor peptide family,FUNCTION: Bradykinin inhibitor peptide antagonizes the vasodilatory actions of bradykinin at the B2 bradykinin receptor (BDKRB2). {ECO:0000250}.,Kunitz Family
2107,P0CV88,SLBH_CROAT,,Snaclec convulxin subunit beta homolog,GFCCPSGWSSYDR,Snaclec family,FUNCTION: Activates platelets by binding to the platelet collagen receptor glycoprotein VI (GP6). {ECO:0000250}.,Binding Protein
2108,P0CV90,VSPH_CROAT,,Snake venom serine protease homolog (Serine proteinase-like protein),FLVALYTFR,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
2110,P0DJB0,3X_MICLE,,Muscarinic toxin Mlalpha (MT-Mlalpha),LICFICFSPTAH,Snake three-finger toxin family,"FUNCTION: Probably blocks muscarinic acetylcholine receptors (CHRM), since it inhibits the binding of the selective muscarinic ligand [3H]QNB and inhibits the carbachol-induced [3H]inositol phosphate accumulation in rat hippocampus. {ECO:0000269|PubMed:22005021}.",Binding Protein
2113,P0DL07,SVMI_BOTCO,,Poly-His-poly-Gly peptide 1 (pHpG-1),HHDHHAAVGGGGGGGGGA,PHpG family,"FUNCTION: May serve as a metalloproteinase inhibitor during glandular storage. Their inhibition may be instantly disengaged, by dilution or physiochemical change, when venom is injected into tissue of the victim. {ECO:0000250|UniProtKB:A8YPR6}.",Kunitz Family
2114,P0DL08,SVMI_BOTFO,,Poly-His-poly-Gly peptide 1 (pHpG-1),HHDHHAAVGGGGGGGGGA,PHpG family,"FUNCTION: May serve as a metalloproteinase inhibitor during glandular storage. Their inhibition may be instantly disengaged, by dilution or physiochemical change, when venom is injected into tissue of the victim. {ECO:0000250|UniProtKB:A8YPR6}.",Kunitz Family
2123,P0DM47,VKT_MICAT,,Protease inhibitor (MALT0027C),GSPKYCHLPADPGPC,Venom Kunitz-type family,FUNCTION: Snake venom serine protease inhibitor. {ECO:0000250}.,Serine Protease
2127,P0DMG7,NGFV_BOTCO,,Venom nerve growth factor Bco12 (v-NGF) (vNGF),EDHPVHNRGEYSVCDSVNVWV,NGF-beta family,"FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. It stimulates division and differentiation of sympathetic and embryonic sensory neurons as well as basal forebrain cholinergic neurons in the brain. Its relevance in the snake venom is not clear. However, it has been shown to inhibit metalloproteinase-dependent proteolysis of platelet glycoprotein Ib alpha, suggesting a metalloproteinase inhibition to prevent metalloprotease autodigestion and/or protection against prey proteases (By similarity). Binds a lipid between the two protein chains in the homodimer. The lipid-bound form promotes histamine relase from mouse mast cells, contrary to the lipid-free form (By similarity). {ECO:0000250|UniProtKB:P61898, ECO:0000250|UniProtKB:P61899}.",Metalloprotease
2129,P0DMH2,VM1_BOTCO,3.4.24.-,Snake venom metalloproteinase Bco22 (SVMP) (EC 3.4.24.-),TPEHQRYVELFIVVD,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
2130,P0DMH3,VM1_BOTFO,3.4.24.-,Snake venom metalloproteinase Bfon25 (SVMP) (EC 3.4.24.-),TPEHQRYVELFIVVDHGM,"Venom metalloproteinase (M12B) family, P-I subfamily",FUNCTION: Snake venom metalloproteinase that impairs hemostasis in the envenomed animal. {ECO:0000250}.,General Toxin
2131,P0DMH4,VM2_BOTFO,,Disintegrin (Platelet aggregation activation inhibitor),EAGEECDCGTPENPCCDAAT,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
2132,P0DMH5,VSP_BOTCO,3.4.21.-,Snake venom serine protease (SVSP) (EC 3.4.21.-),VVGGDECNINEHRFL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000250}.,Serine Protease
2134,P0DSN1,3SAN_NAJNG,,Naniproin,LKCNRLIPPFWKTCPEGKNLCYKMTMRLAPKVPVKRGCIDVCPKSSLLIKYMCCTNDKCN,"Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily","FUNCTION: Basic protein that binds to cell membrane and depolarizes cardiomyocytes. This cytotoxin also possesses lytic activity on many other cells, including red blood cells. Interaction with sulfatides in the cell membrane induces pore formation and cell internalization and is responsible for cytotoxicity in cardiomyocytes. It targets the mitochondrial membrane and induces mitochondrial swelling and fragmentation. Inhibits protein kinases C. It binds to the integrin alpha-V/beta-3 with a moderate affinity. {ECO:0000250|UniProtKB:P01443}.",Vascular Interaction
2136,P0DV81,BPPL_BITRH,,Bradykinin-potentiating peptide-like (Bothrops-like BPP),QNWPHPQIPP,Bradykinin-potentiating peptide family,FUNCTION: Bradykinin-potentiating peptide. It inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain. It evokes transient hypotension. {ECO:0000250|UniProtKB:P68515}.,Vascular Interaction
2138,P0DXT0,3S11_PSECT,,Alpha-elapitoxin-Pc1,MTCCNQQSSQPKTTTTCAGGETSCYKKTWSDHRGSRTERGCGCPHVKPGIKLTCCKTDECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily",FUNCTION: Bird-specific neurotoxin (tested on chicken) that acts as pseudo-irreversible antagonists at the nicotinic acetylcholine receptor (nAChR) of the skeletal neuromuscular junction. Has no significant effect on the electrically-induced twitches of the rat isolated phrenic nerve-diaphragm preparation. {ECO:0000269|PubMed:23545348}.,Neurotoxin
2139,P10455,3S1C_LATCO,,Short neurotoxin C,MKTLLLTLVVVTMVCLDLAYTRRCYNQQSSQPKTTKSCPPGENSCYNKQWRDHRGSITERGCGCPKVKPGIKLRCCESEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2140,P10808,3S11_BUNFA,,Short neurotoxin 1 (Toxin V-II-1),RICLNQQQSTPEDQPTNGQCYIKTDCQNKTWNTHRGSRTDRGCGCPKVKPGINLRCCKTDKCNE,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2141,P12028,MYX1_CROCL,,Myotoxin-1 (Myotoxin I),YKRCHKKEGHCFPKTVICLPPSSDFGKMDCRWKWKCCKKGSVN,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
2143,P14613,3S1B1_NAJKA,,Short neurotoxin 1 (Toxin C-6),LECHNQQSIQTPTTTGCSGGETNCYKKRWRDHRGYRTERGCGCPSVKNGIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2147,P19960,3S14_AIPLA,,Short neurotoxin D,MKTLLLTLVVVTIVCLDLGYTLTCCNQQSSQPKTTTDCADDSCYKKTWKDHRGTRIERGCGCPQVKPGIKLECCKTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2148,P23323,VM2C_PROFL,,Disintegrin CTF-II (Cytotoxic factor 2) [Cleaved into: Disintegrin CTF-I (Cytotoxic factor 1)],ELLEEGEDCYCHIPPNPCCDPATCKLTPGSQCAEGLCCDQCRFKKKGTICRIARGDFPDDRCTGLSDDCPRWNDL,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelet receptors, and inhibits aggregation induced by ADP, thrombin, collagen and platelet-activating factor. Acts by binding to the alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
2149,P24331,MYX1_CRODU,,Myotoxin-1 (Crotamine-1),MKILYLLFAFLFLAFLSEPGNAYKRCHIKGGHCFPKEKICIPPSSDFGKMDCPWRRKCCKKGSGK,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
2150,P24332,MYX2_CRODU,,Myotoxin-2 (Crotamine-2),KILYLLFAFLFLAFLSEPGNAYKRCHIKGGHCFPKEKICIPPSSDFGKMDCPWRRKSLKKGSGK,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
2151,P24333,MYX3_CRODU,,Myotoxin-3 (Crotamine-3),MKILYLLFAFLFLAFLSEPGNAYKRCHIKGGHCFPKGKICIPPSSDFGKMDCPWRRKCCKKGSGK,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
2152,P24334,MYX4_CRODU,,Myotoxin-4 (Crotamine-4),FLSEPGNAYKQCHKKGGHCFPKEKICIPPSSDFGKMDCRWRWKCCKKRSGK,Crotamine-myotoxin family,"FUNCTION: Cationic peptide that possesses multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage-gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. {ECO:0000250|UniProtKB:Q9PWF3}.",Kunitz Family
2155,P25494,3S11_HYDCY,,Short neurotoxin 1 (Hydrophitoxin a),MTCCNQQSSQPKTTTNCAESSCYKKTWSDHRGTRIERGCGCPQVKKGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2156,P25495,3S1A_LATCR,,Short neurotoxin A,RRCFNHPSSQPQTNKSCPPGENSCYNKQWRDHRGTIIERGCGCPTVKPGIKLRCCQSDDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2157,P25496,3S1B_LATCR,,Short neurotoxin B,RRCFNHPSSQPQTNKSCPPGENSCYNKQWRDHRGTIIERGCGCPQVKSGIKLRCCQSDDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2158,P25669,3L22_NAJNA,,Long neurotoxin 2 (Toxin B),IRCFITPDITSKDCPNGHVCYTKTWCDGFCSSRGKRVDLGCAATCPTVRTGVDIQCCSTDDCDPFPTRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2159,P25673,3L25_NAJNA,,Long neurotoxin 5 (Toxin E),IRCFITPDITSKDCPNGHVCYTKTWCDGFCSRRGERVDLGCAATCPTVKTGVDIQCCSTDDCDPFPTRKRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2163,P25679,3NO29_NAJKA,,Weak toxin CM-9a,LTCLNCPEMFCGKFQICRNGEKICFKKLHQRRPLSRYIRGCADTCPVGYPKEMIECCSTDKCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2164,P25680,3NO2A_NAJNI,,Weak toxin CM-10,LRCLNCPEVFCRNFHTCRNGEKICFKRFDQRKLLGKRYTRGCAVTCPVAKPREIVECCSTDGCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2165,P25681,3SEC_DENPO,,Acetylcholinesterase toxin C (Fasciculin),TICYSHTTTSRAILKDCGENSCYRKSRRHPPKMVLGRGCGCPPGDDYLEVKCCTSPDKCNY,"Snake three-finger toxin family, Short-chain subfamily, Acn-esterase inhibitor sub-subfamily",FUNCTION: Inhibits acetylcholinesterase. {ECO:0000250|UniProtKB:P0C1Z0}.,Phosphodiesterase
2167,P29179,3NO25_NAJNA,,Weak neurotoxin 5,LTCLICPEKYCNKVHTCLNGENICFKRFNRILGKRYDLGCAATCPTVKTGIVQCCSTDKCNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2168,P29180,3NO26_NAJNA,,Weak neurotoxin 6,LTCLICPEKYCNKVHTCLNGEKICFKRYSERKLLGKRYIRGCADTCPVRKPREIVQCCSTDKCNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2169,P29181,3NO27_NAJNA,,Weak neurotoxin 7,LTCLNCPEVYCRRFQICRDGEKICFKKFDQRNLLGKRYRRGCAATCPEAKPREIVQCCSTDKCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2170,P29182,3NO28_NAJNA,,Weak neurotoxin 8,LTCLNCPEVYCRRFQKCRNGEKICFKKFDQRNLLGKRYEIGCAATCPEAKPREIVQCCSTDKCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2172,P34073,3L2D_ACAAN,,Alpha-elapitoxin-Aa2d (Alpha-EPTX-Aa2d) (Acanthophin-D) (Postsynaptic neurotoxin),VICYRKYTNNVKTCPDGENVCYTKMWCDGFCTSRGKVVELGCAATCPIRKPGNEVKCCSTNKCNHPPKRKKRRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2175,P58370,3NO48_MICCO,,Alpha-neurotoxin homolog 8 (NXH8),MKTLLLTLVVVTIMCLDLGYTLECKICNFKTCPTDELRHCASGETICYKTFWNTHRGLRIDRGCAATCPTVKPGVNIICCKTDNCN,"Snake three-finger toxin family, Ancestral subfamily, Orphan group IV sub-subfamily",FUNCTION: Binds and inhibits muscular and neuronal nicotinic acetylcholine receptors (nAChR). {ECO:0000250|UniProtKB:P81783}.,Neurotoxin
2176,P60237,3SUB_DENAN,,Muscarinic toxin 2 (m2-toxin),RICHSQMSSQPPTTTFCRVNSCYRRTLRDPHDPRGTIIVRGCGCPRMKPGTKLECCTSDKCNV,"Snake three-finger toxin family, Short-chain subfamily, Type B muscarinic toxin sub-subfamily","FUNCTION: Blocks M2 muscarinic acetylcholine receptors (CHRM2). Fully blocks the binding of N-methylscopolamine (NMS) and oxotremorine-M to M2 receptors, slightly increased NMS binding to M1 receptors. {ECO:0000269|PubMed:10531397}.",Binding Protein
2182,P60774,3S11_NAJSA,,Short neurotoxin 1 (NTX I),LECHNQQSSQAPTTKTCSGETNCYKKWWSDHRGTIIERGCGCPKVKPGVKLNCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission.",Neurotoxin
2183,P60814,3NO2I_NAJAT,,Probable weak neurotoxin NNAM2I,MKTLPLTLVVVTIVCLDLGYTLTCLNCPEMFCGKFQICRNGEKICFKKLHQRRPFSLRYIRGCAATCPGTKPRDMVECCSTDRCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2184,P62389,3S15_HYDSC,,Toxin 5,MTCCNQQSSQPKTTTNCAESSCYKKTWSDHRGTRIERGCGCPQVKSGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2185,P68413,3S11_HYDOR,,Short neurotoxin 1 (Toxin A),MTCCNQQSSQPKTTTNCAGNSCYKKTWSDHRGTIIERGCGCPQVKSGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2187,P80156,3L24_OPHHA,,Long neurotoxin 4 (Alpha-neurotoxin),TKCYKTGDRIISEACPPGQDLCYMKTWCDVFCGTRGRVIELGCTATCPTVKPHEQITCCSTDNCNPHPKMKQ,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2188,P80163,SRTXB_ATRBI,,Bibrotoxin (BTX),CSCADMTDKECLYFCHQDVIW,Endothelin/sarafotoxin family,FUNCTION: Vasoconstrictor activity. These toxins cause cardiac arrest probably as a result of coronary vasospasm. May act by displaying agonistic activities towards endothelin-1 and -2 receptors (EDNRA and EDNRB). {ECO:0000269|PubMed:8416802}.,General Toxin
2189,P80495,3SIMB_DENPO,,Adrenergic toxin rho-elapitoxin-Dp1a (rho-EPTX-Dp1a) (Muscarinic toxin beta) (MT-beta),LTCVTSKSIFGITTEDCPDGQNLCFKRRHYVVPKIYDITRGCVATCPIPENYDSIHCCKTDKCNE,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: This toxin shows activities on different G-protein coupled receptors. It is highly potent on various alpha-adrenoceptors (ADRA) (subnanomolar affinity for ADRA1A). Order of potency is the following: ADRA1A > ADRA1B > ADRA1D > ADRA2C (PubMed:23648423). It is also found to reversibly bind to muscarinic acetylcholine receptors (CHRM), but the affinity is much weaker (CHRM1 and CHRM2, Ki>1 uM; CHRM3, Ki=140 nM; CHRM4, Ki=120 nM; CHRM5, Ki=350 nM) (PubMed:10978757, PubMed:23648423, PubMed:8536706). {ECO:0000269|PubMed:10978757, ECO:0000269|PubMed:23648423}.",General Toxin
2190,P80899,VSPCA_GLOHA,3.4.21.-,Protein C activator (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VVGGDECNINEHRSL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that selectively cleaves the heavy chain of protein C (PROC). This activation is thrombomodulin-independent (By similarity). {ECO:0000250}.,Serine Protease
2192,P81946,3SPT_DENAN,,Thrombostatin (Glycoprotein IIb-IIIa antagonist) (Platelet aggregation inhibitor),LICYNQLGTKPPTTETCGDDSCYKMIWTYDGVIRRGCGCFTPRGDMPRPRCCKSDKCNL,"Snake three-finger toxin family, Short-chain subfamily, Antiplatelet toxin sub-subfamily",FUNCTION: Inhibits ADP-induced platelet aggregation and inhibits the binding of purified platelet fibrinogen receptor alpha-IIb/beta-3 (ITGA2B/ITGB3) to immobilized fibrinogen. {ECO:0000250|UniProtKB:P28375}.,Fibrinogenolytic Enzyme
2199,P82464,3SO8_NAJKA,,Muscarinic toxin-like protein 3 (MTLP-3),TICYNHLTRTSETTEICPDSWYFCYKISLADGNDVRIKRGCTFTCPELRPTGIYVYCCRRDKCNQ,"Snake three-finger toxin family, Short-chain subfamily, Orphan group VIII (haditoxin) sub-subfamily",FUNCTION: Antagonist of muscle and neuronal nicotinic acetylcholine receptors (nAChR) with highest affinity for neuronal alpha-7/CHRNA7 nAChRs. {ECO:0000250|UniProtKB:A8N286}.,Neurotoxin
2200,P82885,VESP_NAJKA,,Thaicobrin,SPPGNWQKADVTFDSNTAFESLVVSPDKKTVENVGVSQVAPDNPERFDGSPCVLGSPGFRSGKHFFEVKYGTQREWAVGLAGKSVKRKGYLRLVPEERIWQKGLWWLG,Ohanin/vespryn family,"FUNCTION: Neurotoxin that produces dose-dependent hypolocomotion and hyperalgesia in mice. May directly act on the central nervous system, as it is 6500-fold more potent when administered intracerebroventricularly than intraperitoneal. {ECO:0000250|UniProtKB:P83234}.",Neurotoxin
2202,P84746,VVP1_BOTJR,,1370.6 Da venom vasodilator peptide,PKVSPRWPPIPP,,FUNCTION: Toxin. Induces vasodilation in mice and rabbits. {ECO:0000269|Ref.1}.,General Toxin
2209,P86530,VSP1_DABRR,3.4.21.-,Vipera russelli proteinase RVV-V homolog 1 (RVV-V 1) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VIGGDECNINEHPFLA,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
2210,P86531,VSP2_DABRR,3.4.21.-,Vipera russelli proteinase RVV-V homolog 2 (RVV-V 2) (EC 3.4.21.-) (Snake venom serine protease) (SVSP) (Vipera russelli proteinase RVV-V homolog 3) (RVV-V 3),VVGGDECNINEHRSL,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
2211,P86532,VSP4_DABRR,3.4.21.-,Vipera russelli proteinase RVV-V homolog 4 (RVV-V 4) (EC 3.4.21.-) (Snake venom serine protease) (SVSP),VVGGDECNINEHPFLV,"Peptidase S1 family, Snake venom subfamily",FUNCTION: Snake venom serine protease homolog that may act in the hemostasis system of the prey. {ECO:0000305}.,Serine Protease
2218,P86544,3SO8_NAJNA,,Muscarinic toxin-like protein 1 (MTLP-1) (Muscarinic toxin-like protein 2) (MTLP-2),TICYNHLTIRSEVTEICIICDDDYYF,"Snake three-finger toxin family, Short-chain subfamily, Orphan group VIII (haditoxin) sub-subfamily",FUNCTION: Antagonist of muscle and neuronal nicotinic acetylcholine receptors (nAChR) with highest affinity for neuronal alpha-7/CHRNA7 nAChRs. {ECO:0000250|UniProtKB:A8N286}.,Neurotoxin
2220,Q0PL65,VKTH7_BUNMU,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B5-B chain (Beta-bungarotoxin B5 chain),RQRHPDCDKPPDTKRCTGHNPAFYYNPRRKNCERFSYGGCGGNGNHFKTKQLCHCHCHEND,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxins are presynaptic neurotoxins of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv) (By similarity). {ECO:0000250}.,Kunitz Family
2221,Q1RPS8,VKTH6_BUNMU,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B6 chain,MSSGGLLLLLGLLRVCAELTPVSSKDPYCNLPPDPGPCHDNKFAFYHHPASNKCKEFVYGGCGGNDNRFKTRNKCQCTCSEYP,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxins are presynaptic neurotoxins of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv) (By similarity). {ECO:0000250}.,Kunitz Family
2222,Q1ZYW0,VNPB_CRYNI,,Natriuretic peptide CnNP-b,SGSKTATKGDGCFGVRIDRIGSTSGMGCGGVPKPTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2223,Q1ZYW1,VNPA_CRYNI,,Natriuretic peptide CnNP-a,SGSKTAKIGDGCFGVRIDRIGSTSGMGCGGVPKPTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2224,Q27J48,VESP_LACMU,,Ohanin-like protein,MSPSAGFQFSLYFLQTKKVLWKLTGLCYILLFTLCFFADQENGGKALASPPGIWKRADVTFDSNTAFSSLVVSANKKTVKNVGVPQVVPDNPERFNSSPCVLGSPGFRSGKHYFEVKYGTQREWAVGLAGKSVKRKGNLNLVPEERIWQTGLWWLRHLETDPGRVHSTSGKITVFVDYSGGNVIFDLNRIITILKANFSGEEVVPFFYLGGTVSLTTL,Ohanin/vespryn family,"FUNCTION: Neurotoxin that produces dose-dependent hypolocomotion and hyperalgesia in mice. May directly act on the central nervous system, as it is 6500-fold more potent when administered intracerebroventricularly than intraperitoneal. {ECO:0000250|UniProtKB:P83234}.",Neurotoxin
2225,Q2ES48,VKT3_DABRR,,Kunitz-type serine protease inhibitor 3 (Kunitz protease inhibitor 3) (Kunitz protease inhibitor III),MSSGGLLLLLGLLTLWAELTPISGHDRPKFCYLPADPGECMAYIRSFHYDSESKKCKEFIYGGCHGNANNFPTRDKCRQTCRGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2226,Q2ES49,VKT2_DABRR,,Kunitz-type serine protease inhibitor 2 (Kunitz protease inhibitor 2) (Kunitz protease inhibitor II),MSSGGLLLLLGLLTLWAEPTPISGQDRPKFCFLRPDFGRYGHPRPRFYYNPATNQCQGFLAQRSRENTNNFDTRDKCRQTCGRK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2227,Q2ES50,VKT1_DABRR,,Kunitz-type serine protease inhibitor 1 (Kunitz protease inhibitor 1) (Kunitz protease inhibitor I),MSSGGLLLLLGLLTLWAELTPISGHDRPTFCNLAPESGRCRGHLRRIYYNLESNKCKVFFYGGCGGNANNFETRDECRQTCGGK,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2230,Q2VBN2,3NO24_OPHHA,,Weak neurotoxin WNTX34,MKTLLLTLVVVTIVCLDLGYSLTCLNCPEQYCKRIHTCRNGENVCFKRFYEGKLLCKQFRRGCAATCPEAKSREIVQCCSTDECNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2232,Q2VBN4,3SDC3_OPHHA,,Beta-cardiotoxin CTX23,MKTLLLTLVVVTIVCLDLGYTRKCLNTPLPLIYKTCPIGQDKCIKMTIKKLPSKYDVIRGCTDICPKSSADVVVVCCDTNKCNK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Acts as a beta-blocker by binding to beta-1 and beta-2 adrenergic receptors (ADRB1 and ADRB2). It dose-dependently decreases the heart rate (bradycardia), whereas conventional cardiotoxins increases it. At 100 mg/kg, intraperitoneal injection into mice provokes labored breathing, impaired locomotion, lack of response to external stimuli, and death (after 30 minutes). {ECO:0000250|UniProtKB:Q69CK0}.",General Toxin
2233,Q2VBN5,3SDC1_OPHHA,,Beta-cardiotoxin CTX21,MKTLLLTLVVVTIVCLDLGYTRKCLNTPLPLIYTTCPIGQDKCVKMTIKKLPSKYDVIRGCTDICPKSSADVVVVCCDTNKCNK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Acts as a beta-blocker by binding to beta-1 and beta-2 adrenergic receptors (ADRB1 and ADRB2). It dose-dependently decreases the heart rate (bradycardia), whereas conventional cardiotoxins increases it. At 100 mg/kg, intraperitoneal injection into mice provokes labored breathing, impaired locomotion, lack of response to external stimuli, and death (after 30 minutes). {ECO:0000250|UniProtKB:Q69CK0}.",General Toxin
2234,Q2VBN7,3SDC4_OPHHA,,Beta-cardiotoxin CTX14,MKTLLLTLVVVTIVCLDLGYTRKCLNTPLPLIYTTCPIGQDKCVKMTIKKLPSKYDVIRGCTDICPKSSADVVVVCCDTNKCDK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Acts as a beta-blocker by binding to beta-1 and beta-2 adrenergic receptors (ADRB1 and ADRB2). It dose-dependently decreases the heart rate (bradycardia), whereas conventional cardiotoxins increases it. At 100 mg/kg, intraperitoneal injection into mice provokes labored breathing, impaired locomotion, lack of response to external stimuli, and death (after 30 minutes). {ECO:0000250|UniProtKB:Q69CK0}.",General Toxin
2235,Q2VBN8,3SDC9_OPHHA,,Beta-cardiotoxin CTX9,MKTLLLTLVVVTIVCLDLGYTRKCLNTPLPLIYKTCPIGQDRCIKMTIKKLPSKYDVIRGCIDICPKSSADVEVLCCDTNKCNK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Acts as a beta-blocker by binding to beta-1 and beta-2 adrenergic receptors (ADRB1 and ADRB2). It dose-dependently decreases the heart rate (bradycardia), whereas conventional cardiotoxins increases it. At 100 mg/kg, intraperitoneal injection into mice provokes labored breathing, impaired locomotion, lack of response to external stimuli, and death (after 30 minutes). {ECO:0000250|UniProtKB:Q69CK0}.",General Toxin
2236,Q2VBN9,3SXQ_OPHHA,,Short neurotoxin SNTX26 (Three-finger toxin) (3FTx),MKTLLLTFLVVTIVCLDLGYTLICHQVHGLQTCEPAQKFCQKRTTMFFPNHPVLLMGCTYNCPTERYSVCCSTDKCNK,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: This three-finger toxin binds and inhibits the nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:P83302}.,General Toxin
2237,Q2VBP0,3SXE_OPHHA,,Short neurotoxin SNTX14 (Three-finger toxin) (3FTx),MKTLLLTFLVVTIVCLDLGYTLICHQLHGLQTCEPAQKFCQKRTTMFFPNHPVLLMGCTYNCPTERYSVCCSTDKCNK,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: This three-finger toxin binds and inhibits the nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:P83302}.,General Toxin
2238,Q2VBP1,3SXB_OPHHA,,Short neurotoxin SNTX11 (Three-finger toxin) (3FTx),MKTLLLTFLVVTIVCLDLGYTLICHRVHGLQTCEPDQKFCFRKTTMFFPNHPVLLMGCTYSCPTEKYSVCCSTDKCNK,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: This three-finger toxin binds and inhibits the nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:P83302}.,General Toxin
2239,Q2VBP2,3SX6_OPHHA,,Short neurotoxin SNTX6 (Three-finger toxin) (3FTx),MKTLLLTFLVVTIVCLDLGYTLICHQLHGLQTCEPAQKFCQKRTTMFSPNHPVLLMGCTYNCPTERYSVCCSTDKCNK,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: This three-finger toxin binds and inhibits the nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:P83302}.,General Toxin
2240,Q2VBP3,3L23X_OPHHA,,Long neurotoxin LNTX37,MKTLLLTLVVVTIMCLDLGYTTKCYKTGERIISETCPPGQDLCYMKTWCDVFCGSRGRVIELGCTATCPTVKHHEQITCCSTDNCNPHPKMKQR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2241,Q2VBP4,3L228_OPHHA,,Long neurotoxin LNTX28,MKTLLLTLVVMTIVCLDLGYTLICFISSHDSVTCAPGENVCFLKSWCDAWCGSRGKKLSFGCAATCPRVNPGIDIECCSTDNCNPHPKLRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2242,Q2VBP5,3L222_OPHHA,,Long neurotoxin LNTX22,MKTLLLTLVVVTIVCLDLGYTTKCYVTPDVKSETCPDGENICYTKSWCEVFCTSRGKRIDLGRAATCPKVKPGVDIKCCSTDNCNPFTPWKRH,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2243,Q2VBP6,3L2X8_OPHHA,,Long neurotoxin LNTX8,MKTLLLTLVVVTIMCLDLGYTTKCYKTGERIISETCPPGQDLCYMKTWCDVFCGSRGRVVELGCTATCPTVKPHEQITCCSTDNCNPHPKMKQR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2255,Q3BK17,DIS_CERVI,,Disintegrin CV (Disintegrin CV-short),CTTGPCCRQCKLKPAGTTCWRTSVSSHYCTGRSCECPSYPGNG,"Disintegrin family, Short disintegrin subfamily",FUNCTION: Specifically interacts with the alpha-1/beta-1 integrin (ITGA1/ITGB1). Exhibits highly inhibitory effects on cell adhesion and cell migration to collagens I and IV. Also shows in vivo anti-angiogenic activity (By similarity). {ECO:0000250|UniProtKB:Q3BK14}.,Kunitz Family
2256,Q3SAE5,VNPB_HOPST,,Natriuretic peptide HsNP-b,SGSKTAKIGDGCFGVPIDHIGSTTDLGCGRPRPKPTPRGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2257,Q3SAE6,VNPA_HOPST,,Natriuretic peptide HsNP-a,SGSKTAKIGDGCFGVRLDRIGSTSGMGCGGVPKPTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2258,Q3SAE7,VNPB_NOTSC,,Natriuretic peptide NsNP-b,SGSKTAKIGDGCFGLPLDRIGSTSGMGCGSVPKPTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2259,Q3SAE8,VNPA_NOTSC,,Natriuretic peptide NsNP-a,SGSEVAKIGDGCFGLPLDRIGSASGMGCRSVPKPTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2260,Q3SAF0,VNPB_PSEPO,,Natriuretic peptide PpNP-b,SGSKTANIGDGCFGVRLDHIGTTSGMGCGRPRPKPTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2261,Q3SAF1,VNPA_PSEPO,,Natriuretic peptide PpNP-a,SGSKTANIGDGCFGVPIDHIGSTSGMGCGSPRPKPTPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2262,Q3SAF2,VNPD_PSEAU,,Natriuretic peptide PaNP-d,SGSKTAEIDDGCFGLPLDPIGSTSGMGCRSVPKPIPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2263,Q3SAF4,VNPB_PSEAU,,Natriuretic peptide PaNP-b,SDSKIGDGCFGLPLDHIGSVSGLGCNRPVQNRPKQIPGGS,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2264,Q3SAF5,VNPA_PSEAU,,Natriuretic peptide PaNP-a,SDPKIGNGCFGFPIDRIGSVSGLGCNRLVQNPPKPISGES,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2265,Q3SAF8,VNPD_OXYMI,,Natriuretic peptide TNPd (OmNP-d),SDPKIGNGCFGFPIDRIGSVSGLGCNRLVQNPPKPISGES,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that exhibits vasoactive and hypotensive activity (By similarity). Stimulates cGMP production through the natriuretic peptide receptor 1 (NPR1) with very high potencies for the rat NPR1 (EC(50)=18 nM), and very weak potencies over human NPR1 (30% activation at 10 uM) (PubMed:37049825). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000269|PubMed:37049825}.",General Toxin
2266,Q3SAX8,VNPD_OXYSC,,Natriuretic peptide OsNP-d,PAAGLSDPKIGNGCFGFPIDRIGSVSGLGCNRLVQNPPKPISGES,Natriuretic peptide family,"FUNCTION: Snake venom natriuretic peptide that targets both NPR1 and NPR2 (By similarity). Exhibits hypotensive and vasodepressor activities (By similarity). {ECO:0000250|UniProtKB:C6EVG7, ECO:0000250|UniProtKB:Q3SAE9}.",General Toxin
2272,Q3SB08,CALGL_PSEPO,,Calglandulin,MAATLTPEQITEYKGIFEMFDEEGNGLVKTDDLESLMSLIGINPTKRDLANMAKDVDKDKKGTFNCDGFLVLMGIYHEKSKNQDEELRAAFKVFDKEHKGYIEWDTLKYVLMNAGEPLNEHEAELMMKEADKDGDGTIDYEEFVAMMTGESFKLTQ,"Calmodulin family, Calglandulin subfamily",FUNCTION: May be involved in the cellular control mechanism of the secretion of toxins from the gland into the venom. {ECO:0000250}.,General Toxin
2273,Q3SB09,CALGL_PSEAU,,Calglandulin,MAATLTPEQITEYKGIFEMFDEEGNGLVKTDDLESLMSLIGINPTKRDLANMAKDVDKDKKGTFNCDGFLVLMGIYHEKSKNQDEELRAAFKVFDKEHKGYIEWDTLKYVLMNAGEPLNEHEAELMMKEADKDGDGTIDYEEFVAMMTGESFKLTQ,"Calmodulin family, Calglandulin subfamily",FUNCTION: May be involved in the cellular control mechanism of the secretion of toxins from the gland into the venom. {ECO:0000250}.,General Toxin
2274,Q3SB10,CALGL_HOPST,,Calglandulin,MAATLTPEQITEYKGIFEMFDEEGNGLVKTDDLESLMSLIGINPTKRDLANMAKDVDKDKKGTFNCDGFLVLMGIYHEKSKNQDEELRAAFKVFDKEHKGYIEWDTLKYVLMNAGEPLNEHEAELMMKEADKDGDGTIDYEEFVAMMTGESFKLTQ,"Calmodulin family, Calglandulin subfamily",FUNCTION: May be involved in the cellular control mechanism of the secretion of toxins from the gland into the venom. {ECO:0000250}.,General Toxin
2275,Q3SB11,CALGL_TROCA,,Calglandulin,MAATLTPEQITEYKGIFEMFDEEGNGLVKTDDLESLMSLIGINPTKRDLANMAKDVDKDKKGTFNCEGFLVLMGIYHEKSKNQDEELRAAFKVFDKEHKGYIEWDTLKYVLMNAGEPLNEHEAELMMKEADKDGDGTIDYEEFVAMMTGESFKLTQ,"Calmodulin family, Calglandulin subfamily",FUNCTION: May be involved in the cellular control mechanism of the secretion of toxins from the gland into the venom. {ECO:0000250}.,General Toxin
2276,Q3SB12,CALGL_NOTSC,,Calglandulin,MAATLTPEQITEYKGIFEMFDEEGNGLVKTDDLESLMSLIGINPTKRDLANMAKDVDKDKKGTFNCDGFLVLMGIYHEKSKNQDEELRAAFKVFDKEHKGYIEWDTLKYVLMNAGEPLNEHEAELMMKEADKDGDGTIDYEEFVAMMTGESFKLTQ,"Calmodulin family, Calglandulin subfamily",FUNCTION: May be involved in the cellular control mechanism of the secretion of toxins from the gland into the venom. {ECO:0000250}.,General Toxin
2277,Q3SB13,CALGL_PSETE,,Calglandulin,MAATLTPEQITEYKGIFEMFDEEGNGLVKTDDLESLMSLIGINPTKRDLANMAKDVDKDKKGTFNCDGFLVLMGIYHEKSKNQDEELRAAFKVFDKEHKGYIEWDTLKYVLMNAGEPLNEHEAELMMKEADKDGDGTIDYEEFVAMMTGESFKLTQ,"Calmodulin family, Calglandulin subfamily",FUNCTION: May be involved in the cellular control mechanism of the secretion of toxins from the gland into the venom. {ECO:0000250}.,General Toxin
2278,Q3SB14,CALGL_OXYMI,,Calglandulin,MAATLTPEQITEYKGIFEMFDEEGNGLVKTDDLESLMSLIGINPTKRDLANMAKDVDKDKKGTFNCDGFLVLMGIYHEKSKNQDEELRAAFKVFDKEHKGYIEWDTLKYVLMNAGEPLNEHEAELMMKEADKDGDGTIDYEEFVAMMTGESFKLTQ,"Calmodulin family, Calglandulin subfamily",FUNCTION: May be involved in the cellular control mechanism of the secretion of toxins from the gland into the venom. {ECO:0000250}.,General Toxin
2279,Q3SB15,CALGL_OXYSC,,Calglandulin,MAATLTPEQITEYKGIFEMFDEEGNGLVKTDDLESLMSLIGINPTKRDLANMAKDVDKDKKGTFNCDGFLVLMGIYHEKSKNQDEELRAAFKVFDKEHKGYIEWDTLKYVLMNAGEPLNEHEAELMMKEADKDGDGTIDYEEFVAMMTGESFKLTQ,"Calmodulin family, Calglandulin subfamily",FUNCTION: May be involved in the cellular control mechanism of the secretion of toxins from the gland into the venom. {ECO:0000250}.,General Toxin
2280,Q4JCS0,VM2D3_BITAR,,Disintegrin isoform D-3,SPPVCGNELLEEGEECDCGSPANCQDRCCNAATCKLTPGSQCSYGECCDQCKFKKARTVCRIARGDWNDDYCTGKSSDCPWNH,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
2281,Q4JCS1,VM2D2_BITAR,,Disintegrin isoform D-2,SPPVCGNELLEEGEECDCDSPANCQDRCCNAATCKLTPGSQCNYGECCDQCKFKKARTVCRIARGDWNDDYCTGKSSDCPWNH,"Venom metalloproteinase (M12B) family, P-II subfamily, P-IIa sub-subfamily","FUNCTION: Inhibits fibrinogen interaction with platelets. Acts by binding to the alpha-IIb/beta-3 (ITGA2B/ITGB3) on the platelet surface and inhibits aggregation induced by ADP, thrombin, platelet-activating factor and collagen (By similarity). {ECO:0000250}.",Fibrinogenolytic Enzyme
2283,Q53B46,3SDC5_OPHHA,,Beta-cardiotoxin CTX15 (OH-84),MKTLLLTLVVVTIVCLDLGYTRKCLNTPLPLIYKTCPIGQDKCIKMTIKKLPSKYDVIRGCIDICPKSSADVEVLCCDTNKCNK,"Snake three-finger toxin family, Short-chain subfamily, Aminergic toxin sub-subfamily","FUNCTION: Acts as a beta-blocker by binding to beta-1 and beta-2 adrenergic receptors (ADRB1 and ADRB2). It dose-dependently decreases the heart rate (bradycardia), whereas conventional cardiotoxins increases it. At 100 mg/kg, intraperitoneal injection into mice provokes labored breathing, impaired locomotion, lack of response to external stimuli, and death (after 30 minutes). {ECO:0000250|UniProtKB:Q69CK0}.",General Toxin
2284,Q53B48,3SX7_OPHHA,,Short neurotoxin OH-46 (Three-finger toxin) (3FTx),MKNLLLTFLVVTIVCLDLGYTLICHQVHGLQTCEPAQKFCQIRTTMFFPNHPVLLMGCTYNCPTERYSVCCSTDKCNK,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: This three-finger toxin binds and inhibits the nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:P83302}.,General Toxin
2286,Q53B50,3SX2_OPHHA,,Short neurotoxin OH-32 (Three-finger toxin) (3FTx),MKNLLLTFLVVTIVCLDLGYTLICNRVHGLQTCEPAHKFCFSKTVMPFPNHPLTLMGCTYSCPTERNAVCCSTDKCN,"Snake three-finger toxin family, Short-chain subfamily",FUNCTION: This three-finger toxin binds and inhibits the nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:P83302}.,General Toxin
2287,Q53B54,3L217_OPHHA,,Long neurotoxin OH-17,TKCYITPDVKSETCPDGENICYTKSWCDVFCTSRGKRIDLGCAATCPKVKPGVDIKCCSTDNCNPFTPWKRH,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2288,Q53B55,3L231_OPHHA,,Long neurotoxin-like OH-31,MKTLLLTLVVVTILCLDLGLELTNAPDSWSSRRTCLCPAWVPLRSRPVAGHSKQCGSRGRRVDLGCAATCPIVKPGVNINCCSTDNCNPFPKRS,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular nicotinic acetylcholine receptors (nAChRs), whereas it binds with a low affinity to neuronal alpha-7/CHRNA7 nAChRs. {ECO:0000250|UniProtKB:P0C8R6}.",Neurotoxin
2289,Q53B56,3L257_OPHHA,,Long neurotoxin OH-57,MKTLLLTLVVVTIVCLDLGYTRICHKSSFISETCPDGQNLCYLKSWCDIFCGSRGERLEFGCAATCPEVKPGVNIECCSTDNCNPHPKLRP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2290,Q53B57,3L256_OPHHA,,Long neurotoxin OH-56,MKTLLLTLVVVTIMCLDLGYTTKCYVTPDVTSQTCPDGQNICYTETWCDAWCGSRGKRVNLGCAATCPKVNPGVDIICCSTDNCNPFPKRS,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2291,Q53B61,3NO2_OPHHA,,Weak neurotoxin OH-72,LTLVVVTIVCLDLGYTLTCLICPEEYCKRIHTCRDGENVCFKGFYEGKQLGKQFRRGCAATCPEGKPNEIVQCCSTDECNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2292,Q5UFR7,3S12_HYDPR,,Short neurotoxin 2,MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTNCAGNSCYKKTWSDHRGTIIERGCGCPQVKSGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2293,Q69CJ8,3S11H_OPHHA,,Weak toxin DE-1 homolog 1 (WTX DE-1 homolog 1),MKPVLLTLVVVTIVCLDLGYTRICLKQEPFQPETTTTCPEGEDACYNLFWSDHSEIKIEMGCGCPKTEPYTNLYCCKIDSCNK,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2295,Q6ITB0,VKT1_TROCA,,Kunitz-type serine protease inhibitor carinatin-1,MSSGGLLLLLGLLTLWEGLTPVSSKDRPDFCELPDDRGPCRGIFHAFYYNPDQRQCLEFIYGGCYGNANNFKTIDECERTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2296,Q6ITB1,VKT_PSEPO,,Kunitz-type serine protease inhibitor blackelin,MSSGGLLLLLGLLTLWEGLTPVSSKDRPDFCELPDDRGPCRGIFHAFYYNPDQRQCLEFIYGGCYGNANNFKTIDECERTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2297,Q6ITB2,VKT2_NOTSC,,Kunitz-type serine protease inhibitor tigerin-2,MSSGGLLLLLGLLTLWAELTPVSSKDHPEFCELPADSGPCRGILHAFYYHPVHRTCLEFIYGGCYGNANNFKTIDECEPPCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2298,Q6ITB3,VKT1_NOTSC,,Kunitz-type serine protease inhibitor tigerin-1,MSSGGLLLLLGLLTLWAELTPVSSKDHPEFCELPADSGPCRGILHAFYYHPVHRTCLEFIYGGCYGNANNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2299,Q6ITB4,VKT2_OXYMI,,Kunitz-type serine protease inhibitor microlepidin-2,MSSGGLLLLLGLLTLWEVLTPVSSKDRPDFCELPADTGPCRVGFPSFYYNPDEKKCLEFIYGGCEGNANNFITKEECESTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2300,Q6ITB5,VKT1_OXYMI,,Kunitz-type serine protease inhibitor microlepidin-1,MSSGGLLLLLGLLTLWEVLTPVSSKDRPDLCELPADTGPCRVGFPSFYYNPDEKKCLEFIYGGCEGNANNFITKEECESTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2301,Q6ITB6,VKT2_OXYSC,,Kunitz-type serine protease inhibitor scutellin-2,MSSGGLLLLLGLLTLWEVLTPVSSKDRPDFCELPADTGPCRVGFPSFYYNPDEKKCLEFIYGGCEGNANNFITKEECESTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2302,Q6ITB7,VKT1_OXYSC,,Kunitz-type serine protease inhibitor scutellin-1,MSSGGLLLLLGLLTLWEVLTPVSSKDRPDFCELPADTGPCRVGFPSFYYNPDEKKCLEFIYGGCEGSANNFITKEECESTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2303,Q6ITB8,VKT4_PSEAU,,Kunitz-type serine protease inhibitor mulgin-4,MSSGGLLLLLGLLTLWEGLTPVSSKDHPRFCELPADPGPCNGLFQAFYYNPVQRTCLKFRYGGCKGNPNTFKTIEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2304,Q6ITB9,VKT3_PSEAU,,Kunitz-type serine protease inhibitor mulgin-3,MSSGGLLLLLGLLTLWEELTPVSSKDRPDFCELPADTGPCRVGFPSFYYNPDEKKCLEFIYGGCQGNANNFITKEECESTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2305,Q6ITC0,VKT2_PSEAU,,Kunitz-type serine protease inhibitor mulgin-2,MSSGGLFLLLGLLTLWEVLTPVSSKDRPKFCELPPDSGSCKGSFQAFYYHPVHRTCLEFIYGGCEGNDNNFKTIDECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2306,Q6ITC1,VKTH1_PSEAU,,Kunitz-type serine protease inhibitor homolog mulgin-1,MSSGGLLLLLGLLTLWEVLTPVSSKDRPRFCELPADPGPCNGLFQAFYYNPVQRTCLKFRYGGCKGNPNTFKTIEECKRTCAA,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor homolog that only shows inhibitory activity against MMP2. {ECO:0000250}.,Serine Protease
2307,Q6IZ95,3NO24_BUNCA,,Neurotoxin Ntx4,MKTLLLTLVVVTIVCLDLGYTLTCLICPEKYCQKVHTCRDGENLCVKRFYEGKRFGKKYPRGCAATCPEAKPHEIVECCSTDKCNK,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2308,Q6T269,VKT3_BITGA,,Kunitz-type serine protease inhibitor bitisilin-3 (Two-Kunitz protease inhibitor),PLRPGTEKHTFPFPAEFCNLPADLGPCKNYTGRFYYDSASNKCEVFIYGGCPGNANNFKTREECRKTCVEICILPAELGPCDEYTGRFYYDSASNKCEVFIYGGCQGNANNFKTRDECRKTCVEICILPAELGPCDEYTGRLLLRLGIKQM,Venom Kunitz-type family,FUNCTION: Serine protease inhibitor. {ECO:0000250}.,Serine Protease
2322,Q70WS8,3NO41_BUNMU,,Neurotoxin BM10-1-like (BM10-1l),MKTLLLTLVVVTIVCLDLGYTMKCKICHFDTCRAGELKVCASGEKYCFKESWREAREVKIIRGCSSSCPEKKNVFCCSTNDCNW,"Snake three-finger toxin family, Ancestral subfamily, Orphan group IV sub-subfamily",FUNCTION: Binds and inhibits muscular and neuronal nicotinic acetylcholine receptors (nAChR). {ECO:0000250|UniProtKB:P81783}.,Neurotoxin
2333,Q75S49,VKTH4_BUNCA,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B4 chain,SSGGLLLLLGLLTLCAELIPVSSRQRHRDCDKPPDKGNCGSVRRAFYYDTRLKTCKAFPYRGCNGNGNHFKTETLCRCECLVYP,Venom Kunitz-type family,FUNCTION: Beta-2 bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and is non-toxic (By similarity). {ECO:0000250}.,Kunitz Family
2334,Q7LZ26,XI_DEIAC,,Coagulation factor X inhibitor,ATPFGGSSYEGH,,FUNCTION: Anticoagulant protein. May prevent the complex of factors Xa (F10) and factor Va (F5) from binding to phospholipid surfaces and to prothrombin (F2). Also blocks the activation of factor X (F10) by factor VIIa (F7) and tissue factor (F3) as well.,Binding Protein
2337,Q7T2I1,3S110_LATLA,,Short neurotoxin OKI-10,KTLLLTLVVVTIVCLDLGYTRRCFNQQSSEPQTNKSCPPGENSCYRKQWRDHRGTIIERGCGCPTVKPGVKLRCCESEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2338,Q7T2I3,3L2L_LATLA,,Long neurotoxin LlLong,KTLLLTLVVVTIICLDFGYTRICFKTPYVKSETCPPGQELCYTKTWCDRFCSIRGKVIELGCTATCPRAEPKEDTTCCSKDNCNPHP,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2341,Q802B2,3NO2A_NAJSP,,Weak neurotoxin 10 (Wntx-10),MKTLLLTLVVVTIVCLDLGYTLTCLNCPEVFCKKFQTCRNGEKICFKKFDERKLFGKRYRRGCAATCPEAKPREIVQCCSTDRCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2342,Q802B3,3NO28_NAJSP,,Weak neurotoxin 8 (Wntx-8),MKTLLLTLVVVTIVCLDLGYTLTCLNCPEMFCGKFQTCRNGEKICFKMLQQRRPFSLRYIRGCAATCPGTKPRDMVECCSTDRCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2343,Q8AY46,VKTHB_BUNCA,,Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B1 chain,MSSGGLLLLLGLLTLCAELTPVSSRQRHRDCDKPPDKGNCGSVRRAFYYDTRLKTCKAFPYRGCNGNGNHFKTETLCRCECLVYP,Venom Kunitz-type family,FUNCTION: Beta-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and is non-toxic (By similarity). {ECO:0000250}.,Kunitz Family
2344,Q8AY49,3NO23_BUNCA,,Weak toxin 3,MKTLLLTLVVVTIVCLDLGYTLTCLICPEKDCQKVHTCRNEEKICVKRFYDKNQLGWRAQRGCAVSCPKAKPNETVQCCSTDDCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2345,Q8AY50,3NO22_BUNCA,,Weak toxin 2,MKTLLLTLVVVAIVCLDLGYTLTCLICPEKDCQKVHTCRNEEKICVKRSYDKNQLGWRAQRGCAVSCPKAKPNETVQCCSTDKCNK,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2346,Q8AY51,3NO21_BUNCA,,Weak toxin 1,MKTLLLTLVVVAIVCLDLGYTLTCLICPEKDCQKVHTCRNEEKICVKRFYDKNQLGWRAQRGCAVSCPKAKPNETVQCCSTDKCNK,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2349,Q8AY55,3LKB_BUNCA,,Kappa 1b-bungarotoxin,MKTLLLTLVVVTIVCLDLGYTRTCLISPSSTPQTCPQGQGICFLKAQCDKFCSIRGPVIEQGCVATCPQFRSNYRSLLCCTTDNCNH,"Snake three-finger toxin family, Long-chain subfamily, Kappa-neurotoxin sub-subfamily","FUNCTION: Postsynaptic neurotoxin that binds and inhibits neuronal nicotinic acetylcholine receptors (nAChR) with high affinity (IC(50)<100 nM). Is a selective, and slowly reversible antagonist of alpha-3/CHRNA3-containing and some alpha-4/CHRNA4-containing AChRs. {ECO:0000250|UniProtKB:P01398}.",Neurotoxin
2350,Q8AY56,3LKA_BUNCA,,Kappa 1a-bungarotoxin,MKTLLLTLVVVTIVCLDLGYTRTCLISPSSTPQTCPQGQDICFLKAQCDKFCSIRGPVIEQGCVATCPQFRSNYRSLLCCTTDNCNH,"Snake three-finger toxin family, Long-chain subfamily, Kappa-neurotoxin sub-subfamily","FUNCTION: Postsynaptic neurotoxin that binds and inhibits neuronal nicotinic acetylcholine receptors (nAChR) with high affinity (IC(50)<100 nM). Is a selective, and slowly reversible antagonist of alpha-3/CHRNA3-containing and some alpha-4/CHRNA4-containing AChRs. {ECO:0000250|UniProtKB:P01398}.",Neurotoxin
2351,Q8AY75,CALGL_BOTIN,,Calglandulin,MAATLTPEQITEYKGIFEMFDEEGNGLVKTDDLESLMSLVGINPTKRDLANMAKDVDKDKKGTFNCDGFLALMGIYHEKSKNQDEELRAAFKVFDKEHKGYIEWDTLKYVLMNAGEPLNEQEAELMMKEADKDGDGTIDYEEFVAMMTGESFKLTQ,"Calmodulin family, Calglandulin subfamily",FUNCTION: May be involved in the cellular control mechanism of the secretion of toxins from the gland into the venom. {ECO:0000269|PubMed:12758151}.,General Toxin
2356,Q8UW27,3S116_HYDHA,,Short neurotoxin SN160,MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTNCAESSCYKKTWSDHRGTRIERGCGCPQVKRGIKLECCHTNECNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2357,Q8UW28,3L23_HYDHA,,Alpha-elapitoxin-Lh2a (Alpha-EPTX-Lh2a) (Long neurotoxin 3),MKTLLLTLVVVTIVCLDLGDSLSCYLGYKRSQTCPPGEKVCFVKSWCDAFCGSRGKRIEMGCAATCPTVKDGIDITCCATDNCNTYANWGSG,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2358,Q8UW29,3L21_HYDHA,,Long neurotoxin 1,MKILLLTLVVVTIVCLDLAYTRTCFRTPYKPETCPPGQNLCYKKSWCDAFCSSRGKVIELGCTAKCPTVKDGKDITCCATDNCNTVANWKSR,"Snake three-finger toxin family, Long-chain subfamily, Type II alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscular (alpha-1/CHRNA1) and neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine from binding to the receptor, thereby impairing neuromuscular and neuronal transmission. {ECO:0000250|UniProtKB:P60615}.",Neurotoxin
2359,Q90W96,VKT6_PSETT,,Kunitz-type serine protease inhibitor textilinin-6 (Txln-6),MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELPADIGPCDDFTGAFHYSPREHECIEFIYGGCKGNANNFNTQEECESTCAA,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor (By similarity). Does not inhibit plasmin, and does not reduce blood loss in the mouse tail vein blood loss model. {ECO:0000250}.",Serine Protease
2360,Q90W97,VKT5_PSETT,,Kunitz-type serine protease inhibitor textilinin-5 (Txln-5),MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELLPDTGSCEDFTGAFHYSTRDRECIEFIYGGCGGNANNFITKEECESTCAA,Venom Kunitz-type family,"FUNCTION: Serine protease inhibitor (By similarity). Does not inhibit plasmin, and does not reduce blood loss in the mouse tail vein blood loss model. {ECO:0000250}.",Serine Protease
2365,Q9DEQ3,3SO8_NAJAT,,Neurotoxin homolog NL1,MKTLLLTLVVVTMVCMDLGYTTICYNHLSRTPETTEICPDSWYFCYKISLADGNDVRIKRGCTFTCPELRPTGKYVYCCRRDKCNQ,"Snake three-finger toxin family, Short-chain subfamily, Orphan group VIII (haditoxin) sub-subfamily",FUNCTION: Antagonist of muscle and neuronal nicotinic acetylcholine receptors (nAChR) with highest affinity for neuronal alpha-7/CHRNA7 nAChRs. {ECO:0000250|UniProtKB:A8N286}.,Neurotoxin
2371,Q9PRT7,PA2H4_BOTAS,,Phospholipase A2 homolog 4 (svPLA2 homolog) (Myotoxin IV),SLVELGKMILQETGKNPVTYGAY,"Phospholipase A2 family, Group II subfamily, K49 sub-subfamily","FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic activity (PubMed:7749580). Induces acute muscle damage after intramuscular injection in mice and disrupts negatively charged liposomes but not positively charged ones (PubMed:7749580). Also exerts a weak anticoagulant effect only at concentrations of 40 ug/ml or higher (PubMed:7749580). A model of myotoxic mechanism has been proposed: an apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of the protein leading to a reorientation of a monomer (By similarity). This reorientation causes a transition between 'inactive' to 'active' states, causing alignment of C-terminal and membrane-docking sites (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in the same plane, exposed to solvent and in a symmetric position for both monomers (By similarity). The MDoS region stabilizes the toxin on membrane by the interaction of charged residues with phospholipid head groups (By similarity). Subsequently, the MDiS region destabilizes the membrane with penetration of hydrophobic residues (By similarity). This insertion causes a disorganization of the membrane, allowing an uncontrolled influx of ions (i.e. calcium and sodium), and eventually triggering irreversible intracellular alterations and cell death (By similarity). {ECO:0000250|UniProtKB:I6L8L6, ECO:0000269|PubMed:7749580}.",Phospholipase
2373,Q9PS08,3SE_DENAN,,Dendrotoxin A (DTX-A) (Fasciculin),TMCYSHTTTSRAILTNCGENSCYRKSRVHP,"Snake three-finger toxin family, Short-chain subfamily, Acn-esterase inhibitor sub-subfamily","FUNCTION: Inhibits acetylcholinesterase (By similarity). Has been described to inhibit both the slowly and the rapidly inactivating phases of potassium efflux (PubMed:1304870). {ECO:0000250|UniProtKB:P0C1Z0, ECO:0000269|PubMed:1304870}.",Phosphodiesterase
2374,Q9PS09,3SOBB_DENAN,,Dendrotoxin B (DTX-B),MICYSHKTPQPSATIGCEEKTCYKKSVRKL,"Snake three-finger toxin family, Short-chain subfamily, Orphan group XI sub-subfamily",FUNCTION: Blocks voltage-gated potassium channels (Kv). This is the slowly inactivating phase of potassium efflux which is blocked by this toxin. {ECO:0000269|PubMed:1304870}.,General Toxin
2376,Q9PTA2,IVBL_BUNMU,,Beta-bungarotoxin B chain-like (BL1),MSSGGLLLLLGLLTLCAELTPVSSKDRH,,FUNCTION: Beta-1-bungarotoxin is a presynaptic neurotoxin of the venom. The B chain is homologous to venom basic protease inhibitors but has no protease inhibitor activity and blocks voltage-gated potassium channels (Kv) (By similarity). {ECO:0000250}.,Kunitz Family
2380,Q9W727,3SO8_BUNMU,,Muscarinic toxin-like protein,MKTLLLTLAVVTMVCMDLGYTTICYNHLSRTPETTEICPDSWYFCYKISLADGNDVRIKRGCTFTCPELRPTGKYVYCCRRDKCNQ,"Snake three-finger toxin family, Short-chain subfamily, Orphan group VIII (haditoxin) sub-subfamily",FUNCTION: Antagonist of muscle and neuronal nicotinic acetylcholine receptors (nAChR) with highest affinity for neuronal alpha-7/CHRNA7 nAChRs. {ECO:0000250|UniProtKB:A8N286}.,Neurotoxin
2381,Q9W729,3LK6_BUNMU,,Kappa-6-bungarotoxin (K-6 bungarotoxin),MKTLLLSLVVVTIVCLDLGYTRTCHISTSSTPQTCPKGQDICFRKTQCDKFCSIRGAVIEQGCVATCPEFRSNYRSLLCCRTDNCNP,"Snake three-finger toxin family, Long-chain subfamily, Kappa-neurotoxin sub-subfamily","FUNCTION: Postsynaptic neurotoxin that binds and inhibits neuronal nicotinic acetylcholine receptors (nAChR) with high affinity (IC(50)<100 nM). Is a selective, and slowly reversible antagonist of alpha-3/CHRNA3-containing and some alpha-4/CHRNA4-containing AChRs. {ECO:0000250|UniProtKB:P01398}.",Neurotoxin
2382,Q9W7I3,3NO29_NAJSP,,Weak neurotoxin 9 (Wntx-9),MKTLLLTLVVVTIVCLDLGYTLTCLNCPEMFCGKFQTCRNGEKICFKMLQQRRPFSLRYIRGCAATCPGTKPRDMVECCNTDRCNR,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2383,Q9W7J9,3S34_PSETE,,Short neurotoxin 4 (SNTX4) (Alpha-neurotoxin 4),MKTLLLTLVMVTIMCLDLGYTLTCYKGYHDTVVCKPHETICYEYFIPATHGNAILARGCGTSCPGGIRPVCCRTDLSNK,"Snake three-finger toxin family, Short-chain subfamily, Type III alpha-neurotoxin sub-subfamily","FUNCTION: Binds with high affinity to muscle nicotinic acetylcholine receptor (nAChR) and hinders acetylcholine binding to the receptor, thereby impairing neuromuscular transmission. Causes muscle paralysis, spasms and increased respiration. {ECO:0000250|UniProtKB:Q9W7K2}.",Neurotoxin
2384,Q9YGC2,3S11_LATLA,,Short neurotoxin OKI-17/NCA-06,MKTLLLTLVVVTIVCLDLGYTRRCFNHPSSQPQTNKSCPPGENSCYNKQWRDHRGTIIERGCGCPTVKPGIKLTCCQSEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2385,Q9YGC4,3S13_LATLA,,Short neurotoxin OKI-01/OKI-19,MKTLLLTLVVVTIVCLDLGYTRRCFNHPSSQPQTNKSCPPGENSCYNKQWRDHRGTITERGCGCPTVKPGIKLTCCQSEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2386,Q9YGC7,3S15_LATCO,,Short neurotoxin NCA-02/NCA-05/UER-05,MKTLLLTLVVVTMVCLDLGYTRRCFNQQSSQPKTTKSCPLGENSCYNKQWRDHRGSITERGCGCPKVKPGIKLRCCESEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2388,Q9YGH9,3NO52_BUNMU,,Long neurotoxin homolog NTL2,MKTLLLSLVVVIIVCLDLGYTMQCKTCSFYTCPNSETCPDGKNICVKRSWTAVRGDGPKREIRRECAATCPPSKLGLTVFCCTTDNCYH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group V sub-subfamily","FUNCTION: Exhibits M2 muscarinic acetylcholine receptor (CHRM2)-blocking activity, but has a weak binding activity toward nicotinic AChR. Moreover, it inhibits collagen-induced platelet aggregation. {ECO:0000250|UniProtKB:Q9YGJ0}.",Binding Protein
2389,Q9YGI1,3NO23_NAJAT,,Probable weak neurotoxin NNAM3,MKTLLLTLVVVTIVCLDLGYTLTCLICPEKYCNKVHTCLNGEKICFKKYDQRKLLGKGYIRGCADTCPKLQNRDVIFCCSTDKCNL,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2390,Q9YGI2,3NO21_NAJAT,,Probable weak neurotoxin NNAM1,MKTLLLSLVVVTIVCLDLGYTLTCLICPEKYCNKVHTCLNGEKICFKKYDQRKLLGKRYIRGCADTCPVRKPREIVECCSTDKCNH,"Snake three-finger toxin family, Ancestral subfamily, Orphan group II sub-subfamily",FUNCTION: Binds with low affinity to muscular (alpha-1-beta-1-delta-epsilon/CHRNA1-CHRNB1-CHRND-CHRNE) and very low affinity to neuronal (alpha-7/CHRNA7) nicotinic acetylcholine receptor (nAChR). {ECO:0000250|UniProtKB:O42255}.,Neurotoxin
2392,Q9YGJ5,3S1A2_NAJSP,,Alpha-neurotoxin NTX-2 (NTX2),MKTLLLTLLVVTIVCLDLGYTLECHNQQSSQAPTTTGCSGGETNCYKKSWRDHRGYRIERGCGCPSVKKGIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2393,Q9YGJ6,3S1A1_NAJSP,,Alpha-neurotoxin NTX-1 (NTX1),MKTLLLTLLVVTIVCLDLGYTLECHNQQSSETPTTTGCSGGETNCYKKSWRDHRGYRIERGCGCPSVKKGIEINCCTTDRCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2394,Q9YGW8,3S14_LATLA,,Short neurotoxin VAN-29,MKTLLLTLVVVTIVCLDLGYTRRCFNQQSSEPQTNKSCPPGENSCYNKQWRDHRGTIIERGCGCPQVKSGIKLTCCQSDDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2395,Q9YGW9,3S12_LATLA,,Short neurotoxin VAN-10,MKTLLLTLVVVTIVCLDLGYTRRCFNQQSSEPQTNKSCPPGENSCYNKQWRDHRGTITERGCGCPQVKSGIKLTCCQSDDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2396,Q9YGX0,3S14_LATCO,,Short neurotoxin NCA-04,MKTLLLTLVVVTTVCLDLGYTRRCFNQQSSQPKTTKSCPLGENSCYNKQWRDHRGSITERGCGCPKVKPGIKLRCCESEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2397,Q9YGX1,3S1ED_LATSE,,Short neurotoxin OKI-Ed,MKTLLLTLVVVTIVCLDLGYTRRCFNQQSSEPQTNKSCPPGENSCYRKQWRDHRGTIIERGCGCPTVKPGIKLRCCESEDCNN,"Snake three-finger toxin family, Short-chain subfamily, Type I alpha-neurotoxin sub-subfamily","FUNCTION: Binds to muscle nicotinic acetylcholine receptor (nAChR) and inhibit acetylcholine from binding to the receptor, thereby impairing neuromuscular transmission. {ECO:0000250|UniProtKB:P60775}.",Neurotoxin
2398,T1DKS4,TCTP_CROHD,,Translationally-controlled tumor protein homolog (TCTP),MIIYRDCISQDEMFSDIYKITEVANGLCLEVEGKMVSRKEGEIDDALIGGNASAEGPEGDGTEATVITGVDIVMNHHLQETSFTKESYKKYIKDYMKSIKARLEETKPERVKPFMTGAAEQVKHILGNFKNYQFFVGENMNPDGMVGLLDFREDGVTPYMIFFKDGLEMEKC,TCTP family,"FUNCTION: Venom protein that causes edema, enhances vascular permeability and is likely related to the inflammatory activity of the venom. {ECO:0000250}.",Vascular Interaction
2399,U3EQ60,TCTP_MICFL,,Translationally-controlled tumor protein homolog (TCTP),MIIYRDCISQDEMFSDIYKITEVANGLCLEVEGKMVSRKEGEIDEALIGGNASADGPEDCTEATVITGVDIVMNHHLQETSFTKESYKKYIKDYMKSIKARLEESKPERVKPFMTGAAEQVKHILGNFKNYQFFVGENMNPDGMVGLLDFREDGVTPYMIFFKDGLEMEKC,TCTP family,"FUNCTION: Venom protein that causes edema, enhances vascular permeability and is likely related to the inflammatory activity of the venom. {ECO:0000250}.",Vascular Interaction
